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Throughout the development of civilization, plants, plant parts, and derived oils and 
extracts have functioned as sources of food and medicine, as symbolic articles in 
religious and social ceremonies, and as remedies to modify behavior. Taste and aroma 
not only determine what we eat but often allow us to evaluate the quality of food and, 
in some cases, identify unwanted contaminants. The principle of self-limitation taken 
together with the long history in the use of natural flavor complexes in food suggests 
that these substances are safe under intended conditions of use. Based on a rich history 
of use of selected plants and plant products that strongly impact the senses, it is not 
unexpected that society would bestow powers to heal, cure diseases, and spur 
desirable emotions, in an effort to improve the human condition. The perception is 
that these products are “natural” which has, in part, mitigated the public’s need to 
know whether these products work or are safe under conditions of intended use. 
Herbs and spices have been used for many centuries to improve the sensory 
characteristics and extend the shelf-life of foods. As a result, considerable research has 
been carried out on the assessment of the biological activity of many herbs, spices and 
their extracts. Overwhelming scientific data, from epidemiological studies, indicate 
that diets rich in fruit, vegetables and grains are associated with a lower risk of several 
degenerative diseases, such as cancers and cardiovascular diseases. Free radicals were 
a major interest for early physicists and radiologists and much later were found to be a 
product of normal metabolism. Today, we know well that radicals cause molecular 
transformations and gene mutations in many types of organisms. Oxidative stress is 
well-known to cause many diseases, and scientists in many different disciplines 
became more interested in natural sources which could provide active components to 
prevent or reduce its impacts on cells.  
Currently, there is a strong debate about the safety aspects of chemical preservatives 
since they are considered responsible for many carcinogenic and teratogenic attributes 
as well as residual toxicity. Plant products are also known to possess potential for food 
preservation. Oxidation of lipids, which occurs during raw material storage, 
processing, heat treatment and further storage of final products is one of the basic 
processes causing rancidity of food products, leading to their deterioration. Synthetic 
antioxidants have been used in the food industry since the 1940s, but trends in many 
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consumers tend to be suspicious of chemical additives and thus the demand for 
natural and socially more acceptable preservatives has been intensified.  
Originally added to change or improve taste, spices and herbs can also enhance shelf-
life because of their antimicrobial nature. Due to undesirable influences of oxidized 
lipids on the human organism, it seems to be essential to decrease contact with 
products of lipid oxidation in food. Plant-derived natural products are highly 
abundant; many exhibit numerous biological activities. Therefore, investigation of 
natural antioxidants has been a major research interest for the past two decades as 
many research groups and institutions have been screening plant materials for 
possible antioxidant properties. Researchers have been interested in biologically active 
compounds isolated from plant species for the elimination of pathogenic 
microorganisms because of the resistance that microorganisms have built against 
antibiotics. Essential oils and extracts obtained from many plants have recently gained 
popularity and scientific interest. Many plants have been used for different purposes, 
such as food, drugs and perfumery. In this book, we were faced with the daunting task 
of making a superior collection of experiences backed by years of combined research 
and observations. One of our goals for this edition was to make the book more accessible 
to those engaged in herbal research. To accomplish this we focused on four specific 
areas: Phytochemicals, anticancer properties, nutritional value and antioxidative 
properties. 
Iraj Rasooli 
Department of Biology 
Shahed University 







Naturally Occurring Organic Sulfur Compounds: 
An Example of a Multitasking Class of 
Phytochemicals in Anti-Cancer Research 
Claudia Cerella1, Mareike Kelkel1, Elodie Viry1, 
Mario Dicato1, Claus Jacob2 and Marc Diederich1 
1Laboratoire de Biologie Moléculaire et Cellulaire du Cancer 
2Division of Bioorganic Chemistry, School of Pharmacy, Saarland University, Saarbruecken, 
1Luxembourg 
2Germany 
1. Introduction  
Allium plants, especially garlic (Allium sativum), have been cultivated since thousands of 
years all over the world not only as spicy food but also as medicinal plant. According to 
Block, the garlic plant was for the first time referred to in an Egyptian medical papyrus 1550 
BC. In this Codex Ebers, 22 formulas of garlic were specified for the treatment of various 
disorders including heart problems, headache, bites, parasites and even tumors (Block, 
1985). Today, the therapeutic value of garlic and other Allium vegetables is confirmed by 
multiple epidemiological and experimental studies. Especially prevention of cardiovascular 
diseases has been attributed to regular garlic consumption (Galeone et al., 2009; Kris-
Etherton et al., 2002; Rahman & Lowe, 2006). Moreover, cholesterol lowering, hypoglycemic, 
immune-stimulatory, anti-microbial and even anti-cancer properties have been reported for 
garlic compounds (Agarwal, 1996; Amagase et al., 2001; Balkwill & Mantovani, 2001; Borrelli 
et al., 2007; Goncagul & Ayaz, 2010; Kalra et al., 2006). Epidemiological studies clearly show 
the correlation between moderate garlic intake and a low cancer incidence (Galeone et al., 
2006; Kim, J.Y. & Kwon, 2009; Salem et al., 2011). A case-control study conducted in the 
1980s in Italy revealed for example that people living in high-risk areas for gastric cancer 
consumed less garlic compared to people in low-risk regions where stomach and colon 
cancers were three times less frequent (Buiatti et al., 1989). The health beneficial effects of 
garlic and other Allium species make this plant family an extremely interesting research 
topic.  
2. Bioactive chemicals and formulations from Allium vegetables  
It appears that the biological activities of Allium plants are primarily attributed to organo-
sulfur compounds (OSCs) (Bianchini & Vainio, 2001; Herman-Antosiewicz et al., 2007a; 
Jacob, 2006; Kalra et al., 2006; Powolny & Singh, 2008). Garlic and other Allium plants 
contain the highest amount of sulfur compounds described for common vegetables. In 1844, 
Wertheim provided evidence that OSCs are also causing the characteristic pungent garlic 
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odor (Lanzotti, 2006; Wertheim, 1844). Other pharmacologically interesting ingredients of 
Allium vegetables, on which we will not focus here, include sapogenins, saponins and 
flavonoids, the latter being mainly present in onion (Miean & Mohamed, 2001). Allixin and 
organo-selenium compounds also contribute to some biological effects (Corzo-Martinez M., 
2007). It has been proposed that these non-sulfur compounds act together with the OSCs in 
a synergistic manner (Amagase, 2006). The composition of OSCs differs depending on the 
Allium species (Nencini et al., 2007), plant cultivation or storage conditions and processing 
methods (Verma S.K., 2008). Some OSCs are absent in the bulbs and require mechanical 
exposure like cutting, crushing or chewing to be formed. According to Verma et al., whole 
garlic bulbs contain 16 OSCs versus 23 OSCs after crushing (Verma S.K., 2008). In other 
reports 33 OSCs are reported in fresh garlic (Kalra et al., 2006). The cytoplasm of intact 
cloves contains biologically inactive -glutamylcysteine and S-alk(en)ylcysteinesulfoxides 
(S-allylcysteinesulfoxide (alliin; 85%), S-methylcysteinesulfoxides (methiin; 10%) and S-
trans-1-propenylcysteinesulfoxides (isoalliin; 5%) (Verma S.K., 2008) that serve as 
precursors of volatile thiosulfinates (Kamel A., 2000; Lanzotti, 2006). -glutamylcysteine is 
hydrolysed and oxidized to S-alk(en)ylcysteinesulfoxides, mainly alliin (Corzo-Martinez M., 
2007) or transformed into S-allylcysteine (SAC) by the action of -glutamyl transpeptidase. 
The latter reaction occurs in particular during wintering and sprouting of the garlic plant in 
order to ensure the production of sufficient alliin and isoalliin (Verma S.K., 2008). SAC can 
be oxidized to alliin (Kamel A., 2000; Lanzotti, 2006), which is then enzymatically 
transformed to diallylthiosulfinate (allicin) following the slicing of garlic cloves. This 
reaction is catalyzed by alliinase (also alliin lyase), an enzyme normally stored inside 
cytoplasmic microcompartments and released only after mechanical crushing (Weiner et al., 
2009). Allylsulfenic acid, which is produced as short-lived intermediate, undergoes a 
spontaneous condensation reaction yielding allicin together with pyruvic acid and 
ammonium. Alliinase transforms cysteinesulfoxides to thiosulfinates in less than 60 seconds. 
The conversion of alliin to allicin is particularly rapid because enzyme and substrate appear 
in equal high amounts within the cell (Verma S.K., 2008). Due to their high instability, the 
volatile thiosulfinates are degraded within 24 hours into “second generation products” like 
oil-soluble mono-, di- and triallylsulfides (DAS, DADS, DATS) as well as vinyldithiins, 
thioacroleines and ajoene (Amagase, 2006; Kamel A., 2000; Munchberg et al., 2007), which 
still possess considerable biological activities and thus possibly represent the actual active 
compounds (Freeman F., 1995; Kamel A., 2000). Figure 1 summarizes the most important 
garlic-derived OSCs and their synthesis. 
Higher polysulfides with four (DATTS) or more sulfur atoms are formed at higher 
temperatures (Lanzotti, 2006). According to data of Block reviewed by Kamel and Saleh, 
vinyldithiins are formed by dimerization of two thioacrolein molecules that arise from -
elimination of allicin whereas the generation of ajoenes is based on an initial S-thioallylation 
reaction of allicin (Block E., 1984; Kamel A., 2000). Further transformation leads to the 
formation of polysulfides that are present in multiple garlic preparations in substantial 
amounts and are comparatively stable. The most common allylsulfides are DAS, DADS, 
DATS and DATTS. Higher polysulfides up to heptasulfides are found less frequently and in 
low concentrations. Additional sulfur species can be generated from the interaction with 
intracellular thiols (cysteine, glutathione (GSH) or proteins) (Kalra et al., 2006; Weisberger & 
Pensky, 1958). Thus, S-allylmercaptocysteine (SAMC) arises from allicin whereas a similar 
reaction between DAS and cysteine gives rise to allylmercaptan (AM) (Kalra et al., 2006). 
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Fig. 1. Overview of the generation of different OSCs in garlic cloves 
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The different garlic formulations that are on the market vary significantly in their chemical 
composition. In view of clinical trials it is important to know about the components 
contained in diverse garlic preparations in order to correctly interpret the results. The most 
common garlic formulations include aqueous extract, garlic powder, garlic oil, oil macerate 
and aged garlic extract (AGE). For the aqueous extract garlic cloves are steeped in purified 
water. The primary compound in this extract is allicin (or alliin if alliinase is inactivated due 
to heating of the garlic extract). Further OSCs are allylmethylthiosulfonate, 1-
propenylallylthiosulfonate and -glutamyl-S-alkylcysteine (Verma S.K., 2008). Garlic 
powder is produced by dehydration of crushed garlic cloves followed by pulverization. 
Thus, the composition of OSCs of the obtained powder is theoretically expected to 
correspond to the raw cloves. Nevertheless, the content of alliin (the major sulfur compound 
in raw and powdered garlic) and allicin varies considerably. Even if alliinase activity is 
comparable to fresh garlic, more than half of the alliin is lost during the dehydration 
process. Allicin is high in fresh garlic cloves, whereas the dehydrated powder is almost free 
of allicin, which might be explained by its instability (Amagase et al., 2001). Two types of 
garlic oil are generally synthesized: steam distilled oil or oil macerate. Garlic oil prepared by 
steam distillation of whole garlic cloves, ground in water, is completely free of hydrophilic 
OSCs and allicin (Amagase et al., 2001). According to Verma et al. it contains 57% 
diallylsulfides (DADS 26%, DATS 19%, DATTS 8% and lower concentrations of penta- and 
hexasulfides) in addition to 37% allylmethyl- and 6% dimethyl mono- to hexasulfides 
(Verma S.K., 2008). The available oil macerate products, consisting of mixtures of chopped 
garlic cloves homogenized and macerated in vegetable oil, are rich in allicin-derived OSCs 
including vinyldithiins, ajoenes and sulfides (Staba et al., 2001). Higher concentrations of 
dithiins and ajoenes are present in essential oil obtained by garlic extracted in organic 
solvents (Verma S.K., 2008). Another garlic preparation frequently used in in vivo studies or 
clinical trials is AGE. In contrast to aqueous extract, this extract prepared from sliced garlic 
cloves is aged for up to 20 months in a 15-20% ethanol solution. This aging process leads to a 
massive loss of allicin whereas water-soluble compounds like SAC and SAMC, which are 
odorless and stable, are enriched. AGE further contains some amounts of oil-soluble OSCs 
(Amagase et al., 2001).  
3. Chemical properties of OSCs 
3.1 Relevance of sulfur atoms for the reactivity of OSCs 
The complex chemistry of garlic is believed to confer the plant anti-microbial activity as self-
defense mechanism (Schneider, T.  et al., 2011b). Chemical properties of the various OSCs 
strongly rely on the presence of highly reactive sulfur atoms, which exert multiple reactions 
including nucleophilic substitutions or redox reactions (Jacob, 2006; Munchberg et al., 2007). 
In line with the importance of sulfur, recent reports provided evidence that the biological 
activity of polysulfides directly correlates with their number of sulfur atoms, even if this 
relationship is not linear (Anwar et al., 2008). Thus, we found DATTS being the most active 
diallylsulfide in inducing apoptosis in U937 lymphoma cells, followed by DATS, whereas 
DAS and DADS instead were rather inactive (Cerella et al., 2009). Similarly, DATTS showed 
the highest antibiotic activity against Staphylococcus aureus (Tsao & Yin, 2001). The general 
trend seems to be that DAS is hardly active, DADS shows some activity, which is strongly 
increased in polysulfides with three or four sulfur atoms. Instead, five or more sulfur atoms 
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do not improve the reactivity of polysulfides significantly and the pentasulfide had for 
example effects on yeast comparable to DATTS (Jirousek L., 1956). Munchberg et al. explain 
these differences as follows. DADS is more active than DAS due to its oxidizing activity and 
the ability to generate thiols. The strong gain of activity of DAT(T)S might result from their 
reaction products, e.g. perthiols (RSSH). Even if perthiol formation is elevated for 
polysufides with four to six sulfur atoms, no further improvement of activity can be 
observed for the penta- and hexasulfides because of their declined stability (Munchberg et 
al., 2007). 
3.2 Interaction with intracellular thiols 
The most remarkable property of OSCs, especially reported for allicin and to some lesser 
extent for allylsulfides, is their reactivity towards intracellular thiols such as cysteine, GSH 
or proteins (Kalra et al., 2006; Weisberger & Pensky, 1958). These thiolation reactions give 
not only rise to the formation of further sulfur species, as mentioned above. More crucially, 
they lead to the inactivation of the affected proteins/enzymes (Weisberger & Pensky, 1958) 
and thus importantly interfere with cellular functions. Allicin is known to interact rapidly 
with thiol groups leading to the formation of S-allyl derivatives. Thus, the antibiotic activity 
of allicin has been suggested to be a consequence of its interaction with cysteine residues of 
different peptides and proteins of the target cell finally inducing cell death (Munchberg et 
al., 2007). Rabinkov et al. studied the chemical interaction between allicin and L-cysteine (as 
-SH carrier) and identified SAMC as the reaction product via RP-HPLC and subsequent 1H 
and 13C NMR analysis (Rabinkov et al., 1998). They further investigated the interaction of 
allicin with thiol-containing enzymes and found a very rapid inactivation of papain and two 
alcohol dehydrogenases, from which NAD+-dependent alcohol dehydrogenase from horse 
liver was even irreversibly inactivated (Rabinkov et al., 1998).  
An exchange reaction between a thiol (R’SH) and a polysulfide (RSxR) will lead to the 
formation of a mixed sulfide (RSxR’) and a perthiol (RSSH) or other RSxH species 
(Munchberg et al., 2007). In the case of a tetrasulfide, two possible sites for a nucleophilic 
attack exist (at the central or the two terminal S-S bonds). Even if the formation of a 
trisulfide and perthiol seems to be the favored reaction, one cannot exclude that in addition 
disulfide (RSSR’) and hydrogentrisulfide (RSSSH) generation takes place (Munchberg et al., 
2007). For DATS, it is well documented that it targets specific cysteine residues within 
tubulin monomers (Hosono et al., 2008) thereby modulating tubulin conformation (Jordan et 
al., 1998) and consequently disturbing the microtubule (MT) network (Hosono et al., 2008). 
Hosono et al. suggested a mechanism by which DATS activates a thiol-disulfide exchange 
reaction through directly interacting with the thiol moiety of the cysteines C12 and C354 of 
-tubulin. Finally, DATS binds covalently to tubulin via formation of SAMC-modifications 
(Hosono et al., 2005). A similar mode of action has also been reported for SAMC (Xiao et al., 
2003). Li et al. likewise described an inhibitory effect of Z-ajoene on tubulin polymerization 
in vitro (Arora & Shukla, 2002). As it has been demonstrated that ajoene induces a rapid 
decrease of GSH (Scharfenberg et al., 1994), one may speculate that this OSC acts in a similar 
manner by directly targeting thiols. Such thiolation reactions on tubulin affect the formation 
of normal spindle microtubules during mitosis and thus trigger the induction of a cell cycle 
arrest (see Section 5.2). Accordingly, many studies showed that N-acetyl-cysteine (NAC), 
which is commonly used as antioxidant, counteracted the biological effects of OSCs (Wu, 
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X.J. et al., 2009; Xiao et al., 2005) (see Sections 5.2 and 5.5.3). The ability of NAC to increase 
the intracellular thiol pool has to be considered, which might quench the OSCs and thus 
prevent their interaction with thiol groups of potential target molecules. It is worth to 
mention that RSxH species arising from these thiolation reactions of polysulfides might also 
contribute to their biological activity as these hydrothiols are highly reactive and can for 
example act by reactive oxygen species (ROS) generation and as ligands for transition metal 
ions (Munchberg et al., 2007). Additional possible biochemical reactions related to 
polysulfides are reviewed by Munchberg 2007 in detail and include homolytic S-S cleavage, 
Sx transfer reactions and hydrophobic interactions with membranes and proteins 
(Munchberg et al., 2007). Antioxidant effects and metal binding ability are two further 
properties of OSCs that significantly contribute to their chemopreventive and 
chemotherapeutic activity and will be therefore discussed later on (see Section 5.3). 
4. Chemopreventive/-therapeutic potentials of Allium-derived OSCs  
4.1 Chemoprevention  
4.1.1 Epidemiological studies 
The endemic abundance of the Allium species contributes to their worldwide consumption 
and availability. The procedures to extract active natural occurring molecules or to 
synthetize them de novo in large amounts require relative low cost. Besides, the millenary 
use of these plants for dietary purposes ensures that the derived active natural compounds 
possess low or null systemic toxicity. All these considerations make the clinical exploitation 
of such derivatives/extracts of these plants an attractive and favorable strategy for 
chemopreventive and therapeutic purposes. Under this view, many epidemiological studies 
have been first conducted to scientifically validate the multi-beneficial effects on health 
(Scherer et al., 2010). Several interesting reviews give a critical overview of epidemiological 
studies examining correlations between the intake of Allium derivatives, in form of 
vegetables or supplements, and the chemoprotection from cardiovascular diseases, diabetes, 
cholesterol level alterations, gallstone formation and specific chronic inflammatory diseases. 
Here, we focus our attention on the studies dealing with the potential anti-cancer properties 
of Allium derivatives, taking into account the current lack of anti-cancer chemopreventive 
agents, on one hand, and the continuous demand of new targeted anti-cancer therapeutics, 
on the other hand.  
From various case-control studies, it emerges that cancers affecting the digestive tract and 
the prostate appear as the most impacted ones. A number of studies investigated any 
inverse correlations between the consumption of Allium species and the incidence of cancers 
affecting the esophageal and stomach tract. These studies have been performed on 
geographical areas located in different continents as in Asia (China (Takezaki et al., 1999; 
You et al., 1989) and Japan (Gao et al., 1999)), Europe (Italy (Pelucchi et al., 2009) and 
Netherlands (Dorant et al., 1996)), or America (Venezuela (Munoz et al., 2001), Uruguay (De 
Stefani et al., 2001) and Hawaii (Hirohata & Kono, 1997)). Overall, a protective effect was 
reported, despite the obvious genetic variance existing among the populations examined in 
the different studies. Similarly, a reduced cancer risk has been widely documented in the 
instance of colorectal and prostate (Galeone et al., 2006; Hsing et al., 2002) (Fleischauer et al., 
2000) forms of cancer. A limited number of studies explored the impact of a regular intake of 
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Allium vegetable on the incidence of cancers affecting breast, endometrium and lungs 
(Challier et al., 1998; Galeone et al., 2009; Satia et al., 2009). In many instances, inverse 
correlations have been also reported. Remarkably, amongst the human malignancies, 
gastric, colorectal and prostate cancers are the best characterized and documented ones for 
their multiple pre-neoplastic stages. This aspect provides additional tools to evaluate the 
impact of natural occurring compounds specifically on tumor progression. Accordingly, a 
regular consumption of garlic has been associated with the reduction in the incidence of pre-
neoplastic lesions occurring in the gastric mucosa of individuals infected by Helicobacter 
pylori (You et al., 1998). In parallel, studies analyzing the preventive effect of garlic extracts 
on colorectal cancer have evidenced their suppressive potential on the development and 
progression of colorectal adenomas (Tanaka et al., 2004; Tanaka et al., 2006). A population-
based study analyzing the impact of a diet rich in Allium vegetables on the incidence of 
prostate cancer showed that the anti-cancer effects were more pronounced in men 
presenting localized rather than advanced forms (Hsing et al., 2002), thus implying major 
effects of Allium derivatives on pre-neoplastic steps.  
The many published epidemiological studies seem to encourage large-scale and long-term 
clinical trials with Allium derivatives. Meta-analyses, however, have not always supported 
the same conclusions. A representative example is a study published in 2009 (Kim, J.Y. & 
Kwon, 2009) and evaluating the impact of garlic intake on the risk of different forms of 
cancer. The study consisted in a critical systematic review of the publications appearing in 
Medline and EMBASE databases in the period 1955-2007 and matching some selected 
keywords. The criterion adopted for the selection of the studies to be considered as relevant 
was the satisfaction of the US Food and Drug Administration’s evidence-based review 
system for scientific evaluation of health claim (http://www.fda.gov/Food/Guidance 
ComplianceRegulatoryInformation/GuidanceDocuments/FoodLabelingNutrition/ucm073
332.htm). The conclusions pointed out the lack of evidence that may support an actual 
chemopreventive effect of garlic. Other critical reviews of epidemiological studies remark 
moderate evidence (Fleischauer & Arab, 2001). Overall, these investigations highlight all the 
limits frequently affecting epidemiological studies. Most of all, the bias due to the interview 
system frequently adopted to screen the population, which does not provide rigorous 
information about the actual amount of product/s intaken; the deep heterogeneity in the 
form of administration/consumption of the vegetable of interest (as food or as supplement; 
if as food, cooked or raw or in form of extract). Therefore, these contradictory analyses 
prompt to select further diversified approaches to validate the anti-cancer effects of Allium 
species.  
4.1.2 Experimental studies 
In this view, an important point is the in vivo experimental investigation of the effects of Allium 
vegetables. Mainly based on murine models, similar studies permit to gain detailed insights. 
First of all, it is possible to select and test specific purified compounds deriving from the Allium 
species and by this way to identify the most active natural occurring compounds. Second, we 
have at our disposal several in vivo models to mimic tumor progression or to evaluate the 
therapeutic impact on different transplanted cancers. Their exploitation is a fundamental part 
in the assessment of the mechanisms implicated in the anti-cancer effects and in the 
establishment of the efficaciousness of new anti-cancer agents as well.  
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Many lines of evidence show an ability of garlic extracts to prevent pre-neoplastic lesions of 
the gastrointestinal tract. Azoxymethane is a carcinogenic agent that induces the 
development of precancerous lesions in the colon consisting of aberrant crypt foci (ACF). 
The regular administration of garlic extracts to rats exposed to this tumor promoter is able 
to reduce the size and the number of ACF (Sengupta et al., 2003, 2004b). The 
chemopreventive effects are associated with an attenuation of early pre-neoplastic events 
(i.e., the expression of cyclooxygenase 2 (Sengupta et al., 2004a); and a reduction in lipid 
peroxidation (Sengupta et al., 2003). Moreover, the histological analysis suggested the 
triggering of apoptosis (Sengupta et al., 2004b). Similar evidence has been accumulated in 
experimental in vivo models of oropharyngeal, gastric and skin carcinogenesis (Arora & 
Shukla, 2002; Balasenthil et al., 2002; Bhuvaneswari et al., 2004; Kalra et al., 2006; Prasad et 
al., 2008; Tanaka et al., 2004; Velmurugan et al., 2005). Garlic extracts or purified OSCs 
generally lead to the expression of markers of apoptosis and the reduction of the pre-
neoplastic lesions. A similar pattern of modulations has been frequently reconfirmed in the 
instance of xenograft mice models of hepatocellular carcinoma (Zhang, Z.M. et al., 2007) and 
refractory forms of prostate cancer (Howard et al., 2008; Singh et al., 2008). 
4.2 Therapeutic implications  
Garlic extracts and isolated OSCs manifest a direct cytocidal activity. This point will be 
discussed in further detail in section 5.5. Here, we focus our attention on the chemoadjuvant 
properties of Allium derivatives. Preclinical studies have demonstrated the ability of garlic 
to modulate carcinogen metabolism, suggesting that its consumption could also influence 
drug intake. Interactions between garlic and drugs have been well described such as in the 
case of AIDS medication (e.g. interaction with saquinavir and darunavir metabolism) 
(Borrelli et al., 2007). Some pieces of evidence underline the ability of OSCs to 
chemosensitize cancer cells to chemotherapeutic treatment by modulation of cytochrome 
P450 isoforms. This, in turn, affects the pharmacokinetics of the corresponding drugs (see 
sections 6). Allium derived compounds have been reported to counteract the nuclear factor 
B (NF-B), which is frequently implicated in the resistance of cancer cells to 
chemotherapeutics. The modulation of both cellular targets may be implicated in the 
chemosensitization to the same treatment. Studies on docetaxel, a chemotherapeutic 
administrated to patients affected by hormonal or colon cancers, show that both 
mechanisms may be implicated in the ability of OSCs to modulate its activity (Ban et al., 
2009; Cox et al., 2006; Howard et al., 2008). Cox et al., however, have shown that co-
administration of garlic and docetaxel did not significantly affect the drug disposition in 
breast cancer patients but a reduction of its clearance in specific cases cannot be excluded 
(Cox et al., 2006). Besides, two studies have shown that powder and AGE feeding to rats 
was able to prevent nephrotoxic and cardiotoxic side effects of both cisplatin and 
doxorubicin, two chemotherapeutic agents successfully used in cancer therapy (Alkreathy et 
al., 2010; Razo-Rodriguez et al., 2008). However, further investigations are needed to 
evaluate the actual potential interaction between garlic and chemotherapeutic agents. In 
addition, data suggested that immune-enhancing activity of garlic could take part in its anti-
tumor effect. Indeed, garlic, and especially AGE, presented similar effectiveness to 
immunotherapy with bacillus Calmette-Guérin in transplanted bladder tumor mice. Garlic 
is able to promote the Th1 immune response by stimulating proliferation and tumor site 
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infiltration of macrophages and lymphocytes, increasing natural killers activity and 
enhancing the release of cytokines (e.g., IL-2, TNF-, INF-) (Lamm & Riggs, 2001).   
5. Mechanisms of chemopreventive/-therapeutic activities of Allium-derived 
OSCs  
5.1 Modulation of detoxification of xenobiotics 
5.1.1 Modulation of the metabolism of carcinogens 
The effectiveness of a chemopreventive compound can be evaluated by its ability to 
interfere with different stages of carcinogenesis: initiation, promotion and progression 
(Surh, 2003). It was found that garlic and some of its constituents prevent tumor initiation by 
inhibiting the activation of pro-carcinogens and by stimulating their elimination (for recent 
reviews, see (Herman-Antosiewicz et al., 2007a; Iciek et al., 2009; Melino et al., 2011)). 
Indeed, the metabolizing-process of carcinogens comprises two phases: bioactivation and 
detoxification. The pro-carcinogens are activated by phase I enzymes through different 
types of reactions such as oxidation, hydroxylation, hydrolysis, cyclization. These reactions 
are generally catalyzed by the superfamily of cytochrome P450-dependent monooxygenases 
(CYP450). In the second step, the reactive carcinogens obtained are inactivated by phase II 
enzymes (e.g., glutathione S-transferases, glutathione peroxidases, UDP-glucuronyl 
transferases, quinone reductases). These detoxication reactions require the conjugation with 
endogenous substrates (e.g. glucuronic acid, glutathione, sulfate) to enable the excretion of 
inactive products (Sheweita & Tilmisany, 2003).  
Several studies have contributed to elucidate the mechanisms by which garlic prevents 
chemical-induced cancer in animal models. Opposite effects have been reported on the 
modulation of CYP450 family members, both up- and downregulation depending on the 
isoenzymes. CYP450 2E1, which is responsible for the activation of small polar molecules 
such as acetaminophens, benzene and nitrosamines, is the isoenzyme most frequently 
reported to be induced by garlic. For example, dietary intake of garlic oil or powder leads to 
the inhibition of the hepatic microsomal CYP450 2E1 activity in mouse and rat, respectively 
(Park et al., 2002; Zeng et al., 2009). Moreover, garlic constituents, especially DAS and 
allylmethylsulfide (AMS), are effective in reducing the hepatic CYP450 2E1 protein level and 
activity (Davenport & Wargovich, 2005; Wargovich, 2006). Brady et al. have investigated the 
mechanisms of action of DAS and showed that this compound could directly act as a 
competitive inhibitor of CYP450 2E1 enzyme (Brady et al., 1988). Moreover, DAS could act 
indirectly through the formation of the oxidized products, diallylsulfoxide (DASO) and 
subsequently diallylsulfone (DASO2), by CYP450 2E1 itself leading to the autocatalytic 
destruction of the enzyme (Brady et al., 1991; Jin & Baillie, 1997). Other CYP450 isoenzymes 
were modulated after garlic treatment. As example, DADS and DATS increased the transcript 
and the protein levels of CYP450 1A1/2, 2B1 and 2E1 in rats (Wu, C.C. et al., 2002). Other 
CYP450 isoenzymes seem to be implicated such as CYP450 2B1/2, 2B6, 2B10 and 3A11 
(Davenport & Wargovich, 2005). Indeed, DAS is able to activate the constitutive androstane 
receptor (CAR), which is known to regulate the expression of those ones (Fisher et al., 2007; 
Sueyoshi et al., 2011). A consisting body of evidence was obtained through animal survey 
model but recently Ho et al. have confirmed the inhibitory effect of garlic on CYP450-
metabolism in Fa2N-4 human hepatocytes. Exposure to garlic extract reduced the expression 
and the activity of CYP450 2C9 but exerted no effect on CYP450 3A4 (Ho et al., 2010). 
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The induction of phase II enzymes of the carcinogen metabolism by garlic was clearly 
described. Especially, many studies have reported that garlic treatment enhanced 
glutathione S-transferase (GSTs) activities. GSTs are important detoxifying enzymes, which 
stimulate the clearance of reactive compounds by conjugation with GSH. The group of 
Singh has shown that the chemopreventive effect of DADS, against benzo[a]pyrene-induced 
forestomach cancer in mice, was mainly mediated through the induction of the pi class 
mGSTP1-1 in liver and forestomach (Bose et al., 2002; Hu et al., 1996). However, different 
isoenzyme profiles could be obtained according to the target tissue considered. Thus, DADS 
administration can also upregulate the alpha and mu (mGSTM1, mGSTM4) classes in 
stomach and small intestine of mice fed with this compound whereas liver and colon GSTs 
were modulated to a lesser extent (Andorfer et al., 2004). More recently, Tsai and colleagues 
have shown that the induction of GSTPs at mRNA and protein levels in Clone 9 cells treated 
by DADS or DATS was dependent on JNK-AP-1 and ERK-AP-1 signaling pathways (Tsai et 
al., 2007; Tsai et al., 2005). In addition to GSTs upregulation, a study performed by Fukao et 
al. has shown that intraperitoneal administration of DADS and DATS in rats led to an 
increase of hepatic quinone reductase activity (Fukao et al., 2004). In 2004, Chen and 
coworkers have suggested that the activation of the antioxidant response element (ARE) and 
the increased level of the transcription nuclear E2-related factor 2 (Nrf2) were correlated 
with the induction of the detoxifying enzymes NAD(P)H :quinone oxidoreductase 1 (NQO1) 
and heme oxygenase 1 (HO1) in human hepatoma HepG2 cells treated with DAS, DADS or 
DATS (Chen, C. et al., 2004). The implication of Nrf2 in garlic chemopreventive effects has 
recently been confirmed (Fisher et al., 2007). 
Finally, data concerning the modulation of phase II enzymes such as GSH peroxidase (GPX), 
superoxide dismutase (SOD), catalase, N-acetyltransferase are more disputed. For example, 
Singh et al. have reported that DATS induces GPX activity in the lung of A/J mice (Singh et 
al., 1997). Conversely, Chen et al. failed to show that DADS treatment modulates GPX or 
SOD activities (Chen, L. et al., 1999).  
5.1.2 Modulation of the efflux of carcinogens  
In addition to the modulation of carcinogen metabolism, OSCs can also influence the 
activity of transporters such as P-glycoprotein (P-gp), which allow the efflux of xenobiotics 
from the cells. This activity is particularly interesting to improve the cancer response to 
chemotherapies in the case of multidrug resistance phenotypes. Indeed, the treatment of 
leukemia K562 cells resistant to vinblastine (K562R) with a non-cytotoxic dose of DAS 
enhanced the cytotoxic activity of vinblastine as well as other Vinca alkaloids. The authors 
showed that DAS reduced the protein level of P-gp in K562R cells at a level comparable to 
non-resistant K562 (Arora et al., 2004). Such beneficial effect was also described for ajoene 
which improves the chemotherapy-induced apoptosis of cytarabine and fludarabine in 
human acute myeloid leukemia cells (Hassan, 2004). 
5.2 Cell cycle arrest 
One fundamental feature of carcinogenesis is the uncontrolled proliferation of tumor cells. 
Under physiological conditions, cell cycle regulation involves sophisticated control systems to 
ensure the precise sequence of the different phases and to obtain two identical daughter cells 
(Vermeulen et al., 2003). Cell cycle progression occurs mainly by the sequential action of 
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cyclin-dependent kinases (Cdks). Cdks are positively regulated by interaction with their 
regulatory subunits cyclins. On the contrary, association with specific inhibitors (e.g., p21, p27, 
p57) negatively regulates their activities. Moreover, phosphorylation-dephosphorylation 
events are implicated. Thus, cell division cycle 25 (CDC25) phosphatases act as negative 
regulators by phosphorylating specific tyrosine and threonine residues on Cdks.  
Cell cycle arrest is triggered in response to cellular stress such as DNA damage or MT 
network alterations through the activation of the cell cycle checkpoints (Sancar et al., 2004). 
The G1/S checkpoint prevents the replication of damaged DNA whereas in G2/M it avoids 
the cell to trigger mitosis until the replication is correctly achieved. The activation of these 
checkpoints involves several signaling pathways such as p53, p38 MAPK, ataxia 
telangiectasia mutated (ATM)/ATM and Rad3-related (ATR) and checkpoint kinase 
(Chk)1/2.  
Many studies have reported antiproliferative effects of garlic and OSCs in various cancer 
cell models, generally through the induction of cell cycle arrest in G2/M phase. In 
particular, detailed studies have been done on neuroblastoma (SH-SY5Y), prostate (PC-3, 
DU145) and colon (SW480) cancer cells (for a recent review see (Scherer et al., 2009)). The 
group of Milner was one of the first to highlight the importance of the modulation of Cdk1 
activity in OSCs-induced cell cycle arrest. They have shown that DADS treatment of human 
colon HCT-115 cells led to G2/M phase arrest by suppressing Cdk1 activity (Knowles & 
Milner, 1998). DADS increased the expression of cyclin B1 but reduced the formation of the 
active cyclin B1/Cdk1 complex. The authors also reported the presence of inactive 
hyperphosphorylation of Cdk1, which seems to be related to the downregulation of 
CDC25C phosphatase (Knowles & Milner, 2000). Singh’s team has extensively studied the 
molecular mechanisms involved the inhibition of CDC25C activity. On one hand, they have 
demonstrated that this inactivation was dependent on the phosphorylation of the serine 
residue S216 CDC25C, which is recognized as a binding site for the cytoplasmic protein 14-
3-3 (Xiao et al., 2005). The activation of ATM/ATR and p38 MAPK signaling pathways, 
leading to Chk1 activation, were clearly involved in this process (Herman-Antosiewicz & 
Singh, 2005; Xiao et al., 2009b; Yuan et al., 2004). Indeed, Chk1 or ATR protein knockdown 
markedly attenuated the DATS-induced cell cycle arrest features in PC3 cells (Herman-
Antosiewicz et al., 2007b). However, no clear evidence was provided about the importance 
of p53 status in ATM/ATR and Chk1/2 signaling pathway activation (Jo et al., 2008; Wang, 
H.C. et al., 2010a; Xiao et al., 2009b). On the other hand, Xiao and colleagues have reported a 
ROS-dependent destruction of CDC25C, which occurred independently of its 
phosphorylation. Implication of ROS generation, such as superoxide (O2•-) and hydrogen 
peroxide (H2O2), was confirmed by pretreatment in the presence of the antioxidant NAC, 
which significantly reduced the oxidation and the degradation of CDC25C in DU145 cells 
treated with DATS (Xiao et al., 2005). However, a recent study of the same group challenged 
the role played by CDC25C in the antiproliferative effect of DATS. Indeed, ectopic 
expression of CDC25C or the presence of its redox-insensitive mutant in DU145 cells failed 
to confer protection against DATS-induced G2/M phase arrest. This effect seems to be 
mainly related to differential kinetics of nuclear translocation between Cdk1 and cyclin B1 
(Herman-Antosiewicz et al., 2010). Finally, a recent report suggested that both diallyl- and 
dipropyltetrasulfides (DPTTS) could act as irreversible inhibitors of CDC25C (IC50 about 
1M) (Viry et al., 2011). 
 
Phytochemicals – Bioactivities and Impact on Health 
 
12
The induction of phase II enzymes of the carcinogen metabolism by garlic was clearly 
described. Especially, many studies have reported that garlic treatment enhanced 
glutathione S-transferase (GSTs) activities. GSTs are important detoxifying enzymes, which 
stimulate the clearance of reactive compounds by conjugation with GSH. The group of 
Singh has shown that the chemopreventive effect of DADS, against benzo[a]pyrene-induced 
forestomach cancer in mice, was mainly mediated through the induction of the pi class 
mGSTP1-1 in liver and forestomach (Bose et al., 2002; Hu et al., 1996). However, different 
isoenzyme profiles could be obtained according to the target tissue considered. Thus, DADS 
administration can also upregulate the alpha and mu (mGSTM1, mGSTM4) classes in 
stomach and small intestine of mice fed with this compound whereas liver and colon GSTs 
were modulated to a lesser extent (Andorfer et al., 2004). More recently, Tsai and colleagues 
have shown that the induction of GSTPs at mRNA and protein levels in Clone 9 cells treated 
by DADS or DATS was dependent on JNK-AP-1 and ERK-AP-1 signaling pathways (Tsai et 
al., 2007; Tsai et al., 2005). In addition to GSTs upregulation, a study performed by Fukao et 
al. has shown that intraperitoneal administration of DADS and DATS in rats led to an 
increase of hepatic quinone reductase activity (Fukao et al., 2004). In 2004, Chen and 
coworkers have suggested that the activation of the antioxidant response element (ARE) and 
the increased level of the transcription nuclear E2-related factor 2 (Nrf2) were correlated 
with the induction of the detoxifying enzymes NAD(P)H :quinone oxidoreductase 1 (NQO1) 
and heme oxygenase 1 (HO1) in human hepatoma HepG2 cells treated with DAS, DADS or 
DATS (Chen, C. et al., 2004). The implication of Nrf2 in garlic chemopreventive effects has 
recently been confirmed (Fisher et al., 2007). 
Finally, data concerning the modulation of phase II enzymes such as GSH peroxidase (GPX), 
superoxide dismutase (SOD), catalase, N-acetyltransferase are more disputed. For example, 
Singh et al. have reported that DATS induces GPX activity in the lung of A/J mice (Singh et 
al., 1997). Conversely, Chen et al. failed to show that DADS treatment modulates GPX or 
SOD activities (Chen, L. et al., 1999).  
5.1.2 Modulation of the efflux of carcinogens  
In addition to the modulation of carcinogen metabolism, OSCs can also influence the 
activity of transporters such as P-glycoprotein (P-gp), which allow the efflux of xenobiotics 
from the cells. This activity is particularly interesting to improve the cancer response to 
chemotherapies in the case of multidrug resistance phenotypes. Indeed, the treatment of 
leukemia K562 cells resistant to vinblastine (K562R) with a non-cytotoxic dose of DAS 
enhanced the cytotoxic activity of vinblastine as well as other Vinca alkaloids. The authors 
showed that DAS reduced the protein level of P-gp in K562R cells at a level comparable to 
non-resistant K562 (Arora et al., 2004). Such beneficial effect was also described for ajoene 
which improves the chemotherapy-induced apoptosis of cytarabine and fludarabine in 
human acute myeloid leukemia cells (Hassan, 2004). 
5.2 Cell cycle arrest 
One fundamental feature of carcinogenesis is the uncontrolled proliferation of tumor cells. 
Under physiological conditions, cell cycle regulation involves sophisticated control systems to 
ensure the precise sequence of the different phases and to obtain two identical daughter cells 
(Vermeulen et al., 2003). Cell cycle progression occurs mainly by the sequential action of 
Naturally Occurring Organic Sulfur Compounds: 
An Example of a Multitasking Class of Phytochemicals in Anti-Cancer Research 
 
13 
cyclin-dependent kinases (Cdks). Cdks are positively regulated by interaction with their 
regulatory subunits cyclins. On the contrary, association with specific inhibitors (e.g., p21, p27, 
p57) negatively regulates their activities. Moreover, phosphorylation-dephosphorylation 
events are implicated. Thus, cell division cycle 25 (CDC25) phosphatases act as negative 
regulators by phosphorylating specific tyrosine and threonine residues on Cdks.  
Cell cycle arrest is triggered in response to cellular stress such as DNA damage or MT 
network alterations through the activation of the cell cycle checkpoints (Sancar et al., 2004). 
The G1/S checkpoint prevents the replication of damaged DNA whereas in G2/M it avoids 
the cell to trigger mitosis until the replication is correctly achieved. The activation of these 
checkpoints involves several signaling pathways such as p53, p38 MAPK, ataxia 
telangiectasia mutated (ATM)/ATM and Rad3-related (ATR) and checkpoint kinase 
(Chk)1/2.  
Many studies have reported antiproliferative effects of garlic and OSCs in various cancer 
cell models, generally through the induction of cell cycle arrest in G2/M phase. In 
particular, detailed studies have been done on neuroblastoma (SH-SY5Y), prostate (PC-3, 
DU145) and colon (SW480) cancer cells (for a recent review see (Scherer et al., 2009)). The 
group of Milner was one of the first to highlight the importance of the modulation of Cdk1 
activity in OSCs-induced cell cycle arrest. They have shown that DADS treatment of human 
colon HCT-115 cells led to G2/M phase arrest by suppressing Cdk1 activity (Knowles & 
Milner, 1998). DADS increased the expression of cyclin B1 but reduced the formation of the 
active cyclin B1/Cdk1 complex. The authors also reported the presence of inactive 
hyperphosphorylation of Cdk1, which seems to be related to the downregulation of 
CDC25C phosphatase (Knowles & Milner, 2000). Singh’s team has extensively studied the 
molecular mechanisms involved the inhibition of CDC25C activity. On one hand, they have 
demonstrated that this inactivation was dependent on the phosphorylation of the serine 
residue S216 CDC25C, which is recognized as a binding site for the cytoplasmic protein 14-
3-3 (Xiao et al., 2005). The activation of ATM/ATR and p38 MAPK signaling pathways, 
leading to Chk1 activation, were clearly involved in this process (Herman-Antosiewicz & 
Singh, 2005; Xiao et al., 2009b; Yuan et al., 2004). Indeed, Chk1 or ATR protein knockdown 
markedly attenuated the DATS-induced cell cycle arrest features in PC3 cells (Herman-
Antosiewicz et al., 2007b). However, no clear evidence was provided about the importance 
of p53 status in ATM/ATR and Chk1/2 signaling pathway activation (Jo et al., 2008; Wang, 
H.C. et al., 2010a; Xiao et al., 2009b). On the other hand, Xiao and colleagues have reported a 
ROS-dependent destruction of CDC25C, which occurred independently of its 
phosphorylation. Implication of ROS generation, such as superoxide (O2•-) and hydrogen 
peroxide (H2O2), was confirmed by pretreatment in the presence of the antioxidant NAC, 
which significantly reduced the oxidation and the degradation of CDC25C in DU145 cells 
treated with DATS (Xiao et al., 2005). However, a recent study of the same group challenged 
the role played by CDC25C in the antiproliferative effect of DATS. Indeed, ectopic 
expression of CDC25C or the presence of its redox-insensitive mutant in DU145 cells failed 
to confer protection against DATS-induced G2/M phase arrest. This effect seems to be 
mainly related to differential kinetics of nuclear translocation between Cdk1 and cyclin B1 
(Herman-Antosiewicz et al., 2010). Finally, a recent report suggested that both diallyl- and 
dipropyltetrasulfides (DPTTS) could act as irreversible inhibitors of CDC25C (IC50 about 
1M) (Viry et al., 2011). 
 
Phytochemicals – Bioactivities and Impact on Health 
 
14
Other mechanisms of action involved in OSCs-mediated cell cycle arrest have also been 
identified. In particular, Hosono et al. have demonstrated, through the use of an in vitro cell-
free model, that DATS inhibited tubulin polymerization. Mass spectrometry analysis has 
demonstrated that DATS induced the oxidation of two cysteine residues in the -tubulin 
(C12 and C354) (Hosono et al., 2005). These results were confirmed in another study by the 
use of reducing agent (2-mercaptoethanol and dithiothreitol), which abolished the MT-
disrupting activity of allicin (Prager-Khoutorsky et al., 2007). In addition, it was also 
reported that OSCs could modulate the transcription of important regulators of the cell 
cycle. As example, the DADS-induced G2/M phase arrest of colon cancer Caco-2 and HT-29 
cells was associated with the upregulation of p21, which appeared to be closely dependent 
on the acetylation status of its promoter (see section 5.4) (Druesne et al., 2004). Figure 2 
summarizes the modulatory effects of OSCs on cell cycle. 
 
 
Fig. 2. Schematic overview of cellular targets of OSCs implicated in cell cycle arrest. 
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Cellular damage by oxidation of macromolecules such as DNA, proteins or membrane lipids 
is an important process during early carcinogenesis (Borrelli et al., 2007; Valko et al., 2006). 
Antioxidant activities of phytochemicals that counteract ROS or free radicals are therefore 
highly desirable for potential anti-cancer compounds. Some OSCs derived from Allium have 
been reported to possess an antioxidant activity (Borek, 2001). Due to their sulfur atoms, 
which can appear in up to ten different oxidation states (-2 to +6), these compounds can 
undergo redox-reactions (Cerella et al., 2009). Nishimura et al. reported that Allium-derived 
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scavenging free hydroxyl (OH) or OOH radicals (Nishimura et al., 2000). Rabinkov and 
colleagues clearly demonstrated the radical scavenging ability of alliin and allicin by using 
the in vitro Fenton oxygen-radical generating system, in which the amount of OH radicals, 
measured with the spin trap 5,5-dimethyl-1-pyrroline N-oxide (DMPO), was significantly 
reduced in response to both OSCs (Rabinkov et al., 1998). Alliin was described as stronger 
superoxide scavenger than allylcysteine or allyldisulfide (Okada et al., 2005). By direct ESR 
detection Okada et al. provided evidence that allicin is a potent scavenger of peroxyl 
radicals (Okada et al., 2005). Structure-activity studies of the same authors revealed that the 
–S(O)S- group in combination with an allyl group is particularly important for the 
antioxidant activity of thiosulfinates (Okada et al., 2005). Several studies performed on 
bovine pulmonary artery endothelial cells revealed that AGE and SAC inhibited O2•- and 
H2O2 formation as well as H2O2-induced lipid peroxidation (Yamasaki & Lau, 1997) (Wei Z., 
1998). Particularly for the stable water-soluble sulfur species SAC and SAMC remarkable 
antioxidant properties are well documented. Thus, Imai et al. who investigated the 
antioxidant effects of AGE, a formulation especially enriched in both SAC and SAMC, 
provided evidence that these OSCs possess extraordinary radical scavenging activity (Imai 
et al., 1994). Counteracting ROS accumulation could also explain the beneficial effects of 
garlic in diseases different from cancer, in which ROS play a major role, for example 
cardiovascular and inflammatory diseases. In this respect, aqueous garlic extract, AGE and 
SAC are effective in the prevention of copper-induced LDL oxidation, a process implicated 
in the pathogenesis of atherosclerosis (Amagase et al., 2001; Galeone et al., 2006). AGE also 
protects rat liver microsomes from thiobarbituric acid-reactive substances (TBARS) 
formation (Horie et al., 1989). Other garlic-derived compounds, including lipophilic 
polysulfides and dithiins have also shown to act as antioxidants (Amagase et al., 2001), e.g. 
by preventing LOOH formation on human LDL (Nishimura et al., 2004). Nishimura et al. 
identified 3,4-dihydro-3-vinyl-1,2-dithiin as the compound with the most efficient 
antioxidant activity on human LDL at physiological concentration (Nishimura et al., 2004). 
Another strategy used by OSCs is the increase in the cellular antioxidant defense by 
upregulating/activating phase II detoxification enzymes (see Section 5.1.1) as well as 
alteration of the GSH redox cycle have been demonstrated in response to AGE and SAC 
(Geng, 1997). Oxidative stress is also linked to inflammation, while the latter is associated 
with carcinogenesis (Bartsch & Nair, 2006; Borrelli et al., 2007; Kundu & Surh, 2008). ROS 
are known to activate the NF-B signalling pathway thereby causing aberrant expression of 
target genes, including pro-inflammatory cytokines and chemokines that are involved in 
tumorigenesis (Balkwill & Mantovani, 2001; Karin & Greten, 2005). Blocking of this pathway 
therefore plays a role in the antioxidant defense. Indeed, SAC was efficient in preventing 
NF-B activation induced by both, tumor necrosis factor alpha and H2O2 in human T 
lymphocytes (Geng, 1997). DADS acts on the NF-B pathway by blocking activation and 
nuclear translocation of p65 and p50 (Pratheeshkumar et al., 2010).  
On the other hand, there are some publications reporting a pro-oxidant activity of 
diallylsulfides and ajoene. These studies suggested that polysulfide/ajoene-induced 
apoptotic cell death is caused by ROS accumulation and peroxide production (Aquilano et 
al., 2010; Charlier et al., 2010; Dirsch et al., 1998; Wang, H.C. et al., 2010a). DADS, DATS and 
DATTS and to a lesser extent the corresponding propylsulfides have been identified as 
hemolytic agents, as they induce oxidative damage in erythrocytes by the formation of H2O2 
in the presence of GSH and haemoglobin (Munday et al., 2003).  
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Other mechanisms of action involved in OSCs-mediated cell cycle arrest have also been 
identified. In particular, Hosono et al. have demonstrated, through the use of an in vitro cell-
free model, that DATS inhibited tubulin polymerization. Mass spectrometry analysis has 
demonstrated that DATS induced the oxidation of two cysteine residues in the -tubulin 
(C12 and C354) (Hosono et al., 2005). These results were confirmed in another study by the 
use of reducing agent (2-mercaptoethanol and dithiothreitol), which abolished the MT-
disrupting activity of allicin (Prager-Khoutorsky et al., 2007). In addition, it was also 
reported that OSCs could modulate the transcription of important regulators of the cell 
cycle. As example, the DADS-induced G2/M phase arrest of colon cancer Caco-2 and HT-29 
cells was associated with the upregulation of p21, which appeared to be closely dependent 
on the acetylation status of its promoter (see section 5.4) (Druesne et al., 2004). Figure 2 
summarizes the modulatory effects of OSCs on cell cycle. 
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scavenging free hydroxyl (OH) or OOH radicals (Nishimura et al., 2000). Rabinkov and 
colleagues clearly demonstrated the radical scavenging ability of alliin and allicin by using 
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detection Okada et al. provided evidence that allicin is a potent scavenger of peroxyl 
radicals (Okada et al., 2005). Structure-activity studies of the same authors revealed that the 
–S(O)S- group in combination with an allyl group is particularly important for the 
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1998). Particularly for the stable water-soluble sulfur species SAC and SAMC remarkable 
antioxidant properties are well documented. Thus, Imai et al. who investigated the 
antioxidant effects of AGE, a formulation especially enriched in both SAC and SAMC, 
provided evidence that these OSCs possess extraordinary radical scavenging activity (Imai 
et al., 1994). Counteracting ROS accumulation could also explain the beneficial effects of 
garlic in diseases different from cancer, in which ROS play a major role, for example 
cardiovascular and inflammatory diseases. In this respect, aqueous garlic extract, AGE and 
SAC are effective in the prevention of copper-induced LDL oxidation, a process implicated 
in the pathogenesis of atherosclerosis (Amagase et al., 2001; Galeone et al., 2006). AGE also 
protects rat liver microsomes from thiobarbituric acid-reactive substances (TBARS) 
formation (Horie et al., 1989). Other garlic-derived compounds, including lipophilic 
polysulfides and dithiins have also shown to act as antioxidants (Amagase et al., 2001), e.g. 
by preventing LOOH formation on human LDL (Nishimura et al., 2004). Nishimura et al. 
identified 3,4-dihydro-3-vinyl-1,2-dithiin as the compound with the most efficient 
antioxidant activity on human LDL at physiological concentration (Nishimura et al., 2004). 
Another strategy used by OSCs is the increase in the cellular antioxidant defense by 
upregulating/activating phase II detoxification enzymes (see Section 5.1.1) as well as 
alteration of the GSH redox cycle have been demonstrated in response to AGE and SAC 
(Geng, 1997). Oxidative stress is also linked to inflammation, while the latter is associated 
with carcinogenesis (Bartsch & Nair, 2006; Borrelli et al., 2007; Kundu & Surh, 2008). ROS 
are known to activate the NF-B signalling pathway thereby causing aberrant expression of 
target genes, including pro-inflammatory cytokines and chemokines that are involved in 
tumorigenesis (Balkwill & Mantovani, 2001; Karin & Greten, 2005). Blocking of this pathway 
therefore plays a role in the antioxidant defense. Indeed, SAC was efficient in preventing 
NF-B activation induced by both, tumor necrosis factor alpha and H2O2 in human T 
lymphocytes (Geng, 1997). DADS acts on the NF-B pathway by blocking activation and 
nuclear translocation of p65 and p50 (Pratheeshkumar et al., 2010).  
On the other hand, there are some publications reporting a pro-oxidant activity of 
diallylsulfides and ajoene. These studies suggested that polysulfide/ajoene-induced 
apoptotic cell death is caused by ROS accumulation and peroxide production (Aquilano et 
al., 2010; Charlier et al., 2010; Dirsch et al., 1998; Wang, H.C. et al., 2010a). DADS, DATS and 
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5.3.2 Interaction with metalloproteins  
Metalloproteins are indispensable for cells to achieve cancer prevention. Matrix 
metalloproteinases for example counteract carcinogenic processes like metastasis or 
angiogenesis by ensuring the consistency of the extracellular matrix, but may facilitate 
tumor invasion if overexpressed (Brew et al., 2000; Gomez et al., 1997; Luttun et al., 2000). 
Members of other metalloprotein classes including the cytochrome P450 family or proteins 
are involved in iron or drug/xenobiotic metabolism and activation of carcinogens 
(Sheweita, 2000; Shimada, 2006). The ability of garlic-derived OSCs to form complexes with 
metal ions might result in the inactivation of metallo-enzymes and therefore represents an 
important anti-cancer strategy of OSCs. Thiolates for example are exceptional ligands for 
various metal ions. Even if an experimental proof for direct binding of OSCs to metal ions is 
still missing, polysulfides are able to coordinate with several sulfur atoms at once and thus 
are likely to form metal complexes (Munchberg et al., 2007). In this respect, different OSCs 
are known to alter the activity of members of the cytochrome P450 family (see Section 5.1.1).  
A family of zinc-dependent endopeptidases, named matrix metalloproteinases (MMPs) 
according to their primary function (Kessenbrock et al., 2010; Nagase & Woessner, 1999), is 
also affected by some garlic-derived OSCs (Ho et al., 2010; Meyer et al., 2004; Peng et al., 
2010; Polette & Birembaut, 1998). Often, high expression levels of MMPs are detected in 
cancer cells, which further increase during tumor progression (Chambers & Matrisian, 
1997). Such an imbalance, particularly of MMP9 (Egeblad & Werb, 2002) and MMP2 activity, 
is associated with cancer cell invasion and metastasis (Ahmed & Mohammed, 2011; 
Ellerbroek & Stack, 1999; Peng et al., 2010; Polette & Birembaut, 1998). MMPs therefore 
represent a crucial target in anti-cancer treatment. Meyer et al. found that DADS decreased 
MMP2 activity in a dose-dependent manner in HUVEC cells (Meyer et al., 2004). AM and 
SAC did not show any effect. DADS affected in addition MMP9 activity, whereas MMP1 
and MMP3 activity/secretion were not altered by any of the OSCs. These results are in line 
with a study of Shin et al. who found DADS suppressing MMP2 and MMP9 in a time-
dependent manner in prostate LNCaP cancer cells (Ho et al., 2010). As already mentioned 
above it has been speculated that perthiols arising from polysulfides might contribute to the 
biological activity of the latter. Similar to thiols, RSxH species serve as good ligands for zinc, 
copper, iron or other metal ions (Munchberg et al., 2007). Based on their low pKa values, 
RSxH species are expected to strongly bind free or protein-bound metal ions (Munchberg et 
al., 2007). Instead of binding directly to the active site metal ion (Schneider, T. et al., 2011a), 
they might also form low molecular weight complexes in the cytosol. Due to these 
disturbances of metal homeostasis the pool of free (i.e. unbound) metal ions is diminished 
and impairs de novo synthesis of functioning metalloproteins (Munchberg et al., 2007). As 
free adventitious transition metal ions are also involved in oxidative stress (Bush, 2000), the 
OSC-induced reduction of the cytosolic metal ion pool contributes to the antioxidant effect 
of these sulfur compounds.  
5.4 Modulation of histone acetylation 
Recent studies have suggested the modulation of histone acetylation as one of the 
mechanisms involved in the anti-cancer activity of garlic (Druesne-Pecollo & Latino-Martel, 
2011). In eukaryotic cells, histones are proteins responsible for the DNA condensation and 
thus play an important role in the regulation of gene expression. Histones are subjected to 
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post-translational modifications, including acetylation, which is a reversible process 
occurring on lysine residues in the N-terminal domain of the protein. In cancer cells, various 
genes are abnormally expressed due to epigenetic modifications of the chromatin, leading to 
the tumor phenotype. Controlling chromatin remodeling and gene expression is a relevant 
strategy for anti-cancer drug development (Espino et al., 2005). Few studies have described 
the ability of OSCs to increase histone acetylation. Lea et al. reported for the first time the 
increased acetylation of histones H3 and H4 in mouse erythroleukemia DS19 and human 
leukemia K562 after treatment with DADS and AM (Lea et al., 1999). Then, the same group 
has confirmed those effects in vivo as histone acetylation was induced in liver and Morris 
hepatoma 7777 in rats treated with DADS and AM (Lea & Randolph, 2001). Data suggested 
a direct link between histone hyperacetylation and the antiproliferative activity of some 
garlic components. First, increased histone acetylation was obtained for concentrations 
similar to those used to inhibit cell proliferation of DS19, human colon cancer Caco-2 cells 
and human breast cancer T47D cells (µM range for allicin and SAMC, mM range for 
allylphenylsulfone and SAC) (Lea et al., 2002). In this study, the authors failed to 
characterize the mechanism involved as no inhibitory effect was observed on histone 
deacetylase (HDAC) activity, enzymes which repress the histone acetylation. Conversely, 
Druesne et al. confirmed the ability of DADS and AM to inhibit HDAC activity in a cell-free 
assay (29 % and 92 % of HDAC inhibition in presence of 200 mM of each compound, 
respectively) (Druesne et al., 2004). Recently, in vitro assay and molecular modeling have led 
to the identification of AM as the most potent competitive inhibitor of HDAC (Ki=24 �M for 
HDAC8). HDAC inhibition appeared to be responsible for the hyperacetylation of the p21 
gene promoter (Nian et al., 2009; Nian et al., 2008).  
Another important consideration is the chemopreventive activity of chromatin remodeling 
molecules. Indeed, it has been shown in vivo that DADS administration to rat effectively 
induced acetylation of histones H3 and H4 in non-tumor colonocytes. Results from 
microarray analysis indicated that DADS was able to modulate the expression of 49 genes 
(24 h after the end of DADS perfusion), mostly implicated in cell cycle regulation, DNA 
repair, cellular adhesion (Druesne-Pecollo et al., 2007). These results suggest a potential link 
between the modulation of gene expression, through histone hyperacetylation, and the 
chemopreventive activity of OSCs. Further investigations are needed to determine whether 
garlic components could be effective in histone acetylation, and thus in cancer prevention, at 
doses achievable in human diet. 
5.5 Induction of apoptosis 
5.5.1 Activation of the mitochondrial apoptotic pathway  
A number of studies document the ability of OSCs to induce apoptosis. Apoptosis is an 
active form of cell death by which cells organize their self-elimination. It may be part of a 
programmed physiological event, including tissue remodeling and turn over; besides, 
irreversibly damaged cells following stress activate this mechanism. The apoptotic program 
is accomplished by the triggering different cascades of biochemical events. Two main 
intracellular routes take place (Coppola & Ghibelli, 2000). The intrinsic or mitochondrial 
pathway typically starts as a consequence of cellular damage. It requires the crucial 
involvement of pro- and anti-apoptotic members of the B-cell lymphoma (Bcl-2) family, 
which control the permeabilization of the outer mitochondrial membrane. The resulting 
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release of cytochrome c (and other additional factors) into the cytoplasm promotes caspase 
cleavage/activation, whose most upstream implicated member is caspase-9. The extrinsic or 
physiological pathway is mediated by the stimulation of specific death receptors on the 
plasma membrane. Once stimulated by their ligands, they unleash an ordered intracellular 
multi-step signaling, which includes the formation of the cell death domain and the 
activation/cleavage of caspase-8. The two pathways are interconnected.  
The activation of the extrinsic or the intrinsic apoptotic pathways is the target of most 
chemotherapeutic agents. OSCs derived from Allium species induce apoptosis by activating 
the intrinsic apoptotic pathway. The release of cytochrome c from mitochondria, the 
decreased level of the anti-apoptotic protein Bcl-2 and the activation of caspase 9/3 are 
common hallmarks (Cerella et al., 2011; Scherer et al., 2009). The findings concern very 
heterogeneous cancer cell models, ranging from adherent (e.g., prostate, lung, colon, breast, 
cervical and thyroid) to non-adherent (e.g., various leukemia and lymphomas) cancer cell 
lines.  
A large body of evidence shows a strong correlation between the number of sulfur atoms 
and the apoptogenic potential manifested by OSCs (see Section 3.1). Less defined, instead, is 
the contribution of the length of the sulfur chain in the anti-cancer role played by OCSs. 
Studies comparing the effects of diallylpolysulfides deriving from garlic, which bring an 
unsatured (alkenyl) chain, with propylpolysulfides extracted from onion, which contain a 
saturated alkyl group, show marginal differences in their apoptogenic potential: generally, 
molecules containing the same number of sulfur atoms, show also a similar impact on 
different cancer cell models (Cerella et al., 2011). In contrast, Hosono and colleagues have 
provided evidence by using a colon cancer cellular model HT29 that the alkenyl group 
impacts intracellular targets (see also section below) much stronger than the corresponding 
compound with an alkyl group (Hosono et al., 2008). This result may lead in this cell system 
to a potential differential role also on apoptosis, which, however, was not yet investigated. 
Further studies are required to explain cell-type specific responses to OSC. 
5.5.2 Mechanisms implicated in G2/M arrest  
In all instances, apoptosis is preceded by alterations in the progression of the cell cycle, 
consisting in a G2/M arrest (section 5.2). The activation/up-regulation of the tumor 
suppressor p53 has been mentioned since very early studies on apoptosis as a crucial and 
very upstream event (Shen & White, 2001). The arrest in G2/M induced by OSCs may be 
compatible with an involvement of p53 to activate apoptosis. p53 expression has been 
effectively found upregulated in studies performed with garlic extracts (Hong et al., 2000) 
(De Martino et al., 2006), as well as in a number of investigations based on the use of 
purified sulfur compounds: DAS (Hong et al., 2000), DADS (Bottone et al., 2002; Hong et al., 
2000; Pratheeshkumar et al., 2010; Song et al., 2009), DATS (Malki et al., 2009) and SAMC 
(Lee, 2008). p53 upregulation, however, seems to be a dispensable event in the apoptogenic 
activity of OSCs, since the use of p53-mutated or deleted cancer cell models has clearly 
demonstrated that OSC-induced apoptosis similarly takes independently of wild-type p53 
(Busch et al., 2010; Lee, 2008; Xiao et al., 2009b).  
A more careful observation of the cellular morphology after OSCs treatment suggests an 
arrest of the cell cycle at early steps of mitosis and more precisely during the pro-metaphase. 
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Accordingly, the nuclear chromatin partially condenses and acquires a dotted pattern. The 
pattern of modulations that OCSs produce on cell cycle-related proteins confirms these 
conclusions. The accumulation of cyclin B1 correlates with the down-regulation of CDC25B 
and 25C, which control the phosphorylation status and the activation of cyclin-dependent 
kinase (Cdk1) (see section 5.2). Besides, treated cells present a high positivity to the 
phosphorylated form of histone H3, at the level of ser 10 (H3P) (Cerella et al., 2009; Herman-
Antosiewicz & Singh, 2005). The degradation of cyclin B1 and H3P is an indispensable event 
to progress during mitosis into the anaphase. Therefore, their accumulation indicates that 
OSCs prevent the transition to this step and, by this way, may trigger the mitochondrial 
apoptotic pathway.  
5.5.3 Alterations induced by OSCs on the MT network as a causative event of 
apoptosis 
Arrest at early steps of mitosis may be the consequence of aberrations occurring during 
the DNA synthesis; alternatively, it occurs after alteration of the MT network. A few 
reports analyzed the potential of OSCs to cause DNA damage (Wang, H.C. et al., 2010a). 
In most instances, this is not an early event, but rather appearing tightly linked to the 
onset of apoptosis. Consequently, DNA damage is not generally considered as the 
causative event determining the OSC-induced apoptosis. A large body of evidence, 
conversely, indicates that OSCs induce strong alterations of MT re-arrangement (see 
figure 3 and section 3.2). This property is common to different natural occurring OSCs 
manifesting apoptogenic properties on the different cancer cell models (Aquilano et al., 
2010; Hosono et al., 2005; Li et al., 2002a; Prager-Khoutorsky et al., 2007; Xiao et al., 2005; 
Xiao et al., 2003).  
Despite the common observation that the MT network is affected by OSCs, there is no 
general consensus about the molecular events leading to these alterations. Canonically, 
stress-induced apoptosis has been always associated with early alterations in the cellular 
redox state (Coppola & Ghibelli, 2000). Changes in the intracellular GSH content and the 
generation of ROS are commonly assumed to act as crucial events in determining the 
commitment to intrinsic apoptosis. Previously published data already showed that a 
pretreatment with antioxidants, mainly with NAC, counteracts OSCs-induced apoptosis 
(Dirsch et al., 1998). Moreover, NAC prevents the G2/M arrest (Wu, X.J. et al., 2005). Similar 
results have provided the strongest evidence that the induction of apoptosis by OSCs 
effectively depends on the alterations of the cell cycle. Besides, the generation of ROS has 
been documented in some studies by the use of the fluorescent tool 2,7-
dichlorodihydrofluorescein diacetate (H2DCFDA) upon incubation of the cells with DADS 
and DATS (Filomeni et al., 2003; Kim, Y.A. et al., 2007; Sriram et al., 2008). Consequently, 
ROS have been considered by a number of studies as the determining event for cell cycle 
arrest and apoptosis induced by OSCs. As previously discussed, agents such as NAC may 
counteract OSCs-dependent cell cycle alterations and, therefore apoptosis, simply by acting 
as donors of thiols and thus competing with the intracellular thiols for the interaction with 
OSCs. Several pieces of evidence support this model. First, the direct ability of NAC to 
prevent the OSCs-induced tubulin depolymerization (see section 3.2). Second, ROS 
production has not always been detected, even if apoptosis was induced (De Martino et al., 
2006). The debate, however, remains open for further discussion. The over-expression of the 
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release of cytochrome c (and other additional factors) into the cytoplasm promotes caspase 
cleavage/activation, whose most upstream implicated member is caspase-9. The extrinsic or 
physiological pathway is mediated by the stimulation of specific death receptors on the 
plasma membrane. Once stimulated by their ligands, they unleash an ordered intracellular 
multi-step signaling, which includes the formation of the cell death domain and the 
activation/cleavage of caspase-8. The two pathways are interconnected.  
The activation of the extrinsic or the intrinsic apoptotic pathways is the target of most 
chemotherapeutic agents. OSCs derived from Allium species induce apoptosis by activating 
the intrinsic apoptotic pathway. The release of cytochrome c from mitochondria, the 
decreased level of the anti-apoptotic protein Bcl-2 and the activation of caspase 9/3 are 
common hallmarks (Cerella et al., 2011; Scherer et al., 2009). The findings concern very 
heterogeneous cancer cell models, ranging from adherent (e.g., prostate, lung, colon, breast, 
cervical and thyroid) to non-adherent (e.g., various leukemia and lymphomas) cancer cell 
lines.  
A large body of evidence shows a strong correlation between the number of sulfur atoms 
and the apoptogenic potential manifested by OSCs (see Section 3.1). Less defined, instead, is 
the contribution of the length of the sulfur chain in the anti-cancer role played by OCSs. 
Studies comparing the effects of diallylpolysulfides deriving from garlic, which bring an 
unsatured (alkenyl) chain, with propylpolysulfides extracted from onion, which contain a 
saturated alkyl group, show marginal differences in their apoptogenic potential: generally, 
molecules containing the same number of sulfur atoms, show also a similar impact on 
different cancer cell models (Cerella et al., 2011). In contrast, Hosono and colleagues have 
provided evidence by using a colon cancer cellular model HT29 that the alkenyl group 
impacts intracellular targets (see also section below) much stronger than the corresponding 
compound with an alkyl group (Hosono et al., 2008). This result may lead in this cell system 
to a potential differential role also on apoptosis, which, however, was not yet investigated. 
Further studies are required to explain cell-type specific responses to OSC. 
5.5.2 Mechanisms implicated in G2/M arrest  
In all instances, apoptosis is preceded by alterations in the progression of the cell cycle, 
consisting in a G2/M arrest (section 5.2). The activation/up-regulation of the tumor 
suppressor p53 has been mentioned since very early studies on apoptosis as a crucial and 
very upstream event (Shen & White, 2001). The arrest in G2/M induced by OSCs may be 
compatible with an involvement of p53 to activate apoptosis. p53 expression has been 
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(De Martino et al., 2006), as well as in a number of investigations based on the use of 
purified sulfur compounds: DAS (Hong et al., 2000), DADS (Bottone et al., 2002; Hong et al., 
2000; Pratheeshkumar et al., 2010; Song et al., 2009), DATS (Malki et al., 2009) and SAMC 
(Lee, 2008). p53 upregulation, however, seems to be a dispensable event in the apoptogenic 
activity of OSCs, since the use of p53-mutated or deleted cancer cell models has clearly 
demonstrated that OSC-induced apoptosis similarly takes independently of wild-type p53 
(Busch et al., 2010; Lee, 2008; Xiao et al., 2009b).  
A more careful observation of the cellular morphology after OSCs treatment suggests an 
arrest of the cell cycle at early steps of mitosis and more precisely during the pro-metaphase. 
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Accordingly, the nuclear chromatin partially condenses and acquires a dotted pattern. The 
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reports analyzed the potential of OSCs to cause DNA damage (Wang, H.C. et al., 2010a). 
In most instances, this is not an early event, but rather appearing tightly linked to the 
onset of apoptosis. Consequently, DNA damage is not generally considered as the 
causative event determining the OSC-induced apoptosis. A large body of evidence, 
conversely, indicates that OSCs induce strong alterations of MT re-arrangement (see 
figure 3 and section 3.2). This property is common to different natural occurring OSCs 
manifesting apoptogenic properties on the different cancer cell models (Aquilano et al., 
2010; Hosono et al., 2005; Li et al., 2002a; Prager-Khoutorsky et al., 2007; Xiao et al., 2005; 
Xiao et al., 2003).  
Despite the common observation that the MT network is affected by OSCs, there is no 
general consensus about the molecular events leading to these alterations. Canonically, 
stress-induced apoptosis has been always associated with early alterations in the cellular 
redox state (Coppola & Ghibelli, 2000). Changes in the intracellular GSH content and the 
generation of ROS are commonly assumed to act as crucial events in determining the 
commitment to intrinsic apoptosis. Previously published data already showed that a 
pretreatment with antioxidants, mainly with NAC, counteracts OSCs-induced apoptosis 
(Dirsch et al., 1998). Moreover, NAC prevents the G2/M arrest (Wu, X.J. et al., 2005). Similar 
results have provided the strongest evidence that the induction of apoptosis by OSCs 
effectively depends on the alterations of the cell cycle. Besides, the generation of ROS has 
been documented in some studies by the use of the fluorescent tool 2,7-
dichlorodihydrofluorescein diacetate (H2DCFDA) upon incubation of the cells with DADS 
and DATS (Filomeni et al., 2003; Kim, Y.A. et al., 2007; Sriram et al., 2008). Consequently, 
ROS have been considered by a number of studies as the determining event for cell cycle 
arrest and apoptosis induced by OSCs. As previously discussed, agents such as NAC may 
counteract OSCs-dependent cell cycle alterations and, therefore apoptosis, simply by acting 
as donors of thiols and thus competing with the intracellular thiols for the interaction with 
OSCs. Several pieces of evidence support this model. First, the direct ability of NAC to 
prevent the OSCs-induced tubulin depolymerization (see section 3.2). Second, ROS 
production has not always been detected, even if apoptosis was induced (De Martino et al., 
2006). The debate, however, remains open for further discussion. The over-expression of the 
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enzyme SOD has been shown in the neuroblastoma SH-SY5Y cells to counteract apoptosis 
(Filomeni et al., 2003). Besides, pre-incubation of cells with catalase, which buffers H2O2 
production, counteracted apoptosis induced by DADS in the HL-60 leukemia cell line 
(Kwon et al., 2002) and in T24 human bladder cancer cells (Lu et al., 2004). Similarly, over-
expression of catalase in the prostate cancer cell line DU145 protects against apoptosis 
induced by DATS (Xiao et al., 2004). A conceivable interpretation is that ROS species may be 
generated downstream of the formation of intracellular thiols after OSC treatment and play 
a determinant role depending on the cell-specific antioxidant reservoir. 
5.5.4 Modulation of Bcl-2 family members by OSCs 
OSCs modulate several proteins belonging to the Bcl-2 family. The anti-apoptotic Bcl-2 
protein has been described to be downregulated. This, in turn, increases Bcl-2-associated X 
protein (Bax)/Bcl-2 ratio, thus promoting apoptosis (Karmakar et al., 2007). The 
downregulation of Bcl-2 is more precisely the consequence of a protein cleavage. In our 
laboratory, we have shown that DATTS promotes Bcl-2 proteolysis (Cerella et al., 2009). This 
finding is in line with previous results collected with Z-ajoene (Li et al., 2002b) and DATS 
(Xiao et al., 2004). Bcl-2 cleavage is preceded by phosphorylation. Xiao and colleagues 
published that Bcl-2 phosphorylation occurs after treatment with DATS in human prostate 
cancer cells PC-3 and DU145 (Xiao et al., 2004). Similarly, the expression of the anti-
apoptotic Bcl-xL protein is modulated by DADS in breast cancer cells (Nakagawa et al., 
2001); in line with these results, we have described that the downregulation of B-cell 
lymphoma-extra large (Bcl-xL) protein upon treatment with DATTS in human leukemia 
cells (Cerella et al., 2009). Specific Bcl-2 homology domain 3 (BH3)-only proteins seem to be 
modulated by OSCs by post-translational modification or by intracellular redistribution. 
Unphosphorylated Bcl-2-associated death promoter (Bad) sequesters Bcl-xL and Bcl-2 thus 
favoring Bax and Bcl-2 homologous antagonist killer (Bak) activation (Yang et al., 1995). 
Dephosphorylation of Bad has been documented after DATTS treatment (Cerella et al., 
2009). Besides, the translocation of Bad to the mitochondria occurs in prostate cancer cells 
upon treatment with DATS (Xiao & Singh, 2006). When breast cancer MDA-MB-435 cells 
were exposed to water-soluble extracts (Lund et al., 2005), expression level, phosphorylation 
and mitochondrial localization of different isoforms of the BH3-only protein BimEL were 
altered. Interestingly, BimEL in normal physiological conditions is anchored to (and 
sequestered by) the MT complex (Chen, D. & Zhou, 2004; Lund et al., 2005). This may 
provide interesting insights about how the MT network is disrupted and the subsequent 
activation of the mitochondrial pathway may be interconnected. 
The permeabilization of the outer mitochondrial membrane is an event controlled by the 
two pro-apoptotic family members, Bax and Bak, which orchestrate the formation of specific 
channels (Antignani & Youle, 2006). OSCs activate Bax and Bak (Cerella et al., 2009; Kim, 
Y.A. et al., 2007; Xiao et al., 2006a; Xiao et al., 2009a). Interestingly, time-course analyses 
have evidenced that Bak might be activated before Bax (Cerella et al., 2009). The activation 
of Bax fits the activation of caspases and the appearance of massive apoptosis (Cerella et al., 
2009), thus suggesting that its activation is crucial for the completion of the apoptotic 
program. In other instances, modifications in the levels of Bak and Bax have been detected, 
with Bak being affected much earlier than Bax (Kim, Y.A. et al., 2007). This evidence is in 
favor of non-redundant roles of Bax and Bak during OSCs-induced apoptosis. How Bax and 
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Bak may promote the formation of channels and the mitochondrial outer membrane 
permeabilization is still unknown. Similarly, differential roles played by Bax and Bak during 
apoptosis remain to be determined. Intriguingly, the chemotherapeutic agent vinblastine, 
which affects the MT network and induces mitotic arrest, also modulates Bak at early 
timepoints (Upreti et al., 2008). These results may suggest a specific interplay between Bak 
and Bax typically activated by tubulin-affecting agents. OSCs might conceivably represent 
an interesting tool to investigate and to clarify some aspects that belong to essential issues of 
apoptosis research.  
 
Fig. 3. Mechanisms involved in the apoptogenic properties of OSCs 
The induction of apoptosis by OSCs occurs via a well-ordered set of events. The first target is 
the MT network whose modification leads to G2/M arrest of the cells in early mitosis. 
Kinases act as sensors of the stress occurring to MT. Once activated, they translate the stress 
signal to the Bcl-2 family proteins, by modulating anti-apoptotic and BH3-only proteins via 
phosphorylation. This impact on Bcl-2 modulatory proteins unleashes the pro-apoptotic Bak 
and Bax, which are now free to trigger the mitochondrial apoptotic pathway (modified from 
(Cerella et al., 2009). 
5.5.5 Involvement of kinases in OSCs-mediated apoptosis 
Different Bcl-2 family members are modulated by OSCs via protein phosphorylation. In 
addition, different kinases are activated upon treatment with several OSCs. The activation of 
c-Jun N-terminal kinase (JNK) appears as the most relevant for the apoptogenic potential of 
OSCs. JNK activation has been commonly reported upon DADS treatment in neuroblastoma 
SH-SY5Y (Filomeni et al., 2003) and breast cancer MCF-7 cells (Lei et al., 2008); in prostate 
PC-3 and DU145 cells in response to DATS (Xiao et al., 2004); by SAMC in colon cancer 
SW480 cells (Xiao et al., 2003). JNK activation is required for the apoptogenic activity of 
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enzyme SOD has been shown in the neuroblastoma SH-SY5Y cells to counteract apoptosis 
(Filomeni et al., 2003). Besides, pre-incubation of cells with catalase, which buffers H2O2 
production, counteracted apoptosis induced by DADS in the HL-60 leukemia cell line 
(Kwon et al., 2002) and in T24 human bladder cancer cells (Lu et al., 2004). Similarly, over-
expression of catalase in the prostate cancer cell line DU145 protects against apoptosis 
induced by DATS (Xiao et al., 2004). A conceivable interpretation is that ROS species may be 
generated downstream of the formation of intracellular thiols after OSC treatment and play 
a determinant role depending on the cell-specific antioxidant reservoir. 
5.5.4 Modulation of Bcl-2 family members by OSCs 
OSCs modulate several proteins belonging to the Bcl-2 family. The anti-apoptotic Bcl-2 
protein has been described to be downregulated. This, in turn, increases Bcl-2-associated X 
protein (Bax)/Bcl-2 ratio, thus promoting apoptosis (Karmakar et al., 2007). The 
downregulation of Bcl-2 is more precisely the consequence of a protein cleavage. In our 
laboratory, we have shown that DATTS promotes Bcl-2 proteolysis (Cerella et al., 2009). This 
finding is in line with previous results collected with Z-ajoene (Li et al., 2002b) and DATS 
(Xiao et al., 2004). Bcl-2 cleavage is preceded by phosphorylation. Xiao and colleagues 
published that Bcl-2 phosphorylation occurs after treatment with DATS in human prostate 
cancer cells PC-3 and DU145 (Xiao et al., 2004). Similarly, the expression of the anti-
apoptotic Bcl-xL protein is modulated by DADS in breast cancer cells (Nakagawa et al., 
2001); in line with these results, we have described that the downregulation of B-cell 
lymphoma-extra large (Bcl-xL) protein upon treatment with DATTS in human leukemia 
cells (Cerella et al., 2009). Specific Bcl-2 homology domain 3 (BH3)-only proteins seem to be 
modulated by OSCs by post-translational modification or by intracellular redistribution. 
Unphosphorylated Bcl-2-associated death promoter (Bad) sequesters Bcl-xL and Bcl-2 thus 
favoring Bax and Bcl-2 homologous antagonist killer (Bak) activation (Yang et al., 1995). 
Dephosphorylation of Bad has been documented after DATTS treatment (Cerella et al., 
2009). Besides, the translocation of Bad to the mitochondria occurs in prostate cancer cells 
upon treatment with DATS (Xiao & Singh, 2006). When breast cancer MDA-MB-435 cells 
were exposed to water-soluble extracts (Lund et al., 2005), expression level, phosphorylation 
and mitochondrial localization of different isoforms of the BH3-only protein BimEL were 
altered. Interestingly, BimEL in normal physiological conditions is anchored to (and 
sequestered by) the MT complex (Chen, D. & Zhou, 2004; Lund et al., 2005). This may 
provide interesting insights about how the MT network is disrupted and the subsequent 
activation of the mitochondrial pathway may be interconnected. 
The permeabilization of the outer mitochondrial membrane is an event controlled by the 
two pro-apoptotic family members, Bax and Bak, which orchestrate the formation of specific 
channels (Antignani & Youle, 2006). OSCs activate Bax and Bak (Cerella et al., 2009; Kim, 
Y.A. et al., 2007; Xiao et al., 2006a; Xiao et al., 2009a). Interestingly, time-course analyses 
have evidenced that Bak might be activated before Bax (Cerella et al., 2009). The activation 
of Bax fits the activation of caspases and the appearance of massive apoptosis (Cerella et al., 
2009), thus suggesting that its activation is crucial for the completion of the apoptotic 
program. In other instances, modifications in the levels of Bak and Bax have been detected, 
with Bak being affected much earlier than Bax (Kim, Y.A. et al., 2007). This evidence is in 
favor of non-redundant roles of Bax and Bak during OSCs-induced apoptosis. How Bax and 
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Bak may promote the formation of channels and the mitochondrial outer membrane 
permeabilization is still unknown. Similarly, differential roles played by Bax and Bak during 
apoptosis remain to be determined. Intriguingly, the chemotherapeutic agent vinblastine, 
which affects the MT network and induces mitotic arrest, also modulates Bak at early 
timepoints (Upreti et al., 2008). These results may suggest a specific interplay between Bak 
and Bax typically activated by tubulin-affecting agents. OSCs might conceivably represent 
an interesting tool to investigate and to clarify some aspects that belong to essential issues of 
apoptosis research.  
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the MT network whose modification leads to G2/M arrest of the cells in early mitosis. 
Kinases act as sensors of the stress occurring to MT. Once activated, they translate the stress 
signal to the Bcl-2 family proteins, by modulating anti-apoptotic and BH3-only proteins via 
phosphorylation. This impact on Bcl-2 modulatory proteins unleashes the pro-apoptotic Bak 
and Bax, which are now free to trigger the mitochondrial apoptotic pathway (modified from 
(Cerella et al., 2009). 
5.5.5 Involvement of kinases in OSCs-mediated apoptosis 
Different Bcl-2 family members are modulated by OSCs via protein phosphorylation. In 
addition, different kinases are activated upon treatment with several OSCs. The activation of 
c-Jun N-terminal kinase (JNK) appears as the most relevant for the apoptogenic potential of 
OSCs. JNK activation has been commonly reported upon DADS treatment in neuroblastoma 
SH-SY5Y (Filomeni et al., 2003) and breast cancer MCF-7 cells (Lei et al., 2008); in prostate 
PC-3 and DU145 cells in response to DATS (Xiao et al., 2004); by SAMC in colon cancer 
SW480 cells (Xiao et al., 2003). JNK activation is required for the apoptogenic activity of 
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OSCs, since the specific JNK inhibitor SP600125 is able to exert a protective effect (Wu, X.J. et 
al., 2009; Xiao et al., 2003). JNK activation and Bcl-2 phosphorylation are events that 
accompany changes in the MT dynamics (Mollinedo & Gajate, 2003). This suggests an 
intermediate role of JNK as a transducer of the stress produced by OSCs between the MT 
network and Bcl-2 (and possibly to other Bcl-2 family members). Alternatively, JNK 
activation has been explained as a consequence of ROS production, which in turn, may 
impair the ability of the JNK guardian GST to sequester and prevent the activation of the 
kinase (Filomeni et al., 2003). Further MAP kinases are activated by OSCs. Phosphorylation 
of extracellular signal-regulated kinase (ERK) has been frequently reported (Xiao et al., 
2004). Similarly, there is evidence of the activation of p38 mitogen-activated protein kinase 
(MAPK) (Das et al., 2007; Zhang, Y.W. et al., 2006) and Akt kinases (Wang, Y.B. et al., 2010b). 
The results, however, are not conclusive because their inhibition did not give univocal 
results. Figure 3 reports a model of interactions between kinases and the other factors/ 
events modulated during OSCs treatment. 
5.6 Inhibition of metastatic process and differentiation 
Metastasis is a major cause of death in cancer patients. Tumor invasion is a multistep 
process involving the detachment of cancer cells at the site of the primary tumor, the entry 
into the systemic circulation and the invasion of new tumor sites. These different steps 
require multiple molecular events including loss of adhesion and motility of cancer cells, 
and stimulating angiogenesis (which appears to be essential for cancer cell spread). First, 
several in vitro studies have reported that garlic extracts and some of its components are 
able to affect cancer cell motility and invasiveness. In 2002, Hu and coworkers published a 
first report showing that AGE suppressed rat sarcoma cell migration in vitro (Hu et al., 
2002). Referring to these results, the antimetastatic activity of purified OSCs (e.g., DADS, 
SAC) was investigated. Shin and colleagues demonstrated that DADS reduced the motility 
of the prostate LNCaP cancer cell model by increasing the tightness of the tight junctions 
and by reducing the activity, the mRNA and protein levels of MMP2 and 9 (Shin et al., 
2010). SAC also altered breast tumor MDA-MB-231 cell adhesion and invasion through the 
induction of adhesion protein E-cadherin expression and the decrease of MMP2 activity 
(Gapter et al., 2008). Recently, Lai et al. have reported that the inhibition of MMP2, 7 and 9 
in colo 2005 cells by DAS, DADS and DATS were mediated through the downregulation of 
phosphoinositide 3-kinase (PI3K), Rat sarcoma (RAS), MAP kinase kinase kinase (MEKK) 3, 
MAP kinase kinase (MKK7), ERK1/2, JNK1/2 and p38 MAPK (Lai et al., 2011). Moreover, 
suppression of angiogenesis, a process leading to the formation of new blood vessels from 
the pre-existing vascular network, has also been reported. This process is essential in cancer 
development as it takes part in primary tumor growth (i.e., provision of oxygen and 
nutrients) and in spreading to distant sites, leading to metastasis. Tumor cells are known to 
promote angiogenesis through the production of several growth factors, which stimulate 
endothelial cell proliferation and migration (for a recent review, see (Makrilia et al., 2009)). 
In 2006, studies have shown that AGE and DATS inhibited the proliferation and the 
migration of endothelial cells as well as the capillary-like tube formation in vitro (Matsuura 
et al., 2006; Xiao et al., 2006b). For example, Xiao et al. reported that DATS exerted its 
antiangiogenic activity through the inhibition of vascular endothelial growth factor (VEGF) 
secretion, the reduction of VEGF receptor 2 expression and the inactivation of Akt signaling 
pathway in human umbilical vein endothelial cells (HUVEC) (Xiao et al., 2006b).  
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In vivo studies have confirmed the evidence supporting the antimetastatic properties of 
garlic in vitro. Oral administration of SAMC to mice bearing prostate tumors reduced the 
number of pulmonary metastasis by 85% and completely abolished their presence in adrenal 
cells (Howard et al., 2007). In another study, Singh and coworkers have shown that oral 
administration of DATS to TRAMP mice decreased the development of pulmonary 
metastasis (about 50% compared with the control mice) without inhibiting angiogenic 
features at the tested dose (Singh et al., 2008). Despite the different evidence obtained in 
vitro, the molecular events implicated in the antimetastatic activity of OSCs remain to be 
clarified. 
Cancer cells are characterized by the loss of growth control mechanisms and thus remain in 
a less differentiated, immature state. One important therapy approach is therefore the 
induction of differentiation in order to restrain the cancer cell proliferation. In this respect, 
garlic oil was described to induce differentiation in human gastric cancer BGC-823 (Brew et 
al., 2000) and HL-60 promyelocytic leukemia cells (Seki et al., 2000). The ability to induce 
cancer cell differentiation could be linked to DADS and SAC. Studies on DADS found that 
upregulation of p21(WAF) and acetylated histones H3 and H4 is associated with the 
induction of differentiation in HL-60 cells (Ling et al., 2006) while in MGC803 gastric cancer 
cells alterations of the ERK1/2 signaling pathway are involved in this process (Chu et al., 
2006). Abnormal expression of cytokeratins (marker of epithelial cell differentiation), which 
is connected to malignant progression, was restored by SAC administration in hamster 
buccal pouch carcinogenesis in Syrian hamsters (Balasenthil et al., 2003). Other studies 
reported that SAC upregulated E-cadherin expression in MDA-MB-231 breast tumor and 
PCa prostate cancer cells (Chiang et al., 2006; Gapter et al., 2008). On the other hand, in 
former studies, no differentiation markers could be detected in neuroblastoma or melanoma 
cells upon SAC treatment (Takeyama et al., 1993; Welch et al., 1992). 
6. Bioavailability and pharmacokinetics of OSCs 
Little is known from preclinical and clinical studies about the bioavailability, the 
metabolism and the excretion of garlic ingredients after consumption. Guo and coworkers 
have reported that pure alliin is absorbed in vivo as it can be detected in stomach (7.2%), 
intestine (22.4%) and liver (2.5%) after oral administration to mice. In this study, neither 
allicin nor other degradation products, such as DAS, DADS, vinyldithiins, were found. This 
clearly indicates that alliin itself is never metabolized, in absence of alliinase, even by liver 
enzymes (Guo et al., 1990). Ex vivo experiments, on isolated perfused rat liver, have 
suggested that allicin is not a biologically active component of garlic. After infusion at low 
concentrations, allicin bound to liver epithelium, reached the hepatic first-pass and was 
rapidly metabolized into DADS and AM, both compounds detectable in hepatic tissue and 
bile; allicin instead was not found (Egen-Schwind et al., 1992b). Another study of the same 
authors confirmed that the metabolism of allicin occurred in liver as it was rapidly 
transformed in presence of liver homogenate (Egen-Schwind et al., 1992a). Experiments 
using intraperitoneal injection of 35S-labeled DADS in mice revealed that a maximum of 
radioactivity (70% of the total amount) was detected in the liver 90 min after administration. 
Actually, mostly 35S-labeled sulfate (80% of the radioactivity of the liver) was detected 
suggesting that the metabolism of DADS occurs in this organ (Pushpendran et al., 1980). 
Germain and coworkers have reported that DADS was mainly transformed into AM, AMS, 
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OSCs, since the specific JNK inhibitor SP600125 is able to exert a protective effect (Wu, X.J. et 
al., 2009; Xiao et al., 2003). JNK activation and Bcl-2 phosphorylation are events that 
accompany changes in the MT dynamics (Mollinedo & Gajate, 2003). This suggests an 
intermediate role of JNK as a transducer of the stress produced by OSCs between the MT 
network and Bcl-2 (and possibly to other Bcl-2 family members). Alternatively, JNK 
activation has been explained as a consequence of ROS production, which in turn, may 
impair the ability of the JNK guardian GST to sequester and prevent the activation of the 
kinase (Filomeni et al., 2003). Further MAP kinases are activated by OSCs. Phosphorylation 
of extracellular signal-regulated kinase (ERK) has been frequently reported (Xiao et al., 
2004). Similarly, there is evidence of the activation of p38 mitogen-activated protein kinase 
(MAPK) (Das et al., 2007; Zhang, Y.W. et al., 2006) and Akt kinases (Wang, Y.B. et al., 2010b). 
The results, however, are not conclusive because their inhibition did not give univocal 
results. Figure 3 reports a model of interactions between kinases and the other factors/ 
events modulated during OSCs treatment. 
5.6 Inhibition of metastatic process and differentiation 
Metastasis is a major cause of death in cancer patients. Tumor invasion is a multistep 
process involving the detachment of cancer cells at the site of the primary tumor, the entry 
into the systemic circulation and the invasion of new tumor sites. These different steps 
require multiple molecular events including loss of adhesion and motility of cancer cells, 
and stimulating angiogenesis (which appears to be essential for cancer cell spread). First, 
several in vitro studies have reported that garlic extracts and some of its components are 
able to affect cancer cell motility and invasiveness. In 2002, Hu and coworkers published a 
first report showing that AGE suppressed rat sarcoma cell migration in vitro (Hu et al., 
2002). Referring to these results, the antimetastatic activity of purified OSCs (e.g., DADS, 
SAC) was investigated. Shin and colleagues demonstrated that DADS reduced the motility 
of the prostate LNCaP cancer cell model by increasing the tightness of the tight junctions 
and by reducing the activity, the mRNA and protein levels of MMP2 and 9 (Shin et al., 
2010). SAC also altered breast tumor MDA-MB-231 cell adhesion and invasion through the 
induction of adhesion protein E-cadherin expression and the decrease of MMP2 activity 
(Gapter et al., 2008). Recently, Lai et al. have reported that the inhibition of MMP2, 7 and 9 
in colo 2005 cells by DAS, DADS and DATS were mediated through the downregulation of 
phosphoinositide 3-kinase (PI3K), Rat sarcoma (RAS), MAP kinase kinase kinase (MEKK) 3, 
MAP kinase kinase (MKK7), ERK1/2, JNK1/2 and p38 MAPK (Lai et al., 2011). Moreover, 
suppression of angiogenesis, a process leading to the formation of new blood vessels from 
the pre-existing vascular network, has also been reported. This process is essential in cancer 
development as it takes part in primary tumor growth (i.e., provision of oxygen and 
nutrients) and in spreading to distant sites, leading to metastasis. Tumor cells are known to 
promote angiogenesis through the production of several growth factors, which stimulate 
endothelial cell proliferation and migration (for a recent review, see (Makrilia et al., 2009)). 
In 2006, studies have shown that AGE and DATS inhibited the proliferation and the 
migration of endothelial cells as well as the capillary-like tube formation in vitro (Matsuura 
et al., 2006; Xiao et al., 2006b). For example, Xiao et al. reported that DATS exerted its 
antiangiogenic activity through the inhibition of vascular endothelial growth factor (VEGF) 
secretion, the reduction of VEGF receptor 2 expression and the inactivation of Akt signaling 
pathway in human umbilical vein endothelial cells (HUVEC) (Xiao et al., 2006b).  
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In vivo studies have confirmed the evidence supporting the antimetastatic properties of 
garlic in vitro. Oral administration of SAMC to mice bearing prostate tumors reduced the 
number of pulmonary metastasis by 85% and completely abolished their presence in adrenal 
cells (Howard et al., 2007). In another study, Singh and coworkers have shown that oral 
administration of DATS to TRAMP mice decreased the development of pulmonary 
metastasis (about 50% compared with the control mice) without inhibiting angiogenic 
features at the tested dose (Singh et al., 2008). Despite the different evidence obtained in 
vitro, the molecular events implicated in the antimetastatic activity of OSCs remain to be 
clarified. 
Cancer cells are characterized by the loss of growth control mechanisms and thus remain in 
a less differentiated, immature state. One important therapy approach is therefore the 
induction of differentiation in order to restrain the cancer cell proliferation. In this respect, 
garlic oil was described to induce differentiation in human gastric cancer BGC-823 (Brew et 
al., 2000) and HL-60 promyelocytic leukemia cells (Seki et al., 2000). The ability to induce 
cancer cell differentiation could be linked to DADS and SAC. Studies on DADS found that 
upregulation of p21(WAF) and acetylated histones H3 and H4 is associated with the 
induction of differentiation in HL-60 cells (Ling et al., 2006) while in MGC803 gastric cancer 
cells alterations of the ERK1/2 signaling pathway are involved in this process (Chu et al., 
2006). Abnormal expression of cytokeratins (marker of epithelial cell differentiation), which 
is connected to malignant progression, was restored by SAC administration in hamster 
buccal pouch carcinogenesis in Syrian hamsters (Balasenthil et al., 2003). Other studies 
reported that SAC upregulated E-cadherin expression in MDA-MB-231 breast tumor and 
PCa prostate cancer cells (Chiang et al., 2006; Gapter et al., 2008). On the other hand, in 
former studies, no differentiation markers could be detected in neuroblastoma or melanoma 
cells upon SAC treatment (Takeyama et al., 1993; Welch et al., 1992). 
6. Bioavailability and pharmacokinetics of OSCs 
Little is known from preclinical and clinical studies about the bioavailability, the 
metabolism and the excretion of garlic ingredients after consumption. Guo and coworkers 
have reported that pure alliin is absorbed in vivo as it can be detected in stomach (7.2%), 
intestine (22.4%) and liver (2.5%) after oral administration to mice. In this study, neither 
allicin nor other degradation products, such as DAS, DADS, vinyldithiins, were found. This 
clearly indicates that alliin itself is never metabolized, in absence of alliinase, even by liver 
enzymes (Guo et al., 1990). Ex vivo experiments, on isolated perfused rat liver, have 
suggested that allicin is not a biologically active component of garlic. After infusion at low 
concentrations, allicin bound to liver epithelium, reached the hepatic first-pass and was 
rapidly metabolized into DADS and AM, both compounds detectable in hepatic tissue and 
bile; allicin instead was not found (Egen-Schwind et al., 1992b). Another study of the same 
authors confirmed that the metabolism of allicin occurred in liver as it was rapidly 
transformed in presence of liver homogenate (Egen-Schwind et al., 1992a). Experiments 
using intraperitoneal injection of 35S-labeled DADS in mice revealed that a maximum of 
radioactivity (70% of the total amount) was detected in the liver 90 min after administration. 
Actually, mostly 35S-labeled sulfate (80% of the radioactivity of the liver) was detected 
suggesting that the metabolism of DADS occurs in this organ (Pushpendran et al., 1980). 
Germain and coworkers have reported that DADS was mainly transformed into AM, AMS, 
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allylmethylsulfoxide and allylmethylsulfone when orally administrated to rats (Germain et 
al., 2002). Pharmacokinectics of vinyldithiins have also been studied in animal models. Both 
2-vinyl-4H-1,3-dithiin and 3-vinyl-4H-1,2-dithiin were found in serum, kidney and fat tissue 
after oral administration to rats, whereas only 2-vinyl-4H-1,3-dithiin was found in liver. The 
latter was more rapidly eliminated probably due to its lower lipophilicity (Egen-Schwind et 
al., 1992a). Bioavailability of SAC, a main constituent of AGE, was more extensively studied 
in animal and human. SAC achieved the intestinal first-pass and occurred in plasma, liver 
and kidney. Its bioavailability was close to 100% when administrated to rat, mouse and dog. 
Interestingly, concentrations detected in blood correlated well with the doses of oral intake, 
suggesting SAC as a biological active component of garlic. Then, SAC was excreted in urine 
as N-acetylated metabolites, indicating a metabolizing-process mediated through N-acetyl 
transferases (Nagae et al., 1994). Comparable results have been obtained from clinical 
studies (Jandke & Spiteller, 1987; Rosen et al., 2001). 
7. Ongoing clinical trials 
At the moment, few clinical trials are ongoing (information available on 
www.clinicaltrials.gov). These studies aim at elucidating the bioavailability of garlic in 
humans and evaluating its benefits in chemoprevention and as supplement in cancer 
treatment. A study with healthy patients deals with the bioavailability of allicin from garlic 
supplements (powder) and garlic clove (raw, cooked, processed). Concerning the 
chemopreventive benefit of garlic consumption, some investigators are recruiting healthy 
volunteers to evaluate the way by which garlic reduces cancer risk (analysis of a panel of 
cancer biomarkers in control vs. treated groups). Finally, two studies are conducted to assess 
the potential benefits of co-administration of garlic and conventional chemotherapeutics in 
cancer patients. As example, we can cite a clinical trial studying how garlic intake affects 
docetaxel treatment in locally advanced or metastatic breast cancer patients. Another phase 
II study, gathering 45 patients with aggressive follicular lymphoma (stage III/IV), has been 
started to assess the ability of garlic extract to impact apoptosis and cancer cell proliferation.  
8. Conclusions 
A large body of evidence supports the anti-cancer potential of OSCs from Allium species. 
The huge amount of data is consistent with a future dual potential clinical application of 
selected compounds, in chemoprevention as well as in chemotherapy. The sulfur 
component is mostly responsible of their chemical properties. The fact that many enzymes 
and proteins are regulated by modifications occurring at the level of redox-sensitive cysteine 
residues accounts for their versatility and multitasking potential. So far a good part of the 
path in the elucidation of the mechanisms responsible for OSCs anti-cancer activities has 
been covered. 
Some important challenges need still to be faced. First, the impact of OSCs on cell cycle 
raises the question if purified agents from Allium species may be nevertheless toxic for not-
malignant proliferating cells, at the concentrations tested in vitro. In this sense, indepth 
investigations confirming the differential effects of OSCs on cancer vs. healthy cells are 
absolutely required. Second, the fact that cancer of the digestive tract and prostate appear as 
the most sensitive ones to the chemopreventive effects of Allium vegetables intake may 
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reflect a problem of their stability. Tissues/organs, which are in inner connection with the 
digestive/urinary systems, are obviously exposed to higher concentrations of biologically 
active products deriving from the degradation/catabolism of any ingested food or 
supplements. This encourages any efforts aimed at increasing the stability of these 
compounds, hopefully without increasing also their toxicity. Finally, the conjugation of 
molecules specifically recognizing and binding to cancer cells together with the enzyme 
alliinase could generate high concentrations of alliin right at the tumor site and may 
represent an interesting attempt to overcome both limiting factors (Appel et al., 2011). 
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after oral administration to rats, whereas only 2-vinyl-4H-1,3-dithiin was found in liver. The 
latter was more rapidly eliminated probably due to its lower lipophilicity (Egen-Schwind et 
al., 1992a). Bioavailability of SAC, a main constituent of AGE, was more extensively studied 
in animal and human. SAC achieved the intestinal first-pass and occurred in plasma, liver 
and kidney. Its bioavailability was close to 100% when administrated to rat, mouse and dog. 
Interestingly, concentrations detected in blood correlated well with the doses of oral intake, 
suggesting SAC as a biological active component of garlic. Then, SAC was excreted in urine 
as N-acetylated metabolites, indicating a metabolizing-process mediated through N-acetyl 
transferases (Nagae et al., 1994). Comparable results have been obtained from clinical 
studies (Jandke & Spiteller, 1987; Rosen et al., 2001). 
7. Ongoing clinical trials 
At the moment, few clinical trials are ongoing (information available on 
www.clinicaltrials.gov). These studies aim at elucidating the bioavailability of garlic in 
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1. Introduction 
Consumption of soy foods has been associated, at least in part, with lower incidences of a 
number of chronic diseases indicated by epidemiological studies (1-4). Soy-based foods 
have been consumed in Asian countries such as China, Japan and Korea for many 
centuries. The lower rates of several chronic diseases in Asia, including cardiovascular 
diseases and certain types of cancer, have been partly attributed to consumption of large 
quantities of soy foods (5, 6). 
Soy-based food was first introduced on a large scale to the general U.S. population as a 
source of high quality protein. A significant increase in soy food consumption during the 
last decade of the 20th century occurred because of the health benefits soy food might offer 
independent of their nutrient content (7). In the last few decades, extensive efforts have 
been made towards identifying bioactive components in soy foods that are responsible for 
the health benefits. Among them, isoflavones and soy proteins are the two major groups 
of components that have received the most attention (8-11). Isoflavones belong to a broad 
group of plant-derived compounds that have structural and functional similarities to 
estrogens, which has led to the term phytoestrogens (12, 13). Indeed, more than half of the 
soy-related papers are related to isoflavones (7). The analysis, bioavailability and the 
health effects of isoflavones have been extensively studied and frequently reviewed (12, 
14-21). Consumption of isoflavones has been suggested to have multiple beneficial effects 
in a number of chronic diseases and medical conditions (4, 22, 23). However, 
accumulating evidence has also suggested that isoflavones only reflected certain aspects 
of the health effects associated with soy consumption. Other components in soy, such as 
soyasaponins, phytic acid or plant sterols, display a wide range of bioactivities, including 
anti-cancer, anti-oxidative, anti-viral, cardiovascular protective effects, and hepato-
protective actions (24).  
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In this chapter, we summarize the structural characterization of major phytochemicals in 
soybean and soy-based foods. Potential health benefits of these phytochemicals, especially 
the non-isoflavone phytochemicals and their preventive effects of chronic and lifestyle-
related diseases, are also briefly discussed.  
2. Phytochemicals in soybean and their health effects  
In this section, the structural characterizations of major phytochemicals that naturally exist 
in soybean are firstly summarized. Composition and contents of phytochemicals in soybean 
vary dramatically depending on the variety and growing environment. In general, the  
 
Fig. 1. The chemical structures of isoflavones in soy. 
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contents of major phytochemicals from high to low in soybean are: phytic acid (1.0-2.2%) 
(25), sterols (0.23-0.46%) (26), saponins (0.17-6.16%) (27), isoflavones (0.1-0.3%) (23), and 
lignans (0.02%) (28). Secondly, the potential health effects of the major phytochemicals are 
outlined. For many years, the studies of health effects of soybean phytochemicals primarily 
focused on isoflavones. However, other phytochemicals in soy, such as soyasaponins, 
phytosterols, lignans, phytic acid, and oligosaccharides, have also been found to exert 
biological activities. These may contribute to overall health effects observed with soy 
consumption.  
2.1 Isoflavones 
2.1.1 Chemical characteristics of isoflavones  
Isoflavones have been known to exist in plants for over 100 years. And soy, including the 
foods derived from this legume, is considered as a richest dietary source of isoflavones (7). 
Isoflavones (3-phenyl-4H-1-benzopyran-4-one) are a subclass of more ubiquitous flavonoids, 
while they differs from flavone (2-phenyl-4H-1-benzopyran-4-one) in that the phenyl group 
(B ring) is connected to position 3 instead of position 2 (Figure 1) (29). Soy mainly contains 
three isoflavones, namely daidzein (7,4'-dihydroxyisoflavone) (1), genistein (5,7,4'-
trihydroxyisoflavone) (2) and glycitein (6-methoxy-7,4'-dihydroxyisoflavone) (3). Genistein 
and daidzein have been found in relatively high concentrations in soybean and most soy-
based foods. In soybean and non-fermented soy foods, they are generally present as one of the 
following three β-glucoside conjugates: a) the corresponding glucosides: daidzin (daidzein 7-
O--D-glucoside) (4), genistin (genistein 7-O--D-glucoside) (5) and glycitin (glycitein 7-O--D-
glucoside) (6); b) the corresponding acetylglucosides: 6-O-acetyldaidzin (7), 6-O-
acetylgenistin (8) and 6-O-acetylglycitin (9); and c) the corresponding malonylglucosides: 6-O-
malonyldaidzin (10), 6-O-malonylgenistin (11) and 6-O-malonylglycitin (12) (29). In addition 
to β-glucoside conjugates, isoflavones conjugated with other sugar moieties, including 6-O--
D-arabinose-genistin (13) and 6-O--D-xylose-genistin (14). Other isoflavones, including    
2,6-O –diacetyloninin (15), and two dihydro-isoflavanones, dihydrodaidzin (16) and 
dihydrogenistin (17) were reported recently in the last ten years (30, 31).  
2.1.2 Health effects of isoflavones 
Health effects of isoflavones were initially thought to be related to their estrogenic activity (23). 
The molecular structures of isoflavones, especially genistein (2), are similar to that of 17β-
estradiol (Figure 2). Isoflavones can bind to both α and β isoforms of esterogen receptor (ER), 
but their binding affinity to ERβ is about 20 times higher than that to ERα (11). However, 
compared to physiological estrogen such as 17β-estradiol, isoflavones have approximately 100 
times weaker affinities (32). Estrogen-like effects have been proposed as one of the major 
mechanism of action of isoflavone related to their health effects (8). A second mechanism of 
action of isoflavones, particularly of genistein, was discovered that genistein is a protein 
tyrosine kinase (PTK) inhibitor (8). Since then, isoflavones have been shown to affect a diverse 
array of intracellular signaling pathways (7). For instance, genistein and other isoflavones were 
found to interact with the peroxisome proliferator activated receptors, PPARα/γ. These 
nuclear receptors are activated by fatty acids (PPARα) and prostaglandins (PPARγ) and serve 
as transcription factors (32). As polyphenols, isoflavones also have antioxidant activities, 
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soybean and soy-based foods. Potential health benefits of these phytochemicals, especially 
the non-isoflavone phytochemicals and their preventive effects of chronic and lifestyle-
related diseases, are also briefly discussed.  
2. Phytochemicals in soybean and their health effects  
In this section, the structural characterizations of major phytochemicals that naturally exist 
in soybean are firstly summarized. Composition and contents of phytochemicals in soybean 
vary dramatically depending on the variety and growing environment. In general, the  
 
Fig. 1. The chemical structures of isoflavones in soy. 
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contents of major phytochemicals from high to low in soybean are: phytic acid (1.0-2.2%) 
(25), sterols (0.23-0.46%) (26), saponins (0.17-6.16%) (27), isoflavones (0.1-0.3%) (23), and 
lignans (0.02%) (28). Secondly, the potential health effects of the major phytochemicals are 
outlined. For many years, the studies of health effects of soybean phytochemicals primarily 
focused on isoflavones. However, other phytochemicals in soy, such as soyasaponins, 
phytosterols, lignans, phytic acid, and oligosaccharides, have also been found to exert 
biological activities. These may contribute to overall health effects observed with soy 
consumption.  
2.1 Isoflavones 
2.1.1 Chemical characteristics of isoflavones  
Isoflavones have been known to exist in plants for over 100 years. And soy, including the 
foods derived from this legume, is considered as a richest dietary source of isoflavones (7). 
Isoflavones (3-phenyl-4H-1-benzopyran-4-one) are a subclass of more ubiquitous flavonoids, 
while they differs from flavone (2-phenyl-4H-1-benzopyran-4-one) in that the phenyl group 
(B ring) is connected to position 3 instead of position 2 (Figure 1) (29). Soy mainly contains 
three isoflavones, namely daidzein (7,4'-dihydroxyisoflavone) (1), genistein (5,7,4'-
trihydroxyisoflavone) (2) and glycitein (6-methoxy-7,4'-dihydroxyisoflavone) (3). Genistein 
and daidzein have been found in relatively high concentrations in soybean and most soy-
based foods. In soybean and non-fermented soy foods, they are generally present as one of the 
following three β-glucoside conjugates: a) the corresponding glucosides: daidzin (daidzein 7-
O--D-glucoside) (4), genistin (genistein 7-O--D-glucoside) (5) and glycitin (glycitein 7-O--D-
glucoside) (6); b) the corresponding acetylglucosides: 6-O-acetyldaidzin (7), 6-O-
acetylgenistin (8) and 6-O-acetylglycitin (9); and c) the corresponding malonylglucosides: 6-O-
malonyldaidzin (10), 6-O-malonylgenistin (11) and 6-O-malonylglycitin (12) (29). In addition 
to β-glucoside conjugates, isoflavones conjugated with other sugar moieties, including 6-O--
D-arabinose-genistin (13) and 6-O--D-xylose-genistin (14). Other isoflavones, including    
2,6-O –diacetyloninin (15), and two dihydro-isoflavanones, dihydrodaidzin (16) and 
dihydrogenistin (17) were reported recently in the last ten years (30, 31).  
2.1.2 Health effects of isoflavones 
Health effects of isoflavones were initially thought to be related to their estrogenic activity (23). 
The molecular structures of isoflavones, especially genistein (2), are similar to that of 17β-
estradiol (Figure 2). Isoflavones can bind to both α and β isoforms of esterogen receptor (ER), 
but their binding affinity to ERβ is about 20 times higher than that to ERα (11). However, 
compared to physiological estrogen such as 17β-estradiol, isoflavones have approximately 100 
times weaker affinities (32). Estrogen-like effects have been proposed as one of the major 
mechanism of action of isoflavone related to their health effects (8). A second mechanism of 
action of isoflavones, particularly of genistein, was discovered that genistein is a protein 
tyrosine kinase (PTK) inhibitor (8). Since then, isoflavones have been shown to affect a diverse 
array of intracellular signaling pathways (7). For instance, genistein and other isoflavones were 
found to interact with the peroxisome proliferator activated receptors, PPARα/γ. These 
nuclear receptors are activated by fatty acids (PPARα) and prostaglandins (PPARγ) and serve 
as transcription factors (32). As polyphenols, isoflavones also have antioxidant activities, 
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which were proposed as another important mechanism of action of isoflavones. However, 
isoflavones are not strong antioxidant may not be able to scavenge oxidants directly. They 
therefore are considered as antioxidants because of their effects on gene expression of enzymes 
that enhance antioxidant defenses (32). In addition to what has been discussed above, several 
other mechanism have been proposed for the activities of isoflavones, including 
stimulation/inhibition of enzyme activities involved in steroid synthesis and metabolism, 
targeting thyroid peroxidase, and inhibiting cancer metastasis (32). 
 
Fig. 2. The chemical structures of genistein and 17β-estradiol.  
Consumption of isoflavones has been suggested to have multiple beneficial effects in a 
number of chronic diseases and medical conditions, including certain types of cancer (33-
35), heart disease (36-38), bone functions (39-42) and most recently, prevention of obesity 
(43, 44). Many excellent reviews regarding the different aspects of health effects of soy 
isoflavone can be found in the literatures, thus, only a brief outline of the health effects of 
isoflavones is provided in this chapter.  
2.1.2.1 Isoflavones and prevention of cancer 
The incidences of breast and prostate cancers are much higher in the United States and 
European countries compared to Asian countries such as Japan and China. One of the major 
differences in diet between these populations is that the Japanese and the Chinese consume a 
traditional diet high in soy products (35). Epidemiological evidence together with preclinical 
data from animal and in vitro studies strongly supported a correlation between soy isoflavone 
consumption and protection towards breast and prostate cancers (45-47). However, clinical 
studies assessing soy consumption and risk of breast cancer have yielded inconsistent results. 
In a most recent meta-analysis of prospective studies suggested that soy isoflavones intake is 
associated with a significantly reduced risk of breast cancer incidence in Asian populations, 
but not in Western populations. Further studies are warranted to confirm the finding of an 
inverse association of soy consumption with risk of breast cancer recurrence (48).  
Except for breast and prostate cancer, isoflavones also showed inhibitory effects on other 
hormone-related (e.g. endometrial, ovarian cancer) or hormone-independent cancers (e.g. 
leukemia and lung cancer) (49).  
2.1.2.2 Isoflavones and prevention of cardiovascular diseases 
A number of cardioprotective benefits have been attributed to dietary isoflavones including 
reduction in LDL cholesterol, inhibition of pro-inflammatory cytokines, cell adhesion 
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proteins and inducible nitric oxide production, potential reduction in the susceptibility of 
the LDL particle to oxidation, inhibition of platelet aggregation and an improvement in 
vascular reactivity (50).There are not randomized trials investigating the action of 
isoflavones on the incidence of clinical events. A few recent, well-designed studies have 
suggested an association of the ingestion of isoflavones with a reduction in the 
atherosclerotic burden, as indicated by the measurement of the intima-media thickness in 
carotid vessels (51).  
2.1.2.3 Isoflavones and bone health 
Observational studies have suggested that populations in Asia with a high dietary soy 
intake have a lower incidence of osteoporosis-related fractures when compared to Western 
populations. Isoflavones were suggested to prevent bone loss associated with menopause. 
Though extensive research using animal models has provided convincing data to indicate a 
significant improvement in bone mass or other end points following feeding with soyabean, 
results from intervention studies are still controversial (52). Additional research is needed to 
determine if isoflavones are an effective alternative to hormone replacement therapy for the 
prevention and treatment of osteoporosis (42). 
2.1.2.4 Isoflavones and prevention of obesity 
The prevalence of obesity and related diseases has increased rapidly in the Western world. 
Obesity is a disorder of energy balance and is associated with hyper-insulinemia, insulin 
resistance, and abnormalities in lipid metabolism, and it is one of the most important risk 
factors in the development of Type II diabetes, cardiovascular disease, atherosclerosis, and 
certain cancers (44). In recent years, evidence is emerging that soy isoflavones play a 
beneficial role in obesity and diabetes. Nutritional intervention studies in animals and 
humans indicate that consumption of soy isoflaovne or soy protein containing isoflavones 
reduces body weight and fat mass by lowering plasma cholesterol and triglycerides as well 
as by other mechanisms (43, 44, 53). Though the published results suggest a beneficial effect 
of soy isoflavone on obesity in human, these results also suggest that the effect may be 
dependent on whether the isoflavones are consumed in combination with soy protein (44).  
2.2 Soyasaponins and soyasapogenols  
2.2.1 Chemical characteristics of soyasaponins and soyasapogenols  
Saponins are sterol or triterpene glycosides that occur in a wide variety of plants. Soy-based 
foods are primary dietary sources of saponins (54). Chemical studies of saponins in soy 
track back to the 1930’s (55, 56). From the 1980’s to 1990’s, a number of papers, especially 
those published by Japanese researchers, significantly enriched our knowledge about 
chemical structure and diversity of this type of compounds in soy (57-65).  
Saponins in soy are often referred to soyasaponins. They differ from each other by the types 
of aglycones and the position where the sugar chain is attached. Generally, saponins are 
classified into four major groups, on the basis of their aglycone structures: group A, B, E and 
DDMP. Group A saponins have a hydroxyl group at the C-21 position, and group B 
saponins have a hydrogen atom at the same position. Group E saponins differ from group A 
and B by having a carbonyl group at C-22. Group B saponins may contain a DDMP (2,3-
dihydro-2,5-dihydroxy-6-methyl-4H-pyran-4-one) moiety at C-22 position, which are 
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which were proposed as another important mechanism of action of isoflavones. However, 
isoflavones are not strong antioxidant may not be able to scavenge oxidants directly. They 
therefore are considered as antioxidants because of their effects on gene expression of enzymes 
that enhance antioxidant defenses (32). In addition to what has been discussed above, several 
other mechanism have been proposed for the activities of isoflavones, including 
stimulation/inhibition of enzyme activities involved in steroid synthesis and metabolism, 
targeting thyroid peroxidase, and inhibiting cancer metastasis (32). 
 
Fig. 2. The chemical structures of genistein and 17β-estradiol.  
Consumption of isoflavones has been suggested to have multiple beneficial effects in a 
number of chronic diseases and medical conditions, including certain types of cancer (33-
35), heart disease (36-38), bone functions (39-42) and most recently, prevention of obesity 
(43, 44). Many excellent reviews regarding the different aspects of health effects of soy 
isoflavone can be found in the literatures, thus, only a brief outline of the health effects of 
isoflavones is provided in this chapter.  
2.1.2.1 Isoflavones and prevention of cancer 
The incidences of breast and prostate cancers are much higher in the United States and 
European countries compared to Asian countries such as Japan and China. One of the major 
differences in diet between these populations is that the Japanese and the Chinese consume a 
traditional diet high in soy products (35). Epidemiological evidence together with preclinical 
data from animal and in vitro studies strongly supported a correlation between soy isoflavone 
consumption and protection towards breast and prostate cancers (45-47). However, clinical 
studies assessing soy consumption and risk of breast cancer have yielded inconsistent results. 
In a most recent meta-analysis of prospective studies suggested that soy isoflavones intake is 
associated with a significantly reduced risk of breast cancer incidence in Asian populations, 
but not in Western populations. Further studies are warranted to confirm the finding of an 
inverse association of soy consumption with risk of breast cancer recurrence (48).  
Except for breast and prostate cancer, isoflavones also showed inhibitory effects on other 
hormone-related (e.g. endometrial, ovarian cancer) or hormone-independent cancers (e.g. 
leukemia and lung cancer) (49).  
2.1.2.2 Isoflavones and prevention of cardiovascular diseases 
A number of cardioprotective benefits have been attributed to dietary isoflavones including 
reduction in LDL cholesterol, inhibition of pro-inflammatory cytokines, cell adhesion 
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proteins and inducible nitric oxide production, potential reduction in the susceptibility of 
the LDL particle to oxidation, inhibition of platelet aggregation and an improvement in 
vascular reactivity (50).There are not randomized trials investigating the action of 
isoflavones on the incidence of clinical events. A few recent, well-designed studies have 
suggested an association of the ingestion of isoflavones with a reduction in the 
atherosclerotic burden, as indicated by the measurement of the intima-media thickness in 
carotid vessels (51).  
2.1.2.3 Isoflavones and bone health 
Observational studies have suggested that populations in Asia with a high dietary soy 
intake have a lower incidence of osteoporosis-related fractures when compared to Western 
populations. Isoflavones were suggested to prevent bone loss associated with menopause. 
Though extensive research using animal models has provided convincing data to indicate a 
significant improvement in bone mass or other end points following feeding with soyabean, 
results from intervention studies are still controversial (52). Additional research is needed to 
determine if isoflavones are an effective alternative to hormone replacement therapy for the 
prevention and treatment of osteoporosis (42). 
2.1.2.4 Isoflavones and prevention of obesity 
The prevalence of obesity and related diseases has increased rapidly in the Western world. 
Obesity is a disorder of energy balance and is associated with hyper-insulinemia, insulin 
resistance, and abnormalities in lipid metabolism, and it is one of the most important risk 
factors in the development of Type II diabetes, cardiovascular disease, atherosclerosis, and 
certain cancers (44). In recent years, evidence is emerging that soy isoflavones play a 
beneficial role in obesity and diabetes. Nutritional intervention studies in animals and 
humans indicate that consumption of soy isoflaovne or soy protein containing isoflavones 
reduces body weight and fat mass by lowering plasma cholesterol and triglycerides as well 
as by other mechanisms (43, 44, 53). Though the published results suggest a beneficial effect 
of soy isoflavone on obesity in human, these results also suggest that the effect may be 
dependent on whether the isoflavones are consumed in combination with soy protein (44).  
2.2 Soyasaponins and soyasapogenols  
2.2.1 Chemical characteristics of soyasaponins and soyasapogenols  
Saponins are sterol or triterpene glycosides that occur in a wide variety of plants. Soy-based 
foods are primary dietary sources of saponins (54). Chemical studies of saponins in soy 
track back to the 1930’s (55, 56). From the 1980’s to 1990’s, a number of papers, especially 
those published by Japanese researchers, significantly enriched our knowledge about 
chemical structure and diversity of this type of compounds in soy (57-65).  
Saponins in soy are often referred to soyasaponins. They differ from each other by the types 
of aglycones and the position where the sugar chain is attached. Generally, saponins are 
classified into four major groups, on the basis of their aglycone structures: group A, B, E and 
DDMP. Group A saponins have a hydroxyl group at the C-21 position, and group B 
saponins have a hydrogen atom at the same position. Group E saponins differ from group A 
and B by having a carbonyl group at C-22. Group B saponins may contain a DDMP (2,3-
dihydro-2,5-dihydroxy-6-methyl-4H-pyran-4-one) moiety at C-22 position, which are 
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denoted as DDMP saponins (66) (Figure 3) . DDMP soyasaponins and the acetylated 
soyasaponins of group A are sometimes considered as the genuine forms of groups A and B 
in soybeans. Group E soyasaponins are also considered to be phyto-oxidation products of 
group B soyasaponins (62, 67, 68). All four groups of soysaponins are glycosides of oleanan 
triterpene aglycones known as soyasapongenols. The oleanan aglycone contains one or 
more hydroxyl groups, and carboxylic groups and double bonds may also be present. The 
sugar moieties are generally attached at the C-3 position and sometimes at the C-22 postion 
of the aglycones. Group A soysaponins have two sugar chains, separately attached to C-3 
and C-22 positions of soyasapogenol A, except for A3 (33), which has only one sugar chain 
at C-3 (Table 1). C-3 sugar chain consists of two or three sugar residues, starting with a 
glucoronyl residue (glcUA) (67). C-22 side chain consists of two sugar residues, starting with 
an anarabinosyl, and ending with a xylosyl or glycosyl residue (58, 63, 65, 69) (Figure 3). 
Group B soysaponins have one sugar chain attached to the C-3 position of soyasapogenol B, 
with three exceptional compounds that have two sugar chains at C-3 and C-22 positions (41-
43) (57, 59, 69-71) (Figure 3). Most recently, a new soyasaponin Bh (40) was identified to bear 
an unique five-membered ring containing a hemiacetal functionality (Figure 3) (72). Group 
E soysaponins contain only one sugar chain at the C-3 position. They are considered to be 
formed by photo-oxidation at C-22 of group B (63, 69) (Figure 3). DDMP soyasaponins are 
categorized under B type soyasaponins by some researchers (27). Their structures were 
characterized as having DDMP group conjugated to group B at C-22 (67, 68, 73, 74) (Figure 
3). Similar to B type soyasaponins, DDMP soyasaponins only contain one sugar chain 
attached to C-3 postion. There are about 36 soysaponins identified in soybean. Their 




NO. name C-3 sugar chain C-22 sugar chain  molecular 
formula 
ref 
18 Aa (acetyl A4) glc(12)gal(12)glcUA(13) 2,3,4-tri-O-acetyl-xyl(13)ara(122) C64H100O31 65 
19 Ab (acetyl A1) glc(12)gal(12)glcUA(13) 2,3,4,6-tetra-O-acetyl-glc(13)ara(122) C67H104O33 64 
20 Ac  rha(12)gal(12)glcUA(13) 2,3,4,6-tetra-O-acetyl-glc(13)ara(122) C67H104O32 63 
21 Ad glc(12)ara(12)glcUA(13) 2,3,4,6-tetra-O-acetyl-glc(13)ara(122) C66H102O32 63 
22 Ae (acetyl A5) gal(12)glcUA(13) 2,3,4-tri-O-acetyl-xyl(13)ara(122) C58H90O26 65 
23 Af (acetyl A2) gal(12)glcUA(13) 2,3,4,6-tetra-O-acetyl-glc(13)ara(122) C61H94O28 64 
24 Ag (acetyl A6) ara(12)glcUA(13) 2,3,4-tri-O-acetyl-xyl(13)ara(122) C57H88O25 65 
25 Ah (acetyl A3) ara(12)glcUA(13) 2,3,4,6-tetra-O-acetyl-glc(13)ara(122) C60H92O27 64 
26 Ax glc(12)ara(12)glcUA(13) 2,3,4-tri-O-acetyl-xyl(13)ara(122) C63H98O30 69 
27 A1 glc(12)gal(12)glcUA(13) glc(13)ara(122) C59H96O29 64 
28 A2 gal(12)glcUA(13) glc(13)ara(122) C53H86O24 64 
29 A3 ara(12)glcUA(13) glc(13)ara(122) C52H84O23 64 
30 A4 glc(12)gal(12)glcUA(13) xyl(13)ara(122) C58H94O28 64 
31 A5 gal(12)glcUA(13) xyl(13)ara(122) C52H84O23 64 
32 A6 ara(12)glcUA(13) xyl(13)ara(122) C51H82O22 64 
33 A3 rha(12)gal(12)glcUA(13)  C48H78O19 58 
Table 1. The structures and molecular formulas of group A soyasaponins 
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34 soyasaponin Ba or V glc(12)gal(12)glcUA(13)  C48H78O19 64 
35 soyasaponin Bb or I rha(12)gal(12)glcUA(13)  C48H78O18 59 
36 soyasaponin Bc or II rha(12)ara(12)glcUA(13)  C47H76O17 59 
37 soyasaponin Bbor III gal(12)glcUA(13)  C42H68O14 59 
38 soyasaponin Bc or Bx glc(12)ara(12)glcUA(13)  C47H76O18 69 
39 soyasaponin IV ara(12)glcUA(13)  C41H66O13 57 































Table 2. The structures  and molecular formulas of group B soyasaponins 
NO. name C-3 sugar chain molecular 
formula 
ref 
44 soyasaponin Bd (sandosaponin A)  glc(12)gal(12)glcUA(13) C48H76O19 63 
45 soyasaponin Be (dehydrosoyasaponin I) rha(12)gal(12)glcUA(13) C48H76O18 63 
46 soyasaponin Bf glc(12)ara(12)glcUA(13) C47H74O18 69 
47 soyasaponin Bg rha(12)ara-(12)glcUA(13) C47H74O17 69 
Table 3. The structures and molecular formulas of group E soyasaponins 
NO. name C-3 sugar chain C-22 DDMP  molecular 
formula 
ref 
48 soyasaponin g glc(12)gal(12)glcUA(13) DDMP(222) C54H84O22 68 
49 soyasaponin a glc(12)ara(12)glcUA(13) DDMP(222) C53H82O21 74 
50 soyasaponin g or VI rha(12)gal(12)glcUA(13) DDMP(222) C54H84O21 68 
51 soyasaponin a rha(12)ara(12)glcUA(13) DDMP(222) C53H82O20 68 
52 soyasaponin g gal(12)glcUA(13) DDMP(222) C48H74O17 68 
53 soyasaponin a ara(12)glcUA(13) DDMP(222) C47H72O16 68 
Table 4. The structures and molecular formulas of group DDMP soyasaponins 
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denoted as DDMP saponins (66) (Figure 3) . DDMP soyasaponins and the acetylated 
soyasaponins of group A are sometimes considered as the genuine forms of groups A and B 
in soybeans. Group E soyasaponins are also considered to be phyto-oxidation products of 
group B soyasaponins (62, 67, 68). All four groups of soysaponins are glycosides of oleanan 
triterpene aglycones known as soyasapongenols. The oleanan aglycone contains one or 
more hydroxyl groups, and carboxylic groups and double bonds may also be present. The 
sugar moieties are generally attached at the C-3 position and sometimes at the C-22 postion 
of the aglycones. Group A soysaponins have two sugar chains, separately attached to C-3 
and C-22 positions of soyasapogenol A, except for A3 (33), which has only one sugar chain 
at C-3 (Table 1). C-3 sugar chain consists of two or three sugar residues, starting with a 
glucoronyl residue (glcUA) (67). C-22 side chain consists of two sugar residues, starting with 
an anarabinosyl, and ending with a xylosyl or glycosyl residue (58, 63, 65, 69) (Figure 3). 
Group B soysaponins have one sugar chain attached to the C-3 position of soyasapogenol B, 
with three exceptional compounds that have two sugar chains at C-3 and C-22 positions (41-
43) (57, 59, 69-71) (Figure 3). Most recently, a new soyasaponin Bh (40) was identified to bear 
an unique five-membered ring containing a hemiacetal functionality (Figure 3) (72). Group 
E soysaponins contain only one sugar chain at the C-3 position. They are considered to be 
formed by photo-oxidation at C-22 of group B (63, 69) (Figure 3). DDMP soyasaponins are 
categorized under B type soyasaponins by some researchers (27). Their structures were 
characterized as having DDMP group conjugated to group B at C-22 (67, 68, 73, 74) (Figure 
3). Similar to B type soyasaponins, DDMP soyasaponins only contain one sugar chain 
attached to C-3 postion. There are about 36 soysaponins identified in soybean. Their 




NO. name C-3 sugar chain C-22 sugar chain  molecular 
formula 
ref 
18 Aa (acetyl A4) glc(12)gal(12)glcUA(13) 2,3,4-tri-O-acetyl-xyl(13)ara(122) C64H100O31 65 
19 Ab (acetyl A1) glc(12)gal(12)glcUA(13) 2,3,4,6-tetra-O-acetyl-glc(13)ara(122) C67H104O33 64 
20 Ac  rha(12)gal(12)glcUA(13) 2,3,4,6-tetra-O-acetyl-glc(13)ara(122) C67H104O32 63 
21 Ad glc(12)ara(12)glcUA(13) 2,3,4,6-tetra-O-acetyl-glc(13)ara(122) C66H102O32 63 
22 Ae (acetyl A5) gal(12)glcUA(13) 2,3,4-tri-O-acetyl-xyl(13)ara(122) C58H90O26 65 
23 Af (acetyl A2) gal(12)glcUA(13) 2,3,4,6-tetra-O-acetyl-glc(13)ara(122) C61H94O28 64 
24 Ag (acetyl A6) ara(12)glcUA(13) 2,3,4-tri-O-acetyl-xyl(13)ara(122) C57H88O25 65 
25 Ah (acetyl A3) ara(12)glcUA(13) 2,3,4,6-tetra-O-acetyl-glc(13)ara(122) C60H92O27 64 
26 Ax glc(12)ara(12)glcUA(13) 2,3,4-tri-O-acetyl-xyl(13)ara(122) C63H98O30 69 
27 A1 glc(12)gal(12)glcUA(13) glc(13)ara(122) C59H96O29 64 
28 A2 gal(12)glcUA(13) glc(13)ara(122) C53H86O24 64 
29 A3 ara(12)glcUA(13) glc(13)ara(122) C52H84O23 64 
30 A4 glc(12)gal(12)glcUA(13) xyl(13)ara(122) C58H94O28 64 
31 A5 gal(12)glcUA(13) xyl(13)ara(122) C52H84O23 64 
32 A6 ara(12)glcUA(13) xyl(13)ara(122) C51H82O22 64 
33 A3 rha(12)gal(12)glcUA(13)  C48H78O19 58 
Table 1. The structures and molecular formulas of group A soyasaponins 
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34 soyasaponin Ba or V glc(12)gal(12)glcUA(13)  C48H78O19 64 
35 soyasaponin Bb or I rha(12)gal(12)glcUA(13)  C48H78O18 59 
36 soyasaponin Bc or II rha(12)ara(12)glcUA(13)  C47H76O17 59 
37 soyasaponin Bbor III gal(12)glcUA(13)  C42H68O14 59 
38 soyasaponin Bc or Bx glc(12)ara(12)glcUA(13)  C47H76O18 69 
39 soyasaponin IV ara(12)glcUA(13)  C41H66O13 57 































Table 2. The structures  and molecular formulas of group B soyasaponins 
NO. name C-3 sugar chain molecular 
formula 
ref 
44 soyasaponin Bd (sandosaponin A)  glc(12)gal(12)glcUA(13) C48H76O19 63 
45 soyasaponin Be (dehydrosoyasaponin I) rha(12)gal(12)glcUA(13) C48H76O18 63 
46 soyasaponin Bf glc(12)ara(12)glcUA(13) C47H74O18 69 
47 soyasaponin Bg rha(12)ara-(12)glcUA(13) C47H74O17 69 
Table 3. The structures and molecular formulas of group E soyasaponins 
NO. name C-3 sugar chain C-22 DDMP  molecular 
formula 
ref 
48 soyasaponin g glc(12)gal(12)glcUA(13) DDMP(222) C54H84O22 68 
49 soyasaponin a glc(12)ara(12)glcUA(13) DDMP(222) C53H82O21 74 
50 soyasaponin g or VI rha(12)gal(12)glcUA(13) DDMP(222) C54H84O21 68 
51 soyasaponin a rha(12)ara(12)glcUA(13) DDMP(222) C53H82O20 68 
52 soyasaponin g gal(12)glcUA(13) DDMP(222) C48H74O17 68 
53 soyasaponin a ara(12)glcUA(13) DDMP(222) C47H72O16 68 
Table 4. The structures and molecular formulas of group DDMP soyasaponins 
 




Fig. 3. The chemical structures of groups A, B, Bh, E and DDMP soyasaponins in soy. 
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Soyasapogenols are aglycones of soyasaponins. They can be obtained by acid or alkaline 
hydrolysis of soyasaponins. Though soyasapogenols don’t exist in soy bean naturally, they 
may exist in certain soy products through food processing. Five soyasapogenols A (54), B 
(55), C (56), D (57) and E (58) have been found through hydrolysis of soyasaponins (59, 62, 
75) (Figure 4). Among them, soyasapogenol A (54) has two hydroxyl groups at C-21 and C-
22 position, which is considered as corresponding aglycones to bis-desmoside soyasaponin 
group A. Soyasapogenol B (55) has only one hydroxyl group at C-22 postion. It is considered 
to be aglycone of both monodesmoside soyasaponin groups B and DDMP. Soyasapogenol E 
(58) is regarded as the corresponding aglycone to soyasaponin group E. Soyasapogenols C 
(56) and D (57) are considered by some researchers not to be genuine aglycones of 
soyasaponins, but as the acid hydrolysis products of soyasapogenol B (55) (76). 
 
Fig. 4. The chemical structures of soyasapogenols A-E (hydrolysis products of soysaponins). 
2.2.2 Health effects of soyasaponins and soyasapogenols 
Plant saponins as a whole have been reported to have a wide range of biological activities, 
which were summarized with a long list in a recent review (77). Soyasaponins and 
soyasapogenols have been reported to display diverse health effects (78), including anti-
cancer, cardiovascular protective effects, anti-virus, hepatoprotective actions and 
antioxidant activities (24, 27, 79, 80). Their health effects largely depend on their chemical 
structures (81). Since this class of soy compounds are so poorly absorbed, their bioactivity 
maybe caused by indirect actions within the GI tract.  
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which were summarized with a long list in a recent review (77). Soyasaponins and 
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structures (81). Since this class of soy compounds are so poorly absorbed, their bioactivity 
maybe caused by indirect actions within the GI tract.  
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2.2.2.1 Anti-carcinogenic activities 
Epidemiological studies have linked soy consumption to lower incidences of various types 
of cancer (82). As a group of major phytochemicals in soy, soyasaponins may be partially 
responsible (27). The evidence for soyasaponins having anti-carcinogenic effects in animal 
models is limited. Nevertheless, soyasaponins and soyasapogenols have been shown to 
have the anti-carcinogenic effects in a number of carcinoma cell lines. Before summarizing 
the data, we must keep in mind that since soy saponins are poorly absorbed, in vitro studies 
of these compounds in cell lines may not be able to provide much meaningful indication 
regarding their in vivo bioactivities.  
Most studies related to the anti-carcinogenic activities of soyasaponins and soyasapogenols 
have been performed in human colon cancer, liver cancer or breast cancer cell lines (83-88). 
The proposed mechanisms of anticarcinogenic properties of soyasaponins and 
soyasapogenols include direct cytotoxicity, induction of apoptosis, anti-estrogenic activity, 
inhibition of tumor cell metastasis, anti-mutagenic activity effect, bile acid binding action 
and normalization of carcinogen-induced cell proliferation (Table 5) (89). From these studies 
done in different cancer cell lines, we’ve learned that there are at least three major factors 
that may affect the observed effects of soyasaponins and soyasapogenols. The first factor is 
the testing materials. Some researchers used crude extracts while others used purified 
saponins. It is possible that components of the crude extract interact synergistically, thus 
inducing effects not observed with pure saponins. Therefore, investigations with purified 
saponins are indispensable for matching a result to the molecular action of a specific 
saponin (90). The second factor is the type of cell lines. It is clearly shown that different 
cancer cell lines respond differently to soy saponins. For instance, soyasaponin I (35) had no 
effect on HT-29 colon cell growth (81), but it can decrease the migratory ability of B16F10 
melanoma cells (91). The third factor is the dose. In another study, soyasaponin III (37) 
showed significant growth suppression at the highest concentration tested (50 ppm), and no 
significant effects from concentrations 6 to 25 ppm.  
2.2.2.2 Cardiovascular protective effects 
Soyasaponins showed cardiovascular protective effects through several different 
mechanisms. 
The hypocholesterolemic effects of soy saponins have long been recognized (92-95). Two 
mechanisms by which saponins can affect cholesterol metabolism were suggested (96): 1) 
some saponins with particularly defined structural characteristics form insoluble complexes 
with cholesterol. When this complex-forming process occurs in the gut, it inhibits intestinal 
absorption of both endogenous and exogenous cholesterol. 2) Saponins can interfere with the 
entero-hepatic circulation of bile acids by forming mixed micelles. The re-absorption of bile 
acids from the terminal ileum is effectively blocked (92).  
In animal models, soyasaponins were found to significantly reduce serum total cholesterol 
(TC), low-density lipoprotein-cholesterol (LDL-C), triglycerides (TG) concentrations, and to 
increase high-density lipoprotein-cholesterol (HDL-C) levels in rats (97). 24-
Methylenecycloartanol (59), in combination with soysterol greatly reduced plasma 
cholesterol and enhanced cholesterol excretion in rats (98). Hamsters fed group B 
soyasaponins had significantly lower plasma TC (by 20%), non-HDL-C (by 33%), TG (by 18%) 
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that may affect the observed effects of soyasaponins and soyasapogenols. The first factor is 
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inducing effects not observed with pure saponins. Therefore, investigations with purified 
saponins are indispensable for matching a result to the molecular action of a specific 
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cancer cell lines respond differently to soy saponins. For instance, soyasaponin I (35) had no 
effect on HT-29 colon cell growth (81), but it can decrease the migratory ability of B16F10 
melanoma cells (91). The third factor is the dose. In another study, soyasaponin III (37) 
showed significant growth suppression at the highest concentration tested (50 ppm), and no 
significant effects from concentrations 6 to 25 ppm.  
2.2.2.2 Cardiovascular protective effects 
Soyasaponins showed cardiovascular protective effects through several different 
mechanisms. 
The hypocholesterolemic effects of soy saponins have long been recognized (92-95). Two 
mechanisms by which saponins can affect cholesterol metabolism were suggested (96): 1) 
some saponins with particularly defined structural characteristics form insoluble complexes 
with cholesterol. When this complex-forming process occurs in the gut, it inhibits intestinal 
absorption of both endogenous and exogenous cholesterol. 2) Saponins can interfere with the 
entero-hepatic circulation of bile acids by forming mixed micelles. The re-absorption of bile 
acids from the terminal ileum is effectively blocked (92).  
In animal models, soyasaponins were found to significantly reduce serum total cholesterol 
(TC), low-density lipoprotein-cholesterol (LDL-C), triglycerides (TG) concentrations, and to 
increase high-density lipoprotein-cholesterol (HDL-C) levels in rats (97). 24-
Methylenecycloartanol (59), in combination with soysterol greatly reduced plasma 
cholesterol and enhanced cholesterol excretion in rats (98). Hamsters fed group B 
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and a lower ratio of total to HDL cholesterol (by 13%) in hamsters fed group B 
soyasaponins, compared to those fed casein. Possible mechanisms involved greater 
excretion of fecal bile acids and neutral sterols (99). 
The anti-thrombogenic action of soyasaponins was evaluated in a model of disseminated 
intravascular coagulation (DIC) induced by infusion of endotoxin or thrombin in rats. Total 
soyasaponins prevented the decrease of blood platelets and fibrinogen, and the increase of 
fibrin degradation products during DIC induced by infusion of endotoxin or thrombin in 
rats. In vitro experiments, total soyasaponins, soyasaponins I (35), II (36), A1 (27), and A2 (28) 
inhibited the conversion of fibrinogen to fibrin (100).  
Total soyasaponins decreased elevated blood sugar and LPO levels, and reversed the 
decreased levels of SOD in streptozocin-induced diabetic rats (101). In an -glucosidase 
inhibitory assay, groups B, E and DDMP soyasaponins were shown to have potent 
inhibitory activities with IC50 values of 10-40 mol/L (102). 
2.2.2.3 Anti-viral activities 
Soyasapogenols A (54), B (55), E (58), and soyasaponin I (35), a major constituent of group B 
saponins, completely inhibited HIV-induced cytopathic effects 6 days after infection at 
concentration greater than 0.25 mg/mL, but had no direct effect on HIV reverse 
transcriptase activity. Soyasaponin I (35) also inhibited HIV-induced cell fusion in the 
MOLT-4 cell system (103).  
Total soyasaponins showed significant inhibitory effect on the replication of HSV-1 and 
CoxB3. A soyasaponin cream was used in the treatment of patients suffering from herpes 
labialis. The treatment was found to be highly effective with a cure rate of 88.8% for the 
disease (104). Soyasaponin II (36) is more potent than soyasaponin I (35) as shown by a 
reduction of simplex virus type 1 (HSV-1) production. Soyasaponin II (36) was also found to 
inhibit the replication of human cytomegalovirus and influenza virus. This action was not 
due to inhibition of virus penetration and protein synthesis, but may involve a virucidal 
effect (105). In a structure–activity relationship study, the activity of soyasapogenol A (54) 
was less than 1/20 of that of soyasapogenol B (55), and the hydroxylation at C-21 seemed to 
reduce anti-HSV-1 activity (106). 
2.2.2.4 Hepatoprotective actions 
The group B soyasaponins I (35), II (36), III (37), and IV (38) all exhibit hepato-protective 
actions towards immunologically induced liver injury in primary cultured rat hepatocytes. 
The action of soyasaponin II (36) is almost comparable with that of soyasaponin I (35), 
whereas soyasaponins III (37) and IV (38) are more effective than soyasaponins I (35) and II 
(36). This suggests that the disaccharide group shows greater action than the trisaccharide 
group. Furthermore, the soyasaponins having a hexosyl unit shows a slightly greater action 
than that of the pentosyl unit in each disaccharide group or trisaccharide group. Structure-
activity relationships suggest that the sugar moiety linked at C-3 may play an important role 
in hepato-protective actions of soyasaponins (107). 
Also in in vivo experiments, total soyasaponins inhibit the elevation of liver transaminases 
when administered orally to rats with peroxidized corn oil. The liver injury caused by 
peroxidized salad oil is inhibited by the addition of soyasaponin A1 (27) during peroxidation 
(108). 
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2.2.2.5 Antioxidant activities 
One mg of DDMP saponin/mL scavenges superoxide at a degree equivalent to 17.1 units of 
superoxide dismutase/mL by the ESR spin trapping method. The scavenging superoxide 
activity of DDMP soyasaponins is caused by the DDMP moiety attached to the triterpene 
aglycon since soyasaponin I (35), which is derived from soyasaponin βg (50). Lack of this 
group didn’t show the scavenging activity (109). 
2.3 Triterpenes and sterols 
2.3.1 Chemical characteristics of triterpenes and sterols 
Triterpenes and sterols are found in soybean oil unsaponifiable matter. They are both 
present in minor quantities.  
Three triterpenes have been identified in soy. They are 24-methylenecycloartenol (59) (98), 
cycloartenol (60) (98) and bacchara-12,21-dien-3-ol (61) (Figure 5) (110), respectively. 
Compounds 59 and 60 belong to the type of lanostane triterpene. In addition to having the 
basic structural characters of lanostane, they bear an extra tri-atomic ring in their structures 
that are formed by cyclization between methyl at C-18 and methine at C-9. Lanostane 
triterpenes in soy were believed to be the original materials for the biosynthesis of soy 
sterols. Bacchara-12,21-dien-3-ol (61) is a natural occurring of baccharane-type triterpene 
which has all six-membered tetracyclic skeleton, and its side chain is at position C-17. This 
type of triterpene is extremely rare in nature and no more than 20 compounds of this type 
have been separated and identified. 
Cholesterol and thirteen so-called plant sterols or phytosterols were found in soybean seed 
or the shoots (111) (Figure 6). Unlike animals, plant membranes generally contain little or no 
cholesterol and instead contain several types of phytosterols. Phytosterols are also steroid 
alcohols, whose chemical structures are similar to that of cholesterol, but with the presence 
of one or two carbon, saturated or unsaturated, substituents in side chains at C-24 differing 
from that of cholesterol (62) (Figure 6) (26, 111). The most abundant phytosterols are 
sitosterol, compesterol and stigmasterol (112). Phytosterols identified from soy so far 
include cholesta-5,24-dien-3-ol (63), -sitosterol (64) (113), stigmasterin (65) (24), sitostanol 
(66)(114), citrostadienol (67) (113), isofucosterol (68) (111), campesterol (69) (115), 24-
epicampesterol (70) (115), 7-dehydrocampesterol (71) (115), campestanol (72) (111), 
obtusifoliol (73) (111), 24-methylenelophenol (74) (111), and 14-methyl-5-ergost-8-en-3-ol 
(75) (111). The most abundant soy phytoserol is -sitosterol (64), followed by campesterol 
(69) (112). These sterols can be divided into four groups based on their backbones, 
cholesterol (62), cholesta (63), stigmasta (64-68) and ergosta (69-75) (Figure 6). Compounds 
62 and 63 have the same backbone except for the type of bond between C-24 and C-25. The 
former is single bond while the latter is double bond (Figure 6). Stigmasta and ergosta also 
share similar structures with the only difference for stigmasta being that it has one more 
methyl group at C-28 (Figure 6). However, nutritionists prefer to divide the phytosterols 
into two categories of “5-sterols”, indicating a double bond at position C-5, and “stanol”, 
indicating 5-reduction of that double bond (114). According to this principle, compounds 
62-65 and 68-71 are 5-sterols; 66-67 and 72-75 are stanols (Figure 6). 
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and a lower ratio of total to HDL cholesterol (by 13%) in hamsters fed group B 
soyasaponins, compared to those fed casein. Possible mechanisms involved greater 
excretion of fecal bile acids and neutral sterols (99). 
The anti-thrombogenic action of soyasaponins was evaluated in a model of disseminated 
intravascular coagulation (DIC) induced by infusion of endotoxin or thrombin in rats. Total 
soyasaponins prevented the decrease of blood platelets and fibrinogen, and the increase of 
fibrin degradation products during DIC induced by infusion of endotoxin or thrombin in 
rats. In vitro experiments, total soyasaponins, soyasaponins I (35), II (36), A1 (27), and A2 (28) 
inhibited the conversion of fibrinogen to fibrin (100).  
Total soyasaponins decreased elevated blood sugar and LPO levels, and reversed the 
decreased levels of SOD in streptozocin-induced diabetic rats (101). In an -glucosidase 
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saponins, completely inhibited HIV-induced cytopathic effects 6 days after infection at 
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due to inhibition of virus penetration and protein synthesis, but may involve a virucidal 
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(36). This suggests that the disaccharide group shows greater action than the trisaccharide 
group. Furthermore, the soyasaponins having a hexosyl unit shows a slightly greater action 
than that of the pentosyl unit in each disaccharide group or trisaccharide group. Structure-
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2.2.2.5 Antioxidant activities 
One mg of DDMP saponin/mL scavenges superoxide at a degree equivalent to 17.1 units of 
superoxide dismutase/mL by the ESR spin trapping method. The scavenging superoxide 
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group didn’t show the scavenging activity (109). 
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cycloartenol (60) (98) and bacchara-12,21-dien-3-ol (61) (Figure 5) (110), respectively. 
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basic structural characters of lanostane, they bear an extra tri-atomic ring in their structures 
that are formed by cyclization between methyl at C-18 and methine at C-9. Lanostane 
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type of triterpene is extremely rare in nature and no more than 20 compounds of this type 
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from that of cholesterol (62) (Figure 6) (26, 111). The most abundant phytosterols are 
sitosterol, compesterol and stigmasterol (112). Phytosterols identified from soy so far 
include cholesta-5,24-dien-3-ol (63), -sitosterol (64) (113), stigmasterin (65) (24), sitostanol 
(66)(114), citrostadienol (67) (113), isofucosterol (68) (111), campesterol (69) (115), 24-
epicampesterol (70) (115), 7-dehydrocampesterol (71) (115), campestanol (72) (111), 
obtusifoliol (73) (111), 24-methylenelophenol (74) (111), and 14-methyl-5-ergost-8-en-3-ol 
(75) (111). The most abundant soy phytoserol is -sitosterol (64), followed by campesterol 
(69) (112). These sterols can be divided into four groups based on their backbones, 
cholesterol (62), cholesta (63), stigmasta (64-68) and ergosta (69-75) (Figure 6). Compounds 
62 and 63 have the same backbone except for the type of bond between C-24 and C-25. The 
former is single bond while the latter is double bond (Figure 6). Stigmasta and ergosta also 
share similar structures with the only difference for stigmasta being that it has one more 
methyl group at C-28 (Figure 6). However, nutritionists prefer to divide the phytosterols 
into two categories of “5-sterols”, indicating a double bond at position C-5, and “stanol”, 
indicating 5-reduction of that double bond (114). According to this principle, compounds 
62-65 and 68-71 are 5-sterols; 66-67 and 72-75 are stanols (Figure 6). 
 





Fig. 5. The chemical structures of triterpenes in soy. 
2.3.2 Health effects of phytosterols 
Phytosterols (not restricted to soy-based sources) that have long been known to reduce 
intestinal cholesterol absorption, lead to decreased blood LDL-cholesterol levels and lower 
cardiovascular disease risk. However, other biological activities for phytosterols have also 
been reported, including anti-cancer and immune modulatory effects.  
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2.3.2.1 Phytosterols and cholesterol absorption 
In the 1950’s, phytosterols from soybeans were found to lower serum cholesterol level (116). 
Since then, the cholesterol-lowering effects of phytosterols have been extensively 
demonstrated in both humans and animals (117-120). A meta-analysis of 41 clinical trials 
showed that intake of 2 g/d of stanols or sterols reduced low-density lipoprotein (LDL) by 
10%, with little additional reduction at higher doses (121). The U.S. National Cholesterol 
Education Program has recommended adding 2.0 g/day of phytosterols to the diet of adults 
to reduce LDL cholesterol and coronary heart disease risk (122).  
Because phytosterols are not systemically absorbed, they are thought to act primarily in the 
intestinal lumen. As cholesterol analogs phytosterols compete for cholesterol in absorptive 
micelles resulting in reduced solubility of cholesterol (118). However, recent evidence 
suggests that the mechanism of action of phytosterols may be more complicated than 
originally thought (119, 123). As summarized in a recent review (123), since 
phytosterols/phytostanols do not need to be present in the intestinal lumen simultaneously 
with cholesterol to inhibit its absorption (120), other studies have suggested that 
phytosterols/phytostanols may exert an unknown molecular action inside enterocytes and 
hepatocytes. In line with this, injected phytosterols/phytostanols reduced plasma 
cholesterol levels in hamsters (124). To gain insight into the phytosterol/phytostanol affects 
on circulating cholesterol concentration via mechanisms independent of the luminal 
incorporation of cholesterol into mixed micelles, the effects of these plant compounds on 
intestinal LXR-mediated targets involved in sterol absorption have been evaluated. 
Conclusive studies using ABCA1 and ABCG5/G8-deficient mice demonstrated that the 
phytosterol-mediated inhibition of intestinal cholesterol absorption is independent of these 
ATP-binding cassette (ABC) transporters. Other reports have raised questions as to whether 
phytosterols/phytostanols regulate cholesterol metabolism in intestinal and hepatic cells 
through independent-LXR pathways. A number of studies have proposed a 
phytosterol/phytostanol action on cholesterol esterification and lipoprotein assembly 
(ACAT, apoB), cholesterol internalisation (NPC1L1, ANXA2), cholesterol synthesis (HMG-
CoA reductase, C-24-reductase) and removal of apoB100-containing lipoproteins (LDLr). 
However, the impact of phytosterol/phytostanol intake on these physiological processes in 
vivo remains unclear (123). 
In one study specifically using soybean-derived phytosterols (125), it was found that 
consumption of phytosterol-supplemented ground beef lowered plasma TC and LDL-
cholesterol concentrations and TC:HDL cholesterol from baseline by 9.3%, 14.6%, and 9.1%, 
respectively.  
2.3.2.2 Anti-cancer effects of phytosterols 
In addition to their cholesterol-lowering actions, mounting evidence suggests that 
phytosterols possess anti-cancer effects against a number of different types of cancers (126-
132). Phytosterols seem to act through multiple mechanisms of action, including inhibition 
of carcinogen production, cancer-cell growth, angiogenesis, invasion and metastasis, and 
through the promotion of apoptosis of cancerous cells. Phytosterol consumption may also 
increase the activity of antioxidant enzymes and thereby reduce oxidative stress. In addition 
to altering cell-membrane structure and function, phytosterols probably promote apoptosis 
by lowering blood cholesterol levels (127). 
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2.3.2.3. Physterols and immune function 
Several reports in the literature suggest that phytosterols may have some immunological 
activity as highlighted in animal models of inflammation or even in in vitro and in vivo 
models of cancer (colorectal and breast cancer). Their direct immune modulatory activity on 
human lymphocytes has been proven, and the mechanism of action in cancer cells has been 
elucidated (133, 134). 
2.4 Lignans 
2.4.1 Chemical characteristics of lignans 
In addition to isoflavones, lignans are considered another main group of phytoestrogens in 
soy, based on their chemical structures. Lignans are defined as dimeric phenylpropanoid 
(C6-C3) compounds, mostly linked at 8-8′ (Figure 7) (135, 136). They are seven lignans 
identified from soy, namely, anhydrosecoisolariciresinol (76), isolariciresinol (77), 
secoisolariciresinol (78), matairesinol (79), lariciresinol (80), pinoresinol (81) and 
syringaresinol (82) (Figure 7) (28, 137). 
2.4.2 Health effects of lignans 
2.4.2.1 Antioxidant activity  
Pinoresinol (81) has been reported frequently as an antioxidant, using thiocyanate 
antioxidant, Cu2+-induced low density lipoprotein oxidation, lipid peroxidation in rat 
liver, DPPH radical, and peroxy radical assays (138). Syringaresinol (82) has also been 
demonstrated as antioxidative in Cu2+-induced low density lipoprotein oxidation and 
DPPH radical assays (138). Lariciresinol (80) has a high radical scavenging capacity 
compared to the well-known antioxidant Trolox. The trapping capacity (mmoles peroxyl 
radicals scavenged per gram of compound) of lariciresinol (80) (7.3 mmol/g) is higher 
than that of trolox (6.8 mmol/g) (139). Secoisolariciresinol (78) showed strong antioxidant 
activity against DPPH with an IC50 of 0.017±0.001 mM. It is about two times stronger than 
the standard antioxidant, 2,6-di-(tert-butyl)-4-methylphenol (BHT), IC50 0.0310.001 mM 
(140). Isolariciresinol (77) showed 86.2 % inhibition of lipid peroxidation (LPO) at 25 
g/ml (141). 
2.4.2.2 Anticancer activity 
Estrogenic enterolignans, END or ENL are the major metabolites of lignans in the 
mammalian gut. Because estrogens were linked to some cancers, especially breast cancer, 
enterolignans could affect some cancer risk. To our knowledge, the estrogenic or anti-
estrogenic effects of enterolignans in humans are not very clear (142). For example, while 
weak estrogenic activity of ENL was demonstrated the anti-estrogenic activity of ENL 
was disclosed through depression of estrogen-stimulated rat uterine RNA synthesis 
(143). 
The lignan ENL was found to have a bi-phasic effect on DNA synthesis in human breast 
cancer MCF-7 cells, showing induction at 10-50 M and inhibition at higher concentrations, 
with an IC50 of 82.0 M (144). END and ENL are weak and moderate inhibitors of aromatase 
enzyme activity in a pre-adipose cell culture system (143). In human colon tumor cell 
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Fig. 7. The chemical structures of lignans in soy. 
lines (LS174T, Caco-2, HCT-15, T-84), the same concentration of END and ENL (100 µM) 
significantly reduce the proliferation of all cell lines, though ENL was more than twice as 
effective as END (145). 
 




2.5.1 Chemical characteristics of phytate 
Phytate (83), the salt of phytic acid (myo-inositol-(1,2,3,4,5,6)hexakisphophate, IP-6, InsP-6) 
(Figure 8), is a naturally occurring polyphosphorylated carbohydrate. It is widely 
distributed in the plant kingdom. Phytate serves as a storage form of phosphorous and 
minerals and contains ~75% of total phosphorous of the kernels (25). It is the major source of 
phosphorus in soy (79). Phytate is considered as a strong chelator of important minerals 
such as calcium, magnesium, iron, and zinc, and can contribute to mineral deficiencies in 
people. However, recent studies demonstrate that this “antinutrient” effect of IP6 is only 
manifested when large quantities of IP6 are consumed in combination with an 
oligoelements-poor diet (146). 
 
Fig. 8. The chemical structures of phytic acid in soy.  
2.5.2 Health effects of phytic acid 
2.5.2.1 Anti-cancer activities 
Phytic acid (83) plays an important role in signal transduction, cell proliferation and 
differentiation (147). Recently phytic acid (83) has received much attention for its role in 
cancer prevention and control of experimental tumor growth, progression, and metastasis 
(148). A great majority of the studies were done in animals and showed that phytic acid had 
anti-neoplastic properties in breast, colon, liver, leukemia, prostate, sarcomas, and skin 
cancer (149, 150). The results and proposed mechanism of anti-carcinogenic activities of IP6 
in various cell lines are summarized in Table 6 (151-154).  
In animal studies, phytic acid can increase blood NK cell activity in DMH-induced colon 
tumors in rats, suppress rhabdomyosarcoma cell growth in a xeno-grafted nude mouse 
model (155), inhibit tumor growth and metastasis in rats (156), prolong survival of tumor-
bearing mice, and reduce the numbers of pulmonary metastases (157). Phytic acid can also 
inhibit DMBA-induced mouse skin tumor development and this inhibitory effect is likely, 
by modulating proliferation, differentiation, or apoptosis (158).  
2.5.2.2 Other health effects 
For a long time IP6 has been recognized as a natural antioxidant. In addition, IP6 possesses 
other significant benefits for human health, such as the ability to enhance the immune  
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Table 6. The anti-carcinogenic activities of IP 
system, prevent pathological calcification and kidney stone formation, lower elevated serum 
cholesterol, and to reduce pathological platelet activity (148). IP6 inhibited the replication of 
HIV-1 in a T cell line and in a freshly isolated strain in peripheral blood mononuclear cells, 
possibly acting on HIV-1 early replicative stage (149) 
 
Fig. 9. The chemical structures of cinnamic acid ester glycosides in soy. 
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2.6 Cinnamic acid ester glycosides 
2.6.1 Chemical characteristics of cinnamic acid ester glycosides 
Two cinnamic acid ester glycosides were isolated by Hosny et al from soybean molasses, 
which is a by-product of aqueous alcohol soy protein concentrate production (70). They were 
identified as 1-O-(E)-feruloy[-L-arabinofuranosyl-(13)][-D-glucopyranosyl(16)]-D-
glucopyranose (84) and 1-O-(E)-3,4,5-trimethoxycinnamoyl[-L-arabinofuranosyl(13)] 
[glucopyranosyl(16)]-D-glucopyranose (85) (Figure 9).  
3. Constituents formed during processing 
Food processing may dramatically change the compositions and relative contents of the 
constituents in soy products and artificial compounds may also occur (159). The processing 
of foods can improve nutrition, quality, and safety; though processing could also lead to the 
formation of anti-nutritional and toxic compounds. These multi-faceted consequences of 
food processing result from molecular interactions among nutrients and with other food 
ingredients, both natural and added (160).  
Some components isolated from soy products such as soy sauce and fermented products do 
not occur naturally in the soybean. And the types of these compounds vary among different 
soy products based upon processing methods. These compounds may be formed by 1) 
soybean processing or fermentation; 2) compounds from other ingredients of soy products; 
3) compounds from reactions of components in soybean and/or other ingredients during 
processing. Even though these compounds are not found naturally in soybean, they do exist 
widely in various soy products and may contribute to important beneficial or detrimental 
biological effects associated with soy consumption. Unfortunately, the key role of these 
compounds is largely ignored.  
In Japan, soybeans molasses and soy fermented with Bacillus subtilis (natto) are very popular 
daily foodstuffs (161). Six isoflavones which differ from that isolated from soy were generated 
by this process. They are glycitein 7-O--D-(2,4,6-O-triacetyl)glucopyranoside (86), 8-(-
hydroxy-,-dimethylpropyl)genistin (87), 5-hydroxy-8-(-hyroxy-,-dimethylpropyl)-3,4-
dimethoxyisoflavone-7-O--D-glucopyranoside (88), 6-O-succinyldaidzin (89), 6-O-
succinylgenistin (90), and 6-O-succinylglycitin (91) (161, 162) (Figure 10). 
Another group of well-known compounds formed during food processing in soy is The 
Maillard reaction products (163, 164). The Maillard reaction is the heat-induced reaction of 
amino groups of amino acids, peptides, and proteins with carbonyl groups of reducing 
sugars such as glucose, that results in the concurrent formation of so-called Maillard 
browning products and acrylamide (165). In the past, extensive work has been done on 
Maillard reaction products in food products including several excellent reviews (160, 164-
167). Five Maillard reaction products, fructose-lysine (92), fructose-alanine (93), fructose-
valine (94), fructose-leucine (95) and fructose-isoleucine (96) (Figure 11) were isolated from 
soy sauce and miso (168, 169).  
Other groups of compounds may also be found in different soy products. Guided by platelet 
aggregation analysis, two anti-platelet alkaloids, 1-methyl-1,2,3,4-tetrahydro--carboline (97) 
and 1-methyl--carboline (98), were obtained from soy sauce. These two compounds 
inhibited the maximal aggregation response induced by epinephrine, platelet-activating 
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dependently (0.5-4 mM) after 24 h.
Inhibit the growth of 
LNCaP prostate 
cancer cell 
Inhibit Akt activation, 
cause CDKI 
accumulation and 






Inhibit the growth of DU145 
prostate cancer cell dose 
dependently (0.25-2 mM) after 24 h.
Inhibit the growth of 
DU145 prostate 
cancer cell 
Induce G1 arrest in 
DU145 cell cycle 
progression. 
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Table 6. The anti-carcinogenic activities of IP 
system, prevent pathological calcification and kidney stone formation, lower elevated serum 
cholesterol, and to reduce pathological platelet activity (148). IP6 inhibited the replication of 
HIV-1 in a T cell line and in a freshly isolated strain in peripheral blood mononuclear cells, 
possibly acting on HIV-1 early replicative stage (149) 
 
Fig. 9. The chemical structures of cinnamic acid ester glycosides in soy. 
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2.6 Cinnamic acid ester glycosides 
2.6.1 Chemical characteristics of cinnamic acid ester glycosides 
Two cinnamic acid ester glycosides were isolated by Hosny et al from soybean molasses, 
which is a by-product of aqueous alcohol soy protein concentrate production (70). They were 
identified as 1-O-(E)-feruloy[-L-arabinofuranosyl-(13)][-D-glucopyranosyl(16)]-D-
glucopyranose (84) and 1-O-(E)-3,4,5-trimethoxycinnamoyl[-L-arabinofuranosyl(13)] 
[glucopyranosyl(16)]-D-glucopyranose (85) (Figure 9).  
3. Constituents formed during processing 
Food processing may dramatically change the compositions and relative contents of the 
constituents in soy products and artificial compounds may also occur (159). The processing 
of foods can improve nutrition, quality, and safety; though processing could also lead to the 
formation of anti-nutritional and toxic compounds. These multi-faceted consequences of 
food processing result from molecular interactions among nutrients and with other food 
ingredients, both natural and added (160).  
Some components isolated from soy products such as soy sauce and fermented products do 
not occur naturally in the soybean. And the types of these compounds vary among different 
soy products based upon processing methods. These compounds may be formed by 1) 
soybean processing or fermentation; 2) compounds from other ingredients of soy products; 
3) compounds from reactions of components in soybean and/or other ingredients during 
processing. Even though these compounds are not found naturally in soybean, they do exist 
widely in various soy products and may contribute to important beneficial or detrimental 
biological effects associated with soy consumption. Unfortunately, the key role of these 
compounds is largely ignored.  
In Japan, soybeans molasses and soy fermented with Bacillus subtilis (natto) are very popular 
daily foodstuffs (161). Six isoflavones which differ from that isolated from soy were generated 
by this process. They are glycitein 7-O--D-(2,4,6-O-triacetyl)glucopyranoside (86), 8-(-
hydroxy-,-dimethylpropyl)genistin (87), 5-hydroxy-8-(-hyroxy-,-dimethylpropyl)-3,4-
dimethoxyisoflavone-7-O--D-glucopyranoside (88), 6-O-succinyldaidzin (89), 6-O-
succinylgenistin (90), and 6-O-succinylglycitin (91) (161, 162) (Figure 10). 
Another group of well-known compounds formed during food processing in soy is The 
Maillard reaction products (163, 164). The Maillard reaction is the heat-induced reaction of 
amino groups of amino acids, peptides, and proteins with carbonyl groups of reducing 
sugars such as glucose, that results in the concurrent formation of so-called Maillard 
browning products and acrylamide (165). In the past, extensive work has been done on 
Maillard reaction products in food products including several excellent reviews (160, 164-
167). Five Maillard reaction products, fructose-lysine (92), fructose-alanine (93), fructose-
valine (94), fructose-leucine (95) and fructose-isoleucine (96) (Figure 11) were isolated from 
soy sauce and miso (168, 169).  
Other groups of compounds may also be found in different soy products. Guided by platelet 
aggregation analysis, two anti-platelet alkaloids, 1-methyl-1,2,3,4-tetrahydro--carboline (97) 
and 1-methyl--carboline (98), were obtained from soy sauce. These two compounds 
inhibited the maximal aggregation response induced by epinephrine, platelet-activating 
 






Fig. 10. The chemical structures of new isoflavones generated during food processing in soy 
products. 
 




Fig. 11. The chemical structures of other components generated during food processing in 
soy products. 
factor, collagen, adenosine 5-diphosphate, and thrombin, respectively (170). Compound 97 
had much greater inhibitory effect than that of 98 on platelet aggregation. Three other 
alkaloids, asperparalines A (99), B (100) and C (101) were found from okara (the insoluble 
residue of whole soybean) fermented with Aspergillus japonicus JV-23 (Figure 11) (171). Since 
soybean does not contain alkaloids, these compounds were likely brought into the soy 
products from other sources. 
A series of aromatic compounds were isolated from soy sauce and miso (a traditional 
Japanese seasoning produced by fermented soybeans) (172-174). Their structures were 
identified as 4-hydroxy-2-ethyl-5-methyl-3(2H)-furanone (HEMF; 102), 4-hydroxy-5-ethyl-2-
methyl-3(2H)-furanone (103) ), 2,5-dimethyl-4-hydroxy-3(2H)-furanone (DMHF; 104) and 3-
hydroxy-2-methyl-4H-pyran-4-one (maltol;105) (Figure 11). They are considered to form the 
base of the sweet aroma of miso. All of these compounds were most likely generated during 
soy processing and/or fermentation.  
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Processing may also significantly elevate or reduce certain naturally occurring soybean 
components. For instance, a remarkable increase in folate content was found after 
fermentation, 5.2-fold and 1.7-fold higher than that of the boiled soybeans and soybean 
seeds, respectively (175). Thus, we must be aware that the composition of soybean products 
may differ substantially from the native soybean.  
4. Conclusion 
The soy bean has been used as a human food source of high quality protein and other 
nutrients for hundreds of years and is currently a major source of protein in commercial 
food products for the beef, pork and chicken industry. This chapter summarizes our current 
knowledge about chemical structures and health effects of the major phytochemicals in soy. 
Clearly, the observed health effects from soy or soy-based foods (other than those attributed 
to nutrients like protein) are not solely from the actions of certain individual or types of 
compounds, but rather are due to the mixed effects of different compounds. Additive, 
synergistic, and/or antagonistic effects of different soy components combine to provide a 
final effect of soy foods and these effects may also be altered by phytochemicals from other 
non-soy foods in the meal. In order to fully understand the mechanism of health effects of 
soy, it is important to identify the genuine bioactive compounds in soy.  
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1. Introduction  
Thelephorales Corn ex. Oberw. belong to the Agaricomycetes (Basidiomycota, Fungi) and 
comprise more than 177 species (Kirk et al., 2008) that are classified into two families: the 
Bankeraceae Donk (mostly with colourless basidiospores) and the Thelephoraceae Chevall. 
(mostly with brown to yellowish basidiospores) (Yorou & Agerer, 2007). Bankeraceae are 
characterized by a typical fenugreek odour, with pileate and stipitate fruit bodies, hydnoid 
to spinose hymenophores with brown and lobed as well as colourless and evenly 
ornamented basidiospores. Bankeraceae comprise 5 distinct genera: Bankera Coker & Beers 
ex Pouzar, Hydnellum P. Karsten, Phellodon P. Karsten, Sarcodon Quél. ex P. Karst and 
Boletopsis Fayod.  
The name Sarcodon was proposed by Quélet in 1878, but as any binomial was  formed, the 
name was established as a genus only later by Karsten (Banker, 1913).  
The name, derived from the ancient greek stems sarco= flesh and odon=tooth, is due to the 
presence of the spines that look like teeth on the hymenophore. For this reason Sarcodon 
species are colloquial called “tooth fungi” (Fig. 1). 
The genus comprises more than 72 species, most of which are not edible, due to the bitter taste. 
Among these species only few have been phytochemically and biologically studied: S. aspratus 
(syn S. imbricatus), S. cyrneus, S. glaucopus, S. leucopus, S. laevigetum (syn. S. laevigatus) and S. 
scabrosus. 
Phytochemical studies were aimed to study either the composition of different extracts or to 
isolate new metabolites and to evaluate biological activity of extracts and isolated compounds. 
2. Phytochemical studies on Sarcodon spp 
2.1 Sarcodon aspratus syn S. imbricatus 
Sarcodon imbricatus (L.) P. Karst. is the current name used for S. aspratus  (Berk.) even though 
several synonyms are used for this mushroom (see Index Fungorum: 
www.indexfungorum.org). It is commonly known as the shingled hedgehog or scaly hedgehog. 
The mushroom has a large, brownish cap with large brown scales and may reach 30 cm in 
diameter. On the underside it sports greyish brittle teeth instead of gills, and has white flesh.  
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Fig. 1. Sarcodon imbricatus (L.: Fr.) Karsten hymenophore 
The fungus can be bitter, although this is less apparent in younger specimens. Submerging 
the mushrooms in boiling water will remove this. It can be pickled or dried and used as 
flavouring. In Bulgaria it is collected, dried and finely ground to be used as an aromatic 
mushroom flour. It is reported as edible, but of poor quality in the United States by some 
sources but as deliciously edible by others. In China Sarcodon aspratus, also known as “black 
tiger’s paw”, is a popular natural edible mushroom. It is used for lowering cholesterol level, 
muscles relaxation and blood circulation. Its special musky aroma enhances the taste in 
meat’s dishes, especially hams (S.K. Kim, 2006), and particularly brings out the sweet 
flavour when making a clear soup out of it.  
Several papers have been published regarding the use of S. aspratus for manufacturing foods 
and beverages (e.g. Hwang & Na, 2009a, 2009b; B.C. Kim et al., 2008, 2009; Jang, 2008; Wang 
& Wang, 2008;  J.K. Kim, 2007).    
2.1.1 Phytochemistry of Sarcodon imbricatus 
In view of its use as a food, the phytochemical composition of S. imbricatus has been studied.  
Proximate constituents (moisture, fat, crude protein, ash and carbohydrates) of this 
mushroom have been reported (Barros et al., 2007a). On the basis of the proximate analysis, 
it can be calculated that a portion of 100 g of this mushroom provides, on average, 24 kcal 
(100 kJ). The analysis of fatty acid composition allowed to determine 15 fatty acids.  
Unsaturated fatty acids (MUFA, monounsaturated fatty acids, 46%, PUFA, polyunsaturated 
fatty acids, 36%) were predominant over SFA (saturated fatty acids, 18%). Methanolic 
extract of S. imbricatus showed the presence (0.5%) of total polyphenols, expressed as g of 
gallic acid /100 g dry weight that justify the radical scavenging activity (DPPH) 
(Marcotullio et al., 2008). On the other hand the amounts of ascorbic acid, β-carotene and 
lycopene found in the mushroom were very low (Barros et al., 2007b). Sterol fraction was 
 




Fig. 2. Sarcodon imbricatus  (L.: Fr.) Karsten  
studied by several research groups. In addition to ergosterol, several other ergostane and 
cholestane compounds have been isolated (Huang et al., 2002; Ueno et al., 1999; Marcotullio 
et al., 2008). Particularly interesting is the presence in the methanolic extract of S. imbricatus 
of ergosterol peroxide (or 3-β-hydroxy-5α,8α-epidioxyergosta-6,22-diene) that shows a 
plethora of biological activities, such as antileukemic and anticancer  (Kobori et al., 2006), 
apoptotic-inducing (Takei et al., 2005), and anti-inflammatory (Kobori et al., 2007). It is 
interesting to note that processing and cooking practices determine a lowering of nutrients 
concentrations and of antioxidant activity (Barros et al., 2007c).  
Other interesting metabolites isolated and identified from S. aspratus are polysaccharides. 
Han and coworkers isolated a water soluble polysaccharide (HCP) with molecular mass of 
6.7 x 105 Da (Han et al., 2011). HCP resulted to be a linear glucan with a backbone structure 
of (1→6)-linked--glupyranosyl residues. Another polysaccharide (HBP) with a molecular 
weight of 4.3 x 105 Da was isolated by the same author in 2010. Even in this case the 
backbone structure was constituted by (1→6)-linked--glupyranosyl residues, which 
occasionally branched at O-3 position (Han et al., 2010).  
Other constituents isolated from S. aspratus were ceramide compounds (Yaoita et al., 2002). 
2.2 Sarcodon cyrneus Maas Gest 
Sarcodon cyrneus, according Myco Bank (www.mycobank.org), has a “pileus up to 65 mm 
across, planoconvex to somewhat depressed in centre, finely tomentose at margin, becoming 
felted farther back, or tomentum collapsed to form smooth and shiny pellicle. Stipe 15-30 x 
6-15 mm, broader when fused, equal or somewhat enlarged below, with abruptly pointed 
base, straight to curved, tomentose, in places glabrescent, pale grey-brown, darkening with 
age and becoming more or less concolorous with, pileus, at extreme base with yellowish 
grey mycelium. Spines up to 3 mm long, 0.1-0.3 mm broad, long decurrent, often almost 
reaching base of stipe, crowded, subulate, first whitish, becoming purplish brown. Context 
pallid (whitish suffused with pinkish when fresh, according to the collector), not greenish in 
base of stipe” (Fig. 3). The taste is bitter and the mushroom is not edible. 
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Fig. 3. Sarcodon cyrneus Maas Geest. 
2.2.1 Phytochemistry of Sarcodon cyrneus 
In the literature only two papers regarding the secondary metabolites isolated from S. 
cyrneus have been reported (Marcotullio et al., 2006b; Marcotullio et al., 2007) and they deals 
with the structural identification of five cyathane diterpenes. These compounds were named 

































Fig. 4. Structures of cyrneines 
2.3 Sarcodon glaucopus Maas Geest. & Nannf. 
According MycoBank (www.mycobank.org) the mushroom has a “pileus up to 110 mm 
across, plano-convex to somewhat depressed; at first tomentose, then matted, forming a cuticle 
which breaks up into scales near margin, into areoles in centre; scales adhering to appressed, 
yellow-brown with vinaceous shade or pale to dark purplish brown, occasionally locally 
violet-grey (giving a peculiar leaden grey impression), at times very dark brown in centre, 
contrasting with dingy yellowish ground colour, not infrequently covered with minute 
yellowish dots of excreted matter when dried. Stipe 27-75 x 10-40 mm, cylindrical, tapering 
below or somewhat broadened below, tomentose, fibrillose, covered with adnate fibrillose 
squamules or partly matted, dingy whitish, soon pinkish brown to purplish brown above, 
grey-green below, with pointed, whitish base. Spines up to 5 mm long, 0.1-0.2 mm broad, 
whitish, finally purplish brown” (Fig. 5). The taste is bitter and the mushroom is not edible.  
 




Fig. 5. Sarcodon glaucopus Maas Geest. & Nannf. 
2.3.1 Phytochemistry of Sarcodon galucopus 
No phytochemical studies regarding proximate composition have been reported for S. 
glaucopus. In the literature there are only two studies on the secondary metabolites of S. 
glaucopus, and they deal with the isolation and structure elucidation of three cyathane 
diterpenes named glaucopine A (5), glaucopine B (6) (Curini et al., 2005) and glaucopine C 














Fig. 6. Structures of glaucopines 
2.4 Sarcodon laevigatus (Sw.) P. Karst. 
Index Fungorum (www.indexfungorum.org)  reports for S. laevigatus (syn. S. leucopus, often 
the term S. laevigatum is used instead of S. laevigatus). A description of Sarcodon leucopus 
(Pers.) Maas Geest. & Nannf. has been reported in MycoBank: “Pileus up to ca. 200 mm 
across, planoconvex or slightly depressed, without concentric or radiate markings, at first 
finely felted; felt collapsed to form smooth, more or less shiny, innate-scaly cuticle, the latter 
subsequently radiately rimose near margin, breaking up into areoles in centre, here with 
scales somewhat more pronounced and tips sometimes slightly raised; pale purplish brown 
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on yellowish drab ground colour or a rich purplish brown to dark brown. Stipe 40-80 x 20-60 
mm, cylindrical to ventricose, finely tomentose, later with smooth or innate-scaly cuticle, 
concolorous with pileus or paler, whitish below, after some time with green spots (always?). 
Spines up to c. 15 x 1 mm, whitish, finally purplish brown. Context up to 40 mm thick near 
centre of pileus, whitish, suffused with purplish brown to violet tints, after some time pale 
greenish. Odour commonly experienced as disagreeable. Taste bitter after some time”.  
2.4.1 Phytochemistry of Sarcodon laevigatus or/and S. leucopus 
In the literature no references to S. laevigatus have been reported, while it is possible to find 
two papers referring to S. laevigatum and to S. laevigetum. The first one reports the isolation 
and the structure identification of three p-terphenyls (8-10), of which 8 (named sarcodan) 
was a new compound (Ma et al., 2006). The second report is a Patent and deals with the 
preparation of compound 9 (named B1-V) by extraction from S. laevigetum (Ma, 2009). 
On the other hand, Tringali and coworkers (Tringali et al., 1987) reported the isolation and 
structure identification of several p-terphenyls from Sarcodon leucopus. 
The first two isolated compounds were 10 and 11. (Fig. 8) 
 
 
Fig. 7. Sarcodon leucopus  (Pers.) Maas Geest. & Nannf. 
It is evident from these reports how the correct identification of the species is important for 
preventing mistakes in the identification of new secondary metabolites. 
Later, the same research group isolated other nitrogen-containing p-terphenyl derivatives 
that they named sarcodonins. The first to be isolated was 12 in 2000 (Geraci et al., 2000) and 
other six related compounds (13-18) were isolated in 2004 (Cali et al., 2004) (Fig. 9). 
 





















































12   R1=Ac; R2=H;   R3=H;   R4=H
13   R1=H;   R2=H;   R3=H;   R4=H
14   R1=H;   R2=Ac; R3=H;   R4=H
15   R1=Ac; R2=H;   R3=Ac; R4=Ac 
16   R1=Ac; R2=H;   R3=H;   R4=H
17   R1=H;   R2=H;   R3=H;   R4=H
18   R1=H;   R2=Ac; R3=H;   R4=H
 
Fig. 9. Structures of sarcodonins isolated from S. leucopus 
Compounds 13-15 were named sarcodonin , , and γ, respectively, while compounds 16-18 
epi-sarcodonin, epi-sarcodonin  and , respectively. Cali et al., (2004) from the same 
mushroom isolated oxidated sarcodonins and named them sarcoviolin (19) and epi-sarcoviolin 














Fig. 10. Structures of sarcoviolins 
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Recently the structures of sarcodonins and sarcoviolins have been revised by synthesis, and 















Fig. 11. Revised structure proposed for sarcodonin 12 
It is very interesting to notice that screening the literature with the term “sarcodonin” 
different structures with the same name have been reported, as we will see checking the 
compounds isolated from S. scabrosus. 
2.5 Sarcodon scabrosus (Fr.) P. Karst. 
Myco Bank describes S. scabrosus  “with pileus up to 120 mm across (fresh), plano-convex, 
more or less deeply depressed in the centre, coarsely scaly, the scales erect in the centre, 
decumbent farther outwards, adnate and woolly near the margin, brown in various 
shades (brick-colour, fulvous, ferruginous, bay) on a fairly pale yellow-brown ground, in 
some specimens passing into a delicate lilac at the margin, with age becoming very dark 
purplish brown, and the scale-tips even blackish, somewhat shiny when dried. Stipe 20-
120 x 10-60 mm (fresh), tapering downwards, usually with pointed base, felted to 
subfibrillose, pinkish brown to brick-colour, becoming concolorous with the pileus, the 
lower part or the base grey-green, when young covered with white mycelium. Spines up 
to 5 mm long (dry), slender (up to 0.3 mm), decurrent, crowded, subulate, long remaining 
yellowish brown, finally purplish brown. Context dingy whitish in the pileus and the top 
of the stipe, vinescent, brownish-marbled with age, grey-green in the base of the stipe. 
Greenish mycelium from the base of the stipe staining dingy pinkish brown to reddish 
brown in KOH solution. Odour of water-melon (Citrullus vulgaris) when cut fresh“ (Fig. 
12). 
Due to its bitter taste it is not edible. 
2.5.1 Phytochemistry of Sarcodon scabrosus 
An analysis of the literature revealed that Sarcodon scabrosus (syn Hydnum scabrosus), 
together with S. imbricatus, is one of the most studied species among Sarcodon. Two classes 
of secondary metabolites have been isolated from this species, and both are represented by 
cythane diterpenes: scabronines and sarcodonins. The use of the same name for different 
classes of secondary metabolites clearly shows how the use of common names can give rise 
to mistakes.  
The first report about the isolation of cyathane diterpenes from S. scabrosus was by Shibata et 
al. (1989) and it is about sarcodonin A (21) and G (22) (Fig. 13).  
 















Fig. 13. Sarcodonins A and G 
Generally sarcodonins and neosarcodonins isolated from S. scabrosus are characterized by 
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Scabronines are characterized by the oxidation of C-17 to carboxylic group. The first 
scabronine that was isolated was scabronine A (23) (Ohta et al., 1998a) and later scabronines 
B-F (24-28) were isolated (Kita et al., 1998) (Fig. 14). 
Among different cyathane diterpenes, the most interesting for its biological properties is 
scabronine G (29) (Fig. 15), that has been isolated in 1998 (Ohta et al., 1998b). In 2004, Ma and 
coworkers reported the isolation of another scabronine G (30), but this compound is 












Fig. 15. Structures of the two scabronines G 
Ma et al. isolated other scabronines (H-J), but they still have sarcodonins structures (Ma et 
al., 2004; Ma et al., 2008). 
From S. scabrosus in addition to the already mentioned sarcodonins A (21) and G (22) in 2002 
other three cyathane diterpenoids have been isolated (Hirota et al., 2002). Three of them 
were named neosarcodonins A-C (31-33). The same group in 2004 isolated neosarcodonin O 
























36    = O-oleil
37    = O-stearil  
Fig. 16. Neosarcodonins isolated from S. scabrosus 
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3. Biological activities of Sarcodon metabolites 
3.1 Biological activities of p-terphenyl derivatives 
Terphenyls are aromatic hydrocarbons consisting of a chain of three benzene rings. From a 
structural point of view three different isomers are possible, in which the terminal rings are 
ortho-, meta-, or para-substituents of the central ring. Most of the natural terphenyls are p-
terphenyl derivatives. In recent years, some terphenyls have been reported to exhibit 
significant biological activity, e.g., potent immunosuppressant, neuroprotective, 
antithrombotic, anticoagulant, specific 5-lipoxygenase inhibitory, and cytotoxic activities 
(Liu, 2007). 
3.1.1 Antibiotic properties 
Compounds 10 and 11 (Tringali et al., 1987) were tested against several Gram-positive and 
Gram-negative bacteria in an agar dilution test and the results showed that among Gram-
positive the most susceptible microorganism was Proteus mirabilis and among Gram-
negative Staphylococcus aureus (MIC 75 and 50 g/ml respectively).  
3.1.2 Antitumoral activity 
Sarcodonin (12) was tested against two different tumor cell lines and it resulted moderately 
active toward KB (ED50 10.0 g/ml) and P-388 (ED50 27.0 g/ml) (Geraci et al., 2000). The 
higher cytotoxic activity of 10 with respect to 12, coupled with mild antibacterial activity 
already described (Tringali et al., 1987) suggest that 10 could play a role in the chemical 
defense of the mushroom.  
Compounds 12, 13 (sarcodonin ), 15 (sarcodonin γ), and 17 (episarcodonin) and the 
mixture of 19 and 20 (sarcoviolins) were tested in the three-cell line panel High Throughput 
PreScreen (one-dose primary anticancer assay) carried out at National Cancer Institute 
(Bethesda, USA). Fully aromatic terphenyls proved to be cytotoxic at a concentration of 5 
x10-5 M against NCI-H460 (Lung), MCF7 (Breast), and SF-268 (CNS) cell lines. In particular, 
12, 15, and 16 show the highest cytotoxicity towards SF-268 cells, with 96, 93, and 95% of 
cells killed, respectively. Sarcoviolins (19 and 20) significantly reduced the growth of all cell 
lines at 10-4 M (MCF7 totally blocked).  
3.2 Biological activities of cyathane diterpenoids 
In 1965 Brodie discovered a new bird’s nest fungus of the genus Cyathus that was named C. 
helenae (Brodie, 1966) and he showed that the metabolites of the mushroom (cyathine 
complex) possessed antibiotic activity (Allbutt et al., 1971). From this first report, in these 40 
years, a great number of cyathane diterpenoids have been isolated, structurally identified 
and tested for their biological activities. 
3.2.1 Antibiotic activity 
In 1998 Shibata (Shibata et al., 1998) and coworkers isolated from S. scabrosus sarcodonins L 
and M and sarcodonin A (21) and G (22). Sarcodonin L and M resulted to be identical to 
scabronines C (25) and B (24), respectively (Kita etal., 1998). All these compounds were 
tested against B. subtilis and S. aureus and the results are reported in Table 1. 
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Compound B. subtilis S. aureus 1.0%* 0.2% 0.05% 1.0% 0.2% 0.05% 
21 6.5**   7.0   
22 6.5   7.5 6.5  
24 14.0 11.0 8.0 22.0 15.0 9.0 
25 9.5 7.5 7.0 18.0 12.0 7.5 
*Disc were soaked in 35 l of each test sample (w/v%); **The diameter of the inhibitory zone was 
measured in mm. 
Table 1. Antibiotic activity of sarcodonins A, G, L and M 
3.2.2 Anti-inflammatory activity 
Anti-inflammatory activity has been tested for sarcodonin A (21), sarcodonin G (22), 
neosarcodonin A-C (31-33) (Hirota et al., 2002), neosarcodonin O (34), acyl derivatives of 
sarcodonin A (35-37) (Kamo et al., 2004) and glaucopines A-C (5-7) (Curini et al., 2005; 
Marcotullio et al., 2006a). The results are reported in Table 2. The topical anti-inflammatory 
activity of compounds  was evaluated observing the reduction of oedema induced by TPA , 
for sarcodonins and neosarcodonins, and Croton oil, for glaucopines, in mouse ear. 
Indomethacin was used as positive control in all tests. 
 
Compound Dose Animals % Oedema Reduction 
5 1.0a 10 62 
6 1.0a 10 55 
7 1.0a 6 39 
Indomethacin 0.3a 10 66 
21 0.63b 5 75 
22 0.63b 5 84 
31 0.57b 5 49 
32 0.57b 5 64 
33 0.53b 5 87 
34 0.63b 5 36 
35 0.63b 5 61 
36 0.63b 5 46 
37 0.63b 5 72 
Indomethacin 0.56b 5 16 
a Dose= Moles/cm2; b Dose= mol 
Table 2. Anti-inflammatory activity of sarcodonins, neosarcodonins and glaucopines 
3.2.3 Antiproliferative and antitumoral activities 
The first report about the antitumor activity of a cyathane diterpene was about sarcodonin G  
isolated from the dichloromethane extract of Sarcolon scabrosus Karst, on HeLa cells in vitro.   
Sarcodonin G (22), isolated from the mushroom Sarcodon scabrosus and already reported to 
have anti-inflammatory activity, inhibited proliferation of HeLa cells (Dong et al., 2009).  
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3.2.4 Stimulation of NGF (Nerve Growth Factor) 
Sarcodon scabrosus and S. cyrneus metabolites have been studied for their unique activity to 
act as neuroprotective agents being able to stimulate the production of neurotrophic factors 
in vitro. Scabronines A-G (23-29) have been tested for their activity to induce NGF secretion 
from 1321N1 human astrocytoma cells and induce neuritogenesis in PC12 cells (rat 
pheochromocytoma cells) (Ohta et al., 1998a, 1998b; Kita et al., 1998; Oshima, Y. et al., 1999).  
Scabronines increased the expression of mRNA for NGF, and the secretion of NGF from 
1321N1 cells in a concentration-dependent mechanism (Obara et al., 1999). Among different 
scabronines, scabronine G methyl ester (SG-ME) (31) resulted to be the most active and the 
mechanism of action was deeply studied. SG-ME activates PKC-ζ, induces the translocation 
NF-κB to nucleus and enhances its transcriptional activity (Fig. 17) (Obara et al., 2001). 
Cyrneine A-D (1-4) and glaucopine C (7) were tested to evaluate their activity to induce NGF 
production from 1321N1 cells, but they resulted much less active than scabronine G (Fig. 18) 
(Marcotullio et al., 2007). Neverthless, cyrneine A and B showed an interesting activity, being 
able to induce directly differentiation on PC-12 cells (Marcotullio et al., 2006b). 
 
 
Fig. 17. Morphological changes of PC-12 cells by the 1321N1 cell culture medium 









Fig. 18. Evaluation of NGF synthesis from 1321N1 induced by cyrneines and glaucopine C. 
SG-ME used as control. 
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As a transcriptional regulation is required for neurite extension, and the activity of three 
major transcription factors (activator protein-1 (AP-1), nuclear factor-κB, and CREB) was 
determined. Cyrneines A and B enhanced activation of AP-1 and NF-κB. Moreover, 
treatment with cyrneine A led to actin translocation and subsequently, to accumulation of F-
actin at the tip of neurites.  Rac1 activity was increased by cyrneine A and expression of a 
dominant-negative Rac1 mutant significantly inhibited the cyrneine A-induced extension of 
neurites.  These results suggest that cyrneine A induces neurite outgrowth in a Rac1-
dependent mechanism (Obara et al., 2007). 
4. Conclusions 
The analysis of the literature about Sarcodon genus showed that these mushrooms produces 
interesting biologically active secondary metabolites such as cyathane e triphenyl 
derivatives. It is interesting to note that the use of  trivial names instead of systematic ones 
generated some confusion (e.g. the term sarcodonins has been used to name both terphenyls 
and  cyathanes). Furthermore, it was evidenced that sometimes there are problems in the 
use of different synonyms for the same species. Neverthless, the interesting biological 
properties of Sarcodon metabolites and the nutritional value of some spp make this genus 
worthy of further investigations.  
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As a transcriptional regulation is required for neurite extension, and the activity of three 
major transcription factors (activator protein-1 (AP-1), nuclear factor-κB, and CREB) was 
determined. Cyrneines A and B enhanced activation of AP-1 and NF-κB. Moreover, 
treatment with cyrneine A led to actin translocation and subsequently, to accumulation of F-
actin at the tip of neurites.  Rac1 activity was increased by cyrneine A and expression of a 
dominant-negative Rac1 mutant significantly inhibited the cyrneine A-induced extension of 
neurites.  These results suggest that cyrneine A induces neurite outgrowth in a Rac1-
dependent mechanism (Obara et al., 2007). 
4. Conclusions 
The analysis of the literature about Sarcodon genus showed that these mushrooms produces 
interesting biologically active secondary metabolites such as cyathane e triphenyl 
derivatives. It is interesting to note that the use of  trivial names instead of systematic ones 
generated some confusion (e.g. the term sarcodonins has been used to name both terphenyls 
and  cyathanes). Furthermore, it was evidenced that sometimes there are problems in the 
use of different synonyms for the same species. Neverthless, the interesting biological 
properties of Sarcodon metabolites and the nutritional value of some spp make this genus 
worthy of further investigations.  
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vegetables. In addition, the source of fibre in a healthy dietary pattern such as 
Mediterranean Diet has been described as an important qualitative difference on health. 
Fruit and vegetable related dietary fibre transports a significant amount of polyphenols and 
carotenoids linked to the fibre matrix through the human gut. Despite these effects and 
recommendations, the intake of plant foods remains low and, consequently, both dietary 
fibre and antioxidant compounds are usually deficient in most diets around the world. 
On the other hand, the food industry processing plant foods produces large amounts of 
waste and residues (leaves, stems, wastewaters, etc.) that are good sources of dietary fibre 
and phytochemicals. Several of them contain more dietary fibre than their respective edible 
portion. 
A variety of plant food byproducts are rich in fibre and polyphenolic compounds meeting 
the criteria of antioxidant dietary fibre. A broad spectrum of these will be summarized in the 
present work. In this chapter information on nutritional and phytochemical composition 
will be also included. Special attention nutritional claims criteria with reference to European 
Regulation has been given to quality ingredients for functional foods and/or dietary 
supplements. The application of byproducts in the food industry results in added value to 
both, the industry and the consumer. The industry benefits from economic incomes and the 
consumer from the excellent nutritional value of these materials with potential health 
claims. 
2. A healthy diet: Mediterranean dietary pattern based on dietary fibre and 
bioactive compounds 
Mediterranean Diet was declared by UNESCO as an Intangible Cultural Heritage, offering 
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Mediterranean Diet offers a nutritional model enriched by diverse cultures which over 
centuries has essentially maintained the same food structure and the same proportions: 
olive oil, fresh fruits and vegetables, grains and derivatives, fish and to a lesser extent, nuts, 
dairy products and meat. There is also a moderate consumption of wine, coffee and tea 
during meals while respecting religious rules and beliefs. Mediterranean Diet is not just a 
diet (mixture of food), it means a lifestyle because it also implies the way to prepare food 
and how foods are consumed around the same table. To eat in the Mediterranean Dietary 
Pattern is a moment of social meeting that complies with several functions: social, cultural 
and nutritional. The recognition of dietary qualities, and the positive impact on the health of 
the people who follow this dietary pattern, indicates the model of healthy diet we must try 
to encourage (UNESCO, 2010). 
The definition of the Mediterranean Diet is mainly based on consumption of foods. 
However, despite the robust inverse association between Mediterranean Diet and mortality 
found in observational and epidemiological studies, it is not clear which food constituents of 
this dietary pattern contribute most to its health effects. 
With regards to the intake of nutrients and / or food constituents, it appears that both 
dietary patterns are similar in terms of energy, energy profile and dietary fibre. As far as 
micronutrients are concerned, clear significant differences in the intake of vitamins and 
minerals in Northern and Southern European countries have not been reported (Elmadfa et 
al, 2004). However, the intake of monounsaturated fatty acids is higher in the Mediterranean 
area in opposition to the intake of saturated fatty acids whose values are higher in countries 
of Northern and Central Europe where there is a higher prevalence of chronic diseases. 
These facts are related to food consumption patterns that show a remarkable difference. In 
countries with Mediterranean diet, consumption of fruit and vegetables is significantly 
higher, being very important not only the quantity of these foods but also the variety of 
them. Moreover, there are also differences in relation to fat consumption. Mediterranean 
recorded high availability of olive oil and unprocessed red meat, while Central and 
Northern European preferably consumed fat from meat products (Naska et al., 2006). These 
data are in agreement with the fatty acid profile of food consumed in both dietary patterns. 
On the other hand, plant foods in Mediterranean Diet, of which there is a considerable 
amount and variety, seems to have a significant impact on the nutritional assessment of the 
Mediterranean Diet, as mentioned later, defines some health indicators of this dietary 
pattern. Plant foods, especially fruit and vegetables contribute a large proportion of the 
overall dietary intake of dietary fibre and bioactive compounds and a small proportion of 
the overall dietary intake of energy. Therefore, the role of bioactive compounds or 
phytochemicals as a key factor in the health effects of the Mediterranean dietary pattern is 
an attractive hypothesis. The composition and the physicochemical structure of dietary fibre 
and phytochemicals in fruit and vegetables have specific characteristics which lend these 
food groups significant nutrition and health related properties. Indeed, the potential health 
benefits of fruit and vegetables are mainly attributed to the effects of dietary fibre and 
antioxidants. 
It is argued that an increasing intake of 400 to 800 g/person/day of fruits and vegetables is a 
public health strategy of considerable importance for individuals and communities 
worldwide. For this reason the World Health Organization (WHO) recommends a daily 
intake of more than 400 g per person daily, and health authorities worldwide promote high 
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consumption of fruit and vegetables. Currently, the Food Standards Agency recommends 
the consumption of five portions of fruit and vegetables daily. There is no guidance on the 
specific type of fruit and vegetables to consume other than a suggestion of a variety; this is 
because to date, there is a lack of convincing evidence for their identification. It is therefore 
of priority to indentify fruit and vegetables which would significantly contribute to a 
reduction in cardiovascular diseases and other chronic non-communicable diseases. This 
way we could make public health recommendations and provide scientific information to 
the food industry about the selection of ingredients for functional foods. 
Although inconclusive, evidence has alluded to synergistic effects of combinations of 
polyphenols, which may be more protective against cardiovascular diseases than isolated 
polyphenols, and that a combination of fruits, in the context of a balanced diet and healthy 
lifestyle, would help to protect against these pathologies (Chong et al., 2010) Many of the 
putative chemoprotective phytochemicals in fruits and vegetables are coloured. Therefore, a 
good strategy may be guidelines based on selecting one daily serving of fruits and 
vegetables from each of seven colour classes, so that a variety of phytochemicals is 
consumed. In this context, a complementary definition of the Mediterranean Diet was 
recently proposed, based on the following dietary indicators: 1) monounsaturated/saturated 
lipid ratio; 2) intake of dietary fibre defined as food indigestible fraction; 3) intake of 
antioxidant capacity of the whole diet; 4) intake of phytosterols. These indicators were 
selected based on the scientific evidence to support the beneficial health effects and because 
they are differential features in Mediterranean Diet (Saura-Calixto & Goñi, 2009). 
There is general consensus among scientists as to the significant role of the 
monounsaturated to saturated fat ratio in disease aetiology. This ratio is predictive of total 
mortality and is a common feature in Mediterranean countries, where is much higher than 
in other parts of the world including northern Europe and North America (Naska et al, 
2006). 
As it is indicated above, dietary fibre intake is quantitatively similar in Mediterranean and 
non-Mediterranean European countries (around 20 g per capita). However, there are 
qualitative differences arising from the fact that a large proportion of the dietary fibre intake 
in Mediterranean countries comes from fresh fruit and vegetables, while in Northern 
European countries it comes more from cereals. Consequently, the composition and 
properties of the dietary fibre in the Mediterranean Diet has specific characteristics related 
to the type of food, nutrient and phytochemicals contents and healthy properties. 
There is a lack of comprehensive data on the antioxidant capacity of whole diets. This 
parameter is derived from the accumulative and synergistic antioxidant power of a wide 
variety of sources. Total dietary antioxidant capacity is probably higher in Mediterranean 
Diet than in other dietary patterns because of the amount and variety of plant foods rich in 
antioxidant phytochemicals. 
Finally, the intake of phytosterols has been established as a factor in the lower 
cardiovascular disease death rates in Mediterranean countries and it is a specific essential 
dietary indicator. 
The intake of bioactive compounds in recognized healthy diets such as the Mediterranean 
Diet may serve as a benchmark until scientific knowledge in this field is sufficiently 
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advanced to establish daily allowances. Traditional Mediterranean foods are rich in dietary 
fibre and bioactive compounds and the Mediterranean Diet is a specific type of healthy diet.  
3. Fruit and vegetables are source of dietary fibre and antioxidant 
phytochemicals 
Plant foods, particularly fruit and vegetables, have been consistently identified in 
epidemiological research as the key components of dietary patterns that reduce risk for the 
development of chronic and degenerative diseases, including atherosclerotic cardiovascular 
diseases, insulin resistance and type II diabetes and many cancers (Hu et al., 2000; Kant et 
al., 2004; Mokdad et al., 2000). One of the predominant mechanisms of their protective 
action is due to their antioxidant activity and the capacity to scavenge free radicals. There 
has been increasing interest in the nutritional properties of fruit and vegetables as sources of 
dietary fibre and other health-promoting phytochemical compounds (Knekt et al., 2002; 
Kris-Etherton et al., 2004; Mennen et al., 2004; Most, 2004).  
Fruit and vegetables are generally high in water, low in fat and, in addition to vitamins and 
minerals, contain significant amounts of dietary fibre and phytochemicals – mainly 
polyphenols and carotenoids - with significant biological properties, including antioxidant 
activity.  
The composition and the physicochemical structure of dietary fibre and phytochemicals in 
fruit and vegetables are specific characteristics which lend significant nutrition- and health-
related properties to this food group. Indeed, the potential health benefits of fruit and 
vegetables are mainly attributed to the effects of dietary fibre and antioxidants. 
3.1 Phytochemicals 
Phytochemicals or phytonutrients are bioactive substances that can be found in foods 
derived from plants and are not essentials for life. The human body is not able to produce 
them. Phenolic compounds are widely distributed throughout the plant kingdom and range 
from simple molecules such as phenolic acids to complex polymerised compounds (i.e. 
polyphenols) (Rice-Evans et al., 1996). Recently, some of their characteristics, mainly their 
antioxidant capacity, have given rise to research related to their protective properties on 
health and the mechanisms of action involved. The health benefits of antioxidant of natural 
origin are associated with their role in the prevention of several disorders called oxidative 
stress pathologies (Herrera et al., 2009). These are related to the damaging effect of oxygen 
free radicals, or more generally reactive oxygen species, products of normal metabolism that 
become harmful when they cannot be neutralized by the cellular antioxidant defense 
systems. In this condition of oxidative stress an uncontrolled oxidizing process may occur 
that damages biological molecules, disturbs cellular functions, and can potentially lead to 
the development of one or more diseases (Valko et al., 2007). 
Dietary phytochemicals are defined as bioactive, non-nutrient plant compounds that are 
associated with reduced risk of chronic diseases (Liu, 2004). Prospective cohort studies 
consistently suggest that when consumed in whole foods, these phytochemicals may 
contribute to important protection against chronic diseases, such as cardiovascular diseases 
and certain cancer (Okarter & Liu, 2010). The additive and synergistic effects of these 
bioactive phytochemicals found in plant foods may be responsible for the health benefits 
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associated with the diet;  additionally, the phytochemicals present in the different groups of 
plant foods in the diet complement each other when they are consumed together (Adom et 
al., 2005; Liu, 2004; Okarter & Liu, 2010). 
Plant foods phenolic compounds may provide benefits to human subjects via several 
mechanisms (Nijveldt et al., 2001). The best described and most well known mechanism is 
through their antioxidant properties and modulation of biological oxidative stress to 
prevent damage to cellular lipids, protein and DNA. Directly, they may scavenge 
superoxide and other reactive oxygen species such as hydroxyl and peroxy radicals. Overall, 
phenolic compounds have multiple paths for benefiting human health, most notably, 
through their actions as antioxidants and modifying cellular events. Their specific actions 
are likely to be dependent on the composition and time course of metabolites appearing in 
plasma (Crozier et al., 2009; Hollman et al., 1997; Manach et al., 2005). The intake of these 
antioxidants can lead to sustained reduction of the kind of oxidative damage to lipids, 
proteins and DNA that is associated with the development of chronic diseases (Evans & 
Halliwell 2001). 
Notwithstanding the need for more research, the collected data suggest that the 
consumption of phenolic-rich fruits increases the antioxidant capacity of blood, and when 
they are consumed with high fat and carbohydrate “pro-oxidant” foods, they may 
counterbalance their negative effects. Given the content and availability of fat and 
carbohydrate in the Western diet, regular consumption of phenolic-rich foods, appears to be 
a prudent strategy to maintain oxidative balance and health (Burton-Freeman, 2010). 
Vitamins (C and E), polyphenolic compounds and carotenoids are the main groups of 
antioxidants present in fruit and vegetables. Vitamins are single molecules, but polyphenols 
and carotenoids are made up of hundreds of compounds with a wide range of structures 
and molecular masses. 
Dietary fibre and antioxidants are generally addressed separately as groups of food 
constituents in both chemical and nutritional studies. However, it is a little known fact that a 
substantial proportion of the antioxidant polyphenols and carotenoids contained in fruit and 
vegetables are linked to dietary fibre (Saura-Calixto et al., 2007), and some of the postulated 
benefits of the fibre intake can be attributed to these associated compounds.  
Most biological properties of polyphenols depend on their bioavailability; the latter is 
largely influenced by chemical and physical properties and plant-derived conjugation. 
While a small proportion of some dietary polyphenols can be absorbed through the small 
intestine, the majority are either not absorbed, or are excreted and become fermentable 
substrates for bacterial microflora in the colon along with the non digestible food fraction 
(Williamson & Manach, 2005). Polyphenols bound to dietary fibre can account for a 
substantial part of total polyphenols in foods. These polyphenols are not bioavailable in the 
human upper intestine and reach the colon, where they become fermentable substrates for 
bacterial microflora, along with the other dietary fibre components. The fermentation of 
polyphenols in the colon improves antioxidant status and yields different metabolites with 
potential systemic effects. 
The majority of studies on determining the bioavailability of phenolic compounds are 
conducted by the analysis of blood phenolic metabolites a short time after ingestion. 
However, it should be noted that among the many polyphenols present in food, most of 
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them do not reach the bloodstream in the early hours of food digestion. Nevertheless, they 
do the transit until the large intestine where they can be metabolized through other 
pathways involving the enzymatic activities of the colonic microbiota. Therefore, it is 
expected that the protective effects of polyphenols are broader than those listed, as will be 
indicated later. 
3.2 Dietary fibre 
Dietary fibre is a major constituent of plant foods and its importance in nutrition and health 
is widely recognized. Numerous clinical and epidemiological studies have addressed the 
role of dietary fibre in intestinal health, prevention of cardiovascular disease, cancer, 
obesity, and diabetes (Buttriss & Stokes, 2008). The recommended daily intake of dietary 
fibre is 25-35 g/person (Buttriss & Stokes, 2008). 
 
 Male Female All 
Italy Not applicable 22.92 (6.94) 22.92 (6.94) 
Spain 24.93 (9.12) 22.02 (7.29) 22.92 (8.01) 
United Kingdom 29.12 (8.34) 23.35 (7.08) 25.52 (8.08) 
Netherlands 20.00 (7.50) 20.39 (7.06) 20.27 (7.20) 
Germany 26.77 (7.61) 22.55 (5.49) 23.63 (6.38) 
Sweden 23.83 (7.51) 21.55 (6.41) 22.53 (7.00) 
Denmark 21.33 (7.78) 19.08 (6.47) 20.06 (7.16) 
Total 22.98 (8.26) 21.52 (6.90) 21.97 (7.38) 
Table 1. Fibre intake (g per day) among EPIC cohort (Bingham et al., 2003). Data are mean 
(SD). EPIC: European Prospective Investigation into Cancer and Nutrition. Cohort numbers: 134 
012 males; 300197 females; 4340209 in total. 
Just as there are significant differences in the consumption of fruit and vegetables among 
European countries we also note differences in dietary fibre intake. The source of fibre in a 
healthy dietary pattern is an important qualitative difference. Table 1 summarizes the daily 
intake of dietary fibre among European countries (Bingham et al., 2003).  
The intake of dietary fibre is low and quantitatively similar in Mediterranean and non-
Mediterranean European countries. These data were consistent with other published works 
(Elmadfa et al., 2005). Dietary fibre intake in Mediterranean countries comes from fresh fruit 
and vegetables, while in Northern European countries it comes more from cereals. 
Accordingly, the incidence of chronic diseases is higher in northern European countries. 
Currently there is not a harmonized definition of dietary fibre at the European Community 
level. The term dietary fibre was originally defined as the portion of food which is derived 
from cellular walls of plants which are digested very poorly by human beings (Trowell, 
1976). The recognition that other food components could have effects similar to those 
originating from plant cell walls led to a redefinition of dietary fibre to include all 
undigestible food components. The indigestible fraction of food has been defined as the part 
of plant foods that is not digested nor absorbed in the small intestine, reaching the colon 
where it is a substrate for the fermentative microbiota. As such, it comprises not only dietary 
fibre (traditional concept), but also other compounds of proven resistance to the action of 
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digestive enzymes such as a fraction of dietary starch (resistant starch), protein, certain 
polyphenols, and other associated compounds (Saura-Calixto et al., 2000, 2007). This 
definition, basically physiological in nature, has been accepted by the majority of scientists 
working in the field. In this line, a method to quantify the food indigestible fraction in plant 
foods was presented. In this method, the digestible portion of the food is removed by using 
digestive enzymes and mimicking the digestive process in the small intestine. Then, a 
majority of indigestible components are isolated (Saura-Calixto et al., 2000). The value of 
dietary fibre includes resistant starch in this analytical method. However, resistant 
oligosaccharides and inulin are not included, and therefore need to be measured separately 
and subsequently added to the total food indigestible fraction estimate. The concept of 
indigestible fraction as dietary fibre is more reliable when applied to epidemiological and 
nutritional studies (Saura-Calixto & Goñi, 2004). 
On the other hand, a number of physiological effects in human beings, e.g. decreased 
intestinal transit time, increased stools bulk, reduction of blood total and/or LDL cholesterol 
levels, and reducing post-prandial blood glucose and/or insulin levels, are often associated 
to the intake of dietary fibre. However, these effects vary depending on fibre component. 
Therefore, each fibre may have specific effects, which suggests not including physiological 
properties in the definition. 
3.3 Dietary fibre as a carrier of bioactive compounds 
Fruit and vegetables possess a higher soluble/insoluble fibre ratio than cereals, what is 
considered as an indicator of nutritional quality. A part of the postulated benefits of the 
Mediterranean dietary pattern might then be attributable to the intake of food undigestible 
components (Saura-Calixto et al., 2000). It is important to note at this point that the use of 
food dietary fibre data in nutrition may be subject to some limitations arising from the 
concept of dietary fibre itself and from the methodology used to determine dietary fibre in 
foods. 
Dietary fibre does not constitute a defined chemical group but a combination of chemically 
heterogeneous substances. Moreover, dietary fibre, especially from fruits and vegetables, is 
a carrier of bioactive compounds. Dietary fibre of fruit and vegetables transports a 
significant amount of polyphenols and carotenoids linked to the fibre matrix through the 
human gut (Saura-Calixto et al., 2006, 2007). Therefore, associated phytochemicals can make 
a significant contribution to the health benefits attributed to the dietary fibre of fruit and 
vegetables. Thus, phytochemicals may be considered dietary fibre constituents in view of 
the similarity of their properties in terms of resistance to digestive enzymes and colonic 
fermentability (Saura-Calixto et al., 2006, 2007). 
Physiological and physicochemical effects of dietary fibres depend on the relative amount of 
individual non-digestible components. Therefore, when a dietary fibre contains associated 
compounds with antioxidant activity, this property is conferred to the total dietary fibre 
complex and may be considered as antioxidant dietary fibre (Saura-Calixto et al., 1998). 
In the Spanish diet, considered as Mediterranean pattern diet, fruit and vegetables provide a 
daily intake of 700-1000 mg of polyphenols/person/diet, a major fraction of this (600 
mg/person/day) associated with dietary fibre (Saura-Calixto et al., 2007). These issues 
constitute an important qualitative difference in relation to other dietary patterns. 
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4. By-Products from plant foods as sources of dietary fibre and antioxidants 
Fruit and vegetables have been recognized as important sources for a wide array of non 
digestible components and phytochemicals that individually, or in combination, may act 
synergistically to contribute to the nutritional and health benefits of these food commodities. 
Despite the consumption recommendations, the intake of fruit and vegetables remains low 
and, consequently, both dietary fibre and antioxidant compounds are usually deficient in 
most diets around the world. 
Nowadays dietary fibre and bioactive compounds are widely used as functional ingredients 
in processed foods. The market in this field is competitive and the development of new 
types of quality ingredients is a challenge for the food industry. In this regard, it is 
interesting to consider not only the nutritional quality of the ingredient, but also its 
distribution, cost and other additional benefits, since the use of these ingredients would give 
added value to the production of these materials. 
 
 Byproducts Edible part Reference 
Agave 40% (rind and pith) 60% Iñiguez-Covarrubias et al., 2001 
Apple 11% (pulp and seed core) 89% Ayala-Zavala et al., 2010 
Artichoke Around 60% (outer bracts, receptacles and stems) 40% Llorach et al., 2002 
Asparagus Up to 40-50% (spear) 50-60% Rodríguez et al., 2006 
Banana Up to 30% (peel) 70% Schieber et al., 2001 
Cactus pear cladodes 20% (spines, glochids and peel) 80% Bensadon et al., 2010 
Cactus pear fruit 45% (spines, glochids, peel and unusable pulp) 65% Bensadon et al., 2010 
Carrot 30-40% (pomace) 60-70% Schieber et al., 2001 
Cyphomandra betacea 15-35% (skin, pulp and seeds) 65-85% Ordóñez et al., 2010 
Guava 10-15% (peel and seeds) 85-90% Schieber et al., 2001 
Mandarin 16% (peels) 84% Ayala-Zavala et al., 2010 
Mango 13.5% (seeds), 11% (peels) and 17.9% (unusable pulp) 58% Ayala-Zavala et al., 2010 
Orange 66% (peel) 44% Li et al., 2006 
Papaya 6.5% (seeds), 8.5% (peels) and 32.1% (unusable pulp) 53% Ayala-Zavala et al., 2010 
Passion fruit >75% (rind and seeds) 25% Schieber et al., 2001 
Pineapple 9.1% (core), 13.5% (peels), 14.9% (top) and 14.5% (pulp) 48% Ayala-Zavala et al., 2010 
Potato 15-40% (peel) 60-85% Schieber et al., 2001 
Tomato 3-7% (peel and seeds) 93-97% Schieber et al., 2001 
Tiger nuts (“Chufa”) Up to 60% (solid and liquid wastes) 40% Sánchez-Zapata et al., 2009 
Table 2. Amount of byproducts generated from fruit and vegetable processing industry. 
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There is a trend to find new sources of functional ingredients such as plant food byproducts 
that have traditionally been undervalued (Rodríguez et al., 2006). The term “byproduct” 
suggests that plant food wastes might be usable and have their own market (Sánchez-
Zapata et al., 2009). The plant food processing industry produces large amounts of wastes 
and residues, estimated to be around 800 000 tons per year of fresh fruit and vegetable 
matter globally, without considering the wastage during processing (Ayala-Zavala et al., 
2010). In India, fruit and vegetable wastes constitute about 5.6 million tons annually 
(Arvanitoyannis & Varzakas et al., 2008). These byproducts might reach around 60% of 
harvested plants. These residues are very perishable products that are difficult to manage 
because of environmental problems in the industries (Arvanitoyannis & Varzakas et al., 
2008). 
Dietary fibre does not constitute a defined chemical group but a combination of 
chemically heterogeneous substances. The health significance of foods fibres has led to the 
development of a large and potential market for fibre-rich products and ingredients 
(Rodríguez et al., 2006). In general, agricultural and industries residues are important 
sources of dietary fibre.  
Table 2 shows the percentage of byproducts generated from fruit and vegetables 
processing industries. These byproducts are made up mainly of skins, seeds, stems, 
leaves, wastewaters and unusable pulp which are normally discarded (Ajila et al., 2007). 
The amount of byproducts might represent more than 40% of total plant food in cases 
such as artichoke, asparagus, cactus pear fruit, mango, orange, papaya, pineapple, red 
chicory and tiger nuts. 
Table 3 displays the total dietary fibre content of byproducts from plant foods widely 
consumed. It is remarkable the important amount of fibre fraction present in byproducts 
ranging from 27 up to 80%, comprising both soluble and insoluble fibre compounds. 
Dietary fibre of fruit and vegetables transports a significant amount of polyphenols and 
carotenoids linked to the fibre matrix through the human gut (Saura-Calixto et al., 2006, 
2007). Therefore, associated phytochemicals can make a significant contribution to the health 
benefits attributed to the dietary fibre of fruit and vegetables. Moreover, phytochemicals 
may be considered dietary fibre constituents in view of the similarity of their properties in 
terms of resistance to digestive enzymes and colonic fermentability (Saura-Calixto et al., 
2006, 2007). 
An interesting approach to providing an added value to byproducts is their use as sources 
of dietary fibre and also as natural antioxidant compounds. Particularly, plant food residues 
are a good source of phytochemicals such as polyphenols.  
The phenolic content of a wide variety of plant food byproducts are displayed in Tables 4 
and 5. It can be noted that peel byproducts from grape, mango, pomegranate, apple, 
bambangan, cactus pear and cladodes as well as seeds of avocado, longan and mango, are 
remarkably the highest in polyphenol concentration. Likewise, general byproducts from 
asparagus, artichoke, blueberry, cranberry, buckwheat and grape seed are rich in 
polyphenols including proanthocyanidins. Grape antioxidant dietary fibre is the most 
concentrated source of polyphenols with a concentration of 19740 mg/100 g dry weight 
(Pérez-Jiménez et al., 2008). 
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Byproducts Dietary fiber (g/100 g dry weight) Reference 
Apple 44.0 Mckee & Latner, 2000 
Brewer’s dried grain 60.0 Mckee & Latner, 2000 
Cabbage outer leaves 40.5 Mckee & Latner, 2000 
Carob 53.0 Bravo, 1994 
Carrot 48.0 Mckee & Latner, 2000 
Cauliflower 65.0 Mckee & Latner, 2000 
Chia 56.5 Vázquez-Ovando et al., 2009 
Pepper 80.4 Mckee & Latner, 2000 
Cocoa hulls 60.5 Lecumberri et al., 2006 
Coconut 63.2 Raghavendra et al., 2006 
Coffee silverskin 69.2 Napolitano et al., 2007 
Date 71.0 Mckee & Latner, 2000 
Grape 77.9 Mckee & Latner, 2000 
Grape antioxidant dietary fibre 73.5 Pérez-Jiménez et al., 2008 
Grapefruit 58.6 Larrauri et al., 1997a 
Guava 48.6 Sánchez-Zapata et al., 2009 
Jack vean 55.9 Vázquez-Ovando et al., 2009 
Kiwi 25.8 Mckee & Latner, 2000 
Lime 64.3 Jongaroontaprangsee et al., 2007 
Tangerine 52.9 Rincon et al., 2005 
Mango 74.0 Larrauri et al., 1996 
Oat bran 8.2 Mckee & Latner, 2000 
Olive 80.0 Mckee & Latner, 2000 
Orange 57-71 Vázquez-Ovando et al., 2009 
Passion fruit 63.3 Pérez-Navarrete, 2003, as cited in Sánchez-Zapata et al., 2009 
Peach 36.0 Mckee & Latner, 2000 
Pear 43.9 Mckee & Latner, 2000 
Peas 82.3 Mckee & Latner, 2000 
Pineapple 70.6 Larrauri et al., 1997b 
Rice bran 27.4 Mckee & Latner, 2000 
Tiger nuts 59.7 Sánchez-Zapata et al., 2009 
Table 3. Total dietary fibre content of byproducts from plant foods. 
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 Peel/skin Pulp General byproducts Reference 
Asparagus   284-371 Rodríguez et al., 2005 
Blanched artichoke   360-440 Llorach et al., 2002 
Cauliflower   110-180 Llorach et al., 2003 
Chicory   77-82 Llorach et al., 2004 
Grape 2890   Saura-Calixto et al., 1998 
Grapefruit 155 135  Gorinstein et al., 2001 
Guava 58.70   Jimenez-Escrig et al., 2001 
Hazelnut 577*  127-241* Shahidi et al., 2007 
Lemon 190.0 164.0  Gorinstein et al., 2001 
Lettuce   14-156 Llorach et al., 2004 
Mango 7000   Larrauri et al., 1996 
Orange 179.0 154.0  Gorinstein et al., 2001 
Peach 133.7 41.5  Chang et al., 2000 
Pomegranate 24990 2440  Li et al., 2005 
Raw artichoke   300-320 Llorach et al., 2002 
Tomato cherry 10.4-40 9.20-27.0  George et al., 2004 
Table 4. Phenolic content (mg/100 g fresh weight) measured in solvent extracts of plant 
byproducts. *mg/g of extract. 
A wide array of phenolic compounds has been described in plant food by-products. 
Almond hull extracts contain hydroxybenzoic and cinnamic acid derivatives, with minor 
presence of flavan-3-ols, including the presence of epicatechin and glycosylated flavonols 
(Rubilar et al., 2007). Five phenolic acids (gallic acid, caffeic acid, p-coumaric acid, ferulic 
acid, and sinapic acid) were identified in hazelnut byproducts (both free and esterified 
forms) (Shahidi et al., 2007).  
Caffeic acid derivatives are the main phenolic compounds in artichoke heads, with a wide 
range of caffeoylquinic acid derivatives with chlorogenic acid (5-Ocaffeoylquinic acid) as the 
most important of these derivatives. Other phenolics such as the flavonoids apigenin and 
luteolin (both glucosides and rutinosides) as well as different cyanidin caffeoylglucoside 
derivatives have been identified (Llorach et al., 2002). The analysis of cauliflower byproduct 
extracts revealed the presence of both flavonoids and hydroxycinamic acids (caffeic acid 
and sinapic acid). Different combinations of flavonols such as kaempferol and quercetin 
with sinapic acid and glucose were the main phenolic compounds present (Llorach et al., 
2003). 
Analyses of lettuce byproducts revealed the occurence of both hydroxycinnamic acids and 
flavonoids. The flavonoid profile of lettuce byproducts was composed of flavones (luteolin 
derivatives) and flavonols (quercetin derivatives), whereas the chicory byproducts were 
composed only of kaempferol derivatives (Llorach et al., 2004). 
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Guava 48.6 Sánchez-Zapata et al., 2009 
Jack vean 55.9 Vázquez-Ovando et al., 2009 
Kiwi 25.8 Mckee & Latner, 2000 
Lime 64.3 Jongaroontaprangsee et al., 2007 
Tangerine 52.9 Rincon et al., 2005 
Mango 74.0 Larrauri et al., 1996 
Oat bran 8.2 Mckee & Latner, 2000 
Olive 80.0 Mckee & Latner, 2000 
Orange 57-71 Vázquez-Ovando et al., 2009 
Passion fruit 63.3 Pérez-Navarrete, 2003, as cited in Sánchez-Zapata et al., 2009 
Peach 36.0 Mckee & Latner, 2000 
Pear 43.9 Mckee & Latner, 2000 
Peas 82.3 Mckee & Latner, 2000 
Pineapple 70.6 Larrauri et al., 1997b 
Rice bran 27.4 Mckee & Latner, 2000 
Tiger nuts 59.7 Sánchez-Zapata et al., 2009 
Table 3. Total dietary fibre content of byproducts from plant foods. 
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 Peel/skin Pulp General byproducts Reference 
Asparagus   284-371 Rodríguez et al., 2005 
Blanched artichoke   360-440 Llorach et al., 2002 
Cauliflower   110-180 Llorach et al., 2003 
Chicory   77-82 Llorach et al., 2004 
Grape 2890   Saura-Calixto et al., 1998 
Grapefruit 155 135  Gorinstein et al., 2001 
Guava 58.70   Jimenez-Escrig et al., 2001 
Hazelnut 577*  127-241* Shahidi et al., 2007 
Lemon 190.0 164.0  Gorinstein et al., 2001 
Lettuce   14-156 Llorach et al., 2004 
Mango 7000   Larrauri et al., 1996 
Orange 179.0 154.0  Gorinstein et al., 2001 
Peach 133.7 41.5  Chang et al., 2000 
Pomegranate 24990 2440  Li et al., 2005 
Raw artichoke   300-320 Llorach et al., 2002 
Tomato cherry 10.4-40 9.20-27.0  George et al., 2004 
Table 4. Phenolic content (mg/100 g fresh weight) measured in solvent extracts of plant 
byproducts. *mg/g of extract. 
A wide array of phenolic compounds has been described in plant food by-products. 
Almond hull extracts contain hydroxybenzoic and cinnamic acid derivatives, with minor 
presence of flavan-3-ols, including the presence of epicatechin and glycosylated flavonols 
(Rubilar et al., 2007). Five phenolic acids (gallic acid, caffeic acid, p-coumaric acid, ferulic 
acid, and sinapic acid) were identified in hazelnut byproducts (both free and esterified 
forms) (Shahidi et al., 2007).  
Caffeic acid derivatives are the main phenolic compounds in artichoke heads, with a wide 
range of caffeoylquinic acid derivatives with chlorogenic acid (5-Ocaffeoylquinic acid) as the 
most important of these derivatives. Other phenolics such as the flavonoids apigenin and 
luteolin (both glucosides and rutinosides) as well as different cyanidin caffeoylglucoside 
derivatives have been identified (Llorach et al., 2002). The analysis of cauliflower byproduct 
extracts revealed the presence of both flavonoids and hydroxycinamic acids (caffeic acid 
and sinapic acid). Different combinations of flavonols such as kaempferol and quercetin 
with sinapic acid and glucose were the main phenolic compounds present (Llorach et al., 
2003). 
Analyses of lettuce byproducts revealed the occurence of both hydroxycinnamic acids and 
flavonoids. The flavonoid profile of lettuce byproducts was composed of flavones (luteolin 
derivatives) and flavonols (quercetin derivatives), whereas the chicory byproducts were 
composed only of kaempferol derivatives (Llorach et al., 2004). 
 
Phytochemicals – Bioactivities and Impact on Health 
 
106 
 Peel/skin Pulp Seed
General 
byproducts Reference 
Apple 3300 11800   Schieber et al., 2003; Wolfe & Liu et al., 2003 
Asparagus    284-371 Rodríguez et al., 2005 
Avocado   8820  Soong & Barlow, 2004 
Bambangan peel powder 9830    Hassan et al., 2011 
Banana 928 232   Someya et al., 2002 
Blueberry    459* Khanal et al., 2009 
Buckwheat bran    406 Zduńczyk et al., 2006 
Buckwheat hulls    448 Zduńczyk et al., 2006 
Cactus pear 2760 3180 1610  Bensadón et al., 2010; Ramírez-Moreno et al., 2011 
Cladodes 3710    Bensadón et al., 2010 
Cranberry    448* Khanal et al., 2009 
Cyphomandra betacea    72 Ordóñez et al., 2010 
Grape antioxidant dietary 
fibre    19740 Pérez-Jiménez et al., 2008 
Grape pomace    20-200 González-Paramás et al., 2004 
Grape seed    120-710 González-Paramás et al., 2004 
Jackfruit  90 2770  Soong & Barlow, 2004 
Longan  160 6260  Soong & Barlow, 2004 
Mango 5467-9020 240 11700  
Ajila et al., 2010a; 
Soong & Barlow, 2004 
Oat bran with hulls    155 Zduńczyk et al., 2006 
Table 5. Phenolic content (mg/100 g dry weight) in different plant foods byproducts. *mg 
proanthocyanidins/100 g dry weight. 
The prominent phenolic compounds identified in peels of raw and ripe mango fruits were 
protocatechuic acid, gentisic acid and gallic acid. Gallic acid, syringic acid, mangiferin, 
ellagic acid, gentisyl-protocatechuic acid, quercetin were the phenolic compounds identified 
in both raw and ripe peels, while raw peel showed the presence of glycosylated 
iriflophenone and maclurin derivatives also (Ajila et al., 2010b). The main flavonoids found 
in citrus species are hesperidin, narirutin, naringin and eriocitrin. Peel and other solid 
residues of lemon waste mainly contained hesperidin and eriocitrin, while the latter was 
predominant in liquid residues (Schieber et al., 2001). Otherwise, the polyphenol profile of 
solvent extracts of various byproducts (barks, kernels, peels, and old and young leaves) 
from Brazilian mango crops showed the occurrence of xanthone C-glycosides, gallotannins, 
and benzophenones (Barreto et al., 2008). 
Apple pomace is a good source of polyphenols which are predominantly localized in the 
peels and are present in the juice to a minor extent (Schieber et al., 2001). The phenolic 
compounds quantified in the apple skin were: the proanthocyanidins (procyanidin B1 and 
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B2), the flavan- 3-ols (epicatechin and catechin), the flavonols (quercetin-3-Ogalactoside, 
quercetin-3-O-rhamnoside, quercetin-3-O-glucoside, quercetin-3-O-rutinoside), the 
dihydrochalcone (phloretin-2-Oglucoside), the anthocyanin (cyanidin-3-O-galactoside), and 
the phenolic acid (chlorogenic acid) (Huber & Rupasinghe, 2009). Also, banana bracts are an 
abundant source of anthocyanins such as delphinidin, cyanidin, pelargonidin, peonidin, 
petunidin and malvidin (Schieber et al., 2001). 
In the composition of extracts of white and red grape pomace several of these compounds 
were also detected but basically consisted of glycosylated flavonols (quercetin, kaempferol) 
(Rubilar et al., 2007). Phenolic compounds present in grape pomace antioxidant dietary fibre 
have been widely described (Tourino et al., 2008), comprising: hydroxybenzoic and phenolic 
acids and their derivatives, monomeric flavonoids (catechins and flavonols aglycones) and 
flavonoids such as oligomeric proanthocyanidins,  flavonols, flavones, and flavanones; 
anthocyanin, anthocyanidins delphinidin, cyaniding, petudin, peonidin, petunidin, 
pelargonidin and malvidin) and their mono and acetyl glucoside derivatives were also 
identified as well as polimeric proanthocyanidins (types A and B). 
One recognized characteristic of a healthy diet includes components that counteract 
oxidative stress, which is involved in the etiopathogeny and progression of chronic 
diseases, contributing to the process of aging (Herrera et al., 2009). Dietary fruit and 
vegetables provide a significant amount of compounds (vitamins, carotenoids and 
polyphenols) that act as physiological antioxidants. Polyphenols are the major dietary 
antioxidants. 
Since part of the total content of antioxidant phytochemicals is linked to dietary fibre as 
noted above, an appreciable proportion of the total antioxidant capacity in fruit and 
vegetables is associated with dietary fibre. We address mainly polyphenols associated with 
dietary fibre in fruit and vegetables because of the important biological properties derived 
from them and the significant phenolic content in these foods. Table 6 summarizes the 
antioxidant or radical scavenging activity of plant food byproducts. Those from bambangan, 
cactus pear, cladodes, hazelnut and, especially grape antioxidant dietary fibre, possess a 
potent antioxidant capacity. 
5. Application of plant food byproducts as functional ingredients 
The definition of a functional food by the International Life of Science Institute (ILSI 1999) is 
“a food product can be functional if it has satisfactorily been proven that it produces a 
beneficial effect on one or more physiological functions, besides its conventional nutritional 
effects, being this relevant for improving human health and/or reducing the risk of 
suffering certain diseases” (Roberfroid, 2000). Dietary fibre holds all the characteristics 
required to be considered as an important ingredient in the formulation of functional foods 
due to its proven beneficial effects (Rodríguez et al., 2006). 
The Regulation on Nutrition and Health Claims (European Comission 2007, EU Regulation 
(EC) No 1924/2006) allows claims to be made with respect to the fibre content of food (Table 
7) as source of fibre if its levels exceed 3 g per 100 g or high in fibre for 6 g per 100 g (Buttriss & 
Stokes, 2008). The claims for dietary fibre are as follows (Table 7) 
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 Peel/skin Pulp Seed
General 
byproducts Reference 
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Mango 5467-9020 240 11700  
Ajila et al., 2010a; 
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Table 5. Phenolic content (mg/100 g dry weight) in different plant foods byproducts. *mg 
proanthocyanidins/100 g dry weight. 
The prominent phenolic compounds identified in peels of raw and ripe mango fruits were 
protocatechuic acid, gentisic acid and gallic acid. Gallic acid, syringic acid, mangiferin, 
ellagic acid, gentisyl-protocatechuic acid, quercetin were the phenolic compounds identified 
in both raw and ripe peels, while raw peel showed the presence of glycosylated 
iriflophenone and maclurin derivatives also (Ajila et al., 2010b). The main flavonoids found 
in citrus species are hesperidin, narirutin, naringin and eriocitrin. Peel and other solid 
residues of lemon waste mainly contained hesperidin and eriocitrin, while the latter was 
predominant in liquid residues (Schieber et al., 2001). Otherwise, the polyphenol profile of 
solvent extracts of various byproducts (barks, kernels, peels, and old and young leaves) 
from Brazilian mango crops showed the occurrence of xanthone C-glycosides, gallotannins, 
and benzophenones (Barreto et al., 2008). 
Apple pomace is a good source of polyphenols which are predominantly localized in the 
peels and are present in the juice to a minor extent (Schieber et al., 2001). The phenolic 
compounds quantified in the apple skin were: the proanthocyanidins (procyanidin B1 and 
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B2), the flavan- 3-ols (epicatechin and catechin), the flavonols (quercetin-3-Ogalactoside, 
quercetin-3-O-rhamnoside, quercetin-3-O-glucoside, quercetin-3-O-rutinoside), the 
dihydrochalcone (phloretin-2-Oglucoside), the anthocyanin (cyanidin-3-O-galactoside), and 
the phenolic acid (chlorogenic acid) (Huber & Rupasinghe, 2009). Also, banana bracts are an 
abundant source of anthocyanins such as delphinidin, cyanidin, pelargonidin, peonidin, 
petunidin and malvidin (Schieber et al., 2001). 
In the composition of extracts of white and red grape pomace several of these compounds 
were also detected but basically consisted of glycosylated flavonols (quercetin, kaempferol) 
(Rubilar et al., 2007). Phenolic compounds present in grape pomace antioxidant dietary fibre 
have been widely described (Tourino et al., 2008), comprising: hydroxybenzoic and phenolic 
acids and their derivatives, monomeric flavonoids (catechins and flavonols aglycones) and 
flavonoids such as oligomeric proanthocyanidins,  flavonols, flavones, and flavanones; 
anthocyanin, anthocyanidins delphinidin, cyaniding, petudin, peonidin, petunidin, 
pelargonidin and malvidin) and their mono and acetyl glucoside derivatives were also 
identified as well as polimeric proanthocyanidins (types A and B). 
One recognized characteristic of a healthy diet includes components that counteract 
oxidative stress, which is involved in the etiopathogeny and progression of chronic 
diseases, contributing to the process of aging (Herrera et al., 2009). Dietary fruit and 
vegetables provide a significant amount of compounds (vitamins, carotenoids and 
polyphenols) that act as physiological antioxidants. Polyphenols are the major dietary 
antioxidants. 
Since part of the total content of antioxidant phytochemicals is linked to dietary fibre as 
noted above, an appreciable proportion of the total antioxidant capacity in fruit and 
vegetables is associated with dietary fibre. We address mainly polyphenols associated with 
dietary fibre in fruit and vegetables because of the important biological properties derived 
from them and the significant phenolic content in these foods. Table 6 summarizes the 
antioxidant or radical scavenging activity of plant food byproducts. Those from bambangan, 
cactus pear, cladodes, hazelnut and, especially grape antioxidant dietary fibre, possess a 
potent antioxidant capacity. 
5. Application of plant food byproducts as functional ingredients 
The definition of a functional food by the International Life of Science Institute (ILSI 1999) is 
“a food product can be functional if it has satisfactorily been proven that it produces a 
beneficial effect on one or more physiological functions, besides its conventional nutritional 
effects, being this relevant for improving human health and/or reducing the risk of 
suffering certain diseases” (Roberfroid, 2000). Dietary fibre holds all the characteristics 
required to be considered as an important ingredient in the formulation of functional foods 
due to its proven beneficial effects (Rodríguez et al., 2006). 
The Regulation on Nutrition and Health Claims (European Comission 2007, EU Regulation 
(EC) No 1924/2006) allows claims to be made with respect to the fibre content of food (Table 
7) as source of fibre if its levels exceed 3 g per 100 g or high in fibre for 6 g per 100 g (Buttriss & 
Stokes, 2008). The claims for dietary fibre are as follows (Table 7) 
 





 Extract Byproducts Method Reference 
Bambangan peel 
powder 
Methanol, acetone and 
water 44.50 µg/mL 
DDPH 
IC50 




TEAC/100 g FW ABTS Llorach et al., 2002 
Buckwheat bran Methanol and water 24.24 µmol TEAC/g DW ABTS Zduńczyk et al., 2006 
Buckwheat hulls Methanol and water 26.15 µmol TEAC/g DW ABTS Zduńczyk et al., 2006 
Cactus pear Acidic methanol, acetone and water 
66.33 µmol 
TEAC/g DW ABTS 
Bensadón et al., 
2010; Ramírez-
Moreno et al., 2011 
Cauliflower Ethanol and water 0.86-3.20  g TEAC/1 kg FW ABTS Llorach et al., 2003 
Chicory Methanol or water 0.6-0.8 mg TEAC/g FW ABTS Llorach et al., 2004 
Cladodes Acidic methanol, acetone and water 
57.55 µmol 
TEAC/g DW ABTS Bensadón et al., 2010 
Coffee silverskin Methanol and water 1-4 mmol TEAC/g FW ABTS 




Acidic ethanol and 
water 
12.24 µmol 





acetone, water and 
buthanol. 
375.5 µmol 
TEAC/g DW ABTS 
Pérez-Jiménez et al., 
2008 




ABTS Shahidi et al., 2007 
Lettuce Methanol or water 0.4-1.3 mg TEAC/g FW ABTS Llorach et al., 2004 
Oat bran with 
hulls Methanol and water 
7.96 µmol 
TEAC/g DW ABTS Zduńczyk et al., 2006 
Raw artichoke Methanol/water 
0.14-0.25 
g TEAC/100 g 
FW 
ABTS Llorach et al., 2002 
 
 
Table 6. Antioxidant activity or radical scavenging activity of plant food byproducts. TEAC: 
trolox equivalent antioxidant capacity. DW: dry weight. FW: fresh weight. 
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Claim Source of fibre Increased in fibre High in fibre 
Requirement Either >3 g/100 g or 
>1.5 g fibre/100 kcal 
>25% more than a similar food 
which no claim is made 
Either >6 g/100 g or 
>3 g fibre/100 kcal 
Table 7. Nutrient claims for dietary fibre based on AOAC (American Organization of 
Analytical Chemists) analysis (EU Regulation (EC) No 1924/2006). 
Byproducts obtained when processing cereal, algae, fruit and vegetables can be added as 
functional ingredients, providing advantageous dietary fibre and bioactive compounds. 
These byproducts serve as non-caloric bulking agents, enhance water and oil retention, and 
improve emulsion and oxidative stability. The literature reports addition of fibre to food 
products such as baked goods, beverages, confectionary, dairy, meat and pasta (Elleuch et 
al., 2011). 
Addition of byproducts in bakery products are muffin butter supplemented with peach 
dietary fibre (Grigelmo-Miguel et al., 1999), and cake dough enhanced with prickly pear 
cladode fibre (Ayadi et al., 2009) at levels up to 5%. Incorporation of cauliflower by-products 
into ready-to-eat snacks enhanced nutritional and textural characteristics, increasing dietary 
fibre levels in the finished product by over 100% (Stojceska et al., 2008). 
Fibres can also be introduced into meat products. Addition of 1.5% of orange fibre or 3% of 
carrot fibre to dry fermented sausages does not affect its organoleptic characteristics (Eim et 
al., 2008; Garcia et al., 2002). Citrus fibre with associated antioxidant bioactive compounds 
when added to meat products inhibits lipid oxidation and decrease residual nitrite levels 
(Fernández-Ginés et al., 2003). Pork burgers elaborated with tiger nut fibre had higher 
nutritional value in terms of fibre content and better cooking characteristics such as higher 
cooking yield, fat and moisture retention (Sánchez-Zapata et al., 2010). Grape pomace 
antioxidant dietary fibre when added to minced fish (Sánchez-Alonso et al., 2007) and 
chicken hamburgers (Sáyago-Ayerdi et al., 2009) improves oxidative stability and thus 
prolong shelf life. By-product fibre addition to burgers is a promising and convenient 
application considering dietary fibre of burgers can be significantly increased without 
changes in sensory acceptance. 
The addition of unripe banana flour to spaghetti increased the dietary fibre and the content 
of phenolic compounds. Consequently, spaghetti had a slow and low rate for enzymatic 
hydrolysis and an increased antioxidant capacity (Ovando-Martínez et al., 2009). Mango 
peel powder was incorporated into macaroni (7.5%) to increase dietary fibre from 8.6 to 
17.8%, polyphenols from 0.46 to 1.80 mg/g and carotenoid content from 5 to 84 µg/g of 
macaroni, resulting in an enhanced nutritional quality without affecting its cooking, textural 
and sensory properties (Ajila et al., 2010a). 
6. Conclusion 
Several fruit and vegetable byproducts from food processing industries meet the criteria of 
antioxidant dietary fibre definition. They are certain to be an excellent source of dietary fibre 
and natural antioxidants if used as high-quality ingredients in functional foods or dietary 
supplements. Furthermore,  compliance with the nutritional claims criteria recognized in the 
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These byproducts serve as non-caloric bulking agents, enhance water and oil retention, and 
improve emulsion and oxidative stability. The literature reports addition of fibre to food 
products such as baked goods, beverages, confectionary, dairy, meat and pasta (Elleuch et 
al., 2011). 
Addition of byproducts in bakery products are muffin butter supplemented with peach 
dietary fibre (Grigelmo-Miguel et al., 1999), and cake dough enhanced with prickly pear 
cladode fibre (Ayadi et al., 2009) at levels up to 5%. Incorporation of cauliflower by-products 
into ready-to-eat snacks enhanced nutritional and textural characteristics, increasing dietary 
fibre levels in the finished product by over 100% (Stojceska et al., 2008). 
Fibres can also be introduced into meat products. Addition of 1.5% of orange fibre or 3% of 
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application considering dietary fibre of burgers can be significantly increased without 
changes in sensory acceptance. 
The addition of unripe banana flour to spaghetti increased the dietary fibre and the content 
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macaroni, resulting in an enhanced nutritional quality without affecting its cooking, textural 
and sensory properties (Ajila et al., 2010a). 
6. Conclusion 
Several fruit and vegetable byproducts from food processing industries meet the criteria of 
antioxidant dietary fibre definition. They are certain to be an excellent source of dietary fibre 
and natural antioxidants if used as high-quality ingredients in functional foods or dietary 
supplements. Furthermore,  compliance with the nutritional claims criteria recognized in the 
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European Regulation would be met. The applications of plant food byproducts will 
definitely bring about added value to both, the industry and the consumer. The industry 
benefits from econimic incomes and the consumer from the excellent nutritional value of 
these materials with potential health claims. 
7. Acknowledgment  
The present work was performed under the financial support of the Spanish Ministry of 
Science and Innovation, National Program of I+D, AGL-2008-01633. D. Hervert-Hernández 
acknowledges predoctoral fellowships from the Mexican institutions CONACyT and SEP.  
8. References 
Adom, K. K., Sorrells, M. E., & Liu, R. H. (2005). Phytochemicals and antioxidant activity of 
milled fractions of different wheat varieties. Journal of Agricultural and Food 
Chemistry, Vol. 53, No.6, (March 2005), pp. 2297-2306, ISSN 0021-8561  
Ajila, C. M., Aalami, M., Leelavathi, K., & Rao, U. J. S. P. (2010a). Mango peel powder: A 
potential source of antioxidant and dietary fiber in macaroni preparations. 
Innovative Food Science & Emerging Technologies, Vol.11, No.1, (January 2010), pp. 
219-224, ISSN 1466-8564  
Alfredo, V., Gabriel, R., Luis, C., & David, B. (2009). Physicochemical properties of a fibrous 
fraction from chia (Salvia hispanica L.). LWT - Food Science and Technology, Vol.42, 
No.1 (2009), pp. 168-173, ISSN 0023-6438  
Arvanitoyannis, I. S., & Varzakas, T. H. (2008). Vegetable waste treatment: Comparison and 
critical presentation of methodologies. Critical Reviews in Food Science and Nutrition, 
Vol.48, No.3, (March 2008), pp. 205-247, ISSN 1040-8398  
Ayadi, M. A., Abdelmaksoud, W., Ennouri, M., & Attia, H. (2009). Cladodes from Opuntia 
ficus indica as a source of dietary fiber: Effect on dough characteristics and cake 
making. Industrial Crops and Products, Vol.30, No.1, (July 2009), pp. 40-47, ISSN 
0926-6690  
Ayala-Zavala, J., Rosas-Domínguez, C., Vega-Vega, V., & González-Aguilar, G. A. (2010). 
Antioxidant enrichment and antimicrobial protection of fresh-cut fruits using their 
own byproducts: Looking for integral exploitation. Journal of Food Science, Vol.75, 
No.8 (2010), pp. R175-R181, ISSN 1750-3841  
Bensadón, S., Hervert-Hernández, D., Sáyago-Ayerdi, S., & Goñi, I. (2010). By-products of 
Opuntia ficus-indica as a source of antioxidant dietary fiber. Plant Foods for Human 
Nutrition (Formerly Qualitas Plantarum), Vol.65, No.3, (September and 2010), pp. 
210-216, ISSN 0921-9668  
Bingham, S. A., Day, N. E., Luben, R., Ferrari, P., Slimani, N., Norat, T., Clavel-Chapelon, F., 
Kesse, E., Nieters, A., Boeing, H., Tjonneland, A., Overvad, K., Martinez, C., 
Dorronsoro, M., Gonzalez, C. A., Key, T. J., Trichopoulou, A., Naska, A., Vineis, P., 
Tumino, R., Krogh, V., Bueno-de-Mesquita, H. B., Peeters, P. H., Berglund, G., 
Hallmans, G., Lund, E., Skeie, G., Kaaks, R., Riboli, E., & European Prospective 
Investigation into Cancer and Nutrition. (2003). Dietary fibre in food and protection 
against colorectal cancer in the European prospective investigation into cancer and 
nutrition (EPIC): An observational study. Lancet, Vol.361, No.9368, (May 2003), pp. 
1496-1501, ISSN 0140-6736  
 
By-Products from Plant Foods are Sources of Dietary Fibre and Antioxidants 
 
111 
Bravo, L., Grades, N., & Saura-Calixto, F. (1994). Composition and potential uses of 
mesquite pods (Prosopis pallida L): Comparison with carob pods (Ceratonia siliqua L). 
Journal of the Science of Food and Agriculture, Vol.65, No.3 (1994), pp. 303-306, ISSN 
1097-0010  
Burton-Freeman, B. (2010). Postprandial metabolic events and fruit-derived phenolics: A 
review of the science. The British Journal of Nutrition, Vol.104 Suppl 3, (October 
2010), pp. S1-14, ISSN 1475-2662, 0007-1145  
Buttriss, J. L., & Stokes, C. S. (2008). Dietary fibre and health: An overview. Nutrition Bulletin, 
Vol.33, No.3 (2008), pp. 186-200, ISSN 1467-3010  
Chang, S., Tan, C., Frankel, E. N., & Barrett, D. M. (2000). Low-density lipoprotein 
antioxidant activity of phenolic compounds and polyphenol oxidase activity in 
selected clingstone peach cultivars. Journal of Agricultural and Food Chemistry, 
Vol.48, No.2, (February 2000), pp. 147-151, ISSN 0021-8561  
Chong, M. F., Macdonald, R., & Lovegrove, J. A. (2010). Fruit polyphenols and CVD risk: A 
review of human intervention studies. The British Journal of Nutrition, Vol.104 Suppl 
3, (October 2010), pp. S28-39, ISSN 1475-2662, 0007-1145  
Crozier, A., Jaganath, I. B., & Clifford, M. N. (2009). Dietary phenolics: Chemistry, 
bioavailability and effects on health. Natural Product Reports, Vol.26, No.8, (Aug and 
2009), pp. 1001-1043, ISSN 0265-0568  
Eim, V. S., Simal, S., Rosselló, C., & Femenia, A. (2008). Effects of addition of carrot dietary 
fibre on the ripening process of a dry fermented sausage (sobrassada). Meat Science, 
Vol.80, No.2, (October 2008), pp. 173-182, ISSN 0309-1740  
Elleuch, M., Bedigian, D., Roiseux, O., Besbes, S., Blecker, C., & Attia, H. (2011). Dietary fibre 
and fibre-rich by-products of food processing: Characterisation, technological 
functionality and commercial applications: A review. Food Chemistry, Vol.124, No.2, 
(January 2011), pp. 411-421, ISSN 0308-8146  
Elmadfa, I., Rust, P., Majchrzak, D., Wagner, K. H., Genser, D., Lettner, R., & Pinter, M. 
(2004). Effects of beta-carotene supplementation on free radical mechanism in 
healthy adult subjects. International Journal for Vitamin and Nutrition Research, 
Vol.74, No.2, (March 2004), pp. 147-152, ISSN 0300-9831  
Elmadfa, I., Weichselbaum, E., Konig, J., de Winter A-M, R., Trolle, E., Haapala, I., Uusitalo, 
U., Mennen, L., Hercberg, S., Wolfram, G., Trichopoulou, A., Naska, A., Benetou, 
V., Kritsellis, E., Rodler, I., Zajkas, G., Branca, F., D'Acapito, P., Klepp, K. I., Ali-
Madar, A., De Almeida, M. D., Alves, E., Rodrigues, S., Sarra-Majem, L., Roman, B., 
Sjostrom, M., Poortvliet, E., & Margetts, B. (2005). European nutrition and health 
report 2004. Forum of Nutrition, Vol.(58), No.58 (2005), pp. 1-220, ISSN 1660-0347, 
0067-8198  
Evans, P., & Halliwell, B. (2001). Micronutrients: Oxidant/antioxidant status. The British 
Journal of Nutrition, Vol.85 Suppl 2, (May 2001), pp. S67-74, ISSN 0007-1145  
Fernández-Ginés, J. M., Fernández-López, J., Sayas-Barberá, E., Sendra, E., & Pérez-Alvarez, 
J. A. (2003). Effect of storage conditions on quality characteristics of bologna 
sausages made with citrus fiber. Journal of Food Science, Vol.68, No.2 (2003), pp. 710-
714, ISSN 1750-3841  
García, M. L., Dominguez, R., Galvez, M. D., Casas, C., & Selgas, M. D. (2002). Utilization of 
cereal and fruit fibres in low fat dry fermented sausages. Meat Science, Vol.60, No.3, 
(March 2002), pp. 227-236, ISSN 0309-1740  
 
Phytochemicals – Bioactivities and Impact on Health 
 
110 
European Regulation would be met. The applications of plant food byproducts will 
definitely bring about added value to both, the industry and the consumer. The industry 
benefits from econimic incomes and the consumer from the excellent nutritional value of 
these materials with potential health claims. 
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1. Introduction  
Higher plants produce a vast variety of secondary metabolites known as phytochemicals 
(PCs) which appear to protect the plant against a variety of stresses such as UV irradiation, 
pathogenic attacks, and perhaps even consumption by herbivores. Many of these non-
nutrient PCs have been shown to exert a wide range of biological effects, and 
epidemiological and nutritional studies have identified a protective role for PCs in the 
prevention of cancer, diabetes, cardiovascular and neurodegenerative diseases (Kris-
Etherton et al., 2002; Aruoma et al., 2003; Surh, 2003; Balunas & Kinghorn, 2005; Duthie, 
2007; Espin et al., 2007; Russo, 2007; Dembinska-Kiec et al., 2008; Hooper et al., 2008; Khan et 
al., 2008). Unlike some cytotoxic chemicals derived from natural products (e.g., etoposide, 
daunorubicin and paclitaxel), PCs are found in high concentrations in fruits, vegetables, 
nuts, wine and tea, and intake can be up to several hundred milligrams per day (Manach et 
al., 2005). PCs which have been associated with health benefits, include glucosinolates, 
organic isothiocyanates, dibenzocyclooctadienes, sulphur-containing compounds of 
alliaceae, terpenoids (carotenoids, monoterpenes, and phytosterols), flavonoids and 
polyphenols (e.g., anthocyanins, flavones, flavan-3-ols, isoflavones, stilbenoids, and ellagic 
acid) (Balunas & Kinghorn, 2005; Espin et al., 2007). Bioavailability and tissue distribution of 
these PCs in humans are key factors that need to be clearly established in association with 
their biological effects. Recently various drug metabolizing enzymes and drug transporters 
such as the ATP binding cassette (ABC) and the solute carrier (SLC) transporters have been 
cloned and functional analyses suggest that they play significant roles in the absorption and 
disposition of most drugs and PCs (Zhang et al., 1998; Zhang & Benet, 2001; Borst & 
Elferink, 2002; Faber et al., 2003; Sarkadi et al., 2006; Shitara et al., 2006; Hu et al., 2003; Zhou 
et al., 2004; Morris & Zhang, 2006; Zhang et al., 2007; Shukla et al., 2008; Zhang et al., 2009). 
They are present in all tissues and play pivotal roles in the defense of the body against 
amphipathic carcinogens and toxins. Many drug metabolizing enzymes and transporters are 
under tight transcriptional regulation by nuclear receptors, suggesting their functions are 
subject to environmental and dietary influences (Borst & Elferink, 2002; Petri et al., 2003; 
Lancon et al., 2007; Giacomini et al., 2010). In addition, PCs may modulate the expression 
and function of drug metabolizing enzymes and drug transporters which govern xenobiotic 
bioavailability (Wang & Morris, 2007; Kim et al., 2009; Shukla et al., 2009). This review will 
highlight the various barriers to dietary phytochemicals, approaches for assessing these 
interactions, and their implications in pharmacokinetics and potential clinical applications.  
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2. Absorption from gastrointestinal (GI) tract  
To achieve their beneficial effects, other than on the GI tract itself, these PC molecules must 
be delivered to target tissues and organs after overcoming several absorption barriers in the 
GI tract (Figure 1). Firstly, they must dissolve in the fluids of the GI tract and survive the 
different pH environment ranges from extreme low in the stomach to slightly basic in some 
segments of the small intestine. They may also be subjected to degradation and metabolism 
by intestinal enzymes, such as the glycosidases, esterases, oxidases and hydrolases, 
originating both from the host and the myriad of microbiota that inhabit the GI tract (Sousa 
et al., 2008). Actually the large intestine accommodates most of the GI microbiota and the 
rate and extent of metabolism by bacteria will be influenced by the amount of the PC that 
reaches the distal gut. Many plant flavonoids exist in the O-glycoside form within the plant 
and undergo rapid GI hydrolysis to remove the glucose conjugates and form their respective 
aglycons (Crespy et al., 2002; Walle et al., 2005). The latter are more lipophilic and and thus 
are more efficiently absorbed across the GI wall than the parent glycoside, providing they 
are not subject to intestinal transporter-mediated absorption. However, interactions with 
intestinal ABC and SLC transporters may cause unpredictable absorption kinetics of many 
PCs which cannot be simply predicted from their physicochemical properties. Transporter-
related absorption phenomena, such as the limited and nonlinear intestinal permeability 
and absorption of PCs, may lead to extensive variability in their oral bioavailability, 
resulting in low plasma concentrations and lack of pharmacological effect on the one hand, 
or elevated concentrations and toxicity on the other. 
 
 
Fig. 1. Absorption and disposition of phytochemicals in humans. 
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The human family of ABC transporters contains 49 members with 7 subfamilies including 
several important xenobiotic transporters, such as P-glycoprotein (P-gp, ABCB1), multidrug 
resistance protein 1-9 (MRP 1-9, ABCC1-6 and ABCC10-12, respectively) and breast cancer 
resistance protein (BCRP, ABCG2) (Borst & Elferink, 2002). They actively transport 
chemically diverse substrates including amino acids, lipids, inorganic ions, peptides, 
saccharides, metals, xenobiotics, and proteins out of cells. In most examples of primary 
active transport that have been observed, transport of the substrates against their 
concentration and chemical potential gradients was driven by the hydrolysis of ATP 
(Higgins, 1992). To date, important SLC transporters involved in xenobiotic absorption and 
disposition mainly include organic cation transporter (OCT) and organic anion transporter 
(OAT); and organic anion transporting polypeptide (OATP) families. 
Many ABC and SLC transporters have been identified in the GI tract including OATPs, P-
gp, MRPs and BCRP on the apical membrane and OCT1 and MRP 3, 4, 5 on the basolateral 
(blood) side (Figure 2). PCs can act as substrates for ABC transporters (Table 1), which can 
severely limit their bioavailability. The expression of BCRP transcripts in human jejunum 
are higher than that of P-gp (Taipalensuu et al., 2001; Maliepaard et al., 2001), suggesting 
that BCRP may play an important role in limiting the intestinal absorption of its substrates. 
Knocking out mouse Bcrp led to significant increases in the oral bioavailability of daidzen 
(3.7-fold) and genistein (1.8-fold) compared to wild type mice (Enokizono et al., 2007). 
Several flavonoids such as quercetin, kaempferol, and diverse anthocyanins and 
anthocyanidins commonly found in grapes and berries, malvidin, petunidin, malvidin-3-
galactoside, malvidin-3,5-diglucoside, cyanidin-3-galactoside, peonidin-3-glucoside and 
cyanidin-3-glucoside have also been identified as BCRP substrates (Dreiseitel et al., 2009; An 
et al., 2010). Thus BCRP may limit the absorption of these PCs, but to date, human 
pharmacokinetic data are not available to confirm this.  
Accumulating evidence, mainly from in vitro studies has indicated that many flavonoid 
aglycones and anthocyanins and anthocyanidins are P-gp and BCRP inhibitors, including 
genistein, biochanin A, quercetin, morin, phloretin, silymarin (a mixture of silibinins, 
 
 
Fig. 2. Localization of ABC and SLC transporters in human small intestine. 
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Table 1. An overview of tissue distribution, substrates and inhibitors of P-gp, MRPs and 
BCRP. 
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isosilyin A and B, silychristin A and B, and silydianin), chrysin, hesperetin, naringenin, and 
the green tea polyphenols, epicatechin gallate, catechin gallate and epigallocatechin gallate 
(Table 1) (Castro & Altenberg, 1997; Jodoin et al., 2002; Wang et al., 2002; Zhang & Morris, 
2003; de Castro et al., 2007; Taur & Rodriguez-Proteau, 2008; Dreiseitel et al., 2009). It has 
been suggested that such inhibitory PCs could be used to reverse the ABC transporter-based 
constraints on the GI absorption of other substrate PCs and that this may represent a useful 
strategy for improving their bioavailability. For example, the oral bioavailability of 
biochanin A was increased approximately 2-fold when coadministered with the BCRP 
inhibitors quercetin and epigallocatechin-3-gallate (EGCG) in rats (Moon & Morris, 2007). 
However this effect may at least partially be due to inhibition of metabolizing enzymes, as 
there is evidence that both quercetin and the green tea polyphenols may inhibit both Phase 1 
and 2 metabolism (Cermak & Wolffram, 2006). Kaempferol has also been reported to 
increase quercetin permeability across MDCKII-Bcrp monolayers by inhibition of Bcrp-
mediated quercetin efflux (An et al., 2010). Recently it has also been suggested that intestinal 
ABC transporters may function as barriers to absorption of PCs (e.g., resveratrol, green tea 
catechins and flavonoids) by cooperating with intestinal Phase 2 metabolizing enzymes 
(Zhang et al., 2004; Ebert et al., 2005; Zhang et al., 2007; Juan et al., 2010), implying a joint 
role in limiting oral absortption of PCs. In an in situ intestine perfusion model in Mrp2-
deficient rats, Bcrp was shown to limit net intestinal absorption of quercetin by pumping 
quercetin glucuronides back into the lumen (Sesink et al., 2005).  
Several uptake transporters, such as organic anion transporting polypeptide (OATP) and 
organic cation transporter (OCT) from the SLC transporter superfamily are also functionally 
expressed on human intestine tissues (Figure 2) (Hagenbuch & Meier, 2003; Giacomini et al., 
2010), and have recently been associated with the oral absorption of some PCs. For example, 
quercetin was absorbed by passive diffusion and a pH-dependent mechanism mediated by 
OATP in a Caco-2 cell monolayer model (Nait Chabane et al., 2009). As quercetin is also a 
substrate for the efflux transporters P-gp and BCRP, a balance between these counteracting 
transporters may allow a more precise control of the cellular accumulation of such substrate 
compounds, but the actual biological implication of this fine-tuning mechanism remains 
unclear at the moment. This transport process may be further complicated in that many PCs 
present in plants are linked to sugar moieties, which may have an impact on their oral 
absorption. For example, there is in vitro and in silico evidence that the human glucose 
transporter 1 (SLC2A1) and rat glucose transporter 4 (slc2a4) transports quercetin (Strobel et 
al., 2005; Cunningham et al., 2006). In addition, the pig but not human sodium-dependent 
glucose transporter-1 (SGLT1) appeared to be involved in the intestinal uptake of quercetin 
glucosides (Cermak et al., 2004; Kottra & Daniel, 2007).  
3. Metabolism (enterocytes & hepatocytes) 
Possibly of greater importance as a defensive barrier against these invading foreign 
molecules is the battery of both Phase 1 and Phase 2 enzymes present in the enterocytes 
(Figure 3). The Phase 1 reactions include oxidation, reduction and hydrolysis, which 
primarily serve to increase the hydrophilicity of the molecule, and expose or add a 
functional group (such as a hydroxyl group) to facilitate Phase 2 conjugation reactions. 
Oxidation is the most predominant reaction involved in the Phase 1 metabolism of 
xenobiotics, and is principally carried out by a family of closely related isozymes known as 
 
Phytochemicals – Bioactivities and Impact on Health 120 
















(Jodoin et al., 2002; 
Wang et al., 2002; 
Zhang & Morris, 
2003; de Castro et 
al., 2007; Taur & 
Rodriguez-
Proteau, 2008) 





A and B, Schisandrol A 
and B   
(Versantvoort et 
al., 1993; 
Versantvoort et al., 
1994; Versantvoort 
et al., 1996) 





Myricetin, robinetin (Borst et al., 1999; 
Zhou et al., 2008) 









(Borst et al., 1999; 
Zhou et al., 2008) 
MRP4 ABCC4 Kidney ? Quercetin, silymarin (Borst et al., 1999; 
Zhou et al., 2008b 
;Wu, 2005) 
MRP5 ABCC5 Most tissues ? Quercetin, silymarin (Borst et al., 1999; 
Zhou et al., 2008b 
;Wu, 2005) 
































(Litman et al., 
2001; Holland et 
al., 2007; de Wolf 
et al., 2008; 
Dreiseitel et al., 
2009) 
Table 1. An overview of tissue distribution, substrates and inhibitors of P-gp, MRPs and 
BCRP. 
 
Oral Bioavailability and Disposition of Phytochemicals 121 
isosilyin A and B, silychristin A and B, and silydianin), chrysin, hesperetin, naringenin, and 
the green tea polyphenols, epicatechin gallate, catechin gallate and epigallocatechin gallate 
(Table 1) (Castro & Altenberg, 1997; Jodoin et al., 2002; Wang et al., 2002; Zhang & Morris, 
2003; de Castro et al., 2007; Taur & Rodriguez-Proteau, 2008; Dreiseitel et al., 2009). It has 
been suggested that such inhibitory PCs could be used to reverse the ABC transporter-based 
constraints on the GI absorption of other substrate PCs and that this may represent a useful 
strategy for improving their bioavailability. For example, the oral bioavailability of 
biochanin A was increased approximately 2-fold when coadministered with the BCRP 
inhibitors quercetin and epigallocatechin-3-gallate (EGCG) in rats (Moon & Morris, 2007). 
However this effect may at least partially be due to inhibition of metabolizing enzymes, as 
there is evidence that both quercetin and the green tea polyphenols may inhibit both Phase 1 
and 2 metabolism (Cermak & Wolffram, 2006). Kaempferol has also been reported to 
increase quercetin permeability across MDCKII-Bcrp monolayers by inhibition of Bcrp-
mediated quercetin efflux (An et al., 2010). Recently it has also been suggested that intestinal 
ABC transporters may function as barriers to absorption of PCs (e.g., resveratrol, green tea 
catechins and flavonoids) by cooperating with intestinal Phase 2 metabolizing enzymes 
(Zhang et al., 2004; Ebert et al., 2005; Zhang et al., 2007; Juan et al., 2010), implying a joint 
role in limiting oral absortption of PCs. In an in situ intestine perfusion model in Mrp2-
deficient rats, Bcrp was shown to limit net intestinal absorption of quercetin by pumping 
quercetin glucuronides back into the lumen (Sesink et al., 2005).  
Several uptake transporters, such as organic anion transporting polypeptide (OATP) and 
organic cation transporter (OCT) from the SLC transporter superfamily are also functionally 
expressed on human intestine tissues (Figure 2) (Hagenbuch & Meier, 2003; Giacomini et al., 
2010), and have recently been associated with the oral absorption of some PCs. For example, 
quercetin was absorbed by passive diffusion and a pH-dependent mechanism mediated by 
OATP in a Caco-2 cell monolayer model (Nait Chabane et al., 2009). As quercetin is also a 
substrate for the efflux transporters P-gp and BCRP, a balance between these counteracting 
transporters may allow a more precise control of the cellular accumulation of such substrate 
compounds, but the actual biological implication of this fine-tuning mechanism remains 
unclear at the moment. This transport process may be further complicated in that many PCs 
present in plants are linked to sugar moieties, which may have an impact on their oral 
absorption. For example, there is in vitro and in silico evidence that the human glucose 
transporter 1 (SLC2A1) and rat glucose transporter 4 (slc2a4) transports quercetin (Strobel et 
al., 2005; Cunningham et al., 2006). In addition, the pig but not human sodium-dependent 
glucose transporter-1 (SGLT1) appeared to be involved in the intestinal uptake of quercetin 
glucosides (Cermak et al., 2004; Kottra & Daniel, 2007).  
3. Metabolism (enterocytes & hepatocytes) 
Possibly of greater importance as a defensive barrier against these invading foreign 
molecules is the battery of both Phase 1 and Phase 2 enzymes present in the enterocytes 
(Figure 3). The Phase 1 reactions include oxidation, reduction and hydrolysis, which 
primarily serve to increase the hydrophilicity of the molecule, and expose or add a 
functional group (such as a hydroxyl group) to facilitate Phase 2 conjugation reactions. 
Oxidation is the most predominant reaction involved in the Phase 1 metabolism of 
xenobiotics, and is principally carried out by a family of closely related isozymes known as 
 
Phytochemicals – Bioactivities and Impact on Health 122 
the cytochrome P450-dependent mixed-function oxidases (CYPs). In humans, CYP1A, 
CYP2C, CYP2D and CYP3A are responsible for metabolising the bulk of xenobiotics that 
enter the body via the oral route (Lewis & Ito, 2008). CYP3A4/5 with its broad substrate 
specificity is particularly important in xenobiotic metabolism, making up 70 and 30% of total 
CYPs in the intestines and liver, respectively (Zhang & Benet, 2001).  
The parent PCs (or their Phase 1 metabolites) that contain suitable functional groups (e.g., a 
hydroxyl group) often undergo conjugation reactions with endogenous compounds to yield 
more polar and water soluble compounds. The latter are usually ideal substrates for active 
transport out of the cell, and eventually excretion from the body. The principal conjugation 
reaction is the formation of β-glucuronides catalysed by a family of enzymes known as the 
uridine diphosphoglucuronosyl transferases (UGTs), but conjugation with a sulpho moiety 
(SO3-) or glutathione also occurs, catalysed by various sulphotransferases (SULTs) and 
glutathione-S-transferases (GSTs), respectively. Less polar conjugates may also be formed by 
methylation, catalysed by catechol-O-methyl transferase (COMT). These Phase 2 
conjugation reactions are particularly important for PCs such as epi-gallocatechin-3-gallate 
(EGCG), which is the most abundant catechin in green tea. EGCG has numerous hydroxyl 
groups and undergoes extensive Phase 2 metabolism, including glucuronidation, 
sulphation, and methylation (Lambert et al., 2007; Yang et al., 2007). Several recent studies 
using liquid chromatography-tandem mass spectrometry (LC-MS/MS) have demonstrated  
 
 
Fig. 3. Metabolism and disposition of phytochemicals (PC) and their metabolites in 
enterocytes and hepatocytes. PC-Gly, glycoside phytochemical; PC-Glu, glucuronide 
conjugate; PC-X, phytochemical metabolite 
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that after ingestion of some flavonoids, Phase 2 conjugates of the aglycon such as 
glucuronides, sulphates and methylated metabolites predominate in the blood circulation, 
rather than the original plant glycoside or aglycon (Janisch et al., 2004; Zhang et al., 2007). 
The extent to which these metabolites contribute to the overall beneficial effects of PCs in the 
body is largely unknown, and needs further investigation. Most evidence for drugs has 
indicated that their Phase 2 conjugates have little pharmacological activity but exceptions 
certainly exist, such as morphine-6-glucuronide and ezetimibe-glucuronide which appear to 
have greater pharmacological activity than their parent compound (Lotsch & Geisslinger, 
2001; Kosoglou et al., 2005). In studies with green tea polyphenols, the metabolites mostly 
had reduced biological activity, but in some systems the metabolites had the equivalent or 
greater activity than the parent PC (Lambert et al., 2007). Other in vitro studies have shown 
that phloridzin-glucuronide is significantly more potent at protecting human SH-SY5Y 
neuroblastoma cells from hydrogen peroxide-mediated cell death than the parent molecule 
phloridzin (Stevenson et al., 2008), and that quercetin-3-glucuronide was significantly more 
potent than quercetin in a model of inflammation using human neutrophils (Suri et al., 
2008). There is also evidence that the position of the glucuronide conjugate on the flavonoid 
can influence its biological activity (Day et al., 2000; O'Leary et al., 2003). Certainly these 
conjugated metabolic products are ideal substrates for various active transmembrane 
transport processes, in particular the excretory processes of the liver and kidney.  
Although the Phase 1 and 2 metabolic enzymes are found in the epithelial cells of the gut wall, 
by far the greatest concentrations are found in the liver (Figure 3), where they form a major 
barrier to the further distribution of the parent PC to other organs, such as of the heart, kidney, 
lungs and brain. The liver’s location and the portal venous blood supply from the intestines 
make it well suited for the protection of the body from possible toxic xenobiotics contained in 
our diet. During this first passage through the liver, many PCs will undergo substantial 
extraction and metabolism (known as first-pass metabolism). The resulting metabolic products 
are then exported back out of the liver into the blood stream and carried to the kidney where 
they may be excreted in the urine. Alternatively, metabolites such as glucuronide conjugates 
may be exported in the bile and released into the gut lumen. Thereafter, the metabolite 
conjugate may be excreted in the faeces, or alternatively it may be further metabolised by gut 
microbial enzymes, such as β-glucuronidase, which has the ability to cleave off the 
glucuronide and reform the less-polar aglycon, which may then be reabsorbed. This cycle is 
known as enterohepatic recirculation and may result in a longer exposure of the body to the 
PC. Evidence for such enterohepatic recirculation has been obtained for the flavonoid baicalein 
7-O-glucuronide with a rat model (Xing et al., 2005), but whether a similar process occurs for 
some PCs in humans is not known. 
4. Distribution 
Presumably, if the PC overcomes the defence mechanisms of the gut and the liver, it will 
enter the systemic circulation and be distributed in the bloodstream to the other major 
organs of the body and possible site(s) of action. In pharmacology, the term bioavailability is 
used to indicate the relative amount of the ingested parent xenobiotic that reaches the main 
cardiovascular circulation. Bioavailability is usually measured by taking peripheral blood 
samples over a period of time after ingestion and analysing for xenobiotic concentration. It 
is assumed that this blood concentration is an acceptable index for the concentration or 
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organs of the body and possible site(s) of action. In pharmacology, the term bioavailability is 
used to indicate the relative amount of the ingested parent xenobiotic that reaches the main 
cardiovascular circulation. Bioavailability is usually measured by taking peripheral blood 
samples over a period of time after ingestion and analysing for xenobiotic concentration. It 
is assumed that this blood concentration is an acceptable index for the concentration or 
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exposure at the site of action. Most PCs can pass with ease through the pores of the 
capillaries of organs such as the heart and lungs, but not some pharmacological sanctuaries, 
such as the brain, testis, fetus and stem cells. The tissue distribution of xenobiotics is 
significantly influenced by ABC transporters as the latter contribute to the maintenance of 
these pharmacological sanctuaries (Borst & Elferink, 2002; Huls et al., 2009; Mruk et al., 
2011). For many PCs present in the bloodstream either as parent compound or metabolite, 
active efflux by ABC transporters may represent a major rate-limiting factor in their 
distribution or access to these sanctuaries. Phytochemical interactions with these efflux 
transporters could result in either: a further decrease in substrate PC distribution to the site, 
if the transporters were stimulated or induced; or accumulation of substrate, if the 
transporters were inhibited. The brain capillaries are surrounded with a protective cellular 
sheath of glial cells (the so-called blood brain barrier, BBB) resulting in permeability 
characteristics more closely resembling those of tightly bound tissue cell walls (Pardridge, 
1993). To gain access to the brain, a PC must be highly lipid-soluble, or subject to uptake 
transport processes. MDR1, BCRP, MRP1, MRP3, MRP4 and MRP5 genes were shown by 
qRT-PCR to be expressed in the BBB (Dauchy et al., 2009). P-gp, BCRP and MRP1 have been 
located at the apical membrane of brain endothelial cells (Figure 4) (Kubota et al., 2006; 
Dauchy et al., 2009), and there is evidence that P-gp limits the penetration of various drugs 
across the BBB (Linnet & Ejsing, 2008). However the effects of several potent PC inhibitors of 
P-gp on passage across the BBB appeared to be minor (Tsai et al., 2001). Similarly, the 
uptake of the BCRP substrates, mitoxantrone and dehydroepiandrosterone sulfate, into the 
brain did not vary significantly between wild type and Bcrp knockout mice (Lee et al., 2005). 
In contrast, significant increases in the brain concentrations of various phytoestrogens 
including genistein (9.2-fold), daidzen (5.6-fold) and coumestrol (3.9-fold) were reported in 
Bcrp knockout mice compared to wild type (Enokizono et al., 2007). Similar results were 
also observed in the testis, suggesting that Bcrp may play a protective role reducing the 
accumulation of such compounds in both the brain and the testis. Likewise in a rat  
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hemisphere perfusion study, the brain accumulation of quercetin was dramatically 
increased by pretreatment with GF120918 (a P-gp and BCRP inhibitor), but not with PSC833 
(a P-gp inhibitor) (Youdim et al., 2004). A recent study using the ex vivo rat BBB model 
indicated that curcumin inhibited BCRP activity at nanomolar concentrations and 
significantly increased the penetration of sulfasalazine across the BBB (Shukla et al., 2009). 
However, due to the low oral bioavailability of curcumin, such concentrations are rarely 
achieved with low to sub nanomolar concentrations typically being observed in plasma, 
even after oral dosing at 8 g/day for 18 months (Dhillon et al., 2008). BCRP is most 
abundantly expressed in the apical membrane of placental syncytiotrophoblasts, suggesting 
that it may play a role in protecting the fetus by impeding xenobiotic penetration across the 
placental barrier (Jonker et al., 2000; Evseenko et al., 2006). It has been shown that genistein 
accumulates in Bcrp knockout mice fetuses when genistein was included in the diet of 
pregnant mice during gestation (Enokizono et al., 2007), implying the involvement of Bcrp 
in genistein efflux in mouse placenta. However, a recent study shows that genistein at low, 
environmentally relevant concentration (10 ng/mL) can transfer across the human placenta 
at term at a extent similar to antipyrine (a well-known passive diffusion marker) in a 
placenta perfusion system (Balakrishnan et al., 2010), which suggests human BCRP may 
play a minor role in limiting the fetal exposure to genistein. These discrepancies may be due 
to species differences or differences between in vivo and ex vivo experimental systems. Since 
fetal exposure to genistein may have adverse consequences with regard to the development 
of the fetus (North & Golding, 2000), the regulatory role of BCRP in genistein transfer in 
term placenta needs further studies. As many flavanoids present in diet are potent 
modulators of BCRP and dietary flavonoids are in greater use, their influence on fetal 
exposure to various PC substrates of BCRP may also require further studies. 
5. Excretion 
The ABC and SLC transporters are abundantly expressed in the liver and kidney and 
regulate the excretion of many compounds, including PCs and their metabolites. In the liver, 
OAT2, OCT1 and OATPs are located in the sinusoid membrane to extract xenobiotics from 
blood; while BCRP, P-gp and MRP2 are found in the hepatocyte canalicular membrane 
effluxing compounds into the bile (Hooivelda & van Montfoorta, 2000). The inhibition of 
these transporters in hepatocytes can increase the concentrations of PC substrates in the 
bloodstream and/or decrease their biliary excretion and prolong their stay in the body. For 
example, biliary excretion of glucuronide and sulfate conjugates of silymarin flavonolignans 
was reduced by approximately 96 and 78%, respectively, in Mrp2-deficient Wistar rats, 
compared to wildtype (Miranda et al., 2008). Since biliary excretion of glucuronide and 
sulfate conjugates is the major route for silymarin's elimination in humans and rodents 
(Miranda et al., 2008), the pharmacokinetics of silymarin may be susceptible to MRP2 
inhibition/induction or to pathological conditions where MRP2 may be deficient, such as in 
cholestatic liver disease or in Dubin-Johnson Syndrome (Keitel et al., 2000; Borst & Elferink, 
2002). In contrast, MRP1 and 3 are found at the sinusoid membrane effluxing substrates 
back into the bloodstream, but are expressed at low levels under normal conditions (Ros et 
al., 2003). However in situations where MRP2 may be deficient, MRP3 may be upregulated, 
apparently to compensate for the diminished ability to excrete organic acids into bile (Keitel 
et al., 2000). Chronic administration of PCs however, may result in the upregulation of 
transporters via activation of the pregnane X receptor (PXR) or the aryl hydrocarbon 
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exposure at the site of action. Most PCs can pass with ease through the pores of the 
capillaries of organs such as the heart and lungs, but not some pharmacological sanctuaries, 
such as the brain, testis, fetus and stem cells. The tissue distribution of xenobiotics is 
significantly influenced by ABC transporters as the latter contribute to the maintenance of 
these pharmacological sanctuaries (Borst & Elferink, 2002; Huls et al., 2009; Mruk et al., 
2011). For many PCs present in the bloodstream either as parent compound or metabolite, 
active efflux by ABC transporters may represent a major rate-limiting factor in their 
distribution or access to these sanctuaries. Phytochemical interactions with these efflux 
transporters could result in either: a further decrease in substrate PC distribution to the site, 
if the transporters were stimulated or induced; or accumulation of substrate, if the 
transporters were inhibited. The brain capillaries are surrounded with a protective cellular 
sheath of glial cells (the so-called blood brain barrier, BBB) resulting in permeability 
characteristics more closely resembling those of tightly bound tissue cell walls (Pardridge, 
1993). To gain access to the brain, a PC must be highly lipid-soluble, or subject to uptake 
transport processes. MDR1, BCRP, MRP1, MRP3, MRP4 and MRP5 genes were shown by 
qRT-PCR to be expressed in the BBB (Dauchy et al., 2009). P-gp, BCRP and MRP1 have been 
located at the apical membrane of brain endothelial cells (Figure 4) (Kubota et al., 2006; 
Dauchy et al., 2009), and there is evidence that P-gp limits the penetration of various drugs 
across the BBB (Linnet & Ejsing, 2008). However the effects of several potent PC inhibitors of 
P-gp on passage across the BBB appeared to be minor (Tsai et al., 2001). Similarly, the 
uptake of the BCRP substrates, mitoxantrone and dehydroepiandrosterone sulfate, into the 
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hemisphere perfusion study, the brain accumulation of quercetin was dramatically 
increased by pretreatment with GF120918 (a P-gp and BCRP inhibitor), but not with PSC833 
(a P-gp inhibitor) (Youdim et al., 2004). A recent study using the ex vivo rat BBB model 
indicated that curcumin inhibited BCRP activity at nanomolar concentrations and 
significantly increased the penetration of sulfasalazine across the BBB (Shukla et al., 2009). 
However, due to the low oral bioavailability of curcumin, such concentrations are rarely 
achieved with low to sub nanomolar concentrations typically being observed in plasma, 
even after oral dosing at 8 g/day for 18 months (Dhillon et al., 2008). BCRP is most 
abundantly expressed in the apical membrane of placental syncytiotrophoblasts, suggesting 
that it may play a role in protecting the fetus by impeding xenobiotic penetration across the 
placental barrier (Jonker et al., 2000; Evseenko et al., 2006). It has been shown that genistein 
accumulates in Bcrp knockout mice fetuses when genistein was included in the diet of 
pregnant mice during gestation (Enokizono et al., 2007), implying the involvement of Bcrp 
in genistein efflux in mouse placenta. However, a recent study shows that genistein at low, 
environmentally relevant concentration (10 ng/mL) can transfer across the human placenta 
at term at a extent similar to antipyrine (a well-known passive diffusion marker) in a 
placenta perfusion system (Balakrishnan et al., 2010), which suggests human BCRP may 
play a minor role in limiting the fetal exposure to genistein. These discrepancies may be due 
to species differences or differences between in vivo and ex vivo experimental systems. Since 
fetal exposure to genistein may have adverse consequences with regard to the development 
of the fetus (North & Golding, 2000), the regulatory role of BCRP in genistein transfer in 
term placenta needs further studies. As many flavanoids present in diet are potent 
modulators of BCRP and dietary flavonoids are in greater use, their influence on fetal 
exposure to various PC substrates of BCRP may also require further studies. 
5. Excretion 
The ABC and SLC transporters are abundantly expressed in the liver and kidney and 
regulate the excretion of many compounds, including PCs and their metabolites. In the liver, 
OAT2, OCT1 and OATPs are located in the sinusoid membrane to extract xenobiotics from 
blood; while BCRP, P-gp and MRP2 are found in the hepatocyte canalicular membrane 
effluxing compounds into the bile (Hooivelda & van Montfoorta, 2000). The inhibition of 
these transporters in hepatocytes can increase the concentrations of PC substrates in the 
bloodstream and/or decrease their biliary excretion and prolong their stay in the body. For 
example, biliary excretion of glucuronide and sulfate conjugates of silymarin flavonolignans 
was reduced by approximately 96 and 78%, respectively, in Mrp2-deficient Wistar rats, 
compared to wildtype (Miranda et al., 2008). Since biliary excretion of glucuronide and 
sulfate conjugates is the major route for silymarin's elimination in humans and rodents 
(Miranda et al., 2008), the pharmacokinetics of silymarin may be susceptible to MRP2 
inhibition/induction or to pathological conditions where MRP2 may be deficient, such as in 
cholestatic liver disease or in Dubin-Johnson Syndrome (Keitel et al., 2000; Borst & Elferink, 
2002). In contrast, MRP1 and 3 are found at the sinusoid membrane effluxing substrates 
back into the bloodstream, but are expressed at low levels under normal conditions (Ros et 
al., 2003). However in situations where MRP2 may be deficient, MRP3 may be upregulated, 
apparently to compensate for the diminished ability to excrete organic acids into bile (Keitel 
et al., 2000). Chronic administration of PCs however, may result in the upregulation of 
transporters via activation of the pregnane X receptor (PXR) or the aryl hydrocarbon 
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receptor (AhR) in hepatocytes, lessening the effects of inhibition (Lim & Lim, 2006; Zhang et 
al., 2007; Zhang et al., 2009).  
In the kidneys, P-gp, MRP2, MRP4 and BCRP are expressed in the apical membranes and 
OCT2, OATs and OATP4C1 in the basolateral side of the cells lining the proximal tubules, 
transporting xenobiotics out of the blood into the urine (Ichikawa et al., 1991; van Aubel et 
al., 2002; Leslie et al., 2005; Huls et al., 2008; Giacomini et al., 2010). MRP2, 4 and BCRP 
efflux anionic or conjugated compounds (e.g., Phase 2 metabolites of some flavanoids), 
while more hydrophobic compounds are extruded by P-gp. As many PCs are excreted as 
conjugated metabolites by the kidney, there exists the possibility of competitive inhibition of 
these transport processes with drugs whose major route of elimination is by the kidney. It 
would appear cautionary to monitor plasma concentrations for drugs with a narrow 
therapeutic index in patients who are also consuming large amounts of PCs, perhaps as 
herbal medications or health supplements.  
6. Modulation of bioavailability by PCs 
There is accumulating evidence that PCs are able to modulate the activity of some ABC and 
SLC transporters by numerous mechanisms, resulting in significant changes in the oral 
bioavailability of substrate xenobiotics. For example, 1-hour pretreatment of mice with oral 
curcumin (400 mg/kg) resulted in a 13-fold increase in the bioavailability (as measured by 
the area under the plasma concentration-time curve (AUC)) of the Bcrp substrate 
sulfasalazine (anti-inflammatory drug) (Shukla et al., 2009). Although inhibition of 
sulfasalazine’s metabolism could not be ruled out, it was believed that direct competitive 
inhibition of Bcrp was the major mechanism involved. In contrast, more prolonged 
treatment of rats with a lower dose of oral curcumin (60 mg/kg for 4 days) produced a 
down regulation in P-gp concentrations (> 50% reduction) in the gut, leading to a 1.6-fold 
increase in the AUC of the β-blocking drug, celiprolol (Zhang et al., 2007). The latter does 
not undergo metabolism and is a P-gp substrate, and thus the reduction in P-gp in the gut 
was deemed responsible for the increased bioavailability of celiprolol. It was also intriguing 
to note that the effect of curcumin was tissue specific, resulting in a greater than 2-fold P-gp 
increase in the liver but no effect in the kidney. Most studies of PC-transporter interactions 
have been undertaken using in vitro systems (Table 2) or in vivo animal studies and the 
difficulty in extrapolating to humans is apparent. Recently Molnar et al. (2006) have 
demonstarated that a wide range of lipophilic PCs (diterpenes, triterpines and carotenoids) 
were able to inhibit human P-gp in vitro at the low µg/ml range, whereas other 
combinations had positive synergistic activity (Molnar et al., 2006). Using purified PCs on P-
gp over-expressing cells in vitro, Patel et al. (2004) showed that quercetin, hypericin and 
kaempferol were able to increase the cellular uptake of ritonavir by 5- to 8-fold (Patel et al., 
2004). It is also interesting to note that in vitro assays or short-term exposure to these 
polyphenols in vivo appears to inhibit the action of efflux pumps and increase substrate 
bioavailability, whilst chronic exposure in healthy volunteers actually increases the 
expression of P-gp. For example, extracts from St John’s Wort (SJW) have been shown to up-
regulate the expression of intestinal P-gp (Durr et al., 2000; Hennessy et al., 2002), that may 
subsequently reduce the bioavailability of substrates, such as the antiviral drugs indinavir 
and saquinavir that are used in the treatment of acquired immune deficiency syndrome 
(AIDS) (Perloff et al., 2001). Treatment with SJW is able to reduce plasma concentrations of 
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these drugs by up to 57% in healthy human volunteers, potentially leading to sub-
therapeutic levels (Piscitelli et al., 2000). Hyperforin has been identified as the most likely 
candidate causing this inducing effect by binding and subsequent activation of PXR leading 
to increased expression not only of P-gp but also various Phase 1 and 2 metabolizing 
enzymes (Moore et al., 2000). In fact, the induction of CYPs and UGTs is probably the more 
important mechanism causing the majority of the many clinically significant drug 
interactions with SJW that have been reported (Hennessy et al., 2002).  
Quercetin has been identified as a P-gp substrate and inhibitor, and has been reported to 
cause a 55 % increase in oral bioavailability of fexofenadine in healthy volunteers (Kim et al., 
2009). Fexofenadine is non-sedating antihistamine which is a P-gp substrate that undergoes 
negligible metabolism in humans. Interestingly the oral bioavailability of fexofenadine is 
significantly decreased when taken with grapefruit juice (GFJ) or one of its major PC 
components, naringin (Bailey et al., 2007). The mechanism responsible is thought to be 
 
 P-gp BCRP MRP1 MRP2 MRP4 MRP5 References 
Phytochemicals        
Apigenin ? I I I ? ? (Versantvoort et al., 1994; Imai et al., 2004) 
Biochanin A Ica Ica Ica ? ? ? 
(Versantvoort et al., 1993; 
Zhang & Morris, 2003; Zhang 
et al., 2004) 
Curcumin I I I ? ? I 
(Anuchapreeda et al., 2002; 
Chearwae et al., 2006; Shukla 
et al., 2009; Li et al., 2010) 
Cyanidin 
 I I ? ? ? ? (Dreiseitel et al., 2009) 
Daidzein ? Ica I ? ? ? (Versantvoort et al., 1994; Imai et al., 2004) 
EGCG × ? S S ? ? (Jodoin et al., 2002; Hong et al., 2003) 
Epicatechin ? ? S S ? ? (Hong et al., 2003) 
Genistein Ica Sca, Ica I S ? ? (Imai et al., 2004) 
Narigenin S, I I I S ? I (Imai et al., 2004) 
Naringin Ica I ? ? ? ? (Imai et al., 2004) 
Puerarin ? ? ? ? ? ? (Imai et al., 2004) 
Quercetin S, I I I S, I I I (Wu et al., 2005) 
Resveratrol I I I ? I × 
(Nabekura et al., 2005; Wu et 
al., 2005; Breedveld et al., 
2007) 
Silymarin Ica I I ? I I 
(Zhang & Morris, 2003; 
Cooray et al., 2004; Wu et al., 
2005) 
Table 2. Phytochemical substrates and inhibitors of P-gp, MRPs and BCRP. I, inhibitor; S, 
Substrate; Ca, Experiments carried only in cancer cells; ×, not a substrate or inhibitor; ? Not 
determined.  
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receptor (AhR) in hepatocytes, lessening the effects of inhibition (Lim & Lim, 2006; Zhang et 
al., 2007; Zhang et al., 2009).  
In the kidneys, P-gp, MRP2, MRP4 and BCRP are expressed in the apical membranes and 
OCT2, OATs and OATP4C1 in the basolateral side of the cells lining the proximal tubules, 
transporting xenobiotics out of the blood into the urine (Ichikawa et al., 1991; van Aubel et 
al., 2002; Leslie et al., 2005; Huls et al., 2008; Giacomini et al., 2010). MRP2, 4 and BCRP 
efflux anionic or conjugated compounds (e.g., Phase 2 metabolites of some flavanoids), 
while more hydrophobic compounds are extruded by P-gp. As many PCs are excreted as 
conjugated metabolites by the kidney, there exists the possibility of competitive inhibition of 
these transport processes with drugs whose major route of elimination is by the kidney. It 
would appear cautionary to monitor plasma concentrations for drugs with a narrow 
therapeutic index in patients who are also consuming large amounts of PCs, perhaps as 
herbal medications or health supplements.  
6. Modulation of bioavailability by PCs 
There is accumulating evidence that PCs are able to modulate the activity of some ABC and 
SLC transporters by numerous mechanisms, resulting in significant changes in the oral 
bioavailability of substrate xenobiotics. For example, 1-hour pretreatment of mice with oral 
curcumin (400 mg/kg) resulted in a 13-fold increase in the bioavailability (as measured by 
the area under the plasma concentration-time curve (AUC)) of the Bcrp substrate 
sulfasalazine (anti-inflammatory drug) (Shukla et al., 2009). Although inhibition of 
sulfasalazine’s metabolism could not be ruled out, it was believed that direct competitive 
inhibition of Bcrp was the major mechanism involved. In contrast, more prolonged 
treatment of rats with a lower dose of oral curcumin (60 mg/kg for 4 days) produced a 
down regulation in P-gp concentrations (> 50% reduction) in the gut, leading to a 1.6-fold 
increase in the AUC of the β-blocking drug, celiprolol (Zhang et al., 2007). The latter does 
not undergo metabolism and is a P-gp substrate, and thus the reduction in P-gp in the gut 
was deemed responsible for the increased bioavailability of celiprolol. It was also intriguing 
to note that the effect of curcumin was tissue specific, resulting in a greater than 2-fold P-gp 
increase in the liver but no effect in the kidney. Most studies of PC-transporter interactions 
have been undertaken using in vitro systems (Table 2) or in vivo animal studies and the 
difficulty in extrapolating to humans is apparent. Recently Molnar et al. (2006) have 
demonstarated that a wide range of lipophilic PCs (diterpenes, triterpines and carotenoids) 
were able to inhibit human P-gp in vitro at the low µg/ml range, whereas other 
combinations had positive synergistic activity (Molnar et al., 2006). Using purified PCs on P-
gp over-expressing cells in vitro, Patel et al. (2004) showed that quercetin, hypericin and 
kaempferol were able to increase the cellular uptake of ritonavir by 5- to 8-fold (Patel et al., 
2004). It is also interesting to note that in vitro assays or short-term exposure to these 
polyphenols in vivo appears to inhibit the action of efflux pumps and increase substrate 
bioavailability, whilst chronic exposure in healthy volunteers actually increases the 
expression of P-gp. For example, extracts from St John’s Wort (SJW) have been shown to up-
regulate the expression of intestinal P-gp (Durr et al., 2000; Hennessy et al., 2002), that may 
subsequently reduce the bioavailability of substrates, such as the antiviral drugs indinavir 
and saquinavir that are used in the treatment of acquired immune deficiency syndrome 
(AIDS) (Perloff et al., 2001). Treatment with SJW is able to reduce plasma concentrations of 
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these drugs by up to 57% in healthy human volunteers, potentially leading to sub-
therapeutic levels (Piscitelli et al., 2000). Hyperforin has been identified as the most likely 
candidate causing this inducing effect by binding and subsequent activation of PXR leading 
to increased expression not only of P-gp but also various Phase 1 and 2 metabolizing 
enzymes (Moore et al., 2000). In fact, the induction of CYPs and UGTs is probably the more 
important mechanism causing the majority of the many clinically significant drug 
interactions with SJW that have been reported (Hennessy et al., 2002).  
Quercetin has been identified as a P-gp substrate and inhibitor, and has been reported to 
cause a 55 % increase in oral bioavailability of fexofenadine in healthy volunteers (Kim et al., 
2009). Fexofenadine is non-sedating antihistamine which is a P-gp substrate that undergoes 
negligible metabolism in humans. Interestingly the oral bioavailability of fexofenadine is 
significantly decreased when taken with grapefruit juice (GFJ) or one of its major PC 
components, naringin (Bailey et al., 2007). The mechanism responsible is thought to be 
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al., 2005; Breedveld et al., 
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Table 2. Phytochemical substrates and inhibitors of P-gp, MRPs and BCRP. I, inhibitor; S, 
Substrate; Ca, Experiments carried only in cancer cells; ×, not a substrate or inhibitor; ? Not 
determined.  
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inbition of OATP1A2 which is involved in intestinal uptake of fexofenadine, and naringin (and 
hesperidin, also found in GFJ) have been identified as potent inhibitors of this transporter. This 
is an uncharacteristic interaction with GFJ as most reported interactions have involved 
markedly increased drug bioavailability, often resulting in significant toxicity (Bailey et al., 
1991). Further studies have indicated that the main mechanism was inhibition of intestinal 
CYP3A4 by the furanocoumarins in GFJ, including bergamottin and 6’,7’-hydroxybergamottin 
(Dahan & Altman, 2004). However these may not be the sole contributors, as other PCs found 
in GFJ, such as quercetin and kaempferol have also been shown to cause inhibition of the CYPs 
in vitro (Zhou et al., 2003; Dahan & Altman, 2004; Rodeiro et al., 2008). These studies serve to 
illustrate the potential complexity of the interactions between multiple PCs acting by different 
mechanisms dependent on the period of exposure to modulate uptake and efflux transporters 
and metabolizing enzymes in both enterocytes and hepatocytes.  
7. Improving the bioavailability of PCs 
Although many PCs have postulated health benefits, most appear to suffer from poor oral 
bioavailability which makes their utility as such agents rather tenuous. The biological 
activity of many of these PCs have been amply demonstrated in vitro but the effects in vivo 
are much more limited, probably due to the sub-micromolar concentrations achieved in 
plasma after ingestion (Baur & Sinclair, 2006; Moon & Morris, 2007; Zhang et al., 2007) 
(Anand et al., 2007). Apart from modulating ABC transporter function, PCs can also act as 
substrates for these efflux pumps, which can severely limit their bioavailability. For 
example, quercetin has very limited bioavailability through gut epithelia and regardless of 
the amount consumed orally, plasma concentrations of quercetin rarely exceed 1 µM. 
Although not specifically proven, this is likely to be at least in part due to BCRP expression 
in gut epithelia (see (Murakami & Takano, 2008) for review). Curcumin has well 
demonstrated antitumour activity in vitro and is currently in clinical trials for the treatment 
of various cancers but with limited success (Dhillon et al., 2008; Hatcher et al., 2008). 
However, the poor absorption and rapid first-pass metabolism resulting in poor oral 
bioavailability and low systemic concentrations, continue to be a major problem with 
curcumin’s use in the clinic and appear to be responsible for the disconnect between 
curcumin’s in vitro vs in vivo biological activity (Anand et al., 2007). To overcome this, the 
development of liposomal and nanoparticle formulations of curcumin has been investigated 
with reports of significant increases in its bioavailability (Bisht et al., 2007; Chen et al., 2009; 
Cui et al., 2009). Such strategies are also being employed to increase the oral bioavailability 
of resveratrol to improve its therapeutic potential (Santos et al., 2011). However, P-gp 
substrates (e.g., paclitaxel), delivered to P-gp overexpressing cells by nanoparticles, are 
susceptible to efflux by P-gp (Chavanpatil et al., 2006). It has also been shown that 
conjugation of negatively charged nanoparticles to glutathione led to nanoparticle efflux 
from the cell via MRP-transporters (Zhang et al., 2007; Holpuch et al., 2011). Some excipients 
are also potent ABC transporter inhibitors (Yamagata et al., 2007) and may be used in novel 
formulations to further improve PC bioavailability and targeted tissue distribution. 
8. Conclusions 
In conclusion, it is now apparent that the physicochemical properties of phytochemicals are 
not the only factors determining their oral bioavailability, and that there is a complex 
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interplay between these properties and the processes of metabolism and active transport in 
absorption, distribution and excretion, which determine the extent of exposure to their 
bioactive site(s) in the body. There is still much to be learned about the application of 
phytochemicals to the improvement of human health as these compounds have multiple 
complex effects on the body apart from their interactions with drug metabolizing enzymes 
and transporters. Despite limited data from human studies, the sheer amount and diversity 
of available phytochemicals continues to encourage researchers to look for new candidates 
with therapeutic potential and to improve their bioavailability and consequently their 
efficacy by developing new delivery systems.  
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1. Introduction 
Plant use in treating diseases is as old as civilization (Fabricant & Farnsworth, 2001) and 
traditional medicines are still a major part of habitual treatments of different maladies 
(Alviano & Alviano, 2009). In recent times and due to historical, cultural, and other reasons, 
folk medicine has taken an important place especially in developing countries where limited 
health services are available. However, the absence of scientific evaluation of medicinal 
plants to validate their use may cause serious adverse effects (Souza et al., 2004). 
Plants are considered as one of the main sources of biologically active materials. Recent 
records reported that medicinal herbs are used by 80% of the people living in rural areas as 
primary healthcare system (Sakarkar & Deshmukh, 2011). It has been estimated that about 
50% of the prescription products in Europe and USA are originating from natural products 
including plants or their derivatives (Cordell, 2002; Newman et al., 2003). Out of the 250,000 
– 500,000 plant species on earth, only 1-10 % have been studied chemically and 
pharmacologically for their potential medicinal value (Verpoote, 2000). In the Middle East 
region 700 species of the identified plants are known for their medicinal values (Azaizeh et 
al., 2006).  
In spite of the recent domination of the synthetic chemistry as a method to discover and 
produce drugs, the potential of bioactive plants or their extracts to provide new and novel 
products for disease treatment and prevention is still enormous (Raskin et al., 2002). 
Compared with chemical synthesis, plant derived natural products represent an attractive 
source of biologically active agents since they are natural and available at affordable prices 
(Ghosh et al., 2008). Also plants derived agents may have different mechanisms than 
conventional drugs, and could be of clinical importance in health care improvement (Eloff et 
al., 1998). Plant materials might be bioactive secondary metabolites that have the potential to 
treat different afflictions. Examples of these compounds include phenols, phenolic 
glycosides, unsaturated lactones, sulphur compounds, saponins, cyanogenic glycosides and 
glucosinolates (Mukherjee et al., 2001; Quiroga et al., 2001). Such plant derived natural 
products are the main focus of many scientists to develop new medication for different 
diseases like cancer and microbial infection.  
Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal 
cells (Karp, 1999). The high mortality rate among cancer patients is an indication of the 
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limited efficiency of the current therapies including radiation, chemotherapy and surgery 
(Xu et al., 2009). Cancer development is a multi-step process including induction of genetic 
instability, abnormal expression of genes, abnormal signal transduction, angiogenesis, 
metastasis, and immune evasion (Boik, 2001). For many years, scientists were searching for 
miracle cures for cancer using chemically synthesized or natural pure compounds.  In the 
last few decades, research has been focused on the use of natural products such as crude 
plant extracts or a combination of different phytochemicals for cancer therapy; this trend is 
based upon: first, the synergistic effect of the different plant metabolites in the crude extract, 
second, is the multiple points of intervention of such extracts (Neergheen, 2009). This is one 
of the many faces of using plants in the quest of controlling different diseases. Another face 
is the use of such plant products in controlling microbial resistance spread. As a result of the 
uncontrolled use of many antibiotics, their efficiency is being threatened by the emergence 
of microbial resistance to existing chemotherapeutic agents (Cowan, 1999; Pareke & Chanda, 
2007). Bacterial strains such as methicilin-resistant Staphylococcus aureus (MRSA), pencillin-
resistant Streptococcus pneumonia (PRSP), and Vancomycin- resistant enterococci (VRE) in 
addition to the development of multidrug-resistant (MDR) bacterial strains (Alanis, 2005) 
are just few examples that made the search for new and novel bioactive substances among 
the first priorities in the search for antitumor, antibacterial, and antifungal substances 
(Ficker et  al., 2005).  
Realizing all the aforementioned, it is clear that there is a pressing need to participate in the 
search for new and novel bioactive agents that would help in providing new avenues in 
fighting diseases and reducing suffering. This chapter will provide information about 
selected plants that have a potential to provide new anticancer and/or antimicrobial agents. 
2. The history of traditional medicine 
For thousands of years and in different parts of the world, medicinal plants have been used 
to treat different diseases (Palombo, 2009). Fossil records documented the use of medicinal 
plants by humans before 60,000 years (Fabricant & Farnsworth, 2001). Nowadays plants 
continue to be the major source of medicine in rural regions of developing countries (Chitme 
et  al., 2003) and it has been estimated that about 80% of  peoples in developing countries are 
still using medicinal plants for their health care ( Kim, 2005).  
The Eastern region of the Mediterranean has been characterized by high inventory of 
medicinal herbs used by local traditional healers to treat different ailments (Azaizeh et al., 
2006). Research on medicinal plant treasures is based on present day and historical systems 
of traditional and local medicine (Al-Qura’n, 2009). During the Ottoman Empire and 
following the Byzantine traditions, hospitals were run by physician who used pharmacists 
to gather medicinal plants and prepare remedies originating from classical Greek and folk 
medicinal practice (Littlewood et al., 2002). 
A comprehensive study on practitioners and herbalist in Palestine revealed that 
approximately 129 plant species are still prescribed to treat different diseases including 
liver, digestive tract, respiratory system, skin, cancer and other diseases (Azaizeh et al., 
2003). On the other hand, the high diversity of plant species in Jordan encouraged many to 
study the distribution and use of medicinal plants in this country. More than 100 herbalists 
were interviewed in an extensive survey for Jordanian medicinal plants indicated the 
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presence of 150 herbal plants used in folkloric medicine (Abu-Irmaileh & Afifi, 2003). 
Seventy nine plant species are still in use in traditional medicine in the Showbak region 
(south of Jordan) while forty six are part of the popular medicine in the Ajloun Heights 
region (north of Jordan) and some of the plants are used in both regions ( Aburjai et  al., 
2007; Al-Qura’n, 2009). Most of the practitioners were not licensed and have no scientific 
information about medicinal plants (Abu-Irmaileh & Afifi, 2003; Azaizeh et al., 2003). 
The diversity of plants in the Mediterranean region is declining, were recent estimates 
reported less than 200-250 plant species are used to treat different ailments in the Arab 
traditional medicine (Said et al., 2002; Abu-Irmaileh & Afifi, 2003; Saad et al., 2005), 
compared to more than 700 species which were identified for their medicinal uses in 
previous decades (Azaizeh et al., 2006). The high rate of plant extinction on the earth 
necessitates an increase in the efforts to study plant natural products for their potential to 
provide treatment for different afflictions.  
3. Cancer biology  
DNA damage causes conversion of normal cell into a cancer cell. Cancer cells lack the ability 
to communicate with their neighboring cells. The first cancer cell starts to divide producing 
daughter cells, which in turn divide to produce more and more cancer cells. As cancer cells 
divide, they develop malignant characteristics including metastasis, immune system 
evasion, and induction of blood vessels formation (angiogenesis). Continuous cell division 
of cancer cells lead to the formation of tumors. In solid tumors, blood vessels become 
structurally and functionally abnormal; this abnormality leads to heterogeneous blood flow 
which creates chronically hypoxic and acidic regions in the core of the solid tumor (Brown & 
Wilson, 2004). These hypoxic regions lead to the activation of angiogenesis and cell survival 
genes in addition to other genes that induce drug resistant (Chen et al., 2003). Furthermore, 
the low pH microenvironment of cancer cells in the tumor core may prevent the active 
uptake of some anticancer drugs (Mahoney et al., 2003). 
The two traditional therapies (chemotherapy and radiation) are not greatly efficient in 
treating hypoxic cancer cells (Tannock et al., 1998). The killing effect of ionizing radiation 
depends on the presence of oxygen which is absent or very low in the tumor core and the 
poor vascularization minimizes the delivery of chemotherapeutic agents (Brown & Wilson, 
2004). This makes the poorly vascularized regions of tumors a major obstacle to effective 
treatment and opens the door to other therapies that may use different mechanisms to 
targets highly resistant cancer cells. 
4. Oncogenes and tumor suppressor genes 
Two sets of genes are controlling cancer development. Oncogenes are the first set of genes 
and are involved in different cell activities including cell division. However, overexpression 
of these genes transforms a normal cell into a cancer cell. On the other hand, the second set 
of genes (tumor suppressor genes) inhibits cancer cell formation by different mechanisms. 
Tumor suppressor genes are underexpressed in cancer cells while, oncogenes are 
overexpressed. Table 1 summarizes the main oncogenes and tumor suppressor genes and 
their role in cancer development. Oncogenes and their products represent good targets for 
cancer therapy. Other targets include enzymes involved in cell division like topoisomerases 
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that unwind the DNA during replication. The diversity of plant derived natural products 
can provide therapeutic products attacking different targets in cancer cells. 
 
Oncogenes  Functions of their proteins 
Bcl-2 Inhibits apoptosis and protect cancer cell from 
free radicals. 
c-myc Initiate cell division and inhibits differentiation. 
HER-2/neu( c-erb-2) Facilitates signal transduction, expressed in 33% 
of breast cancers. 
MDM2 Protect cancer cells from apoptosis by binding 
and inhibiting p53 (tumor suppressor gene that 
induces apoptosis in damaged cells). 
ras  Facilitate tumor invasion by stimulation of 
collagenase production and inhibits apoptosis by 
increasing MDM2 expression. 
fos and jun Promote uncontrolled proliferation by their 
participation in cell cycle initiation. 
Tumor suppressor genes Functions of their proteins 
Bax An inducer of apoptosis 
Cx32, Cx 43 and other connexin 
producing genes 
Inhibits carcinogenesis by restoring 
communication between cells through gap 
junctions. 
p53 Initiates DNA repair and induce apoptosis in 
cells that cannot be repaired. 
Reference: Boik, 2001 
Table 1. The main oncogenes and tumor suppressor genes. 
5. The use of plants in cancer therapy 
Cancer is one of the major causes of death and the number of cancer patients is in continuous 
rise. Every year 2-3 % of deaths recorded world wide arise from different types of cancer 
(Madhuri & Pandey, 2009). The available treatment methods include surgery, chemotherapy, 
and radiation (Tannock et al., 1998). The increasing costs of conventional treatments 
(chemotherapy and radiation) and the lack of effective drugs to cure solid tumors encouraged 
people in different countries to depend more on folk medicine which is rooted in medicinal 
plants use (Wood-Sheldon et al., 1997). Such plants have an almost unlimited capacity to 
produce substances that attract researchers in the quest for new and novel chemotherapeutics 
(Reed & Pellecchia, 2005).  Although some plant products are used in cancer therapy, plant 
derived anticancer agents represent only one-fourth of the total treatments options. Since 1961, 
nine compounds originating from plants have been approved for use in cancer therapy in the 
United States. These agents are vinblastine, vincristine, navelbine, etoposide, teniposide, taxol, 
taxotere, topotecan, and irinotecan (Lee, 1999). In an extensive study, the anticancer properties 
of 187 plant species were evaluated. Among them, only 15 species have been used to treat 
cancer clinically (Kintzios, 2006). It was observed that different plants contain different 
bioactive compounds and these vary with area, climate and mode of agricultural practice if 
they are not present in wild environment. 
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Herbivory, pathogens and competition are the driving forces that induce plant species to 
develop chemical defense compounds. These plant origin compounds are good models for 
elucidation of their functional roles in medication and treatment of different afflictions 
(Wood-Sheldon et al., 1997). For example, the lignin in the roots of Anthriscus sylvestris 
showed an insecticidal activity (Kozawa et al., 1982). Poisonous plants exposed to frequent 
grazing by animals are commonly rich in alkaloids which have many biological activities 
including anticancer potential (Kintzios, 2006). However, the growth regulatory properties 
of some plant metabolites allow them to act as chemotherapeutical agents. Flavonoids from 
Scutellaria baicalensis act on cyclin-dependent kinases to inhibit cancer cell proliferation (Dai 
& Grant, 2003; Chang et al., 2004). 
Thirteen distinct groups of plant-derived natural products with antitumor properties were 
documented (Kintzios, 2006). Among them, alkaloids (Facchini, 2001), phenylpropanoids 
(Dixon & Paiva, 1995) and terpenoids (Trapp & Croteau, 2001) are well known for their 
antitumor potentials. 
An integrated part of cancer cell development is the resistance to programmed cell death 
(apoptosis). Re-establishment of apoptosis in cancer cells is a target mechanism for 
anticancer agents (Joshi et al., 1999). Some plant-derived products are known to selectively 
induce apoptosis in cancer cells, which represent the ideal property for successful anticancer 
agents (Hirano et al., 1995). Identifying the mode of action of anticancer agents of plant 
origin provide helpful information for their future use. Thus it is important to screen the 
apoptotic potential of plants either in their crude extract form or as pure compounds 
(Tarapadar et al., 2001). Due to their multiple intervention strategies, crude plant extracts 
have been proposed to prevent, arrest, or reverse the cellular and molecular processes of 
carcinogenesis (Neergheen et al., 2009). 
Since the distribution of bioactive compounds differs according to the plant used, different 
solvents were used to extract these compounds from different plants. The methanol extract 
of Scutellaria orientalis showed potent anti-leukemic activity against HL-60 cell line (Ozmen 
et al., 2010). The water extract of Rheum officinale exhibited significant antiproliferative 
activity by inducing apoptosis in MCF-7 and A549 cell lines (Li et al., 2009). A potent 
antiproliferative activity was also reported for the hexane extract of Casearia sylvestris stem 
bark against different cancer cell lines (Mesquita  et  al., 2009) and the butanol extract of 
Pfuffia paniculata demonstrated high cytotoxic activity against MCF-7 cell line (Nagamine et  
al., 2009). Additionally, the Physalis minima chloroform extract induced apoptosis in human 
lung adenocarcinoma cell line (Leong et al., 2009). Out of 76 Jordanian plant species, the 
ethanolic extracts of Inula graveolens, Salvia dominica, Conyza canadiensis and Achillea santolina 
showed potent antiproliferative activity against MCF-7 cell line (Abu-Dahab &Afifi, 2007). 
The aqueous methanol of Ononis hirta and Inula visocsa showed high ability to selectively 
target MCF-7 cancer cells and induced apoptosis (Talib & Mahasneh, 2010a). 
A substantial progress has been made in the treatment of cancer since the early years of 
anticancer drug research. An example of successful anticancer plant products are the vinca 
alkaloids which were isolated from Catharanthus roseus. The first identified vinca alkaloids 
were Vincristine and Vinblastine (Duflos et al., 2002). The antitumor activities of these 
compounds involve binding to tubulin and disruption of mitotic spindle assembly (Nobili et 
al., 2009). Myelosuppression and neurotoxicity were reported as side effects of vinca 
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Table 1. The main oncogenes and tumor suppressor genes. 
5. The use of plants in cancer therapy 
Cancer is one of the major causes of death and the number of cancer patients is in continuous 
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and radiation (Tannock et al., 1998). The increasing costs of conventional treatments 
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people in different countries to depend more on folk medicine which is rooted in medicinal 
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produce substances that attract researchers in the quest for new and novel chemotherapeutics 
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derived anticancer agents represent only one-fourth of the total treatments options. Since 1961, 
nine compounds originating from plants have been approved for use in cancer therapy in the 
United States. These agents are vinblastine, vincristine, navelbine, etoposide, teniposide, taxol, 
taxotere, topotecan, and irinotecan (Lee, 1999). In an extensive study, the anticancer properties 
of 187 plant species were evaluated. Among them, only 15 species have been used to treat 
cancer clinically (Kintzios, 2006). It was observed that different plants contain different 
bioactive compounds and these vary with area, climate and mode of agricultural practice if 
they are not present in wild environment. 
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Herbivory, pathogens and competition are the driving forces that induce plant species to 
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showed an insecticidal activity (Kozawa et al., 1982). Poisonous plants exposed to frequent 
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including anticancer potential (Kintzios, 2006). However, the growth regulatory properties 
of some plant metabolites allow them to act as chemotherapeutical agents. Flavonoids from 
Scutellaria baicalensis act on cyclin-dependent kinases to inhibit cancer cell proliferation (Dai 
& Grant, 2003; Chang et al., 2004). 
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(Dixon & Paiva, 1995) and terpenoids (Trapp & Croteau, 2001) are well known for their 
antitumor potentials. 
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(apoptosis). Re-establishment of apoptosis in cancer cells is a target mechanism for 
anticancer agents (Joshi et al., 1999). Some plant-derived products are known to selectively 
induce apoptosis in cancer cells, which represent the ideal property for successful anticancer 
agents (Hirano et al., 1995). Identifying the mode of action of anticancer agents of plant 
origin provide helpful information for their future use. Thus it is important to screen the 
apoptotic potential of plants either in their crude extract form or as pure compounds 
(Tarapadar et al., 2001). Due to their multiple intervention strategies, crude plant extracts 
have been proposed to prevent, arrest, or reverse the cellular and molecular processes of 
carcinogenesis (Neergheen et al., 2009). 
Since the distribution of bioactive compounds differs according to the plant used, different 
solvents were used to extract these compounds from different plants. The methanol extract 
of Scutellaria orientalis showed potent anti-leukemic activity against HL-60 cell line (Ozmen 
et al., 2010). The water extract of Rheum officinale exhibited significant antiproliferative 
activity by inducing apoptosis in MCF-7 and A549 cell lines (Li et al., 2009). A potent 
antiproliferative activity was also reported for the hexane extract of Casearia sylvestris stem 
bark against different cancer cell lines (Mesquita  et  al., 2009) and the butanol extract of 
Pfuffia paniculata demonstrated high cytotoxic activity against MCF-7 cell line (Nagamine et  
al., 2009). Additionally, the Physalis minima chloroform extract induced apoptosis in human 
lung adenocarcinoma cell line (Leong et al., 2009). Out of 76 Jordanian plant species, the 
ethanolic extracts of Inula graveolens, Salvia dominica, Conyza canadiensis and Achillea santolina 
showed potent antiproliferative activity against MCF-7 cell line (Abu-Dahab &Afifi, 2007). 
The aqueous methanol of Ononis hirta and Inula visocsa showed high ability to selectively 
target MCF-7 cancer cells and induced apoptosis (Talib & Mahasneh, 2010a). 
A substantial progress has been made in the treatment of cancer since the early years of 
anticancer drug research. An example of successful anticancer plant products are the vinca 
alkaloids which were isolated from Catharanthus roseus. The first identified vinca alkaloids 
were Vincristine and Vinblastine (Duflos et al., 2002). The antitumor activities of these 
compounds involve binding to tubulin and disruption of mitotic spindle assembly (Nobili et 
al., 2009). Myelosuppression and neurotoxicity were reported as side effects of vinca 
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alkaloids (Yun-San et al., 2008). Another example of plant products in cancer therapy is taxol 
which was extracted from the bark of Taxus brevifolia (Wani et al., 1971). Its cytotoxic activity 
is mediated by stabilizing microtubules rather than destabilizing them (Horwitz et al., 1993). 
Since taxol drugs have low solubility, they are administered together with solvents which 
cause some adverse effects like hypersensitivity and neuropathies (Onetto et al., 1993). 
Other anticancer plant products mediate their activities by inhibiting the enzyme DNA 
topoisomerase. Plants under this category include camptothecins extracted from the Chinese 
tree Camptotheca acuminate (Wall et al., 1966) and Podophyllotoxins extracted from the roots 
of the Indian plant Podophyllum peltatum (Nobili et al., 2009). 
In spite of the success of previously mentioned anticancer plant products, the development 
of multi-drug resistance in cancer chemotherapy still one of the major problems (Xu et al., 
2009). To avoid this problem, researchers focused on other targets including starving cancer 
cells by targeting the process of angiogenesis (formation of new blood vessels) which 
represent an attractive target since tumors depend on angiogenesis for survival and 
metastasis (Griggs et al., 2001). Some plant derived agents showed promising anti-
angiogenic activity such as stilbene combretsatatin- A4 which was isolated from Combretum 
caffrum (Young & Chaplin, 2004). Another strategy to target multi-drug resistance cancers is 
to use a combination of chemotherapy with other strategies including anaerobic bacteria 
which experimentally showed promising results in targeting solid tumors (Dang et al., 
2001). Many plants exhibited promising anticancer activities (Table 2). Such plants may 
provide compounds that can change the list of drugs available for cancer treatment in the 
future. 
 
Family Species  Compounds  
Anacardiaceae Rhus succedanea Flavones, aldehydes 
Annonaceae Annona chrimola, A. muricata, A. 
senegalensis, 
Annonaceous acetogenins  
A. reticulate, A. squamosa, A. bullata (lactones) 
Goniothalamus gardneri, G. amuyon 
and G. giganteus 
lactones 
Polyathia barnesii Clerodane diterpenes 
Xylopia aromatica Annonaceous acetogenins 
Apiaceae Anthriscus sylvestris Lignans 
Seseli mairei Polyacetylenes 
Apocynaceae Alstonia scholaris R. BR. Extract, indole alkaloids 
Ervatamia divaricata, E. microphylla, 
E. heyneana 
Alkaloids 
Plumeria rubra Alkaloids (iridoids), lignans 
Araliaceae Dendropanax arboreus Oxylipins (linoleic acid 
derivatives) 
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Aristolochiaceae Aristolochia elegans, A. versicolar Sesquiterpene lactones 
Asclepiadaceae Calotropis procera, C. gigantea Glycosides 
Asteraceae Neurolaena lobata Sesquiterpene lactones 
Bigoniaceae Kigelia pinnata Dichloromethane extracts 
Burseraceae Bursera simaruba, B. permollis, B. 
morelensis, B. microphylla, B. klugii, B. 
schlechtendalii 
Lignans 
Caesalpiniaceae Caesalpinia sappan Ethyl acetate extracts 
Campanulaceae Platycodon grandiflorum Polysaccharides 
Capparaceae Polanisia dodecandra Flavonols 
Celastraceae Glyptopetalum sclerocarpum Terpenoids 
Maytenus boaria, M. guangsiensis, M. 
ovatus, M. senegalensis, M. 
wallichiana and M. emarginata 
Triterpenes 
Combretaceae Bucida buceras Flavanones, diterpenes 
Terminalia arjuna Flavones, tannins 
Compositae Eupatorium cannabinum Lactones 
E. cuneifolium, E. rotundifolium, E. 
semiserratum, E. altissimum 
Flavones 
Hellenium microcephalum, H. hoopesii Sesquiterpene lactones 
Xanthium strumarium Alkaloids 
Inula viscosa Flvonoids and alkaloids 
Inula graveolens, Achillea santolina, 
Conyza canadiensis 
Ethanol extract 
Conifereae J. virginiana, J. chinensis Podophyllotoxin (lignans) 
Cucurbitaceae Cucurbita moschata, Mormodica 
charantia 
Proteins 
Cupressaceae Chamaecyparis lawsonianna, Thujopsis 
dolabrata 
Alkaloids 
Ericaceae Vaccinium macrocarpon, V. smallii Triterpenes, flavonol, 
glycosides 
Eriocaulaceae Paepalanthus latipes Naphthoquinones 
Euphorbiaceae Emblica offcinalis Aqueous extracts, 
Norsesquiterpenoid, 
glycosides 
Euphorbia amygdaloides, E. helioscopic,
E. lathyris, E. mongolica, E. pubescens 
Jatrophane diterpenoids 
Jatropha curcas, J. macrorhiza Jatrophane diterpenoids and 
triterpenoids 
Mallotus phillipinensis Rottlerin, phloroglucinol 
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Phyllanthus acuminatus, P. amarus, P. 
emblica, P. urinaria 
Glycosides 
Fabaceae Ononis sicula, Ononis hirta Aqueous methanol extract 
Flacourtiaceae Caesaria sylvestris Clerodane diterpenes 
Guttiferae Garcinia hunburyi Processed extract 
Hernandiaceae Hernandia sp. Lignans 
Hyacynthaceae Scilla scilloides, S. peruviana Glycosides 
Hypericaceae Hypericum perforatum, H. drummondii Polycyclic diones 
Iridaceae Crocus sativus Carotenoids 
Lamiaceae Hyptis martiusii, H. verticillata Diterpenes, lignans 
Origanum vulgare, O. majorana Quinines, quinine glycosides 
Rabdosia ternifolia, R. trichocarpa, R. 
macrophylla 
Diterpenoids, lactones 
Salvia sclarea Lectins, Ursolic acid 
(carboxylic acids) 
Salvia pinardi Aqueous methanol extract 
Salvia przewalskii Quinones 
Salvia dominica Ethanol extract 
Scutellaria barbata, S. lateriflora, S. 
baicalensis 
Flavonoids, flavones 
Lauraceae Cinnanomum camphora Cinnamaldehydes 
Leguminosae 
 
Acacia catechu, A. victoriae, A. 
confuse, A. auriculiformis A. Cunn. 
and A. nilotica  
Proteins 
Bauhinia racemosa Methanol extracts 
Cassia acutifolia, C. angustifolia, C. 




C. pudibunda Glycyrrhiza glabra, G. 
uralensis, G. inflata 
Anthraquinones Glycyrrhizic 
acid, glycyrrhetinic acid, 
flavonoids and  
Tamarindus indica Triterpenoids, Polysaccharides 
Liliaceae Colchicum autumnale, C. speciosum
Crinum asiaticum var. toxicarium 
Alkaloids 
Linaceae Linum usitatissimum Lignans 
 Viscum cruciatum Hexanoic acid extracts 
Magnoliaceae M. offcinalis, M. grandiflora, M. 
virginiana 
Neolignans 
Malvaceae G. herbaceum G., indicum Cathechin (phenolics) 
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Meliaceae Azadirachta indica Limonoids (triterpenes) 
Melia azedarach Limonoids (triterpenes) 
Myrtaceae Eugenia jambos Hydrolyzable tannins 
Ochnaceae Ouratea hexasperma, O. semiserrata Biflavonoids
Pinaceae Pseudolarix kaempferi Triterpene lactones, diterpenes 
Polygalaceae Polygala vulgaris Xanthones
Polygonaceae Polygonum cuspidatum Flavonoids, anthraquinones 
Ranunculaceae Nigella sativa Quinones, fatty acids 
 Pulsatilla koreana Lignans, saponins 
Rosaceae Agrimonia pilosa Tannins, methanolic extracts 
Rubiaceae Nauclea orientalis Angustine alkaloids 
Psychotria. rubra, P. forsteriana Napthoquinones, alkaloids 
Rubia cordifolia, R. akane Cyclic hexapeptides 
Naphthoquinones, 
anthraquinones 








Sapindaceae Koelreuteria henryi Anthraquinone, stilbene, and 
flavonoids
Simaroubaceae Brucea dysenterica, B. javanica Quassinoid glycosides, 
Alkaloids 
Eurycoma harmadiana Alkaloids, quassinoids 
Hannoa chlorantha, H. kleineana Quassinoids, chaparrinones 
Solanaceae Solanum pseudocapsicum Alkaloids
Scrophulariaceae Verbascum sinaiticum Aqueous methanol extract 
Theaceae Camellia sinensis Polyphenols
Thymelaceae Stellera chasmaejasme Diterpenes
Tropaeolaceae Wikstroemia foetida, W. uvaursi, W. 
indica, Tropaeloum majus 
Polysaccharides, Aromatic 
plant hormones 
Umbellifereae Angelica archangelica A. keiskei, A. 
sinensis,A. gigas, A. acutiloba, A. 
radix, A. japonika, A. edulis 
Pyranocoumarins, chalcones, 
polysaccharides 
Urticaceae Ficus carica Lectins
Verbenaceae Vitex rotundifolia Flavonoids
Violaceae Viola odorata Nucleotides
References: (Kintzios, 2006), (Abu-Dahab and Afifi, 2007), (Talib and Mahasneh, 2010) 
Table 2. Plants with potential anticancer activity 
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6. Plants as a source of antimicrobial agents 
The discovery of antibiotics has decreased the spread and severity of a wide variety of 
inferior diseases. However, and as a result of their uncontrolled use, the efficiency of many 
antibiotics is being threatened by the emergence of microbial resistance to existing 
chemotherapeutic agents (Cowan, 1999). While bioactive natural compounds have been 
isolated mainly from cultivable microbial strains, an untapped biologically active 
metabolites of different resources including plants remains to be investigated (Quiroga et 
al., 2001) to alleviate or help responding to current health care situations; such situations 
include but not limited to unmet clinical needs, increasing cost of chemotherapy, 
mycobacterial reemergence, and the emergence of antibiotic resistant microbial strains such 
as MRSA (Alanis et al., 2005) . 
Microbial resistance occurs mainly in three general mechanisms: prevention of interaction of 
the drug with target; direct destruction or modification of the drug; and efflux of the drug 
from the cell (Alviano & Alviano, 2009). These mechanisms were used by different 
microorganisms and led to the emergence of many pathogenic bacterial strains (Alanis et al., 
2005). With pathogenic fungi, the situation is not so bright also, where Amphotericin B was 
for many years the only treatment available for fungal infections. In late 1980s fluconazole 
and itracozole was developed as additional therapeutic options (Ficker et al., 2002). 
Recently, azole derivatives are most widely used antifungal agents, although resistance for 
these drugs is emerging (Groll et al., 1998). All the available antifungal drugs used to date 
are not ideal in efficiency, safety, and antifungal spectrum (Di Domenico, 1998). 
Combination antifungal therapy was also used to increase the efficiency but there is a real 
demand for a next generation of safer and more powerful antifungal agents (Bartoli et al., 
1998). Knowing that modifying known antimicrobial compounds is increasingly difficult 
created an urgent and very pressing need for isolation and identification of new bioactive 
chemicals from new sources including plants (Barker, 2006). 
Plant derived natural products represent an attractive source of antimicrobial agents since 
they are natural, have manageable side effects and available at affordable prices (Ghosh et 
al., 2008). Also plants derived agents may have different mechanisms than conventional 
drugs, and could be of clinical importance in health care improvement (Ellof, 1998).  
There are two main classes of plant derived agents.1) phytoalexins which are low molecular 
weight compounds produced in response to microbial, herbivorous, or environmental 
stimuli (Van Etten et al., 1994). Phytoalexins include simple phenylpropanoid derivatives, 
flavonoids, isoflavonoids, terpenes and polyketides (Grayer & Harbborne, 1994). 2) 
Phytoanticipins which are produced in plants before infection or from pre-existing 
compounds after infection (Van Etten et al., 1994). Phytoanticipins include: glycosides, 
glucosinolates and saponins that are normally stored in the vacuoles of plant cells (Osbourn, 
1996). The antimicrobial potential of plant derived natural products is well documented. 
Schelz and colleagues reported the potential of menthol isolated from peppermint oil to 
eliminate the resistance plasmids of bacteria (Schelz et al., 2006). In another study carbazole 
alkaloids isolated from Clausena anisata stem bark showed high antibacterial and antifungal 
activities (Chakraborty et al., 2003). 
Thousands of other phytochemicals having in vitro antimicrobial activities were also 
screened. Such screening programs are essential for validating the traditional use of 
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medicinal plants and for providing leads in the search for new antimicrobial agents 
(Alviano & Alviano, 2009). A number of studies of the bioactivity of plant extracts have been 
conducted and many of these studies showed promising results in developing new 
biologically active agents. The methanolic extract of clove Caryophyyllus aromaticus showed 
antibacterial activity against many bacterial genera and the highest activity was against 
Staphylococcus aureus (Ushimaru et al., 2007). Association of clove extract and antibiotics 
showed synergistic antibacterial activity against antibiotic resistant Pseudomonas aeruginosa 
(Nascimento et al., 2000). Out of the 50 plants used in Indian traditional medicine, 72% 
showed antimicrobial activity including nine plants showed antifungal activity (Srivnivasan 
et al., 2001). When some Palestinian plants were tested for bioactivity, out of fifteen used in 
traditional medicine, only eight showed antibacterial activity against eight different 
bacterial strains (Essawi & Srour, 2000). Butanol extracts of Rosa damascene, Narcissus tazetta, 
and Inula viscose exhibited potent antimicrobial activities against different microorganism 
including Methicillin-resistant Staphylococcus aureus and Candida albicans (Talib & Mahasneh, 
2010b). 
During the past decade there is an increase in the number of immuno-compromised 
patients. This is probably due to the alteration of the immune system caused by human 
immunodeficiency virus (HIV), cancer chemotherapy, and organ and bone marrow 
transplantation in addition to the use of immune suppressors to treat many diseases 
(Alexander & Perfect, 1997). The compromised immune system facilitates microbial 
infections including systemic mycosis. This leads to extensive use of Amphotericin B and 
azole derivatives as antifungal agents. Unfortunately, the wide range use of these antifungal 
agents leads to the emergence of drug resistant pathogenic fungi (Alexander & Perfect, 
1997). Candida albicans is opportunistic yeast that can cause vaginal, oral, and lung infections 
in addition to systemic tissue damage in AIDS patients (Madigan & Martinko, 2006). This 
yeast was the target of many researchers to develop new antifungal agents. Out of twenty 
four medicinal plants used in traditional medicine in South Africa, two showed high 
potential to treat candidiasis (Motsei et al., 2003). Also some indigenous plants of Lebanon 
showed antimicrobial activity against Candida albicans and other tested microorganisms 
(Barbour et al., 2004).  
 Successive isolation of antimicrobial compounds from plants depends upon the type of 
solvent used in extraction procedure (Parekh & Chanda, 2007). Literature reported the use 
of different solvents to extract antimicrobial agents. The ethanol/methanol extracts of 
thirty four medicinal plants were more active than aqueous extracts against bacterial 
strains belonging to Enterobacteriaceae (Parekh & Chanda, 2007). Methanolic extract of 
Terminallia chebula showed higher antibacterial potential compared with aqueous extract 
(Ghosh et al., 2008). Mahasneh found that butanol extracts of several plants including:  
Lotus halophpilus, Pulicaria gnaphaloides, Capparis spinosa, Medicago laciniata, Limonium 
axillare to exhibit superior antimicrobial activity compared with ethanol and aqueous 
extracts (Mahasneh, 2002). The ethanolic extract of 11 plant species from Argentina 
showed high antimicrobial activity against a list of microorganisms including methicillin, 
oxacillin, and gentamicin resistant Staphylococcus (Zampini et al., 2009). Of 16 plants 
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Jordanian plants were the focus of many researchers for their antimicrobial activities.  
Butanol, ethanol, petroleum ether, and aqueous extracts were prepared from nine Jordanian 
plants. Butanol extract showed superior antimicrobial activity compared with other extracts 
(Mahasneh & El-Oqlah, 1999). Of 27 ethanol extracts prepared from indigenous Jordanian 
plants, six plants showed promising antimicrobial activity against different test 
microorganisms (Al-Bakri & Afifi, 2007). In addition to their broad antimicrobial activities 
some Jordanian plants like Sonchus oleraceus and Laurus nobilis exhibited high antiquorum 
sensing activities (Al-Hussaini & Mahasneh, 2009). Other Jordanian plants like Crupina 
crupinastrum and Achillea biebersteinii showed high antimicrobial activity against bacteria 
and fungi (Khalil et al., 2009). Additionally the methanolic extracts of two Jordanian plants 
Artemisia herba-alba and Artemisia arborescens showed high antibacterial activity against 32 
isolates of Mycoplasma species (Al-Momani et al., 2007). 
7. Conclusions 
The potential isolation and use of new and novel bioactive products from plant origins is 
still very productive playground for the development of new drugs to improve health care 
in certain medical fields. It is essential to emphasize that extensive in vitro and in vivo tests 
must be conducted to assure the selection of active and nontoxic anticancer and 
antimicrobial phytochemicals. 
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1. Introduction 
Cancer remains a major health problem and is responsible for one in eight deaths worldwide. 
Genome-wide association studies have identified hundreds of genetic variants associated with 
complex human diseases and traits, and have provided valuable insights into their genetic 
architecture. Despite the success of genome-wide association studies in identifying loci 
associated with cancer, a substantial proportion of the causality remains unexplained, leaving 
many questions how the remaining ‘missing’ heritability can be explained, although polygenic 
disease traits may account for some of these limitations (Maher, 2008; Manolio et al., 2009; 
Rakyan et al., 2011). Only a minority of cancers are caused by germline mutations, whereas the 
vast majority (90%) are linked to somatic mutations and environmental factors (Anand et al., 
2008). Also, an estimated 55% increase in cancer incidence is expected by the year 2020 
(Chaturvedi et al., 2011). A recent survey of the global incidence of cancer shows that the age-
adjusted cancer incidence in the Western world is above 300 cases per 100,000 population, 
whereas that in Asian countries is less than 100 cases per 100,000. Observational studies have 
suggested that lifestyle risk factors such as tobacco, obesity, alcohol, sedentary lifestyle, high-
fat diet, radiation, and infections are major contributors in cancer causes, which is further 
emphasized by the increase in cancer cases among immigrants from Asian to Western 
countries (Anand et al., 2008; Messina & Hilakivi-Clarke, 2009; Shu et al., 2009)). Reciprocally, 
a reasonable good fraction of cancer deaths may be prevented by modifying the diet 
composition (i.e. content of fiber, fruit, vegetable, fat/oil, protein, spices, cereals, etc.) and 
regular physical exercise (Anand et al., 2008; Bingham & Riboli, 2004; Boffetta et al., 2010; 
Tennant et al., 2010). Rather than the chemical conversion of food to energy and body matter 
of classic metabolism, food is now also a conditioning environment that shapes the activity of 
the (epi)genome and determines stress adaptative responses, metabolism, immune 
homeostasis and the physiology of the body. 
The contribution of epigenetic changes (epimutations) in cancer is probably underestimated. 
Epigenetics encompasses several extra-genetic processes such as DNA methylation 
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(methylation of cytosines within CpG dinucleotides), histone tail modifications (including 
acetylation, phosphorylation, methylation, sumoylation, ribosylation and ubiquitination), 
noncoding RNA functions, regulation of polycomb group proteins and the epigenetic 
cofactor modifiers, all of which may alter gene expression but do not involve changes in the 
DNA sequence itself (Chi et al., 2010; Davalos & Esteller, 2010; Guil & Esteller, 2009; B. M. 
Lee & Mahadevan, 2009; Vanden Berghe et al., 2006b). Furthermore, many activities 
controlling chromatin dynamics require metabolites that shuttle between different cellular 
functions and pathways. One critical facet of histone and DNA modifying enzymes is that 
their activity also depends on intracellular levels of essential metabolites (acetyl-coA, Fe, 
ketoglutarate, NAD+, S-adenosylmethionine, see Figure 1) of which the concentrations are 
tighly linked to global cellular metabolism and energy levels (Bellet & Sassone-Corsi, 2010; 
Chang et al., 2010; Ladurner, 2009; Luo & Kuo, 2009; Wallace, 2010a; 2010b). Gene regulation 
is thus linked to the metabolic status of cells. To maintain uncontrolled cell proliferation of 
cancer cells, energy metabolism needs to be adjusted in order to fuel cell growth and invasion. 
In contrast to "healthy" cells which mainly generate energy from oxidative breakdown of 
pyruvate, cancer cell reprogram their glucose metabolism, limiting their energy metabolism 
largely to glycolysis. The fundamental difference in ratio of glycolysis to mitochondrial 
respiration between normal and cancerous cells is also known as the Warburg effect. As such, 
dynamic changes in energy levels and metabolite concentrations in the inflammatory tumor 
microenvironment can have significant epigenetic changes through variable activity of 
cofactor enzymes (Bonuccelli et al., 2010; Figueroa et al., 2010; Martinez-Outschoorn et al., 
2011; Rathmell & Newgard, 2009; Teperino et al., 2010; Wellen et al., 2009).  
The combinatorial nature of DNA methylation and histone modifications significantly extends 
the information potential of the genetic cancer code (Brower, 2011)(Figure 2). The most studied 
epigenetic lesion, which is DNA hypermethylation at the promoter region of many genes 
(Esteller, 2007; Mulero-Navarro & Esteller, 2008), is proved to be responsible for silencing of 
more than 600 cancer-related genes and this number is still rising. Besides effects on tumour 
suppressor genes, DNA methylation changes have also been detected in oncogenes as well as 
genes involved in the cell-cycle regulation, DNA repair, angiogenesis, metastasis and 
apoptosis (Herceg, 2007). Also oxidative stress (ROS, RNS) and inflammatory damage play an 
important role in epigenetic reprogramming of expression of cytokines, oncogenes and tumor 
suppressor genes, thereby setting up a ground for chronic inflammatory diseases and 
carcinogenesis (B. B. Aggarwal, 2009; B. B. Aggarwal & Gehlot, 2009; S. I. Grivennikov & 
Karin, 2010). On the other hand, global hypomethylation of the DNA is said to activate 
endoparasitic sequences and causes the global chromosome instability leading to various 
mutations and cancer progression (Esteller, 2008). Epigenetic defects in DNA methylation 
patterns at CpG sites (epimutations), abnormalities in histone modifications, chromatin 
remodelling and noncoding RNAs (microRNA, long noncoding RNA) or corrupt chromatin 
states of tumor suppressor genes or oncogenes recently emerged as major governing factors in 
tumor progression and cancer drug sensitivity (Backdahl et al., 2009; Davalos & Esteller, 2010; 
Esteller, 2007; 2008; Guil & Esteller, 2009; Hesson et al., 2010; Lai & Wade, 2011; Lujambio et al., 
2008; Lujambio & Esteller, 2007; Vanden Berghe et al., 2006b). In addition, genetic mutations of 
epigenetic modifying (“writer”) enzymes add another level of regulatory complexity (Chi et 
al., 2010; Dalgliesh et al., 2010; Delhommeau et al., 2009; Elsasser et al., 2011; Ko et al., 2010; 
Varela et al., 2011). Recent advances in genomic technologies have initiated large-scale studies 
to map cancer-associated epigenetic variation, specifically variation in DNA methylation and 
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chromatin states (Berdasco & Esteller, 2010; Birney et al., 2007; Brower, 2011; Ernst & Kellis, 
2010; Ernst et al., 2011; Myers et al., 2011; Rakyan et al., 2011; Raney et al., 2011). Given the 
prevalence of reversible epigenetic abnormalities in different cancers, epigenetic therapy holds 
great promise for treatment. The future of specific and effective epigenetic drug design will 
rely on our ability in understanding epigenomic landscapes in normal and cancerous disease 
states (Hakim et al., 2011; Christopher A. Hamm & Costa, 2011; Gioacchino Natoli, 2010; G. 
Natoli et al., 2011; Tolhuis et al., 2011; B. van Steensel, 2011).  
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Once critical facet of histone modifications is that they are elicited by specific enzymatic 
activities that depend on the intracellular levels of essential metabolites: these metabolites 
sense cellular metabolism, nutrients and energy levels in the cell. 
Changes in DNA methylation have been recognized as one of the most common molecular 
alterations in human neoplasia and hypermethylation of gene-promoter regions is being 
revealed as one of the most frequent mechanisms of loss of gene function. This figure 
summarizes how changes in DNA-methylation (epimutations) contribute to the 6 hallmarks 
of a cancer cell i.e. limitless replicative potential, self-sufficiency in growth signals, 
insensitivity to growth-inhibitory signals, evasion of programmed cell death, sustained 
angiogenesis and tissue invasion and metastasis. Since epigenetic changes (epimutations) 
are more easily reversible (when compared with genetic mutations), this has inspired 
various research efforts aiming to identify dietary phytochemicals (nutri-epigenomics) 
which can reverse epimutations and/or prevent cancer progression. 
2. Dietary chemoprevention of cancer-inflammation 
Cancer cells are distinguished by several distinct characteristics, such as self-sufficiency in 
growth signal, resistance to growth inhibition, limitless replicative potential, evasion of 
apoptosis, sustained angiogenesis, and tissue invasion and metastasis (Hanahan & 
Weinberg, 2011) (Figure 2). Tumor cells acquire these properties due to the dysregulation of 
multiple genes and associated cell signaling pathways, most of which are linked to 
inflammation. Immune cells also inltrate in tumors, engage in an extensive and dynamic 
crosstalk with cancer cells (B. B. Aggarwal, 2009; S. I. Grivennikov et al., 2010a; Mantovani et 
al., 2008). Inammation also affects immune surveillance and responses to therapy (D. 
Iliopoulos et al., 2011; M. Liu et al., 2010a; Rajasekhar et al., 2011; S. V. Sharma et al., 2010). 
For that reason, rationally designed drugs that target a single gene product are unlikely to 
be of use in preventing or treating cancer. Moreover, targeted drugs can cause serious and 
even life-threatening side effects or therapy resistance (Hanahan & Weinberg, 2011). When a 
complex system starts to dysfunction, it is generally best to fix it early. Often, cancers have a 
long latency period –often 20 years or more-. By the time they are clinically detectable, the 
system has degenerated into a disorganized, chaotic mess at which point it may be beyond 
repair (Sporn, 2011). Therefore, there is an urgent need for safe and effective 
chemopreventive multifunctional drugs that act at entire networks in the body, rather than 
single targets (Deocaris et al., 2008). The basic idea of cancer chemoprevention is to arrest or 
reverse the progression of premalignant cells towards full malignancy using physiological 
mechanisms that do not kill healthy cells, but attenuate cancer-inflammation (B. B. 
Aggarwal & Gehlot, 2009; Anand et al., 2008; Jirtle & Skinner, 2007; Surh, 2003)(Figure 3).  
The global demand for more affordable therapeutics and concerns about side effects of 
commonly used drugs has renewed interest in phytochemicals and traditional medicines 
which allow chronic use (Harvey, 2008; J. W. H. Li & Vederas, 2009; Singh, 2007). Studies on 
a wide spectrum of plant secondary metabolites extractable as natural products from fruits, 
vegetables, teas, spices, and traditional medicinal herbs have identified various bioactive 
plant phytochemicals that regulate multiple cancer-inflammation pathways and epigenetic 
cofactors, are cost effective, exhibit low toxicity, and are readily available (B. B. Aggarwal et 
al., 2011; Deorukhkar et al., 2007; Ki Won Lee et al., 2011; Yang & Dou, 2010). The recent 
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advances in genomics and metabolomics have enabled biologists to better investigate the 
potential use of immunomodulatory natural products for treatment or control of cancerous 
diseases. More recently, evidence is emerging that specific combinations of phytochemicals 
maybe far more effective in protecting against cancer than isolated compounds (Harvey, 
2008; Kok et al., 2008). The cancer preventive or protective activities of the various 
immunomodulatory natural products lie in their effects on cellular defenses including 
detoxifying and antioxidant enzyme systems, and the induction of anti-inflammatory and 
antitumor or antimetastasis responses, often by targeting specific key transcription factors 
(i.e. like nuclear factor kappa B (NFB), activator protein (AP-1), signal transducers and 
activators of transcription (STAT3), nuclear factor erythroid 2-related factor (NRF2), 
peroxisome proliferator-activated receptor- γ (PPAR γ ), estrogen receptor, liver X receptor 
(LXR), hypoxia inducible factor-1 (HIF-1)), epigenetic cofactors and microRNAs which are 
involved in tumor progression (Figure 4) (Meeran et al., 2010; Parasramka et al., 2011; Szarc 
vel Szic et al., 2010). Typically, dysregulation of transcription factor activity is the result of 
numerous mechanisms, such as changes in gene expression, protein – protein interactions 
and post-translational modifications, leading to deregulation of gene products that are 
involved in both inflammation and carcinogenesis. Remarkably, “transient” inflammatory 
pathways can also trigger mitotic stable epigenetic switches from nontransformed to 
metastatic cancer cells via feedback signaling involving NFB and Stat3 transcription factors, 
Lin28 and let-7 microRNAs and the cytokine IL6 in the tumor microenvironment (D. 
Iliopoulos et al., 2009; D. Iliopoulos et al., 2010). Furthermore, emerging data demonstrate 
the direct influence of certain anti-inflammatory dietary factors (for example polyphenols, 
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isothiocyanates, epicatechins) and micronutrients (for example folic acid, selenium) on 
heritable gene expression, activity of the epigenetic machinery, DNA methylation or 
chromatin remodelling (Burdge & Lillycrop, 2010; Delage & Dashwood, 2008; Fang et al., 
2007; Folmer et al., 2010; Hauser & Jung, 2008; Kirk et al., 2008; Kontogiorgis et al., 2010; 
Link et al., 2010; Suzuki & Miyata, 2006, Szarc vel Szic et al., 2010). Because epigenetic 
changes are reversible, developing drugs that control epigenetic regulation now attracts 
substantial research investment, including the development of functional foods or 
supplements as nutrition based epigenetic modulators for cancer chemoprevention (2008; 
Arasaradnam et al., 2008; Bingham & Riboli, 2004; Dashwood & Ho, 2007; Dashwood et al., 
2006; Hurt & Farrar, 2008; Kawasaki et al., 2008; b; Parasramka et al., 2011; Szarc vel Szic et 
al., 2010) 
The basic idea of cancer chemoprevention by dietary phytochemicals is to arrest or reverse 
the progression of premalignant cells towards full malignancy using physiological 
mechanisms by attenuating cancer-inflammation pathways. Chronic inflammation 
associated with infections or autoimmune disease precedes tumor development and can 
contribute to it through induction of oncogenic mutations, genomic instability, 
epimutations, changed expression of epigenetic “writer-reader-eraser” enzymes, oncomirs 
and long noncoding RNAs affecting early tumor promotion, and enhanced angiogenesis. 
Prolonged exposure to environmental irritants, Western diet or obesity can also result in 
low-grade chronic inflammation that precedes tumor development and contributes to it 
through the mechanisms mentioned above. Tumor-associated inflammation goes hand in 
hand with tumor development. This inflammatory response can enhance neoangiogenesis, 
promote tumor progression and metastatic spread, cause local immunosuppression, and 
further augment genomic instability. Cancer therapy can also trigger an inflammatory 
response by causing trauma, necrosis, and tissue injury that stimulate tumor re-emergence 
and resistance to therapy. However, in some cases, therapy-induced inflammation can 
enhance antigen presentation, leading to immune-mediated tumor eradication. 
3. Chromatin states and methylomes in the epigenomic landscape 
In general, DNA is wrapped around nucleosomes, which are arranged as regularly spaced 
beads (146 bp DNA/nucleosome) along the DNA. Typically, nucleosomes consist of a 
histone octamer of histones (H)2A/B, H3 and H4. The DNA bridging two adjacent 
nucleosomes is normally bound by the linker histone H1 and is termed linker DNA. While 
the core histones are bound relatively tightly to DNA, chromatin is largely maintained by 
the dynamic association with its architectural proteins. Before most activators of a gene 
access their DNA-binding sites, a transition from a condensed heterochromatin ("solenoid-
like fiber") to a decondensed euchromatin ("beads on a string") structure appears to take 
place. Conversely, the acquisition of a more condensed heterochromatin structure is often 
associated with gene silencing (Chi et al., 2010). This structural restriction of silenced 
chromatin on gene expression can be overcome by chromatin cofactor complexes, which 
remodel nucleosomes along the DNA or reversibly modify (acetylation, phosphorylation, 
ubiquitylation, glycosylation, sumoylation) histones on lysine, arginine, serine or threonine 
residues of amino-terminal histone tails. Since the discovery of histone-modifying enzymes, 
N-terminal histone tails protruding from nucleosomes were found to be 'velcro patches' for 
polycomb proteins, (de)acetylases (HDAC/HAT), (de)methylases (HMT/HDMT), ubiquitin 
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ligases, small ubiquitin-related modifier (SUMO) ligases, kinases, phosphatases, ribosylases, 
which together establish specific chromatin states involved in transcription (Chi et al., 2010; 
Ernst & Kellis, 2010; Ernst et al., 2011). Specific sets of histone modifications and/or variants 
are associated with genes that are actively transcribed or are repressed, a phenomenon 
defined as the "histone code" (Chi et al., 2010). Based on coexisting histone marks and 
genomewide ChIP-seq data available within the ENCODE consortium, principal component 
analysis allowed to reduce the complexity of the histone code into 9 different chromatin 
states with different functional regulatory features (Ernst & Kellis, 2010; Ernst et al., 2011).  
To establish specificity of epigenetic marks, histone modifying complexes have to be 
recruited to relevant genomic locations by DNA-binding proteins, RNAs or protein-RNA 
complexes that bind to their specific DNA sites as a consequence of their own binding 
specificities and cellular concentrations (Brenner et al., 2005; Gupta et al., 2010; Hervouet et 
al., 2009; Perissi et al., 2010; Vire et al., 2006). It cannot come from the enzymatic activities 
per se as neither DNMTs, nor enzymes which modify histones, know which part of the 
genome needs to be tagged. Furthermore, there is now a large body of evidence showing 
that modifications of the histone tails provide signals ("binary switches") that are recognized 
by specific binding proteins, such as chromo-, bromo- or tudor-domains which in turn can 
influence gene expresion and other chromatin functions (Fischle, 2008; Schreiber & 
Bernstein, 2002; Seet et al., 2006). The dynamic time-dependent combinations of histone 
modifications or threedimensional locus configuration further increase the complexity of 
information contained in chromatin (Bickmore et al., 2011; Chi et al., 2010; Fischle, 2008; G. 
Natoli, 2010; G. Natoli et al., 2011; Schreiber & Bernstein, 2002; B. van Steensel, 2011).  
DNA methylation is the best known epigenetic mark (Bird, 2002; Esteller, 2007). It is 
catalyzed by two types of DNMTs: DNMT1 is a maintenance methyltransferase, whereas 
both DNMT3A and DNMT3B are de novo methyltransferases (P. A. Jones & Liang, 2009; Law 
& Jacobsen, 2010). The role of DNMT2 in DNA methylation is minor, its enzymology being 
largely directed to tRNA. DNA methylation is normally associated with gene inactivation 
and it usually occurs in CpG dinucleotides. Alternatively, DNA methylation of transcription 
factor binding sites which prevents binding of repressor proteins, may paradoxically induce 
gene activation. CpGs are normally methylated when scattered throughout the genome, but 
are mostly unmethylated when they are clustered as CpG islands at 5’ ends of many genes. 
Hypermethylation of CpG-rich promoters triggers local histone code modifications resulting 
in a cellular camouflage mechanism that sequesters gene promoters away from transcription 
factors and results in stable silencing of gene expression. DNA methylation at CpG 
dinucleotides occurs upon transfer of S-adenosylmethionine (SAM) on cytosine by DNMTs. 
Whereas DNMT3A/B are responsible for DNA methylation during development 
(differentiation), DNMT1 is in charge of maintaining DNA methylation patterns in DNA 
replication during cell division. In mammalian cells, the fidelity of maintenance of 
methylation is 97–99.9% per mitosis, whereas de novo methylation is as high as 3–5% per 
mitosis, thus creating possibilities for epigenetic changes. DNA methylation also regulates 
genomic imprinting (Lees-Murdock & Walsh, 2008), X-chromosome inactivation (K. D. 
Robertson, 2005) and silencing of repetitive sequences (Miranda & Jones, 2007). Although in 
most cases DNA methylation is a stable epigenetic mark, reduced levels of methylation can 
also be observed during development. This net loss of methylation can either occur 
passively by replication in the absence of functional maintenance methylation pathways, or 
actively, by removing methylated cytosines. In plants active demethylation is achieved by 
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in a cellular camouflage mechanism that sequesters gene promoters away from transcription 
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mitosis, thus creating possibilities for epigenetic changes. DNA methylation also regulates 
genomic imprinting (Lees-Murdock & Walsh, 2008), X-chromosome inactivation (K. D. 
Robertson, 2005) and silencing of repetitive sequences (Miranda & Jones, 2007). Although in 
most cases DNA methylation is a stable epigenetic mark, reduced levels of methylation can 
also be observed during development. This net loss of methylation can either occur 
passively by replication in the absence of functional maintenance methylation pathways, or 
actively, by removing methylated cytosines. In plants active demethylation is achieved by 
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DNA glycosylase activity, probably in combination with the base excision repair pathway. 
In mammals, coupling of 5-methylcytosine deaminase and thymine DNA glycosylase 
activities maybe responsible for DNA demethylation. Alternatively, a role for the 5-
hydroxymethylcytosine modification in mammalian DNA demethylation has also been 
proposed as an intermediate in an active DNA demethylation pathway involving DNA 
repair and 5-hydroxymethylcytosine-specific DNA glycosylase activity (Law & Jacobsen, 
2010). Of particular interest, ROS and oxidative stress may affect DNA demethylation by 
DNA oxidation or TET-mediated DNA hydroxymethylation (Perillo et al., 2008; Luan Wang 
et al., 2011).  
Although DNA methylation is the best-known epigenetic mark (P. A. Jones & Liang, 2009; 
Lande-Diner & Cedar, 2005; Scarano et al., 2005), DNA methylation does not act alone. It 
occurs in the context of nucleosome positioning, DNA sequence composition and histone 
modifications (Chodavarapu et al., 2010; B. M. Lee & Mahadevan, 2009; Vaissiere et al., 
2008). For example, high resolution DNA methylation analysis has revealed 10-base 
periodicities (i.e one helical turn) in the DNA methylation status of nucleosome-bound DNA 
and found that nucleosomal DNA was more highly methylated than flanking DNA 
(Chodavarapu et al., 2010). These data revealed that nucleosome positioning influences 
DNA methylation patterning of promoters and intron-exon boundaries throughout the 
genome and that DNA methyltransferases preferentially target nucleosome-bound DNA. 
Whether nucleosome strings provide a combinatory histone code is a matter of debate (Chi 
et al., 2010; Cosgrove & Wolberger, 2005; Fischle, 2008; Guil & Esteller, 2009; Jenuwein & 
Allis, 2001; B. M. Lee & Mahadevan, 2009; Margueron et al., 2005), but in any event, histone 
modifications influence gene activity and regulation. For example, acetylation of lysines is 
generally associated with transcriptional activation whereas lysine methylation can dictate 
either activation (e.g. H3K4, H3K36, H3K79) or suppression (e.g. H3K9, H3K27 or H4K20). 
Specific histone modifications have been shown to be associated with DNA 
hypermethylation of CpG islands, including deacetylation of histones H3 and H4, loss of 
H3K4me, and gain of H3K9me3 and H3K27me3 (R. S. Jones, 2007; A. G. Robertson et al., 
2008). DNA methylation marks are recognized by DNA methyl-binding proteins (MBD) 
which can interact with corepressor-associated enzymes (i.e. HDACs, enhancer of zeste 
homologue (EZH)2, ...), thus further linking DNA methylation and chromatin regulation 
(Perissi et al., 2010; Perissi & Rosenfeld, 2005). Altogether, "histone code" may only become 
biologically meaningful at the level of domains which, upon integration of conformations of 
multiple nucleosomes, translates allosteric changes into specific gene (cluster) activities, in 
order to establish specific regulatory programs at the genome level (Chi et al., 2010; Fujioka 
et al., 2009; Nolis et al., 2009; Nunez et al., 2009; B. van Steensel, 2011). In analogy to 
allosteric control of enzymes, specific gene activity may be determined by the spatial 
organization (compartmentalization in discrete territories) and structural landscape (three-
dimensional structure) of a gene locus, by altering the higher order structure of chromatin 
(cis mechanism) or by generating a binding platform for effector proteins (trans 
mechanisms) (Lieberman-Aiden et al., 2009; Metivier et al., 2006; G. Natoli, 2010; G. Natoli et 
al., 2011; Nolis et al., 2009; Nunez et al., 2009; Bas van Steensel, 2011).  
There is good evidence that also noncoding RNAs regulate chromatin architecture (Guil & 
Esteller, 2009; Gupta et al., 2010; Mattick et al., 2009a; Mattick et al., 2009b; Taft et al., 2009a; 
Taft et al., 2009b; Tsai et al., 2010). The term noncoding RNA (ncRNA) is commonly 
employed for RNA that does not encode a protein. Although it has been generally assumed 
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that most genetic information is transacted by proteins, recent evidence suggests that the 
majority of the genomes of mammals and other complex organisms is in fact transcribed 
into ncRNAs, many of which are alternatively spliced and/or processed into smaller 
products. Besides tRNA and rRNA, these ncRNAs include long-noncodingRNAs 
(lncRNAs), microRNAs (miRNAs) and tinyRNAs (tiRNAs) as well as several other classes 
of, sometimes yet-to-be-discovered, small regulatory RNAs such as snoRNAs (Gupta et al., 
2010; Mattick et al., 2009b; Taft et al., 2009a; Taft et al., 2009b). These RNAs (including those 
derived from introns) appear to comprise a hidden layer of internal signals that control 
various levels of gene expression in physiology and development, including chromatin 
architecture/epigenetic memory, transcription (enhancer function), RNA splicing, editing, 
translation and turnover (De Santa et al., 2010). RNA regulatory networks may determine 
most of our complex characteristics and play a significant role in disease (De Santa et al., 
2010). For example, miRNAs can change expression levels of the epigenetic machinery 
(DNMT, HDAC, sirtuin (SIRT), polycomb (Pc) proteins, etc.) by posttranscriptional gene 
regulation involving base pairing with 3’untranslated (UTR) regions in their target mRNAs 
resulting in mRNA degradation or inhibition of translation (Denis et al., 2011; Guil & 
Esteller, 2009; Lujambio et al., 2008; Lujambio & Esteller, 2007; 2009; ’M.N. Ndlovu et al., 
2011; Parasramka et al., 2011). Alternatively, long ncRNAs and tiRNAs can regulate gene 
expression and/or DNA methylation by promoter association (De Santa et al., 2010; Gupta 
et al., 2010; Taft et al., 2009a; Taft et al., 2009b; Tsai et al., 2010). DNA-methylation can thus 
also be RNA-directed (Denis et al., 2011; Guil & Esteller, 2009; Mahfouz; ’M.N. Ndlovu et al., 
2011).  
4. Immunity, cancer-inflammation and the epigenomic landscape 
Pathologists have long recognized  that some tumors are densely infiltrated by cell of both 
the innate and adaptive arms of the immune system and thereby mirror inflammatory 
conditions arising in non-neoplastic tissues (Hanahan & Weinberg, 2011). Originally, these 
immune responses were believed to eradicate tumors, which to some extent is true, 
although this pressure on the tumor triggers some escape programs to evade immune 
destruction. As such, solid tumors that do appear have somehow managed to avoid 
detection by the various arms of the immune system or have been able to limit the extent of 
immunological killling, thereby evading eradication. For example, cancer cells may paralyze 
infiltrating CTLs and NK cells, by secreting TGF or other immunosuppressive factors. As 
such, immunoevasion can be considered as an emerging hallmark of carcinogenesis. 
Furthermore, since 2000, various clues were reported that the tumor-associated 
inflammatory response had the unanticipated, paradoxical effect of enhancing 
tumorigenesis and progression (B. B. Aggarwal, 2009; B. B. Aggarwal & Gehlot, 2009; S.I. 
Grivennikov & Karin, 2010a& c; Ning Li et al., 2011; Naugler & Karin, 2008). Inflammation 
contributes to cancer progression by supplying bioactive molecules to its microenvironment, 
including growth factors that sustain proliferative signaling, survival factors that limit cell 
death, proangiogenic factors, extracellular matrix-modifying enzymes that facilitate 
angiogenesis, invasion and metastasis, and signals that trigger activation of endothelial 
mesenchymal transition (S.I. Grivennikov et al., 2010b). The complexity of the inflammatory 
response requires that its many functional programs are controlled coordinately in some 
situations but independently in others (Medzhitov & Horng, 2009; Pasparakis, 2009). This is 
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(DNMT, HDAC, sirtuin (SIRT), polycomb (Pc) proteins, etc.) by posttranscriptional gene 
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achieved through multiple mechanisms that operate at different levels, including alterations 
in the composition of immune cells in tissues, changes in cell responsiveness to 
inflammatory stimuli, regulation of signaling pathways and epigenetic control of gene 
expression.  
4.1 Cell specific mechanisms in the tumor microenvironment 
Today, tumors are increasingly recognized as organs which can only be understood by 
studying the individual specialized cell types within it as well as the tumor 
microenvironment. Besides cancer cells, the parenchyma and stroma of tumors contain 
cancer stem cells, immune cells, endothelial cells, invasive cancer cells, cancer-associated 
fibroblasts that collectively enable tumor growth and progression. Cell-specific mechanisms 
operate at the level of different cell types, and include regulation of their recruitment and 
activation. The most frequently found immune cells within the tumor microenvironment are 
tumor-associated macrophages (TAMs) and T cells and are an important source of cytokines 
(Balkwill et al., 2005; Balkwill & Mantovani, 2010; Mantovani et al., 2008). TAMs mostly 
promote tumor growth and may be obligatory for angiogenesis, invasion, and metastasis 
and high TAM content generally correlates with poor prognosis (B. B. Aggarwal & Gehlot, 
2009; Balkwill et al., 2005; Balkwill & Mantovani, 2010; S. I. Grivennikov & Karin, 2010b). 
Moreover, most cancers contain an inflammatory infiltrate that is hijacked by tumor cells to 
promote angiogenesis, tissue invasion and cell proliferation. Also, overnutrition and obesity 
activate the immune system which at long-term switches to chronic inflammatory condition 
which is a fertile soil for cancer development (Bharat B. Aggarwal, 2010; Anand et al., 2008; 
Hotamisligil, 2010; Mandl et al., 2009; Olefsky, 2009; E. J. Park et al., 2010; Solinas & Karin, 
2010; Zhang et al., 2008).  
4.2 Regulation of transcription factors in cancer-related inflammation 
Production of tumor-promoting cytokines by immune/inflammatory cells that activate 
transcription factors in premalignant cells to induce genes that stimulate cell proliferation 
and survival, is a major tumor promoting mechanism. Among all the mediators and cellular 
effectors of inflammation, NFκB is perhaps the central transcription factor, which regulates 
expression of more than 400 genes (Chaturvedi et al., 2011; L. F. Chen & Greene, 2004; 
Ghosh & Hayden, 2008; Karin & Greten, 2005). NFκB family transcription factors are rapidly 
activated in response to various stimuli, including cytokines, infectious agents, 
overnutrition (metabolic stress, endoplasmic reticulum stress) or danger signals (bacteria, 
viruses, chemicals, pathogen associated molecular patterns (PAMPs), danger associated 
molecular patterns (DAMPs), and radiation-induced DNA double-strand breaks. 
Furthermore, the NFκB pathway is regulated by many other pathways, i.e. EGFR/Her2-
PI3K-Akt/IKK, RSK2, MSK1, TP53 PTEN, Akt-mTOR, Ras, Raf, Wnt-catenin, hypoxia, 
oxidative stress (Chaturvedi et al., 2011). In nonstimulated cells, NFκB TFs are bound to 
inhibitory (I)κB proteins and are thereby sequestered in the cytoplasm. Activation leads to 
phosphorylation of IκB proteins and their subsequent recognition by ubiquitinating 
enzymes. The resulting proteasomal degradation of IκB proteins liberates NFκB 
transcription factors, which translocate to the nucleus to drive expression of target genes. 
Two protein kinases with a high degree of sequence similarity, IκB kinase (IKK)α and IKKβ, 
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mediate phosphorylation of IκB proteins and represent a convergence point for most signal 
transduction pathways leading to NFκB activation. Most of the IKKα and IKKβ molecules in 
the cell are part of IKK complexes that also contain a regulatory subunit called IKKγ or 
NFκB-essential modulator (NEMO). Alternative to IKK, various additional kinases have 
been identified which modulate transcriptional nuclear activity of NFκB, including mitogen- 
and stress-activated protein kinase (MSK), protein kinase (PK)Ac, phosphoinositide 3-
kinases PI3K and AKT (L. F. Chen & Greene, 2004; Edmunds & Mahadevan, 2006; Vanden 
Berghe et al. 2011; Vermeulen et al., 2009; Vermeulen et al., 2003; Viatour et al., 2005). 
Members of the NFκB family of dimeric transcription factors regulate expression of a large 
number of genes involved in immune responses, inflammation, metabolic stress, cell 
survival, cell proliferation and cancer. At the same time, it is responsible for many aspects of 
inflammatory disease and malignancy by inducing transcription of soluble mediators that 
amplify inflammation, angiogenesis and neoplastic cell proliferation, and affect progression 
to more aggressive disease states (S. I. Grivennikov & Karin, 2010b).  Furthermore, 
constitutive activity of NFκB/IKK has been observed in many cancer cells, inflammatory 
disorders, obesity and insulin resistance (Arkan et al., 2005; Ghosh & Hayden,2008;  
Hotamisligil, 2010; Karin, 2006; Karin & Greten, 2005; Mandl et al., 2009; Nakanishi & Toi, 
2005; Olefsky, 2009; E. J. Park et al., 2010; Perkins, 2007). Besides constitutively activated 
NFκB found in several human cancer cell lines, including lymphomas and carcinomas of the 
breast, prostate, lung, colon, pancreas, head and neck and oesophagus, activated NFκB has 
also been noted in tissue samples from cancer patients (Baud & Karin, 2009; Chaturvedi et 
al., 2011; Dey et al., 2008). Studies of cancer-associated mutations have also reported that 
mutations in the upstream signal components of NFκB or p53 mutations could direct 
constitutive NFκB activation in cancer cell lines and patient samples (Dey et al., 2008; 
Dijsselbloem et al. 2007; Weisz et al., 2007). Therefore, inhibition of NFκB activity has been 
found to be a useful addition to chemotherapy regimens of a variety of cancers (Baud & 
Karin, 2009; Karin et al., 2004). Although quite a number of genes contain NFκB-responsive 
elements in their regulatory regions, their expression pattern can significantly vary from 
both a kinetic and quantitative point of view (Ghosh & Hayden, 2008; Hayden & Ghosh, 
2008; Medzhitov & Horng, 2009; G. Natoli et al., 2005; O'Dea & Hoffmann, 2010; Perkins, 
2007; Ramirez-Carrozzi et al., 2009; Vanden Berghe et al., 2006b; Werner et al., 2005). At the 
transcription level, selectivity is conferred by the expression or activation of specific NFκB 
subunits and their respective posttranslational modifications, and by combinatorial 
interactions between NFκB and other transcription factors, such as activator protein (AP-
1), signal transducers and activators of transcription (STAT3), nuclear factor erythroid 2-
related factor (NRF2), peroxisome proliferator-activated receptor- γ (PPAR γ ), estrogen 
receptor (ER), liver X receptor (LXR), hypoxia inducible factor-1 (HIF-1), p53 which are 
involved in angiogenesis, chemoresistance, stem cell survival, cancer invasion and 
tumour progression (B. B. Aggarwal & Gehlot, 2009; Dey et al., 2008; Eferl & Wagner, 
2003; Reuter et al., 2010; Rohwer et al., 2010; van Uden et al., 2011). Various naturally 
occurring phytochemicals such as withaferin, curcumin, resveratrol, mangiferin hold 
promise as anti-cancer drugs by interfering with NFκB, STAT3, AP1, HIF, PPAR, ER, LXR, 
p53 activities and gene expression programs (Dijsselbloem et al., 2007; Garcia-Rivera et 
al., 2011; Harvey, 2008; Kaileh et al. 2007; Kontogiorgis, C. et al. 2010; J. W. H. Li & 
Vederas, 2009; Surh, 2003; Vanden Berghe et al., 2006 &2011; Suttana et al., 2010)  
(Figure 4) 
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Fig. 4. Modulation of tumor promoting transcription factor pathways by dietary 
phytochemicals (adapted from Sung et al. 2011). 
4.3 Chromatin dynamics in cancer-inflammation  
Since transcription factors bind very poorly or not at all to nucleosomal DNA, their 
activation is coordinated to recruitment of noncoding RNAs (Gupta et al., 2010; Tsai et al., 
2010), DNMTs (Hervouet et al., 2009) and epigenetic writer, reader or eraser proteins (Chi et 
al., 2010), including ATP-dependent chromatin-remodeling factors [swith/sucrose non 
fermentable SWI/SNF, Brahma (Brm), brahma-related gene Brg1], histone-enzyme 
complexes such as kinases [IKK, MSK, ataxia telangiectasia mutated (ATM), AKT, PI3K], 
poly(ADP-ribose) polymerase (PARP), methylases (EZH2, coactivator-associated arginine 
methyltransferase (CARM)1, protein arginine methyltransferases (PRMT)), demethylases 
(lysine specific demethylase (LSD)1, Jumonji C family histone demethylase (JMJD)3), prolyl 
isomerase (PIN1), acetylases (p300, CREB binding protein (CBP), p300/CBP-associated 
factor (p/CAF)), deacetylases (HDAC, SIRT) and DNMTs (Dong et al., 2008; Ghosh & 
Hayden, 2008; Perissi et al., 2010; Rosenfeld et al., 2006; Vanden Berghe et al., 2006b; 
Vermeulen et al., 2009). Parallel posttranslational modifications (phosphorylation, 
acetylation, methylation, ribosylation, sumoylation, ubiquitination) of histone and non-
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histone transcription factor and cofactor complexes in response to signalling components 
allow displacement of polycomb complexes and formation of dynamic enhanceosome 
complexes which establish a distinct chromatin structure (Bracken & Helin, 2009; Dawson et 
al., 2009; Gehani et al., 2010; N. Ndlovu et al., 2009; Schreiber & Bernstein, 2002; Vanden 
Berghe et al., 1999a; Vermeulen et al., 2009; Vermeulen et al., 2003). These epigenetic settings 
are the ultimate integration sites of both environmental and differentiative inputs, 
determining proper expression of each target gene (Ford & Thanos, 2010; Ghosh & Hayden, 
2008; Hayden & Ghosh, 2008; G. Natoli & De Santa, 2006; Vanden Berghe et al., 2006b). 
Investigation of epigenetic regulation of cancer-inflammation genes, revealed different 
subclasses according to chromatin activation mode and gene expression profile (Ramirez-
Carrozzi et al., 2009; Ramirez-Carrozzi et al., 2006). A major class of primary response genes 
is characterized by CpG-island promoters, which facilitate promiscuous induction from 
constitutively active chromatin without a requirement for SWI/SNF nucleosome-
remodeling complexes. The low nucleosome occupancy at promoters in this class can be 
attributed to the assembly of CpG-islands into unstable nucleosomes, which may lead to 
SWI/SNF independence. Another major class consists of non-CpG-island promoters that 
assemble into stable nucleosomes, resulting in SWI/SNF dependence and the requirement 
for transcription factors that promote selective nucleosome remodeling. Some inflammatory 
stimuli, exhibit a strong bias toward activation of SWI/SNF-independent CpG-island genes. 
In contrast interferon (IFN) preferentially activates SWI/SNF-dependent non-CpG-island 
promoters. At the level of CpG methylation, changes in DNA methylation of IKK, IB and 
RelB promoters (G. Maeda et al., 2007; O'Gorman et al., 2010; Puto & Reed, 2008) affect gene 
induction properties upon re-exposure to a inflammatory stimulus (Ashall et al., 2009; El-
Osta et al., 2008; El Gazzar et al., 2009; El Gazzar et al., 2007; Puto & Reed, 2008). 
Furthermore, CpG-methylation of certain genes enables some cells to acquire new 
capabilities needed for tumorigenesis (Widschwendter & Jones, 2002)(Figure 2). Cells which 
accumulated DNA methylation at various loci as a function of time (age) and as a function 
of exposure to growth factors or chronic inflammation gain novel capabilities to promote 
carcinogenesis, i.e. limitless replicative potential, selfsufficiency in growth signals, 
insensitivity to growth-inhibitory signals, evasion of programmed cell death, sustained 
angiogenesis and tissue invasion and metastasis (Teschendorff et al., 2010; Widschwendter 
& Jones, 2002)(Figure 2). 
5. Cancer-inflammation, cancer metabolism and epimutations: cause or 
consequence? 
Since inflammatory gene expression dynamics is highly dependent on epigenetic control 
mechanisms (De Santa et al., 2007; Medzhitov & Horng, 2009; Messi et al., 2003; G. Natoli & 
De Santa, 2006; G. Natoli et al., 2005; Vanden Berghe et al., 2006b), we have previously 
characterized chromatin organization in weak or strong inflammatory cancer cell types with 
inducible or constitutive interleukin (IL)6 gene expression patterns. Upon investigation of 
autocrine IL6 gene expression production in aggressive myeloma cells or metastatic breast 
cancer cells, we observed euchromatin-like properties and highly accessible chromatin at the 
IL6 gene promoter (Gerlo et al., 2008; N. Ndlovu et al., 2009). Furthermore, recruitment of 
CBP/p300 acetylases and MSK kinase seems to prevent heterochromatinisation and 
recruitment of heterochromatin protein (HP)1 upon phosphacetylation of transcription 
factor and histone components (Boeke et al., 2010; N. Ndlovu et al., 2009; Vanden Berghe et 
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al., 1999a; Vermeulen et al., 2009; Vermeulen et al., 2003). Along the same line, the kinase 
MSK kinase was found to displace polycomb repressor complexes during gene activation 
(Gehani et al., 2010). Interestingly, promoter-binding activity of Sp1 and AP1 Fra1 are 
responsible for priming IL6 promoter chromatin relaxation, which further promotes binding 
of NFκB transcription. Interestingly, complementation of low invasive cancer cells with Fra1 
seems to convert the promoter chromatin architecture in a highly accessible chromatin 
configuration. Reciprocally, highly accessible chromatin in invasive cancer cells can be 
silenced with anti-inflammatory phytochemicals, or following silencing of AP1/NFκB 
transcription factors, demonstrating reversible epigenetic changes towards a less aggressive 
phenotype (Dijsselbloem et al., 2007; N. Ndlovu et al., 2009; Vanden Berghe et al., 2006a). 
Furthermore, we and others observed DNA hypermethylation at the IL6 gene promoter in 
cancer cells with low NFκB/AP1 activity and inducible IL6 gene expression, as compared to 
DNA hypomethylation in cancer cells with hyperactivated NFκB/AP1 transcription factors 
and elevated constitutive IL6 gene expression (Armenante et al., 1999; Dandrea et al., 2009). 
Similarly, various transcription factors (p53, cmyc, ER, GR, NFkB p65 and others) were 
found to recruit DNMTs and modulate promoter enhancer function in a time-dependent 
and signal specific fashion (Aaltonen et al., 2008; Brenner et al., 2005; Hervouet et al., 2009; 
Kangaspeska et al., 2008; Y. Liu et al., 2011; Metivier et al., 2008; Santourlidis et al., 2001; 
Wiench et al., 2011). Reciprocally, depletion of NFκB can also trigger DNA demethylation 
and gene reactivation, illustrating gene-specific epigenetic effects which may further depend 
on posttranslational NFκB modifications (Dong et al., 2008; X. Liu et al., 2010b; Y. Liu et al., 
2011). Also, chronic exposure to chemotherapeutic agents may epigenetically reprogram 
cancer cell metabolism and gene expression and trigger chemoresistance (Blair et al., 2011; 
Kujjo et al., 2011; S. V. Sharma et al., 2010; W. Suttana et al., 2010). As such, this 
demonstrates that cancer-inflammation pathways and transcription factors are able to 
rewire epigenetic settings and amplify gene expression in an autocrine fashion (Hervouet et 
al., 2009; S. Liu et al., 2008).  
Of special note, despite promising (pre)clinical studies with epigenetic drugs (azacytidin, 
suberoylanilide hydroxamic acid (SAHA)) for reactivation of silenced tumor suppressor 
genes in cancer treatment, one should also be precautious, as these compounds may also 
boost gene expression of inflammatory oncogenes such as IL6, which promote aggressive 
carcinogenesis, cancer stem cell proliferation, metastasis and hormone resistance (B. B. 
Aggarwal & Gehlot, 2009; S. Grivennikov et al., 2009; D. Iliopoulos et al., 2009; S. Maeda et 
al., 2009; Min et al., 2010; Naugler & Karin, 2008; W. Suttana et al., 2010; H. Wang et al., 2009; 
Yu et al., 2009). In line with this, knocking out DNMT1 or treatment of tumors with a global 
DNA hypomethylating agent was found to promote aspects of tumor progression and was 
accompanied by increased invasion in vitro and increase tumor growth in vivo (Eden et al., 
2003; Gaudet et al., 2003; Christopher A. Hamm & Costa, 2011; C. A. Hamm et al., 2009). 
Furthermore, the inflammatory cytokine IL6 is able to trigger epigenetic changes of tumor 
suppressor genes via regulation of DNMTs (Gasche et al., 2011; Hodge et al., 2007; Hodge et 
al., 2005b; Peng et al., 2005; Pompeia et al., 2004), microRNAs (Braconi et al., 2010; D. 
Iliopoulos et al., 2009; Meng et al., 2008) and histone methyltransferases (Ezh2) (Croonquist 
& Van Ness, 2005). Another regulatory circuit involving NFB, STAT3, IL6, and let7, miR-21 
and miR-181b-1 triggers an epigenetic switch driving tumor progression (D. Iliopoulos et al., 
2009 & 2010). Remarkably, expression of enzymes central to cellular methylation, S-
adenosylmethionine synthetase and S-adenosylhomocysteine, as well levels of specific 
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metabolites associated with cellular methylation reactions are significantly altered during 
inflammation, which results in a global change in DNA/histone methylation during 
inflammation (Kominsky et al., 2011). This suggests that epigenetic regulators themselves 
and methylation of tumor suppressor genes are also susceptible to dynamic inflammatory 
control (Braconi et al., 2010; Hodge et al., 2005a; Hodge et al., 2001; D. Iliopoulos et al., 2009; 
Kawasaki et al., 2008; Mathews et al., 2009; Meng et al., 2008; Peng et al., 2005), which adds 
an extra level of complexity to the cancer-inflammation link.  
Furthermore, besides epigenetic changes in neoplastic cells, inflammatory stimuli in the 
tumor microenvironment can also epigenetically reprogram tumor-associated immune cells, 
as demonstrated for the NFB-dependent histone demethylase JMJD3 which determines cell 
fate and transdifferentiation of tumor-associated macrophages (De Santa et al., 2007; K. C. 
Kim et al., 2009b). Reports on epigenetic events in cancer are traditionally produced from 
analyses on “bulk” tumor samples, i.e. without distinction between neoplastic cells on one 
hand and the tumoral stroma on the other. The pro-inflammatory micro-environment that 
drives many tumor types is as such capable of triggering these epigenetic alterations within 
cancer progenitor cells, alterations which can substitute for genetic defects later in tumour 
progression (D. Iliopoulos et al., 2009; S. V. Sharma et al., 2010). However, also tumor 
stromal components (which include bone-marrow-derived cells, tumor-associated 
macrophages) are a target of epigenetic events (De Santa et al., 2007; Dijsselbloem et al., 
2007; Messi et al., 2003). Besides inflammatory factors, the micro-environment also contains 
free radicals produced by neutrophils, macrophages, endothelial and other cells. Reactive 
Oxygen Species (ROS) such as •O2, •OH, H2O2 and Reactive Nitrogen Species (RNS) such 
as •NO and •NO2 can injure cellular biomolecules such as nucleic acids, enzymes, 
carbohydrates, and lipid membranes, causing cellular and tissue damage, which in turn 
augments the state of inflammation. In addition, reactive ROS and RNS intermediates, 
indirectly also modulate activity of epigenetic machinery which finally will affect chromatin 
dynamics and DNA (hydroxyl)methylation in tumor-associated immune cells (Brewer, 2010; 
Carta et al., 2009; Forneris et al., 2008; Franco et al., 2008; Illi et al., 2009). 
6. Nutri-epigenomics: Lifelong remodelling of our epigenomes 
Human epidemiological studies and appropriately designed dietary interventions in animal 
models have provided considerable evidence to suggest that maternal nutritional imbalance 
and metabolic disturbances, during critical time windows of development, may have a 
persistent effect on the health of offspring and may even be transmitted to the next 
generation (Aguilera et al., 2010; Burdge & Lillycrop, 2010; Cooney, 2006; Gallou-Kabani et 
al., 2007; Godfrey et al., 2010; Weaver, 2009; Youngson & Whitelaw, 2008). This has led to 
the hypothesis of ‘‘fetal programming’’ and new term ‘‘developmental origin of health and 
disease’’ (DOHaD): common disorders, such as cancer, obesity, cardiovascular disease 
(CVD), diabetes, hypertension, asthma and even schizophrenia, take root in early nutrition 
during gestation and continues during lactation (Anway et al., 2005; Anway & Skinner, 
2006; Barker & Martyn, 1992; Burdge & Lillycrop, 2010; Chmurzynska, 2010; Gluckman et 
al., 2008; Hochberg et al., 2011; Jackson et al., 2010; Jirtle & Skinner, 2007). Similarly, there is 
increasing evidence in animals that nutritional intervention (caloric, iron and protein 
restriction, polyphenol-, folate-, micronutrient-, fat- or carbohydrate-rich diet) and maternal 
diabetes occurring during pregnancy and the lactation period, affects health in following 
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models have provided considerable evidence to suggest that maternal nutritional imbalance 
and metabolic disturbances, during critical time windows of development, may have a 
persistent effect on the health of offspring and may even be transmitted to the next 
generation (Aguilera et al., 2010; Burdge & Lillycrop, 2010; Cooney, 2006; Gallou-Kabani et 
al., 2007; Godfrey et al., 2010; Weaver, 2009; Youngson & Whitelaw, 2008). This has led to 
the hypothesis of ‘‘fetal programming’’ and new term ‘‘developmental origin of health and 
disease’’ (DOHaD): common disorders, such as cancer, obesity, cardiovascular disease 
(CVD), diabetes, hypertension, asthma and even schizophrenia, take root in early nutrition 
during gestation and continues during lactation (Anway et al., 2005; Anway & Skinner, 
2006; Barker & Martyn, 1992; Burdge & Lillycrop, 2010; Chmurzynska, 2010; Gluckman et 
al., 2008; Hochberg et al., 2011; Jackson et al., 2010; Jirtle & Skinner, 2007). Similarly, there is 
increasing evidence in animals that nutritional intervention (caloric, iron and protein 
restriction, polyphenol-, folate-, micronutrient-, fat- or carbohydrate-rich diet) and maternal 
diabetes occurring during pregnancy and the lactation period, affects health in following 
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generation(s) (Dolinoy & Jirtle, 2008; Jirtle & Skinner, 2007; Kirk et al., 2008; Waterland, 2009; 
Waterland & Jirtle, 2004; Waterland et al., 2008; Youngson & Whitelaw, 2008). The various 
non-Mendelian features of metabolic disease, cancer or chronic inflammatory disorders, 
clinical differences between men and women or monozygotic twins and fluctuations in the 
course of the disease are consistent with epigenetic mechanisms in the influence of fetal 
and/or lifelong nutrition or stochastic events on adult phenotype (Aguilera et al., 2010; Bell 
& Spector, 2011; Burdge & Lillycrop, 2010; Cooney, 2006; Gallou-Kabani et al., 2007; Godfrey 
et al., 2010; Kaminsky et al., 2009; Petronis, 2006; Weaver, 2009; Youngson & Whitelaw, 
2008). Thus, lifetime shapes the multitude of epigenomes not only within, but also across 
generations (Anway & Skinner, 2006; Burdge & Lillycrop, 2010; Chong et al., 2007; Godfrey 
et al., 2010; Hochberg et al., 2011; Skinner et al., 2011; Youngson & Whitelaw, 2008). Interest 
in transgenerational epigenetic effects of food components has been fueled by observations 
in Agouti mice fed with a soy polyphenol diet, which revealed epigenetic changes in DNA 
methylation patterns in their offspring. This in turn protected them against diabetes, obesity 
and cancer across multiple generations (Dolinoy & Jirtle, 2008; Dolinoy et al., 2006; 
Waterland, 2009). Furthermore, maternal nutrient supplementation with soy polyphenols 
was found to counteract xenobiotic-induced DNA hypomethylation in early development 
(Dolinoy et al., 2007; Dolinoy & Jirtle, 2008; Dolinoy et al., 2006; Jirtle & Skinner, 2007; Kujjo 
et al., 2011; Skinner et al., 2011).  
Recently, evidence emerged that also timing (preconception, pregnancy, lactation, neonatal 
life, early life, pre-/post-menopause, puberty) of various dietary exposures may be vitally 
important in determining health beneficial effects, as epigenetic plasticity changes 
continually from conception to death (Burdge et al., 2009; Faulk & Dolinoy, 2011). Studies of 
human populations following famine have suggested that pathologies in later life are 
dependent on the critical timing of nutritional insult during pregnancy (Lumey & Stein, 
2009; Painter et al., 2008; Roseboom et al., 2006). In principle, epigenetic changes occurring 
during embryonic development will have a much greater impact on the overall epigenetic 
status of the organism because, as they can be transmitted over consecutive mitotic 
divisions, alterations occurring in single embryonic stem cells will affect many more cells 
than those occurring in adult stem and/or somatic cells during postnatal development 
(Aguilera et al., 2010). In addition to epigenetic imprinting during crucial periods of 
development, stochastic or genetically and environmentally triggered epigenomic changes 
(epimutations) occur day after day and accumulate over time, as maximal differences in 
DNA methylation profiles are observed in aged monozygotic twins with a history of non-
shared environments (Christensen et al., 2009; Fraga et al., 2005). Although it has long been 
thought that the epigenomic profile is wiped clean in the embryo shortly after fertilization, 
with the exception of imprinted genes, methylation clearing is not complete after 
fertilization and on a global DNA level is reduced to 10% (Hajkova et al., 2008; Surani et al., 
2004). Remarkably, recent evidence suggests that DNA methylation is rather converted into 
hydroxymethylation than erased (Ficz et al., 2011; Iqbal et al., 2011; Wossidlo et al., 2010; 
Wossidlo et al., 2011). Alternatively, it can not be excluded that transgenerationally 
inherited nutritional effects may also depend on polycomb proteins (Blewitt et al., 2006; 
Bracken & Helin, 2009; Chong et al., 2007; Youngson & Whitelaw, 2008), miRNA profiles 
(Guil & Esteller, 2009; Y. Li et al., 2010) or epigenetic capacitor properties of hsp proteins 
present in the fertilized embryo (Ruden et al., 2005a; Ruden et al., 2005b; Sollars et al., 
2003). 
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7. Epigenetic targets of bioactive dietary components for cancer prevention 
and therapy  
A next challenge will be to determine which adverse epigenomic marks in cancer-
inflammation are reversible or can be prevented by specific diets, natural phytochemicals or 
lifestyle changes (Burdge & Lillycrop, 2010; Burdge et al., 2009; Godfrey et al., 2010; Kirk et 
al., 2008). Numerous botanical species and plant parts contain a diverse array of 
polyphenolic phytochemicals which exert cancer-chemopreventive effects in man by its anti-
inflammatory, anti-oxidant, phytohormonal, homeostatic effects (hormesis) in immune cells 
and/or cancer (stem)cells (Bickford et al., 2006; Blanpain & Fuchs, 2009; Crea et al., 2009; 
Dijsselbloem et al., 2004; Kawasaki et al., 2008; Shytle et al., 2007; Surh, 2003; Zhou et al., 
2008). Upon re-exploration of its biological activities, various nutritional natural compounds 
(including epigallocatechingallate, resveratrol, genistein, curcumin, isothiocyanates, 
withanolides, …) were found to interfere with enzymatic activity of DNMT, Class I, II, IV 
HDAC, HAT and Class III HDAC sirtuins (SIRT) which modulate cancer-inflammation 
((Arasaradnam et al., 2008; Burdge & Lillycrop, 2010; Delage & Dashwood, 2008; Fang et al., 
2007; Folmer et al., 2010; Hauser & Jung, 2008; Jackson et al., 2010; Kirk et al., 2008; 
Kontogiorgis et al., 2010; Link et al., 2010; Suzuki & Miyata, 2006; Szarc vel Szic et al., 2010; 
Vaquero & Reinberg, 2009), and references included). HDACs are zinc metalloproteins 
which rely on Zn2+ for their activity and are divided into 4 classes based on their homology 
with yeast HDACs. Class III HDACs, called sirtuins are zinc-independent but nicotinamide 
adenine dicnucleotide (NAD+)-dependent. Class I, II, IV HDAC inhibitors characteristically 
contain a Zn2+ chelating group consisting of a thiolate, thiol, hydroxamate, carboxylate, 
mercaptoamide, epoxide or ketone group. Natural HDAC inhibitors can be divided in 
following groups based on their chemical characteristics: carboxylates, organosulfides, 
isothiocyanates, hydroamates, cyclic tetrapeptides and macrocyclic depsipeptides (Folmer et 
al., 2010). In contrast to natural HDAC inhibitors, only few natural products (i.e. niacine, 
vitamin B3, dihydrocoumarin) have been identified as inhibitors of class III HDACs. 
Reciprocally, various natural flavonoids have been identified as activators of class III 
HDACs (SIRTs). Turmeric and green tea have been identified as sources of natural inhibitors 
of p300/CBP HAT. Finally DNMT inhibitors work mainly through one of the following 
mechanisms, either covalent trapping of DNMT through incorporation into DNA (i.e. 
nucleoside analogues decitabine, 5-azacytidine), non-covalent blocking of DNMT catalytic 
active site (i.e. EGCG, parthenolide), interruption of binding site of DNMT to DNA (i.e. 
procaine), degradation of DNMT (i.e; decitabine), or suppression of DNMT expression (i.e. 
miRNAs). Specific epigenetic effects of natural phytochemicals may be the result of a 
superposition of combined concentration-dependent actions of the compound as a nuclear 
hormone receptor ligand and/or modulator of histone-modifying enzymes and DNMTs 
(Darbre & Charles, 2010; Denison & Nagy, 2003; Kuniyasu, 2008; Mai et al., 2008; Newbold 
et al., 2009) which may target chromatin dynamics of specific gene clusters. Although effects 
of dietary factors and extracts have frequently been demonstrated in in vitro experiments at 
concentrations which can never be achieved in vivo, “epigenetics” sheds a more realistic light 
on dietary studies, as longlife exposure at physiological concentrations can remodel the 
epigenome in a cumulative fashion by repetitive effects on the epigenetic machinery (Manach 
& Donovan, 2004; Manach et al., 2005a; Manach et al., 2004; Manach et al., 2005b; Williamson 
& Manach, 2005). Furthermore, it should be evaluated which epigenetic changes are stable 
over time. Interestingly, even transient exposure to a specific dietary component can induce 
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generation(s) (Dolinoy & Jirtle, 2008; Jirtle & Skinner, 2007; Kirk et al., 2008; Waterland, 2009; 
Waterland & Jirtle, 2004; Waterland et al., 2008; Youngson & Whitelaw, 2008). The various 
non-Mendelian features of metabolic disease, cancer or chronic inflammatory disorders, 
clinical differences between men and women or monozygotic twins and fluctuations in the 
course of the disease are consistent with epigenetic mechanisms in the influence of fetal 
and/or lifelong nutrition or stochastic events on adult phenotype (Aguilera et al., 2010; Bell 
& Spector, 2011; Burdge & Lillycrop, 2010; Cooney, 2006; Gallou-Kabani et al., 2007; Godfrey 
et al., 2010; Kaminsky et al., 2009; Petronis, 2006; Weaver, 2009; Youngson & Whitelaw, 
2008). Thus, lifetime shapes the multitude of epigenomes not only within, but also across 
generations (Anway & Skinner, 2006; Burdge & Lillycrop, 2010; Chong et al., 2007; Godfrey 
et al., 2010; Hochberg et al., 2011; Skinner et al., 2011; Youngson & Whitelaw, 2008). Interest 
in transgenerational epigenetic effects of food components has been fueled by observations 
in Agouti mice fed with a soy polyphenol diet, which revealed epigenetic changes in DNA 
methylation patterns in their offspring. This in turn protected them against diabetes, obesity 
and cancer across multiple generations (Dolinoy & Jirtle, 2008; Dolinoy et al., 2006; 
Waterland, 2009). Furthermore, maternal nutrient supplementation with soy polyphenols 
was found to counteract xenobiotic-induced DNA hypomethylation in early development 
(Dolinoy et al., 2007; Dolinoy & Jirtle, 2008; Dolinoy et al., 2006; Jirtle & Skinner, 2007; Kujjo 
et al., 2011; Skinner et al., 2011).  
Recently, evidence emerged that also timing (preconception, pregnancy, lactation, neonatal 
life, early life, pre-/post-menopause, puberty) of various dietary exposures may be vitally 
important in determining health beneficial effects, as epigenetic plasticity changes 
continually from conception to death (Burdge et al., 2009; Faulk & Dolinoy, 2011). Studies of 
human populations following famine have suggested that pathologies in later life are 
dependent on the critical timing of nutritional insult during pregnancy (Lumey & Stein, 
2009; Painter et al., 2008; Roseboom et al., 2006). In principle, epigenetic changes occurring 
during embryonic development will have a much greater impact on the overall epigenetic 
status of the organism because, as they can be transmitted over consecutive mitotic 
divisions, alterations occurring in single embryonic stem cells will affect many more cells 
than those occurring in adult stem and/or somatic cells during postnatal development 
(Aguilera et al., 2010). In addition to epigenetic imprinting during crucial periods of 
development, stochastic or genetically and environmentally triggered epigenomic changes 
(epimutations) occur day after day and accumulate over time, as maximal differences in 
DNA methylation profiles are observed in aged monozygotic twins with a history of non-
shared environments (Christensen et al., 2009; Fraga et al., 2005). Although it has long been 
thought that the epigenomic profile is wiped clean in the embryo shortly after fertilization, 
with the exception of imprinted genes, methylation clearing is not complete after 
fertilization and on a global DNA level is reduced to 10% (Hajkova et al., 2008; Surani et al., 
2004). Remarkably, recent evidence suggests that DNA methylation is rather converted into 
hydroxymethylation than erased (Ficz et al., 2011; Iqbal et al., 2011; Wossidlo et al., 2010; 
Wossidlo et al., 2011). Alternatively, it can not be excluded that transgenerationally 
inherited nutritional effects may also depend on polycomb proteins (Blewitt et al., 2006; 
Bracken & Helin, 2009; Chong et al., 2007; Youngson & Whitelaw, 2008), miRNA profiles 
(Guil & Esteller, 2009; Y. Li et al., 2010) or epigenetic capacitor properties of hsp proteins 
present in the fertilized embryo (Ruden et al., 2005a; Ruden et al., 2005b; Sollars et al., 
2003). 
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7. Epigenetic targets of bioactive dietary components for cancer prevention 
and therapy  
A next challenge will be to determine which adverse epigenomic marks in cancer-
inflammation are reversible or can be prevented by specific diets, natural phytochemicals or 
lifestyle changes (Burdge & Lillycrop, 2010; Burdge et al., 2009; Godfrey et al., 2010; Kirk et 
al., 2008). Numerous botanical species and plant parts contain a diverse array of 
polyphenolic phytochemicals which exert cancer-chemopreventive effects in man by its anti-
inflammatory, anti-oxidant, phytohormonal, homeostatic effects (hormesis) in immune cells 
and/or cancer (stem)cells (Bickford et al., 2006; Blanpain & Fuchs, 2009; Crea et al., 2009; 
Dijsselbloem et al., 2004; Kawasaki et al., 2008; Shytle et al., 2007; Surh, 2003; Zhou et al., 
2008). Upon re-exploration of its biological activities, various nutritional natural compounds 
(including epigallocatechingallate, resveratrol, genistein, curcumin, isothiocyanates, 
withanolides, …) were found to interfere with enzymatic activity of DNMT, Class I, II, IV 
HDAC, HAT and Class III HDAC sirtuins (SIRT) which modulate cancer-inflammation 
((Arasaradnam et al., 2008; Burdge & Lillycrop, 2010; Delage & Dashwood, 2008; Fang et al., 
2007; Folmer et al., 2010; Hauser & Jung, 2008; Jackson et al., 2010; Kirk et al., 2008; 
Kontogiorgis et al., 2010; Link et al., 2010; Suzuki & Miyata, 2006; Szarc vel Szic et al., 2010; 
Vaquero & Reinberg, 2009), and references included). HDACs are zinc metalloproteins 
which rely on Zn2+ for their activity and are divided into 4 classes based on their homology 
with yeast HDACs. Class III HDACs, called sirtuins are zinc-independent but nicotinamide 
adenine dicnucleotide (NAD+)-dependent. Class I, II, IV HDAC inhibitors characteristically 
contain a Zn2+ chelating group consisting of a thiolate, thiol, hydroxamate, carboxylate, 
mercaptoamide, epoxide or ketone group. Natural HDAC inhibitors can be divided in 
following groups based on their chemical characteristics: carboxylates, organosulfides, 
isothiocyanates, hydroamates, cyclic tetrapeptides and macrocyclic depsipeptides (Folmer et 
al., 2010). In contrast to natural HDAC inhibitors, only few natural products (i.e. niacine, 
vitamin B3, dihydrocoumarin) have been identified as inhibitors of class III HDACs. 
Reciprocally, various natural flavonoids have been identified as activators of class III 
HDACs (SIRTs). Turmeric and green tea have been identified as sources of natural inhibitors 
of p300/CBP HAT. Finally DNMT inhibitors work mainly through one of the following 
mechanisms, either covalent trapping of DNMT through incorporation into DNA (i.e. 
nucleoside analogues decitabine, 5-azacytidine), non-covalent blocking of DNMT catalytic 
active site (i.e. EGCG, parthenolide), interruption of binding site of DNMT to DNA (i.e. 
procaine), degradation of DNMT (i.e; decitabine), or suppression of DNMT expression (i.e. 
miRNAs). Specific epigenetic effects of natural phytochemicals may be the result of a 
superposition of combined concentration-dependent actions of the compound as a nuclear 
hormone receptor ligand and/or modulator of histone-modifying enzymes and DNMTs 
(Darbre & Charles, 2010; Denison & Nagy, 2003; Kuniyasu, 2008; Mai et al., 2008; Newbold 
et al., 2009) which may target chromatin dynamics of specific gene clusters. Although effects 
of dietary factors and extracts have frequently been demonstrated in in vitro experiments at 
concentrations which can never be achieved in vivo, “epigenetics” sheds a more realistic light 
on dietary studies, as longlife exposure at physiological concentrations can remodel the 
epigenome in a cumulative fashion by repetitive effects on the epigenetic machinery (Manach 
& Donovan, 2004; Manach et al., 2005a; Manach et al., 2004; Manach et al., 2005b; Williamson 
& Manach, 2005). Furthermore, it should be evaluated which epigenetic changes are stable 
over time. Interestingly, even transient exposure to a specific dietary component can induce 
 
Phytochemicals – Bioactivities and Impact on Health 
 
176 
long-lasting epigenetic changes in the promoter of the NFB subunit p65, which acts as a 
master switch in cancer-inflammation (El-Osta et al., 2008). Alternatively, compounds may 
chemically interfere with histone mark interacting effector domains (such as chromo-, bromo- 
or tudor domains) (Seet et al., 2006; Wigle et al.; Zheng et al., 2008). Though, upon performing 
in vitro compound screenings in cofactor activity assays based on peptide-protein interactions, 
one should be careful with interpretation as peptide interactions may not always represent 
true targets in vivo (Altucci & Minucci, 2009; Pacholec et al., 2010). 
 
NAD, acetyl-coenzyme A (Acetyl-coA) and S-adenosylmethionine (SAM) are elemental for epigenetic 
control of transcription including methylation of DNA and posttranslational modifications of histones 
and non-histone chromatin factors (not shown). NAD contributes to transcriptional control mainly via 
the activity of the protein deacetylase sirtuin (SIRT), which uses NAD as one of the substrates. Sirtuins 
are also important for maintaining the activity of the acetyl-coA acetyltransferases. Ac-coA is 
synthesized by acetyl-coA-synthetase and ATP-citrate lyase that use acetate and citrate as the precursor, 
respectively. Citrate is an intermediate/product of the TCA cycle. SAM is the methyl donor for DNA, 
RNA, histones and non-histone protein methylation. SAH generated in each round of methylation 
reaction is a potent inhibitor of methyltransferases and has to be cleared by SAH hydrolase. NAD is an 
essential coenzyme for SAHH. Synthesis of methionine from homocystein is achieved through 
extracting the methyl group from betaine, derived from choline, or 5-methyl-THF, a derivative of folic 
acid. Metabolism of phospholipids and folic acid may thus indirectly contribute to epigenetic regulation. 
Likewise, the abundance of NAD and citrate is linked to the cellular energy flux, e.g. the TCA cycle. 
Changes in the expression of certain genes may therefore be influenced significantly. Abbreviations used: 
Ac-coA, acetyl-coenzyme A; ACS, acetyl-coA-synthetase; AC-ACS acetylated-ACS; Ado, adenosine; HAT, 
histone acetyltransferase; Hcy homocysteine; MTases, methyltransferases; NAD, Nicotinamide adenine 
dinucleotide; SAH, S-adenosyl homocysteine; TCA tricarboxylic cycle; THF tetrahydrofolate. 
Fig. 5. Global shifts in cancer epigenome regulation depend on metabolic shifts in cofactors 
for epigenetic enzymes (adapted from Luo et al. 2009) 
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From another perspective, chemopreventive phytochemicals may indirectly modulate 
chromatin dynamics and epigenetic effects upon interference with global cancer 
metabolism. As such, epigenetic changes may follow biochemical metabolisation of dietary 
factors, which can deplete cellular pools of acetyl-CoA, NAD+ and methyldonors, resulting 
in unbalanced DNA methylation and/or protein acetylation or methylation (Imai & 
Guarente, 2010; Ladurner, 2009; Vaquero & Reinberg, 2009) (Figure 1&5). For example, 
flavanol-rich diets interfere with the methyldonor metabolism and the available pool of S-
adenosylmethionine, resulting in changes in DNA methylation (Bistulfi et al., 2010; N. C. 
Chen et al., 2010; Ghoshal et al., 2006; J. M. Kim et al., 2009a; Ulrich et al., 2008) and histone 
methylation, which is also affected by alterations in SAM/SAH ratios (Pogribny et al., 2007; 
P. Sharma et al., 2006). Furthermore, even without nutritional deficiency of methyl groups, 
impaired synthesis of SAM and perturbed DNA methylation can happen when the need for 
the synthesis of the detoxification enzyme glutathione transferase (GSH) synthesis increases 
(D. H. Lee et al., 2009). Diets or nutritional compounds which affect energy metabolism or 
mitochondrial respiration can have global epigenetic effects upon changes in NAD+ 
availability and SIRT activity (Whittle et al., 2007). Since SIRT activation has been linked to 
longevity (increased lifespan and healthy aging) and mimics a caloric restricted diet, SIRT 
activators such as resveratrol represent a major class of caloric mimetic epigenetic 
modulator phytochemicals which could reverse metabolic disease (Imai & Guarente, 2010). 
Along the same line, flavanol-rich diets which interfere with the methyldonor metabolism 
and the available pool of S-adenosylmethionine will result in (Global) changes in DNA and 
histone methylation (Bistulfi et al., 2010; Ghoshal et al., 2006; J. M. Kim et al., 2009a; 
Pogribny et al., 2007; P. Sharma et al., 2006; Ulrich et al., 2008). As such, specific dietary 
classes of functional food maybe designed as therapeutic epigenetic modulators in cancer-
inflammation.  
8. Conclusion & future perspectives 
The phenotype of an individual is the result of complex gene-environment interactions in 
the current, past and ancestral environment, leading to lifelong remodelling of our 
epigenomes. In recent years, several studies have demonstrated that disruption of epigenetic 
mechanisms can alter immune function and contribute to many cancer types. Various 
replication-dependent and -independent epigenetic mechanisms are involved in 
developmental programming, lifelong recording of environmental changes and transmitting 
transgenerational effects. It is likely that understanding and manipulating the epigenome, a 
potentially reversible source of biological variation, has great potential in chemoprevention 
or stabilization of cancer. Much attention is currently focusing on modulating DNA 
hyper/hypomethylation of key inflammatory genes by dietary factors as an effective 
approach to cure or protect against cancer-inflammation (Burdge & Lillycrop, 2010; Delage 
& Dashwood, 2008; Fang et al., 2007; Folmer et al., 2010; Hauser & Jung, 2008; Jackson et al., 
2010; Kirk et al., 2008; Kontogiorgis et al., 2010; Link et al., 2010; Suzuki & Miyata, 2006; 
Vaquero & Reinberg, 2009). In this respect, “Let food be your epigenetic medicine” could 
represent a novel interpretation of what Hippocrates said already 25 centuries ago. As such, 
it will be a challenge for future anti-inflammatory therapeutics and preventive cancer 
research to identify novel epigenetic targets which allow selective modulation of the 
inflammatory signaling network in the diseased tumor microenvironment (Bremner & 
Heinrich, 2002; Deorukhkar et al., 2007; Karin et al., 2004; Khanna et al., 2007; Paul et al., 
 
Phytochemicals – Bioactivities and Impact on Health 
 
176 
long-lasting epigenetic changes in the promoter of the NFB subunit p65, which acts as a 
master switch in cancer-inflammation (El-Osta et al., 2008). Alternatively, compounds may 
chemically interfere with histone mark interacting effector domains (such as chromo-, bromo- 
or tudor domains) (Seet et al., 2006; Wigle et al.; Zheng et al., 2008). Though, upon performing 
in vitro compound screenings in cofactor activity assays based on peptide-protein interactions, 
one should be careful with interpretation as peptide interactions may not always represent 
true targets in vivo (Altucci & Minucci, 2009; Pacholec et al., 2010). 
 
NAD, acetyl-coenzyme A (Acetyl-coA) and S-adenosylmethionine (SAM) are elemental for epigenetic 
control of transcription including methylation of DNA and posttranslational modifications of histones 
and non-histone chromatin factors (not shown). NAD contributes to transcriptional control mainly via 
the activity of the protein deacetylase sirtuin (SIRT), which uses NAD as one of the substrates. Sirtuins 
are also important for maintaining the activity of the acetyl-coA acetyltransferases. Ac-coA is 
synthesized by acetyl-coA-synthetase and ATP-citrate lyase that use acetate and citrate as the precursor, 
respectively. Citrate is an intermediate/product of the TCA cycle. SAM is the methyl donor for DNA, 
RNA, histones and non-histone protein methylation. SAH generated in each round of methylation 
reaction is a potent inhibitor of methyltransferases and has to be cleared by SAH hydrolase. NAD is an 
essential coenzyme for SAHH. Synthesis of methionine from homocystein is achieved through 
extracting the methyl group from betaine, derived from choline, or 5-methyl-THF, a derivative of folic 
acid. Metabolism of phospholipids and folic acid may thus indirectly contribute to epigenetic regulation. 
Likewise, the abundance of NAD and citrate is linked to the cellular energy flux, e.g. the TCA cycle. 
Changes in the expression of certain genes may therefore be influenced significantly. Abbreviations used: 
Ac-coA, acetyl-coenzyme A; ACS, acetyl-coA-synthetase; AC-ACS acetylated-ACS; Ado, adenosine; HAT, 
histone acetyltransferase; Hcy homocysteine; MTases, methyltransferases; NAD, Nicotinamide adenine 
dinucleotide; SAH, S-adenosyl homocysteine; TCA tricarboxylic cycle; THF tetrahydrofolate. 
Fig. 5. Global shifts in cancer epigenome regulation depend on metabolic shifts in cofactors 
for epigenetic enzymes (adapted from Luo et al. 2009) 
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From another perspective, chemopreventive phytochemicals may indirectly modulate 
chromatin dynamics and epigenetic effects upon interference with global cancer 
metabolism. As such, epigenetic changes may follow biochemical metabolisation of dietary 
factors, which can deplete cellular pools of acetyl-CoA, NAD+ and methyldonors, resulting 
in unbalanced DNA methylation and/or protein acetylation or methylation (Imai & 
Guarente, 2010; Ladurner, 2009; Vaquero & Reinberg, 2009) (Figure 1&5). For example, 
flavanol-rich diets interfere with the methyldonor metabolism and the available pool of S-
adenosylmethionine, resulting in changes in DNA methylation (Bistulfi et al., 2010; N. C. 
Chen et al., 2010; Ghoshal et al., 2006; J. M. Kim et al., 2009a; Ulrich et al., 2008) and histone 
methylation, which is also affected by alterations in SAM/SAH ratios (Pogribny et al., 2007; 
P. Sharma et al., 2006). Furthermore, even without nutritional deficiency of methyl groups, 
impaired synthesis of SAM and perturbed DNA methylation can happen when the need for 
the synthesis of the detoxification enzyme glutathione transferase (GSH) synthesis increases 
(D. H. Lee et al., 2009). Diets or nutritional compounds which affect energy metabolism or 
mitochondrial respiration can have global epigenetic effects upon changes in NAD+ 
availability and SIRT activity (Whittle et al., 2007). Since SIRT activation has been linked to 
longevity (increased lifespan and healthy aging) and mimics a caloric restricted diet, SIRT 
activators such as resveratrol represent a major class of caloric mimetic epigenetic 
modulator phytochemicals which could reverse metabolic disease (Imai & Guarente, 2010). 
Along the same line, flavanol-rich diets which interfere with the methyldonor metabolism 
and the available pool of S-adenosylmethionine will result in (Global) changes in DNA and 
histone methylation (Bistulfi et al., 2010; Ghoshal et al., 2006; J. M. Kim et al., 2009a; 
Pogribny et al., 2007; P. Sharma et al., 2006; Ulrich et al., 2008). As such, specific dietary 
classes of functional food maybe designed as therapeutic epigenetic modulators in cancer-
inflammation.  
8. Conclusion & future perspectives 
The phenotype of an individual is the result of complex gene-environment interactions in 
the current, past and ancestral environment, leading to lifelong remodelling of our 
epigenomes. In recent years, several studies have demonstrated that disruption of epigenetic 
mechanisms can alter immune function and contribute to many cancer types. Various 
replication-dependent and -independent epigenetic mechanisms are involved in 
developmental programming, lifelong recording of environmental changes and transmitting 
transgenerational effects. It is likely that understanding and manipulating the epigenome, a 
potentially reversible source of biological variation, has great potential in chemoprevention 
or stabilization of cancer. Much attention is currently focusing on modulating DNA 
hyper/hypomethylation of key inflammatory genes by dietary factors as an effective 
approach to cure or protect against cancer-inflammation (Burdge & Lillycrop, 2010; Delage 
& Dashwood, 2008; Fang et al., 2007; Folmer et al., 2010; Hauser & Jung, 2008; Jackson et al., 
2010; Kirk et al., 2008; Kontogiorgis et al., 2010; Link et al., 2010; Suzuki & Miyata, 2006; 
Vaquero & Reinberg, 2009). In this respect, “Let food be your epigenetic medicine” could 
represent a novel interpretation of what Hippocrates said already 25 centuries ago. As such, 
it will be a challenge for future anti-inflammatory therapeutics and preventive cancer 
research to identify novel epigenetic targets which allow selective modulation of the 
inflammatory signaling network in the diseased tumor microenvironment (Bremner & 
Heinrich, 2002; Deorukhkar et al., 2007; Karin et al., 2004; Khanna et al., 2007; Paul et al., 
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2006; Rios et al., 2009; Surh, 2003). Given several encouraging trials, prevention and therapy 
of age- and lifestyle-related diseases by individualised tailoring of optimal epigenetic diets 
or supplements are conceivable. However, these interventions will require intense efforts to 
unravel the complexity of these epigenetic, genetic and environmental interactions. Another 
goal is to evaluate their potential reversibility with minimal side effects as diet components 
may reprogram malignant cells as well as the host immune system and HPA-axis 
depending on the bioavailability of the dietary compounds (Burdge & Lillycrop, 2010; 
Dijsselbloem et al., 2007; Manach et al., 2005b; N. Ndlovu et al., 2009; Vanden Berghe et al., 
2006a; Williamson & Manach, 2005). There is some concern that epigenetic therapy with 
dietary inhibitors of DNMT, HDAC, histone (de)methylases in longterm treatment setups 
may suffer from lack of specificity (Altucci & Minucci, 2009; Mai et al., 2008; Zheng et al., 
2008). As such, the possible alternative is to combine nonselective epigenetic therapies with 
more targeted approaches (Hervouet et al., 2009). For example, combined treatment of 
specific transcription factor inhibitors and/or hormone receptor ligands with epigenetic 
drugs may trigger synergistic activities at subsets of inflammatory genes (Biddie et al., 2010; 
Di Croce et al., 2002; Fiskus et al., 2009; Hervouet et al., 2009; Perissi et al., 2010). An 
excellent example of cooperation between a dietary vitamin A-derivative targeting a nuclear 
receptor and the HDAC inhibitor butyrate has been described in the treatment of acute 
promyelocytic leukemias (Delage & Dashwood, 2008). Finally, microRNA and long ncRNA 
pathways also hold promise to join soon the arsenal of epigenetic combination therapies, as 
their target sequence specificity may bridge the gap between genetic and epigenetic changes 
(De Santa et al., 2010; Guil & Esteller, 2009; Gupta et al., 2010; Parasramka et al., 2011; Tsai et 
al., 2010). In conclusion, cancer-inflammaton studies are revealing a dazzling complexity in 
the mechanisms leading to dynamic alterations of the epigenome and the need of 
combination therapies targeting different chromatin modifiers, to reverse disease prone 
epigenetic alterations for chemoprevention. Medical benefits of dietary compounds as 
epigenetic modulators, especially with respect to their chronic use as nutraceutical agents in 
cancer chemoprevention, will rely on our further understanding of their epigenetic effects 
during embryogenesis, early life, aging, carcinogenesis as well as through different 
generations.  
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1. Introduction 
The word natural literally means something that is present in or produced by nature and not 
artificial or man-made (Spainhour, 2005). Although, many effective poisons are natural 
products (Schoental, 1965). When the word natural is used in written or verbiage form, many 
a times refer to something good or pure (Spainhour, 2005). Today, the term natural products 
are commonly understood to refer to herbs, herbal concoctions, dietary supplements, 
traditional medicine including Chinese traditional medicine, or other alternative medicine 
(Holt, and Chandra, 2002). In general, natural products are either of prebiotic origin or 
originate from microbes, plants, or animal sources (Nakanishi, 1999a; Nakanishi, 1999b). As 
chemicals, natural products include such classes of compounds as terpenoids, polyketides, 
amino acids, peptides, proteins, carbohydrates, lipids, nucleic acid bases, ribonucleic acid 
(RNA), deoxyribonucleic acid (DNA), and so forth. Natural products are an expression of 
organism’s increase in life complexity by nature (Jarvis, 2000). 
It is good to understand what ‘nutrition’ and ‘a nutrition perspective’ mean. It should be 
understood that food and nutrition are not the same. Nutrition is both the outcome and the 
process of providing the nutrients needed for health, growth, development and survival. 
Although food—as the source of these nutrients—is an important part of this process, it is 
not by itself sufficient. Good health management services, as well as good caring practices 
are other important and necessary inputs needed in maintaining good health apart from 
good nutrition (SCN, 2004). 
2. World status of nutrition and health 
During the past two to three decades there have been rapid changes in global economy 
accompanied by several significant changes in the nutritional status and health of 
developing countries (Evans et al., 2002). Significant reductions in the prevalence of 
undernutrition are some of the good changes recorded. The increased prevalence of obesity 
and diet-related chronic disease are some of the negative changes related to human nutrition 
(Hoffman, 2001). More also, on the increase is the data suggesting the existence of a 
biological link between poor nutrition in early life and chronic diseases in adulthood 
(Jackson et al., 2010; Langley-Evans and McMullen, 2010). 
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The prevalence of undernutrition in today’s world varies greatly base on region and 
country, there has also been a decrease in global trends in wasting and stunting. However, 
the situation is still different in countries with extremely unstable governments and those 
with civil strife, with records of higher prevalence rate up to 20-30% (Bryce et al., 2008). 
Undernutrition in developed nations happen to be a problem among people living in rural 
areas, this could be due to the fact that inhabitants of rural areas mostly suffer from poor 
nutrition in terms of micronutrient deficiencies. Low income and poor access to nutritious 
foods is a common factor in poor urban societies leading to undernutrition (Shetty, 2009; 
Black et al., 2008). The prevalence of undernutrition remains moderate to high in developing 
nations, depending on the relative degree of economic development. These countries have 
relatively higher prevalence rate of children wasting and stunting of approximately 30-40% 
(Gutierrez-Delgado and Guajardo-Barron, 2009; Delisle, 2008). 
3. Natural products and body anatomy 
Most of the body structures like bones and muscle tissues are formed and nourished by 
natural products like calcium, phosphorus, vitamin D, proteins and so forth. Bone formation 
consists of a biological cascade through mesenchymal proliferation, chondrogenesis, 
osteogenesis, and remodelling (Reddi, 1994). For optimal bone mineral accrual in the 
developing skeleton, calcium and vitamin D are very important. Human skeleton is rich in 
calcium supply, with finely tuned mechanisms for release of calcium as needed. Calcium 
homeostasis is maintained during either low calcium intake or vitamin D status, through the 
regulation of parathyroid gland and kidneys, at the expense of bone. Adolescents are at risk 
for poor nutritional status in both calcium and vitamin D. Lack of calcium accumulation in 
the skeleton of an adolescent or a growing child can have negative consequences for 
achievement of peak bone mass (Bailey et al., 2000; Bachrach, 2001; Harkness and Bonny, 
2005). Differentiation of mesenchymal stem cells into osteoblast to produce new bone tissue 
was capably induced by bone morphogenetic proteins (BMP), a phenomenon known as 
osteoinduction (Urist, 1965; Wozney, 2002). Growth factors contained in platelet-rich plasma 
(PRP) have been proposed to enhance bone grafts maturation and to support repair in the 
treatment of small bone defects in maxillofacial surgery, when in combination with an 
organic bovine bone (Roldan et al., 2004). The composition of collagens and noncollagenous 
matrix proteins defined the organic phase of mineralized tissues. Bone, dentin, and 
cementum contains collagen type I, cartilage contains collagen type II, and enamel is 
virtually free of collagen (Sommer et al., 1996). Proteins are the most important nutrients for 
maintaining body structures, they are the major component of muscles, it is generally 
believe that flesh makes flesh (Bischoff and Voit, 1860). Skin and bone contain a fibrous 
protein. Keratinocytes undergo a series of morphological and biochemical changes 
including the expression of large quantities of proteins which constitute cytoplasmic 
filamentous networks, keratohyalin granules and cornified envelopes in the course of 
differentiation (Manabe et al., 1997). Stiffness and rigidity to fluid biological components is 
provided by structural proteins most of which are fibrous proteins, actin and tubulin are 
globular and soluble as monomers, which upon polymerization form long, stiff fibres that 
comprise cytoskeleton, which allows the cell to maintain its shape and size. Connective 
tissue like cartilage has collagen and elastin as its main components, and keratin is an 
important component of hard or filamentous structures such as hair, nails, feathers, hooves, 
and some animal shells (Van Holde and Mathew, 1996). 
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4. Natural products and body physiology 
Natural products are the potential sources of organic nutrients like carbohydrate, fats, 
proteins or amino acids and vitamins, as well as dietary minerals necessary for normal 
physiological functioning of the body. 
Body physiological reactions involving nerve, muscle, blood, bone, endocrine and visceral 
tissues require constant renewal, a delicate balance of which human health is depended 
upon. Vital exchanges constantly occur, involving many enzymatic systems activated by 
minerals or trace elements (Speich et al., 2001). The contraction of skeletal, cardiac and 
smooth muscles aided by calcium ions and involving neuronal and hormonal interplay are 
responsible for a lot of vital functions in the body such as movements, heartbeats, blood 
circulation, respiration, parturition, micturition, digestion, and so forth. These activities are 
important for life maintenance, some of the crucial roles of natural products in maintaining 
body physiology such as cell signalling electrophysiology, muscle contraction, enzymes and 
hormones synthesis, etc. are outline below:---  
5. Cell signalling  
Natural products play important roles in a lot of cellular activities such as cell signalling that 
aids in cellular communications. Calcium and vitamin D are necessary for many cellular 
processes. Primarily, the role of calcium is to serve as a second messenger in virtually all 
cells. The most common signal transduction is the ionized calcium due to its ability to 
reversibly bind to proteins. Vitamin D receptors have been identified in most body cells 
such as the small intestine, colon, brain, skin, prostate, gonads, breast, lymphocytes, 
osteoblasts, B-islet cells, and mononuclear cells (Holick, 2004). At intracellular level, 1,25-
dihydroxyvitamin D interacts with vitamin D receptors and retinoic acid X receptor to 
enhance or inhibit the transcription of vitamin D-responsive genes, including calcium-
binding protein. Stimulation of many noncalcemic physiological functions including insulin 
production, thyroid hormone secretion, and activated T and B lymphocyte function has 
been shown to be promoted by 1, 25-dihydroxyvitamin D (Harkness and Bonny, 2005).  
Apart from Vitamin D and calcium, Proteins are also involved in several cellular processes. 
Being the chief actors within the cell, proteins are said to be carrying out the duties specified 
by the information encoded in genes (Lodish et al., 2004). Most of the biological molecules 
are relatively inert elements upon which proteins act, with the exception of certain types of 
RNA (Voet and Voet, 2004). Within the cell proteins acts as enzymes that catalyse chemical 
reactions. Due to specific nature of enzymes they accelerate only one or few chemical 
reactions. Most of the reactions involved in metabolism, as well as manipulating DNA in 
processes such as DNA replication, DNA repair, and transcription are carried out by 
enzymes (Bairoch, 2000). 
Cell signalling and signalling transduction are among the numerous processes involved by 
many proteins. Insulin is a good example of extracellular proteins that transmit a signal 
from a cell in which it was synthesized to other cells in distant tissues. Some proteins are 
membrane proteins that act as receptors, which function mainly to bind a signalling 
molecule and induce a biochemical response in the cell (Branden and Tooze, 1999). The 
protein components of adaptive immune system are the antibodies, whose main function is 
to bind antigens or foreign substances in the body, and target them for destruction. 
Antibodies are either secreted into the extracellular environment or anchored in the 
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membranes of specialized B cells called the plasma cells (Van Holde and Mathews, 1996). 
This phenomenon assists in maintaining body immunity. 
6. Electrophysiology  
Electrophysiological properties of some natural products serve as a means of 
communication or cell signalling in several body cells and glands. Many cellular functions, 
such as electrical signal generation in nerve and muscle cells, contraction in muscle cells, 
and secretion in nerve and gland cells depends on the significant role of widely distributed 
voltage-dependent calcium channels (Hagiwara, 1983; Hagiwara and Byerly, 1981). They 
exist not only in fully differentiated cells but also already in oocytes (Okamoto et al., 1977) 
and in developing nerve and muscle cells (Spitzer, 1979). There are several reports that 
calcium channels are restricted to, or more prominent in, the less differentiated states of 
excitable cells such as skeletal cells (Kano, 1975; Kidokoro, 1973; Kidokoro, 1975) and nerve 
cells (Matsuda et al., 1978; Mori-Okamoto et al., 1983; Spitzer and Baccaglini, 1976). 
The involvement of calcium channels as well as sodium channels in generating action 
potentials in embryonic chick skeletal muscle cells has been established. (Fukuda et al., 1976; 
Kano, 1975; Kano and Yamamoto, 1977). The involvement of a chloride component has also 
been shown in addition to the sodium and calcium component of the action potential, in 
particular in the long-lasting plateau phase of the action potential in these muscle cells 
(Fukuda et al., 1976).The availability of ATP in mammalian neurones is due to its well-
known role as a major energy carrier for cellular metabolism and has been reported to act as 
a fast transmitter in mammalian brain (Edwards and Gibb, 1993). An action potential is a 
transient depolarization of the membrane potential of excitable cells. They serve two main 
functions: to transmit and encode information, and to initiate cellular events such as 
muscular contraction. An action potential results from a transient change to the properties of 
the cell membrane, from a state where it is much more permeable to K+ than Na+, to a 
reversal of these permeability properties. Thus during the action potential an influx of Na+ is 
responsible for the rapid depolarization and an efflux of K+ causes repolarization. Changes 
to membraneionic permeability are due to the opening and closing of voltage-gated ion 
channels, and the properties of such channels explain additional phenomena such as 
refractoriness, threshold and cellular excitability. Action potentials conduct with a finite 
velocity along nerve axons, and the actual velocity depends on a number of factors that 
include: fibre radius, temperature, functional ion channel number and the presence of a 
myelin sheath (Fry and Jabr, 2010). The cations Na+, K+, Mg2+, and Ca2, are involved in the 
propagation of nerve impulses and in muscle and heart contraction. Phosphorus (P), in 
phosphoric ester form (ATP), results from the third step of cell respiration. The active 
transport of Na+ and K+ through the plasma membrane involves the energy of ATP 
hydrolysed by Na+ K+ ATPase and activated by Mg2+, constituting an essential cell function 
requiring around 25% of the energy metabolism of man at rest (Lehninger et al., 1994). The 
formation and the use of energy-rich bonds require Mg2+ (Durlach et al., 2000). 
7. Muscle contraction  
Although there are hormonal and neuronal interplay, diverse functions in the body like 
movement, respiration, digestion, blood circulation, heartbeat, micturition, parturition etc. 
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are facilitated by muscle contraction. Communication between muscle cells that lead to 
muscle contraction results from formation of action potential which is due to the 
electrophysiological properties of these tissues. It is an established fact that all muscle fibres 
use Ca2+ as their main regulatory and molecule signalling. Therefore, the variable expression 
of proteins involved in Ca2+ signalling and handling play a key role in the contractile 
properties of muscle fibres. Contraction and relaxation properties of a muscle fibre are 
largely determines by molecular diversity of the main proteins in the Ca2+ signalling 
apparatus otherwise known as the calcium cycle. The Ca2+ signalling apparatus includes: the 
ryanodine receptor that is the sarcoplasmic reticulum Ca2+ release channel, the troponin 
complex that mediates the Ca2+ effect to the myofibrillar structures leading to contraction, 
the Ca2+ pump responsible for Ca2+ reuptake into the sarcoplasmic reticulum, and 
calsequestrin--the Ca2+ storage protein in the sarcoplasmic reticulum. In addition, a 
multitude of Ca2+ binding proteins is present in muscle tissue including paryalbumin, 
calmodulin, S100 proteins, annexins, sorcin, myosin light chains, β-actin, calcineurin, and 
calpain. These Ca2+ binding proteins may either exert an important role in Ca2+ triggered 
muscle contraction under certain conditions or modulate other muscle activities such as 
protein metabolism, differentiation, and growth. Muscle diseases have been shown to be 
associated with alteration of several Ca2+ signalling and handling molecules. 
Pathophysiological conditions like malignant hyperthermia, dystrophinopathies and 
Brody’s disease are seem to be associated with functional alterations of Ca2+ handling. These 
also underline the importance of the affected molecules for correct muscle performance 
(Berchtold et al., 2000). 
8. Body electrolytes and homeostasis  
The major electrolytes found in the body are sodium (Na+), potassium (K+), calcium 
(Ca2+), magnesium (Mg2+), chloride (Cl-), bicarbonate (HCO3-), phosphate (HPO42), and 
sulphate (SO42) (Ahmad and Ahmad, 1993). For humans to be in an adequate physical 
condition and a highly efficient state, stable volume, osmotic concentration and electrolyte 
composition of internal fluids are necessary prerequisites (Zorbas et al., 2002). The 
macroelements Ca, Mg, K, Na, and phosphorus (P) are generally integrated into anatomic 
structures (bone elements, nucleic acids, membranes, proteins, enzymes) although they 
are also involved in the ionized active form and regarded as essential trace elements, as in 
voltage-gated ionic channels (Allain, 1996). In active form, they are of particular 
importance for metabolic balance in sports and during physical exercise (Maughan, 1999). 
Na+ contributes to the maintenance of osmotic pressure, water regulation, and acid-base 
balance. Ca 2+ controls vascular tonicity and coagulation of the blood (Lehninger et al., 
1994).  
9. Blood composition  
Among the components of blood are protein (albumin, globulin, and fibrinogen), fat 
cholesterol, carbohydrate glucose, calcium, phosphorus, sodium chloride (NaCl), urea, uric 
acid, nonprotein nitrogen (N.P.N) compounds, and creatine. These natural products 
component are distributed by the blood to body cells and tissues for necessary physiological 
activities. 
 
Phytochemicals – Bioactivities and Impact on Health 204 
membranes of specialized B cells called the plasma cells (Van Holde and Mathews, 1996). 
This phenomenon assists in maintaining body immunity. 
6. Electrophysiology  
Electrophysiological properties of some natural products serve as a means of 
communication or cell signalling in several body cells and glands. Many cellular functions, 
such as electrical signal generation in nerve and muscle cells, contraction in muscle cells, 
and secretion in nerve and gland cells depends on the significant role of widely distributed 
voltage-dependent calcium channels (Hagiwara, 1983; Hagiwara and Byerly, 1981). They 
exist not only in fully differentiated cells but also already in oocytes (Okamoto et al., 1977) 
and in developing nerve and muscle cells (Spitzer, 1979). There are several reports that 
calcium channels are restricted to, or more prominent in, the less differentiated states of 
excitable cells such as skeletal cells (Kano, 1975; Kidokoro, 1973; Kidokoro, 1975) and nerve 
cells (Matsuda et al., 1978; Mori-Okamoto et al., 1983; Spitzer and Baccaglini, 1976). 
The involvement of calcium channels as well as sodium channels in generating action 
potentials in embryonic chick skeletal muscle cells has been established. (Fukuda et al., 1976; 
Kano, 1975; Kano and Yamamoto, 1977). The involvement of a chloride component has also 
been shown in addition to the sodium and calcium component of the action potential, in 
particular in the long-lasting plateau phase of the action potential in these muscle cells 
(Fukuda et al., 1976).The availability of ATP in mammalian neurones is due to its well-
known role as a major energy carrier for cellular metabolism and has been reported to act as 
a fast transmitter in mammalian brain (Edwards and Gibb, 1993). An action potential is a 
transient depolarization of the membrane potential of excitable cells. They serve two main 
functions: to transmit and encode information, and to initiate cellular events such as 
muscular contraction. An action potential results from a transient change to the properties of 
the cell membrane, from a state where it is much more permeable to K+ than Na+, to a 
reversal of these permeability properties. Thus during the action potential an influx of Na+ is 
responsible for the rapid depolarization and an efflux of K+ causes repolarization. Changes 
to membraneionic permeability are due to the opening and closing of voltage-gated ion 
channels, and the properties of such channels explain additional phenomena such as 
refractoriness, threshold and cellular excitability. Action potentials conduct with a finite 
velocity along nerve axons, and the actual velocity depends on a number of factors that 
include: fibre radius, temperature, functional ion channel number and the presence of a 
myelin sheath (Fry and Jabr, 2010). The cations Na+, K+, Mg2+, and Ca2, are involved in the 
propagation of nerve impulses and in muscle and heart contraction. Phosphorus (P), in 
phosphoric ester form (ATP), results from the third step of cell respiration. The active 
transport of Na+ and K+ through the plasma membrane involves the energy of ATP 
hydrolysed by Na+ K+ ATPase and activated by Mg2+, constituting an essential cell function 
requiring around 25% of the energy metabolism of man at rest (Lehninger et al., 1994). The 
formation and the use of energy-rich bonds require Mg2+ (Durlach et al., 2000). 
7. Muscle contraction  
Although there are hormonal and neuronal interplay, diverse functions in the body like 
movement, respiration, digestion, blood circulation, heartbeat, micturition, parturition etc. 
 
From Nutrition to Health: The Role of Natural Products – A Review 205 
are facilitated by muscle contraction. Communication between muscle cells that lead to 
muscle contraction results from formation of action potential which is due to the 
electrophysiological properties of these tissues. It is an established fact that all muscle fibres 
use Ca2+ as their main regulatory and molecule signalling. Therefore, the variable expression 
of proteins involved in Ca2+ signalling and handling play a key role in the contractile 
properties of muscle fibres. Contraction and relaxation properties of a muscle fibre are 
largely determines by molecular diversity of the main proteins in the Ca2+ signalling 
apparatus otherwise known as the calcium cycle. The Ca2+ signalling apparatus includes: the 
ryanodine receptor that is the sarcoplasmic reticulum Ca2+ release channel, the troponin 
complex that mediates the Ca2+ effect to the myofibrillar structures leading to contraction, 
the Ca2+ pump responsible for Ca2+ reuptake into the sarcoplasmic reticulum, and 
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8. Body electrolytes and homeostasis  
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sulphate (SO42) (Ahmad and Ahmad, 1993). For humans to be in an adequate physical 
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structures (bone elements, nucleic acids, membranes, proteins, enzymes) although they 
are also involved in the ionized active form and regarded as essential trace elements, as in 
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Among the components of blood are protein (albumin, globulin, and fibrinogen), fat 
cholesterol, carbohydrate glucose, calcium, phosphorus, sodium chloride (NaCl), urea, uric 
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10. Red blood cells maturation 
Red blood cells formation is important for maintaining normal red blood cells count and 
blood volume. The erythropoietic cells of the bone marrow are among the most rapidly 
growing and reproducing cells in the entire body, due to the continuing need to replenish 
red blood cells. Their maturation and rate of production are affected greatly by a person’s 
nutritional status. For final maturation of the red blood cells two vitamins, vitamin B12 
(cyanocobalamin) and folic acid are important. Both of these are essential for the synthesis of 
DNA, because each in a different way is required for the formation of thymidine 
triphosphate, one of the essential building blocks of DNA. Abnormal and diminished DNA 
and, as well as failure of nuclear maturation and cell division could be caused by lack of 
either vitamin B12 or folic acid (Guyton, 2006). 
11. Haemoglobin formation  
Haemoglobin serves as oxygen transportation medium through the formation of 
oxyhaemoglobin in the blood, which is distributed to other body cells and tissues. 
Maintenance of this role is achieved by maintaining the normal haemoglobin count. Initially, 
to form a pyrrole molecule, succinyl-CoA formed in the Krebs metabolic cycle, binds with 
glycine. In turn, to form the heme molecule, four pyrroles combine to form protoporphyrin 
IX, which then combines with iron. Finally, each heme molecule combines with a long 
polypeptide chain, a globin synthesized by ribosomes, forming a subunit of haemoglobin 
called a haemoglobin chain. Four of these chains in turn bind together loosely to form the 
whole haemoglobin molecule. The different types of chains base on the amino acid 
composition of the polypeptide portion are designated alpha chains, beta chains, gamma 
chains, and delta chains. The most common form of haemoglobin in the adult human being, 
haemoglobin A, is a combination of two alpha chains and two beta chains (Guyton, 2006).  
12. Heredity  
The role of natural products like deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) 
in heredity is too important to be overlooked. It is a widely accepted hypothesis that 
deoxyribonucleic acid (DNA) is the genetic carrier of information and that ribonucleic acid 
(RNA) is an essential component in the expression of this information in polypeptide 
synthesis (Hurwitz and August, 1963). DNA molecule is a repository of genetic information. 
Therefore, there must be some precise mechanism for duplicating DNA so that the 
information within it can be handed down unchanged from one generation to the next. 
Inherited information resides in the precise sequence of bases in DNA and that this 
information is transferred to messenger RNA which can then specify the sequence of amino 
acids in some particular protein (Davern and Cairns, 1963). 
13. Enzymes and hormones synthesis 
Almost all process in a biological cell needs enzymes to occur at significant rates, the set of 
enzymes made in a cell determines which metabolic pathways occur in that cell. Pancreatic 
adaptation to the diet is a phenomenon due to the dietary induced modifications in enzyme 
composition of pancreatic tissue and secretion, which has been described in many species 
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(Poort and Poort, 1980; Corring, 1977; Ben Abdeljilil and Desnuelle, 1964; Reboud et al., 
1966). A carbohydrate-rich diet results in an increase in the specific activity of amylase with 
a concomitant decrease in the specific activity of chymotrypsinogen. The converse is true for 
a protein-rich diet (Ben Abdeljilil and Desnuelle, 1964) and the same phenomenon has been 
described for the lipase-colipase system (Bazin et al., 1978). Such modifications of pancreatic 
content are now thought to be induced by changes in the biosynthetic rate of individual 
enzymes rather than by non-parallel secretion (Palade, 1975; Dagorn, 1978) or differential 
enzyme catabolism (Kramer and Poort, 1972). Changes in the individual rates of enzyme 
biosynthesis have been shown to occur in the developing embryonic pancreas (Kemp et al., 
1972) and also after 30 days (Reboud et al., 1966) and more recently after 5 days of dietary 
adaptation in the adult rat (Poort and Poort, 1980). These long-term adjustments in enzyme 
synthesis have been correlated to concomitant adaptive modifications in pancreatic content 
(Reboud et al., 1966). However, no data are available to extend these conclusions to the 
short-term modifications in enzyme content that have been reported to occur within 24 
hours (Deschodt-Lanckman et al., 1971). It became evident that rapid modulation of 
pancreatic enzyme synthesis was possible. Hormonal stimulation (Dagorn and Mongeau, 
1977) or enteral administration of a product of digestion (Dagorn et al., 1977) produced 
changes in the biosynthetic rates of amylase, chymotrypsinogen and lipase within 15-30 
min. It thus becomes possible that a meal may have an immediate regulatory function on 
pancreatic enzyme synthesis (Dagorn and Lahaie, 1981). 
The entire organs functions are controlled by hormones; affecting diverse processes as 
growth and development, reproduction, and sexual characteristics. Energy storage and uses 
are also influence by hormones as well as controlling the volume of fluid and levels of salts 
and sugars in the blood. Large responses in the body could be triggered by very small 
amounts of hormones. Secretin and glucagon are members of a family of peptides, the 
vasoactive intestinal polypeptide (VIP)-secretin-glucagon family, which also includes 
pituitary adenylate cyclase-activating polypeptide (PACAP), gastric inhibitory polypeptide 
(GIP), parathyroid hormone (PTH), growth hormone-releasing hormone (GHRH), and 
exendins (Chow et al., 1997; Paul and Ebadi, 1993). All these peptides possess a marked 
amino acid sequence homology, are widely distributed in the body, and exert pleiotropic 
physiological effects, in many instances acting in a paracrine manner. The effects of these 
peptides are initiated by their specific interaction with cell-surface receptors, belonging to 
the superfamily of G-proteins-coupled receptors. These receptors are glycoproteins with a 
large hydrophilic extracellular domain followed by 7 highly conserved hydrophilic 
transmembrane helices, and their signalling mechanism primarily involves the activation of 
adenylate cyclase (AC)/protein kinase A (PKA) and phospholipase C (PLC)/PKC cascades 
(Arimura and Shioda, 1995; Chow et al., 1997; Fahrenkrug, 1989; Harmar and Lutz, 1994; 
Paul and Ebadi, 1993; Nussdorfer et al., 2000). 
14. Natural products as nutritional supplements 
Apart from being the major sources of nutrition in form of carbohydrate, protein, fat, etc. 
natural products are also used as nutritional supplements. According to the Dietary 
Supplement Health and Education Act of 1994 of the United States (Public Law 103-417, 
DSHEA), a dietary supplement is a product that is meant to supplement one’s diet. Dietary 
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hours (Deschodt-Lanckman et al., 1971). It became evident that rapid modulation of 
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(GIP), parathyroid hormone (PTH), growth hormone-releasing hormone (GHRH), and 
exendins (Chow et al., 1997; Paul and Ebadi, 1993). All these peptides possess a marked 
amino acid sequence homology, are widely distributed in the body, and exert pleiotropic 
physiological effects, in many instances acting in a paracrine manner. The effects of these 
peptides are initiated by their specific interaction with cell-surface receptors, belonging to 
the superfamily of G-proteins-coupled receptors. These receptors are glycoproteins with a 
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transmembrane helices, and their signalling mechanism primarily involves the activation of 
adenylate cyclase (AC)/protein kinase A (PKA) and phospholipase C (PLC)/PKC cascades 
(Arimura and Shioda, 1995; Chow et al., 1997; Fahrenkrug, 1989; Harmar and Lutz, 1994; 
Paul and Ebadi, 1993; Nussdorfer et al., 2000). 
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Apart from being the major sources of nutrition in form of carbohydrate, protein, fat, etc. 
natural products are also used as nutritional supplements. According to the Dietary 
Supplement Health and Education Act of 1994 of the United States (Public Law 103-417, 
DSHEA), a dietary supplement is a product that is meant to supplement one’s diet. Dietary 
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supplements contain one or more of the following ingredients: a vitamin, a mineral, an herb 
or other botanical, an amino acid, or another dietary substance, or a combination of these 
ingredients or their extracts. By definition, a dietary supplement is intended for ingestion in 
pill, capsule, tablet, or liquid form, but it is not for parenteral use. The most commonly used 
dietary supplement products are: enchinacea, ginseng, ginkgo, garlic, glucosamine, st. 
John’s worth, peppermint, fish oils/omega-3 fatty acids, ginger, soy and so forth (Low Dog 
and Markham, 2007). Elemental analysis of garlic indicated that the powdered plant 
material contained mainly potassium, phosphorus, iron and calcium among others. While 
it’s phytochemical screening revealed presence of chemical compounds like saponins, 
steroids, tannins, carbohydrates and cardiac glycosides (Mikail, 2010). 
Vitamin/mineral supplements can be defined as products that are formulated to supply 
vitamin and/or mineral nutrients. They are often categorized as vitamin A, vitamin E, 
vitamin B-complex, multi-vitamins, calcium (Ca), iron (Fe), and multi-vitamins with mineral 
supplements (Kim, 1997; Kim-Park et al., 1991). In general, it has been found that school 
children select multi-vitamins with minerals and multi-vitamin supplements more 
frequently than other types of supplements (Bowering and Clancy, 1986). Vitamin/mineral 
supplement use has been reported to be influenced by several factors. With respect to young 
children, daily eating habits can be a particularly significant factor affecting supplement use, 
as mothers of children often adopt vitamin/mineral supplements as an insurance against 
possible poor or unbalanced meals. Supplements are also often given to promote appetite in 
young children (Song and Kim, 1998). This is perceived to be an important issue, as it is 
thought that young children have numerous eating problems including skipping meals, 
eating small meals and a strong dislike for some foods (Pipes, 1992). According to 
demographic characteristics, females, individuals in high socioeconomic categories, and 
individuals living in large cities tend to take vitamin/mineral supplements more often than 
their contrasting groups (Bowering and Clancy, 1986; Kim, 1997; Slesinski et al, 1995; 
Schellhorn et al., 1998; Kim and Keen, 2002). 
Nutritional supplements aimed at improving physical performance or altering body 
compositions have become readily available worldwide. Athletes have been the greatest 
consumers of many of these products (Burk et al., 2006; Erdman et al., 2006; Huang et al., 
2006) and their habits may be followed by other groups of individuals (Sobal and Marquart, 
1994; Striegel et al., 2006), mainly those who exercise in gyms regularly (Morrison et al., 
2004). The desire for achieving quick results has made the use of such substances very 
attractive (Rocha and Pereira, 1998). However, it is known that, in general, physically active 
people do not need additional nutrients apart from those obtained from a balanced diet 
(Rockwell et al., 2001; Costill, 2003; Silva, 2005; Goston and Correia, 2010). 
15. Natural products roles in sanitation and personal care/cosmetics 
Not only use as nutritional supplements, rather natural products have interesting roles in 
sanitation, personal care and cosmetic surgery. Large variety of products and formulations 
are considered as personal care products in the United States (US) and cosmetics in the 
European Union (EU), these products includes soaps, shampoos and shower products, 
sunscreens, skin and hair care products, hair dyes, make ups, lip sticks, toothpastes, dental 
care products, deodorants, personal hygiene products and many others(Antignac et al., 
 
From Nutrition to Health: The Role of Natural Products – A Review 209 
2011). Decorative cosmetics are principally used to beautify or cover minor, visible 
imperfections. Shiny, oily, inhomogeneous colourings, as well as slight imperfections on 
skin surface are corrected by these kinds of cosmetics. These products play an important 
role, creating the effect of youthfulness and wholesomeness which are becoming more and 
more important in our society today (Valet et al., 2007).  
Personal care products (PCP) from botanical ingredients include a variety of preparations, 
such as plant extracts, expressed juices, tinctures, waxes, vegetable oils, lipids, plant 
carbohydrates, essential oils, as well as purified plant components, such as vitamins, 
antioxidants or other substances with biological activity (Allemann and Baumann, 2009). For 
thousands of years, soap has been used as probably the oldest skin and cloth cleanser. Soap 
is produced from the saponification of fats and oils by alkali. The manufacturing process of 
soap involved saponification by which triglycerides (fats and oils) or fatty acids are 
transformed into the corresponding alkali salt mixtures of fatty acids (Friedman and Wolf, 
1996). From the pulp industry soft and liquid soap are prepared from tall oil as tall resin by-
products (Rappe et al., 1990). Products designed to improve the appearance of the aging face 
by altering the structure and function of the skin in ways that are important for cosmetic 
surgeons are termed cosmeceutics. Thus, cosmeceutics aids cosmetic operations, these 
products include alpha hydroxy acids, beta hydroxy acids, polyhydroxy acids, vitamins, 
retinoid, skin lightening agents, and sunscreens (Draelos, 1999). 
16. Natural products as sources of drugs 
Natural products have played an important role throughout the world for thousands of 
years in human diseases treatments and preventions. Natural product medicines have 
come from various source materials including terrestrial plants, terrestrial 
microorganisms, marine organisms, and terrestrial vertebrates and invertebrates 
(Newman et al., 2000). An analysis of the origin of the drugs developed between 1981 and 
2002 showed that natural products or natural product-derived drugs comprised 28% of all 
new chemical entities (NCEs) launched onto the market (Newman et al., 2003). In 
addition, 24% of these NCEs were synthetic or natural mimic compounds, based on the 
study of pharmacophores related to natural products (Newman et al., 2000). This 
combined percentage (52% of all NCEs) suggests that natural products are important 
sources for new drugs, are also good lead compounds suitable for further modification 
during drug development (Chin et al., 2006). 
Natural products can come from anywhere. People most commonly think of plants first 
when talking about natural products, but trees and shrubs can also provide excellent 
sources of material that could provide the basis of a new therapeutic agent. Animals too, 
whether highly developed or poorly developed, whether they live on land, sea, or in the air 
can be excellent sources of natural products. Bacteria, smuts, rusts, yeast, moulds, fungi, and 
many other forms of what we consider to be primitive life can provide compounds or leads 
to compounds that can potentially be very useful therapeutic agents (Spainhour, 2005).  
Some of the provision of nature to human kind over the years includes the tools for the first 
attempts at therapeutic intervention (Nakanishi, 1999a; Nakanishi, 1999b). The Nei Ching is 
one of the earliest health science anthologies ever produced and dates back to the thirtieth 
century BC (Nakanishi, 1999a; Nakanishi, 1999b). Some of the first records on the use of 
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when talking about natural products, but trees and shrubs can also provide excellent 
sources of material that could provide the basis of a new therapeutic agent. Animals too, 
whether highly developed or poorly developed, whether they live on land, sea, or in the air 
can be excellent sources of natural products. Bacteria, smuts, rusts, yeast, moulds, fungi, and 
many other forms of what we consider to be primitive life can provide compounds or leads 
to compounds that can potentially be very useful therapeutic agents (Spainhour, 2005).  
Some of the provision of nature to human kind over the years includes the tools for the first 
attempts at therapeutic intervention (Nakanishi, 1999a; Nakanishi, 1999b). The Nei Ching is 
one of the earliest health science anthologies ever produced and dates back to the thirtieth 
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natural products in medicine were written in cuneiform in Mesopotamia on clay tablets and 
date to approximately 2600 BC (Cragg and Newman, 2001a; Cragg and Newman, 2001b; 
Nakanishi, 1999a; Nakanishi, 1999b). Indeed, many of these agents continue to exist in one 
form or another to this day as treatments for inflammation, influenza, coughing, and 
parasitic infestations (Holt and Chandra, 2002; Spainhour, 2005). The best known natural 
products documentation is the Ebers Papyrus, which documents nearly 1000 different 
substances and formulations, most of which are plant-based medicines (Nakanishi, 1999a; 
Nakanishi, 1999b; Spainhour, 2005). More also, to date natural products continue to be the 
potential sources of new compounds or molecules that awaits further scientific elucidations, 
like the newly isolated alkylresorcinols from Urginea indica (Mikail et al., 2010). 
The World Health Organization estimates that approximately 80% of the world’s population 
relies primarily on traditional medicines as sources for their primary health care 
(Farnsworth et al., 1985). Over 100 chemical substances that are considered to be important 
drugs are either currently in use or have been widely used in one or more countries in the 
world have been derived from a little under 100 different plants. Approximately 75% of 
these substances were discovered as a result of chemical studies focused on the isolation of 
active substances from plants used in traditional medicine (Cragg and Newman, 2001a; 
Cragg and Newman, 2001b, Spainhour, 2005). A lot of natural products medications are 
derived from polyketides, which includes antibiotic, antifungal, anticancer, anthelmintic 
and immunosuppressant compounds such as erythromycins, tetracyclines, amphotericins, 
daunorubicins, avermectins, and rapamycins. These derivatives are used in treatment of 
host of disease situations affecting various body systems such as central nervous system, 
cardiovascular system, renal system, visual system and common integument.  
17. Natural products as sources of antibiotics 
Antibiotic is a word originally coined for those natural compounds with antimicrobial 
properties (Strohl et al., 2001; Overbye and Barrett, 2005; Palaez, 2006). The word antibiotic 
now a day no longer refers only to natural compounds; most of the marketed antibiotics are 
based on natural chemotypes. In the years 1982-2002 seventy out of the ninety antibiotics 
marketed originated from natural products (Newman et al., 2003; Palaez, 2006).The 
discoveries of sulphonamide antibiotics in the 1930s and penicillin in the 1940s have 
reduced the fatality rates of bacterial infections (Sneader, 2005; Newman et al., 2000; Drews, 
2000). These has led to the discovery of most of the classes of antibacterial drug known 
today, many of which derived from natural products (Sneader, 2005; Walsh and Wright, 
2005; Finch et al., 2003). The natural products-derived drugs mostly belong to five different 
structural classes namely: the β-lactam, the streptogramin, the macrolide, the tetracycline 
and the daptomycin (Butler and Buss, 2006). 
Natural product-derived antibacterial drug prevalence may be due to the evolution of 
secondary metabolites as biologically active chemicals which conferred some selectional 
advantages to the producing organisms. There is likelihood of natural products to have 
evolved to penetrate the cell membranes and interact with specific proteins targets (Stone 
and Williams, 1992). The structural complexity of many natural products is required for the 
inhibition of many antibacterial protein targets (Butler, 2004; Koehn and Carter, 2005; Butler 
and Buss, 2006). 
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Some of the representative antibiotics of natural product origin include Daptomycin, 
Vancomycin, Ramoplanin, Tetracycline, Streptomycin, Erythromycin, Chloramphenicol, 
Penicillins, Cephalosporins, Carbapenems (Singh and Barret, 2006).However, as reported by 
Palaez (2006), Penicillins, Cephalosporins, Erythromycin, Thienamycin, Vancomycin, 
Fosfomycin, Mupirocin, Fusidic acid, Streptogramins, and Daptomycin are some of the 
marketed antibiotics that originated from microbial natural products. Some of the natural 
product-derived antibiotics currently in clinical development include the followings: 
Daptomycin, Dalbavancin, Telavancin, Oritavancin, Ramoplanin, Efiprestin, Lyostaphin and 
so forth (Clardy, et al., 2006). 
18. Antivirals derived from natural products 
Numerous compounds have been revealed through antiviral testing from structural classes 
that include peptides, terpenoids, polysaccharides, steroids and alkaloids that potentially 
inhibit both RNA and DNA viruses (Abad Martinez et al., 2008). Infections with viruses are 
counteracted by the host natural defences which prevent or limit the extent of these 
diseases. Interferon, a protein moiety produced in virus infected cells provides one of these 
defences. Interferon causes the production of a new protein that shuts off virus replication 
when attached to the cell membrane and consequently may lead to suppression of the viral 
infection. Therefore, antiviral compounds could be produce by the synthesis of drugs that 
induce interferon production before or after the infection in the sense that they activate 
certain host defence mechanisms (Becker, 1980). Marine compounds are good sources of 
Pharmacological agents. In the market today, there are over 40 pharmacological 
compounds, including alternative antiviral medicines or those being tested as potential 
antiviral drugs at preclinical and clinical stages (Yasuhara-Bell and Lu, 2010). 
Some of the marine-derived antiviral agents circulating in market and are on clinical 
development include: Acyclovir, Ara-A (vidarabine), Ara-C (cytarabine), Avarol, 
Azidothymidine (zidovudine), and Cyanovirin-N (Yasuhara-Bell and Lu, 2010). 
Triterpenoids isolated from plants are biologically active natural products attracting 
considerable interest due to their variety of structures and their broad range of biological 
activities. Some compounds having significant anti-tumor activities in an in vivo assay 
have been reported. Some of these compounds are useful in the development of novel 
drugs with pharmacological actions (Barquero et al., 2006). Triterpenoidal saponins family 
of which Avicins is a member reduce both oxidative and nitrosative cellular stress, which 
result in developmental suppression of malignancies and other related diseases (Haridas 
et al., 2001).  
Milk has been reported to contain antiviral agents (Matthews et al., 1976; Newburg et al., 
1992). Lactoferrin is one of such agents that later shown to in vitro inhibit the human 
immunodeficiency virus (HIV-1), human herpes simplex virus (HSV-1 and -2), human 
cytomegalovirus, respiratory syncytial virus, poliovirus and rotavirus (Marchetti et al., 
1999). Assayed chemically modified proteins presented antiviral activity against HSV-1 
before, during and after infection. Higher concentrations of modified proteins are required if 
present before infection as compared to during or after infection. This therefore, suggests 
that targeted chemical modification of some natural products might provide antiviral 
compounds effective against HSV-1 infection (Oevermann et al., 2003). 
 
Phytochemicals – Bioactivities and Impact on Health 210 
natural products in medicine were written in cuneiform in Mesopotamia on clay tablets and 
date to approximately 2600 BC (Cragg and Newman, 2001a; Cragg and Newman, 2001b; 
Nakanishi, 1999a; Nakanishi, 1999b). Indeed, many of these agents continue to exist in one 
form or another to this day as treatments for inflammation, influenza, coughing, and 
parasitic infestations (Holt and Chandra, 2002; Spainhour, 2005). The best known natural 
products documentation is the Ebers Papyrus, which documents nearly 1000 different 
substances and formulations, most of which are plant-based medicines (Nakanishi, 1999a; 
Nakanishi, 1999b; Spainhour, 2005). More also, to date natural products continue to be the 
potential sources of new compounds or molecules that awaits further scientific elucidations, 
like the newly isolated alkylresorcinols from Urginea indica (Mikail et al., 2010). 
The World Health Organization estimates that approximately 80% of the world’s population 
relies primarily on traditional medicines as sources for their primary health care 
(Farnsworth et al., 1985). Over 100 chemical substances that are considered to be important 
drugs are either currently in use or have been widely used in one or more countries in the 
world have been derived from a little under 100 different plants. Approximately 75% of 
these substances were discovered as a result of chemical studies focused on the isolation of 
active substances from plants used in traditional medicine (Cragg and Newman, 2001a; 
Cragg and Newman, 2001b, Spainhour, 2005). A lot of natural products medications are 
derived from polyketides, which includes antibiotic, antifungal, anticancer, anthelmintic 
and immunosuppressant compounds such as erythromycins, tetracyclines, amphotericins, 
daunorubicins, avermectins, and rapamycins. These derivatives are used in treatment of 
host of disease situations affecting various body systems such as central nervous system, 
cardiovascular system, renal system, visual system and common integument.  
17. Natural products as sources of antibiotics 
Antibiotic is a word originally coined for those natural compounds with antimicrobial 
properties (Strohl et al., 2001; Overbye and Barrett, 2005; Palaez, 2006). The word antibiotic 
now a day no longer refers only to natural compounds; most of the marketed antibiotics are 
based on natural chemotypes. In the years 1982-2002 seventy out of the ninety antibiotics 
marketed originated from natural products (Newman et al., 2003; Palaez, 2006).The 
discoveries of sulphonamide antibiotics in the 1930s and penicillin in the 1940s have 
reduced the fatality rates of bacterial infections (Sneader, 2005; Newman et al., 2000; Drews, 
2000). These has led to the discovery of most of the classes of antibacterial drug known 
today, many of which derived from natural products (Sneader, 2005; Walsh and Wright, 
2005; Finch et al., 2003). The natural products-derived drugs mostly belong to five different 
structural classes namely: the β-lactam, the streptogramin, the macrolide, the tetracycline 
and the daptomycin (Butler and Buss, 2006). 
Natural product-derived antibacterial drug prevalence may be due to the evolution of 
secondary metabolites as biologically active chemicals which conferred some selectional 
advantages to the producing organisms. There is likelihood of natural products to have 
evolved to penetrate the cell membranes and interact with specific proteins targets (Stone 
and Williams, 1992). The structural complexity of many natural products is required for the 
inhibition of many antibacterial protein targets (Butler, 2004; Koehn and Carter, 2005; Butler 
and Buss, 2006). 
 
From Nutrition to Health: The Role of Natural Products – A Review 211 
Some of the representative antibiotics of natural product origin include Daptomycin, 
Vancomycin, Ramoplanin, Tetracycline, Streptomycin, Erythromycin, Chloramphenicol, 
Penicillins, Cephalosporins, Carbapenems (Singh and Barret, 2006).However, as reported by 
Palaez (2006), Penicillins, Cephalosporins, Erythromycin, Thienamycin, Vancomycin, 
Fosfomycin, Mupirocin, Fusidic acid, Streptogramins, and Daptomycin are some of the 
marketed antibiotics that originated from microbial natural products. Some of the natural 
product-derived antibiotics currently in clinical development include the followings: 
Daptomycin, Dalbavancin, Telavancin, Oritavancin, Ramoplanin, Efiprestin, Lyostaphin and 
so forth (Clardy, et al., 2006). 
18. Antivirals derived from natural products 
Numerous compounds have been revealed through antiviral testing from structural classes 
that include peptides, terpenoids, polysaccharides, steroids and alkaloids that potentially 
inhibit both RNA and DNA viruses (Abad Martinez et al., 2008). Infections with viruses are 
counteracted by the host natural defences which prevent or limit the extent of these 
diseases. Interferon, a protein moiety produced in virus infected cells provides one of these 
defences. Interferon causes the production of a new protein that shuts off virus replication 
when attached to the cell membrane and consequently may lead to suppression of the viral 
infection. Therefore, antiviral compounds could be produce by the synthesis of drugs that 
induce interferon production before or after the infection in the sense that they activate 
certain host defence mechanisms (Becker, 1980). Marine compounds are good sources of 
Pharmacological agents. In the market today, there are over 40 pharmacological 
compounds, including alternative antiviral medicines or those being tested as potential 
antiviral drugs at preclinical and clinical stages (Yasuhara-Bell and Lu, 2010). 
Some of the marine-derived antiviral agents circulating in market and are on clinical 
development include: Acyclovir, Ara-A (vidarabine), Ara-C (cytarabine), Avarol, 
Azidothymidine (zidovudine), and Cyanovirin-N (Yasuhara-Bell and Lu, 2010). 
Triterpenoids isolated from plants are biologically active natural products attracting 
considerable interest due to their variety of structures and their broad range of biological 
activities. Some compounds having significant anti-tumor activities in an in vivo assay 
have been reported. Some of these compounds are useful in the development of novel 
drugs with pharmacological actions (Barquero et al., 2006). Triterpenoidal saponins family 
of which Avicins is a member reduce both oxidative and nitrosative cellular stress, which 
result in developmental suppression of malignancies and other related diseases (Haridas 
et al., 2001).  
Milk has been reported to contain antiviral agents (Matthews et al., 1976; Newburg et al., 
1992). Lactoferrin is one of such agents that later shown to in vitro inhibit the human 
immunodeficiency virus (HIV-1), human herpes simplex virus (HSV-1 and -2), human 
cytomegalovirus, respiratory syncytial virus, poliovirus and rotavirus (Marchetti et al., 
1999). Assayed chemically modified proteins presented antiviral activity against HSV-1 
before, during and after infection. Higher concentrations of modified proteins are required if 
present before infection as compared to during or after infection. This therefore, suggests 
that targeted chemical modification of some natural products might provide antiviral 
compounds effective against HSV-1 infection (Oevermann et al., 2003). 
 
Phytochemicals – Bioactivities and Impact on Health 212 
19. Antiprotozoal potentials of natural products 
Parasitic diseases are major public health problem especially in tropical developing 
countries, affecting hundred millions of people (Tagboto and Townson, 2001). 
During phagocytosis reactive oxygen species are generated by neutrophilic granulocytes as 
a means of natural defence against invading microorganisms (Baehner et al., 1982). It is 
believed that this oxygen radicals formed by electron transfer processes have significant role 
in xenobiotic mechanism of action (Eberson, 1985; Halliwell and Gutteridge, 1985). Some 
antiprotozoal agents have been tested to possess this form of mechanism of action (Kovacic 
et al., 1989) although others may act in different ways. 
Among the established antiprotozoal drugs from natural sources used in treating human 
protozoan infections are quinine from Cinchona species, artemisinin from Artemisia annua for 
malarial treatment and Psychotria ipecacuanha for treating amoebiasis (Tagboto and 
Townson, 2001). Three alkaloids namely quinidine, cinchonine, and cinchonidine together 
with quinine have significant antimalarial activity. All of these compounds were isolated 
from Cinchona trees. Totaquine is an antimalarial agent containing all the four alkaloids used 
in the past as a cheap alternative to quinine sulphate (Dobson, 1998). Seven out of 14 anti-
parasitic drugs approved from 1981-2006 are natural products derivatives including 
artemisinin (Newman and Cragg, 2007). Apart from the established antiprotozoal drugs, 
natural products still possess the potentials of providing more alternative sources of 
antiprotozoal medications that needs further scientific elucidations. Allium sativum has been 
shown to possess trypanocidal activity both in vitro and in vivo (Mikail, 2009a). There are 
several other plants that possess this activity (Mikail, 2009b). 
20. Antifungal property of natural products 
Antifungal drugs are used in treating any of the following disease conditions: allergic 
reactions to fungal proteins, toxic reactions to toxins present in certain fungi and infectious 
mycoses which is the most serious and difficult to diagnose and treat due to the fact that 
mycoses come in many forms (Barret, 2002). Polyene natural product amphotericin B is the 
most commonly drug used in treating these disease conditions (Gallis et al., 1990; Wingard 
et al., 1999). Other various newer lipid formulations are also used in handling such disease 
conditions (Hiemenz and Walsh, 1996). Griseofulvin which was first isolated from the 
fungus Penicillium griseofulvin has been used in the treatment of dermatophyte infections for 
the past 30 years (Finkelstein et al., 1996). Polyene antifungal antibiotic nystatin, is used for 
prophylaxis and treatment of candidiasis of the skin and mucous membranes (Waugh, 
2008). In Brazil, many plants biomes, such as the Cerado (savannah), the Atlantic and the 
Amazon rain-forest, have been used in the treatment of several tropical diseases, such as 
leishmaniasis, malaria, schistosomiasis, fungal and bacterial infections. These are mostly 
used by local populations as natural medicines (Alves et al., 2000). 
21. Anthelminthic activity of natural products 
More than 1 billion people are reported by the World Health Organization to suffer from 
neglected tropical diseases such as helminthiasis. This disease condition is a major health 
problem throughout developing countries and is also a food safety issue worldwide (Savioli, 
2009). Th2 immunity is the key for protective immunity to all helminths, although the final 
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effector mechanisms for helminths expulsion are distinct for each helminths, which could be 
due to the different invasion strategy of each helminth (Shigeo Koyasu et al., 2010). Worm 
expulsion is dependent on Th2 immune responses. Critical for worm expulsion are Th2 
cytokines, IL-4 and IL-13. Both of these cytokines significantly delays worm expulsion 
(Finkelman et al., 2004). Anthelmintic act rapidly and selectively on neuromuscular 
transmission of nematodes, agonism at nicotinic acetylcholine receptors of nematode muscle 
and cause spastic paralysis, organophosphorus cholinesterase antagonism, increasing the 
opening of glutamate-gated chloride (GluCl) and produce paralysis of pharyngeal pumping, 
increasing calcium permeability, while other anthelmintics have a biochemical mode of 
action (Martin, 1997). 
Ivermectin was discovered from a microorganism, Streptomyces avermitilis, isolated from an 
Oceanside golf course soil in japan, it was found to have potent bioactivity. It has systemic 
anti-parasitic activities, effective against helminths, arachnids, and insects, but not against 
protozoa, bacteria, flatworms or fungi (Omura, 2008) Ivermectin was the first ‘ 
endoectoparasites’ discovered due its proven activity against endo- and ectoparasites , at 
unprecedented low doses it could be easily used orally, topically and parentally (Arena et al., 
1992; Omura, 2002). Digenea simplex and Chondria armata are two Japanese red algae, which 
have been used for their potent anthelminthic properties for more than 1000 years. Elimination 
of intestinal worms, such as parasitic round worms (Ascaris lumbricoides), tape worms (Taenia 
spp), and wip worms (Trichuris trichura) are some of the anthelminthic properties of these 
Japanese algae. Domoic acid and kainic acid are two closely related compounds isolated from 
these red algae, which are responsible for these curative properties (Gerwick et al., 2007). A 
wide range of plant and plant extracts has been used as potential alternative anthelminthic 
strategy for the treatment of helminth infections. Many species of fig tree from the genus Ficus 
and the papaya tree, Carica papaya, the crude latex was extracted and used successfully against 
ascarids, tapeworms, whipworms and hookworms in the early 19th century (Berger and 
Asenjo, 1940; Waller et al., 2001; Tagboto and Townson, 2001; Stepek et al., 2004). 
22. Role of natural products in treating non infectious diseases 
Although natural products are the origin of several drugs used in the treatment of many 
infectious diseases, they also play a significant role in the treatment of several non-infectious 
disease conditions. 
23. Diabetes mellitus and obesity 
Hyperglycaemia is the unifying feature of this heterogeneous endocrine disorder. Every 
year the number of diabetic patients is rising by 4-5% (Wagman and Nuss, 2001). Plant 
extract and complex microbial secondary metabolites of natural products have attracted the 
attention of scientific world for their potential use as drugs for the treatment of chronic 
diseases such as Type II diabetes (Bedekar et al., 2010). Acarbose was discovered from 
compounds isolated from Actinomycetes species, which are potent inhibitors of digestive 
enzymes such as α-amylase, sucrase, and maltase. Acarbose is the most widely used 
digestive enzyme inhibitor among the numerous antidiabetic drugs used for the treatment 
of Type-II diabetes (Bedekar et al., 2010). Maglitol which was derived from 1-
deoxynorjirimycin is one of the widely used α-glucosidase inhibitors used in the treatment of 
Type II diabetes. Nojirimycin, deoxynojirimicin, and their derivatives are new compounds 
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with inhibitory properties derived from various Bacillus and Streptomyces strains (Schmidt et 
al., 1979; Tan, 1997). Another α-glucosidase inhibitor used as antidiabetic drug mostly in Asia 
is voglibose, which is synthesized from valiolamine isolated from fermentation broth of 
Streptomyces hydroscopicus subsp. Limoneus (Matsuo et al., 1992; Goke et al., 1995). 
Interestingly, polyphenols natural compounds such as flavonoids have demonstrated 
numerous health benefits, by addressing the issue of obesity and diabetes due to their 
digestive enzyme inhibition activity, induction of apoptosis in adipose tissue, etc. (Nelson-
Dooley et al., 2005). A subgroup of flavonoids, the anthocyanins is water-soluble plant 
pigments responsible for the blue, purple and red coloration of many plant tissues. 
Anthocynanins are extracted mostly from plants or plant waste in a form of a mixture. 
Anthocyanidins are the aglycon forms of anthocynanins of which 17 of them are found in 
nature. Anthocyanins have antioxidant and antihypertensive activities, they have also 
demonstrated the inhibition of lipid oxidation. Anthocyanins specifically inhibit α-
glucosidase activity and have the potential to reduce blood glucose levels after starch-rich 
meals. (Matsui et al., 2001a; Bedekar, 2010). Through influencing signalling molecules 
natural products can prevent both adult and childhood obesity. During physiological 
conditions such as exercise, hypoxia, the presence of reactive oxygen species (ROS), and 
ischemia/reperfusion activated protein kinase (AMPK) is activated, which is the master 
regulator of metabolic processes. Natural products also activate AMPK to reduce obesity 
through the regulation of fatty acid metabolism-related proteins such as acetyl-coenzyme A 
(CoA) carboxylase (ACC), sterol regulatory element-binding protein (SREBP), fatty acid 
synthase (FAS) and so forth (Hwang et al., 2011). 
24. Hypertension 
The hypothesis that meat is a source of peptides that are effective in preventing and 
reducing chronic life style-related diseases (CLSRDS) such as hypertension has been tested. 
Empowering hypertensive people in quality life such as offering nutritional food rich in 
antioxidant vitamins, and proteins or biologically active peptides, can lower blood pressure, 
possibly by preventing an underlying cause of the condition. Provision of these forms of 
functional food is useful even to the normotensive individuals nutritionally. The underlying 
aetiology to clinical hypertension may be due to a deficiency in proteins from meat origins, 
along with abnormalities in carbohydrate and fat metabolism. Proteolysis of meat muscle 
generate multiple number of amino acid peptides with nutrafunctional roles, the have 
strong angiotensin-converting enzyme inhibitory activity, which perhaps lower blood 
pressure (Ahmed and Muguruma, 2010). Dietary supplements promote cholesterol-
lowering benefits, some of these supplements reported to have significant low-density 
lipoprotein-cholesterol (LDL-C)  lowering properties are soluble plant fibre (oats, psyllium, 
pectin, flaxseed, barley, guar gum, cellulose, lignins, wheat bran), plant sterols, soy proteins, 
nuts ( almonds, pecan, walnut) and red yeast rice supplements (Nijjar et al., 2010). 
25. Analgesia and recreaction 
Pain is simply an undesirable physical or emotional experience. For the past 7000 years ago 
natural products have been used to treat pain disorders. A good example is opium poppy 
(Papaver soniferum) and the bark of willow tree (Salix spp.). In 19th century some individual 
components of different natural products remedies were identified and purified. One of the 
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most widely used and available compounds for the management of mild pain is Aspirin or 
acetylsalicylic acid derived from salicylic acid, which is extracted from Willow tree (Salix 
alba). Opioid is a name given to all compounds having the same mechanism of action as the 
constituents of opium. These are derived from opium juice from Papaver somniferum; 
examples of these groups of drugs include morphine, codeine and thebaine. These drugs are 
also use for recreational purposes apart from their use as analgesics (McCurdy and Scully, 
2005). Cocaine interact with voltage-gated ion channels and blocks sodium channels which 
is responsible for its local anaesthetic activity. Cocaine has the ability to block the dopamine 
transporter due to its ability to create a euphoric state, meaning it is also use for recreational 
purposes (McCurdy and Scully, 2005). Caffeine is the most widely used psychoactive drug 
in the world, found in a number of plant sources. Coffee (Coffea arabica, native to Africa), tea 
(Camellia sinensis, native to China), and cacao (Theobroma cacao, native to South and Central 
America), from which chocolate is made. Other caffeine-containing plants include kola (Cola 
acuminate), guarana (Paullinia cupana), and yerba mate (Ilex paraguarienis). Theophyllines 
found in tea and theobromines found in cacao are other botanical methylated xanthines 
closely related to caffeine with psychoactive effects. Nicotine from tobacco plant ( Nicotiana 
tabacum, Nicotiana rustica ) and related species are other psychoactive substances. Cannabis 
plant is the source of cannabinoids such as marijuana and hashish which also possess 
psychoactive effects in form of relaxation, sedation, intensification of thoughts and feelings, 
alterations of perception, and increased appetite (Presti, 2003). 
26. Antipsychotics 
From ancient times to present in Indian ayurvedic medicine, extracts of the snakeroot plant, 
Rauwolfia serpentine, have been used to treat psychotic symptoms. Reserpine was isolated 
and identified in the 20th century from R. serpentine, and was found to cause decreases in 
the activity of monoaminergic neurons using the neurotransmitters dopamine, 
norepinephrine, and serotonin (Presti, 2003). Polygalasaponins is an extract of a plant 
(Polygala tenuifolia Willdenow) that has been used as antipsychotic for hundred years in 
Korean traditional medicine. Polygalasaponin has been shown to have dopamine and 
serotonin receptor antagonism properties in vivo, suggesting its possible utility as an 
antipsychotic agent (Chung et al., 2002). 
27. Antidepressants 
Saint John’s wort (Hypericum perforatum) for centuries in Europe, the extract of this plant 
has been used for their antidepressant effects (Presti, 2003). Pharmacophores are natural 
products derived from chemically defended marine organisms related to serotonin or 
clinically utilized antidepressant drugs. Aaptamine and 5,6-dibromo-N,N-
dimethyltryptamine are two marine natural products which produced significant 
antidepressant-like activity in the forced swim tests. In the tail suspension test 
antidepressant-like effects of 5,6-dibromo-N,N-dimethyltryptamine were confirmed, 
whereas aaptamine has not produce significant results (Diers et al., 2008).  
28. Wound healing (angiogenesis) 
The plant Saint John’s wort when used in topical preparations facilitates wound healing. Its 
healing properties were mentioned in the ancient medical texts of Hippocrates, Pliny, and 
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with inhibitory properties derived from various Bacillus and Streptomyces strains (Schmidt et 
al., 1979; Tan, 1997). Another α-glucosidase inhibitor used as antidiabetic drug mostly in Asia 
is voglibose, which is synthesized from valiolamine isolated from fermentation broth of 
Streptomyces hydroscopicus subsp. Limoneus (Matsuo et al., 1992; Goke et al., 1995). 
Interestingly, polyphenols natural compounds such as flavonoids have demonstrated 
numerous health benefits, by addressing the issue of obesity and diabetes due to their 
digestive enzyme inhibition activity, induction of apoptosis in adipose tissue, etc. (Nelson-
Dooley et al., 2005). A subgroup of flavonoids, the anthocyanins is water-soluble plant 
pigments responsible for the blue, purple and red coloration of many plant tissues. 
Anthocynanins are extracted mostly from plants or plant waste in a form of a mixture. 
Anthocyanidins are the aglycon forms of anthocynanins of which 17 of them are found in 
nature. Anthocyanins have antioxidant and antihypertensive activities, they have also 
demonstrated the inhibition of lipid oxidation. Anthocyanins specifically inhibit α-
glucosidase activity and have the potential to reduce blood glucose levels after starch-rich 
meals. (Matsui et al., 2001a; Bedekar, 2010). Through influencing signalling molecules 
natural products can prevent both adult and childhood obesity. During physiological 
conditions such as exercise, hypoxia, the presence of reactive oxygen species (ROS), and 
ischemia/reperfusion activated protein kinase (AMPK) is activated, which is the master 
regulator of metabolic processes. Natural products also activate AMPK to reduce obesity 
through the regulation of fatty acid metabolism-related proteins such as acetyl-coenzyme A 
(CoA) carboxylase (ACC), sterol regulatory element-binding protein (SREBP), fatty acid 
synthase (FAS) and so forth (Hwang et al., 2011). 
24. Hypertension 
The hypothesis that meat is a source of peptides that are effective in preventing and 
reducing chronic life style-related diseases (CLSRDS) such as hypertension has been tested. 
Empowering hypertensive people in quality life such as offering nutritional food rich in 
antioxidant vitamins, and proteins or biologically active peptides, can lower blood pressure, 
possibly by preventing an underlying cause of the condition. Provision of these forms of 
functional food is useful even to the normotensive individuals nutritionally. The underlying 
aetiology to clinical hypertension may be due to a deficiency in proteins from meat origins, 
along with abnormalities in carbohydrate and fat metabolism. Proteolysis of meat muscle 
generate multiple number of amino acid peptides with nutrafunctional roles, the have 
strong angiotensin-converting enzyme inhibitory activity, which perhaps lower blood 
pressure (Ahmed and Muguruma, 2010). Dietary supplements promote cholesterol-
lowering benefits, some of these supplements reported to have significant low-density 
lipoprotein-cholesterol (LDL-C)  lowering properties are soluble plant fibre (oats, psyllium, 
pectin, flaxseed, barley, guar gum, cellulose, lignins, wheat bran), plant sterols, soy proteins, 
nuts ( almonds, pecan, walnut) and red yeast rice supplements (Nijjar et al., 2010). 
25. Analgesia and recreaction 
Pain is simply an undesirable physical or emotional experience. For the past 7000 years ago 
natural products have been used to treat pain disorders. A good example is opium poppy 
(Papaver soniferum) and the bark of willow tree (Salix spp.). In 19th century some individual 
components of different natural products remedies were identified and purified. One of the 
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most widely used and available compounds for the management of mild pain is Aspirin or 
acetylsalicylic acid derived from salicylic acid, which is extracted from Willow tree (Salix 
alba). Opioid is a name given to all compounds having the same mechanism of action as the 
constituents of opium. These are derived from opium juice from Papaver somniferum; 
examples of these groups of drugs include morphine, codeine and thebaine. These drugs are 
also use for recreational purposes apart from their use as analgesics (McCurdy and Scully, 
2005). Cocaine interact with voltage-gated ion channels and blocks sodium channels which 
is responsible for its local anaesthetic activity. Cocaine has the ability to block the dopamine 
transporter due to its ability to create a euphoric state, meaning it is also use for recreational 
purposes (McCurdy and Scully, 2005). Caffeine is the most widely used psychoactive drug 
in the world, found in a number of plant sources. Coffee (Coffea arabica, native to Africa), tea 
(Camellia sinensis, native to China), and cacao (Theobroma cacao, native to South and Central 
America), from which chocolate is made. Other caffeine-containing plants include kola (Cola 
acuminate), guarana (Paullinia cupana), and yerba mate (Ilex paraguarienis). Theophyllines 
found in tea and theobromines found in cacao are other botanical methylated xanthines 
closely related to caffeine with psychoactive effects. Nicotine from tobacco plant ( Nicotiana 
tabacum, Nicotiana rustica ) and related species are other psychoactive substances. Cannabis 
plant is the source of cannabinoids such as marijuana and hashish which also possess 
psychoactive effects in form of relaxation, sedation, intensification of thoughts and feelings, 
alterations of perception, and increased appetite (Presti, 2003). 
26. Antipsychotics 
From ancient times to present in Indian ayurvedic medicine, extracts of the snakeroot plant, 
Rauwolfia serpentine, have been used to treat psychotic symptoms. Reserpine was isolated 
and identified in the 20th century from R. serpentine, and was found to cause decreases in 
the activity of monoaminergic neurons using the neurotransmitters dopamine, 
norepinephrine, and serotonin (Presti, 2003). Polygalasaponins is an extract of a plant 
(Polygala tenuifolia Willdenow) that has been used as antipsychotic for hundred years in 
Korean traditional medicine. Polygalasaponin has been shown to have dopamine and 
serotonin receptor antagonism properties in vivo, suggesting its possible utility as an 
antipsychotic agent (Chung et al., 2002). 
27. Antidepressants 
Saint John’s wort (Hypericum perforatum) for centuries in Europe, the extract of this plant 
has been used for their antidepressant effects (Presti, 2003). Pharmacophores are natural 
products derived from chemically defended marine organisms related to serotonin or 
clinically utilized antidepressant drugs. Aaptamine and 5,6-dibromo-N,N-
dimethyltryptamine are two marine natural products which produced significant 
antidepressant-like activity in the forced swim tests. In the tail suspension test 
antidepressant-like effects of 5,6-dibromo-N,N-dimethyltryptamine were confirmed, 
whereas aaptamine has not produce significant results (Diers et al., 2008).  
28. Wound healing (angiogenesis) 
The plant Saint John’s wort when used in topical preparations facilitates wound healing. Its 
healing properties were mentioned in the ancient medical texts of Hippocrates, Pliny, and 
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Galen (Presti, 2003). Honey has been shown to possessed various antimicrobial activities in 
addition to its wound healing effect, a good example is the manuka honey (Leptospermum 
scoparium). Preparations of aloe vera (Aloe barbadensis), cocoa and oak bark extracts have 
been used to treat various ailments especially those of the skin (Davis and Perez, 2009). 
Upon injury papaya and fig trees produce latex rich in proteolytic enzymes, the juices 
extracted from the stem or fruit of plants such as the pineapple, contain large amount of 
cysteine proteinases (Rowan et al., 1990). Chymopapain, is one of these enzymes used in 
medicine to treat intervertebral disc prolapse with a similar success rate to surgery (Smith 
and Brown, 1967). For burn injuries ananain and comosain are used as debriding agents 
(Rowan et al., 1990). Bromelain, papain, and ficin have been used to replace glucocorticoids 
and non-steroidal anti-rheumatics as anti-inflammatory drugs (Lotz-Winner, 1990; Maurer, 
2001; Stepek et al., 2004). 
29. Role of natural products in preventive medicine 
Natural products like medicinal plants and foodstuffs are used for their preventive effects 
against life-style related diseases such as coronary heart diseases, hypertension, thrombosis, 
allergic inflammation, arteriosclerosis, diabetes and cancer, although clinical basis and 
experimental evidence are insufficient and unclear. However, biochemical and 
pharmacological study of isolated natural compounds from various medicinal plants and 
foodstuffs indicate that fucoidan (polysaccharides), carp oil (fatty acids) and triterpenoids 
inhibited the tumour growth and/or metastasis in the liver, through the inhibition of tumour 
induced neovascularization, in tumour-bearing mice. The inhibition of thrombin-induced 
adhesion molecule through protein C kinase activation inhibition has been demonstrated by 
baicalein (flavones) isolated from Scutellaria baicalensis roots. Furthermore, through 
endothelium-dependent nitric oxide production, xanthoangelol (chalcones) isolated from 
Angelica keiskei roots inhibited catecholamine-induced vasoconstriction (Kimura, 2005). Many 
plants are used in traditional medicine as active agents against various effects induced by 
snakebite. Baccharis trimera (Asteraceae), known in as carqueja in Brazil, has been shown to 
inhibit haemorrhagic and proteolytic activity caused by Bothrops snake vemons (Januario et al., 
2004). Biologicals like vaccines and antisera have a great role in preventive medicine. 
Polyclonal antibodies are mixture of antibody specificities which all recognize the same 
antigen. Blood serum that contains polyclonal antibodies is known as antiserum. Polyclonal 
antibodies are used in medicine to confer passive immunity to certain diseases. For instance, 
transfusion of serum antibodies from a human survivor of Ebola virus is the only effective 
treatment for the viral infection. Antiserum is also used in medicine as antitoxin or antivenin, 
which contain antibodies specific for venom from poisonous reptiles, arachnids and insects. 
People who have been bitten or stung by these animals are treated with this antiserum. 
Vaccine is a biological preparation that improves immunity to a particular disease made from 
attenuated or killed forms of a microbe or its toxins. Vaccines are used for either prophylaxis 
or therapy against certain disease conditions such as smallpox. Smallpox vaccine was the first 
successful vaccine to be developed in 1796 by Edward Jenner (Stewart and Devlin, 2006). 
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Galen (Presti, 2003). Honey has been shown to possessed various antimicrobial activities in 
addition to its wound healing effect, a good example is the manuka honey (Leptospermum 
scoparium). Preparations of aloe vera (Aloe barbadensis), cocoa and oak bark extracts have 
been used to treat various ailments especially those of the skin (Davis and Perez, 2009). 
Upon injury papaya and fig trees produce latex rich in proteolytic enzymes, the juices 
extracted from the stem or fruit of plants such as the pineapple, contain large amount of 
cysteine proteinases (Rowan et al., 1990). Chymopapain, is one of these enzymes used in 
medicine to treat intervertebral disc prolapse with a similar success rate to surgery (Smith 
and Brown, 1967). For burn injuries ananain and comosain are used as debriding agents 
(Rowan et al., 1990). Bromelain, papain, and ficin have been used to replace glucocorticoids 
and non-steroidal anti-rheumatics as anti-inflammatory drugs (Lotz-Winner, 1990; Maurer, 
2001; Stepek et al., 2004). 
29. Role of natural products in preventive medicine 
Natural products like medicinal plants and foodstuffs are used for their preventive effects 
against life-style related diseases such as coronary heart diseases, hypertension, thrombosis, 
allergic inflammation, arteriosclerosis, diabetes and cancer, although clinical basis and 
experimental evidence are insufficient and unclear. However, biochemical and 
pharmacological study of isolated natural compounds from various medicinal plants and 
foodstuffs indicate that fucoidan (polysaccharides), carp oil (fatty acids) and triterpenoids 
inhibited the tumour growth and/or metastasis in the liver, through the inhibition of tumour 
induced neovascularization, in tumour-bearing mice. The inhibition of thrombin-induced 
adhesion molecule through protein C kinase activation inhibition has been demonstrated by 
baicalein (flavones) isolated from Scutellaria baicalensis roots. Furthermore, through 
endothelium-dependent nitric oxide production, xanthoangelol (chalcones) isolated from 
Angelica keiskei roots inhibited catecholamine-induced vasoconstriction (Kimura, 2005). Many 
plants are used in traditional medicine as active agents against various effects induced by 
snakebite. Baccharis trimera (Asteraceae), known in as carqueja in Brazil, has been shown to 
inhibit haemorrhagic and proteolytic activity caused by Bothrops snake vemons (Januario et al., 
2004). Biologicals like vaccines and antisera have a great role in preventive medicine. 
Polyclonal antibodies are mixture of antibody specificities which all recognize the same 
antigen. Blood serum that contains polyclonal antibodies is known as antiserum. Polyclonal 
antibodies are used in medicine to confer passive immunity to certain diseases. For instance, 
transfusion of serum antibodies from a human survivor of Ebola virus is the only effective 
treatment for the viral infection. Antiserum is also used in medicine as antitoxin or antivenin, 
which contain antibodies specific for venom from poisonous reptiles, arachnids and insects. 
People who have been bitten or stung by these animals are treated with this antiserum. 
Vaccine is a biological preparation that improves immunity to a particular disease made from 
attenuated or killed forms of a microbe or its toxins. Vaccines are used for either prophylaxis 
or therapy against certain disease conditions such as smallpox. Smallpox vaccine was the first 
successful vaccine to be developed in 1796 by Edward Jenner (Stewart and Devlin, 2006). 
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1. Introduction 
In the last 40 or 50 years mankind, particularly in the western world, has modified its diet to 
include a reduced amount of fruits and vegetables, while increasing its intake of processed 
foods with a high content in fats and simple carbohydrates. This change has brought on 
consequences such as the development of a vast array of conditions like the metabolic 
syndrome (also known as syndrome X or insulin resistance syndrome), which is known to 
include dyslipidemia and oxidative stress among other physiologic disturbances, and be 
itself a risk factor for the development of diabetes and cardiovascular disease (CVD). On the 
other hand, studies suggest that a diet rich in fruits and vegetables can have a positive 
impact on dyslipidemia and oxidative stress markers, as well as other components of the 
metabolic syndrome. These positive effects are mediated mainly by the antioxidant vitamins 
(A, C and E), carotenoids, polyphenols and other important phytochemicals.  
2. Diet, the metabolic syndrome, dyslipidemia and oxidative stress 
In 2007, the World Health Organization (WHO) estimated that about 1.7 billion people 
worldwide were overweight (including at least 155 million children) (Hossain et al., 2007), 
these numbers have transformed obesity and its related maladies into a worldwide 
epidemic. Even though obesity is almost always assumed to be a necessary condition for the 
development of dyslipidemia, metabolic syndrome, diabetes and CVD, and these terms are 
sometimes used as if they all occur alongside each other, this may not always be true, since 
overweight people may in fact present normal lipid and glucose concentrations, as well as 
normal blood pressure, normal insulin metabolism and low inflammatory markers (Barter et 
al., 2007) (the term marker in this chapter is to be understood as measurable markers such as 
cholesterol concentration and not genetic markers). Therefore it is the clustering of factors 
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defined as metabolic syndrome that confers the highest risk for CVD mortality, although 
many of the isolated conditions are also risk factors for CVD (Isomaa et al., 2001). 
Since diet is a major contributor to metabolic syndrome, some authors have noted the 
particular relationship between the two. Fructose has been consumed mainly from fruits 
and honey at about 16-20 g/day since early times, while having a recent and significant 
increase to 85-100 g/day with the addition of high-fructose corn syrup (HFCS) as a 
sweetener in products such as soft drinks, fruit juices and many other items commonly 
included in western diets; this rise in consumption has important metabolic consequences 
for the individual (Basciano et al., 2005). When adequate amounts of fructose are ingested 
it can have a positive effect on glucose metabolism, like the reduction in glycemic 
response and a better tolerance to glucose, however, when fructose is ingested in greater 
quantities it directs the liver (the main organ responsible for metabolizing it) to increase de 
novo lipogenesis, in other words, it deviates the metabolism in favor of storing energy in 
the form of triacylglycerols while increasing their plasma levels, which in turn translates 
into obesity and insulin resistance, all of which part of the metabolic syndrome (Basciano 
et al., 2005). 
A high fat diet can also have important effects on the individual, including induction of 
oxidative stress. A study compared the effects of the consumption of a high fat breakfast 
(fast food style) in patients with metabolic syndrome, to a meal recommended by the 
American Heart Association (control). An increase in triacylglycerols, with a concomitant 
decrease in HDL, was found in the fast food breakfast group; at the same time, 
biomarkers of oxidative stress rose significantly in this group compared to the control 
(Devaraj et al., 2008). These effects have also been noted on animal models, for example, 
when New Zealand White rabbits were subjected to a diet rich in cholesterol for six 
months their lipid profiles changed; their triacylglycerols, total and LDL cholesterol rose 
while HDL cholesterol was reduced; oxidative stress markers were also elevated when 
cholesterol was administered in the diet, these effects were not apparent when coconut or 
sunflower oil were administered instead of cholesterol (Sabitha et al., 2010). The 
aforementioned experiments show how dyslipidemia and oxidative stress can occur 
simultaneously as consequences of a high fat diet; however this apparently simple 
relationship can become more intertwined thereafter, since the products of oxidative 
stress can oxidize lipid-containing molecules such as LDL to form oxLDL (which can be 
considered a marker of oxidative stress), and in turn, generate an inflammatory response. 
The organism cannot cope with these extenuating circumstances for an extended period of 
time and cardiovascular disease takes place (Rizzo et al., 2009). It is therefore possible to 
argue that initially both conditions take place side by side, and after a while the two 
become part of the same cumulative disorder, in which oxidative stress can synergize 
with altered lipid levels and aid in the development of cardiovascular disease. 
Sachidanandam in 2009 (Sachidanandam et al., 2009) shows that in rats fed a high fat diet, 
the collagen patterns were altered favoring matrix accumulation, as well as increased 
constriction and impaired relaxation of the vascular tissue (Sachidanandam et al., 2009). 
Similar results were obtained in mice by Poirier in 2005, who reported that a high fat diet 
can lead to the development of obesity, insulin resistance and other symptoms similar to 
metabolic syndrome in humans (Poirier et al., 2005). This evidence shows that the 
dyslipidemia and oxidative stress (initially brought on by diet) can lead to the 
development of CVD by impacting specific tissues like the arteries.  
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Dyslipidemia is so called because it involves a high serum triacylglycerol concentration (≥ 
200 mg/dL), low high-density lipoprotein cholesterol (HDL) concentration (< 35 mg/dL), 
small dense low-density lipoproteins (sdLDL) and an increased concentration of 
inflammatory markers (Adiels et al., 2008; Barter et al., 2007; Bestehorn et al., 2010; Rader, 
2007). The first three biomarkers have even been referred to as the “lipid triad”, and because 
they have been found in patients with CVD, it is also called the “atherogenic lipoprotein 
phenotype” (Bestehorn et al., 2010; Grundy, 1998; Rizzo & Berneis, 2005).  
Oxidative stress can be described as an imbalance in the REDOX homeostasis of the cell, 
although it lacks a precise definition. Under normal circumstances the cell produces an 
assortment of oxidant molecules that can become extremely detrimental if their 
concentrations are not kept under strict regulation and whose elimination takes place via 
enzymatic and non-enzymatic systems. The synthesis of these oxidant molecules, usually 
known as reactive oxygen species (ROS) is an unfortunate byproduct of having an aerobic 
metabolism and underlies the so called oxygen toxicity (Auten & Davis, 2009). Nevertheless, 
the cell has an impressive array of defense mechanisms that, in healthy individuals and 
under an optimal diet, can be quite effective in maintaining ROS under adequate 
concentrations. This balance of oxidation and reduction can be a fragile one, and when it is 
broken cells and tissues are led to oxidative stress. This can occur by an acute or chronic 
overproduction of ROS brought on by trauma, toxicity (by the consumption of ethanol, 
cigarette smoke, xenobiotics and others), genetic factors, stress, poor or unhealthy eating 
habits (something already acknowledged) and many other factors (Augustyniak & 
Skrzydlewska, 2009; Studzinski et al., 2009; Talukder et al., 2011). It can also be caused by a 
deficient antioxidant defense system even if the oxidative molecules are present in normal 
quantities. In any case, this brittle balance is overwhelmed to the side of the oxidative 
molecules, and it is at this point where the negative effects can become apparent in the 
progression of CVD as well as other conditions like different types of cancers, diabetes and 
the progression of aging (Agalliu et al., 2010; Gupta et al., 2010; Kenyon, 2010). Another 
interesting point is that oxidative stress is a condition that cannot be completely neutralized, 
since there is constant damage being inflicted on the cell from its own metabolism as well as 
environmental sources (Costantini & Verhulst, 2009). 
Oxidative stress is a complex condition, and it can affect the organisms in many different 
ways, there are various ways that it can be measured; these can be grouped into four general 
categories: free radical production, antioxidant mechanisms, oxidative damage and repair 
mechanisms (Monaghan et al., 2009). 
Thiobarbituric acid reacting substances (TBARS) is one of the most popular techniques used 
to evaluate oxidative stress in living organisms (Alturfan et al., 2009). It is also used to 
evaluate oxidation of food systems. TBARS are used to determine malondialdehyde (MDA) 
and other molecules that are generated as byproducts of lipid oxidation, (it is therefore a 
measure of oxidative damage) although it can be somewhat unspecific since other 
compounds also react with thiobarbituric acid (Caprioli et al., 2011).  
Antioxidant capacity of plasma can also be used as a marker of oxidative stress or REDOX 
status of live systems. A number of methods are used to measure plasma antioxidant capacity, 
some of the most popular are ferric reducing ability of plasma (FRAP), oxygen radical 
scavenging capacity (ORAC), total radical-trapping antioxidant parameter (TRAP) and trolox 
equivalent antioxidant capacity (TEAC) among others (Grigelmo-Miguel et al., 2009).  
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Other indicators of oxidative stress or REDOX status include activity and expression of 
antioxidant enzymes and concentration of non-enzymatic antioxidants in plasma and tissues 
(Beltowski et al., 2008). 
2.1 Oxidative stress and antioxidants 
The main molecules implicated in the occurrence of oxidative stress are free radicals and 
ROS. Free radicals are defined as species having one or more unpaired electrons which 
make them unstable and highly reactive. Among the most common oxygen free radicals are 
the superoxide anion (O2· -), the hydroxyl radical (· OH) and peroxyl radicals (ROO·). Other 
kinds of ROS are not free radicals, the most important one being hydrogen peroxide (H2O2). 
The sources of the O2· - are dioxygen-reducing enzymes such as NADPH oxidases, xanthine 
oxidase, monoamine oxidase, prostaglandin synthases (Peyrot & Ducrocq, 2008) and 
cytochrome P450-dependant oxygenases, some of which are located in the cell membrane of 
polymorphonuclear cells, macrophages and endothelial cells (Turrens, 2003). The 
mammalian mitochondria complexes I and III have been shown to produce O2· -, however, 
these are not the only sites inside the mitochondria that produce it, the others are mainly 
enzymes that interact with the matrix NADH pool and/or the CoQ pool (Murphy, 2009). 
Non-enzymatic sources of the anion have also been reported, mainly by the action of 
coenzymes (flavins), prosthetic groups (iron-sulfur clusters) or enzyme-reduced xenobiotics 
(adriamycin) (Turrens, 2003). 
Some of the negative effects that ROS can exert is DNA and RNA damage which can lead to 
an increased number of mutations, membrane lipid peroxidation, and protein tyrosine 
nitration (this last one being a marker for so called nitrosative stress), and after the cell 
sustains too many of these insults, it may become mutated or direct itself to apoptosis, 
giving way to the development of the previously mentioned oxidative stress-related 
diseases, like CVD, cancer diabetes and aging (Corpas et al., 2008). Some ROS molecules are, 
under certain conditions, non-toxic, but can react with other free radicals such as NO·, to 
form the peroxynitrate ion (Corpas et al., 2008; Peyrot & Ducrocq, 2008; Valko et al., 2007): 
 NO·  +  O2· -  ONOO- (1) 
This reaction has been known to take place in situations such as hyperglycemia, 
atherosclerosis, inflammation and others, while at the same time modulating important 
signaling pathways such as the one mediated by the serine/threonine protein kinase Akt, 
which is involved in cell growth, glycogen synthesis, cell proliferation and apoptosis (Song 
et al., 2007). Since the production of ROS is largely inevitable, the cell has evolved 
mechanisms to cope with them and maintain an acceptable REDOX state, they can be 
divided into two broad groups; enzymatic and non-enzymatic. 
The enzymatic antioxidant mechanisms are sensitive to the REDOX state of the cell, and are 
thus activated when an overproduction of free radicals starts to become a threat to the 
wellbeing of the cell. Their function is to neutralize a free radical or potentially toxic 
molecule by either converting it to an innocuous compound, or to another one that is less 
reactive and/or less toxic. Among them are superoxide dismutase (SOD), catalase (CAT), 
glutathione peroxidase (GPX), glutathione reductase (GR) and glutathione-S-transferase 
(GST). These enzymes work in synergy with non-enzymatic compounds, such as 
phytochemicals, obviously ingested in the diet. 
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SOD (E.C. 1.15.1.1) is an enzyme whose function is to catalyze the dismutation of the O2· - 
into H2O2. This important reaction has been known to take place on both the cell’s interior 
and exterior, mediated however by different isoenzymes. SOD1 is present in the cytosol, 
nucleus and intermembrane space in the mitochondria; it is also called the Cu/Zn SOD 
because it requires these two metals in order to be catalytically active. SOD2 is dependent 
not on Cu/Zn but on Mn, and it is found on the mitochondrial matrix. SOD3 contains Cu 
and it is found on the extracellular matrix of tissues, being therefore called EC-SOD (Gao et 
al., 2008; Juarez et al., 2008; Wilcox et al., 2009). These enzymes play an important role in 
maintaining the O2· - concentration in a range of about 10-10 M, nevertheless they do it by 
transforming it into H2O2 that is still toxic; it is at this point that CAT and GPX becomes 
active. Catalase (E.C. 1.11.1.6) is a heme-containing enzyme that is almost ubiquitously 
expressed in aerobic organisms. It is an oxidoreductase that is capable of converting the 
toxic H2O2 into water and molecular oxygen without the parallel synthesis of free radicals, a 
critical feature since H2O2 itself may have been formed from the O2· -; a free radical. It is also 
known for having one of the fastest catalytic rates (~ 107 M/s) (Goyal & Basak, 2010; 
Odajima et al., 2010; Prakash et al., 2009). GPX (E.C. 1.11.1.9 and 1.11.1.12) is another 
enzyme that also performs a similar function as CAT, while at the same time having broader 
substrate range, therefore being able to remove other organic peroxides and converting 
them into water and the corresponding alcohols while utilizing glutathione as an electron 
donor. GPX is a family of enzymes that may be Se-dependent (in the form of a 
selenocysteine); and in mammals there are four isoenzymes. GPX1 is found in all tissues, 
and is abundant in erythrocytes, liver, lungs and kidneys; GPX2 or gastrointestinal GPX is 
found in the gastrointestinal tract, GPX3 is present in plasma, and GPX4, or phospholipid 
GPX is ubiquitous, as GPX1, but is selective towards lipid hydroperoxides (Arsova-
Sarafinovska et al., 2009; Margis et al., 2008). When the toxic hydroperoxides have been 
neutralized by GPX, glutathione is oxidized in the process and in order to return it to its 
reduced state, GR (E.C. 1.8.1.7) must participate at this time. GR is a flavoprotein capable of 
reducing glutathione by oxidizing NADPH, therefore contributing to maintaining a pool of 
reduced glutathione and helping to preserve the REDOX state of the cell (Marty et al., 2009; 
Meister, 1988). Finally, GST (E.C. 2.5.1.18) is a family (containing at least the , , , , , and 
 isoforms) pertaining to the Phase II detoxification enzymes. They are responsible for 
transferring glutathione to electrophilic molecules of diverse nature, such as xenobiotics, 
environmental toxins, a number of drugs and of course products of oxidative stress; thereby 
making them less reactive and easier to excrete (Burmeister et al., 2008; Carlsten et al., 2008; 
D. M. Townsend & Tew, 2003; Danyelle M. Townsend et al., 2009). All of these enzymes 
work in unison to maintain the ROS and free radicals under tolerable concentrations; a 
simplified scheme of how they do so is exemplified in Fig. 1 
Although the enzymes are quite efficient in maintaining the cell’s REDOX state they must be 
aided by non-enzymatic molecules. These can be of endogenous (glutathione) and of 
exogenous origin (ascorbate, tocopherols, carotenes, retinols and polyphenols among others) 
and their functions are to neutralize free radicals by either acting on their own or in 
conjunction with the enzymatic systems. Glutathione is a tripeptide (-glutamyl-
cysteinylglycine) synthesized in the cell by a two-step process involving -glutamyl cysteine 
synthetase and glutathione synthetase, both of which are ATP-dependent. This molecule is 
found in the millimolar concentration range in the cytoplasm and within many organelles. 
Since it has a thiol functional group, it can become oxidized and reduced and thus function 
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Other indicators of oxidative stress or REDOX status include activity and expression of 
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oxidase, monoamine oxidase, prostaglandin synthases (Peyrot & Ducrocq, 2008) and 
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polymorphonuclear cells, macrophages and endothelial cells (Turrens, 2003). The 
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these are not the only sites inside the mitochondria that produce it, the others are mainly 
enzymes that interact with the matrix NADH pool and/or the CoQ pool (Murphy, 2009). 
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coenzymes (flavins), prosthetic groups (iron-sulfur clusters) or enzyme-reduced xenobiotics 
(adriamycin) (Turrens, 2003). 
Some of the negative effects that ROS can exert is DNA and RNA damage which can lead to 
an increased number of mutations, membrane lipid peroxidation, and protein tyrosine 
nitration (this last one being a marker for so called nitrosative stress), and after the cell 
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diseases, like CVD, cancer diabetes and aging (Corpas et al., 2008). Some ROS molecules are, 
under certain conditions, non-toxic, but can react with other free radicals such as NO·, to 
form the peroxynitrate ion (Corpas et al., 2008; Peyrot & Ducrocq, 2008; Valko et al., 2007): 
 NO·  +  O2· -  ONOO- (1) 
This reaction has been known to take place in situations such as hyperglycemia, 
atherosclerosis, inflammation and others, while at the same time modulating important 
signaling pathways such as the one mediated by the serine/threonine protein kinase Akt, 
which is involved in cell growth, glycogen synthesis, cell proliferation and apoptosis (Song 
et al., 2007). Since the production of ROS is largely inevitable, the cell has evolved 
mechanisms to cope with them and maintain an acceptable REDOX state, they can be 
divided into two broad groups; enzymatic and non-enzymatic. 
The enzymatic antioxidant mechanisms are sensitive to the REDOX state of the cell, and are 
thus activated when an overproduction of free radicals starts to become a threat to the 
wellbeing of the cell. Their function is to neutralize a free radical or potentially toxic 
molecule by either converting it to an innocuous compound, or to another one that is less 
reactive and/or less toxic. Among them are superoxide dismutase (SOD), catalase (CAT), 
glutathione peroxidase (GPX), glutathione reductase (GR) and glutathione-S-transferase 
(GST). These enzymes work in synergy with non-enzymatic compounds, such as 
phytochemicals, obviously ingested in the diet. 
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SOD (E.C. 1.15.1.1) is an enzyme whose function is to catalyze the dismutation of the O2· - 
into H2O2. This important reaction has been known to take place on both the cell’s interior 
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and it is found on the extracellular matrix of tissues, being therefore called EC-SOD (Gao et 
al., 2008; Juarez et al., 2008; Wilcox et al., 2009). These enzymes play an important role in 
maintaining the O2· - concentration in a range of about 10-10 M, nevertheless they do it by 
transforming it into H2O2 that is still toxic; it is at this point that CAT and GPX becomes 
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reduced state, GR (E.C. 1.8.1.7) must participate at this time. GR is a flavoprotein capable of 
reducing glutathione by oxidizing NADPH, therefore contributing to maintaining a pool of 
reduced glutathione and helping to preserve the REDOX state of the cell (Marty et al., 2009; 
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D. M. Townsend & Tew, 2003; Danyelle M. Townsend et al., 2009). All of these enzymes 
work in unison to maintain the ROS and free radicals under tolerable concentrations; a 
simplified scheme of how they do so is exemplified in Fig. 1 
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conjunction with the enzymatic systems. Glutathione is a tripeptide (-glutamyl-
cysteinylglycine) synthesized in the cell by a two-step process involving -glutamyl cysteine 
synthetase and glutathione synthetase, both of which are ATP-dependent. This molecule is 
found in the millimolar concentration range in the cytoplasm and within many organelles. 
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Fig. 1. The relationships between the different enzymatic antioxidant mechanisms. GR: 
glutathione reductase; GSH: reduced glutathione; GSSG: oxidized glutathione; GPX: 
glutathione peroxidase; SOD: superoxide dismutase; X: xenobiotic; GS-X : glutathione-
conjugated xenobiotic. Equations are not balanced. 
as an antioxidant, donating an electron and sacrificing itself to neutralize ROS in addition to 
many other molecules of diverse natures. The neutralization of oxidative molecules can take 
place without an enzymatic component by a direct interaction of the oxidant and the 
antioxidant, but when other molecules such as hydroperoxides are involved, an enzymatic 
system such as GPX is crucial to the process. Since reduced glutathione is oxidized during 
the course of these reactions, the enzyme GR is in charge of maintaining the pool of reduced 
glutathione consuming NADPH (from the pentose phosphate shunt) in the process. There 
are plasma membrane transporters that can also modulate the cell’s REDOX state by 
importing and exporting reduced glutathione, oxidized glutathione and many conjugates of 
glutathione. The depletion of glutathione can be an important indicator of oxidative stress 
via the ratio of reduced to oxidized glutathione (Ballatori et al., 2009; Diaz Vivancos et al., 
2010; Foyer & Noctor, 2011; Martin & Teismann, 2009). 
Ascorbate, also known as vitamin C, is one of the exogenous molecules obtained through 
the diet. It is present in a diverse variety of vegetable foodstuffs such as apples, papaya, 
mango, guava oranges and others (Oliveira et al., 2010; Suárez-Jacobo et al., 2011). It is 
known as a free radical scavenger that does not act as a pro-oxidant under normal 
conditions, and it has been mentioned to function in parallel with glutathione (Cuddihy et 
al., 2008; Foyer & Noctor, 2011; Frei & Lawson, 2008; Valero et al., 2009). Because of its 
ability to neutralize free radicals it has been mentioned as having a possible therapeutic use 
in disorders such as ischemic stroke, Alzheimer’s, Parkinson’s and Huntington’s diseases 
(Harrison & May, 2009), and it is sometimes consumed by athletes to neutralize the ROS 
produced during exercise (Gomez-Cabrera et al., 2008), it can neutralize protein radicals 
(Domazou et al., 2009) and its role in the improvement of endothelial function (a precursor 
of atherogenesis) has also been noted (Frikke-Schmidt & Lykkesfeldt, 2010; May & Qu, 2011; 
Sabharwal & May, 2008). 
Vitamin E is the collective term for at least eight structurally related molecules: four 
tocopherols and four tocotrienols, of which -tocopherol is the most studied (Ravaglia et al., 
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2008). Since tocopherols are of non-polar nature, their main function lies in the hydrophobic 
environment of cell and organelle membranes, protecting these structures from free radicals 
and also by stabilizing them (Atkinson et al., 2008; Naumowicz et al., 2009). Tocopherols 
induce a protective effect against oxidative stress linked to metabolic syndrome as well as 
other sources (Chung et al., 2010; Devaraj et al., 2008; Grattagliano et al., 2008; Roberts & 
Sindhu, 2009). 
Carotenoids are other important molecules with antioxidant activity. They are hydrophobic 
vegetal pigments derived from isoprenoid units with up to 15 conjugated double bonds 
(Costantini & Moller, 2008; Tanaka et al., 2008). This large family of molecules contains more 
than 700 different structures identified so far, and are thought to play an essential role in the 
life cycle of the plants that produce them (Nishino et al., 2009; Tanaka et al., 2008). Even 
though some animals like birds, fishes and invertebrates use them in order to generate 
colorations for structures such as their skin and feathers, none of them have the ability to 
synthesize them and must therefore obtain them from exogenous plant sources. Of the most 
relevant ones we find  and  carotene (the later one being the one with the most 
provitamin A activity, and also one of the most thoroughly studied), lutein, lycopene, 
zeaxanthin and -cryptoxanthin (Britton & Khachik, 2009; Costantini & Moller, 2008). These 
pigments have been shown to interact with virtually all the radicals present in biological 
systems and are, consequently, significant antioxidants. In animals they have the potential 
to not only act upon free radicals, but also to modulate critical functions such as 
immunostimulation, and inhibition of the tumorigenesis process (Krinsky & Yeum, 2003; 
Nishino et al., 2009). 
The last exogenous antioxidant to be mentioned is retinol (Vitamin A), a molecule that is 
related to the previously mentioned carotenoids. -carotene can in fact be transformed to 
retinol, and this can in turn be transformed into retinal and retinoic acid, all of which have 
different biological functions on many tissues (Bremner & McCaffery, 2008). This 
compound, as well as its other metabolites, affects important processes such as immunity, 
reproduction, growth, development and, perhaps its best known function, it holds a vital 
role in the visual cycle (Pasquali et al., 2008; Redmond, 2009; Redmond et al., 2010). -
carotene has been characterized as an antioxidant, nevertheless, it can have toxic effects and 
has been named as a pro-oxidant when it is administered at higher doses and on certain 
types of cell cultures (Pasquali et al., 2008; Roehrs et al., 2009). When it functions as an 
antioxidant it has been positively linked to diverse ailments related to oxidative stress, such 
as diabetes (Ramakrishna & Jailkhani, 2008), obesity (Botella-Carretero et al., 2010), low 
sperm motility (Kao et al., 2008), hearing loss (Michikawa et al., 2009) and others. 
Aside from the “antioxidant vitamins” the polyphenol group is another very diverse family 
of molecules present in fruits and vegetables. They are plant secondary metabolites that can 
be subdivided into many groups according to their molecular structure. Some of the 
representative molecules included here are quercetin, coumaric acid, proanthocyanidins 
resveratrol among others. Although traditionally considered antioxidants, they can also 
have antimicrobial, antiviral and anti-inflammatory properties (Ignat et al., 2011); they have 
consequently gained attention because of these in vivo health-promoting properties (Brisdelli 
et al., 2009; Chong et al., 2010; Huang et al., 2010; Massaro et al., 2010). 
Since fruits and vegetables are rich in all types of exogenous antioxidant molecules, 
scientists have linked these bioactive molecules to the positive health effects of a fruit and 
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importing and exporting reduced glutathione, oxidized glutathione and many conjugates of 
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Ascorbate, also known as vitamin C, is one of the exogenous molecules obtained through 
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known as a free radical scavenger that does not act as a pro-oxidant under normal 
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(Domazou et al., 2009) and its role in the improvement of endothelial function (a precursor 
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2008). Since tocopherols are of non-polar nature, their main function lies in the hydrophobic 
environment of cell and organelle membranes, protecting these structures from free radicals 
and also by stabilizing them (Atkinson et al., 2008; Naumowicz et al., 2009). Tocopherols 
induce a protective effect against oxidative stress linked to metabolic syndrome as well as 
other sources (Chung et al., 2010; Devaraj et al., 2008; Grattagliano et al., 2008; Roberts & 
Sindhu, 2009). 
Carotenoids are other important molecules with antioxidant activity. They are hydrophobic 
vegetal pigments derived from isoprenoid units with up to 15 conjugated double bonds 
(Costantini & Moller, 2008; Tanaka et al., 2008). This large family of molecules contains more 
than 700 different structures identified so far, and are thought to play an essential role in the 
life cycle of the plants that produce them (Nishino et al., 2009; Tanaka et al., 2008). Even 
though some animals like birds, fishes and invertebrates use them in order to generate 
colorations for structures such as their skin and feathers, none of them have the ability to 
synthesize them and must therefore obtain them from exogenous plant sources. Of the most 
relevant ones we find  and  carotene (the later one being the one with the most 
provitamin A activity, and also one of the most thoroughly studied), lutein, lycopene, 
zeaxanthin and -cryptoxanthin (Britton & Khachik, 2009; Costantini & Moller, 2008). These 
pigments have been shown to interact with virtually all the radicals present in biological 
systems and are, consequently, significant antioxidants. In animals they have the potential 
to not only act upon free radicals, but also to modulate critical functions such as 
immunostimulation, and inhibition of the tumorigenesis process (Krinsky & Yeum, 2003; 
Nishino et al., 2009). 
The last exogenous antioxidant to be mentioned is retinol (Vitamin A), a molecule that is 
related to the previously mentioned carotenoids. -carotene can in fact be transformed to 
retinol, and this can in turn be transformed into retinal and retinoic acid, all of which have 
different biological functions on many tissues (Bremner & McCaffery, 2008). This 
compound, as well as its other metabolites, affects important processes such as immunity, 
reproduction, growth, development and, perhaps its best known function, it holds a vital 
role in the visual cycle (Pasquali et al., 2008; Redmond, 2009; Redmond et al., 2010). -
carotene has been characterized as an antioxidant, nevertheless, it can have toxic effects and 
has been named as a pro-oxidant when it is administered at higher doses and on certain 
types of cell cultures (Pasquali et al., 2008; Roehrs et al., 2009). When it functions as an 
antioxidant it has been positively linked to diverse ailments related to oxidative stress, such 
as diabetes (Ramakrishna & Jailkhani, 2008), obesity (Botella-Carretero et al., 2010), low 
sperm motility (Kao et al., 2008), hearing loss (Michikawa et al., 2009) and others. 
Aside from the “antioxidant vitamins” the polyphenol group is another very diverse family 
of molecules present in fruits and vegetables. They are plant secondary metabolites that can 
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vegetable-rich diet. However, fruit and vegetable intake cannot be replaced by a single 
antioxidant molecule or supplement; that is, ingesting vitamins or polyphenols in a purified 
form is not the same as acquiring them from the diet, since other nutrients present in fruits 
and vegetables may synergize with each other in order to elicit an effect (Liu, 2004). 
2.2 The role of vegetable foodstuffs 
Up until this point we have established that diet can have a profound impact in the 
development of conditions like oxidative stress and dyslipidemia, which are in turn related 
to metabolic syndrome and CVD. We have also defined oxidative stress and the ways the 
cell protects itself from it, and described some of the molecules which may be found in fruits 
and vegetables that contribute to mitigate oxidative stress in animal cells and tissues. The 
discussion now turns to the in vivo effects of fruits and vegetables, and the scientific 
evidence that shows their potential role (either positive, negative or neutral) on human 
health as well as on animal models.  
There are epidemiological studies which underlie the relationship between the consumption 
of vegetable foodstuffs with a number of positive health effects. One of those is a sixty year 
follow up study that associates the consumption of fruits during childhood with a protective 
effect against cancer in adulthood (Maynard et al., 2003). Other authors have noted the link 
between consuming plant-derived products with a reduced risk for developing CVD and 
other non-communicable diseases (Liu, 2004), while some have found a correlation between 
a diet containing fruits and vegetables with a lower LDL concentration in both men and 
women (Djousse et al., 2004). Although most of the evidence supporting a cardioprotective 
effect of fruit and vegetable consumption comes from observational epidemiological studies, 
many of these studies have reported either weak or non significant associations (Dauchet et 
al., 2009). These weak associations may indicate that, aside from consuming fruits and 
vegetables, other factors may contribute to their positive health effects, for example, people 
who regularly consume fruits and vegetables tend to smoke less, exercise more and be better 
educated than those who do not (Dauchet & Dallongeville, 2008). Therefore, diet would not 
be the only factor for the prevention of CVD; exercise, smoking and drinking habits, genetic 
variability and many other influences must surely impact on heart health (Dauchet et al., 
2009). In addition to epidemiologic studies, many dietary interventions have been carried 
out focused on individual fruits, vegetables or bioactive molecules isolated from them, in 
order to establish a direct effect of those particular foodstuffs on specific markers of health 
and disease. Table 1 briefly lists some experiments which have measured the effect of fruits 
and vegetables on oxidative stress and dyslipidemia markers in human and animal models. 
From the first two studies shown in the table, it can be assumed that strawberries have the 
ability to regulate both dyslipidemia and oxidative stress markers. In the study by Jenkins et 
al., a very high dose of fruit (1 lb. daily) was administered to patients in a cholesterol-
lowering diet. Strawberries improved the oxidative stress markers but had no effect on 
dyslipidemia markers additional to the cholesterol-lowering diet alone. Although it can be 
argued that such a regimen would seldom be followed by a healthy subject with a non-
restrictive diet, the authors claim that this was actually a point in their favor since the 
inclusion of strawberries made the cholesterol-lowering diet, which limits or prohibits the 
ingestion of certain items, more palatable (Jenkins et al., 2008). This diet would therefore be 
a viable option in patients who may complain about the dullness in flavor of their available 
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health as well as on animal models.  
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Table 1. Different studies on fruit and vegetable consumption, and their effect upon 
dyslipidemia and oxidative stress markers in human and animal models. – indicates no 
difference, ↓ decrease, ↑ increase. TC, total cholesterol; TAG, triacylglycerols; AC, 
antioxidant capacity; AOX, antioxidant. 
eating options. In another study done by Basu et al., they administered a more modest dose 
of strawberries (2-3 cups daily) to obese patients with metabolic syndrome and found that 
this lower dose of strawberries modulated dyslipidemia markers in a positive way by 
decreasing cholesterol, LDL and LDL particles (Basu et al., 2010). This second study was a 
randomized controlled trial, in which patients continued with their regular diet and 
lifestyle, strawberries were added as a drink and water was used as a control. Therefore, it 
can be argued that the large dose of strawberries used in the study of Jenkins showed no 
further improvement on the lipid markers because the dyslipidemia of those patients was 
already controlled. In contrast, the patients in the study of Basu did not receive any 
additional treatment for their dyslipidemia, making the strawberries' effects more 
prominent. 
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To further scrutinize the family of berries, Erlund et al., administered an assortment of them 
to human subjects and detected no effect on total cholesterol or triacylglycerols, a fact that 
may be put aside by an important (5 %) increase in HDL. They also determined that the 
concentrations of vitamin C and polyphenols in plasma were increased, and, although they 
did not measure plasma antioxidant capacity, it seems likely that ascorbate and polyphenols 
would have had a positive effect on this marker (Erlund et al., 2008). Another study with 
berries, specifically blueberries, was done on pigs and found a decrease in total cholesterol, 
LDL and HDL, while having no effect on triacylglycerols. While the cholesterol lowering 
effect is a positive one, a reduction in HDL is not, since the decrease in this molecule is a 
feature of dyslipidemia (Kalt et al., 2008). Taken together these studies suggest that berries 
have the ability to influence lipid metabolism in a complex manner, depending on the 
model of study, the type of berry and the specific lipid. Effects may be regarded generally as 
positive or non-existing, for example triglycerides, total and LDL cholesterol might be 
reduced or unaltered. Only in one study, preformed in pigs, a negative result was observed 
as a reduction in HDL. Berry consumption showed a consistent improvement of different 
oxidative stress markers, although very few studies evaluated them. The effects of 
strawberries (as well as other berries) may be mediated by their high content of compounds 
such as -carotene, vitamin C and phenolic antioxidants (ellagic-acid, proanthocyanidins, 
quercetin, kampferol, anthocyanins, p-coumaric acid and others), which give them their 
characteristic bright color (Azzini et al., 2010; Pineli et al., 2011). 
Mangoes have also been found to have an effect on both humans and animals. Robles et al., 
administered mangoes to healthy human subjects and found a decrease in both 
triacylglycerols and VLDL particles, while at the same time increasing plasma antioxidant 
capacity; in other words, they can have a positive effect upon dyslipidemia and oxidative 
stress markers (Robles-Sánchez et al., 2011). Since this effect was demonstrated in healthy 
adults, it can be argued that mangoes can be an important tool in preventing the onset of 
CVD, that is, they can be a preventive measure rather than a remedial one. Previous studies 
on mango consumption were done in mice, showing a positive effect on different markers of 
oxidative stress. Prasad et al. (2008), using an extract from the pulp of the mango in mice, 
suggested that the decrease in the production of ROS molecules in the prostate could be 
related to a protective role of this extract against prostate cancer, since its onset has been 
linked to oxidative damage when the REDOX balance is altered. The previously stated 
effects of mangoes can be attributed to the many antioxidant molecules present in the fruit, 
namely, antioxidants such as -carotene, vitamins C and E and polyphenols (particularly 
mangiferin xanthone) (Masibo & He, 2008; Shah et al., 2010).  
The antioxidant potential of mango extracts has been tested on several in vitro and cell-based 
assays. Ajila & Rao (2008) found that mangoes can protect the cell lipids and proteins from 
oxidative damage induced by H2O2 in erythrocytes; the cells morphology was also 
preserved, which indicates the major role of this fruit´s antioxidant activity in live cells (Ajila 
& Rao, 2008). Mangiferin, a polyphenolic antioxidant particularly abundant in mango, has 
been shown to inhibit the generation of O2·- in polymorphonuclear cells and in 
hypoxanthine-xanthine oxidase cell-free system; this result may pinpoint the precise 
enzymatic system affected by mangoes in whole organisms (Peyrot & Ducrocq, 2008). In 
mice, mangiferin protected mitochondria from oxidative stress, another finding of crucial 
importance since these organelles are the main source of oxidant molecules as a normal 
consequence of aerobic metabolism.  
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consequence of aerobic metabolism.  
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Grapes are an important crop grown commercially for winemaking as well as to be 
processed into juice; after they have been manufactured the seeds may be discarded but are 
sometimes further treated to make grape seed oil. The effects of the oil have been studied in 
rats; it was established that the oil has the ability to reduce total cholesterol and LDL (Kim et 
al., 2010). Another study notes similar results in the same animal model using grape seed 
extract. They showed that the extract is capable of inducing not only a decrease in 
cholesterol and LDL, but also in VLDL while increasing HDL and antioxidant systems 
(Thiruchenduran et al., 2010). This last observation may be explained by the fact that the 
compounds present in the seeds, namely phenolic acids, anthocyanins and 
proanthocyanidins, are of antioxidant nature, however the relationship between the 
phenolic antioxidants and the modulation of serum lipids is still not well understood.  
In order to clarify this issue, the role of grape seed proanthocyanidins has been further 
studied in a rat model in which the animals were fed either a standard diet or a high fat diet 
(that the authors dub the cafeteria diet). After 13 weeks on this diet, the animals were 
subdivided into two groups, one of which consumed grape seed proanthocyanidins extract. 
It was determined that the treatment normalized plasma triacylglycerol and LDL levels, 
while also decreasing fatty liver (Quesada et al., 2009). The authors also evaluated the 
expression of some genes related to hyperlipidemia, like the SREBP1 (sterol regulatory 
element binding protein 1), DGAT2 (diacylglycerol O-acyl transferase 2) and MTP 
(microsomal transfer protein) genes, all of which are involved in the synthesis of VLDL, free 
fatty acids and triacylglycerols. Those genes were found to be overexpressed by the cafeteria 
diet and normalized with the proanthocyanidins, which in turn contributed to the 
stabilization of the lipid profile. Therefore this study suggests a possible mechanism of 
action of these phenolic phytochemicals in modulating lipid levels. Proanthocyanidins (in 
the form of commercially-available capsules; Leucoselect) are also capable of reducing 
postprandial oxidative stress in healthy human subjects after ingesting a meal rich in 
oxidized and oxidizable lipids (Milanese meat). Immediately after a meal is ingested the 
individual’s antioxidant status is expected to change, one way this can be determined is by 
measuring LDL’s susceptibility to become oxidized; this susceptibility was lower in the 
antioxidant-enriched meal than the control one, albeit, not statistically significant (Natella et 
al., 2002). Although the results in this study were not statistically significant, other 
publications have determined a significant effect over LDL’s susceptibility to oxidation. 
Chopra, et al. found that after supplementing smoker’s and non-smokers diets with green 
(-carotene and lutein-rich) or red (lycopene-rich) vegetables for a period of 7 days, the red 
vegetables significantly reduced LDL’s susceptibility to oxidation (Chopra et al., 2000). 
Stein, et al. showed that patients with coronary artery disease (CAD) who consumed grape 
juice for a period of 14 days reduced their LDL’s susceptibility to oxidation as well as 
presenting an improvement in other parameters (Stein et al., 1999). Another publication by 
Upritchard, et al. found similar results; they supplemented the diet of type 2 diabetic 
patients with tomato juice, vitamin E or vitamin C and found that after four weeks of this 
regimen LDL’s susceptibility to oxidation was significantly decreased. The effect was more 
prominent with tomato juice and vitamin E; vitamin C however, showed no such effect 
which the authors attribute to the fact that lycopene and vitamin E are both non polar and 
therefore transported by LDL, while vitamin C is water soluble and does not get 
incorporated into LDL (Upritchard et al., 2000). Contrasting these publication with the one 
by Natella indicates that phytochemicals can have an effect in a short period of time, 
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however, not statistically significant, while other authors report a significant effect on longer 
timeframes (7 days, 14 days and 4 weeks); which may indicate that the phytochemicals 
present in the consumed foodstuffs may require subsequent doses in order for their effects 
to become more evident. 
The effect of bananas, one commonly consumed fruit in the western world, in short term 
regulation of plasma lipid levels and oxidative stress has also been explored. In one study, 
healthy subjects drank a single banana-containing drink and after two hours their 
triacylglycerol levels rose, while plasma lipid peroxidation was decreased; it was also 
shown that LDL was more resistant to oxidation after the treatment, suggesting that 
bananas were capable of excreting a short-term antioxidant effect in vivo (Yin et al., 2008). 
The effect of bananas is apparently due to the flavonoids they contain; an experiment done 
with rats estimates the effect these phytochemicals may have on the medium or long-term 
lipid metabolism. The animals were fed a banana-derived polyphenol-enriched diet for a 
period of 45 days, after this time it was found that cholesterol, phospholipids, free fatty 
acids and triacylglycerols in various tissues were lowered, as well as an increase in HDL 
(Vijayakumar et al., 2009). Although these results suggest the flavonoids are exerting a 
hypolipidemic effect, it should be noted that a dose over 5 mg/100 g of body weight/day of 
polyphenols resulted in an increase in cholesterol, mediated (at least in part) by an increase 
in 3-hydroxy-3-methyl-glutaryl-CoA reductase activity (HMG CoA) in the liver, an enzyme 
responsible for cholesterogenesis, meaning the rate of cholesterol synthesis seemed to be 
amplified. Even so the overall effect of a banana-rich diet tended to a total cholesterol 
reduction, explained by an increase in lecithin-cholesterol acyltransferase (LCAT) activity, 
an enzyme that removes tissue cholesterol in order to degrade it; bile acids and neutral 
sterols in the feces were also increased. This experiment points to a possible role of banana 
flavonoids in regulating lipid metabolism in favor of a total cholesterol decrease; however, it 
also indicates the importance of regulating the ingested doses, due to the possibility of 
finding dose-dependent negative effects.  
Garlic has been used in herbal medicine to treat various ailments for centuries. A study 
administered turmeric and garlic in combination in the form of capsules of the extracts 
prepared to obtain the main bioactive compounds to determine their effect on type 2 
diabetes mellitus patients that also presented dyslipidemia. The patients were divided in 
three groups that ingested 1.2, 1.6 or 2.4 g extract/day (groups A, B and C respectively). It 
was found that after eight weeks of treatment, group A significantly decreased their total 
cholesterol concentration, while LDL also decreased, although the change was not 
statistically significant. After 10 and 12 weeks groups A and C respectively showed a 
significant increase in HDL. Two of the groups (B and C) decreased their triacylglycerol 
concentrations, but once again it was not statistically significant (Sukandar et al., 2010). The 
authors of this study suggest that the observed effects could be related to the ability of the 
compounds present in garlic to inhibit liver lipogenic or cholesterogenic enzymes, and also 
by delaying lipid absorption in the gastrointestinal tract. Turmeric on the other hand may 
affect cholesterol catabolism by means of an increase in the activity of cholesterol 7a-
hydroxylase activity, hindering cholesterol synthesis by inhibiting HMA CoA reductase, 
increasing the levels of LDL receptors (which aid in its elimination from blood) and by 
inhibiting dietary cholesterol absorption. This study points out a fact not previously 
mentioned, how two (or more) foodstuffs can interact with one another in order to synergize 
a particular effect, that is, both turmeric and garlic may have hypolipidemic effects by 
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themselves but taking them together may improve this effect. Garlic and aged black garlic 
have also been studied in an animal model of type 2 diabetes, mice were fed diets containing 
5 % of either garlic of aged black garlic for a 7 week period; it was determined that the 
animals’ hepatic TBARS were significantly decreased with the treatments; being the aged 
black garlic group levels significantly lower than both the control group and the garlic 
group. Hepatic SOD and GPX activities were significantly increased by both treatments 
while CAT was significantly increased in the aged black garlic group. These results indicate 
garlic may also have antioxidant effects as determined by an increase in the hepatic 
endogenous antioxidant systems, being the aged black garlic the one with the most effect. 
The better in vivo antioxidant effect of aged black garlic may be related to its higher in vitro 
antioxidant activity (4.5 times higher TEAC value). One of the most important bioactive 
compounds found in garlic is -glutamyl cysteine, which is converted to alliin and then to 
allicin by alliinase upon crushing, cutting, chewing of dehydrating the bulb (Pal et al., 2006); 
this last compound has also been studied by other authors. In an article by Ashraf, they 
administered 300 mg garlic tablets (or a placebo to the control group) containing 1.3 % 
allicin twice daily to type 2 diabetic human subjects with newly diagnosed dyslipidemia for 
a 12 week period. After the treatment they found a significant reduction in total cholesterol 
and LDL with a simultaneous increase in HDL, triacylglycerols were not affected. They 
explain that the effect of the garlic extract may be due to the presence of allicin and note the 
importance of the delivery method used to administer this compound. 
Tomatoes are grown commercially for the preparation of many different products, one of 
which is tomato juice. The consumption of this beverage was able to reduce total cholesterol 
and TBARS in healthy human subjects (Jacob, 2008) indicating a positive effect of this 
vegetable product in both dyslipidemia and oxidative stress. Furthermore, it was 
established by Jamshidzadeh that a tomato extract can have cell protecting effects against 
drug-induced toxicity in rats, that is, it can reduce TBARS, prevent glutathione depletion 
and tissue damage (Jamshidzadeh et al., 2008). These experiments seem to highlight the 
antioxidant-promoting ability of tomatoes, something that has been linked by some authors 
to lycopene, an important carotenoid molecule present in them. 
The role of lycopene was established in a study where the purified compound was 
administered in capsules to healthy humans, they found lymphocyte DNA damage was 
reduced, but without significantly affecting other markers of oxidative stress or antioxidant 
health (Devaraj et al., 2008). The effect of lycopene and other carotenoids has also been 
analyzed in vivo. Porrini et al., found that after ingesting a tomato and spinach diet the 
intracellular concentrations of the three main carotenoids present in both foodstuffs (lutein, 
-carotene and lycopene) were significantly increased in lymphocytes (Porrini et al., 2002). 
At the same time, vegetable puree consumption provided the cells with an increased 
resistance to oxidative damage from H2O2. However there was no correlation between the 
cell’s lycopene concentration and its resistance to oxidative damage. The authors conclude 
that even though vegetables rich in carotenoids are considered to elicit an antioxidant effect, 
it is yet to be clarified if that antioxidant capacity is related to carotenoids or to other 
molecules; it is also possible that the relationship is not simple and cannot be described with 
a linear model. Another possible explanation to these results is that carotenoids do not 
behave like direct antioxidants, but rather act by stimulating the cell’s endogenous 
enzymatic antioxidant mechanisms such as CAT or GPX, both of which are capable of 
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removing H2O2; in other words, these molecules may be acting on a genetic level to 
stimulate the cell’s own defense systems. 
Murashima et al., studied the effects of broccoli sprouts upon metabolism and oxidative 
stress markers of healthy human subjects. They found that after a week of consuming 100 
g/day of fresh broccoli sprouts total and LDL cholesterol concentrations were significantly 
lower and HDL was increased but only in the female subjects, the triacylglycerol 
concentration of three subjects shifted to a normal concentration (out of six who had 
abnormal values). Oxidative stress markers were also affected as determined by a reduction 
in phosphatidylcholine hydroperoxides, 8-isoprostane (a product of non-enzymatic tissue 
phospholipid oxidation) and 8-hydroxydeoxyguanosine (a product of oxidative DNA 
damage). This study remarks how gender differences in lifestyle and dietary habits, as well 
as hormonal levels can influence how the individuals respond to a treatment such as this 
one; and highlights how heterogeneous a response may be within a population. 
Similar observations were made by Alvarez-Parrilla et al., (2010) who investigated the effect 
of consuming orange juice, a pear and an apple in both smokers and non-smokers healthy 
adults. They found that in non-smokers total cholesterol, LDL and HDL were significantly 
increased, while in smokers initial cholesterol and LDL values were higher than those of 
non-smokers, but after the intervention significantly decreased to values similar to those of 
non-smokers; triacylglycerols were not affected in either group. Plasma antioxidant activity 
(measured by the ORAC and FRAP techniques) was also differently affected by the dietary 
intervention: in non-smokers it was either increased (ORAC) or not affected (FRAP), while 
in smokers it was not affected (ORAC) or decreased (FRAP) (Alvarez-Parrilla et al., 2010). 
This studied suggested that plasma antioxidant activity was not a sensitive marker to detect 
oxidative stress in smokers and that the habit of smoking can be an important variable that 
can alter the way the phytochemicals present in fruits and vegetables interact with the 
individual and affect health-related physiological responses. This can once again point to 
how synergy occurs not only among the items that we eat but also with other environmental 
stimuli. 
The interaction between carbohydrates and phytochemicals, and their effect on lipid levels 
and antioxidant status has also been studied. A recent study determined the effect of 
consuming a diet containing simple carbohydrates (sucrose), one of complex carbohydrates 
(starch) and a third containing complex carbohydrates and antioxidant micronutrients 
(potatoes) in a rat model. It was found that after consuming the diets for a period of three 
weeks, the animals’ plasma and liver cholesterol levels were significantly lower with the 
potato-based diet; the triacylglycerol levels in the liver were also decreased. The plasma 
antioxidant levels were also increased. This study suggests that simple carbohydrates 
initiate liver de novo lipogenesis which in turn increases plasma triacylglycerol levels, an 
effect that is avoided when carbohydrates are ingested in the form of starch from potatoes, 
which in addition to carbohydrates contain other important non-energetic micronutrients. 
Some of the reported micronutrients from potatoes are vitamins C and E, carotenoids and 
phenolic acids, which may account for the in vivo antioxidant effect of this vegetable. In 
addition to starch and antioxidants, potatoes contain fiber in the form of resistant starch, 
molecules that have the ability to induce the fecal excretion of cholesterol, bile acids and 
other lipids, another mechanism that may explain the observed hypolipidemic effect.  
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themselves but taking them together may improve this effect. Garlic and aged black garlic 
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black garlic group levels significantly lower than both the control group and the garlic 
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it is yet to be clarified if that antioxidant capacity is related to carotenoids or to other 
molecules; it is also possible that the relationship is not simple and cannot be described with 
a linear model. Another possible explanation to these results is that carotenoids do not 
behave like direct antioxidants, but rather act by stimulating the cell’s endogenous 
enzymatic antioxidant mechanisms such as CAT or GPX, both of which are capable of 
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Regular consumption of a fruit and vegetable rich diet has undeniable positive effects on 
health, although the markers to evaluate these effects are sometimes hard to demonstrate. 
We analyzed the effects of fruit and vegetable consumption on dyslipidemia and oxidative 
stress markers, two hallmarks of metabolic syndrome and CVD risk, among other diseases. 
We have found mostly positive effects of certain fruit and vegetable products. Interestingly, 
the effects can be found after short term (hours) and midterm (several weeks) interventions; 
and they are, in general, more clearly related to attenuating oxidative stress than to 
regulating lipid levels, in fact the effects of fruit and vegetable products on lipid levels are 
heterogeneous, usually positive or non-existent. We may conclude that oxidative stress 
markers are useful tools to evaluate the effects of a fruit and vegetable rich diet, however 
since oxidative stress is a complex condition, several markers should be analyzed in order to 
provide a better understanding of it. Dyslipidemia markers are probably more valuable for 
assessment of risk groups that for healthy individuals. In some cases the effects of fruit and 
vegetable consumption can be traced to a specific molecule(s) and the mechanisms of action 
of these compounds seem to involve regulation of gene expression. However, since food is 
not made up of individual molecules but rather a vast number of them, it makes sense that 
the isolated compounds won’t have the same effect as eating the whole fruit or vegetable, 
because the different bioactive molecules present in the foodstuff can interact with one 
another and with innumerable cell targets; therefore, altering their individual bioactive 
properties. It is highly difficult to describe the biochemical mechanisms of action of whole 
fruit or vegetable products. Moreover variation in individual responses to food-derived 
phytochemicals is also great in human populations due to genetic and environmental 
variations. Consequently, the search for these factors may help to better understand how to 
take advantage of the many potential benefits of a healthy diet rich in fruits and vegetables. 
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1. Introduction 
Nowadays, people are struggling with stress, either from environmental pollutions and 
daily life routines of urgency and competition. From the risk of exposure to toxic or 
pathogenic substances from various routes, our bodies have to adapt and maintain a 
systemic balance for physiological functions. Obtaining the supplements or substances that 
promote good health is the recommended choice for people in this century. This is the 
beginning of the word “adaptogens” or "balancing material" that will help the body adjust 
and increase the tolerance to physical, emotional and environmental stresses as well as 
promote the metabolic system and homeostasis of the body. 
An adaptogen was previously defined as a substance that had to; show some nonspecific 
effect, such as increasing bodily resistance to physically, chemically, or biologically noxious 
agents or factors; had a normalizing influence on a pathologic state, independent of the 
nature of that state; and was innocuous and not disturb body function at a normal level 
(Lasarev, 1947). Panossian and Wagner (2005) suggested that the adaptogenic substance 
from plants was a substance that increased the ability of an organism to adapt in various 
factors in the environment and to prevent damage caused by such factors. Some plants have 
been used for adaptogenic purposes as shown in Table 1. 
Panossian (2003) suggested that most of the active phytochemicals separated from the 
adaptogenic plants were in 3 main chemical groups; phenolic compounds such as 
phenylpropanoids, phenylethane derivatives and lignans; tetracyclic triterpenes; and 
unsaturated trihydroxy or epoxy fatty acids. Chemical structures of some adaptogenic 
compounds are shown in Figure 1. 
To demonstrate the adaptogenic effects of medicinal plants, related pharmacological activity 
determinations were studied including in vivo effects for decreasing the stress, promote 
physical performance, anabolic efficacy, and brain metabolism. Some in vitro studies were 
also conducted such as antioxidative and anti-inflammatory effect experiments. 
Adaptogenic plants can promote anti-stress effects via several mechanisms including 
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increasing of body temperature, improvements of body function, enhancing of cognitive 
abilities, promoting of locomotor and exploration activities, and moderating the emotional 
behavior (Wagner et al., 1994).  
 
Fig. 1 Adaptogenic compounds; 1= ginsenoside Rb1, 2= eleutheroside B, 3= ellagic acid, 4= 
withanolide, 5= glycyrrhizin, 6= schisandrin, 7= ursolic acid.  
Free radicals and reactive oxygen species are some chemical species that have odd number 
of electrons which have high reactivities and are capable to cause reversibly or irreversibly 
oxidative damages to compounds of all biochemical classes including nucleic acids, proteins 
and free amino acids, lipids and lipoproteins, carbohydrates and connective tissue 
macromolecules (Halliwell and Gutteridge, 1999). Oxidative stress is considered some 
importance for many ailments and pathologies including cardiovascular diseases, cancers, 
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Common name Scientific name Family Part used 
American ginseng Panax quinquefolius Araliaceae Root
Indian gooseberry Emblica officinalis Euphorbiaceae Fruit 
Ashwagandha Withania somnifera Solanaceae Root
Korean ginseng Panax ginseng Araliaceae Root
Siberian ginseng Eleutherococcus senticosus Araliaceae Root, stem bark 
Indian tinospora Tinospora cordifolia Menispermaceae Root, stem 
Holy basil Ocimum sanctum Lamiaceae Whole plant 
Jiaogulan Gynostemma pentaphyllum Cucurbitaceae Whole plant 
Licorice Glycyrrhiza glabra Fabaceae Root
Reishi Ganoderma lucidum Ganodermataceae Mushroom 
Schisandra Schisandra chinensis Schisandraceae Fruit, seed 
Table 1. Reported adaptogenic plants (Winston and Maimes, 2007).  
stress are key components of the pathology of chronic neurodegenerative conditions, in 
particular Alzheimer’s disease, Down syndrome, multiple sclerosis and dementia (Auroma 
et al.,  2003). Previous studies indicated that oxidative injury is present in the brains of 
patients with Alzheimer’s disease may play important role in the development of the 
disease (Grundman and Delaney, 2002, Pratico and Delantly, 2000, Rottkamp et al., 2000, 
Smith et al., 2000). Excessive lipid peroxidation and increasing of malondialdehyde 
concentrations have been found in the patients’ brains of Alzheimer’s disease (Grundman 
and Delaney, 2002). From ethnomedical intellectual, various plants have been used to 
enhance cognitive function and to relieve other symptoms associated with Alzheimer’s 
disease. The effects of traditional herbal drugs may not only be relevant in managing the 
cognitive decline that can be associated with general aging but may also be relevant in the 
treatment of specific cognitive disorders such as Alzheimer’s disease. Therefore, plants with 
anti-aging or memory enhancing activities can be considered for potential efficacy in 
cognitive dysfunction including conditions that feature dementia. The activities of plants 
that show the effects in relation to cognitive disorders are including anti-cholinesterase 
(anti-AChE), anti-inflammation and antioxidant (Howes and Houghton, 2003).     
Health promotion by Thai wisdom has been conducted from the Thai traditional practice in 
prevention, diagnosis, and treatment of imbalancing in human bodies and minds. The 
process is accompanied with folk medicine which herbs and natural products in each region 
all over the country are main constituents. The knowledge and medical procedures have 
been transferred from generation to generation until nowadays. In Thai traditional 
medicine, herbs with adaptogenic or antioxidative effects should relate to plants that exhibit 
detoxification, blood purifying, jaundice curing, hepatoprotection, tonic and haematonic, 
aphrodisiac, anti-fatigue, nourishment and longevity promotion (Faculty of Pharmacy, 
Mahidol University, 1998).    
Eleven indigenous plant species traditionally used as ginseng-like agents or  adaptogens 
were collected from the north and northeastern parts of Thailand and evaluated for 
adaptogenic-related properties including antioxidant and anti-anxiety activities as well as 
total phenolic and total flavonoid contents. Along with the rhizome extract of Smilax 
corbularia, leaf decoction extract of Acanthopanax trifoliatus (A. trifoliatus) exhibited strong 
antioxidant activity with high amount of phenolic and flavonoid contents (Sithisarn et al., 
2010). The results suggested that A. trifoliatus is an interesting plant that could promote 
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increasing of body temperature, improvements of body function, enhancing of cognitive 
abilities, promoting of locomotor and exploration activities, and moderating the emotional 
behavior (Wagner et al., 1994).  
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2010). The results suggested that A. trifoliatus is an interesting plant that could promote 
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significantly pharmacological activities related to adaptogenic properties, which supported 
the ethnomedical uses of this plant.    
2. Botanical characteristics of A. trifoliatus 
A. trifoliatus is a shrub that belongs to the family Araliaceae. Its taxonomic position is as follows: 
Order  Apiales 
Suborder   Apiineae 
Family   Araliacea (ginseng family) 
Genus   Acanthopanax (Eleutherococcus) 
Species   trifoliatus 
In Flora of China (2004), A. trifoliatus was described as a shrub, scandent or climber that 
usually reaches a height of 7 m. The branches are scattered with recurved prickles. The 
glabrous and prickly petioles are 2-6 cm long with the 2-8 mm long petiolules. The papery, 
adaxially glabrous or slightly setose on midvein and veins, secondary veins 5 or 6 pairs, 
base cuneate, margin serrulate, apex acute or acuminate leaves are 4-10 x 2-4.5 cm and the 
ovate, elliptic-ovate, or oblong leaflets  which number up to 3 or 5. The inflorescence is 
terminal raceme, umbel or compound umbel which borne on leafy shoots and 3-10 umbels. 
The peduncles are 2-7 cm long with the 1-2 cm long pedicels. The glabrous calyx has 5 teeth. 
The ovary has 2 carpellates, the styles are united to middle. The fruit is globose and laterally 
compressed with the size of 3-4 mm. The flowering period is from August to November. 
The fruiting time is during September to December.  
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Normally A. trifoliatus thrives in shrub fields, roadsides, forest margins, in valleys or on 
mountain slopes; below 1000 m in the East and 3200 m in the West part of range. This plant 
is widely distributed in India, Japan, the Philippines, Thailand, Vietnam, and many 
provinces of China including Anhui, Fujian, Guangdong, Guangxi, Guizhou, Hunan, Hubei, 
Jiangsu, Jiangxi, Sichuan, Taiwan, Yunnan and Zhejiang. The photos of A. trifoliatus from 
Chiang Mai province, Thailand are shown in Figure 2. 
3. Ethnomedical uses and previous reported biological activities of A. 
trifoliatus 
The leaves of A. trifoliatus have been used as a tonic to improve general weakness, the leaves 
and young shoots are also used for treatments of tuberculosis, lung hemorrhages, bruises, 
ulcers and, contusion (Perry and Metzger, 1981a, Perry and Metzger, 1981b, Chi, 1997, Loi, 
2000). The stem bark is used as antiflatulent agent and is used for treatments of emaciation and 
neurosis (Petelot, 1954). The root bark and stem bark are used in the treatments of rheumatism, 
lumbago, ostealgia and impotence (Nguyen and Doan, 1989). The bark was reported to be 
used as tonic, CNS stimulant, and memory enhancer (Nguyen and Doan, 1989). In Chinese 
medicine, this plant was used for the treatments of cold, cough, neuralgia and rheumatism 
(Duke and Ayensu, 1985). Moreover, young leaves and the shoots are popularly consumed in 
Northern Thai traditional cuisine as vegetables. Antioxidant and anti-inflammatory activities 
of the extracts from A. trifoliatus have been previously reported and suggested that young 
leaves provided the most active sample (Sithisarn and Jarikasem, 2009, Sithisarn et al.,  2009). 
Anti-anxiety effects in animal models of leaf extract from A. trifoliatus were also reported 
(Sithisarn et al.,  2010). 
4. Chemical constituents of A. trifoliatus 
Some chemical components including terpenoids, phenylpropanoids, phenolics, flavonoids, 
lactones and essential oils were separated and identified from various parts of A. trifoliatus 
as shown in Table 2. 
5. Antioxidant activity of A. trifoliatus 
The extracts from some parts of A. trifoliatus including leaves, stems, stem barks, roots and 
root barks with various extraction methods were tested for free radical scavenging activity 
using DPPH scavenging method and inhibitory effect to lipid peroxidation of rat brain 
homogenate by thiobarbituric acid reactive substances (TBARS) method. 1,1-Diphenyl-2-
picrylhydrazyl (DPPH) radical is a stable radical with a deep violet color. When DPPH 
radical receives a proton from antioxidants, it converts to a colorless protonated DPPH 
molecule. After 15 minutes of DPPH scavenging reaction, the absorbance at 517 nm was 
determined then % of inhibition and EC50 value were calculated (Yamasaki et al., 1994). It 
was found that the leaf decoction extract, the root bark decoction and 75% ethanolic 
refluxing extracts and the stem bark 75% ethanolic refluxing extract showed high radical 
scavenging activity with EC50 values of 14.50  1.04, 34.24  5.01, 34.51  2.74 and 37.85  0.85 
μg/ml, respectively (Sithisarn and Jarikasem, 2009). TBARS method is popular single assay 
for the measurement of lipid peroxidation. The sample under test is treated with 
thiobarbituric acid (TBA) at low pH, and a maximum absorption of pink chromogen is 
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A. trifoliatus is a shrub that belongs to the family Araliaceae. Its taxonomic position is as follows: 
Order  Apiales 
Suborder   Apiineae 
Family   Araliacea (ginseng family) 
Genus   Acanthopanax (Eleutherococcus) 
Species   trifoliatus 
In Flora of China (2004), A. trifoliatus was described as a shrub, scandent or climber that 
usually reaches a height of 7 m. The branches are scattered with recurved prickles. The 
glabrous and prickly petioles are 2-6 cm long with the 2-8 mm long petiolules. The papery, 
adaxially glabrous or slightly setose on midvein and veins, secondary veins 5 or 6 pairs, 
base cuneate, margin serrulate, apex acute or acuminate leaves are 4-10 x 2-4.5 cm and the 
ovate, elliptic-ovate, or oblong leaflets  which number up to 3 or 5. The inflorescence is 
terminal raceme, umbel or compound umbel which borne on leafy shoots and 3-10 umbels. 
The peduncles are 2-7 cm long with the 1-2 cm long pedicels. The glabrous calyx has 5 teeth. 
The ovary has 2 carpellates, the styles are united to middle. The fruit is globose and laterally 
compressed with the size of 3-4 mm. The flowering period is from August to November. 
The fruiting time is during September to December.  
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Normally A. trifoliatus thrives in shrub fields, roadsides, forest margins, in valleys or on 
mountain slopes; below 1000 m in the East and 3200 m in the West part of range. This plant 
is widely distributed in India, Japan, the Philippines, Thailand, Vietnam, and many 
provinces of China including Anhui, Fujian, Guangdong, Guangxi, Guizhou, Hunan, Hubei, 
Jiangsu, Jiangxi, Sichuan, Taiwan, Yunnan and Zhejiang. The photos of A. trifoliatus from 
Chiang Mai province, Thailand are shown in Figure 2. 
3. Ethnomedical uses and previous reported biological activities of A. 
trifoliatus 
The leaves of A. trifoliatus have been used as a tonic to improve general weakness, the leaves 
and young shoots are also used for treatments of tuberculosis, lung hemorrhages, bruises, 
ulcers and, contusion (Perry and Metzger, 1981a, Perry and Metzger, 1981b, Chi, 1997, Loi, 
2000). The stem bark is used as antiflatulent agent and is used for treatments of emaciation and 
neurosis (Petelot, 1954). The root bark and stem bark are used in the treatments of rheumatism, 
lumbago, ostealgia and impotence (Nguyen and Doan, 1989). The bark was reported to be 
used as tonic, CNS stimulant, and memory enhancer (Nguyen and Doan, 1989). In Chinese 
medicine, this plant was used for the treatments of cold, cough, neuralgia and rheumatism 
(Duke and Ayensu, 1985). Moreover, young leaves and the shoots are popularly consumed in 
Northern Thai traditional cuisine as vegetables. Antioxidant and anti-inflammatory activities 
of the extracts from A. trifoliatus have been previously reported and suggested that young 
leaves provided the most active sample (Sithisarn and Jarikasem, 2009, Sithisarn et al.,  2009). 
Anti-anxiety effects in animal models of leaf extract from A. trifoliatus were also reported 
(Sithisarn et al.,  2010). 
4. Chemical constituents of A. trifoliatus 
Some chemical components including terpenoids, phenylpropanoids, phenolics, flavonoids, 
lactones and essential oils were separated and identified from various parts of A. trifoliatus 
as shown in Table 2. 
5. Antioxidant activity of A. trifoliatus 
The extracts from some parts of A. trifoliatus including leaves, stems, stem barks, roots and 
root barks with various extraction methods were tested for free radical scavenging activity 
using DPPH scavenging method and inhibitory effect to lipid peroxidation of rat brain 
homogenate by thiobarbituric acid reactive substances (TBARS) method. 1,1-Diphenyl-2-
picrylhydrazyl (DPPH) radical is a stable radical with a deep violet color. When DPPH 
radical receives a proton from antioxidants, it converts to a colorless protonated DPPH 
molecule. After 15 minutes of DPPH scavenging reaction, the absorbance at 517 nm was 
determined then % of inhibition and EC50 value were calculated (Yamasaki et al., 1994). It 
was found that the leaf decoction extract, the root bark decoction and 75% ethanolic 
refluxing extracts and the stem bark 75% ethanolic refluxing extract showed high radical 
scavenging activity with EC50 values of 14.50  1.04, 34.24  5.01, 34.51  2.74 and 37.85  0.85 
μg/ml, respectively (Sithisarn and Jarikasem, 2009). TBARS method is popular single assay 
for the measurement of lipid peroxidation. The sample under test is treated with 
thiobarbituric acid (TBA) at low pH, and a maximum absorption of pink chromogen is 
 




chemical Chemical compounds (plant part) Reference 
Terpenoid - acanthoic, continentalic, kaurenoic acids (root, stem, 
leaves) 
- acantrifoic acid A, acantrifoside C (leaves) 
- acantrifoside D (stem bark) 
- 16H, 17-isovalerate-ent-kauran-19-oic acid, ent-Kaur-16-
en-19-oic acid, ent-Primara-8(14), 15-dien-19-oic acid (stem 
bark) 
- acantrifoside A (leaves) 
- lupane triterpene glycoside (leaves) 




- kaur-16-en-19-oic acid, taraxerol, taraxerol-acetate (leaves)
Phuong, 2006 










Phenylpropanoid - 1--D-glucopyranosyl-2,6-dimethoxy-4-propenylphenol, 
1-[-D-glucopyranosyl-(16)--D-glucopyranosyl]-2,6-




- syringin, quercitrin (stem bark) 
- nevadensin (leaves) 
Kiem, 2003b 
Du, 1992 
Lactone - eleutheroside E, (2R,3R)-2,3-di-(3,4-
methylenedioxybenzyl)-butyrolactone (stem bark) 
Kiem, 2003b 
Essential oil - -pinene, sabinene, terpinen-4-ol, -pinene, p-cymene, 
carissone (leaves) 
Muselli, 1999 
Table 2. Reported chemical constituents in A. trifoliatus. 
measured at 532 nm (Punchard, 1996). Inhibitory effects to lipid peroxidation of rat brain 
homogenate of various extracts from A. trifoliatus ranged from EC50 of 11.18  2.60 to 75.35  
7.52 g/ml. Root and leaf decoction extracts showed significantly higher effects (EC50 of 
11.18  2.60 and 16.11  0.29 g/ml, respectively) (Sithisarn and Jarikasem, 2009).   
6. Anti-cholinesterase activity of A. trifoliatus 
Cholinergic deficit was reported to associate with memory loss and the severity of 
Alzheimer’s (Bierer, 1995). To restore cholinergic function in AD, many mechanisms are 
studied including stimulation of cholinergic receptors or prolonging the availability of 
acetylcholine (ACh) released into neuronal synaptic cleft by inhibiting ACh hydrolysis by 
acetylcholinesterase (AChE) which can be developed by the applications of proper AChE 
inhibitors. Extracts from several parts of A. trifoliatus were tested for AChE inhibitory 
activity using Ellman’s colorimetric method in 96-well microplate. According to Vinutha et 
al. (2007), at the concentration of 100 g/ml, most tested extracts exhibited moderate 
acetylcholinesterase inhibitory effect (30-50% inhibition). All root extracts including  95% 
ethanolic, decoction and 75% ethanolic extracts showed the highest effects among tested 
samples with AChE inhibition of 40.24  3.56, 42.06  5.29 and 47.41  3.52 %, respectively. 
The results of inhibitory effect of A. trifoliatus extracts to AChE are shown in Table 3. 
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Sample AChE inhibitory activity* 
LM 15.51  9.95a,e,g,h,i,j 
LR 22.82  8.71a,b,e,h,i,j 
LD 31.76  2.51c,g 
SBM 36.83  3.34b,c,d 
SBR 22.51  0.53e 
SBD 25.78  1.92i,j 
SM 31.27  3.54a,c,j 
SR 16.98  4.36e,h 
SD 15.37  1.68h 
RBM 36.26  4.09b,c,d 
RBR 36.30  1.50a,c,d 
RBD 20.65  3.14e,h,i 
RM 40.24  3.56b,d 
RR 47.41  3.52f 
RD 42.06  5.29d,f 
Galanthamine Completely inhibit 
Physostigmine Completely inhibit 
* different letters in the same column are significantly different  (P<0.05) 
Table 3. Acetylcholinesterase inhibitory effect of extracts and standard compounds at 100 
g/ml from various parts of A. trifoliatus. LM: leaf maceration, LR=leaf refluxing, LD=leaf 
decoction, SBM=stem bark maceration, SBR=stem bark refluxing, SBD=stem bark decoction, 
SM=stem maceration, SR=stem refluxing, SD=stem decoction, RBM= root bark maceration, 
RBR=root bark refluxing, RBD=root bark decoction, RM=root maceration, RR=root 
refluxing, RD=root decoction.   
7. Anti-anxiety activity of A. trifoliatus 
Adult male ICR mice with a weight range 30-35 g were used for determination of anti-anxiety 
effect of A. trifoliatus by light-dark task and hole-board test. Tested mice were received for 
corticosterone solution about 13 mg/kg per day via drinking water for 17 consecutive days. 
Then mice were tested for anxiety-like behavior in the light-dark task and hole-board test. 
7.1 Light-dark task 
Thirty mice were randomly divided into five groups of six mice. Each group of mice was 
orally administered with distilled water as a control group, phenobarbital (30 mg/kg) was 
used as a standard drug, and A. trifoliatus leaf decoction extract in 3 different doses of 500, 
750 and 1000 mg/kg, respectively. Modified from Ardayfio and Kim (2006) and Krishna et 
al (2006), the apparatus consisted of a Plexiglas box with two compartments, one of which 
was illuminated with a white light while the other remained dark. One hour after drugs 
administration, each mouse was placed at one corner of the dark compartment, facing 
against of the light area. The time spent in illuminated and dark places, as well as the 
number of entries in each space, was recorded for 10 min. The administration of all 3 
different doses of the extract in mice induced both significant increments (P<0.05) of the 
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measured at 532 nm (Punchard, 1996). Inhibitory effects to lipid peroxidation of rat brain 
homogenate of various extracts from A. trifoliatus ranged from EC50 of 11.18  2.60 to 75.35  
7.52 g/ml. Root and leaf decoction extracts showed significantly higher effects (EC50 of 
11.18  2.60 and 16.11  0.29 g/ml, respectively) (Sithisarn and Jarikasem, 2009).   
6. Anti-cholinesterase activity of A. trifoliatus 
Cholinergic deficit was reported to associate with memory loss and the severity of 
Alzheimer’s (Bierer, 1995). To restore cholinergic function in AD, many mechanisms are 
studied including stimulation of cholinergic receptors or prolonging the availability of 
acetylcholine (ACh) released into neuronal synaptic cleft by inhibiting ACh hydrolysis by 
acetylcholinesterase (AChE) which can be developed by the applications of proper AChE 
inhibitors. Extracts from several parts of A. trifoliatus were tested for AChE inhibitory 
activity using Ellman’s colorimetric method in 96-well microplate. According to Vinutha et 
al. (2007), at the concentration of 100 g/ml, most tested extracts exhibited moderate 
acetylcholinesterase inhibitory effect (30-50% inhibition). All root extracts including  95% 
ethanolic, decoction and 75% ethanolic extracts showed the highest effects among tested 
samples with AChE inhibition of 40.24  3.56, 42.06  5.29 and 47.41  3.52 %, respectively. 
The results of inhibitory effect of A. trifoliatus extracts to AChE are shown in Table 3. 
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Sample AChE inhibitory activity* 
LM 15.51  9.95a,e,g,h,i,j 
LR 22.82  8.71a,b,e,h,i,j 
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RR 47.41  3.52f 
RD 42.06  5.29d,f 
Galanthamine Completely inhibit 
Physostigmine Completely inhibit 
* different letters in the same column are significantly different  (P<0.05) 
Table 3. Acetylcholinesterase inhibitory effect of extracts and standard compounds at 100 
g/ml from various parts of A. trifoliatus. LM: leaf maceration, LR=leaf refluxing, LD=leaf 
decoction, SBM=stem bark maceration, SBR=stem bark refluxing, SBD=stem bark decoction, 
SM=stem maceration, SR=stem refluxing, SD=stem decoction, RBM= root bark maceration, 
RBR=root bark refluxing, RBD=root bark decoction, RM=root maceration, RR=root 
refluxing, RD=root decoction.   
7. Anti-anxiety activity of A. trifoliatus 
Adult male ICR mice with a weight range 30-35 g were used for determination of anti-anxiety 
effect of A. trifoliatus by light-dark task and hole-board test. Tested mice were received for 
corticosterone solution about 13 mg/kg per day via drinking water for 17 consecutive days. 
Then mice were tested for anxiety-like behavior in the light-dark task and hole-board test. 
7.1 Light-dark task 
Thirty mice were randomly divided into five groups of six mice. Each group of mice was 
orally administered with distilled water as a control group, phenobarbital (30 mg/kg) was 
used as a standard drug, and A. trifoliatus leaf decoction extract in 3 different doses of 500, 
750 and 1000 mg/kg, respectively. Modified from Ardayfio and Kim (2006) and Krishna et 
al (2006), the apparatus consisted of a Plexiglas box with two compartments, one of which 
was illuminated with a white light while the other remained dark. One hour after drugs 
administration, each mouse was placed at one corner of the dark compartment, facing 
against of the light area. The time spent in illuminated and dark places, as well as the 
number of entries in each space, was recorded for 10 min. The administration of all 3 
different doses of the extract in mice induced both significant increments (P<0.05) of the 
 
Phytochemicals – Bioactivities and Impact on Health 
 
260 
number of entries and time spent by mice in light chamber of the light-dark apparatus 
(Sithisarn et al., 2010).  
7.2 Hole-board test 
Applied from Brown and Nemes (2008), the apparatus consisted of a square plastic plate 
with 16 holes, regularly spaced on the surface. Each hole contains sensors for detecting 
when animal dips the head in a hole. Thirty mice were randomly divided into five groups of 
six mice. Each group of mice was orally administrated with distilled water as a control 
group, phenobarbital (30 mg/kg) was used as a standard drug, and A. trifoliatus leaf extract 
in 3 different doses of 500, 750 and 1000 mg/kg, respectively. Forty five minutes after drug 
administration, each mouse was placed on the centre of the board and the number of head 
dips was automatically counted for 3 min. Administration of the leaf decoction extract of A. 
trifoliatus in the concentration of 1000 mg/kg in mice significantly (P<0.05) induced an 
increment of the number of head-dip of the animals, similar to the effect observed in 
phenobarbital treated group (Sithisarn et al., 2010). 
8. Anti-inflammatory activity of A. trifoliatus 
Leaf decoction extract from A. trifoliatus was tested for anti-inflammatory effect using rat 
paw edema model induced by carrageenan injection. Thirty adult male Wistar rats with a 
weight range of 180-200 g were randomly divided into five groups of six rats. Each group of 
rats was orally administrated with distilled water as a control group, indomethacin (20 
mg/kg) was used as a standard drug, and A. trifoliatus leaf extract in 3 different doses of 
100, 300 and 600 mg/kg, respectively. The method of edema induction described by Winters 
et al. (1987) was modified to induce inflammation in rats’ paws. 1% carrageenan in 0.9% 
sodium chloride solution was injected into the right hind paw of each rat after 1 h of each 
treatment. The volumes of rat paw edema were determined using plethysmometer at 1, 2, 
and 3 h after edema induction. The percentage of edema inhibition was calculated 
(Palanichamy and Nagarajan, 1990). Two hours after edema induction, the extract showed 
dose-dependent inhibition and the extract at the dose of 600 mg/kg exhibited significantly 
anti-inflammatory activity (41% inhibition). While the standard drug, indomethacin in the 
dose of 20 mg/kg showed significant effects at both 2 h and 3 h with the percentages of 
inhibition of 35 and 26, respectively (Sithisarn et al., 2009). 
9. Toxicity of A. trifoliatus 
Acute toxicity of the decoction extract from the A. trifoliatus leaves collected from 
Sunpathong district, Chiang Mai province, of Thailand which contained total phenolic and 
total flavonoid of 16.26 and 1.31 g% CAE and g% RE was determined for an oral lethal dose 
in rats. Adult male Wistar rats with a weight range of 215-250 g and adult female Wistar rats 
with a weight range of 178-198 g were randomized into control and experimental groups. 
Each tested group of rats consisting of 5 males and 5 females was orally administered a dose 
of 2 g/kg of A. trifoliatus leaf decoction extract while the control animals were administered 
distilled water. The animals were observed for mortality or any signs of abnormalities 
periodically during the first 0.5, 1 and 3 h and once daily for 14 days thereafter. Clinical sign, 
morbidity and mortality of tested group was observed for 14 days and compared to the 
respective control group. Body weight of each animal was recorded on day 1, 8 and 15. The 
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position, shape, size and color of visceral organs, i.e., heart, kidneys, lungs, stomach, 
intestine, liver, pancreas and sex organ were visually observed for any signs of gross lesions. 
Upon gross examinations of visceral organs, no abnormality sign was observed in all tested 
groups compared to the control. In addition, there was no significant difference in average 
body weights of treated and controlled animals. According to the common classification of 
chemicals (Auletta, 1995, Organization for Economic Co-operation and Development, 2001), 
the extract showed no sign of toxicity (LD50 > 2 g/kg body weight). 
10. Phytochemistry of A. trifoliatus 
Extracts of the leaves and roots of A. trifoliatus prepared by different methods of extraction 
were chromatographic analyzed by thin layer chromatography. Flavonoids and polyphenolic 
compounds were detected with natural product/polyethylene glycol (NP/PEG) spraying 
reagent which showed fluorescence bands under UV 366 nm. Thin layer chromatographic 
fingerprints of A. trifoliatus extracts are shown in Figure 3. From TLC, extracts from the roots 
and leaves of A. trifoliatus showed some chromatographic bands positive to NP/PEG spraying 
reagent under UV 366 nm suggested the presence of phenolic and flavonoid compounds. TLC 
of the root extracts from refluxing with 75% ethanol and decoction as shown in track number 3 
and 5 revealed bright blue fluorescence band corresponded to chlorogenic acid while those of 
the leaf extracts as shown in track number 2 and 4, other than chlorogenic acid, also contained 
orange fluorescence band corresponded to rutin. The leaf 95% ethanol maceration extract as 
shown in track number 2 also positively showed some chromatographic bands to the spraying 
reagent while the root 95% ethanol maceration extract revealed very weak chromatographic 
bands as shown in track number 1. 
 
 
Fig. 3. TLC chromatogram of extracts from A. trifoliatus. Track : 1= root 95% maceration, 2= 
leaf 95% maceration, 3= root 75% refluxing, 4= leaf 75% refluxing, 5= root decoction, 6= leaf 
decoction, 7= standard chlorogenic acid, 8= standard quercetin, Stationary phase: silica gel 
GF254 Solvent system: ethyl acetate: acetic acid : formic acid : water 137: 11: 11: 26 Detection: 
NP-PEG spraying reagent / UV 366 nm.  
1        2          3        4           5          6         7       8 
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number of entries and time spent by mice in light chamber of the light-dark apparatus 
(Sithisarn et al., 2010).  
7.2 Hole-board test 
Applied from Brown and Nemes (2008), the apparatus consisted of a square plastic plate 
with 16 holes, regularly spaced on the surface. Each hole contains sensors for detecting 
when animal dips the head in a hole. Thirty mice were randomly divided into five groups of 
six mice. Each group of mice was orally administrated with distilled water as a control 
group, phenobarbital (30 mg/kg) was used as a standard drug, and A. trifoliatus leaf extract 
in 3 different doses of 500, 750 and 1000 mg/kg, respectively. Forty five minutes after drug 
administration, each mouse was placed on the centre of the board and the number of head 
dips was automatically counted for 3 min. Administration of the leaf decoction extract of A. 
trifoliatus in the concentration of 1000 mg/kg in mice significantly (P<0.05) induced an 
increment of the number of head-dip of the animals, similar to the effect observed in 
phenobarbital treated group (Sithisarn et al., 2010). 
8. Anti-inflammatory activity of A. trifoliatus 
Leaf decoction extract from A. trifoliatus was tested for anti-inflammatory effect using rat 
paw edema model induced by carrageenan injection. Thirty adult male Wistar rats with a 
weight range of 180-200 g were randomly divided into five groups of six rats. Each group of 
rats was orally administrated with distilled water as a control group, indomethacin (20 
mg/kg) was used as a standard drug, and A. trifoliatus leaf extract in 3 different doses of 
100, 300 and 600 mg/kg, respectively. The method of edema induction described by Winters 
et al. (1987) was modified to induce inflammation in rats’ paws. 1% carrageenan in 0.9% 
sodium chloride solution was injected into the right hind paw of each rat after 1 h of each 
treatment. The volumes of rat paw edema were determined using plethysmometer at 1, 2, 
and 3 h after edema induction. The percentage of edema inhibition was calculated 
(Palanichamy and Nagarajan, 1990). Two hours after edema induction, the extract showed 
dose-dependent inhibition and the extract at the dose of 600 mg/kg exhibited significantly 
anti-inflammatory activity (41% inhibition). While the standard drug, indomethacin in the 
dose of 20 mg/kg showed significant effects at both 2 h and 3 h with the percentages of 
inhibition of 35 and 26, respectively (Sithisarn et al., 2009). 
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Acute toxicity of the decoction extract from the A. trifoliatus leaves collected from 
Sunpathong district, Chiang Mai province, of Thailand which contained total phenolic and 
total flavonoid of 16.26 and 1.31 g% CAE and g% RE was determined for an oral lethal dose 
in rats. Adult male Wistar rats with a weight range of 215-250 g and adult female Wistar rats 
with a weight range of 178-198 g were randomized into control and experimental groups. 
Each tested group of rats consisting of 5 males and 5 females was orally administered a dose 
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distilled water. The animals were observed for mortality or any signs of abnormalities 
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position, shape, size and color of visceral organs, i.e., heart, kidneys, lungs, stomach, 
intestine, liver, pancreas and sex organ were visually observed for any signs of gross lesions. 
Upon gross examinations of visceral organs, no abnormality sign was observed in all tested 
groups compared to the control. In addition, there was no significant difference in average 
body weights of treated and controlled animals. According to the common classification of 
chemicals (Auletta, 1995, Organization for Economic Co-operation and Development, 2001), 
the extract showed no sign of toxicity (LD50 > 2 g/kg body weight). 
10. Phytochemistry of A. trifoliatus 
Extracts of the leaves and roots of A. trifoliatus prepared by different methods of extraction 
were chromatographic analyzed by thin layer chromatography. Flavonoids and polyphenolic 
compounds were detected with natural product/polyethylene glycol (NP/PEG) spraying 
reagent which showed fluorescence bands under UV 366 nm. Thin layer chromatographic 
fingerprints of A. trifoliatus extracts are shown in Figure 3. From TLC, extracts from the roots 
and leaves of A. trifoliatus showed some chromatographic bands positive to NP/PEG spraying 
reagent under UV 366 nm suggested the presence of phenolic and flavonoid compounds. TLC 
of the root extracts from refluxing with 75% ethanol and decoction as shown in track number 3 
and 5 revealed bright blue fluorescence band corresponded to chlorogenic acid while those of 
the leaf extracts as shown in track number 2 and 4, other than chlorogenic acid, also contained 
orange fluorescence band corresponded to rutin. The leaf 95% ethanol maceration extract as 
shown in track number 2 also positively showed some chromatographic bands to the spraying 
reagent while the root 95% ethanol maceration extract revealed very weak chromatographic 
bands as shown in track number 1. 
 
 
Fig. 3. TLC chromatogram of extracts from A. trifoliatus. Track : 1= root 95% maceration, 2= 
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10.1 Total phenolic and total flavonoid contents  
Phenolics and flavonoids are known to be strong antioxidants especially through a free 
radical scavenging mechanism (Tyrrell, 1992). Total phenolic and total flavonoid contents in 
plant extracts can be determined colorimetically using specific reagents such as Folin-
Ciocalteu and aluminium chloride reagents, respectively. Extracts from various parts of A. 
trifoliatus were determined for total phenolic content using Folin-Ciocalteu reagent 
(Dasgupta and De, 2007) and showed high concentration of phenolic compounds especially 
75% refluxing extracts from stem barks and stems and root bark decoction extract (21.79  
0.23, 19.17  0.58 and 20.74  0.44 g chlorogenic acid equivalent (CAE) in 100 g extract 
(Sithisarn and Jarikasem, 2009). Total flavonoid content of extracts was determined using 
the method adapted by Meda et al. (2005). Aluminium chloride solution was mixed with the 
same volume of the sample solution. Absorption readings at 415 nm were taken and total 
flavonoid content was calculated as g rutin equivalent (RE)/100 g extract. Among tested 
extracts, leaf 95% ethanolic maceration extracts contained the highest amounts of flavonoids 
(9.61  0.52 g% RE) (Sithisarn and Jarikasem, 2009).  
10.2 High performance liquid chromatography  
Leaf decoction extract of A. trifoliatus was subjected for HPLC-DAD and HPLC-MS  analysis, 
six main peaks were separated by column chromatographic technique and were identified 
by their mass spectra and UV absorption spectra as chlorogenic acid, 3,5-di-O-caffeolyquinic 
acid, rutin, isoquercetin, 4,5-di-O-caffeolyquinic acid and quercitrin, respectively (Sithisarn 
and Jarikasem, 2009). MS chromatogram and HPLC chromatogram of these compounds are 
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leaf extract from A. trifoliatus (Sithisarn et al., 2008). No. of peak (tR, min); 1= chlorogenic 
acid (16.6), 2= 3,5-di-O-caffeolyquinic acid (47.2), 3= rutin and isoquercetin (49.1), 4= 4,5-di-
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11. Standardization of A. trifoliatus  
Chemical and biological standardizations of plant extracts are also needed to be clarified 
before further studies in animal model or clinical trial. The major variables in plant 
geography are area, annual rain fall, ground water, types of soil, pH of soil, temperature, 
altitude, wind, light and local insecticides. These factors, especially rain fall and 
 
Fig. 5. Chemical structures of compounds from n-butanol fraction of leaf extract from A. 
trifoliatus : 1 = chlorogenic acid, 2 = 3,5-di-O-caffeolyquinic acid, 3 = 4,5-di-O-caffeolyquinic 
acid, 4 = rutin, 5 = isoquercetin, 6 = quercitrin. 
temperature, could affect the biosynthesis of caffeoylquinic acid and flavonoid in A. trifoliatus 
(Sithisarn et al., 2011a). Chemical, physical and biological standardization of decoction extract 
of A. trifoliatus was set up by determination of antioxidant activity and quantitative analysis of 
the marker compositions of 11 A. trifoliatus leaf samples harvested in Chaing Mai province at 
different time intervals within a year. Using decoction, the most suitable extraction method for 
active A. trifoliatus leaf extract as previously reported (Sithisarn, and Jarikasem, 2009), it was 
found that samples collected in Winter and Fall contained significantly higher amount of total 
phenolic (12.72 – 14.66 g% CAE in dried extract) and total flavonoid (1.97 – 2.20 g% RE in dried 
extract) (Sithisarn et al., 2011b). HPLC analysis of marker components including 
monocaffeoylquinic acid (chlorogenic acid), dicaffeoylquinic acids (3,5-di-O-caffeoylquinic 
acid and 4,5-di-O-caffeoylquinic acid), and flavonoid glycosides (rutin, isoquercetin and 
quercitrin) revealed that samples collected in January and November significantly contained 
high amount of phenolic and flavonoid contents suggesting the harvesting period of A. 
trifoliatus leaf samples during Winter or in low temperature condition (Sithisarn et al., 2011a). 
HPLC fingerprints of all extracts as shown in Figure 6 showed the similar chromatographic 
characteristics suggested that this HPLC fingerprint could be used for both quantitative and 
qualitative analysis of leaf extracts of A. trifoliatus. 
Free radical scavenging activity of the collected extracts was studied by DPPH scavenging 














































































Phytochemicals – Bioactivities and Impact on Health 
 
262 
10.1 Total phenolic and total flavonoid contents  
Phenolics and flavonoids are known to be strong antioxidants especially through a free 
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(Cervantes-Cervantes, 2005). Samples which contained high amount of total phenolic and total 
flavonoid contents significantly exhibited the strongest activity. The high correlations of total 
phenolic and total flavonoid contents with DPPH scavenging activity were found to be 0.863 
and 0.831 (P  0.05), respectively. For the capacity to inhibit iron-induced lipid peroxidation, 
moderate correlations of 0.586 and 0.389 (P  0.05) were found between the inhibition and total 
flavonoid and total phenolic contents, respectively (Sithisarn et al., 2011b). 
An excess of water in medicinal plant materials will lead to microbial growth, the presence 
of fungi or insects, and deterioration following hydrolysis. Therefore, limits for the amount 
of water should be set for plant materials. This is especially important for materials which 
absorb moisture easily or deteriorate quickly in the presence of water (World Health 
Organization, 1992). Extracts and the leaves of A. trifoliatus collected at 11 different times 
were investigated for loss on drying as mentioned in BP (2004). Loss on drying of plant 
samples ranged from 6.58 ± 0.13 to 15.06 ± 0.05 % while the extract contained the loss on 
drying amount of 8.28 ± 3.30 to 11.51 ± 0.52 %. 
 
Fig. 6. HPLC chromatogram of leaf decoction extracts from A. trifoliatus collected from 11 
different durations. No. of peak; 1= chlorogenic acid, 2= 3,5-di-O-caffeolyquinic acid, 3= 
rutin and isoquercetin, 4= 4,5-di-O-caffeolyquinic acid, 5= quercitrin. 
12. Conclusion  
As the mention of Teeguarden (1998), “an adaptogen is substance that helps bring the body 
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systematic balance. This harmonizing function reduces the effects of unfavorable conditions 
and stimulates the body’s own immune and healing functions. These adaptogenic 
substances help the body to adapt to various stressful challenges presented by the 
environment and reduce the damage inflicted on the body. They tend to promote the body’s 
own ability to cope successfully with stress, thus prolonging well-being”, the effects of 
adaptogen could relate to some biological activities including antioxidative, anti-
cholinesterase, anti-inflammatory and anti-anxiety, which associated with the excessive 
activity of stress system (Chrousos and Gold, 1992, Panossian, 2003). Several parts of 
Acanthopanax trifoliatus, a Thai traditional herb promoted in vitro antioxidant and anti-
cholinesterase activities. Extracts from the leaves of this plant could also exhibit in vivo 
adaptogenic related biological effects including anti-inflammatory and anti-anxiety 
activities. Polyphenolics and flavonoid, phytochemicals that play important role in 
antioxidation, anti-inflammatory and adaptogenic actions in plants (Hoorn, 2003, Panossian 
and Wagner, 2005, Wagner et al., 1994) were found to available in high amount in A. 
trifoliatus, especially in the leaves and the roots. Active polyphenolics and flavonoid 
compounds were structurally identified. A. trifoliatus could then be considered as the 
potential plant that promote adaptogenic effects which conduced to the chemical, biological 
and physical standardization of the leaf extract of this plant. However, at present there is no 
A. trifoliatus product used for health or medicinal purposes in the marketplace, especially in 
Thailand. Since young leaves of A. trifoliatus have been traditionally consumed as 
vegetables, and the leaf extract of this plant showed various biological activities related to 
adaptogenic properties with no acute toxicity was found, therefore, it would be great 
opportunity to develop the effective, high quality and standardized health supplement or 
herbal medicine for adaptogenic related purposes in the near future. 
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1. Introduction 
1.1 The history of the use of barley 
The beginning of agriculture is dated back to 10,000 years ago in the Pre-Pottery Neolithic 
Near East. Barley (Hordeum vulgare L.) is one of the cereal founder crops and it is believed 
that first plant domestication took place within the Fertile Crescent (Lev-Yadun et al., 2000). 
Hordeum vulgare L. subsp. spontaneum (wild barley) is said to be the ancestor of today’s 
barley. The spread of barley most likely started in present-day Israel, northern Syria, 
southern Turkey, eastern Iraq and western Iran. With the movement of civilizations 
accompanied by the establishment of trade routes the use and cultivation of barley reached 
Europe. Barley was a popular food in ancient Greece and Italy and used as an ingredient for 
preparing porridge or unleavened bread. Greek and Roman scholars such as Hippocrates or 
Pliney the Elder, respectively, considered barley as a healthy and nourishing food and 
barley gained as well recognition for medical treatments. In the ancient Rome, gladiators 
believed that barley could increase strength and stamina and thus preferred it to other 
cereals. Barley reached Spain around 5,000 BC and spread then over today’s Germany and 
France. Indications of domestication of barley on the British Isles date back until 3,000 BC 
and one millennium later, barley was introduced to Northern Europe. Probably due to the 
nourishing properties and the ruggedness of the crop, barley became a major food especially 
for poor people throughout history (Newman & Newman, 2005).  
In 2009, barley was the twelfth most important agricultural commodity of the world in 
terms of production. After maize, wheat and paddy rice it was the fourth most important 
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cereal crop (FAO, 2011). The annual production was about 152 million tons, of which the 
Russian Federation produced around 17.9 million tons followed by France, Germany and 
Ukraine with 12.9, 12.3 and 11.8 million tons, respectively. In the European Union, barley 
still attains distinction as the second cereal crop after wheat. 
Barley falls botanically into the family of the grasses (Poacea=Gramineae), tribe Triticeae, 
genus Hordeum. It is a diploid (2n=2x=14) mainly self-pollinating crop. In contrast to 
domesticated variations wild barley has a brittle spike where the ripe spikelets separate 
from each other easily; this favours the spread of the seed but complicates harvest. Non-
brittle variations can be harvested unproblematically but survive only under domestication. 
A barley head consists of triplets of spikelets that are alternatively arranged on the rachis. 
Due to the morphology of the spikelets one can distinguish between two- and six-rowed 
barleys. Two-rowed barleys have two lateral unfertile spikelets in each triplet and thus only 
two rows of fertile spikelets. In six-rowed barley all six spikelets are fertile (Takahashi, 1955; 
Zohary & Hopf, 2000).  
Cultivated barley can as well be classified by the form of their caryopsis. In hulless (syn. 
hull-less or naked) barley varieties the expression of the recessive naked caryopsis gene 
(nud, nudum) prevents the intergrowth of husks and caryopsis. Consequently, the kernels 
thresh free and lemma and palea do not adhere to the caryopsis at maturity. This is why 
hulless barley (Hordeum vulgare var. nudum) requires no further dehulling for the production 
of food. Cultivation of hulless barley is as old as that of hulled barley but is less common 
worldwide due to significantly lower yields and only minor breeding activities (Atanassov 
et al., 2001; Pandey et al., 2006). Compared to hulled barley, the free-threshing character of 
hulless barley proportionally increases contents of protein and the limiting amino acids 
lysine and thereonine, respectively, (Baidoo & Liu, 1998; Bhatty, 1999) and as well levels of 
β-glucan but lowers contents of insoluble dietary fibre components (Xue et al., 1997; Baidoo 
& Liu, 1998). 
1.2 Importance of barley as food ingredient 
Starch is the major component in barley kernels amounting 60 – 70% of the dry matter. 
Starch itself is composed of two types of glucose polymers namely the highly branched 
amylopectin and the linear amylose. According to the proportions of amylose and 
amylopectin barley can further be classified: normal naked barley contains 25 – 30% 
amylose, waxy varieties less than 15% whereas high-amylose cultivars more than 35% 
amylose (Ajithkumar et al., 2005; Bhatty, 1986; 1999). Among the waxy cultivars there are 
also zero-amylose waxy barleys that contain no amylose (Izydorczyk et al., 2000). Both 
polymers strongly influence the quality of the obtained products, where amylopectin is 
responsible for the crystallinity of starch and excellent water absorbing properties (Bhatty, 
1997).  
Hulless barley is a good source of dietary fibre providing soluble and insoluble dietary fibre 
fractions (Bhatty, 1999; Izydorczyk et al., 2000). Mixed-linkage (1→3),(1→4)-β-D-glucans 
(hereafter termed as β-glucan) are a major part of the soluble dietary fibre (SDF) in barley. 
Nevertheless, its content generally underlies a natural fluctuation depending on the variety 
and conditions before and after harvest (Ehrenbergerová et al., 2008). Together with 
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arabinoxylans, a fraction of partly soluble nonstarch polysaccharides (NSP) occurring in the 
cell walls, β-glucan has a great impact on cereal processing and product properties. In 
Europe, the European Food Safety Authority (EFSA) has come to the decision that a claim 
like “regular consumption of β-glucans contributes to maintenance of normal blood 
cholesterol concentrations” will be allowed (EFSA, 2009). Until then, the interest of food 
producers and consumers in using hulless barley for food purposes may increase, although 
up to now, barley flour is hardly used for human consumption. It is assumed that barley β-
glucans have the same effects than oat β-glucans. In order to bear the claim, EFSA demands 
a quantity in food of at least 3 g/day of β-glucans from oats, oat bran, barley, barley bran, or 
from mixtures of non-processed or minimally processed β-glucans in one or more servings.  
On the other side of the coin, the higher the β-glucan content in barley flours the worsen are 
the baking qualities, due to the high water binding capacity and thus decreasing the water 
availability for the gluten network (Gill et al., 2002). Furthermore, high β-glucan contents 
must not necessarily go along with increased health enhancing properties unless the 
extractability and/or digestibility are not considered (Xue et al., 1997).  
1.3 Phytochemicals in barley 
Over the last decade, fruits, vegetables and cereals have been studied for various bioactive 
compounds such as phenolics and flavonoids as health promoting and disease preventing 
effects were found in both in vitro and in vivo studies. Phytochemicals, per definition, are 
substances that are likely to contribute to health or are essential for the maintenance of 
health (Cooke et al., 2002). In contrary to vitamins or minerals, there is no evidence that they 
are essential or even required to sustain life. It is hypothesised that phytochemicals that are 
located in the fibre matrix, in addition to or instead of the fibre itself, are responsible for the 
reduced risk of various diseases associated with oxidative stress, such as cancer, 
cardiovascular and neurodegenerative diseases (Jacobs & Steffen, 2003). Thus, the 
consumption of whole grains is seen as health-promoting (Slavin, 2003), because whole-
grains and products thereof present a good source of natural antioxidants (Decker et al., 
2002). Polyphenols constitute together with carotenoids the only dietary antioxidants 
present in the colon in valuable concentrations (Scalbert & Williamson, 2000; Manach et al., 
2004). The release of phenolics in the colon may explain the inverse association between 
whole-grain consumption and incidence of certain chronic diseases (Andreasen et al., 2001; 
Kern et al., 2003). Moreover, an apparent increase of antioxidant release during enzymatic 
incubation was found in in vitro studies (Pérez-Jiménez & Saura-Calixto, 2005; Nagah & 
Seal, 2005; Menga et al., 2010). 
Barley grains contain a wide range of phenolic acids, which are either derivatives of benzoic 
acid (C6-C1) or cinnamic acid (C6-C3). In general, higher levels of phenolic compounds were 
reported for barley and oat compared to wheat and rye (Zielinski & Kozlowska, 2000). 
Ferulic acid is the most abundant phenolic acid present in cereals, representing up to 90% of 
total polyphenols (Sosulski et al., 1982). Also Hernanz et al. (2001) and Naczk & Shahidi 
(2006) reported that ferulic acid is the dominant free phenolic acid in barley seeds. The 
composition of phenolic acids in 30 barley varieties was investigated by Yu et al. (2002) 
where they found varying levels of benzoic and cinnamic acids. Phenolic compounds are 
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said to exhibit one or more of the following roles: free radical scavenger, reducing agent, 
potential producer of prooxidant metals and quencher of singlet oxygen formation.  
Anthocyanins in wheat and barley are found either in the pericarp or the aleurone layer 
causing purple and blue hues of kernel colour, respectively. The black pigmentation of the 
lemma and pericarp of barley, however, is described to be due to melanin-like pigment 
(Woodward, 1941; Lundqvist et al., 1996) which may overlap other pigments. Black kernel 
colour due to melanin-like pigment is unknown to wheat species.  
Lutein and zeaxanthin are the two main carotenoids identified in barley (Goupy et al., 1999; 
Panfili et al., 2004). The electron rich chain makes them effective radical scavengers (Cooke 
et al., 2002) and inhibit free radical propagation reactions such as lipid peroxidation. Lutein 
and zeaxanthin are responsible for the coloration of the macula lutea (‘yellow spot’) of the 
retina, the area of maximal visual acuity. Hence, dietary lutein and zeaxanthin are supposed 
to protect against age-related macular degeneration and cataract (Seddon et al., 1994; Beatty 
et al., 2000). Furthermore, lutein and zeaxanthin possibly act together with other bioactive 
compounds against cancer, cardiovascular risk and other diseases (Wahlqvist & 
Wattanpenpiaboon, 1998; Mares-Perlman et al., 2002; Calvo, 2005). Vitamin E or tocopherols 
are also present in markedly concentrations (Cavallero et al., 2004; Andersson et al., 2008).  
2. Materials and methods 
2.1 Barley samples 
Twenty-nine barley varieties were grown at the experimental station Groß-Enzersdorf 
(16°35‘ E; 48°13‘ N) in 2007, 2008 and 2009. The varieties were sown at the beginning of 
March and harvested mid July. Monthly precipitation and mean temperature of the growing 
seasons at the growing site for the three years are shown in Fig. 1. Post-harvest treatment 
included sifting via air classification. Barley samples were stored at 4 °C until use. Samples 
were milled directly before analyses using a laboratory mill (MF10 basic with a 1 mm sieve, 
IKA, Austria) to obtain wholemeal samples.  
Twelve coloured naked barley varieties were further selected to study the distribution of the 
compounds of interest within the different milling fractions. These varieties were milled with a 
MLU 202 roller mill (Bühler, Switzerland). The grain was not conditioned before milling and 
the feed rate for milling was approximately 5 kg h-1. Six flour fractions (B1-B3, C1-C3) from the 
starchy endosperm were collected and merged to give a straight-run white flour. Brans and 
shorts were collected separately. All millstreams were stored at 4 °C until use. 
2.2 Analyses 
2.2.1 Agronomic traits 
Data were collected for thousand kernel weight (TKW, g), hectolitre weight (HLW, kg hL-1) 
and seed plumpness (SP25, %). HLW was measured by a ¼ L chondrometer. Counting of 
seeds was done by a Contador machine (Pfeuffer GmbH, Kitzingen, Germany) and 
weighed. SP25 was determined by sieving 100 g of grain with a Sortimat laboratory machine 
(Pfeuffer GmbH, Kitzingen, Germany). Grains remaining on the 2.5 mm sieve were 
considered as plump.  
Hulless Barley – A Rediscovered Source for Functional Foods Phytochemical Profile  
and Soluble Dietary Fibre Content in Naked Barley Varieties and Their Antioxidant Properties 
 
273 
2.2.2 Basic chemical composition 
Moisture and ash content of the barley flour was determined according to AOAC approved 
standard methods 940.56 and 920.153, respectively (AOAC, 1995). Crude protein (PROT) 
was determined according to the ICC standard method 105/2 using the factor 5.83N for 
conversion, whereas total starch content was determined according to the ICC standard 
method 168 (ICC, 2001).  
2.2.3 Dietary fibre 
Mixed linkage β-glucan (BG) (AOAC method 995.16) content was determined in barley 
wholemeal samples using a commercially available test kit (Megazyme, Bray, Ireland). 
Total pentosanes (PENT) and water-extractable pentosanes (we-PENT) were analysed 
according to the method described by Douglas (1981). Briefly, for determination of we-
PENT, 25 mg sample were suspended in 10 mL water and extracted for 2 h on a rotary 
shaker. One millilitre of the aqueous phase was mixed with 5 mL of the reaction solution 
(consisting of 110 mL glacial acid, 2 mL HCl conc., 5 mL phloroglucinol solution (20% (w/v) 
in ethanol) and 1 mL 1.75% (w/v) glucose solution) and incubated for 25 min in a boiling 
water bath and shaken from time to time. After cooling, the we-PENT content was 
calculated from the difference of the absorbances at 510 and 552 nm according to a xylose 
calibration curve (2 g L-1). To determine total pentosanes (PENT) content, 5 mg of the 
sample was suspended in 2 - 4 mL water and incubated with the reaction solution. 
2.2.4 Secondary plant metabolites 
Extraction of free and bound phenolic compounds 
Free and bound phenolic acids were extracted according to the methods of Adom et al. 
(2003) and Mattila et al. (2005) with minor modifications. Briefly, 0.15 g of barley flour was 
extracted twice with 80% aqueous methanol for 30 min. Supernatants were pooled after 
centrifugation at 2500g for 10 min and represented the crude extracts of free phenolics. 
Samples were stored at -20 °C until HPLC analysis and filtered prior injection into the 
HPLC.  
To extract the bound phenolic compounds, the above obtained residues were blended with 
sodium hydroxide to reach a final concentration of 2 M NaOH. Samples were vortex mixed 
and incubated in the dark on a shaker (Rotator, VWR, Austria) overnight (16 h). The mixture 
was brought to pH 3 with hydrochloric acid. After centrifugation, supernatants and residues 
were extracted separately three times with ethyl acetate. The combined ethyl acetate fractions 
were evaporated to dryness and stored at -20 °C until analysis. Before quantification, bound 
phenolic compounds were dissolved in 50% methanol.  
Anthocyanin content 
Anthocyanins were extracted with acidified methanol (methanol and 1 M HCl, 85:15, v/v) 
with a solvent to sample ratio of 1:10 for 30 min on a magnetic stirrer and then separated by 
centrifugation. The supernatants were collected and kept in the dark and cold (+4 °C) until 
procedure. The residues were twice re-extracted under the same conditions, and supernatants 
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said to exhibit one or more of the following roles: free radical scavenger, reducing agent, 
potential producer of prooxidant metals and quencher of singlet oxygen formation.  
Anthocyanins in wheat and barley are found either in the pericarp or the aleurone layer 
causing purple and blue hues of kernel colour, respectively. The black pigmentation of the 
lemma and pericarp of barley, however, is described to be due to melanin-like pigment 
(Woodward, 1941; Lundqvist et al., 1996) which may overlap other pigments. Black kernel 
colour due to melanin-like pigment is unknown to wheat species.  
Lutein and zeaxanthin are the two main carotenoids identified in barley (Goupy et al., 1999; 
Panfili et al., 2004). The electron rich chain makes them effective radical scavengers (Cooke 
et al., 2002) and inhibit free radical propagation reactions such as lipid peroxidation. Lutein 
and zeaxanthin are responsible for the coloration of the macula lutea (‘yellow spot’) of the 
retina, the area of maximal visual acuity. Hence, dietary lutein and zeaxanthin are supposed 
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Wattanpenpiaboon, 1998; Mares-Perlman et al., 2002; Calvo, 2005). Vitamin E or tocopherols 
are also present in markedly concentrations (Cavallero et al., 2004; Andersson et al., 2008).  
2. Materials and methods 
2.1 Barley samples 
Twenty-nine barley varieties were grown at the experimental station Groß-Enzersdorf 
(16°35‘ E; 48°13‘ N) in 2007, 2008 and 2009. The varieties were sown at the beginning of 
March and harvested mid July. Monthly precipitation and mean temperature of the growing 
seasons at the growing site for the three years are shown in Fig. 1. Post-harvest treatment 
included sifting via air classification. Barley samples were stored at 4 °C until use. Samples 
were milled directly before analyses using a laboratory mill (MF10 basic with a 1 mm sieve, 
IKA, Austria) to obtain wholemeal samples.  
Twelve coloured naked barley varieties were further selected to study the distribution of the 
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2.2 Analyses 
2.2.1 Agronomic traits 
Data were collected for thousand kernel weight (TKW, g), hectolitre weight (HLW, kg hL-1) 
and seed plumpness (SP25, %). HLW was measured by a ¼ L chondrometer. Counting of 
seeds was done by a Contador machine (Pfeuffer GmbH, Kitzingen, Germany) and 
weighed. SP25 was determined by sieving 100 g of grain with a Sortimat laboratory machine 
(Pfeuffer GmbH, Kitzingen, Germany). Grains remaining on the 2.5 mm sieve were 
considered as plump.  
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calculated from the difference of the absorbances at 510 and 552 nm according to a xylose 
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2.2.4 Secondary plant metabolites 
Extraction of free and bound phenolic compounds 
Free and bound phenolic acids were extracted according to the methods of Adom et al. 
(2003) and Mattila et al. (2005) with minor modifications. Briefly, 0.15 g of barley flour was 
extracted twice with 80% aqueous methanol for 30 min. Supernatants were pooled after 
centrifugation at 2500g for 10 min and represented the crude extracts of free phenolics. 
Samples were stored at -20 °C until HPLC analysis and filtered prior injection into the 
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To extract the bound phenolic compounds, the above obtained residues were blended with 
sodium hydroxide to reach a final concentration of 2 M NaOH. Samples were vortex mixed 
and incubated in the dark on a shaker (Rotator, VWR, Austria) overnight (16 h). The mixture 
was brought to pH 3 with hydrochloric acid. After centrifugation, supernatants and residues 
were extracted separately three times with ethyl acetate. The combined ethyl acetate fractions 
were evaporated to dryness and stored at -20 °C until analysis. Before quantification, bound 
phenolic compounds were dissolved in 50% methanol.  
Anthocyanin content 
Anthocyanins were extracted with acidified methanol (methanol and 1 M HCl, 85:15, v/v) 
with a solvent to sample ratio of 1:10 for 30 min on a magnetic stirrer and then separated by 
centrifugation. The supernatants were collected and kept in the dark and cold (+4 °C) until 
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of all three cycles were combined. Total anthocyanin content (TAC) was calculated using a 
calibration curve of cyanidin-3-O-glucoside (C-3-glc) as reference. Extracts were measured at 
525 nm in a U-1100 spectrophotometer (Hitachi, Tokyo, Japan). Contents were expressed as 
mg C-3-glc equ. per 100 g, dm (Abdel-Aal & Hucl, 1999).  
Extracts were further proceeded to quantify different anthocyanidins. Therefore, samples 
were kept at -30 °C overnight and the precipitates were separated via centrifugation at 2500g 
thereafter. The solvent was removed at 40 °C using a rotary evaporator and the resulting 
anthocyanin concentrates were re-suspended in methanol prior to HPLC analysis. 
Carotenoid content 
Five gram of barley flour and 0.02 g butylated hydroxytoluene (BHT) were weighed into 
amber glass flasks. After addition of 20 mL of the extraction solvent (MeOH:ethyl 
acetate:petroleum ether, 1:1:1, v/v/v), samples were extracted on a magnetic stirrer for 2 h 
and then filtrated to recover the extract and the residue. The extraction procedure was 
repeated twice using the residue. The collected combined supernatants were transferred into 
a separation funnel and washed three times with a saturated NaCl-solution (37.5% NaCl 
in water). Remaining water in the organic phase was thereafter removed with sodium 
sulphate and the extract was evaporated until dryness at 35 °C. Samples were further kept 
under a stream of nitrogen to avoid any oxidation, sealed and immediately stored at -20 
°C until analysis. Prior analysis, samples were thawed, solubilised in tetrahydrofuran 
(THF) and transferred into amber glass HPLC vials and kept under nitrogen-stream 
before closing. 
HPLC analysis 
The profile of anthocyanidins and their corresponding glycosides as well as phenolic 
compounds and carotenoids were determined using a HPLC system (Shimadzu, Korneuburg, 
Austria) consisting of a SPD-M10AVP photodiodearray detector, chromatogram integrator, 
LC-10ADVP pump and online degasser. Data signals were processed on a PC running the LC 
solution Multi software (Shimadzu, Korneuburg, Austria). Analytical separation of 
anthocyanidins and phenolic acids was carried out using a Phenomenex Luna 2504.6 mm, 5 
µm (HPLC Services, Breitenfurt, Austria) column, whereas carotenoids were separated on a 
Vydac 201TP54, C18 5µm, 2504.6 mm (MZ-Analysentechnik GmbH, Mainz, Germany) 
column. 
For the determination of anthocyanidins, dissolved anthocyanidin concentrates were passed 
through a 0.45 µm PTFE-filter and a 20 µL aliquot of the sample solution was injected. 
Elution for anthocyanidins was executed under gradient conditions with (A) 4.5% formic 
acid in water and (B) acetonitrile. The solvent gradient was programmed as follows: 10% B 
at 0 min, increasing to 12% within 9 min, to 13% within the next 7.5 min, 25% within the 
next 13.5 min, 90% within the next 15 min, holding at 90% for 5 min, followed by a decrease 
to 10% within the next 5 min, before equilibration at 10%. The solvent flow rate was set at 
0.8 mL min-1 and the chromatogram was recorded at 520 nm (anthocyanidins and 
glycosides) at 35 °C. Peak areas were used for all calculations. Identification of compounds 
was done by comparing the retention time and the UV spectra with those of pure 
substances. DAD response was linear for all anthocyanidins and anthocyanins within the 
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calibration range of 0.05 – 40.0 µg mL-1, with correlation coefficients exceeding 0.999. 
Coefficients of variation for sample replicates were consistently below 10%.  
Phenolic acids were determined as follows: Twenty microliter of sample were injected into 
the column and eluted under gradient conditions performed with 0.05% trifluoroacetic acid 
in water (A) and 0.05% trifluoroacetic acid in acetonitrile (B). The solvent gradient was 
programmed as follows: at 0 min, 10% B; increasing from 3 to 15 min to 15% B; 25 min, 20% 
B; 30 min, 40% B; 36 – 40 min, 80% B; decreasing thereafter to 10% B within the next 4 min 
and equilibrating before the next injection. The flow rate was 1.0 mL min-1. Analyte 
detection was at 260 nm for 4-OH-benzoic and vanillic acid and at 280 nm for caffeic, p-
coumaric and trans-ferulic acid. DAD response was linear for all phenolic acids within the 
calibration range of 0.06 – 125.0 µg mL-1, with correlation coefficients exceeding 0.999. 
Phenolic acids in the samples were identified by comparing their relative retention times 
and UV spectra with authentic compounds. Coefficients of variation for sample replicates 
were consistently below 10%.  
Carotenoids were separated under isocratic conditions with methanol:acetonitrile (9:1, v/v) 
and 1 mL min-1 flow rate. The temperature was set at 25 °C, and lutein (LUT) and zeaxanthin 
(ZEA) were detected at 450 nm. Peak areas were used for all calculations. Identification of 
compounds was done by comparing the retention time and the UV spectra with those of pure 
substances. 
2.2.5 Determination of the antioxidant capacity 
Extracts containing the free and bound phenolic compounds were analysed for their total 
antioxidant capacity by the ABTS radical cation scavenging assay (Trolox equivalent 
antioxidant capacity (TEAC)) and the ferric reducing antioxidant power (FRAP) assay. To 
distinguish between the two extracts, the terms TEACf and FRAPf were used for the extract 
containing the free phenolic acids, whereas TEACb and FRAPb refer to the extract 
containing the bound phenolic acids. 
The total phenolic content (TPC) of extracts was determined using the Folin-Ciocalteu 
reagent (Singleton et al., 1999) and was termed thereafter as TPCf or TPCb for free and 
bound phenolics, respectively. An appropriate dilution of extracts (120 µL) was added to 600 
µL of freshly diluted 10-fold Folin-Ciocalteu reagent. 960 µL of sodium carbonate solution 
(75 g L-1) was added to the mixture after 2 min reaction time. The absorbance of the resulting 
blue colour was measured at 760 nm against a blank after 5 min of reaction at 50 °C. Ferulic 
acid was used as standard, and TPC was expressed as mg ferulic acid (FA) equ. per 100 g, 
dm.  
The TEAC assay was analysed following a modified method of Pellegrini et al. (2003) and 
Moore et al. (2005). A stable stock solution of ABTS radical cation was produced by reacting 
a 7 mmol L-1 aqueous solution of ABTS with 2.45 mmol L-1 potassium persulfate (final 
concentration) and allowing the mixture to stand in the dark at room temperature for 12 – 16 
h before use. On the day of analysis, an ABTS radical cation working solution was obtained 
by diluting the stock solution in ethanol to an absorbance of 0.70 ± 0.02 AU at 734 nm. 
Hundred microliters of extract were mixed with 1.25 mL of the ABTS working solution and 
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of all three cycles were combined. Total anthocyanin content (TAC) was calculated using a 
calibration curve of cyanidin-3-O-glucoside (C-3-glc) as reference. Extracts were measured at 
525 nm in a U-1100 spectrophotometer (Hitachi, Tokyo, Japan). Contents were expressed as 
mg C-3-glc equ. per 100 g, dm (Abdel-Aal & Hucl, 1999).  
Extracts were further proceeded to quantify different anthocyanidins. Therefore, samples 
were kept at -30 °C overnight and the precipitates were separated via centrifugation at 2500g 
thereafter. The solvent was removed at 40 °C using a rotary evaporator and the resulting 
anthocyanin concentrates were re-suspended in methanol prior to HPLC analysis. 
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amber glass flasks. After addition of 20 mL of the extraction solvent (MeOH:ethyl 
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in water). Remaining water in the organic phase was thereafter removed with sodium 
sulphate and the extract was evaporated until dryness at 35 °C. Samples were further kept 
under a stream of nitrogen to avoid any oxidation, sealed and immediately stored at -20 
°C until analysis. Prior analysis, samples were thawed, solubilised in tetrahydrofuran 
(THF) and transferred into amber glass HPLC vials and kept under nitrogen-stream 
before closing. 
HPLC analysis 
The profile of anthocyanidins and their corresponding glycosides as well as phenolic 
compounds and carotenoids were determined using a HPLC system (Shimadzu, Korneuburg, 
Austria) consisting of a SPD-M10AVP photodiodearray detector, chromatogram integrator, 
LC-10ADVP pump and online degasser. Data signals were processed on a PC running the LC 
solution Multi software (Shimadzu, Korneuburg, Austria). Analytical separation of 
anthocyanidins and phenolic acids was carried out using a Phenomenex Luna 2504.6 mm, 5 
µm (HPLC Services, Breitenfurt, Austria) column, whereas carotenoids were separated on a 
Vydac 201TP54, C18 5µm, 2504.6 mm (MZ-Analysentechnik GmbH, Mainz, Germany) 
column. 
For the determination of anthocyanidins, dissolved anthocyanidin concentrates were passed 
through a 0.45 µm PTFE-filter and a 20 µL aliquot of the sample solution was injected. 
Elution for anthocyanidins was executed under gradient conditions with (A) 4.5% formic 
acid in water and (B) acetonitrile. The solvent gradient was programmed as follows: 10% B 
at 0 min, increasing to 12% within 9 min, to 13% within the next 7.5 min, 25% within the 
next 13.5 min, 90% within the next 15 min, holding at 90% for 5 min, followed by a decrease 
to 10% within the next 5 min, before equilibration at 10%. The solvent flow rate was set at 
0.8 mL min-1 and the chromatogram was recorded at 520 nm (anthocyanidins and 
glycosides) at 35 °C. Peak areas were used for all calculations. Identification of compounds 
was done by comparing the retention time and the UV spectra with those of pure 
substances. DAD response was linear for all anthocyanidins and anthocyanins within the 
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bound phenolics, respectively. An appropriate dilution of extracts (120 µL) was added to 600 
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dm.  
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absorbance was red at 734 nm after a 1 min reaction time. Results were expressed as TEAC 
in mmol of Trolox per kg, dm.  
The FRAP assay is based on the reduction of the Fe3+–TPTZ complex to the ferrous form at 
low pH. This reduction is monitored by measuring the absorption change at 595 nm (Benzie 
& Strain, 1999). Briefly, 0.2 mL of sample extract was mixed with 1.3 mL of the FRAP 
reagent. Absorption was measured at 595 nm in a spectrophotometer (U-1100, Hitachi, 
Japan) after 30 min of incubation at 37 °C. The FRAP reagent was prepared daily and 
consisted of 0.3 M acetate buffer (pH 3.6), 10 mM TPTZ in 40 mM HCl, and 20 mM FeCl3 in a 
ratio of 10:1:1 (v/v/v). FRAP values were obtained by comparing the absorption change in 
the test mixture with doses obtained from increasing concentrations of Fe(III) and expressed 
as mmol of Fe(II) equ. per kg, dm.  
2.2.6 Statistical analysis 
Data were reported as mean ± standard deviation for at least duplicate extracts. Statistical 
analysis were carried out using STATGRAPHICS Centurion® XV (StatPoint Technologies 
Inc., Warrenton, VA), SAS® 9.2 (SAS Institute Inc., Cary, NC) and/or GenStat® 13th Ed. 
(VSN International Ltd., Hemel Hempstead, UK) software packages. Linear mixed model 
analysis of variance was carried out for the multi-year data (2007-2009) with genotypes as 
fixed effects and year and genotype by year interaction (G×Y) as random effects. Model 
selection was based on the corrected Akaike information criterion (AIC). Significance of 
random effects was tested by the log-likelihood ratio test. Multivariate analyses were 
performed with collected data from 2008, i.e. principal component analysis (PCA) and 
canonical discriminant analysis. Multiple mean comparisons were carried out at the 5% 
significance level using the Duncan’s multiple range test.  
3. Results 
3.1 Description of investigated hulless barley genotypes 
Twenty-nine spring barley genotypes with different countries of origin, two- or six-rowed 
types as well as different seed colours were selected for this study. HB803 and Pronghorn 
(Washonubet) are white waxy genotypes, whereas all others were of normal starch type. 
Pronghorn was produced by crossing Wanubet and Shonubet and is currently filed as 
patent (Patent No. 20090064357).  
The seed colour of barley genotypes is dependent on different pigments which are located in 
different seed layers. A great diversity from yellowish-white to blue, purple and black is 
reported in the literature. The interest in re-introducing coloured varieties is closely 
associated with their possible health promoting effects. Most of black and blue genotypes 
came from Ethiopia, a country rich in coloured barley germplasm. Apart from Purple 
Nudum, all purple classified genotypes are 6-rowed and bear the term “black” in their 
name. As they originated in majority from China, it is anticipated that the investigated 
genotypes have been selected from Chinese landraces. After their first propagations in 2006, 
all genotypes have been classed according to their seed colour. As the colour appeared dark-
purple to black, they were finally carried on as purple (Table 1).  
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3.2 Analyses of three consecutive harvests 
In 2007, sowing of spring cereals was followed by a six weeks period without rainfall 
resulting in reduced plant emergence and development of stands with the consequence of 
lower performance of spring barley in regard to agronomic traits. The establishment of 
stands was also limited in 2008 due to the absence of sufficient rainfall in March and April. 
At anthesis (end of May), during the soft dough stage of grain filling and at harvest (mid 
July), the rainfalls were higher than the average. The climatic conditions of 2009 were 
comparable with 2007 in spring, whereas sufficient rainfall was available in June and July 
(Fig. 1). In a previous study, no correlation was found for the precipitation between 2006 
and 2007, whereas the mean temperatures showed a strong association. Therefore, the 
limiting factor for a sustainable spring crop production in eastern Austria is the unequal 
distribution of rainfall from year to year (Bokore, 2008). 
 
Fig. 1. Precipitation (illustrated as bars) and mean temperature (displayed as triangles) at the 
experimental site over the investigation period 
Mixed model ANOVA revealed significant differences among genotypes (Table 1). Mean 
TKW and HLW of three consecutive harvests varied within genotypes and ranged from 26 – 
46 g and 68 – 81 kg hL-1, respectively. Highest TKW on a three years average was found for 
the white waxy genotype HB803 followed by the black Murasaki Hadaka and the white 
Lawina. Only a small range within HLW was observed, where highest values were found in 
the group of purple genotypes (Schwarze Nackte Kraftborn, Schwarze Chinesische and 
Purple Nudum). Highest seed plumpness (SP25) was recorded for HB803, Hora and the 
purple Lih Dhanra Gal. Regarding the investigated quality traits, highest protein values 
were found in the group of purple genotypes (Black Hull-less) and the blue Ederle Sel. Blau. 
β-Glucan content ranged from 4 to 6% in average, where the highest value belong to 
Pronghorn, a white waxy genotype followed by Debre Zeit AES 2 (5.8% dm) and Purple 
Nudum (5.7% dm). TPCf differed between the sample set widely, where the lowest levels 
were recorded for black genotypes and the highest for the white and blue group. By far the 
highest TAC was found for the purple genotypes, followed by the blue and black genotypes. 
LUT and ZEA were quantified using HPLC, and highest levels were found for the black 
genotypes SNG04, Violaceum 2 and Murasaki Hadaka. 
Eticha et al. (2011) recently published a comparison of agronomic and quality traits of 13 
diverse anthocyanin pigmented wheat genotypes. Concerning random effects, they found 
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significant greater variance components for G×Y than that of the year effect for all traits with 
the exception of heading date.  
An excerpt of the gross composition of whole meal samples of the 29 barley genotypes, 
harvested in 2008 is presented in Table 2. Available starch was the major constituent (43 - 
65% dm), whereas the protein content ranged from 8.7 to 13.3% dm.  
Earlier studies indicated that hulless barley genotypes are richer in β-glucan compaired to their 
hulled counterparts. In this study, the β-glucan content of the 29 hulless barley genotypes 
ranged from 3.2 (Hora) to 6.1%. With 4.8 and 5.6% β-glucan the waxy genotypes HB308 and 
Pronghorn were significantly higher than the average of this sample set, but lower as the 
purple variety Purple Nudum (Table 2). There seems to be no relationship between kernel size 
and the content. The variation in the β-glucan content might underlie other genetic variations 
and is strongly determinated by the variety. Generally, high-amylose and waxy hulless barleys 
tend to contain more β-glucan than zero-amylose and regular hulless barleys. More precisely, 
waxy barley cultivars possess higher levels of water and acid extractable β-glucans than 
regular barleys (Ajithkumar et al., 2005; Izydorczyk et al., 2000). Our results are consistent with 
previously published studies (Andersson et al., 2008; Gao et al., 2009).  
Total pentosanes (PENT) in barley wholemeal flours varied greatly between 4.1 and 9.2% 
dm (Table 2). With that wide range, barley genotypes are between the ranges of wheat and 
rye. Holtekjølen et al. (2006) found generally higher values for hulless genotypes and this 
observation was later on confirmed within the HEALTHGRAIN diversity screen 
(Andersson et al., 2008). Water-extractable pentosanes (we-PENT) were a minor constituent 
ranging from 0.1% (Taiga) to 1.1% (Purple Nudum).  
Wholemeal samples were as well extracted for free and bound phenolic acids and the Folin 
Ciocalteu reagent was used to measure the total phenolic content (TPC). Antioxidant 
properties were determined from both extracts by estimating the radical scavenging abilities 
using the stable ABTS radical (thereafter termed TEACf and TEACb) and the reducing 
abilities of Fe(III). The latter results were expressed as FRAPf and FRAPb (Table 2). Highest 
TPCf and TPCb were found for the blue genotypes Debre Zeit AES 2 and Addis Ababa 56, 
followed by the white genotype Lawina. Interestingly, both TPC of the free and the bound 
fraction ranged between 200 and 500 mg FA equ. 100 g-1 and thus are at the first glance in 
contrast with findings from Verardo et al. (2011) and Madhujith & Shahidi (2009) who 
observed higher phenolic contents in the bound fraction. However, similar observations 
were found with samples of 2009, when twelve genotypes were milled and the three 
millstreams were analysed for their content of phytochemicals. Mean average of TPCf was 
higher than TPCb for the flour (grouped according to seed colour) (Fig. 3 & 4) but not for the 
shorts and bran fraction, whereas the content of quantified phenolic acids determined by 
HPLC showed clearly higher contents in the bound fraction for almost all detected phenolic 
acids. Thus, components co-extracted with the phenolic compounds may have interfered 
with the test reagent. Similarly, no differences between free and bound phenolics were 
found in terms of reducing abilities of Fe(III), but with ABTS●+ scavenging capacities.  
None of the attributes correlated with TPCf, whereas highly significant (p<0.0001) correlations 
were obtained for the antioxidant properties and the TPC of the bound phenolic fraction, i.e. 
TEACb correlated with TPCb (r=0.74) and with FRAPb (r=0.82). Correlation was as well found 
between FRAPb and TEACb (r=0.81). Comparable correlation coefficients for phenolic  
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compounds and antioxidant activity were obtained for durum and common wheat (Adom 
et al., 2003; Siebenhandl et al., 2007), whereas an earlier study with three common wheats 
reports no correlation between TPC and the radical scavenging capacity (Yu et al., 2002). 
3.3 Multivariate analysis 
Principal components (PCs) analysis revealed four principal components with eigenvalues 
>1. Variation explained by these four PCs was 35.1, 16.0, 12.2 and 9.1%. The biplot of PC1 
and PC2 is demonstrated in Figure 2. From the biplot it can be seen that on the one hand 
TPCb, FRAPb and TEACb are highly correlated (acute angles between the respective vectors 
of similar size), whereas TPCf, FRAPf and TEACf show no to small correlations. The well-
known negative correlation between STARCH and PROT can be seen by the opposite 
direction of the variable vectors. BG shows no correlation to PROT, STARCH or PENT. The 
biplot also reveals a certain grouping of genotypes according to their seed colour. White 
seeded genotypes are mainly located in the upper left part of the plot, black seeded types in 
the lower left part (with the exception of Violaceum 2), blue aleurone types are located in the 
lower central part and purple types are located in the lower right part of the plot.  
 
 
The length of each variable vector is proportional to its contribution to separating the genotypes, and 
the direction of the vector indicates its relative contribution to PC1 and PC2. Genotypes are presented 
with their ID as indicated in Table 1, where black letters were used for black genotypes, blue letters for 
blue, red letters for purple and small black letters for the white ones. Abbreviations used for traits are 
according to Table 2. 
Fig. 2. Biplot of spring barley genotypes and variables  
According to the canonical discriminant analysis the seed colour groups can be significantly 
separated by the data from the chemical analysis. Highly significant first (Can1) and second 
(Can2) discriminant functions were observed. The plot of discriminant scores is shown in 
Figure 3. It is obvious that along Can1 three colour groups can be separated, i.e. purple, 
black and white together with blue. Can1 is mainly determined by TAC and TPCf. While 
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white and blue seeded genotypes are overlapping along Can1 they can be significantly 
separated along Can2, which is mainly influenced by we-PENT, ASH and FRAPb. Thereby, 
discriminant analysis confirmed impressively the separation of seed colour groups which 
was already suggested by PCA. 
 
 
The length of each variable is proportional to its contribution to separating the seed colour classes, and 
the direction of the vector indicates its relative contribution to the Can1 and Can2 linear combinations. 
Abbreviations for variables see Table 2. 
Fig. 3. Plot of canonical discriminant scores with 95% confidence regions for the mean (big 
cross) of each seed colour class  
3.4 Comparison of milling fractions of different genotypes 
The milling process was done using a roller mill. Six flour fractions (B1-B3, C1-C3) from the 
starchy endosperm were collected and merged to give a straight-run white flour. Brans and 
shorts were collected separately. The investigated twelve genotypes showed differences in 
the flour yield. Generally, the flour yields were very low (in average 29%) with higher yields 
of shorts (65%) and bran (6.6%) (Table 3). White coloured hulless barley varieties had the 
highest flour yield, whereas the proportion of bran was smallest in the group of black 
genotypes. 
3.4.1 Distribution of phenolic acids 
As shown in Fig. 4, all colour groups had in common that the flour fraction showed the 
lowest content of phenolic compounds and antioxidant properties, followed by the shorts 
and bran fraction. It is visible from the shapes of the boxes that all colour groups contained 
genotypes with higher and lower attribute levels. In general, bran levels were 
approximately three to five times higher than the corresponding flour and all millstreams 
differed significantly from each other. Within the different milling fractions and using the 
seed colour as criterion, a few significant differences were found in respect to phenolic 
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ID Genotype Flour (%) Shorts (%) Bran (%) 
4 Violaceum 2 23.5 72.1 4.4 
5 Ethiopia 179 26.8 68.3 4.9 
7 Black Naked 25.4 72.1 2.5 
10 HB803 36.2 54.1 9.7 
11 Hora 41.8 54.0 4.2 
12 Lawina 36.3 55.7 8.0 
15 Himalayense Type 5 25.0 61.0 14.1 
17 Addis Ababa 56 24.4 72.6 2.9 
21 GHO 1 26.4 67.3 6.3 
25 Black Hulless 36.3 59.1 4.6 
27 Purple Nudum 21.1 68.8 10.1 
29 Lih Dhanra Gal 23.1 68.8 8.1 
Table 3. Flour yield of twelve different hulless barley genotypes 
content (TPC) and antioxidant properties (FRAP, TEAC), although the ranking varied with 
the analysis: within the flour fraction, black genotypes differed significantly from the others 
in respect to their ability to scavenge the ABTS radical (p=0.0086). Regarding the bran 
fractions, a significant difference was found for TPC, where the purple ones yielded in the 
highest content and differed significantly from the others. Differences between the 
genotypes were found within each milling fraction with different orders of rankings but 
following the same trend. Flours with high antioxidative properties or high yield on 
phenolic substances were genotypes like Black Naked (ID 7) and Addis Ababa 56, whereas 
flours of the genotypes Himalayense Type 5 and HB803 had the lowest values. Lawina and 
Black Naked were highest in shorts and bran fraction, and the purple Lih Dhanra Gal in the 
bran fraction. Low values were found for the black Ethiopia 179 and Violaceum 2.  
It is difficult to compare the phenolic acid profile and the antioxidant properties compiled 
by different researchers, as each group uses a different methodology to extract and measure 
the effect. Throughout the literature, the phenolic content correlated significantly with the 
antioxidant capacity. Thus, there is no doubt that phenolic compounds are mainly 
responsible for the antioxidant properties in cereals (Perez-Jimenez & Saura-Calixto, 2005). 
Furthermore, a high correlation was as well found for the total phenolic content, determined 
with the Folin-Ciocalteu reagent and test systems using DPPH- and ABTS radicals as well as 
the reducing ability as in the FRAP assay. 
Sharma & Gujral (2010) estimated the phenolic content in barley ranging from 2.14 to 2.36 µg 
FA g-1 flour and 3.57 – 5.02 µg g-1 in bran. Madhujith et al. (2006) reported a range of 0.17 to 
6.26 mg FA g-1, depending on genotype and fraction, and Menga et al. (2010) found varying 
levels of TPC and TEAC, when comparing a methanolic extract with an extract after 
enzymatic digestion.  
Residues after the extraction of the free phenolic compounds were used to isolate the bound 
phenolic compounds after an alkaline hydrolysis. As it was observed for the free phenolic 
compounds, differences were found between the milling fractions, where the flour fractions 
were lowest in the phenolic content and the antioxidant properties (Fig. 5). Comparing the 
four colour groups, significant differences were only found for the flour fraction, whereas the 
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shorts and the bran fraction did not differ in any of the investigated attributes. It is the group 
of white genotypes which was lowest, followed by the blue, purple and black ones. The more 
detailed examination of differences between the genotypes revealed a similar picture as was 
already observed for the free phenolic compounds. Flours with high phenolic content and 
antioxidant properties derive from the genotypes Violaceum 2, Black Naked (ID 7) and Purple 
Nudum with a three-fold difference to genotypes with lower expression of these attributes, 
e.g. Lawina and HB803. In compliance with the flour fractions, the genotype Purple Nudum 
showed high levels of phenolic compounds and antioxidant properties in the shorts fractions. 
A different picture was observed when genotypes were classed by the bran fraction. Here, the 
white genotypes Hora and HB803 exceeded the investigated set of genotypes two- to threefold 
in terms of FRAP and TPC levels. The occurrence of higher levels of bound phenolic 
compounds is in agreement with Nordkvist et al. (1984), Verardo et al. (2008) and Madhujith & 
Shahidi (2009). 
In addition to the determination of the TPC with the spectrophotometric method, extracts 
were as well analysed by HPLC in order to quantify individual phenolic acids. The phenolic 
acids quantified in this study included 4-hydroxybenzoic acid, vanillic acid, caffeic acid, p-
coumaric acid and ferulic acid (Table 4). Generally, free phenolic acids comprised a very small 
proportion of the quantified phenolic acids. Highest content was found for the blue genotype 
Himalayense Type 5. Bound phenolic acid content made up more than two thirds of the total 
content. Ferulic acid was by far the abundant phenolic acid and the difference between the 
flour and bran fraction was in average 10fold. Highest content was found in the waxy HB803 
and Purple Nudum, whereas Lawina and Ethiopia 179 contained fewest of all. p-Coumaric 
acid was the second phenolic acid and was significantly higher in HB803 and Hora. 
3.4.2 Distribution of anthocyanins 
Bran, shorts and flour fractions of the black, purple and blue genotypes were screened and 
compared for their total content of anthocyanins (TAC) and their individual anthocyanins. 
In general, a sharp decline in the content of anthocyanins was observed with the increase in 
endosperm in the millstream. Black Hull-less (ID 25) and Purple Nudum were the only 
genotypes which contained malvidin-3-O-glucoside and apigeninidin. Sorghum is the only 
plant known to contain significant quantities of luteolinidin and apigeninidin (both 3-
deoxyanthocyanidins), which are not commonly found in higher plants. First indications by 
their existence were given by Nip & Burns (1969; 1971) who isolated apigeninidin and 
luteolinidin from the seeds of red and white sorghum varieties. Both 3-deoxyanthocyanidins 
are also reported as the major anthocyanidins from black sorghum varieties (Awika et al., 
2004). High contents of cyanidin-3-O-glucoside were found as well in Purple Nudum. 
Delphinidin was dominant in the black genotype Violaceum 2 (Table 5) but also present in 
purple genotypes like Black Hull-less (ID 25), Purple Nudum and Lih Dhanra Gal. Kim et al. 
(2007) reported that cyanindin 3-glucoside was predominant in the purple group, followed 
by peonidin-3-glucoside and pelargonidin 3-glucoside, whereas delphinidin 3-glucoside 
was highest in the blue and black group. Thus, our results basically display the same 
observations. The black 6-rowed genotype Violaceum 2 was salient in respect to the position 
in the biplot (Fig. 2), as it was displayed in the upper right corner together with the purple 
representatives Lih Dhanra Gal and Purple Nudum. It is therefore an apposite argument to 
question the taken classification as the stem of the name contains as well an indication for 
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purple colour. Probably, the kernels appeared black due to the high content of anthocyanins 
or the latter have been overlaid by some other darker pigments. On the other hand, the 
tested Violaceum 2 line could be the result of outcrossing between a purple and a black 





















































































































 B 30.3 2.6 0.8 5.8 8.2 
S n.d. 1.1 0.1 4.0 n.d. S 29.6 2.5 0.4 8.6 14.1 
F 5.2 2.0 0.1 3.3 6.6 F 15.2 1.1 0.2 5.4 7.1 
bo
un
d B 6.6 25.6 74.7 1854.1 10.6
bo
un
d B 11.9 15.9 82.3 887.1 17.4 
S 4.8 11.2 10.7 852.3 3.9 S 5.0 8.2 17.9 639.5 2.5 








 B 12.9 3.4 0.3 5.8 3.9 
S 20.4 3.4 5.2 5.4 19.5 S 9.6 1.6 0.3 8.3 9.2 
F 10.4 0.1 2.1 1.4 6.9 F 5.9 0.6 0.4 3.7 6.1 
bo
un
d B 6.8 14.0 27.9 936.8 8.1
bo
un
d B 4.7 11.3 39.0 1342.3 23.2 
S 4.1 8.2 7.9 510.3 3.6 S 5.4 9.0 11.4 707.5 3.0 








 B 21.6 2.1 0.7 7.3 5.8 
S 1.2 8.0 0.9 4.1 n.d. S 22.0 0.7 0.1 7.0 9.8 
F 1.3 1.2 0.5 4.6 4.4 F 14.3 0.2 0.4 4.3 10.2 
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un
d B 10.1 28.1 353.4 1534.5 14.0
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d B 12.1 27.6 170.3 1587.7 25.5 
S 6.2 12.9 22.2 790.3 14.3 S 3.1 5.3 14.0 563.7 12.5 








 B 1.3 8.2 4.2 15.9 n.d. 
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d B 14.1 43.7 1733.6 2311.2 26.3
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d B 13.8 22.7 38.8 1618.6 7.6 
S 5.8 11.2 167.4 759.7 4.9 S 5.8 10.2 14.9 867.1 4.4 
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S 4.2 11.1 87.3 805.9 6.2 S 6.8 13.8 11.0 997.6 2.8 
F 0.7 2.0 15.2 102.6 0.7 F 1.4 3.9 2.5 220.2 1.0 
1 ID number according to Table 1. 2 F, flour fraction; S, shorts; B, bran fraction. 
Table 4. Content and composition of free and bound phenolic acids (in ppm) in the different 
millstreams of barley genotypes 
 
Phytochemicals – Bioactivities and Impact on Health 
 
286 
shorts and the bran fraction did not differ in any of the investigated attributes. It is the group 
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flour and bran fraction was in average 10fold. Highest content was found in the waxy HB803 
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3.4.2 Distribution of anthocyanins 
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compared for their total content of anthocyanins (TAC) and their individual anthocyanins. 
In general, a sharp decline in the content of anthocyanins was observed with the increase in 
endosperm in the millstream. Black Hull-less (ID 25) and Purple Nudum were the only 
genotypes which contained malvidin-3-O-glucoside and apigeninidin. Sorghum is the only 
plant known to contain significant quantities of luteolinidin and apigeninidin (both 3-
deoxyanthocyanidins), which are not commonly found in higher plants. First indications by 
their existence were given by Nip & Burns (1969; 1971) who isolated apigeninidin and 
luteolinidin from the seeds of red and white sorghum varieties. Both 3-deoxyanthocyanidins 
are also reported as the major anthocyanidins from black sorghum varieties (Awika et al., 
2004). High contents of cyanidin-3-O-glucoside were found as well in Purple Nudum. 
Delphinidin was dominant in the black genotype Violaceum 2 (Table 5) but also present in 
purple genotypes like Black Hull-less (ID 25), Purple Nudum and Lih Dhanra Gal. Kim et al. 
(2007) reported that cyanindin 3-glucoside was predominant in the purple group, followed 
by peonidin-3-glucoside and pelargonidin 3-glucoside, whereas delphinidin 3-glucoside 
was highest in the blue and black group. Thus, our results basically display the same 
observations. The black 6-rowed genotype Violaceum 2 was salient in respect to the position 
in the biplot (Fig. 2), as it was displayed in the upper right corner together with the purple 
representatives Lih Dhanra Gal and Purple Nudum. It is therefore an apposite argument to 
question the taken classification as the stem of the name contains as well an indication for 
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purple colour. Probably, the kernels appeared black due to the high content of anthocyanins 
or the latter have been overlaid by some other darker pigments. On the other hand, the 
tested Violaceum 2 line could be the result of outcrossing between a purple and a black 
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B +4 + + • + + • +++ •  
S + • • • + + • ++ • • 
F • • • + • • + + • • 
5 
B • • • • • • • • 
S • • • • • • •  
F • • + • • • • 
15 
B + + • • + • • ++   
S • • • • + • • +   
F • • + + • + • • • 
17 
B + • • • + • • ++ • • 
S + • • • • • + • • 
F • • • • + • • • 
21 
B + • • • + + ++ •  
S • • • • • • + •  
F • • • • • • •  
25 
B + + • + + ++ + + +++ •  
S • + • • + + + + ++ •  
F • • + • +++ + • • • 
27 
B • +++ ++ ++ + + + ++ + • 
S • ++ + + + + • + + • 
F • + + • +++ • • • • 
29 
B + • • • • + • ++ •  
S • • • • • • • + •  
F • • + • • + • • • 
1 ID number according to Table 1. 2 F, flour fraction; S, shorts; B, bran fraction. 3 Delph, Delphinidin; 
Cyan, Cyanidin; Pel, Pelargonidin; Mal, Malvidin; Luteo, Luteolinidin; Api, Apigeninidin; Peo, 
Peonidin.4• = in traces, + = 1.0 – 3.0 ppm, ++ = 3.1 – 5.0 ppm, +++ = > 5.1 ppm. 
Table 5. Distribution of various anthocyanins (ppm) within the three milling fractions of 
barley genotypes 
4. Conclusion 
The basic function of food to satiate and to provide macro- and micronutrients has become 
in the Western industrialised countries less and less important. With increasing prosperity 
and/or educational knowledge additional attributes are demanded by consumers who 
search for sensorial sensations or tie their consumption of food with social prestige or ethical 
reasons. Among these supplementary functions of food the health-awareness of consumers 
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is used to a high degree by the food and marketing industry for the promotion of existing 
and newly developed food products. 
Thus, scientists work together interdisciplinary to study the biochemical mechanisms of 
food in order to quantify possible health benefits. Since the late 1980s, most studies have 
mainly focused on the polysaccharide moiety, while the potential role of whole grain 
antioxidants was considered less up to now. The newly introduced term “dietary fibre-
antioxidants” assumes that the beneficial effects attributed to the cereal dietary fibre are not 
only due to the polysaccharide moiety, but also to the associated polyphenolic compounds 
(Vitaglione et al., 2008).  
These phytochemicals as well as the insoluble fraction of dietary fibres are located in the 
outer parts of the kernel and thus are removed within the milling process when gaining 
refined white flour. Barley grains differ considerably from those of other cereals in regard to 
their chemical constitution, as a large proportion of the soluble dietary fibre is located in the 
endosperm. Hence, this valuable fraction will not be lost by using normal milling practise 
for the production of flour. A recent experiment showed that the baking quality of hulless 
barley flour is sufficient to bake pure barley bread. Thus, hulless barley is an interesting 
alternative for commonly used grains and could contribute to a higher diversity in human 
nutrition (Kinner et al., 2011). 
In this context, the phytochemical content and total antioxidant capacity of 29 hulless barley 
genotypes with different seed colours were investigated. Significant differences in the 
content of anthocyanins and carotenoids, and in reducing power were observed between 
genotypes, and between the different millstreams of the respective plant material. From the 
results of this study, and from other studies previously carried out (Siebenhandl et al., 2007; 
Bokore, 2008; Menga et al., 2010) it can be concluded that on the one hand genetic and 
environmental factors have a major impact on the phytochemical profile and the antioxidant 
activity, but on the other hand also postharvest treatments such as fractionation of the raw 
material can have a major influence. Thus, it is anticipated that the development of barley 
cultivars for human consumption should focus on breeding for specific end uses (Hang et 
al., 2007). Due to significant environmental influences on many phytochemicals genotypes 
with a stable performance across a wide range of environments are necessary to assure a 
continuous quality for food processors. Before a specific breeding programme can be 
started, the already existing germplasm has to be evaluated to identify possible genotypes 
which could serve as donors of valuable traits in cross breeding programmes.  
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1. Introduction 
Life expectancy has nearly doubled during the 20th century. This dramatic increase in the 
aging population presents with an enormous challenge to maintain a healthy old age.  A 
comprehensive solution to address this important problem is compounded by a multitude 
of factors that contribute to the accumulation of damage to macromolecules, cells, tissues 
and organs during aging. The rejuvenation strategies, currently being employed with a 
targeted approach, to reverse or repair the damage associated with aging have only yielded 
partial benefits. The complexity of the aging process highlights the need for a holistic 
approach, as recommended by the alternative systems of medicine, to prevent the 
progressive deterioration of the aging cells. Herbal antioxidants have been successfully 
employed as rejuvenators, for several centuries in the Indian systems of alternative 
medicine. This chapter describes the concepts behind the application of herbal antioxidants 
to promote longevity and scientifically validate their potential by highlighting the molecular 
mechanisms underlying the biological activity of the phytochemicals in these herbs.  
2. Oxidative and nitroxidative stress – major etiological factors in aging 
phenomenon 
Oxidative stress is widely recognized to play a causal role in the aging phenomenon. Every 
day metabolic activities including breathing could lead to the exposure of cells to 
biochemical substances such as free radicals and the gradual accumulation of free radicals 
can induce cellular damage. According to the free radical theory of aging, which is based on 
Harman’s hypothesis, continued creation of free radicals influenced by a multitude of 
factors associated with routine life style is responsible for the aging process (Harman, 1972). 
Normally, the antioxidant mechanism fails either due to overproduction of free radicals or 
insufficient activities of scavenging enzymes, or both causing lipid peroxidation. Since lipid 
peroxidation is a self-propagating chain reaction the initial oxidation of only a few lipid 
molecules can result in significant tissue damage and disease. 
Moreover, it has already been established that superoxide radicals that are generated during 
normal cellular respiration could eventually lead to nitration of proteins (Figure 1). 
Nitration of tyrosine, a posttranslational modification of immense functional importance, 
occurs by the substitution of a nitro group in place of hydrogen on carbon 3 in the phenolic 
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Fig. 1. Protein nitration and its consequences  
ring of a tyrosine residue (Radi, 2004). In vivo nitration mostly depends on superoxide (O2·-) 
and nitric oxide (NO) radicals, generated during routine cellular activity, as they react to 
form peroxynitrite (ONOO-). Peroxynitrite eventually leads to the formation of one-electron 
oxidants (CO3·-, ·OH, NO2) which can oxidize the phenolic ring of tyrosine to yield the 
tyrosyl radical (Tyr·). The addition of NO2 to Tyr· in a radical–radical termination reaction 
results in tyrosine nitration.  
Although the nitration of tyrosine occurs at relatively low levels compared to tyrosine 
phosphorylation, protein nitration can result in serious biological consequences as it can 
modulate phosphorylation cascades. Nitrated proteins are often targets of proteasomal 
degradation. Age-related increase in nitrotyrosine has been reported in the hippocampus, 
which is responsible for spatial memory, in humans with mild cognitive impairment 
(Butterfield et al., 2007). As the metabolic activity of brain is relatively high, the aberrant 
electron transfers result in additional free radical formation and subsequent protein 
nitration in aged brain tissue. Therefore, protein nitration is generally considered as a 
biomarker for age-related neurodegeneration (Butterfield et al., 2006; Chung and David, 
2010). Moreover, nitroxidative damage of neurons can also contribute to age-related deficits 
in memory function. Thus, oxidative and nitroxidative stress are crucial factors responsible 
for the aging process. 
3. Alternative medicine concepts in promoting longevity 
Herbal antioxidants are widely used as dietary supplements for promoting longevity in 
alternative medicine systems of Ayurveda and Siddha, which originate from India (Table 1). 
These traditional systems of medicine are based on the concept of tridosha theory, according 
to which vatha, pitha and kapha are the three humors that govern the physiological function 
of the body. When the normal balance of the three humors is deranged they are known as 
doshas which ultimately results in pathological consequences during the aging process. A 
set of applications known as “Kaya Karpam”, which literally means transforming the body 
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from its fragile state to a stable stone like state, are used to attenuate vatha, pitha or kapha 
rationalizing their extensive use in complementary and alternative medicines for promoting 
health and wellness.  
S. No. Common name  Botanical name   Part used 
  
1. Aloe    Aloe vera   Succulent leaf 
2. Ashwagandha  Withania somnifera  Root 
3. Black nightshade  Solanum nigrum   Fruits and leaves 
4. Cardamom   Elateria cardamom  Fruit 
5. Chaste tree  Vitex negundo   Leaves 
6. Clearing nut   Strychnos potatorum  Seed 
7. Country green   Amaranthus gangeticus  Leaves 
8. Cumin    Cuminum cyminum  Seed 
9. False daisy   Eclipta alba   Leaves 
10. Ginger    Zingiber officinale  Rhizome 
11. Indian acalypha  Acalypha indica   Leaves 
12. Indian Sarsaparilla  Hemidesmus indicus  Root  
13. Indian sorrel  Oxalis corniculata  Leaves 
14. Lemon    Citrus medica   Fruit 
15. Neem    Azardirachta indica  Leaves 
16. Nut grass  Cyperus rotundus  Tuberous root 
17. Red spiderling  Boerhaavia diffusa  Whole plant 
18. Sessile joyweed  Alternanthera sessilis  Leaves 
19. Stonebreaker  Phyllanthus niruri  Whole plant 
20. Triphala   Terminalia chebula  Dried fruit 
    Terminalia bellerica  Dried fruit 
    Emblica officinalis  Dried fruit 
21. Tulsi  / Holy basil Ocimun sanctum   Leaves 
 
Table 1. Medicinal herbs used as rejuvenators in Indian system of alternative medicine 
This concept is similar to one of the central theories of aging which suggests that every day 
metabolic activities including breathing could lead to the exposure of cells to biochemical 
substances such as free radicals and antioxidants can be employed to prevent the gradual 
accumulation of free radical induced cellular damage during aging. Several studies have 
shown that the life span of an organism can be extended by diminishing oxidative stress 
(Finkel and Holbrook, 2000). Consistent with this notion, the “Kaya Karpam” herbs 
extensively used to promote longevity in alternative medicine systems have been found to 
have significant antioxidant properties. Some of the current research findings also substantiate 
the use of medicinal herbs, because phytochemicals such as resveratrol, sulforaphanes and 
curcumin, are considered to possess neurohormetic property because of their ability to protect 
neurons against injury and disease by stimulating the production of antioxidant enzymes, 
neurotrophic factors, protein chaperones and other proteins that help cells to withstand stress 
(Mattson and Cheng, 2006). The subsequent sections describes the mechanism underlying the 
prophylactic as well as therapeutic effects of some common herbal antioxidants employed in 
Indian systems of alternative medicine to promote longevity. 
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4. Common herbal antioxidants used in Indian system of alternative medicine 
Triphala, ashwagandha, tulsi, ginger and neem are extensively used in Indian systems of 
alternative medicine, as they are considered to possess significant rejuvenating properties. 
4.1 Triphala 
Triphala is an herbal formula consisting of dried fruits from A) Terminalia chebula, B) 
Terminalia bellirica and C) Emblica officinalis, the three myrobalans, in equal parts (Figure 2). 
The chebulic and belleric myrobalans belong to the family Combretaceae, while the emblic 
myrobalan, commonly known as amlaki, belongs to the family Phyllanthaceae. Triphala is 
widely used as a dietary supplement for promoting longevity in alternative medicine 
systems of Ayurveda and Siddha (Jagetia et al., 2002). Triphala is classified as a kaya 
karpam and has already been reported for its significant antioxidant activity (Naik et al., 
2005; Hazra et al., 2010). The constituents of triphala were reported to enhance the 
antioxidant status in aging animal models (Yokozawa et al., 2007; Mahesh et al., 2009). In 
addition, triphala has been reported to possess several other important medicinal properties 
(Srikumar et al., 2005; Rasool and Sabina, 2007; Shi et al., 2008) that strengthen its potential 
to deal with multiple problems associated with aging. Such a multi-faceted activity of 
triphala is consistent with the complementary and alternative medicine concepts of a holistic 
approach to restore the normal balance of the three humors and supports its potential to 
rejuvenate the aging cells. 
 
Fig. 2. Constituents of triphala 
4.2 Ashwagandha 
Ashwagndha (Withania somnifera, Figure 3) belongs to Solanaceae family and has been used for 
centuries in Indian systems of alternative medicine to treat various ailments. It is commonly 
known as Indian Ginseng because of its comparable medicinal value to ginseng which is 
acclaimed for its adaptogenic activity in alleviating stress induced illness. The medicinal 
properties of ashwagandha are mostly attributed to its tuberous roots whose extracts are 
widely marketed as an over the counter herbal supplement. Adaptogens, like ashwagandha, 
are believed to facilitate the maintenance of homeostasis by normalizing physiological as well 
as biochemical changes induced by stress. The anti-inflammatory (Maitra et al., 2009), anti-
cancer (Ichikawa et al., 2006) and immunomodulatory (Bhattacharya and Muruganandam, 
2003) activities of ashwagandha rationalize its extensive use in promoting longevity. 
Ashwagandha’s antioxidant activity (Udayakumar et al., 2010) suggests that a common 
molecular mechanism may be responsible for its diverse biological effects. 
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Fig. 3. Ashwagandha herb 
4.3 Tulsi  
Tulsi (Ocimum sanctum, Figure 4), a medicinal herb classified as a kaaya karpam, is 
cultivated in India for medicinal as well as religious purposes. It is commonly known as 
“holy basil”. It is an aromatic plant which belongs to the family Lamiaceae. Due to its 
immense medicinal value it is extensively used in Indian systems of alternative medicines to 
heal a number of ailments. Several studies have reported the significant antioxidant activity 
of tulsi (Kelm et al., 2000; Yanpallewar et al., 2004; Samson et al., 2007). Tulsi treatment 
enhanced the antioxidant status in discrete regions of brain (Samson et al., 2007) and the 
phytochemical contents of tulsi have been suggested to be responsible for this effect. The 
stress alleviating potential of Ocimum sanctum extract is also reflected by its efficacy in 
attenuating the immunological changes induced by noise exposure (Archana and 
Namasivayam, 2000). In addition, tulsi has been reported to possess several other important 
medicinal properties (Singh et al., 1996; Mediratta et al., 2002; Adhvaryu et al., 2007; Kim et al., 
2010) that strengthen its potential to deal with aging and oxidative stress. Thus, Tulsi is 
capable of promoting a healthy aging due to its multiple but complimentary and synergistic 
medicinal properties which can combat a diverse spectrum of disorders associated with aging.  
 
Fig. 4. Fresh and shade dried tulsi 
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4.4 Ginger 
Ginger (Figure 5) is a widely used herbal supplement, often used in a number of culinary 
preparations all around the world. It is a rhizome of the herb Zingiber officinale, which 
belongs to the family Zingiberaceae. Due to its diverse healing properties it is extensively 
used in alternative medicines such as Chinese medicine, Ayurveda, Siddha and Unani. The 
Indian systems of medicines recommend the use of ginger as a kaya karpam or rejuvenator. 
It is used both in fresh and dried form to treat nausea and vomiting (Jewell, 2003; Borrelli et 
al., 2005; Chaiyakunapruk et al., 2006), osteo and rheumatoid arthritis (Srivastava and 
Mustafa, 1992; Bliddal et al., 2000; Altman and Marcussen, 2001), diabetes mellitus (Sekiya et 
al., 2004; Goyal and Kadnur, 2006; Heimes et al., 2009), indigestion and some cardiovascular 
disorders (Jiang et al., 2005; Nicoll and Henein, 2009). Various studies have demonstrated 
the anti-oxidant (Kabuto et al., 2005; Ahmed et al., 2008; Pan et al., 2008; Dugasani et al., 
2010), anti-inflammatory (Young et al., 2005), anti-cancer (Jiang et al., 2005; Rhode et al., 
2007; Shukla and Singh, 2007) and anti-microbial (Park et al., 2008; Singh et al., 2008b) 
properties of ginger. These multiple biological properties of ginger support its clinical 




Fig. 5. Fresh and dried ginger 
4.5 Neem 
Azardirachta indica, commonly known as neem, belongs to the family Meliaceae, is a large 
ever green tree with immense medicinal applications. Various parts of the neem tree such 
as leaves (Figure 6), flowers, seeds, roots and bark are used as traditional remedies for a 
number of ailments in the Indian systems of alternative medicine. However, the wide 
ranging medicinal value of the neem leaves stands out in comparison with other parts of 
the tree. Various studies have indicated that the neem leaves have anti-microbial 
(Wolinsky et al., 1996; Thakurta et al., 2007; Zhang et al., 2010), anti-inflammatory 
(Okpanyi and Ezeukwu, 1981; Thoh et al., 2010), analgesic (Khattak et al., 1985), anti-
diabetic (van der Nat et al., 1991), immunomodulatory (Ray et al., 1996), anti-oxidant 
(Arivazhagan et al., 2000) and anti-cancer (Miller et al., 1992; Akudugu et al., 2001) 
properties. Due to its numerous pharmacological activities neem leaves are used as a kaya 
karpam to promote longevity. 
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Fig. 6. Neem leaves 
5. Phytochemicals responsible for the therapeutic effects of herbal 
antioxidants 
Triphala has been used for centuries in Indian systems of alternative medicine as a dietary 
supplement for rejuvenation due to its prophylactic and therapeutic properties (Jagetia et 
al., 2002). The three constituents of triphala have distinct as well as common phytochemicals 
that are considered to complement each other and act in a synergistic manner. Terminalia 
chebula is reported to contain ascorbic acid, gallic acid, tannic acid, syringic acid and 
epicatechin while Terminalia bellerica has gallic acid, tannic acid and ascorbic acid (Singh et 
al., 2008a). Emblica officinalis is a rich source of vitamin C and also has flavanoids, 
kaempferol, ellagic acid and gallic acid (Singh et al., 2008a).   
Several active compounds of ashwagandha, especially steroidal lactones, have been isolated, 
in the quest to identify the constituent(s) responsible for its wide ranging clinical application 
in alternative medicine. A HPLC analysis demonstrated the presence of Withanolide-A, 
withanone, withaferine-A, withastramonolide, 27-hydroxywithanone, withanoside, 
physagulin (Dhar et al., 2006). Although active compounds like withaferin A and 
withanasoide D are considered as major players, it is still not clear whether any one of these 
compounds are responsible for the biological activities of ashwagandha or whether they 
exert a synergistic action when administered in their natural form.  
Basils contain a wide range of essential oils rich in phenolic compounds (Phippen and 
Simon, 2000) and a wide array of other natural products including polyphenols such as 
flavonoids and anthocyanins. Epidemiological studies have suggested positive associations 
between the consumption of phenolic-rich foods or beverages and the prevention of disease 
(Scalbert and Williamson, 2000). These effects have been attributed to antioxidant 
components such as plant phenolics, including flavonoids and phenylpropanoids among 
others. One of the widely used medicinal herb among the basils is Ocimum sanctum Linn, 
which is commonly known as holy basil or ‘‘Tulsi’’. Ocimum sanctum has been reported to 
exhibit several medicinal properties and the active principles present in Ocimum species 
such as rosmarinic acid, lithospermic acid, eugenol, methyleugenol, urosolic acid, h-
caryophyllene, methylchavicol, linalool, 1,8-cineole phenolics and flavonoids such as 
orientin, vicenin etc have been attributed to be responsible for its diverse medicinal activities 
(Hase et al., 1997; Kelm et al., 2000).   
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Fig. 5. Fresh and dried ginger 
4.5 Neem 
Azardirachta indica, commonly known as neem, belongs to the family Meliaceae, is a large 
ever green tree with immense medicinal applications. Various parts of the neem tree such 
as leaves (Figure 6), flowers, seeds, roots and bark are used as traditional remedies for a 
number of ailments in the Indian systems of alternative medicine. However, the wide 
ranging medicinal value of the neem leaves stands out in comparison with other parts of 
the tree. Various studies have indicated that the neem leaves have anti-microbial 
(Wolinsky et al., 1996; Thakurta et al., 2007; Zhang et al., 2010), anti-inflammatory 
(Okpanyi and Ezeukwu, 1981; Thoh et al., 2010), analgesic (Khattak et al., 1985), anti-
diabetic (van der Nat et al., 1991), immunomodulatory (Ray et al., 1996), anti-oxidant 
(Arivazhagan et al., 2000) and anti-cancer (Miller et al., 1992; Akudugu et al., 2001) 
properties. Due to its numerous pharmacological activities neem leaves are used as a kaya 
karpam to promote longevity. 
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Fig. 6. Neem leaves 
5. Phytochemicals responsible for the therapeutic effects of herbal 
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orientin, vicenin etc have been attributed to be responsible for its diverse medicinal activities 
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Ginger has a rich array of useful bio-active compounds. The antioxidant property of ginger 
can be attributed to the phytochemicals present in ginger which includes volatile 
compounds such as sesquiterpenes (curcumene β-phellandrene, geraniol, 1,8-cineole, citral, 
terpineol, borneol, linalool, neral) and monoterpenoid hydrocarbons (α-zingiberene, β-
sesquiphellandrene, α-farnesene, β-bisabolene, α-curcumene) and non-volatile compounds 
like gingerols, shogaols, paradols, and zingerone (Gong et al., 2004; Jolad et al., 2004). 
A large number of medicinally useful phytochemicals have been isolated and identified 
from the neem leaves. They include azadirachtanin, azadirachtanin-A, β-sitosterol, 
hyperoside, isoazadirolide, nimbaflavone, nimbandiol, nimbinene, nimbolide, quercetin, 
quercitrin, rutin, vilasanin, 3-acetyl-7-tigloyl-lactone-vilasinin (Akhila and Rani, 1999; 
Siddiqui et al., 2004). These wide ranging bio-active compounds of neem leaves can be 
considered to be responsible for its multiple biological / medicinal applications. 
6. Signaling molecules that mediate the biological effects of herbal 
antioxidants 
Recent studies have identified some of the molecular targets of triphala. Activation of ERK 
and p53 were found to mediate the growth inhibitory effects of triphala in pancreatic cancer 
(Shi et al., 2008). Chebulagic acid isolated from Terminalia chebula has been reported to 
inhibit COX-2/5-LOX (Reddy et al., 2010). Apart from this, triphala has been shown to 
possess significant antioxidant (Naik et al., 2005; Mahesh et al., 2009; Hazra et al., 2010) and 
nitric oxide scavenging activity (Jagetia et al., 2004). In addition, the anti-cancer (Deep et al., 
2005; Sandhya and Mishra, 2006; Shi et al., 2008), immunomodulatory (Srikumar et al., 2005) 
and anti-inflammatory (Rasool and Sabina, 2007) activity of triphala directly targets the 
common health problems associated with aging. The selective cytotoxic and apoptotic 
activity of triphala on cancer cells while sparing the adjacent normal cells (Shi et al., 2008) 
further strengthens its compelling role as a dietary supplement to promote longevity. 
The biological effects of ashwagandha have been shown to be mediated by several signaling 
molecules. The anti-cancer activity of ashwagandha has been attributed to suppression of 
NF-κB (Kaileh et al., 2007) and inhibition of notch-1 signaling (Koduru et al., 2010). 
Withaferin A, an active principle in ashwagandha, has been reported to cause FOXO3a- and 
Bim-dependent apoptosis in breast cancer cells (Stan et al., 2008) and inhibit Hsp90 
chaperone activity in pancreatic cancer cells (Yu et al., 2010). Ashwagandha’s anti-
inflammatory activity has been attributed to the inhibition of nitric oxide production and 
iNOS expression and subsequent downregulation of NF-κB (Oh et al., 2008). Alkaloids of 
ashwagandha have been reported to enhance neurite outgrowth and spatial memory (Tohda 
and Joyashiki, 2009). Deceleration of senescence has been reported in fibroblasts (Widodo et 
al., 2009). Such a broad spectrum of biological effects suggests that a common systemic 
mechanism regulated by the antioxidant property of ashwagandha underlies its 
adaptogenic activity in promoting a healthy aging. 
The antioxidant activity of tulsi has been demonstrated by its attenuation of stress-induced 
changes in antioxidant enzymes like superoxide dismutase, catalase and glutathione 
peroxidase and endogenous antioxidants such as reduced glutathione (Samson et al., 2007). 
Moreover, Ocimum sanctum was effective in scavenging the DPPH, superoxide, nitric oxide, 
hydroxyl and ABTS radicals in a dose dependent manner (Samson et al., 2007). The 
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interruption of the free-radical chain of oxidation by the hydrogen donated from the phenolic 
compound’s hydroxyl groups, thereby forming stable free radicals, which do not initiate or 
propagate further oxidation of lipids, is probably responsible for the antioxidant property of 
Tulsi. The anti-oxidant property of Ocimum sanctum has also been confirmed by other reports 
(Devi and Ganasoundari, 1999). Furthermore, flavonoids are useful exogenous agents in 
protecting the aging brain, other organs and tissues of the body against free-radical induced 
damage. It appears that the phenolic and flavonoid contents of Ocimum sanctum are 
responsible for the attenuation of oxidative damage.  Ocimum sanctum treatment attenuated 
noise-induced changes in levels of neurotransmitters such as dopamine and serotonin in brain 
(Samson et al., 2006). Ocimum sanctum has also been reported to normalize the stress induced 
membrane changes in the hippocampus and sensorimotor cortex (Sen et al., 1992). These 
reports indicate that Ocimum sanctum is a non-specific anti-stressor. Apart from these, 
treatment with Ocimum sanctum extract decreased the expression of PCNA, GST-pi, Bcl-2, CK 
and VEGF, and increased the expression of Bax, cytochrome C, and caspase 3 in gastric 
carcinoma (Manikandan et al., 2007), suggesting that these molecules may be potential targets 
that mediate the pharmacological effects of Ocimum sanctum.  
The active principles of ginger such as 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol 
demonstrated significant free radical scavenging activity particularly against DPPH radical, 
superoxide radical and hydroxyl radical in in-vitro assays (Dugasani et al., 2010). Moreover, 
the efficacy of ginger in protecting the cells from oxidative stress was indicated by the 
attenuation of lindane-induced lipid peroxidation, and modulation of reduced glutathione 
(GSH), glutathione peroxidase (Gpx), glutathione reductase (GR), and glutathione-S-
transferase (GST) after dietary treatment with ginger (Ahmed et al., 2008). The active 
compound 6-shogaol was found to downregulate iNOS and COX-2 gene expression by 
inhibiting the activation of NF-κB (Pan et al., 2008). Zingerone, another major active 
compound of ginger, has been reported to modulate age-related NF-κB activation through 
the MAPK signaling pathway (Kim et al., 2010).  Another study indicated that 6-gingerol has 
been reported to inhibit NO synthesis and protect against peroxynitrite-mediated damage 
(Ippoushi et al., 2003). Apart from these, several studies investigating the anti-cancer 
potential of ginger have reported the involvement of signaling molecules such as NF-κB, 
TNF-α, AKT, ERK1/2, p38 MAPK, MMP-2 and MMP-9 in mediating the cellular responses 
to various phytochemicals of ginger (Rhode et al., 2007; Habib et al., 2008; Hung et al., 2009; 
Yodkeeree et al., 2009; Kim et al., 2010). 
The biological effects of the active principles present in neem are regulated through various 
signaling molecules. Increase in expression levels of HMOX1, AKR1C2, AKR1C3, and 
AKR1B10 was observed in prostate cancer cells after treatment with an ethanolic extract of 
neem leaves (Mahapatra et al., 2011). Inhibition of PC-3 cell proliferation and Bcl-2 
expression was observed after neem treatment (Priyadarsini et al., 2009). A methanolic 
extract of neem leaves inhibited NF-κB activity in cultured human leukemia cells 
(Schumacher et al., 2011). Azadirachtin, an active principle of neem, has been reported to 
activate transcription factors like CREB, Sp1, NF-κB (Thoh et al., 2011). The viability of 
human cervical cancer HeLa cells were suppressed by azadirachtin and nimbolide by p53-
dependent p21 accumulation and down-regulation of cell cycle regulatory proteins cyclin B, 
cyclin D1 and PCNA (Priyadarsini et al., 2010). Apart from this, the antioxidant potential of 
neem leaves were demonstrated by the reduction of DPPH, ABTS, superoxide, hydroxyl, 
and nitric oxide radicals by different extracts of neem leaves (Manikandan et al., 2009).  
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7. Conclusion 
Emerging studies on herbs employed as rejuvenators, for centuries in Indian system of 
alternative medicine, validates their clinical application by highlighting the mechanistic 
principle underlying the biological effects of these herbs. Analytical reports on triphala, 
ashwagandha, tulsi, ginger and neem suggest that these medicinal herbs have a rich array of 
a diverse spectrum of bio-active compounds. The abundance of phytochemicals with 
antioxidant properties, such as phenolics, flavonoids and carotenoids, may be held 
responsible for the rejuvenating activity of these medicinal herbs. The molecular targets of 
major phytochemicals identified in each of the herbal antioxidants discussed in this chapter 
suggest that NF-κB signaling pathway plays an important role in regulating the biological 
activity of the herbal rejuvenators. In addition, it is also evident that several other signaling 
pathways, which differ for each of these herbs, also mediate their biological effects. Thus, 
the medicinal herbs employed to promote longevity in Indian systems of alternative 
medicine have multiple pharmacological effects. However, the antioxidant property of these 
herbs seems to have a major role in determining their rejuvenating potential. 
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It has been estimated that diabetes will affect 439 million adults by 2030, with the major 
increase occurring in developing countries (Shaw et al., 2010). It is projected that it will rank 
as the 9th leading cause of death in low-income countries (Mathers & Loncar, 2006). There 
are two major types of diabetes, i.e. type 1 (T1D) or insulin dependent diabetes and type 2 
(T2D) or non-insulin dependent diabetes. The incidence of T2D is reaching epidemic 
proportions and has been associated with an increase in obesity (Venables & Jeukendrup, 
2009). According to the World Health Organisation (WHO, 2011) the main complications 
associated with diabetes are cardiovascular disease and renal failure. Although genetic 
factors may play a role, life-style factors, such as reduced exercise and poor diet, specifically 
a high carbohydrate, high fat diet devoid or low in fruit and vegetables, have been shown to 
increase the risk of diabetes (Astrup, 2001). 
Medicinal plants have been used in folk medicine and traditional healing systems such as 
Ayurveda and Traditional Chinese Medicine (TCM) for the treatment of diabetes (T.S.C. Li, 
2003; Modak et al., 2007; Singh et al., 2009; Yen et al., 2003). On the African continent as 
many as 90% of the populations of some countries relies on plants as the principal source of 
medicine for the treatment of different diseases, including diabetes (Hostettman et al., 2000), 
as they provide an affordable alternative to drugs. In South Africa a large number of plants, 
belonging to plant families such as the Asteraceae and Lamiaceae, amongst others, have 
been traditionally used for the treatment of diabetes (Deutschländer et al., 2009; Erasto et al., 
2005; Thring & Weitz, 2006).  
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Globally, there is a movement towards alternatives to single chemical entities as favoured 
by the pharmaceutical industry. These alternatives are rationally selected, carefully 
standardised, synergistic traditional herbal formulations and botanical drug products which 
are supported by robust scientific evidence (Patwardhan & Mashelkar, 2009). In many 
instances the value of herbal and medicinal plant extracts lies not in a single compound, but 
in their complex phytochemical nature. These complex mixtures of often unspecified 
compounds are able to modulate multiple targets (Y. Li et al., 2008). Antidiabetic phenolic 
compounds in the extracts also have the ability to ameliorate oxidative stress (Han et al., 
2007), an underlying mechanism to the pathogenesis of diabetes (Ceriello & Motz, 2004). 
One such compound is the xanthone C-glucoside, mangiferin (1,3,6,7-tetrahydroxy-xanthone-
C2-β-D-glucoside), demonstrating antihyperlipidaemic, antihyperglycaemic and antioxidant 
properties (Wauthoz et al., 2007). Mangiferin (Fig. 1) was shown to protect against 
streptozotocin (STZ)-induced oxidative damage to cardiac and renal tissues in Wistar rats 
(Muruganandan et al., 2002). Its presence in the endemic South African Cyclopia spp. (family 
Fabaceae; tribe Podalyrieae) suggested the potential use of these plant species as antidiabetic 
nutraceuticals or even phytopharmaceuticals. Hesperidin (Fig. 1), another antioxidant and 
compound demonstrating hypoglycaemic properties in rodents (Akiyama et al., 2010; Jung et 
al., 2004), is also one of the major monomeric polyphenols present in Cyclopia spp. (Joubert et 
al., 2003). A decoction of Cyclopia spp. was used in the past as a restorative and as an 
expectorant in chronic catarrh and pulmonary tuberculosis. However, it is as the herbal tea, 
honeybush, that Cyclopia spp. are increasingly appreciated by consumers world-wide. The tea 
is primarily exported to the Netherlands, Germany, United Kingdom and United States of 
America. It is even exported to traditional tea-drinking countries such as Sri Lanka, India, 
Japan and China. Commercial herbal tea production comprised three main species, viz. C. 
genistoides, C. intermedia and C. subternata. Of these, C. intermedia, harvested almost exclusively 
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Fig. 1. Structures of phenolic compounds of C. intermedia extract. 
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A contributing factor to its growing popularity is the body of scientific evidence that 
honeybush has potential health benefits, including antioxidant, anticancer and 
phytoestrogenic properties (Joubert et al., 2008a). The greatest demand is for the traditional 
product, which is ‘fermented’ (oxidised) to form the characteristic dark-brown colour and 
sweet flavour. However, this is accompanied by a substantial reduction in the phenolic 
content of the plant material and extract, as well as a decrease in antioxidant activity 
(Joubert et al., 2008b), justifying investigating the benefits of unfermented C. intermedia for 
human health.  
With T2D being the most common form of diabetes, representing more than 90% of all cases 
(WHO, 2011), the antidiabetic potential of unfermented C. intermedia was investigated using 
a diet-induced obese insulin resistant (OBIR) rat model. Feeding rats a high fat diet induces 
a state of insulin resistance associated with impaired insulin-stimulated glycolysis and 
glycogen synthesis (Kim et al., 2000). The STZ-induced diabetic rat model, following 
pancreatic β-cell destruction and resulting in insulin deficiency rather than insulin resistance 
(OBIR model), was used to establish the optimal acute glucose lowering dose of a C. 
intermedia extract. The investigation focused on a hot water extract of C. intermedia as it 
represents normal preparation of the herbal tea, albeit under more severe extraction 
conditions, but without introducing qualitative changes to composition as is the case for 
organic solvent extraction. 
2. Material and methods 
2.1 Chemicals 
General analytical grade laboratory reagents were purchased from Sigma-Aldrich (St. Louis, 
USA) and Merck (Darmstadt, Germany). Authentic reference standards were obtained from 
Sigma-Aldrich (mangiferin, hesperidin) and Extrasynthese (Genay, France; eriocitrin, 
luteolin). Isomangiferin was isolated from C. subternata (De Beer et al., 2009). Acetonitrile for 
HPLC analysis was gradient grade for liquid chromatography (Merck, Darmstadt, 
Germany). HPLC grade water was prepared by purifying laboratory grade water 
(Continental Water Systems Corp., San Antonio, USA) with a Milli-Q 185 Académic Plus 
water purification system (Millipore, Bedford, USA). 
STZ, fluothane, 50% dextrose solution, metformin hydrochloride and rosiglitazone maleate 
(Avandia®) were obtained from Sigma-Aldrich, AstraZeneca Pharmaceuticals 
(Johannesburg, South Africa), Intramed (Johannesburg, South Africa), Rolab (Johannesburg, 
South Africa) and GlaxoSmithKline (Bryanston, South Africa), respectively. 
2.2 Plant material and extract preparation 
Cyclopia intermedia shoots (ca 220 kg) were harvested according to normal practice by cutting 
the shoots sprouting from the rootstock directly above soil level. All the plant material was 
harvested from a natural stand on Nooitgedacht Farm in the Langkloof area, South Africa. The 
part of the stem without leaves or with only a few leaves (Fig. 2) was removed before further 
processing, entailing cutting of the shoots into small pieces (<4 mm) and mechanical drying at 
40 °C to less than 10% moisture content (Joubert et al., 2008b), giving ca 50 kg dried plant 
material. The plant material was pulverised with a Retsch rotary mill before pilot plant 
extraction. Water heated to >95 °C was added to the pulverised plant material in a 1:10 (m/v) 
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ratio and continuously stirred for 30 min. (final extract temperature was 70 °C), whereafter the 
extract was pumped to an in-line continuous centrifuge for removal of the insoluble matter. 
Following centrifugation, the extract, containing 2.69 g soluble matter/100 mL, was cooled to 
ca 20 °C using a tubular heat exchanger and aliquots bottled for daily feeding of OBIR rats. 
The aliquots were stored at -20 °C until use. An aliquot (ca 1000 mL) was freeze-dried in an 
Edwards Modulyo bench-top freeze-drier (Edwards High Vacuum Ltd, Crowley, UK) for 
acute dosing of STZ-induced diabetic rats and for phenolic content analysis. 
 
 
                                           (a)                                                                   (b) 
Fig. 2. (a) Cyclopia intermedia plant showing aerial parts (top section of a typical shoot with thin 
stems and leaves). (b) Harvested shoots before removal of the stem parts without leaves. 
2.3 HPLC analysis of extract 
HPLC analysis was performed using an Agilent 1200 series HPLC system consisting of a 
quaternary pump, autosampler, in-line degasser, column oven and diode-array detector 
(Agilent Technologies Inc., Santa Clara, USA) controlled with Chemstation 3D LC software. 
Separation was performed on a Zorbax Eclipse XDB-C18 column (150 x 4.6 mm, 5 m 
particle size, 80 Å pore size) from Agilent Technologies protected by a guard column with 
the same stationary phase. The separation was achieved with mobile phases consisting of 
0.1% formic acid and acetonitrile using the solvent gradient reported previously (De Beer & 
Joubert, 2010). The flow-rate and column temperature were maintained at 1 mL/min and 30 
°C, respectively. The freeze-dried extract was dissolved in 16% DMSO (ca 5 mg/mL) and 
filtered using a 33 mm Millex-HV PVDF syringe filter unit with 0.45 m pore size 
(Millipore) before injection (20 L). Compound identification was based on retention times 
and UV-Vis spectra of authentic standards where available (mangiferin, isomangiferin, 
eriocitrin, hesperidin, luteolin and hesperetin). An additional peak was identified as an 
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eriodictyol-glucoside based on similarity of its retention time and UV-Vis spectrum with a 
compound identified previously using liquid chromatography with mass spectrometric 
detection (De Beer & Joubert, 2010). An unidentified compound was also observed, which 
had retention time and UV-Vis characteristics similar to a compound previously detected in 
several Cyclopia spp. (De Beer & Joubert, 2010). Mangiferin, isomangiferin and luteolin were 
quantified using the peak areas at 320 nm, while the eriodictyol-glucoside, eriocitrin, 
hesperidin, hesperetin and the unidentified compound were quantified using the peak areas 
at 288 nm. A calibration series consisting of mangiferin (0.05-2.5 µg injected), isomangiferin 
(0.05-2.5 µg injected), eriocitrin (0.01-0.8 µg injected), hesperidin (0.01–1.5 µg injected), 
hesperetin (0.003-0.25 μg injected) and luteolin (0.05-0.35 µg injected) was used for external 
calibration. The eriodictyol-glucoside was quantified in terms of eriocitrin equivalents, 
while the unidentified compound was quantified in terms of hesperidin equivalents. 
2.4 Animal study  
Ethical approval was obtained from the Ethics Committee for Research on Animals (ECRA) 
of the Medical Research Council of South Africa. 
Male Wistar rats, obtained from the Primate Unit of the Medical Research Council 
(Tygerberg, South Africa), were used throughout the study. The rats were housed 
individually in wired top and bottom cages, fitted with PerspexTM houses and kept in a 
controlled environment of 23–24 °C, 50% humidity and a 12 h light/dark cycle. 
2.4.1 STZ-induced diabetic rats  
Adult male Wistar rats (200-250 g) were injected intramuscularly with freshly prepared STZ 
[35 mg/kg body weight (BW)] in 0.1 M citrate buffer (pH 4.5) to induce stable non-
ketoacidotic diabetic rats. Blood samples were taken from the tail tip 72 hrs after STZ 
injection and the plasma glucose concentrations determined using a glucometer (Precision 
Q.I.D, Abbott Laboratories, Johannesburg, South Africa). Rats with fasting blood glucose 
levels of >15.0 mmol/L were considered diabetic and were selected for the acute dose 
finding study of the extract. 
2.4.2 Acute dosing of diabetic STZ rats with honeybush extract 
The efficacy of a single dose of honeybush extract was determined by administering 
different doses of freeze-dried extract to STZ diabetic rats. Following a 3 hr fast, baseline 
plasma glucose concentrations of diabetic STZ rats were determined. The freeze-dried 
honeybush extract (reconstituted in a fixed volume of distilled water yielding e.g. 5 mg/mL 
for the 5 mg/kg BW dose, etc.) was administered by oral gavage under light anaesthesia (by 
inhalation of 2% fluothane with 98% oxygen) to four experimental groups of five STZ rats 
each at doses of 0 (vehicle control), 5, 25 and 50 mg/kg BW. Plasma glucose concentrations 
were determined hourly over a 6 hr period. 
2.5 Chronic treatment of OBIR rats with honeybush extract  
The efficacy of honeybush extract to ameliorate diet-induced insulin resistance, characterised by 
hyperglycaemia, hyperinsulinaemia, hyperglucagonaemia and dyslipidaemia was investigated 
using OBIR Wistar rats chronically exposed to the extract for 12 wks (described below). 
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Fig. 2. (a) Cyclopia intermedia plant showing aerial parts (top section of a typical shoot with thin 
stems and leaves). (b) Harvested shoots before removal of the stem parts without leaves. 
2.3 HPLC analysis of extract 
HPLC analysis was performed using an Agilent 1200 series HPLC system consisting of a 
quaternary pump, autosampler, in-line degasser, column oven and diode-array detector 
(Agilent Technologies Inc., Santa Clara, USA) controlled with Chemstation 3D LC software. 
Separation was performed on a Zorbax Eclipse XDB-C18 column (150 x 4.6 mm, 5 m 
particle size, 80 Å pore size) from Agilent Technologies protected by a guard column with 
the same stationary phase. The separation was achieved with mobile phases consisting of 
0.1% formic acid and acetonitrile using the solvent gradient reported previously (De Beer & 
Joubert, 2010). The flow-rate and column temperature were maintained at 1 mL/min and 30 
°C, respectively. The freeze-dried extract was dissolved in 16% DMSO (ca 5 mg/mL) and 
filtered using a 33 mm Millex-HV PVDF syringe filter unit with 0.45 m pore size 
(Millipore) before injection (20 L). Compound identification was based on retention times 
and UV-Vis spectra of authentic standards where available (mangiferin, isomangiferin, 
eriocitrin, hesperidin, luteolin and hesperetin). An additional peak was identified as an 
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eriodictyol-glucoside based on similarity of its retention time and UV-Vis spectrum with a 
compound identified previously using liquid chromatography with mass spectrometric 
detection (De Beer & Joubert, 2010). An unidentified compound was also observed, which 
had retention time and UV-Vis characteristics similar to a compound previously detected in 
several Cyclopia spp. (De Beer & Joubert, 2010). Mangiferin, isomangiferin and luteolin were 
quantified using the peak areas at 320 nm, while the eriodictyol-glucoside, eriocitrin, 
hesperidin, hesperetin and the unidentified compound were quantified using the peak areas 
at 288 nm. A calibration series consisting of mangiferin (0.05-2.5 µg injected), isomangiferin 
(0.05-2.5 µg injected), eriocitrin (0.01-0.8 µg injected), hesperidin (0.01–1.5 µg injected), 
hesperetin (0.003-0.25 μg injected) and luteolin (0.05-0.35 µg injected) was used for external 
calibration. The eriodictyol-glucoside was quantified in terms of eriocitrin equivalents, 
while the unidentified compound was quantified in terms of hesperidin equivalents. 
2.4 Animal study  
Ethical approval was obtained from the Ethics Committee for Research on Animals (ECRA) 
of the Medical Research Council of South Africa. 
Male Wistar rats, obtained from the Primate Unit of the Medical Research Council 
(Tygerberg, South Africa), were used throughout the study. The rats were housed 
individually in wired top and bottom cages, fitted with PerspexTM houses and kept in a 
controlled environment of 23–24 °C, 50% humidity and a 12 h light/dark cycle. 
2.4.1 STZ-induced diabetic rats  
Adult male Wistar rats (200-250 g) were injected intramuscularly with freshly prepared STZ 
[35 mg/kg body weight (BW)] in 0.1 M citrate buffer (pH 4.5) to induce stable non-
ketoacidotic diabetic rats. Blood samples were taken from the tail tip 72 hrs after STZ 
injection and the plasma glucose concentrations determined using a glucometer (Precision 
Q.I.D, Abbott Laboratories, Johannesburg, South Africa). Rats with fasting blood glucose 
levels of >15.0 mmol/L were considered diabetic and were selected for the acute dose 
finding study of the extract. 
2.4.2 Acute dosing of diabetic STZ rats with honeybush extract 
The efficacy of a single dose of honeybush extract was determined by administering 
different doses of freeze-dried extract to STZ diabetic rats. Following a 3 hr fast, baseline 
plasma glucose concentrations of diabetic STZ rats were determined. The freeze-dried 
honeybush extract (reconstituted in a fixed volume of distilled water yielding e.g. 5 mg/mL 
for the 5 mg/kg BW dose, etc.) was administered by oral gavage under light anaesthesia (by 
inhalation of 2% fluothane with 98% oxygen) to four experimental groups of five STZ rats 
each at doses of 0 (vehicle control), 5, 25 and 50 mg/kg BW. Plasma glucose concentrations 
were determined hourly over a 6 hr period. 
2.5 Chronic treatment of OBIR rats with honeybush extract  
The efficacy of honeybush extract to ameliorate diet-induced insulin resistance, characterised by 
hyperglycaemia, hyperinsulinaemia, hyperglucagonaemia and dyslipidaemia was investigated 
using OBIR Wistar rats chronically exposed to the extract for 12 wks (described below). 
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2.5.1 Inducing insulin resistance in Wistar rats 
Three-week old weanling Wistar rats (male) were fed a 40% high fat diet (Table 1) and 30% 
sucrose in their drinking water ad libitum for 9 wks. The high fat diet in combination with 
sucrose induces insulin resistance and obesity with slightly elevated fasting glucose 
concentrations (Hallfrisch et al., 1981; Krygsman et al., 2010). After 9 wks on the high fat and 
sucrose diet, blood was collected for baseline glucose and insulin determination. Thereafter 
the rats were allocated into experimental groups and maintained on the high fat and sucrose 
diet during the subsequent 12-wk treatment. 
2.5.2 Experimental groups  
The untreated control consisted of six 12-wk old OBIR rats that were randomly assigned to 
the control group.  
Groups E1 – E5 (honeybush extract treated groups) consisted of five groups of ten OBIR rats 
each, receiving 538, 1075, 1792, 2150 or 2688 mg/100 mL honeybush extract (hot water 
soluble solids), respectively, as their drinking fluid, which also contained 30% sucrose 
(Table 2). The daily fluid intake was measured for each rat and the average amount of liquid 
 
Nutrients % Energy 
Protein 15.09 
Fat 40.17 
Saturated fatty acids 18.27 
Monounsaturated fatty acids 11.45 
Polyunsaturated fatty acids 5.75 
Carbohydrate 44.73 
Kcal/g of food 2.06 
Kcal/g of sucrose 0.60 
Total energy of diet (Kcal/g) 2.66 
Table 1. High fat diet (HFD) macronutrient and calorific composition. 
 










Control 476 ± 20 – 30 ± 2 – – – 
E1 441 ± 12 538 33 ± 4   77.2 ±   9.6   4.47 ± 0.55 0.27 ± 0.03 
E2 456 ± 20 1075 42 ± 5 206.9 ± 27.5 11.99 ± 1.60 0.73 ± 0.10 
E3 442 ± 25 1792 31 ± 4 255.1 ± 64.6 14.79 ± 3.74 0.65 ± 0.23 
E4 438 ± 21 2150 32 ± 2 299.1 ± 23.5 17.33 ± 1.36 1.06 ± 0.08 
E5 457 ± 36 2688 43 ± 2 531.3 ± 61.1 30.79 ± 3.54 1.88 ± 0.22 
Met 489 ± 22 – 31 ± 4 22.0 – – 
Rosi 479 ± 26 – 29 ± 2   4.0 – – 
Table 2. OBIR rat body weight (g), extract concentration (mg/100 mL), fluid intake (mL), 
treatment intake (mg/kg BW), i.e. C. intermedia extract (E1-5), metformin (Met) or 
rosiglitazone (Rosi), as well as equivalent intake of mangiferin (mg/kg BW) and hesperidin 
(mg/kg BW), for chronic treatment experiment. 
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consumed per week for each rat was calculated (Table 2). Aliquots of the aqueous 
honeybush extract were defrosted daily. In the case of E1 to E4 the extract was diluted with 
water to give the required concentration of hot water soluble solids, while E5 represented 
the undiluted extract. 
The metformin and rosiglitazone treated groups consisted of three OBIR rats each that 
received metformin hydrochloride or rosiglitazone maleate at dosages of 22 and 4 mg/kg 
BW, respectively, in distilled water. 
2.5.3 Blood parameters 
Determination of fasting plasma glucose. The STZ-induced diabetic and OBIR rats were fasted 
for 3 hrs and overnight, respectively, prior to determining their fasting plasma glucose 
concentrations. A drop of blood was collected from the tail tip and the plasma glucose 
concentration determined. 
Determination of fasting serum insulin. Rats were anaesthetised by 2% fluothane inhalation 
with 98% oxygen. Blood was collected from the tail tip into Eppendorf tubes and stored on 
ice until centrifuged at 2500 rpm for 15 min. at 4 °C. Following centrifugation, the serum 
samples were stored at -20 °C until analysis. The serum insulin concentration was 
determined by radioimmunoassay using a rat insulin measurement kit from Linco® 
Research (St. Charles, USA). 
Intravenous glucose tolerance test (IVGTT). Rats fasted overnight were anaesthetised as 
described above and a drop of blood obtained from the tail tips. This was used for 
measuring baseline glucose. Glucose (50% dextrose solution), at a dose of 0.5 mg/kg BW, 
was injected intravenously over 20 sec and glucose measurements taken at 5, 10, 20, 30, 40, 
50 and 60 min. 
Determination of fasting plasma cholesterol. Rats were anaesthetised as described above and 
blood, collected from the tail tips, was prepared and stored at -20 °C for analysis. Total 
cholesterol concentrations were determined by Pathcare Laboratories (Cape Town, South 
Africa), using a Bayer-Technicon RA 1000 auto-analyser. 
2.5.4 Immunocytochemistry and image analysis of the pancreata  
Harvesting of pancreata. After 12 wks of treatment the rats were euthanised by exsanguination 
under sodium barbital anaesthesia and pancreata harvested. The whole pancreas was 
removed, fixed overnight in 4% buffered formaldehyde (pH 7.5) and processed into paraffin 
wax by standard histological methods. Serial 4 μm thick sections were cut for 
immunocytochemistry. 
Immunocytochemistry. Serial wax sections attached onto silane coated slides were de-waxed 
with xylene and hydrated through descending grades of ethanol into water. Slides were rinsed 
in 50 mM Tris–buffered-saline (pH 7.4) and double immuno-stained, using anti-insulin and 
anti-glucagon primary antibodies. Primary antibody binding to insulin or glucagon was 
detected by avidin D-biotinylated horseradish peroxidase or streptavidin-biotin-
complex/alkaline phosphatase conjugated link antibodies. Insulin positive labeling (β-cells) 
was visualised with fuchsin red and α-cells with diaminobenzidine tetrahydrochloride. 
Method controls involved omission of the primary antibody (anti-insulin or anti-glucagon). 
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consumed per week for each rat was calculated (Table 2). Aliquots of the aqueous 
honeybush extract were defrosted daily. In the case of E1 to E4 the extract was diluted with 
water to give the required concentration of hot water soluble solids, while E5 represented 
the undiluted extract. 
The metformin and rosiglitazone treated groups consisted of three OBIR rats each that 
received metformin hydrochloride or rosiglitazone maleate at dosages of 22 and 4 mg/kg 
BW, respectively, in distilled water. 
2.5.3 Blood parameters 
Determination of fasting plasma glucose. The STZ-induced diabetic and OBIR rats were fasted 
for 3 hrs and overnight, respectively, prior to determining their fasting plasma glucose 
concentrations. A drop of blood was collected from the tail tip and the plasma glucose 
concentration determined. 
Determination of fasting serum insulin. Rats were anaesthetised by 2% fluothane inhalation 
with 98% oxygen. Blood was collected from the tail tip into Eppendorf tubes and stored on 
ice until centrifuged at 2500 rpm for 15 min. at 4 °C. Following centrifugation, the serum 
samples were stored at -20 °C until analysis. The serum insulin concentration was 
determined by radioimmunoassay using a rat insulin measurement kit from Linco® 
Research (St. Charles, USA). 
Intravenous glucose tolerance test (IVGTT). Rats fasted overnight were anaesthetised as 
described above and a drop of blood obtained from the tail tips. This was used for 
measuring baseline glucose. Glucose (50% dextrose solution), at a dose of 0.5 mg/kg BW, 
was injected intravenously over 20 sec and glucose measurements taken at 5, 10, 20, 30, 40, 
50 and 60 min. 
Determination of fasting plasma cholesterol. Rats were anaesthetised as described above and 
blood, collected from the tail tips, was prepared and stored at -20 °C for analysis. Total 
cholesterol concentrations were determined by Pathcare Laboratories (Cape Town, South 
Africa), using a Bayer-Technicon RA 1000 auto-analyser. 
2.5.4 Immunocytochemistry and image analysis of the pancreata  
Harvesting of pancreata. After 12 wks of treatment the rats were euthanised by exsanguination 
under sodium barbital anaesthesia and pancreata harvested. The whole pancreas was 
removed, fixed overnight in 4% buffered formaldehyde (pH 7.5) and processed into paraffin 
wax by standard histological methods. Serial 4 μm thick sections were cut for 
immunocytochemistry. 
Immunocytochemistry. Serial wax sections attached onto silane coated slides were de-waxed 
with xylene and hydrated through descending grades of ethanol into water. Slides were rinsed 
in 50 mM Tris–buffered-saline (pH 7.4) and double immuno-stained, using anti-insulin and 
anti-glucagon primary antibodies. Primary antibody binding to insulin or glucagon was 
detected by avidin D-biotinylated horseradish peroxidase or streptavidin-biotin-
complex/alkaline phosphatase conjugated link antibodies. Insulin positive labeling (β-cells) 
was visualised with fuchsin red and α-cells with diaminobenzidine tetrahydrochloride. 
Method controls involved omission of the primary antibody (anti-insulin or anti-glucagon). 
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Image analysis. Both β- and α-cell areas were measured on each section (minimum of ten 
sections per group). Computer-assisted measurements were taken with a Canon Powershot 
S40 digital camera (Tochigi, Japan) mounted on an Olympus BX60 light microscope (Tokyo, 
Japan), attached to a personal computer to capture images. The acquired images were 
transferred to the computer using remote capture software from Canon. Image analysis was 
performed with Leica Qwin Plus Software (Cambridge, UK). The ratio of either the β-cell 
positive or the α-cell positive area to the total pancreas area was calculated. β-Cell and α-cell 
sizes were calculated by dividing the total area of each of the cell types by the number of 
nuclei counted. 
2.6. Statistical analysis  
Results were entered into an Excel spreadsheet and statistically analysed. For the acute STZ 
rat experiment hourly (t = 1–6) glucose concentrations were compared against baseline (t = 
0) and the control for each corresponding time point. For the chronic OBIR rat experiments 
each data point was compared to the corresponding control value using ANOVA with a 
Dunnet post-hoc test (Prism version 5, Graphpad software®). The values presented are the 
mean ± SE. 
3. Results 
3.1 Extract composition  
The phenolic compound structures for the major compounds of the C. intermedia extract are 
shown in Fig. 1, the plant shoots in Fig. 2 and the extract HPLC profile and quantitative data 
in Fig. 3. The major compounds detected included the xanthone isomers, mangiferin and 
isomangiferin, the flavanone glycoside, hesperidin (hesperetin-7-O-rutinoside), and an 
unidentified compound previously detected in several Cyclopia spp. (De Beer & Joubert,  
2010). Additionally, a flavone, luteolin, and three flavanones, namely an eriodictyol- 
 
 
Fig. 3. Phenolic profile and phenolic composition (g/100 g) of C. intermedia extract (1, 
unidentified compound; 2, mangiferin; 3, isomangiferin; 4, eriodictyol-glucoside; 5, 
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glucoside, eriocitrin (eriodictyol-7-O-rutinoside) and hesperetin, the aglycone of hesperidin, 
were also detected in small quantities.  
3.2 Animal study 
Results of the intake data are summarised in Table 2. The average intake of honeybush 
extract by the various treatment groups varied from 77 to 531 mg/kg BW. This equals 4.5 to 
30.8 mg/kg BW of the major xanthone, mangiferin, and 0.3 to 1.9 mg/kg BW of the major 
flavanone, hesperidin. 
Intramuscular injection of Wistar rats with STZ (35 mg/kg BW) induced diabetes in the rats 
at an average fasting plasma glucose concentration of 27.8 ± 1.0 mmol/L (data not shown). 
The acute effects of administering the honeybush extract by oral gavage under light 
anaesthesia at doses of 0 (vehicle control), 5, 25 and 50 mg/kg BW are shown in Fig 4. The 
optimal acute oral glucose lowering dose for the honeybush extract in STZ-induced diabetic 
rats for the dose range tested was 50 mg/kg BW. This was the only acute dose of the extract 
that significantly reduced the mean blood glucose concentrations relative to the baseline 
fasting blood glucose concentration. Reductions of 33.5 ± 1.7% (p<0.05), 34.3 ± 3.6% (p<0.05) 
and 35.6 ± 3.5% (p<0.01) were observed after 4, 5, and 6 hrs, respectively (Fig. 4). 
After a chronic 3-month treatment of OBIR rats with aqueous honeybush extract their 
hyperglycaemic fasting blood glucose concentrations were reduced to normoglycaemic 
values. In other words, the honeybush extract reduced the fasting blood glucose levels from 
12.2 mmol/L of the control to 4.8 – 5.4 mmol/L (p<0.001). All extract concentrations were 
effective. Metformin and rosiglitazone had very similar effects and reduced the fasting 
glucose to 6.3 mmol/L (p<0.001) and 5.6 mmol/L (p<0.001), respectively (Fig. 5). 
Untreated control OBIR rats had IVGTT peak glucose concentrations of 18.2 ± 1.74 mmol/L. 
Treatment with the honeybush extract reduced this value to 14.9 ± 0.7 mmol/L (treatment 






















Fig. 4. Acute glucose lowering effect of C. intermedia extract in STZ diabetic rats (n=5). 
Significant differences from baseline indicated with * (p<0.05) or ** (p<0.01). 
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Fig. 4. Acute glucose lowering effect of C. intermedia extract in STZ diabetic rats (n=5). 
Significant differences from baseline indicated with * (p<0.05) or ** (p<0.01). 
 


























Fig. 5. The effect of chronic treatment with C. intermedia extract, metformin and rosiglitazone 
(see Table 2 for treatment codes and dosage) on fasting plasma glucose concentration of 
OBIR rats (n=10). Significant differences from control indicated with *** (p<0.001). 
p<0.05), respectively (only E3 is shown for clarity; Fig. 6). The IVGTT area under the curve 
values were reduced from 670 ± 9 for the control to 474 ± 15 (p<0.05) and 496 ± 13 (p<0.05) 
for E2 and E5, respectively (data not shown). E1 (the lowest dose), as well as the known 
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Fig. 6. The effect of C. intermedia extract, metformin (Met) and rosiglitazone (Rosi) treatment 
on intravenous glucose tolerance in OBIR rats (n=10) (see Table 2 for treatment codes and 
dosage). E3 differs significantly from the control as indicated with * (p<0.05). 
Treatment of OBIR rats with honeybush extracts, E1 to E5, for 3 months lowered the total 
plasma cholesterol concentration compared to the untreated rats (2.9 ± 0.3 mmol/L) by 31.6 - 
39.1% (Fig. 7). The effect of metformin and rosiglitazone on total cholesterol was not 
determined. 
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Fig. 7. The effect of chronic treatment with C. intermedia extract (see Table 2 for treatment 
codes and dosage) on fasting total cholesterol concentrations in OBIR rats (n=10). Significant 
differences from control indicated with * (p<0.05) or ** (p<0.01). 
The average α-cell size in untreated OBIR rats was 106 ± 13.6 μm2. Treatment with the 
honeybush extracts, E1 to E4, reduced the α-cell size to about half, i.e. to 48.4 – 54.9 μm2 
(p<0.01). Metformin and rosiglitazone had similar effects and also reduced the average α- 
cell size to 41.2 ± 1.9 μm2 and 44.0 41.2 ± 1.9 μm2, respectively (p<0.01) (Fig. 8). No data were 
available for E5. These changes in the α-cell size were also reflected in the decreased α-cell to 





























Fig. 8. The effect of chronic treatment with C. intermedia extract, metformin and rosiglitazone 
(see Table 2 for treatment codes and dosage) on mean α-cell size in the pancreata of OBIR 
rats (n=10). Significant differences from control indicated with ** (p<0.01). 
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honeybush extracts, E1 to E4, reduced the α-cell size to about half, i.e. to 48.4 – 54.9 μm2 
(p<0.01). Metformin and rosiglitazone had similar effects and also reduced the average α- 
cell size to 41.2 ± 1.9 μm2 and 44.0 41.2 ± 1.9 μm2, respectively (p<0.01) (Fig. 8). No data were 
available for E5. These changes in the α-cell size were also reflected in the decreased α-cell to 





























Fig. 8. The effect of chronic treatment with C. intermedia extract, metformin and rosiglitazone 
(see Table 2 for treatment codes and dosage) on mean α-cell size in the pancreata of OBIR 
rats (n=10). Significant differences from control indicated with ** (p<0.01). 
 



















Fig. 9. The effect of chronic treatment with C. intermedia extract, metformin and rosiglitazone 
(see Table 2 for treatment codes and dosage) on α- to -cell ratio in the pancreata of OBIR 
rats (n=10). Significant differences from control indicated with * (p<0.05), ** (p<0.01) or *** 
(p<0.001). 
4. Discussion 
The content of mangiferin, isomangiferin and the unidentified compound was higher than 
the average for unfermented C. intermedia extracts previously analysed (De Beer & Joubert, 
2010; Joubert et al., 2008b), while the hesperidin and eriocitrin contents of the present extract 
were lower. De Beer & Joubert (2010) detected luteolin only in trace amounts, while no 
hesperetin was detected. Joubert et al. (2003) found that the plant material (dry mass basis) 
contain 1.69% mangiferin, while isomangiferin and hesperidin, respectively, comprised 0.22 
and 1.76% of the dry plant material. Other phenolic compounds of C. intermedia include 
flavones, isoflavones, other flavanones and coumestans (Ferreira et al., 1998; Kamara et al., 
2003). Quantitative differences between the present extract and aqueous hot water extracts 
analysed previously (De Beer & Joubert, 2010; Joubert et al., 2008b) could be attributed to 
natural variation and/or selective use of the upper part of the shoot. This has implications 
for standardisation and efficacy. Testing of more C. intermedia extracts, specifically for their 
efficacy as antidiabetic extracts, is required before more comprehensive claims can be made. 
STZ was originally developed as an antibiotic derived from Streptomyces achromogenes but it 
is toxic to pancreatic β-cells. It selectively enters insulin producing β-cells via their GLUT2 
glucose transporter proteins, inducing irreparable DNA damage and death of β-cells in a 
dose dependent manner (Lenzen, 2008). In the Wistar rat, intramuscular injection of STZ (35 
mg/kg BW) increased fasting plasma glucose concentrations by ca 500% from the average 
normoglyceamic concentration of 5.3 mmol/L, resulting in stable non-ketoacidotic T1D 
diabetic rats. An acute 50 mg/kg BW dose of the aqueous honeybush extract induced a 
sustained glucose lowering effect from 3 to at least 6 hrs in these STZ-induced diabetic rats. 
These results are comparable to that of Miura et al. (2001) who assessed the acute 
antidiabetogenic effect of an extract of Anemarrhena aspholoides in a hyperglycaemic KK-Ay 
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diabetic mouse model. This plant, which contains the xanthones, mangiferin and a 7-
glucoside of mangiferin, is used as an Oriential medicine for the treatment of diabetes. After 
oral treatment the maximal glucose lowering effect of the aqueous Anemarrhena aspholoides 
extract was achieved after 7 hrs. Mangiferin and its glucoside showed similar activity at a 
dose of 90 mg/kg BW. Mangiferin administered intraperitoneally for 30 days to mildly 
hyperglycaemic STZ-induced rats at doses of 10 and 20 mg/kg BW ameliorated the diabetic  
effects including weight loss, hyperglycaemia and hypercholesterolaemia (Dineshkumar et 
al., 2010). Prior to the latter study, the antidiabetic effects of mangiferin in STZ-induced 
diabetic Wistar rats were shown at the same doses after chronic treatment for 14 and 28 days 
(Muruganandan et al., 2005). 
In the present study 50 mg/kg BW of honeybush extract, equalling a dose of 2.90 mg 
mangiferin, was effective at reducing plasma glucose concentrations in our STZ-induced 
diabetic rat model. Other compounds in the extract could also contribute to the observed 
hypoglycaemic effect through synergistic or additive effects. Hesperidin, in particular, 
comprising 0.35% of the honeybush extract, was shown to have a hypoglycaemic effect in 
marginally hyperglycaemic Wistar rats normalising their blood glucose concentrations after 
16 days (Akiyama et al., 2010). Jung et al. (2004), using a spontaneously diabetic C57BL/KsJ-
db/db mouse model, showed that a 5-wk supplementation of the diet with 0.02% 
hesperidin ameliorated the development of hyperglycaemia in these mice. Both Akiyama et 
al. (2010) and Jung et al. (2004) attributed the hypoglycaemic effect of hesperidin to 
upregulation of glucose regulating enzymes, in particular glucokinase, which enhances 
glycolysis and increases glycogen synthesis. 
Confirmation of the antidiabetic potential of C. intermedia extract in the STZ-induced 
diabetic rat model was followed up with a chronic study in the high fat diet-induced OBIR 
rat model. Feeding non-predisposed Wistar rats a high fat (Table 1) and sucrose diet from 
weanling for three months induces obesity and glucose intolerance. Although these obese 
rats maintain near normal fasting glucose levels they present with hyperinsulinaemia,  
hyperglucagonaemia and dyslipidaemia (Buettner et al., 2006; Chalkley et al., 2002; 
Kamgang et al., 2005). The addition of refined sugars, i.e. sucrose, exacerbates the metabolic 
aberrations by the disruption of fatty acid metabolism resulting in hepatic and subsequent 
muscle insulin resistance (Fukuchi et al., 2004). The chronic hyperinsulinaemia associated 
with insulin resistance increases hepatic lipogenesis due to increased expression of the 
major lipogenesis gene sterol response element-binding protein 1c (SREBP1c). In these obese 
rats increasing levels of glucagon fail to regulate the insulin action, leading to increases in 
hepatic fat accumulation and hypertriglyceridaemia (Buettner et al., 2006). Interestingly, 
whereas the insulin sensitivity of the SREBP1c pathway is retained, the forkhead box protein 
O1 (FOXO1) pathway becomes insulin resistant, resulting in decreased hepatic glucose 
uptake and increased gluconeogenesis. Together the increase in fatty acid synthesis and 
hepatic glucose release worsens muscle and pancreatic islet insulin resistance (Liu et al., 
2011). Ultimately, high fat feeding is directly associated with pancreatic endocrine 
dysfunction and subsequent morphological changes of the pancreatic islets’ endocrine cell 
ratios and cell sizes. The compensatory response to the increased demand for insulin results 
in pancreatic β-cell hypertrophy and an increase in α-cell number and volume (Buettner et 
al. (2007). As the diabetic pathogenesis worsens the β-cell mass declines and the α- to β-cell 
ratio increases (Liu et al., 2011). Feeding the same 40% high fat diet to pregnant Wistar dams 
during gestation resulted in offspring with similar increases in α-cell volume, while β-cell 
 



















Fig. 9. The effect of chronic treatment with C. intermedia extract, metformin and rosiglitazone 
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volume decreased (Cerf et al., 2005). In human T2D pancreatic islets, larger islets with an 
increased proportion of pancreatic α-cells have been shown to have impaired function  
(Deng et al., 2004). Despite the diet-induced metabolic and morphological aberrations these 
rats only develop slight hyperglycaemia over time without progressing to overt T2D. The 
similarities of the diet-induced OBIR rat to the pathophysiology of human obesity and the 
metabolic syndrome are well established (Buettner et al., 2007) and this animal model was 
therefore selected to test the possible ameliorating effects of honeybush extract on these 
metabolic aberrations. 
Inclusion of the honeybush extract in an otherwise diabetogenic diet for OBIR rats resulted 
in normalisation of the pre-existing hyperglycaemia over a wide range of dosages. This 
confirms that the extract has glucose lowering potential without causing hypoglycaemia. 
The latter is a potentially undesirable side effect of some T2D agents, specifically the 
sulfonylureas and meglitinides (Bennett et al., 2011). In addition, the normoglycaemic effect 
of the honeybush extract was achieved without dietary intervention. The extract proved to 
be as effective as metformin and rosiglitazone, which are regarded as the gold standards for 
treating human T2D. The efficacy of the extract at all doses and the lack of a clear dose 
response could be contributed to the length of the treatment (12 wks) and relative high 
doses even at the lowest dosage level. The reduction in IVGTT peak values and the area 
under the curve values in OBIR rats treated with the honeybush extract clearly indicated 
improved glucose homeostasis. Further, the improvement in glucose control was not 
associated with significantly increased fasting insulin concentrations. This may suggest that 
the mechanism whereby the extract elicits its effect on glucose metabolism is independent of 
insulin, reflecting adaptive mechanisms in the fasted state. This would imply that, due to the 
low fasting glucose concentrations, β-cells need to release less insulin to maintain glucose 
homeostasis.  
Plasma cholesterol levels of honeybush extract treated OBIR rats were significantly reduced 
when compared with the plasma cholesterol levels of the untreated control rats. Mangiferin 
and hesperidin have been shown to lower plasma cholesterol levels of diabetic rats 
(Akiyama et al., 2010; Dineshkumar et al., 2010; Muruganandan et al., 2005). Mangiferin, 
apart from lowering total cholesterol, also increases high-density lipoprotein-cholesterol 
levels and therefore decreases the atherogenic index in diabetic rats (Muruganandan et al., 
2005). The hypolipidaemic effect of hesperidin has been attributed to the inhibition of 
hepatic 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA:cholesterolacyl 
transferase, key enzymes in cholesterol synthesis and cholesterol esterification, resulting in 
the reduction of plasma cholesterol (Bok et al., 1999; Jung et al., 2006). Finally, a potential 
role of some minor compounds such as the inositol, (+)-pinitol, shown to be present in C. 
intermedia plant material (Ferreira et al., 1998), in the glucose- and cholesterol-lowering 
effects (Bates et al., 2000; Choi et al., 2009) elicited by the honeybush extract cannot be 
excluded. 
World-wide over 18 million people have died of cardiovascular disease in 2005. WHO has 
identified high total cholesterol as a major contributing risk factor which is modifiable and 
thereby could potentially reduce the incidence of cardiovascular disease (Rodgers et al., 
2004; Roth et al., 2011). Polyphenols have anti-atherosclerotic properties and are protective 
against cardiovascular disease. Apart from their plasma cholesterol lowering effects, 
polyphenols are associated with improved endothelial function and oxidative status 
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(Badimon et al., 2010). The protective effects of dietary flavonol intake against coronary 
heart disease mortality in humans was highlighted in a meta-analysis (Huxley & Neil, 2003), 
indicating a 20% lower risk in individuals with the highest consumption of dietary 
flavonols. In another study, Peters et al. (2001) suggested drinking three cups of tea (Camellia 
sinensis) a day could reduce the risk of myocardial infarction by 11%. In human trials 
coronary artery disease patients have shown improved endothelial function and coronary 
microcirculation following polyphenolic treatment (Hozumi et al., 2006). 
The main morphometrical finding following honeybush treatment for 12 wks was a 
decrease in the α-cell area, and subsequently by inference, total pancreas α-cell volume. The 
role of glucagon in the pathogenesis of T2D has been largely neglected by researchers. In 
mice, persistent hyperglucagonaemia induced by glucagon-producing glucagonomas results 
in T2D (Y. Li et al., 2008). Glucagon secretion by the α-cell is tightly regulated by insulin via 
insulin receptors at the surface of α-cells. This ensures that normoglycaemia is maintained. 
However, as insulin resistance increases, as is the case with the OBIR rat model, 
dysregulation of glucagon secretion by insulin occurs, resulting in persistent 
hyperglucagonaemia. Morphologically, this results in increased α-cell numbers, α-cell 
volume and glucagon secretion that worsen the insulin resistance of the liver causing more 
hyperglycaemia and T2D (Liu et al., 2011). Honeybush extract treatment reduced the 
average α-cell size and subsequently the total α-cell area leading to an improved α- to β-cell 
ratio in OBIR rats. The reduction of α-cell size and therefore glucagon secretion can have 
profound effects on glucagon induced insulin secretion and thereby alleviate the increased 
stress of hypersecretion on the β-cells (Liu et al., 2011). Similar to our findings, treatment of 
a high fat diet/STZ T2D mouse model with sitagliptin, a dipeptidyl peptidase-4 inhibitor 
and a new generation of antidiabetic drug, reversed the increased proportion and 
distribution of pancreatic α-cells and thereby restored the α- to β-cell ratio following chronic 
11 week treatment. As with our study the reduction of the α- to β-cell ratio reflected the 
overall improvement of the glucose and lipid metabolism (Mu et al., 2006). The fact that 
metformin and rosiglitazone had a similar beneficial effect on the pancreatic α- to β-cell ratio 
as the honeybush extract is not surprising. Both metformin and rosiglitazone are established 
oral drugs for the treatment of T2D. Metformin, an activator of AMP-activated protein 
kinase (AMPK), not only ameliorates hyperglycaemia but has been shown to have 
additional beneficial effects on lipid metabolism. Activation of AMPK by metformin 
increases fatty acid oxidation by inactivation of acetyl-CoA carboxylase and suppression of 
lipogenesis by inhibiting SREBP-1 expression (Zhou et al., 2001). Rosiglitazone, a 
peroxisome proliferator activated receptors-γ agonist, has been shown to improve insulin 
resistance and to have a positive effect on lipid metabolism in pre-diabetic animals by 
inhibiting malonyl-CoA and thereby increasing fatty acid oxidation in skeletal muscle and 
liver (Zhao et al., 2009). In addition, rosiglitazone has also been demonstrated to activate 
AMPK but via a different pathway from metformin (Fryer et al., 2002). Taken together, the 
positive morphological changes observed support the improved metabolic changes induced 
by chronic ingestion of aqueous honeybush extract. 
5. Conclusion 
The efficacy of an aqueous hot water honeybush extract in reducing hyperglycaemia was 
demonstrated in two different diabetic rodent models (STZ-induced T1D and diet-induced 
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T2D OBIR rat models). Furthermore, the extract promoted normoglycaemia in the diet-
induced T2D OBIR rat model and improved other metabolic aberrations associated with 
T2D. The high concentration of mangiferin and hesperidin in the extract could be partially 
responsible for the observed effects. 
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1. Introduction 
Glycaemia is a homeostatic parameter that is very efficiently controlled thanks to the 
equilibrium that exists between the mechanisms involved in supply and removal of blood 
glucose (Fig. 1). 
 
 
Fig. 1. Control of glycaemia. Plasma glucose concentration is closely controlled thanks to 
equilibrium between the mechanisms that supply glucose to the blood and remove it. 
The intestinal absorption is one of the mechanisms that supplies glucose to the blood and 
occurs in two steps (Fig. 2): the first is mediated by the Na+-glucose transporter (SGLT1) 
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located at the apical membrane of the enterocyte and it translates 2 Na+ ions in favour of its 
concentration gradient per molecule of glucose moved in favour or against its concentration 
gradient into the cell, depending on the amount of the carbohydrate ingested and the time 
of digestion. The second step is carried out by the glucose transporter 2 (GLUT2) situated at 
the basolateral membrane of the enterocyte and this is able to transport glucose by a 
facilitated diffusion in or out of the cell (Nelson & Cox, 2005). 
During a short fasting period, hepatic glycogen is degraded (glycogenolysis) in order to 
supply glucose to the blood. If the fasting period is prolonged a new synthesis of glucose 
occurs (gluconeogenesis) especially in liver and kidney. The final product of both processes 
is glucose-6-phosphate which is hydrolyzed to glucose and phosphate by the enzyme 
glucose-6-phosphatase (EC 3.1.3.9), allowing the glucose to exit the cell and enter the blood. 
In consequence this enzyme plays an important role in controlling the glycaemia (Ashmor 
and Weber 1959). The glucose-6-phosphatase is located in the endoplasmic reticulum (80-90 
%) and nuclear envelope (10-20 %) mainly in the liver, kidney, enterocyte and β cells of 
pancreatic islets. Based on kinetic, genetic and molecular studies, Arion et al., (1975) and 
Burchell & Waddell (1991) postulated that the glucose-6-phosphatase is constituted by (Fig. 
3): A transmembrane protein, the catalytic subunit, whose active centre faces the cistern of 
the endoplasmic reticulum and shows a low specificity, being able to hydrolyze several 
phosphoric esters and pyrophosphate. 
 
 
Fig. 2. Glucose intestinal absorption. It is a process that occurs in two steps, the first is 
mediated by SGLT1, which transports one molecule of glucose and 2 Na+ and is located at 
the apical membrane of the enterocyte. The second is carried out by the GLUT2 which 
transports glucose in favour of it gradient and is placed at the basolateral membrane of the 
cell. The participation of the Na+-K+ ATPase located on the basolateral membrane is also 
required to maintain the ionic gradients. 
T1 is a highly specific transporter for glucose-6-phosphate, the substrate of the enzyme. The T2 
is able to transport phosphate, pyrophosphate and carbamoylphosphate, and it has been 
suggested that comprises by 2 subunits. The glucose produced by the enzyme is transported 
by T3 also called GLUT 7. Finally it is thought there exists a stabilizing protein for the catalytic 
subunit. The glucose-6-phosphatase in addition to its hydrolytic activity, in conditions of high 
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glucose concentration and a phosphate donor such as pyrophosphate or carbamoylphosphate 
is able to synthesize glucose-6-phosphate (Foster &  Nordlie, 2002). 
 
 
1. Glucose-6-phosphate + H2O ---------------------------- glucose + phosphate 
2. Mannose-6-phosphate + H2O ------------------------ mannose + phosphate 
3. Pyrophosphate + H2O ----------------------------------------------- 2 phosphates 
4. Glucose + pyrophosphate --------------- glucose6-phosphate + phosphate 
5. Glucose + carbamoylphosphate ----- glucose-6-phosphate + NH3 + CO2 
Fig. 3. Glucose-6-phosphatase model. Arion et al., (1975) and Burchell & Waddell (1991) 
postulated the model of the catalytic subunit and transporters for the microsomal glucose-6-
phosphatase. G-6-Pase: catalytic subunit; S.P: stabilizing protein; PPi: pyrophosphate; Pi: 
phosphate and E.R: endoplasmic reticulum. The glucose-6-phosphatase catalytic subunit is 
able to catalyze reactions 1-5. 
The glucose transporters, GLUTs, (Joost & Thorens, 2001) mediate the facilitated transport of 
the glucose in and out of the different cells; of particular interest is the participation of the 
GLUT 4 which is located in skeletal  and hart muscle and adipose tissue. The GLUT 4 is held 
in intracellular vesicles and by insulin action is translated to the plasma membrane and in 
consequence entry of glucose into those tissues increases thus lowering the glycaemia. 
Drugs that inhibit the mechanism supplying glucose to the blood are considered 
antihyperglycaemic agents, on the other hand those that increase, directly or indirectly, the 
glucose entry to the tissues are considered hypoglycaemic agents. McCormack et al., (2001) 
suggest that the enzyme glucose-6-phosphatase could be a potential target for 
antihyperglycaemic agents. 
The microsomal fraction, which is enriched in endoplasmic reticulum, obtained by 
differential centrifugation is composed of intact and disrupted vesicles; the proportions of 
each can be measured assaying the glucose-6-phosphatase using mannose-6-phosphate as 
substrate, a molecule that is not translated by the T1 transporter (Arion et al., 1976) in 
consequence all the mannose-6-phosphate hydrolyzed, by the microsomal fraction, is due to 
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prepared without further treatment is called non-treated; the microsomes can be disrupted 
by the use of detergents, nitrogen cavitation, sonic disruption and more recently by the use 
of histones (Benedetti et al., 2002). The term intact microsome is theoretical, and is estimated 
by subtracting from the enzyme activity of the non-treated microsomes that of the enzyme 
exhibited by the disrupted vesicles present in such preparations. Latency is a common 
characteristic of membranes bound enzymes, corresponding to the activity expressed only 
when the membrane are disrupted and is not present in the non-treated system. Generally it 
is calculated as the percentage of increase in activity due to the disruption of the vesicles. 
Since time immemorial humans have been using plants for the empirical treatment of different 
illnesses, and in particular diabetes. In Venezuela, like many other tropical countries, the 
leaves of the Bauhinia species have been used by folk medicine in the empirical treatment of 
diabetes. The plants, belonging to the Fabaeceae family (Hoyos 1978) are trees that can reach 10 
m in height, with large well-developed evergreen leaves divided from the apex to 1/3 of its 
length and are hermaphrodite. The specie Bauhinia megalandra is characterized by having white 
flowers either single or in raceme with long and thin petals; the fruit is brown located in a 
compact pod. It is fast growing, long-lived and with deep roots (Figure 4).  
The Bauhinia megalandra used on this work was always collected during the rainy season in the 
campus of the Universidad Central de Venezuela at Caracas and identified by Dr. Stefen Tillett 
of the Ovalles Herbarium of the Pharmacy Faculty of the Universidad Central de Venezuela.  
2. Effects of Bauhinia megalandra leaf aqueous extract on gluconeogenesis 
and glucose-6-phosphatase 
Due to good results reported for metabolic studies using precision-cut liver slices (McKee et 
al., 1988; Dogterom, 1993), we studied the gluconeogenesis capacity of 200 μm thick liver 
slices prepared from 48 h fasted rats using a Krundieck Tissue Slicer (Alabama Research and 
Development, Alabama, USA), and incubated as described elsewhere (Krebs et al., 1963), in 
Krebs-Ringer bicarbonate buffer supplemented with bovine serum albumin saturated with 
oleic acid and using lactate or fructose as gluconeogenic substrate (Gonzalez-Mujica et al., 
1998) in the absence (control) or presence an aqueous extract of Bauhinia megalandra leaves. 
As shown in Table 1, the gluconeogenic activity of the control liver slices was almost linear 
during 90 minutes and of the same magnitude with both substrates.  
In the presence of the plant extract there was a drastic decrease in the gluconeogenic 
capacity of the liver slices, this being of higher magnitude when lactate was the 
gluconeogenic substrate in comparison with fructose, these results suggest that in the 
Bauhinia megalandra leaf extract compounds are present that inhibit the gluconeogenesis at a 
point further on than the entrance of both substrates. 
The microsomal fraction used as source of the enzyme glucose-6-phosphatase was prepared 
as described elsewhere (Marcuci et al., 1983), briefly: livers from overnight fasted rat were 
homogenized in 3 volumes of 0.32 M sucrose, 3 mM MgCl2, centrifuged at 20000 g for 20 
min at 4º C, the supernatant was centrifuged at 105000 g for 1h at 4º C, the pellet constituting 
the microsomal fractions and was resuspended in 0.25 M sucrose 1 mM MgCl2 5 mM HEPES 
pH 6.5 at a final protein concentration of 20 mg/mL and kept at -80º C until use. The entire 
microsomal fraction used in this work was at least constituted by 95 % intact vesicles. 
 




Fig. 4. Bauhinia megalandra, flower and leaves. 
 
Incubation  Control Bauhinia megalandra 
Time (min) Lactate or Fructose Lactate Fructose 
30 31.1 ± 9.3 15.9 ± 7.3 18.1 ± 3.8  
60 54.5 ± 17.2 11.6 ± 6.5 38.0 ± 6.0 
90 90.2 ± 18.5 16.9 ± 8.8 34.0 ± 9.0 
Table 1. Effects of Bauhinia megalandra leaf aqueous extract on hepatic gluconeogenesis. Liver 
slices from 48 hours fasted rats were incubated in Krebs-Ringer bicarbonate, supplemented 
with oleic acid saturated bovine serum albumin and in the presence of lactate or fructose as 
gluconegenic substrate in the absence (control) or in the presence of 1 mg/mL of the 
Bauhinia megalandra leaf extract. At the indicated times, samples of the medium were 
withdrawn in order to measure glucose by the glucose oxidase-peroxidase method (Trinder 
1969). The results are expressed in nmol of glucose produced/mg of liver dry weight and 
correspond to the means of 8-13 experiments ± standard deviation. The differences between 
control and plant extract treated were statistically significant at p<0.05 for fructose and 
p<0.005 for lactate. 
The activity of the enzyme glucose-6-phosphatase was carried out following the method 
described by Burchell et al., (1988) using glucose-6-phosphate or pyrophosphate as substrate in 
intact and disrupted (histone treated) hepatic microsmes. In brief, in a volume of 0.1 mL, 1-30 
mM glucose-6-phosphate, 2 mM EDTA, 16 mM HEPES, pH: 6.5 and approximately 20 μg of 
microsomal proteins were present. In order to disrupt microsomes, 80 μg of histones were 
present in the incubation medium. The reaction was carried out at 30º C for 10 min without 
shaking and stopped by the addition of 0.9 mL of 0.28 % ammonium molybdate, 1.11 % SDS 
and 1.11 % ascorbic acid in 0.33 M sulphuric acid. The colour was developed at 47º C for 20 
min and the absorbance was read at 820 nm. The assay was similar when pyrophosphate was 
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the substrate of the enzyme with the following differences: 0.5-5 mM pyrophosphate, 16 mM 
cacodilate, pH: 6.5, and the colour was developed at 30º C during 10 mim.  
 
 Glucose-6-phosphate as substrate 
 Intact Disrupted 
 VMAX KM VMAX KM 
Control 7.4 ± 0.9* 5.4 ± 1.1 9.8 ± 0.8 0.6 ± 0.1 
10 μg/mL 6.2 ± 1.4 5.6 ± 0.7 9.8 ± 0.7 0.7 ± 0.2 
20 μg/mL 5.1 ± 1.0* 7.5 ± 0.6 9.5 ± 0.3 0.7 ± 0.1 
 
 Pyrophosphate as substrate 
 Intact Disrupted 
 VMAX KM VMAX KM 
Control 6.6 ± 1.4 1.3 ± 0.5 7.0 ± 0.9 0.4 ± 0.1 
10 μg/mL 5.7 ± 1.6 1.0 ± 0.6 7.4 ± 0.8 0.4 ± 0.2 
20 μg/mL 6.0 ± 1.5 1.2 ± 0.4 6.6 ± 1.3 0.3 ± 0.3 
Table 2. Kinetic parameters of hepatic microsomal glucose-6-phosphatase in the absence or 
presence of the aqueous extract of Bauhinia megalandra leaves. The activity of the hepatic 
microsomal glucose-6-phosphatase was assayed using glucose-6-phosphate or 
pyrophosphate as substrate in the absence (control) or in the presence of the indicated 
concentration of the aqueous extract of Bauhinia megalandra leaves. The kinetic parameters 
were calculated from the Michaelis and Menten graphs using the Enzfitter program 
(Leatherbarrow 1987) and the VMAX for glucose-6-phosphatase activity is expressed in μmol 
of phosphate liberated/h x mg of microsomal proteins and the VMAX for the 
pyrophosphatase activity is expressed in μmol of pyrophosphate hydrolyzed/h x mg of 
microsomal proteins; for both the KM is expressed in mM. The experiments were performed 
using the liver of 3-5 fasted (24 h) rats, and each point represents the mean of 3-4 
experiments ± standard deviation. * Means differences statistically significant at p< 0.05. 
As shown in Table 2, when glucose-6-phosphate was the substrate of the glucose-6-
phosphatase of intact microsomes, the plant extract decreased in a statistically significant 
way the VMAX with a moderate increase of the KM without affecting the enzyme of disrupted 
microsomes.  
The plant extract was without effect on the glucose-6-phosphatase activity in intact or 
disrupted microsomes when pyrophosphate was the substrate (Table 2). These results 
suggest that the compounds present in the Bauhinia megalandra aqueous extract inhibit one 
of the transporters of the glucose-6-phosphatase system, probably T1 (Gonzalez-Mujica et 
al., 1998). The inhibition of the hepatic gluconeogenesis could be a consequence of the 
inhibition of the glucose-6-phosphate transporter (T1). 
The glucose-6-phosphatase activity of non-treated microsomes, when assayed with 15 mM 
glucose-6-phosphate as substrate, was linear during 30 min. (Figure 5); in the other hand, in 
the presence of 20 μg/mL of the plant extract the enzyme activity was linear just up to 20 
min, but all the values were lower than the control, after that an inflexion occurred and the 
slope of the line declined (Figure 5), suggesting that some compound(s) present in the 
Bauhinia megalandra leaf extract inhibit other transporter of the glucose-6-phosphatase 
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system, different than T1, and in consequence the enzyme products accumulated in the 
microsomal cistern leading to inhibition of the catalytic subunit. Due to the fact that the 
plant extract does not affect the kinetic parameters of the glucose-6-phosphatsase using 
pyrophosphate as substrate, there is no effect on the pyrophosphate transporter (T2), it is 
possible to suggest that the inhibition occurs at the glucose transporter (T3). 
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Fig. 5. Effects of Bauhinia megalandra leaf extract on the time course of hepatic microsomal 
glucose-6-phosphatase. The activity of the glucose-6-phosphatase was measured in the 
absence (■) or in the presence (●) of 20 μg/mL of Bauhinia megalandra leaf extract at 15 mM 
glucose-6-phosphate; each point represents the mean of 5 experiments and the vertical bars 
correspond to standard deviation. The enzyme activity is expressed in μmol of phosphate 
(Pi) released /hour x mg of protein. All the differences observed between control and extract 
treated microsomes were statistically significant at p < 0.05 except that seen at 20 min. 
3. Isolation and identification of flavonoids from Bauhinia megalandra leaves. 
Characterization of their effects on hepatic microsomal glucose-6-
phosphatase and gluconeogenesis 
We fractionated the methanol extract of fresh Bauhinia megalandra leaves using different 
solvents (methanol : water 1:1; ethyl acetate : acetone 8:2) and column chromatography on 
sephadex LH-20 and RP-18 (Estrada et al., 2005) to obtain the following flavonoids: astilbin 
(1) , quercetin 3-O-α-rhamnoside (2), kaempferol 3-O-α-rhamnoside (3), quercetin 3-O-α-
arabinoside (4), quercetin 3-O-α-(2”-galloyl)rhamnoside (5), kaempferol 3-O-α-(2”-
galloyl)rhamnoside (6), quercetin (7) and kaempferol (8). The identification of the above 
mentioned flavonoids was established by comparing their 1H and 13C 
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the substrate of the enzyme with the following differences: 0.5-5 mM pyrophosphate, 16 mM 
cacodilate, pH: 6.5, and the colour was developed at 30º C during 10 mim.  
 
 Glucose-6-phosphate as substrate 
 Intact Disrupted 
 VMAX KM VMAX KM 
Control 7.4 ± 0.9* 5.4 ± 1.1 9.8 ± 0.8 0.6 ± 0.1 
10 μg/mL 6.2 ± 1.4 5.6 ± 0.7 9.8 ± 0.7 0.7 ± 0.2 
20 μg/mL 5.1 ± 1.0* 7.5 ± 0.6 9.5 ± 0.3 0.7 ± 0.1 
 
 Pyrophosphate as substrate 
 Intact Disrupted 
 VMAX KM VMAX KM 
Control 6.6 ± 1.4 1.3 ± 0.5 7.0 ± 0.9 0.4 ± 0.1 
10 μg/mL 5.7 ± 1.6 1.0 ± 0.6 7.4 ± 0.8 0.4 ± 0.2 
20 μg/mL 6.0 ± 1.5 1.2 ± 0.4 6.6 ± 1.3 0.3 ± 0.3 
Table 2. Kinetic parameters of hepatic microsomal glucose-6-phosphatase in the absence or 
presence of the aqueous extract of Bauhinia megalandra leaves. The activity of the hepatic 
microsomal glucose-6-phosphatase was assayed using glucose-6-phosphate or 
pyrophosphate as substrate in the absence (control) or in the presence of the indicated 
concentration of the aqueous extract of Bauhinia megalandra leaves. The kinetic parameters 
were calculated from the Michaelis and Menten graphs using the Enzfitter program 
(Leatherbarrow 1987) and the VMAX for glucose-6-phosphatase activity is expressed in μmol 
of phosphate liberated/h x mg of microsomal proteins and the VMAX for the 
pyrophosphatase activity is expressed in μmol of pyrophosphate hydrolyzed/h x mg of 
microsomal proteins; for both the KM is expressed in mM. The experiments were performed 
using the liver of 3-5 fasted (24 h) rats, and each point represents the mean of 3-4 
experiments ± standard deviation. * Means differences statistically significant at p< 0.05. 
As shown in Table 2, when glucose-6-phosphate was the substrate of the glucose-6-
phosphatase of intact microsomes, the plant extract decreased in a statistically significant 
way the VMAX with a moderate increase of the KM without affecting the enzyme of disrupted 
microsomes.  
The plant extract was without effect on the glucose-6-phosphatase activity in intact or 
disrupted microsomes when pyrophosphate was the substrate (Table 2). These results 
suggest that the compounds present in the Bauhinia megalandra aqueous extract inhibit one 
of the transporters of the glucose-6-phosphatase system, probably T1 (Gonzalez-Mujica et 
al., 1998). The inhibition of the hepatic gluconeogenesis could be a consequence of the 
inhibition of the glucose-6-phosphate transporter (T1). 
The glucose-6-phosphatase activity of non-treated microsomes, when assayed with 15 mM 
glucose-6-phosphate as substrate, was linear during 30 min. (Figure 5); in the other hand, in 
the presence of 20 μg/mL of the plant extract the enzyme activity was linear just up to 20 
min, but all the values were lower than the control, after that an inflexion occurred and the 
slope of the line declined (Figure 5), suggesting that some compound(s) present in the 
Bauhinia megalandra leaf extract inhibit other transporter of the glucose-6-phosphatase 
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system, different than T1, and in consequence the enzyme products accumulated in the 
microsomal cistern leading to inhibition of the catalytic subunit. Due to the fact that the 
plant extract does not affect the kinetic parameters of the glucose-6-phosphatsase using 
pyrophosphate as substrate, there is no effect on the pyrophosphate transporter (T2), it is 
possible to suggest that the inhibition occurs at the glucose transporter (T3). 
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Fig. 5. Effects of Bauhinia megalandra leaf extract on the time course of hepatic microsomal 
glucose-6-phosphatase. The activity of the glucose-6-phosphatase was measured in the 
absence (■) or in the presence (●) of 20 μg/mL of Bauhinia megalandra leaf extract at 15 mM 
glucose-6-phosphate; each point represents the mean of 5 experiments and the vertical bars 
correspond to standard deviation. The enzyme activity is expressed in μmol of phosphate 
(Pi) released /hour x mg of protein. All the differences observed between control and extract 
treated microsomes were statistically significant at p < 0.05 except that seen at 20 min. 
3. Isolation and identification of flavonoids from Bauhinia megalandra leaves. 
Characterization of their effects on hepatic microsomal glucose-6-
phosphatase and gluconeogenesis 
We fractionated the methanol extract of fresh Bauhinia megalandra leaves using different 
solvents (methanol : water 1:1; ethyl acetate : acetone 8:2) and column chromatography on 
sephadex LH-20 and RP-18 (Estrada et al., 2005) to obtain the following flavonoids: astilbin 
(1) , quercetin 3-O-α-rhamnoside (2), kaempferol 3-O-α-rhamnoside (3), quercetin 3-O-α-
arabinoside (4), quercetin 3-O-α-(2”-galloyl)rhamnoside (5), kaempferol 3-O-α-(2”-
galloyl)rhamnoside (6), quercetin (7) and kaempferol (8). The identification of the above 
mentioned flavonoids was established by comparing their 1H and 13C 
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NMR chemical shifts and proton coupling constants in DMSO-d6 with those reported 
(Agrawal, 1989; Markham and Geiger, 1994; De Brito et al., 1995; Méndez et al., 1995; Bilia et 
al., 1996) and the structure of compounds 5 and 6 is shown in Figure 6. To the best of our 
knowledge, this was the first report of the isolation of kaempferol 3-O-α-(2”-
galloyl)rhamnoside from nature.  
The effect of the isolated flavonoids on the activity of the hepatic glucose-6-phosphatase was 
carried out using intact and disrupted microsomes with glucose-6-phosphate as substrate as 
indicated above. 
The inhibition of the enzyme by the flavonoids isolated from Bauhinia megalandra leaves in 
intact microsomes, but not in disrupted ones (Table 3), is a clear indication that they interact 
with the glucose-6-phosphate transporter (T1) of the glucose-6-phosphatase system with no 
effect on the catalytic subunit. It is interesting to point out that the flavonoids tested behave 
in a similar way to phlorizin (Table 3) only inhibiting the T1 transporter (Arion et al., 1980). 
 
 
Fig. 6. Structure of quercetin 3-O-α-(2”-galloyl)rhamnoside (5) and kaempferol 3-O-α-(2”-
galloyl)rhamnoside (6) 
As can be seen in Table 3, the aglycones, quercetin (7) and kaempferol (8), showed the 
lowest inhibitory effect on the enzyme and the percentage inhibition increased with the 
addition of the polar group rhamnose or arabinose as in the case of compounds 1, 2, 3 and 4, 
which exhibited moderate effects. The flavanonol glycoside evaluated (1) showed a similar 
behavior to compounds 2 and 3, but to a smaller extent; this could be attributed to the 
saturation of the double bond in the C-ring of the flavonoid nucleus. The strongest 
inhibitory effect was observed when the galloyl moiety was present (5 and 6). This 
observation suggests the possibility of a particular interaction between this polyphenolic 
residue and the glucose-6-phosphate transporter (T1), because the complex formation 
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between proteins and tannins in which gallic acid is usually one of the main components, is 
well known (Haslam et al., 1989). 
 
 Intact microsomes Disrupted microsomes 
Compound Activity %  IC50 Activity %  
Control 2.77 ± 0.28   5.66 ± 0.45  
Astilbin (1) 2.23 ± 0.42a -19.5 9.59 ± 27 5.80 ± 0.43 +2.5 
Quercetin 3-O-α-rhamnoside (2) 1.95 ± 0.36b -29.6 246 ± 5 5.42 ± 0.53 -4.2 
Kaempferol 3-O-α-rhamnoside (3) 2.04 ± 0.25b -26.4 186± 4  5.84 ± 0.46 +3.2 
Quercetin 3-O-α-arabinoside (4) 2.04 ± 0.23b -26.4 1069 ± 31 5.77 ± 0.18 +3.0 
Quercetin 3-O-α-(2”-
galloyl)rhamnoside (5) 
1.02 ± 0.22c -63.2 27 ± 1 6.43 ± 0.52a +13.6 
Kaempferol 3-O-α-(2”-
galloyl)rhamnoside (6) 
0.93 ± 0.27c -66.4 31 ± 2 6.61 ± 0.41b +16.8 
Quercetin (7) 2.43 ± 0.05c -12.3 1330 ± 39 5.81 ± 0.52 +2.7 
Kaempferol (8) 2.71 ± 0.49 -2.2 555 ± 6 5.98 ± 0.16 +5.7 
Phorizin 2.00 ± 0.11b -27.8 4.66 ± 19 5.71 ± 0.40 +0.9 
Table 3. Effects of flavonoids isolated from Bauhinia megalandra on glucose-6-phosphatase. 
The glucose-6-phosphatase was assayed using 5 mM glucose-6-phosphate as substrate in 
intact and disrupted microsomes in the absence (control) or presence of 50 μM of each of the 
flavonoids isolated from Bauhinia megalandra leaves or 50 μM phlorizin. The enzyme activity 
is expressed as μmol of phosphate released /h x mg of microsomal protein and each value 
represents the means of 5-9 experiments ± standard deviation. The percentage inhibition (-) 
or activation (+) was also calculated. 
The IC50 was carried out following Arion et al., (1998) using intact microsomes with 1mM 
glucose-6-phosphate in the presence of increasing concentrations (including values below 
and above the IC50) of the isolated flavonoids; the result are the average of 3 experiments ± 
standard deviation, and expressed in μM.  
The increase in the glucose-6-phosphatase inhibition capacity with increase in the polarity of 
the flavonoids suggests a specific interaction with the glucose-6-phosphate transporter of 
the enzyme system because it cannot be related to a higher solubility in the endoplasmic 
reticulum membrane. Also, the interaction seems to be specific view of the fact that none of 
the flavonoids was able to inhibit the catalytic subunit of the glucose-6-phosphatase system 
(Table 3). The greater enzyme inhibition exerted by quercetin (7) in comparison to 
kaempferol (8)(Table 3) could be explained by the fact that the former has one additional 
vicinal hydroxyl group on the B-ring with respect to the latter. The difference in polarity 
between the aglycones is overcome by the presence of the carbohydrate and galloyl 
moieties, and in consequence, the inhibitory effect was also affected. 
The compounds 5 and 6 showed the lowest IC50 value and were very close to each other 
(Table 3). The lack of gallic acid in compounds 2 and 3 increased the IC50 value 9 and 6 times 
respectively, with respect to compounds 5 and 6. The aglycones, compounds 7 and 8, 
exhibited high IC50 values, which are 49 and 18 times higher than those obtained with 
compounds 5 and 6, respectively (Table 3). Compounds 1 and 4, although glycosylated, 
showed high IC50 values, comparable to that observed with the aglycone quercetin (7). To 
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NMR chemical shifts and proton coupling constants in DMSO-d6 with those reported 
(Agrawal, 1989; Markham and Geiger, 1994; De Brito et al., 1995; Méndez et al., 1995; Bilia et 
al., 1996) and the structure of compounds 5 and 6 is shown in Figure 6. To the best of our 
knowledge, this was the first report of the isolation of kaempferol 3-O-α-(2”-
galloyl)rhamnoside from nature.  
The effect of the isolated flavonoids on the activity of the hepatic glucose-6-phosphatase was 
carried out using intact and disrupted microsomes with glucose-6-phosphate as substrate as 
indicated above. 
The inhibition of the enzyme by the flavonoids isolated from Bauhinia megalandra leaves in 
intact microsomes, but not in disrupted ones (Table 3), is a clear indication that they interact 
with the glucose-6-phosphate transporter (T1) of the glucose-6-phosphatase system with no 
effect on the catalytic subunit. It is interesting to point out that the flavonoids tested behave 
in a similar way to phlorizin (Table 3) only inhibiting the T1 transporter (Arion et al., 1980). 
 
 
Fig. 6. Structure of quercetin 3-O-α-(2”-galloyl)rhamnoside (5) and kaempferol 3-O-α-(2”-
galloyl)rhamnoside (6) 
As can be seen in Table 3, the aglycones, quercetin (7) and kaempferol (8), showed the 
lowest inhibitory effect on the enzyme and the percentage inhibition increased with the 
addition of the polar group rhamnose or arabinose as in the case of compounds 1, 2, 3 and 4, 
which exhibited moderate effects. The flavanonol glycoside evaluated (1) showed a similar 
behavior to compounds 2 and 3, but to a smaller extent; this could be attributed to the 
saturation of the double bond in the C-ring of the flavonoid nucleus. The strongest 
inhibitory effect was observed when the galloyl moiety was present (5 and 6). This 
observation suggests the possibility of a particular interaction between this polyphenolic 
residue and the glucose-6-phosphate transporter (T1), because the complex formation 
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between proteins and tannins in which gallic acid is usually one of the main components, is 
well known (Haslam et al., 1989). 
 
 Intact microsomes Disrupted microsomes 
Compound Activity %  IC50 Activity %  
Control 2.77 ± 0.28   5.66 ± 0.45  
Astilbin (1) 2.23 ± 0.42a -19.5 9.59 ± 27 5.80 ± 0.43 +2.5 
Quercetin 3-O-α-rhamnoside (2) 1.95 ± 0.36b -29.6 246 ± 5 5.42 ± 0.53 -4.2 
Kaempferol 3-O-α-rhamnoside (3) 2.04 ± 0.25b -26.4 186± 4  5.84 ± 0.46 +3.2 
Quercetin 3-O-α-arabinoside (4) 2.04 ± 0.23b -26.4 1069 ± 31 5.77 ± 0.18 +3.0 
Quercetin 3-O-α-(2”-
galloyl)rhamnoside (5) 
1.02 ± 0.22c -63.2 27 ± 1 6.43 ± 0.52a +13.6 
Kaempferol 3-O-α-(2”-
galloyl)rhamnoside (6) 
0.93 ± 0.27c -66.4 31 ± 2 6.61 ± 0.41b +16.8 
Quercetin (7) 2.43 ± 0.05c -12.3 1330 ± 39 5.81 ± 0.52 +2.7 
Kaempferol (8) 2.71 ± 0.49 -2.2 555 ± 6 5.98 ± 0.16 +5.7 
Phorizin 2.00 ± 0.11b -27.8 4.66 ± 19 5.71 ± 0.40 +0.9 
Table 3. Effects of flavonoids isolated from Bauhinia megalandra on glucose-6-phosphatase. 
The glucose-6-phosphatase was assayed using 5 mM glucose-6-phosphate as substrate in 
intact and disrupted microsomes in the absence (control) or presence of 50 μM of each of the 
flavonoids isolated from Bauhinia megalandra leaves or 50 μM phlorizin. The enzyme activity 
is expressed as μmol of phosphate released /h x mg of microsomal protein and each value 
represents the means of 5-9 experiments ± standard deviation. The percentage inhibition (-) 
or activation (+) was also calculated. 
The IC50 was carried out following Arion et al., (1998) using intact microsomes with 1mM 
glucose-6-phosphate in the presence of increasing concentrations (including values below 
and above the IC50) of the isolated flavonoids; the result are the average of 3 experiments ± 
standard deviation, and expressed in μM.  
The increase in the glucose-6-phosphatase inhibition capacity with increase in the polarity of 
the flavonoids suggests a specific interaction with the glucose-6-phosphate transporter of 
the enzyme system because it cannot be related to a higher solubility in the endoplasmic 
reticulum membrane. Also, the interaction seems to be specific view of the fact that none of 
the flavonoids was able to inhibit the catalytic subunit of the glucose-6-phosphatase system 
(Table 3). The greater enzyme inhibition exerted by quercetin (7) in comparison to 
kaempferol (8)(Table 3) could be explained by the fact that the former has one additional 
vicinal hydroxyl group on the B-ring with respect to the latter. The difference in polarity 
between the aglycones is overcome by the presence of the carbohydrate and galloyl 
moieties, and in consequence, the inhibitory effect was also affected. 
The compounds 5 and 6 showed the lowest IC50 value and were very close to each other 
(Table 3). The lack of gallic acid in compounds 2 and 3 increased the IC50 value 9 and 6 times 
respectively, with respect to compounds 5 and 6. The aglycones, compounds 7 and 8, 
exhibited high IC50 values, which are 49 and 18 times higher than those obtained with 
compounds 5 and 6, respectively (Table 3). Compounds 1 and 4, although glycosylated, 
showed high IC50 values, comparable to that observed with the aglycone quercetin (7). To 
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our knowledge, this has been the first report of the IC50 for phlorizin and glucose-6-
phosphatase.There is a good agreement between the percentages of glucose-6-phosphatase 
inhibition and the IC50 produced by the flavonoids tested. The sugar bound to the flavonoid 
seems to be important due to the fact that substitution of rhamnose by arabinose increases 
by more than 4 times the IC50 (Table3). The reduction of the double bond of ring C, in 
astilbin, also increases the IC50 by almost 4 times (Table 3). 
All the flavonoid isolated, but one (2) produce activation of the glucose-6-phosphatase 
catalytic subunit, however, only compounds 5 and 6 (Table 3) do so to an appreciable 
magnitude and this could be due to modifications in the microsomal membranes that expose 
the active center of the enzyme, as a consequence of the presence of the tannic flavonoids. 
Due to the fact, that quercetin 3-O-α-(2”-galloyl)rhamnoside (5) exerts high  inhibition of the 
T1 transporter of the glucose-6-phosphatase system and showed the lowest IC50 of all the 
flavonoids tested, we studied the effects of that compound on the kinetic parameters of the 
enzyme using glucose-6-phosphate or pyrophosphate as substrate. The enzyme assay was 
carried out as described above. The enzyme assays, with both substrates were carried out in 
the absence (control) or presence of 15 μM quercetin 3-O-α-(2”-galloyl)rhamnoside (5).  
 
Glucose-6-phosphate as substrate 
 Intact microsomes Disrupted microsomes 
 VMAX KM VMAX KM 
Control 7.59 ± 0.91 4.78 ± 1.10 11.57 ± 1.55 0.79 ± 0.27 
Quercetin 3-O-α-(2”-galloyl)rhamnoside (5) 7.36 ± 1.79 7.44 ± 0.42* 10.47 ± 1.45 0.57 ± 0.17 
Pyrophosphate as substrate 
 Intact microsomes Disrupted microsomes 
 VMAX KM VMAX KM 
Control 7.61 ± 2.45 2.28 ± 1.35 8.40 ± 1.73 0.40 ± 0.11 
Quercetin 3-O-α-(2”-galloyl)rhamnoside (5) 6.72 ± 1.33 1.87 ± 0.41 7.58 ± 0.73 0.24 ± 0.07 
Table 4. Effects of quercetin 3-O-α-(2”-galloyl)rhamnoside (5) on the kinetic parameters of 
the glucose-6-phosphatase. Microsomal glucose-6-phosphatase was assayed using glucose-
6-phosphate (1-30 mM) or pyrophosphate (0.5-5 mM) as substrate in the absence (control) or 
presence of 15 μM quercetin 3-O-α-(2”-galloyl)rhamnoside (5) as described in the text. The 
kinetic parameters were calculated from the Michaelis and Menten graph using the Enzfitter 
program. The VMAX is expressed as μmol of phosphate released /h/mg proteins when 
glucose-6-phosphatase was the substrate and in μmol of pyrophosphate hydrolysed /h/mg 
proteins and the KM in mM. Each value represents the means of 3-5 experiments ± standard 
deviation and in each experiment, the livers of 3-4 rats were used. * Means differences 
statistically significant at p< 0.005.  
Table 4 show the effects of quercetin 3-O-α-(2”-galloyl)rhamnoside (5) on the kinetic 
parameters of the microsomal glucose-6-phosphatase using glucose-6-phosphate or 
pyrophosphate as substrate. In controls using glucose-6-phosphate as substrate, when the 
microsomes were disrupted by the presence of histones, there was an increase in the VMAX 
with a latency of 34.4% and the KM was 1/6 of the value observed in the intact system; these 
results are in good agreement with those reported elsewhere (Blair and Burchell, 1988; 
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Gonzalez-Mujica et al., 1993, 1998). In intact microsomes the presence of quercetin 3-O-α-(2”-
galloyl)rhamnoside (5) increased the KM for glucose-6-phosphate by nearly 56%, a change 
that was statistically significant at p < 0.005. On the other hand, there were no changes in the 
VMAX of intact microsomes neither in the VMAX nor in the KM of the disrupted system. When 
pyrophosphate was the substrate, the activity showed a lower latency (9.4%) and a similar 
decrease of the KM (1/6) compared with that shown when glucose-6-phosphate was the 
substrate and the microsomes were disrupted, results that are similar to those reported by 
others (Blair and Burchell, 1988; Gonzalez-Mujica et al., 1993, 1998). The kinetic parameters 
of the enzyme using pyrophosphate as substrate in intact and disrupted microsomes were 
not altered by the inclusion of the flavonol. 
From the above results: increase of the KM for glucose-6-phosphate in intact microsomes 
without affecting the other kinetic parameter in intact or disrupted microsomes using 
glucose-6-phosphate or pyrophosphate as substrates, is a clear indication that quercetin 3-O-
α-(2”-galloyl)rhamnoside (5) behaves as a competitive inhibitor of the T1 transporter with 
out altering the catalytic subunit nor the other transporters of the glucose-6-phosphatase 
system. It is interesting to point out that a synthetic derivative of chlorogenic acid, a 
compound without any structural relationship with glucose-6-phosphate has been reported 
as a competitive inhibitor of T1 (Arion et al., 1998)  
Hepatic gluconeogenesis was studied using 48 h fasted rat liver slices of 200 μm thick 
incubated in Krebs-Ringer bicarbonate buffer, as described above, in the absence (control) or 
the presence of 30 μM quercetin 3-O-α-(2”-galloyl)rhamnoside (5). The incubations were 
carried out with 10 mM lactate as gluconeogenic substrate, at 37 °C, under an O2:CO2 (95:5) 
atmosphere, with continuous shaking in an orbital bath (60 cycles/min), for a total time of 
90 min. Samples for glucose determination were taken every 30 min. At the end, the slices 
were dehydrated with acetone and dried at 70 °C for 24 h and the dry weight of the slices 
was determined. Glucose determination was made by the glucose oxidase method (Trinder, 
1969) and the gluconeogenic activity was expressed as nmol of glucose produced/mg liver 
dry weight. 
The gluconeogenic capacity of the rat liver slices in the absence (control) and presence of 
quercetin 3-O-α-(2”-galloyl)rhamnoside (5) is shown in Fig. 7. The glucose production by the 
control liver slices was almost linear with time and similar to that reported earlier (Gonzalez-
Mujica et al., 1998). Quercetin 3-O-α-(2”-galloyl)rhamnoside (5) drastically reduced the 
gluconeogenic capacity of the liver slices at all the times studied: at 30 min the inhibition was 
approximately 85%; the inhibition was nearly 50% at 60 min. and 41% at 90 min. 
The inhibition of the T1, the glucose-6-phosphate transporter, of the hepatic microsomal 
glucose-6-phosphatase system by quercetin 3-O-α-(2”-galloyl)rhamnoside (5), might explain 
the inhibition of the gluconeogenic capacity of the rat liver slices in the presence of the 
flavonol and, in turn, could reduces the hepatic glucose production; this antihyperglycaemic 
effect serve to decrease the blood glucose level in diabetic patients. 
4. Effects of Bauhinia megalandra leaf aqueous extract on glycogenolysis 
An aqueous extract of Bauhinia megalandra leaves was administered by a gastric tube to rats 
anesthetized with sodium pentobarbital (30 mg/Kg body weight), 1 h later a blood sample 
was taken from the tail and 0.15 mg/Kg body weight of epinephrine (Cori and Cori 1928)  was  
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our knowledge, this has been the first report of the IC50 for phlorizin and glucose-6-
phosphatase.There is a good agreement between the percentages of glucose-6-phosphatase 
inhibition and the IC50 produced by the flavonoids tested. The sugar bound to the flavonoid 
seems to be important due to the fact that substitution of rhamnose by arabinose increases 
by more than 4 times the IC50 (Table3). The reduction of the double bond of ring C, in 
astilbin, also increases the IC50 by almost 4 times (Table 3). 
All the flavonoid isolated, but one (2) produce activation of the glucose-6-phosphatase 
catalytic subunit, however, only compounds 5 and 6 (Table 3) do so to an appreciable 
magnitude and this could be due to modifications in the microsomal membranes that expose 
the active center of the enzyme, as a consequence of the presence of the tannic flavonoids. 
Due to the fact, that quercetin 3-O-α-(2”-galloyl)rhamnoside (5) exerts high  inhibition of the 
T1 transporter of the glucose-6-phosphatase system and showed the lowest IC50 of all the 
flavonoids tested, we studied the effects of that compound on the kinetic parameters of the 
enzyme using glucose-6-phosphate or pyrophosphate as substrate. The enzyme assay was 
carried out as described above. The enzyme assays, with both substrates were carried out in 
the absence (control) or presence of 15 μM quercetin 3-O-α-(2”-galloyl)rhamnoside (5).  
 
Glucose-6-phosphate as substrate 
 Intact microsomes Disrupted microsomes 
 VMAX KM VMAX KM 
Control 7.59 ± 0.91 4.78 ± 1.10 11.57 ± 1.55 0.79 ± 0.27 
Quercetin 3-O-α-(2”-galloyl)rhamnoside (5) 7.36 ± 1.79 7.44 ± 0.42* 10.47 ± 1.45 0.57 ± 0.17 
Pyrophosphate as substrate 
 Intact microsomes Disrupted microsomes 
 VMAX KM VMAX KM 
Control 7.61 ± 2.45 2.28 ± 1.35 8.40 ± 1.73 0.40 ± 0.11 
Quercetin 3-O-α-(2”-galloyl)rhamnoside (5) 6.72 ± 1.33 1.87 ± 0.41 7.58 ± 0.73 0.24 ± 0.07 
Table 4. Effects of quercetin 3-O-α-(2”-galloyl)rhamnoside (5) on the kinetic parameters of 
the glucose-6-phosphatase. Microsomal glucose-6-phosphatase was assayed using glucose-
6-phosphate (1-30 mM) or pyrophosphate (0.5-5 mM) as substrate in the absence (control) or 
presence of 15 μM quercetin 3-O-α-(2”-galloyl)rhamnoside (5) as described in the text. The 
kinetic parameters were calculated from the Michaelis and Menten graph using the Enzfitter 
program. The VMAX is expressed as μmol of phosphate released /h/mg proteins when 
glucose-6-phosphatase was the substrate and in μmol of pyrophosphate hydrolysed /h/mg 
proteins and the KM in mM. Each value represents the means of 3-5 experiments ± standard 
deviation and in each experiment, the livers of 3-4 rats were used. * Means differences 
statistically significant at p< 0.005.  
Table 4 show the effects of quercetin 3-O-α-(2”-galloyl)rhamnoside (5) on the kinetic 
parameters of the microsomal glucose-6-phosphatase using glucose-6-phosphate or 
pyrophosphate as substrate. In controls using glucose-6-phosphate as substrate, when the 
microsomes were disrupted by the presence of histones, there was an increase in the VMAX 
with a latency of 34.4% and the KM was 1/6 of the value observed in the intact system; these 
results are in good agreement with those reported elsewhere (Blair and Burchell, 1988; 
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Gonzalez-Mujica et al., 1993, 1998). In intact microsomes the presence of quercetin 3-O-α-(2”-
galloyl)rhamnoside (5) increased the KM for glucose-6-phosphate by nearly 56%, a change 
that was statistically significant at p < 0.005. On the other hand, there were no changes in the 
VMAX of intact microsomes neither in the VMAX nor in the KM of the disrupted system. When 
pyrophosphate was the substrate, the activity showed a lower latency (9.4%) and a similar 
decrease of the KM (1/6) compared with that shown when glucose-6-phosphate was the 
substrate and the microsomes were disrupted, results that are similar to those reported by 
others (Blair and Burchell, 1988; Gonzalez-Mujica et al., 1993, 1998). The kinetic parameters 
of the enzyme using pyrophosphate as substrate in intact and disrupted microsomes were 
not altered by the inclusion of the flavonol. 
From the above results: increase of the KM for glucose-6-phosphate in intact microsomes 
without affecting the other kinetic parameter in intact or disrupted microsomes using 
glucose-6-phosphate or pyrophosphate as substrates, is a clear indication that quercetin 3-O-
α-(2”-galloyl)rhamnoside (5) behaves as a competitive inhibitor of the T1 transporter with 
out altering the catalytic subunit nor the other transporters of the glucose-6-phosphatase 
system. It is interesting to point out that a synthetic derivative of chlorogenic acid, a 
compound without any structural relationship with glucose-6-phosphate has been reported 
as a competitive inhibitor of T1 (Arion et al., 1998)  
Hepatic gluconeogenesis was studied using 48 h fasted rat liver slices of 200 μm thick 
incubated in Krebs-Ringer bicarbonate buffer, as described above, in the absence (control) or 
the presence of 30 μM quercetin 3-O-α-(2”-galloyl)rhamnoside (5). The incubations were 
carried out with 10 mM lactate as gluconeogenic substrate, at 37 °C, under an O2:CO2 (95:5) 
atmosphere, with continuous shaking in an orbital bath (60 cycles/min), for a total time of 
90 min. Samples for glucose determination were taken every 30 min. At the end, the slices 
were dehydrated with acetone and dried at 70 °C for 24 h and the dry weight of the slices 
was determined. Glucose determination was made by the glucose oxidase method (Trinder, 
1969) and the gluconeogenic activity was expressed as nmol of glucose produced/mg liver 
dry weight. 
The gluconeogenic capacity of the rat liver slices in the absence (control) and presence of 
quercetin 3-O-α-(2”-galloyl)rhamnoside (5) is shown in Fig. 7. The glucose production by the 
control liver slices was almost linear with time and similar to that reported earlier (Gonzalez-
Mujica et al., 1998). Quercetin 3-O-α-(2”-galloyl)rhamnoside (5) drastically reduced the 
gluconeogenic capacity of the liver slices at all the times studied: at 30 min the inhibition was 
approximately 85%; the inhibition was nearly 50% at 60 min. and 41% at 90 min. 
The inhibition of the T1, the glucose-6-phosphate transporter, of the hepatic microsomal 
glucose-6-phosphatase system by quercetin 3-O-α-(2”-galloyl)rhamnoside (5), might explain 
the inhibition of the gluconeogenic capacity of the rat liver slices in the presence of the 
flavonol and, in turn, could reduces the hepatic glucose production; this antihyperglycaemic 
effect serve to decrease the blood glucose level in diabetic patients. 
4. Effects of Bauhinia megalandra leaf aqueous extract on glycogenolysis 
An aqueous extract of Bauhinia megalandra leaves was administered by a gastric tube to rats 
anesthetized with sodium pentobarbital (30 mg/Kg body weight), 1 h later a blood sample 
was taken from the tail and 0.15 mg/Kg body weight of epinephrine (Cori and Cori 1928)  was  
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Fig. 7. Effects of quercetin 3-O-α-(2”-galloyl)rhamnoside (5) on hepatic gluconeogenesis. Liver 
slices from 48 h fasted rats were incubated in 4 mL Krebs-Ringer bicarbonate buffer 
supplemented with oleate saturated albumin using lactate as gluconeogenic substrate, in the 
absence (light grey) or presence of 30 μM of Quercetin 3-O-α-(2”-galloyl)rhamnoside (5) (dark 
gray). At the indicated times, medium samples were withdrawn in order to measure glucose 
by the glucose oxidase method. The results are the average of 7–9 separate experiments ± 
standard deviation. All the differences between the gluconeogenesis of controls and quercetin 
3-O-α-(2”-galloyl)rhamnoside (5) treated liver slices were statistically significant at p < 0.005. 
given by intraperitoneal injection, and afterwards blood samples were taken, as before, 
every 30 min for 2 h; glucose was estimated by the glucose oxidase-peroxidase method 
(Trinder 1969).  
As shown in Figure 8, the administration of epinephrine substantially increases the 
glycaemia with a maximum at 60 min (over 80 % increases). When the plant extract was 
given before the catecholamine there was an important reduction of the hyperglycaemia 
induced by epinephrine (over 24 % reduction), been statistically significant at 60 min 
(Fernández- Peña, et al., 2008). These results suggest the intestinal absorption of compounds 
present in the Bauhinia megalandra leaves, which reach the liver via the portal vein and are 
capable of inhibiting the glycogenolysis direct or indirectly. 
In order to establish the mechanism of action of such compounds, we incubated fed rats 
liver slices in the same way as described before (Figure 7) with just buffer alone (control) or 
in the presence of epinephrine (3.3 μM) or dibutyryl cyclic AMP (10 nM) or the plant extract 
(3.44 mg/L) or the combinations of epinephrine and the vegetal extract or dibutyryl cyclic 
AMP and the plant extract. 
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Fig. 8. Effects of Bauhinia megalandra aqueous extract on the hyperglycaemia induced by 
epinephrine. Male rats were anaesthetized (sodium pentobarbital 30 mg/Kg body weight) 
before the administration by a gastric tube of water (control -■-) or 3.44 g/Kg of body 
weight of the plant extract (-▲-). One h later the animals receive by intraperitoneal injection 
0.15 mg/Kg body weight of epinephrine and the glycaemia was measured every 30 min for 
2 h. The basal glycaemia of fed rats (100 %) was 7.2 ± 0.5 mM. The values represent the 
means ± standard deviation of 5 – 6 experiments and in each 3 rats were used. At 60 min the 
differences between control and experimental was statistically significant a p < 0.001.  
As shown in Figure 9 the amount of glucose released by the rat liver slices was increased by 
the presence of the catecholamine, being 60 and 54% of the control values at 60 and 90 min 
respectively. When epinephrine and the plant extract were present simultaneously, the 
glucose production by the liver slices was almost parallel with, but significantly lower than 
that observed with the hormone alone (Figure 9), being 35; 25 and 24% of the control values 
at 30; 60 and 90 min respectively. It is interesting to point out, that at 30 min the glucose 
production in the joint presence of epinephrine and the plant extract was 35% lower than 
that observed in the control. 
As shown in Figure 10, the presence of dibutyryl cAMP produced an increase in the glucose 
release by the liver slices (Fernández-Peña, et al., 2008) at all times studied, being more 
evident at 60 min, when it was 2.6 times the control value. 
In the joint presence of the cyclic nucleotide and the plant extract there was a drastic 
reduction of the dibutyryl cAMP effect, at 60 min the glucose production was decreased by 
almost 50 %. The results presented (Figures 8; 9 and 10) strongly suggest that in Bauhinia 
megalandra leaf extract there are compounds that inhibit hepatic glycogenolysis. We also 
presented evidences that the plant extract inhibits the gluconeogenesis (Table 1 and Figure 7),  
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Fig. 7. Effects of quercetin 3-O-α-(2”-galloyl)rhamnoside (5) on hepatic gluconeogenesis. Liver 
slices from 48 h fasted rats were incubated in 4 mL Krebs-Ringer bicarbonate buffer 
supplemented with oleate saturated albumin using lactate as gluconeogenic substrate, in the 
absence (light grey) or presence of 30 μM of Quercetin 3-O-α-(2”-galloyl)rhamnoside (5) (dark 
gray). At the indicated times, medium samples were withdrawn in order to measure glucose 
by the glucose oxidase method. The results are the average of 7–9 separate experiments ± 
standard deviation. All the differences between the gluconeogenesis of controls and quercetin 
3-O-α-(2”-galloyl)rhamnoside (5) treated liver slices were statistically significant at p < 0.005. 
given by intraperitoneal injection, and afterwards blood samples were taken, as before, 
every 30 min for 2 h; glucose was estimated by the glucose oxidase-peroxidase method 
(Trinder 1969).  
As shown in Figure 8, the administration of epinephrine substantially increases the 
glycaemia with a maximum at 60 min (over 80 % increases). When the plant extract was 
given before the catecholamine there was an important reduction of the hyperglycaemia 
induced by epinephrine (over 24 % reduction), been statistically significant at 60 min 
(Fernández- Peña, et al., 2008). These results suggest the intestinal absorption of compounds 
present in the Bauhinia megalandra leaves, which reach the liver via the portal vein and are 
capable of inhibiting the glycogenolysis direct or indirectly. 
In order to establish the mechanism of action of such compounds, we incubated fed rats 
liver slices in the same way as described before (Figure 7) with just buffer alone (control) or 
in the presence of epinephrine (3.3 μM) or dibutyryl cyclic AMP (10 nM) or the plant extract 
(3.44 mg/L) or the combinations of epinephrine and the vegetal extract or dibutyryl cyclic 
AMP and the plant extract. 
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Fig. 8. Effects of Bauhinia megalandra aqueous extract on the hyperglycaemia induced by 
epinephrine. Male rats were anaesthetized (sodium pentobarbital 30 mg/Kg body weight) 
before the administration by a gastric tube of water (control -■-) or 3.44 g/Kg of body 
weight of the plant extract (-▲-). One h later the animals receive by intraperitoneal injection 
0.15 mg/Kg body weight of epinephrine and the glycaemia was measured every 30 min for 
2 h. The basal glycaemia of fed rats (100 %) was 7.2 ± 0.5 mM. The values represent the 
means ± standard deviation of 5 – 6 experiments and in each 3 rats were used. At 60 min the 
differences between control and experimental was statistically significant a p < 0.001.  
As shown in Figure 9 the amount of glucose released by the rat liver slices was increased by 
the presence of the catecholamine, being 60 and 54% of the control values at 60 and 90 min 
respectively. When epinephrine and the plant extract were present simultaneously, the 
glucose production by the liver slices was almost parallel with, but significantly lower than 
that observed with the hormone alone (Figure 9), being 35; 25 and 24% of the control values 
at 30; 60 and 90 min respectively. It is interesting to point out, that at 30 min the glucose 
production in the joint presence of epinephrine and the plant extract was 35% lower than 
that observed in the control. 
As shown in Figure 10, the presence of dibutyryl cAMP produced an increase in the glucose 
release by the liver slices (Fernández-Peña, et al., 2008) at all times studied, being more 
evident at 60 min, when it was 2.6 times the control value. 
In the joint presence of the cyclic nucleotide and the plant extract there was a drastic 
reduction of the dibutyryl cAMP effect, at 60 min the glucose production was decreased by 
almost 50 %. The results presented (Figures 8; 9 and 10) strongly suggest that in Bauhinia 
megalandra leaf extract there are compounds that inhibit hepatic glycogenolysis. We also 
presented evidences that the plant extract inhibits the gluconeogenesis (Table 1 and Figure 7),  
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Fig. 9. Effects of epinephrine and of Bauhinia megalandra leaf extract on hepatic 
glycogenolysis. Fed rats liver slices were incubated in 4 mL of Krebs-Ringer bicarbonate 
buffer pH 7.4 in an atmosphere of O2/CO2 95/5 without additions for control (-■-), or in the 
presence of 3.3 μM epinephrine (-▲-), or the combination of 3.3 μM epinephrine and 13.8 μg 
of the plant extract (-☻-). At the indicated times glucose was measured in samples of the 
incubation medium as before. The values are the means ± standard deviations of 5 – 6 
experiments, in each 3 rats were used. At 60 and 90 min, the differences between 
epinephrine and control and the combination of epinephrine and the plant extract were 
statistically significant at p< 0.001. 
and due to the fact that the only enzyme common to both metabolic pathways, 
glycogenolysis and gluconeogenesis is the glucose-6-phosphatase in consequence this 
enzyme should be the target of the compounds present in Bauhinia megalandra leaf extract. 
Furthermore, the plant extract and the flavonoids isolated from it, inhibit the T1, the 
glucose-6-phosphate transporter of the hepatic microsomal glucose-6-phosphatase system. 
The above result, strongly suggest that the flavonoids present in Bauhinia megalandra leaf 
extract inhibit hepatic glycogenolysis and gluconeogenesis because of inhibition of the 
glucose-6-phosphatase and in consequence there is a reduction in the glucose production by 
the liver. These flavonoids might be useful in the treatment of non insulin dependent 
diabetes because of its antihyperglycaemic activity. 
5. Effects of Bauhinia megalandra aqueous extract and Kaempferol 3-O-α-
rhamnoside on glucose intestinal absorption 
The glucose intestinal absorption was measured by the method described by Gonzalez-
Mujica et al., (2003). In rats anaesthetized with sodium pentobarbital (60 mg/Kg body 
weight), the intestine was exposed and divided in situ into 4 cm segments by ligatures; 1 mL 
of 10 mM glucose, 0.9 % NaCl alone or with the plant extract (1.14-9.10 mg) or extract 
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Fig. 10. Effects of dibutyryl cAMP and of Bauhinia megalandra leaf extract on hepatic 
glycogenolysis. All conditions were the same as those indicated in Figure 9, without 
addition for control (-■-), or in the presence of 10 nM of dibutyryl cAMP(-▲-), or the 
combination of 10 nM of dibutyryl cAMP and 13.8 μg of the plant extract (-☻-). At 60 min 
the differences observed between the values obtained in the presence of the cyclic nucleotide 
alone and those in controls and in the presence of the mixture of dibutyryl cAMP and the 
plant extract were statistically significant at p< 0.001. 
fractions (10 mg/mL) or pure compounds (5 mM), as indicated in the figures, was injected. 
Phlorizin, a well known inhibitor of sodium-glucose cotransporter 1 (SGLT1)(Panayatova-
Heiermann, et al., 1995), at a concentration of 0.1 mM was used as a positive control. After 30 
min the intestinal segment contents were recovered without significant change in volume, 
and the glucose was measured (Trinder, 1969).  
As shown in Table 5, the aqueous extract of Bauhinia megalandra leaves inhibits the glucose 
intestinal absorption in a concentration- dependant way. When the plant extract (4.55 mg) 
was injected together with 0.1 mM phlorizin, an additive inhibitor effect was observed. The 
concentration dependent inhibition exerted by the plant extract indicates a specific action 
and due to the fact that phlorizin is a known inhibitor of the sodium-glucose cotransporter 1 
(Panayatova-Heiermann, et al., 1995), the observed additive effect of Bauhinia megalandra leaf 
extract and phlorizin suggest that in the plant there are compounds that inhibit that 
cotransporter. 
Vesicles from enterocyte apical membrane were prepared by the Ca++ precipitation method 
described by Kessler et al., (1978). The intestinal membrane vesicles obtained contained 
maltase measured as described by SaMoita, et al., (1989) in a ratio vesicles/homogenate 9.84; 
a small amount of Na+/K+ ATPase sensitive to ouabain, estimated following Del Castillo & 
Robinson (1982) in a ratio vesicles/homogenate 0.42; succinate-cytochrome c reductase  
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Fig. 9. Effects of epinephrine and of Bauhinia megalandra leaf extract on hepatic 
glycogenolysis. Fed rats liver slices were incubated in 4 mL of Krebs-Ringer bicarbonate 
buffer pH 7.4 in an atmosphere of O2/CO2 95/5 without additions for control (-■-), or in the 
presence of 3.3 μM epinephrine (-▲-), or the combination of 3.3 μM epinephrine and 13.8 μg 
of the plant extract (-☻-). At the indicated times glucose was measured in samples of the 
incubation medium as before. The values are the means ± standard deviations of 5 – 6 
experiments, in each 3 rats were used. At 60 and 90 min, the differences between 
epinephrine and control and the combination of epinephrine and the plant extract were 
statistically significant at p< 0.001. 
and due to the fact that the only enzyme common to both metabolic pathways, 
glycogenolysis and gluconeogenesis is the glucose-6-phosphatase in consequence this 
enzyme should be the target of the compounds present in Bauhinia megalandra leaf extract. 
Furthermore, the plant extract and the flavonoids isolated from it, inhibit the T1, the 
glucose-6-phosphate transporter of the hepatic microsomal glucose-6-phosphatase system. 
The above result, strongly suggest that the flavonoids present in Bauhinia megalandra leaf 
extract inhibit hepatic glycogenolysis and gluconeogenesis because of inhibition of the 
glucose-6-phosphatase and in consequence there is a reduction in the glucose production by 
the liver. These flavonoids might be useful in the treatment of non insulin dependent 
diabetes because of its antihyperglycaemic activity. 
5. Effects of Bauhinia megalandra aqueous extract and Kaempferol 3-O-α-
rhamnoside on glucose intestinal absorption 
The glucose intestinal absorption was measured by the method described by Gonzalez-
Mujica et al., (2003). In rats anaesthetized with sodium pentobarbital (60 mg/Kg body 
weight), the intestine was exposed and divided in situ into 4 cm segments by ligatures; 1 mL 
of 10 mM glucose, 0.9 % NaCl alone or with the plant extract (1.14-9.10 mg) or extract 
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Fig. 10. Effects of dibutyryl cAMP and of Bauhinia megalandra leaf extract on hepatic 
glycogenolysis. All conditions were the same as those indicated in Figure 9, without 
addition for control (-■-), or in the presence of 10 nM of dibutyryl cAMP(-▲-), or the 
combination of 10 nM of dibutyryl cAMP and 13.8 μg of the plant extract (-☻-). At 60 min 
the differences observed between the values obtained in the presence of the cyclic nucleotide 
alone and those in controls and in the presence of the mixture of dibutyryl cAMP and the 
plant extract were statistically significant at p< 0.001. 
fractions (10 mg/mL) or pure compounds (5 mM), as indicated in the figures, was injected. 
Phlorizin, a well known inhibitor of sodium-glucose cotransporter 1 (SGLT1)(Panayatova-
Heiermann, et al., 1995), at a concentration of 0.1 mM was used as a positive control. After 30 
min the intestinal segment contents were recovered without significant change in volume, 
and the glucose was measured (Trinder, 1969).  
As shown in Table 5, the aqueous extract of Bauhinia megalandra leaves inhibits the glucose 
intestinal absorption in a concentration- dependant way. When the plant extract (4.55 mg) 
was injected together with 0.1 mM phlorizin, an additive inhibitor effect was observed. The 
concentration dependent inhibition exerted by the plant extract indicates a specific action 
and due to the fact that phlorizin is a known inhibitor of the sodium-glucose cotransporter 1 
(Panayatova-Heiermann, et al., 1995), the observed additive effect of Bauhinia megalandra leaf 
extract and phlorizin suggest that in the plant there are compounds that inhibit that 
cotransporter. 
Vesicles from enterocyte apical membrane were prepared by the Ca++ precipitation method 
described by Kessler et al., (1978). The intestinal membrane vesicles obtained contained 
maltase measured as described by SaMoita, et al., (1989) in a ratio vesicles/homogenate 9.84; 
a small amount of Na+/K+ ATPase sensitive to ouabain, estimated following Del Castillo & 
Robinson (1982) in a ratio vesicles/homogenate 0.42; succinate-cytochrome c reductase  
 





Extract nmol of glucose absorbed Addition 
nmol of glucose 
absorbed 
0 mg 774.2 ± 34.4* 0 773.6 ± 70.3 
1.14 mg 602.2 ± 103.2** 
4.55 mg B megalandra extract 348.9 ± 79.1** 
2.28 mg 464.5 ± 60.2** 
4.55 mg 395.7 ± 51.6** 0.1 mM phlorizin 392.1 ± 80.9** 
6.5 mg 223.7 ± 36.1** 4.55 mg B megalandra 
extract + 0.1 mM phlorizin 87.9 ± 35.2** 9.10 mg 141.1 ± 25.8** 
Table 5. Effects of Bauhinia megalandra extract on glucose intestinal absorption. In each of 
four consecutive intestinal segments were injected, in situ, 1mL of 10 mM glucose, 0.14% 
NaCl alone (0 mg) or in the presence of increasing amounts of Bauhinia megalandra leaf 
extract (A); or in the presence of 4.55 mg of the plant extract, or 0.1 mM phlorizin or the 
combination of 4.55 mg of plant extract and 0.1 mM phlorizin (B). After 30 min the glucose 
was measured in the intestinal segments content, expressed in nmol of glucose absorbed in 
30 min and each value corresponds to the mean ± standard deviation of eight experiments. * 
Means p< 0.005 and ** means p<0.0005. 
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Fig. 11. Effects of Bauhinia megalandra on 14C-glucose uptake by enterocyte brush border 
membrane vesicles. Rat enterocyte brush border membrane vesicles internally filled with 
100 mM KCl were incubated with 2 mM 14C-glucose (0.1 μCi) and 100 mM NaCl for the 
control (-■-) or with the addition of 4.55 μg of Bauhinia megalandra aqueous extract  (-▲-) or 
with the addition of 1 mM phlorizin (-☻-). At the indicated times the reaction was stopped 
by the fast filtration method (Hopfer, et al., 1973) and the radioactivity was measured. The 
values are expressed in nmol of glucose uptake/ mg of vesicles protein and correspond to 
the mean ± standard deviation of 9 experiments with at least 2 rats in each one. 
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quantified by the method of Green, et al., (1955) in a ratio vesicles/homogenate 0.36 and β-
glucuronidase measured as described by Bergmeyer (1965) in a ratio vesicles/homogenate 
0.09. Electronmicroscopy showed vesicles with a single membrane without electron dense 
material inside. These results are in good agreement with those reported by Kessler et al., 
(1978) and indicate that the vesicles fraction obtained was enriched with brush border 
membrane, with low contamination with other cellular membrane. The 14C-glucose uptake 
by the intestinal brush border membrane vesicles, obtained as described above, was 
performed by the fast filtration method (Hopfer, et al., 1973) in the absence or presence of 
the Bauhinia megalandra leaves extract or 1mM phlorizin.  
As shown in Figure 11 the 14C-glucose uptake by intestinal brush border membrane vesicles 
exhibits a peak at 30 s followed by a plateau between 45 and 150 s, a result very similar to 
that previously published (Kessler et al., 1978). When the intestinal brush border membrane 
vesicles were incubated in the presence of 4.55 μg of the plant extract or 1 mM phlorizin 
there was complete inhibition of the 30 s 14C-glucose peak uptake. These results clearly 
indicate that in the plant extract there are compounds that inhibit the sodium-glucose 
cotransporter 1 and in consequence are similar to those reported for green tea polyphenols 
(Kobayashi, et al., 2000) and soyabean isoflavone (Vedavanam, et al., 1999).    
As shown in Figure 12-A, the simultaneous administration of Bauhinia megalanda leaf extract 
(260 mg) together with glucose (1g/Kg body weight) by gastric catheter produced an almost 
flat glucose tolerance, with a decrease in nearly 28 % in the 30 min peak which was 
statistically significant in comparison with the control receiving water instead of the plant 
extract. On the other hand, when the Bauhinia megalandra leaf extract (260 mg) was 
administrated orally and the glucose (1g/Kg body weight) by subcutaneous injection 
(Figure 12-B) there was no difference with the control that received water instead of the 
plant extract. The flat oral glucose tolerance (Figure 12-A) in comparison with the normal 
subcutaneous glucose tolerance (Figure 12-B) when the glucose was administered 
simultaneously with plant extract, strongly suggest that the main effect of Bauhinia 
megalandra extract is on the glucose intestinal absorption without any important effect on 
insulin release nor on the tissue glucose consumption. 
We tested the effects of: quercetin 3-O-α-rhamnoside (2), kaempferol 3-O-α-rhamnoside (3) 
and kaempferol 3-O-α-(2”-galloyl)rhamnoside (6), presented in Table 3, with the intention to 
establish the compound, present in Bauhinia megalandra leaves, responsible for the inhibition 
of the glucose intestinal absorption. The glucose intestinal absorption was measured using 
the method described above (Gonzalez-Mujica, et al., 2003) in the absence (control) or the 
presence of 5 mM of the compounds 2, 3 or 6; phlorizin at a concentration of 0.1 mM was 
used as a positive control. The combined effect of kaempferol 3-O-α-rhamnoside (3) and 0.1 
mM phlorizin was also studied (Rodríguez et al., 2010). The kinetic parameters, KM and 
VMAX, of glucose intestinal absorption were measured using increasing glucose 
concentration (12.5 – 50 mM), in the absence and in the presence of 5 mM kaempferol 3-O-α-
rhamnoside (3), but reducing the time of absorption to 15 min in order to guarantee 
measurement at the initial velocity. KM and VMAX were calculated from the Michaelis and 
Menten graph (Rodríguez et al., 2010) using the Enzfitter program (Leatherbarrow, 1989).  
As shown in Table 6, kaempferol 3-O-α-rhamnoside (3) exerts a statistically significant 
inhibition of glucose intestinal absorption, which was more than double that exhibited by 
quercetin 3-O-α-rhamnoside (2), inhibition also statistically significant; on the other hand 
kaempferol 3-O-α-(2”-galloyl)rhamnoside (6) lacked any effect. 
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0 mg 774.2 ± 34.4* 0 773.6 ± 70.3 
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Table 5. Effects of Bauhinia megalandra extract on glucose intestinal absorption. In each of 
four consecutive intestinal segments were injected, in situ, 1mL of 10 mM glucose, 0.14% 
NaCl alone (0 mg) or in the presence of increasing amounts of Bauhinia megalandra leaf 
extract (A); or in the presence of 4.55 mg of the plant extract, or 0.1 mM phlorizin or the 
combination of 4.55 mg of plant extract and 0.1 mM phlorizin (B). After 30 min the glucose 
was measured in the intestinal segments content, expressed in nmol of glucose absorbed in 
30 min and each value corresponds to the mean ± standard deviation of eight experiments. * 
Means p< 0.005 and ** means p<0.0005. 
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Fig. 11. Effects of Bauhinia megalandra on 14C-glucose uptake by enterocyte brush border 
membrane vesicles. Rat enterocyte brush border membrane vesicles internally filled with 
100 mM KCl were incubated with 2 mM 14C-glucose (0.1 μCi) and 100 mM NaCl for the 
control (-■-) or with the addition of 4.55 μg of Bauhinia megalandra aqueous extract  (-▲-) or 
with the addition of 1 mM phlorizin (-☻-). At the indicated times the reaction was stopped 
by the fast filtration method (Hopfer, et al., 1973) and the radioactivity was measured. The 
values are expressed in nmol of glucose uptake/ mg of vesicles protein and correspond to 
the mean ± standard deviation of 9 experiments with at least 2 rats in each one. 
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quantified by the method of Green, et al., (1955) in a ratio vesicles/homogenate 0.36 and β-
glucuronidase measured as described by Bergmeyer (1965) in a ratio vesicles/homogenate 
0.09. Electronmicroscopy showed vesicles with a single membrane without electron dense 
material inside. These results are in good agreement with those reported by Kessler et al., 
(1978) and indicate that the vesicles fraction obtained was enriched with brush border 
membrane, with low contamination with other cellular membrane. The 14C-glucose uptake 
by the intestinal brush border membrane vesicles, obtained as described above, was 
performed by the fast filtration method (Hopfer, et al., 1973) in the absence or presence of 
the Bauhinia megalandra leaves extract or 1mM phlorizin.  
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cotransporter 1 and in consequence are similar to those reported for green tea polyphenols 
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We tested the effects of: quercetin 3-O-α-rhamnoside (2), kaempferol 3-O-α-rhamnoside (3) 
and kaempferol 3-O-α-(2”-galloyl)rhamnoside (6), presented in Table 3, with the intention to 
establish the compound, present in Bauhinia megalandra leaves, responsible for the inhibition 
of the glucose intestinal absorption. The glucose intestinal absorption was measured using 
the method described above (Gonzalez-Mujica, et al., 2003) in the absence (control) or the 
presence of 5 mM of the compounds 2, 3 or 6; phlorizin at a concentration of 0.1 mM was 
used as a positive control. The combined effect of kaempferol 3-O-α-rhamnoside (3) and 0.1 
mM phlorizin was also studied (Rodríguez et al., 2010). The kinetic parameters, KM and 
VMAX, of glucose intestinal absorption were measured using increasing glucose 
concentration (12.5 – 50 mM), in the absence and in the presence of 5 mM kaempferol 3-O-α-
rhamnoside (3), but reducing the time of absorption to 15 min in order to guarantee 
measurement at the initial velocity. KM and VMAX were calculated from the Michaelis and 
Menten graph (Rodríguez et al., 2010) using the Enzfitter program (Leatherbarrow, 1989).  
As shown in Table 6, kaempferol 3-O-α-rhamnoside (3) exerts a statistically significant 
inhibition of glucose intestinal absorption, which was more than double that exhibited by 
quercetin 3-O-α-rhamnoside (2), inhibition also statistically significant; on the other hand 
kaempferol 3-O-α-(2”-galloyl)rhamnoside (6) lacked any effect. 
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* Means difference statistically significant at p< 0.005. 
Fig. 12. Effects of Bauhinia megalandra extract on oral and subcutaneous glucose tolerance. 
Rats under light anesthesia (30mg of sodium pentobarbital/Kg of body weight) received 1 
g/Kg body weight of glucose by gastric catheter (A) or by subcutaneous injection (B) 
together with 260 mg of Bauhinia megalandra leaf extract (-☻-) or an equivalent amount of 
water (-■-) by gastric catheter. At the indicated times, blood samples were taken for glucose 
determination. The glycaemia at time zero was 75.0 ± 9.4 mg/dl. The results are expressed 
as the percentage of change in relation to zero-time value (100 %) and represent the means ± 
standard deviation of 7 experiments with at least 2 rats in each one.  
Regarding chemical structure and related biological activity, it is interesting to note that the 
presence of the galloyl group bound to the rhamnosyl moiety in kaempferol 3-O-α-(2”-
galloyl)rhamnoside (6) annuls the inhibitory effect of kaempferol 3-O-α-rhamnoside (3). The 
rhamnosyl moiety is present in both kaempferol 3-O-α-rhamnoside (3) and quercetin 3-O-α-
rhamnoside (2) but only the first compound efficiently inhibit glucose intestinal absorption, 
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indicating that the hexose is not a determinant for biological activity. The presence of an H 
(kaempferol 3-O-α-rhamnoside) in stead of an OH (quercetin 3-O-α-rhamnoside) in the 3’ 
position of the flavonoid B ring is a determinant for the biological activity. 
 
Compound Glucose absorption 
nmol/30 min 
% inhibition 
Control 933, 4 ± 44.3  
Quercetin 3-O-α-rhamnoside (2) 822.2 ± 22.1 * 12 
kaempferol 3-O-α-rhamnoside (3) 666.7 ± 4.5 ** 29 
Kaempferol 3-O-α-(2”-galloyl)rhamnoside (6) 895.6 ± 17.8 NS 4 
Phlorizin 700.0 ± 71.1 ** 25 
kaempferol 3-O-α-rhamnoside (3) + Phlorizin 300.0 ± 44.3 *** 68 
Table 6. Effects of flovonoids purified from Bauhinia megalandra leaves and phlorizin on the 
glucose intestinal absorption. Isolated intestinal segments were injected in situ with 1 mL of 
10 mM glucose and 0.9 % NaCl for control. In the test procedures the flavonoids: quercetin 
3-O-α-rhamnoside (2), kaempferol 3-O-α-rhamnoside (3) or Kaempferol 3-O-α-(2”-
galloyl)rhamnoside (6)were added at a final concentration of 5 mM. The final concentration 
of phlorizin used was 0.1 mM, and the combination of 5 mM kaempferol 3-O-α-rhamnoside 
(3) and 0.1 mM phlorizin was also used. After 30 min the glucose absorbed was estimated. 
The results correspond to the means ± standard deviation of 4 experiments. * Indicate p< 
0.05, **Indicate p< 0.005 ***indicate p<0.001 and NS not significant, according to the Student 
t test. 
As it can be seen in Table 6, the combined use of kaempferol 3-O-α-rhamnoside (3) and 
phlorizin inhibits glucose intestinal absorption by more than double the effect of either of 
these alone, indicating an additive effect of both compounds. Due to the fact that phlorizin is 
a known inhibitor of the sodium-glucose cotransporter 1 (Panayatova-Heiermann, et al., 
1995) in consequence kaempferol 3-O-α-rhamnoside (3) should be acting on the same 
transporter.  
 
 KM in mM VMAX in μmol/min 
Control 38.93 ± 4.92 * 42.33 ± 5.02 NS 
Kaempferol 3-O-α-rhamnoside (3) 67.24 ± 11.12 * 50.04 ± 4.59 NS 
Table 7. Effect of kaempferol 3-O-α-rhamnoside (3) on the kinetic parameters of glucose 
intestinal absorption. Isolated intestinal segments were injected in situ with 0.9 % NaCl and 
increasing concentration of glucose (12.5-50 mM) for control, and in the test procedure 5 mM 
kaempferol 3-O-α-rhamnoside was added. After 15 min the glucose absorbed was estimated 
and the KM and VMAX were calculated from the Michaelis and Menten graph using the 
Enzfitter program (Leatherbarrow, 1987). The results correspond to the means ± standard 
deviation of 4 experiments. * Means p< 0.005, NS means not significant according to the 
Student t test.  
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* Means difference statistically significant at p< 0.005. 
Fig. 12. Effects of Bauhinia megalandra extract on oral and subcutaneous glucose tolerance. 
Rats under light anesthesia (30mg of sodium pentobarbital/Kg of body weight) received 1 
g/Kg body weight of glucose by gastric catheter (A) or by subcutaneous injection (B) 
together with 260 mg of Bauhinia megalandra leaf extract (-☻-) or an equivalent amount of 
water (-■-) by gastric catheter. At the indicated times, blood samples were taken for glucose 
determination. The glycaemia at time zero was 75.0 ± 9.4 mg/dl. The results are expressed 
as the percentage of change in relation to zero-time value (100 %) and represent the means ± 
standard deviation of 7 experiments with at least 2 rats in each one.  
Regarding chemical structure and related biological activity, it is interesting to note that the 
presence of the galloyl group bound to the rhamnosyl moiety in kaempferol 3-O-α-(2”-
galloyl)rhamnoside (6) annuls the inhibitory effect of kaempferol 3-O-α-rhamnoside (3). The 
rhamnosyl moiety is present in both kaempferol 3-O-α-rhamnoside (3) and quercetin 3-O-α-
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kaempferol 3-O-α-rhamnoside (3) + Phlorizin 300.0 ± 44.3 *** 68 
Table 6. Effects of flovonoids purified from Bauhinia megalandra leaves and phlorizin on the 
glucose intestinal absorption. Isolated intestinal segments were injected in situ with 1 mL of 
10 mM glucose and 0.9 % NaCl for control. In the test procedures the flavonoids: quercetin 
3-O-α-rhamnoside (2), kaempferol 3-O-α-rhamnoside (3) or Kaempferol 3-O-α-(2”-
galloyl)rhamnoside (6)were added at a final concentration of 5 mM. The final concentration 
of phlorizin used was 0.1 mM, and the combination of 5 mM kaempferol 3-O-α-rhamnoside 
(3) and 0.1 mM phlorizin was also used. After 30 min the glucose absorbed was estimated. 
The results correspond to the means ± standard deviation of 4 experiments. * Indicate p< 
0.05, **Indicate p< 0.005 ***indicate p<0.001 and NS not significant, according to the Student 
t test. 
As it can be seen in Table 6, the combined use of kaempferol 3-O-α-rhamnoside (3) and 
phlorizin inhibits glucose intestinal absorption by more than double the effect of either of 
these alone, indicating an additive effect of both compounds. Due to the fact that phlorizin is 
a known inhibitor of the sodium-glucose cotransporter 1 (Panayatova-Heiermann, et al., 
1995) in consequence kaempferol 3-O-α-rhamnoside (3) should be acting on the same 
transporter.  
 
 KM in mM VMAX in μmol/min 
Control 38.93 ± 4.92 * 42.33 ± 5.02 NS 
Kaempferol 3-O-α-rhamnoside (3) 67.24 ± 11.12 * 50.04 ± 4.59 NS 
Table 7. Effect of kaempferol 3-O-α-rhamnoside (3) on the kinetic parameters of glucose 
intestinal absorption. Isolated intestinal segments were injected in situ with 0.9 % NaCl and 
increasing concentration of glucose (12.5-50 mM) for control, and in the test procedure 5 mM 
kaempferol 3-O-α-rhamnoside was added. After 15 min the glucose absorbed was estimated 
and the KM and VMAX were calculated from the Michaelis and Menten graph using the 
Enzfitter program (Leatherbarrow, 1987). The results correspond to the means ± standard 
deviation of 4 experiments. * Means p< 0.005, NS means not significant according to the 
Student t test.  
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As shown in Table 7 the control values of the kinetic parameters of glucose intestinal 
absorption are different to those reported by Ader, et al., (2001) and Li, et al., (2006), however 
it is important to point out that in these two cases the KM and VMAX correspond to the 
sodium-glucose cotransporter function and in our case the kinetic parameters correspond to 
the total process of the glucose intestinal absorption. The presence of 5 mM kaempferol 3-O-
α-rhamnoside (3) increases in 1.7 times the KM without a significant change by the VMAX of 
the glucose intestinal absorption, these results strongly suggest that kaempferol 3-O-α-
rhamnoside (3) behaves as a competitive inhibitor of the intestinal sodium-glucose 
cotransporter 1.  
6. Intestinal absorption of flavonoids from Bauhinia megalandra 
The compounds present in the plant extract, prior to develop any biological function, have 
to be absorbed by the intestine and pass through the blood to reach the target tissue. With 
the intention of obtaining information on the intestinal absorption of the compounds present 
the Bauhinia megalandra leaves; we studied the urine of rats that drank, during a week, the 
plant extract instead of water. The urine was treated with acid acetone, the supernatant 
dried and fractionated using different solvents and column chromatography on silica gel to 
yield a compound that was present neither in the plant extract nor in the urine of the control 
rats. The structure of the compound was established using 1H and 13C NMR as being an 
ortho-substituted benzene; however, currently we do not know the types of radicals present 
(results not published). Due to the fact, that the ortho-substituted benzene was present 
neither in the plant extract nor in the Bauhinia megalandra leaf extract, this  must correspond 
to a compound, probably a flavonoid, present in the plant extract that was absorbed at the 
intestine level, afterwards metabolized and excreted in the urine. This ortho-substituted 
benzene, is different to the phenolic acid that has been reported (Touriño, et al., 2009) are 
eliminated by the urine of animals that ingest flavonoids. This is direct evidence of the 
intestinal absorption of compounds present in the Bauhinia megalandra leaf extract.  
7. Conclusions 
The aqueous extract of Bauhinia megalandra leaves inhibited the gluconeogenesis and 
glycogenolysis, stimulated by epinephrine or dibutyril AMPc, activity of liver slices, 
reduced the hyperglycaemia promoted by epinephrine in the intact animal and inhibited the 
glucose intestinal absorption in a dose dependant way by affecting the SGLT 1. From the 
methanol extract of the Bauhinia megalandra leaves, we purified and characterized 8 
flavonoids for one of which, kaempferol 3-O-α-(2”galloyl)-rhamnoside (6), to the best of our 
knowledge, this was the first report of its being isolated from nature; all of the flavonoids 
isolated were able to inhibit the enzyme glucose-6-phosphatase, the most active ones being 
those with the galloyl group with IC50 of approximately 30 μM. Quercetin 3-O-α-
(2”galloyl)-rhamnoside (5) behaved as a competitive inhibitor of the glucose-6-phosphatase 
transporter of the glucose-6-phosphate system and drastically reduced the liver 
gluconeogenic activity. The reduction of the glycogenolysis and gluconeogenesis might be a 
consequence of the inhibition of the hepatic glucose-6-phosphatase by the flavonoids 
present in the plant extract. Kaempferol 3-O-α-rhamnoside (3) was a competitive inhibitor of 
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the glucose intestinal absorption. In the urine of the rats that drank the Bauhinia megalandra 
leaves aqueous extract we identified an ortho-substituted benzene, probably a product of 
the metabolism of one of the flavonoides. 
We have presented direct and indirect evidences of the intestinal absorption of compounds 
present in the Bauhinia megalandra leaf extract which are responsible for the reduction in the 
hepatic production of glucose and of the glucose intestinal absorption, events that are 
important for the reduction of the supply of glucose to the blood. As a  consequence the 
compounds present in this plant may well be useful in the treatment of diabetic patients due 
to their antihyperglycaemic activity.  
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1. Introduction 
The suboptimal penetration of highly active antiretroviral therapy (HAART) drugs into the 
virus reservoirs and sanctuary sites ensures that the replication-competent HIV viruses or 
integrated HIV virions remain sheltered from HAARTs pharmacological activity (Saksena 
et al, 2010). Persistent virus replication thus sustains continuous colonization of different 
tissues and cellular targets, which contributes to the disease relapse and to the emergence of 
virus resistance to HAART therapy (Saksena et al, 2010; Hoggs et al, 2006). Drug resistance 
is usually triggered by increased gene expression of the efflux transporters in the infected 
cells, resulting in even lower amounts of antiretrovirals residing in the HIV reservoirs 
(Löscher&Potschka, 2005; Kis et al, 2009). The persistent infection of the immune cells 
subjects HIV-infected to opportunistic infections (Orenstein et al, 1997), which alongside the 
metabolic syndrome, induced by long-term HAART therapy (Unger, 2003), contributes to 
the concomitant consumption of garlic supplements to ameliorate these symptoms 
(Amagase, 2006). However garlic phytochemicals have been shown to modulate the 
activities of intestinal (Berginc et al, 2009), and hepatic transporters (Berginc et al, 2010a) and 
CYP3A4 enzymes (Foster et al, 2001), the pivotal impediment to attaining therapeutic 
plasma concentrations after peroral administration and gastrointestinal absorption (Piscitelli 
et al, 2002; Vermier et al, 2009) of the protease inhibitors (i.e. saquinavir – Saq, darunavir – 
Dar) of human immunodeficiency virus (HIV-PI). Following that, concomitant application 
of antiretrovirals and garlic supplements could lead to pharmacokinetic interactions and 
possibly to therapy failure or to intensification of undesired effects. Piscitelli (Piscitelli et al, 
2002) investigated the impact of long-term garlic supplements consumption (garlic caplets 
GarliPure® from Natrol) on the pharmacokinetics of Saq by conducting a clinical study on 
healthy male volunteers. A significant decline in the extent of saquinavir absorption was 
noted, which even after 10-day washout period did not return to the baseline values. The 
volunteers were administered higher Saq doses than needed for therapy (1200 mg 3-times 
daily); therefore the potential garlic modifying effects on the Saq pharmacokinetics could be 
even more pronounced among the infected patients, because they receive lower HIV-PI 
doses. Investigators suggested that the observed detrimental effect of garlic on the Saq 
pharmacokinetics could be caused by the formation of garlic metabolite(s) with enzyme-
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transporter induction properties. Hypothetically, this would lead to the increased formation 
of Saq metabolites capable of inducing the metabolism of the parent drug. Plasma samples 
of the volunteers were not analyzed for the presence of potential garlic metabolites and the 
necessary in vitro studies to elucidate the hypothetical interaction mechanisms were never 
conducted. Therefore, these assumptions could not be verified. Furthermore, it has never 
been resolved, whether gut wall could represent an important hindrance to the absorption 
(Kis et al, 2009) and consequently to the therapeutic efficacy of HIV-PIs.  
To address these questions, we performed in vitro studies with hepatic and intestinal tissues 
of rats, fed garlic supplements for two weeks. This approach allowed us to distinguish the 
influence, which garlic supplements could exert on first-pass Saqs metabolism in the gut 
and in the liver. Based on the knowledge of short-term influence of garlic phytochemicals 
and/or supplements on transporter-enzyme interplay (Berginc et al, 2009; Berginc et al, 
2010a) and clinical data for Saq (Piscitelli et al, 2002), the mechanisms behind 
pharmacokinetic interactions between Saq and garlic were elucidated. 
According to the clinical experience with Saq, a warning regarding the possibility of 
interactions with garlic or garlic supplements has been extended also to other HIV-PIs. 
Therefore, our research also aimed to identify, whether the “in vitro” transport and 
metabolism and perhaps therapeutic efficacy of Dar, a novel, second-generation HIV-PI, 
could really be affected by garlic consumption in a similar fashion. Furthermore, we 
hypothesized that differences may exist between the influences of different garlic 
supplements on HIV-PI pharmacokinetics. Rats were thus fed two garlic supplements with 
very distinct composition; aged garlic extract – AGE, a preferentially hydrophilic product 
rich in water-soluble -glutammyl derivatives of organosulfur compounds, flavonoids and 
other substances (Berginc et al, 2010b) and garlic oil macerate – GOM, containing 
preferentially oil-soluble allicin degradation products (i.e. various sulfides, ajoene, vinyl 
dithiins and other) (Yoschida et al, 1999). We also analyzed plasma samples of fed rats to 
identify potential garlic metabolites/phytochemicals, which could modify gene expression 
as suggested by Piscitelli (Piscitelli et al, 2002). 
2. Methods and materials 
2.1 Materials 
Salts for incubation salines, sunflower seed oil from Helianthus annuu, Williams medium E, 
L-glutamine, insulin, gentamicin and ampicillin, analytical standards for constituents of 
garlic supplements (rutin, tangeretin, bergamottine, adenosine, S-allyl cisteine and 
quercetin) were from Sigma Aldrich Chemie (Deisenhofen, Germany). Saq and ritonavir 
(Rito) were purchased at Sequoia Research Products. All chemicals used in this study were 
of the highest grade available. Kyolic® liquid aged garlic extract (AGE) was produced by 
Wakanuga of America CO., LTD (Mission Viejo, CA, USA), lot number 5H04A. The AGE 
used in this study was standardized to 1.27 g/l S-allylcysteine content, the compound 
normally used for the standardization of AGE. Commercially available garlics soft-gelatin 
capsules filled with garlic oil macerate (GOM) were purchased in a local pharmacy. Dar was 
extracted from Prezista® tablets (300mg) by ethanol extraction, evaporation and 
reconstitution in DMSO. The purity of extracted Dar was confirmed by HPLC analysis at 
240 nm; the Dar peak surface represented 97% of the total chromatogram surface area.  
 




2.2.1 Test system 
The experiment was conducted with adult, at the start 12 weak old, male Wistar rats. The 
study conformed to the Law for the Protection of Animals (Republic of Slovenia) and was 
registered at the Veterinary Administration of Republic of Slovenia No. 34401-41/2008/2. 
Animals were treated according to the principles of Convention ETS 123 (The convention for 
the protection of animals used for experimental and other scientific purposes) and Directive 
86/609/EEC (Council directive on the protection of animals used for experimental and 
other scientific purposes).  
 






saline 3 3.6 mL/kg 357 363 
AGE 
group 





sunflower seed oils 3 2.6 mL/kg 387 391 
GOM 
group 
GOM 3 0.3 % garlic oil macerate in 2.6 
mL per kg 
371 386 
N – The number of fed rats; Mbefore - the mean rat weight before supplementation; Mafter – the mean rat 
weight on day 15. 
Table 1. The experimental design of chronic/long-term garlic supplementation to rats. 
Animals were fed with pelletized feed Global Diet 2018 ad libidum and had free access to 
the drinking water through the experimental period. Animals were weighed before first 
application, on day 7 and at the end of the study. The first weighing was used for 
randomization, group formation and dose adjustments. From the first and last weighing of 
animals the mean body weight at the start and at the end of the study were calculated. The 
experiment was designed with 4 groups of animals. Two different garlic supplements (aged 
garlic extract – AGE or soft gelatin capsules with garlic oil macerates - GOM) were given 
orally to two groups daily by gavage for 14 days. The recommended human single oral 
doses of garlic supplements (2.5 mL of liquid AGE and 2 soft gelatin capsules of GOM, 
respectively) were adjusted according to the rats weight; AGE was diluted by saline and the 
content of soft gelatin capsules was diluted by sunflower seed oil (Table 1). Separately we 
also evaluated the impact of intragastric gavage of saline (sham-A group) and of 
sunflower seed oil (sham-B group), because they were used to dilute both garlic 
suspplements. The oil was chosen in compliance with OECD repeated dose methods 
where oil is recommended as vehicle for worse soluble items (OECD, 2008). Apart from 
intragastric gavage of different supplements/saline/sunflower seed oil, all groups had 
access to standard rat chow and water ad libidum. On day 15, rat small intestine, liver and 
plasma were obtained from rats after short fastening period before the sacrificing. After 
euthanasia and laparotomy, the intestine was rinsed with ice-cold 10 mM glucose Ringer 
solution and jejunum was used. Rat liver was preserved in ice-cold transportation 
medium, consisting of Williams medium E supplemented with L-glutamine (0.29 
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mL per kg 
371 386 
N – The number of fed rats; Mbefore - the mean rat weight before supplementation; Mafter – the mean rat 
weight on day 15. 
Table 1. The experimental design of chronic/long-term garlic supplementation to rats. 
Animals were fed with pelletized feed Global Diet 2018 ad libidum and had free access to 
the drinking water through the experimental period. Animals were weighed before first 
application, on day 7 and at the end of the study. The first weighing was used for 
randomization, group formation and dose adjustments. From the first and last weighing of 
animals the mean body weight at the start and at the end of the study were calculated. The 
experiment was designed with 4 groups of animals. Two different garlic supplements (aged 
garlic extract – AGE or soft gelatin capsules with garlic oil macerates - GOM) were given 
orally to two groups daily by gavage for 14 days. The recommended human single oral 
doses of garlic supplements (2.5 mL of liquid AGE and 2 soft gelatin capsules of GOM, 
respectively) were adjusted according to the rats weight; AGE was diluted by saline and the 
content of soft gelatin capsules was diluted by sunflower seed oil (Table 1). Separately we 
also evaluated the impact of intragastric gavage of saline (sham-A group) and of 
sunflower seed oil (sham-B group), because they were used to dilute both garlic 
suspplements. The oil was chosen in compliance with OECD repeated dose methods 
where oil is recommended as vehicle for worse soluble items (OECD, 2008). Apart from 
intragastric gavage of different supplements/saline/sunflower seed oil, all groups had 
access to standard rat chow and water ad libidum. On day 15, rat small intestine, liver and 
plasma were obtained from rats after short fastening period before the sacrificing. After 
euthanasia and laparotomy, the intestine was rinsed with ice-cold 10 mM glucose Ringer 
solution and jejunum was used. Rat liver was preserved in ice-cold transportation 
medium, consisting of Williams medium E supplemented with L-glutamine (0.29 
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mg/mL), insulin (0.13 I.U/mL), gentamicin (50 µg/mL) and ampicilin (100 µg/mL). 
Plasma samples of rats fed with AGE, GOM and of reference animals were withdrawn 
and stored at -70C until LC/MS/MS analysis. 
2.2.2 Saq and Dar permeability through rat jejunum 
The intestinal tissue was cut into 3 cm long segments, excluding visible Peyer’s patches. 
Intestinal segments were opened along the mesenteric border, stretched onto inserts with 
exposed tissue area of 1 cm2 and placed between two compartments of EasyMount side-by-
side diffusion chambers (Physiologic Instruments, San Diego, USA). 2.5 mL of bathing 
solution (Ringer buffer, pH 7.4) on each side of intestine was maintained at 37°C and 
continuously oxygenated and circulated by bubbling with carbogen (95% O2, 5% CO2). 625 
mM glucose and 625 mM mannitol were always added to the serosal (S) and mucosal (M) 
sides, respectively, to give 10 mM final concentrations. After 25 min of pre-incubation, 
incubation salines were replaced by donor solutions containing HIV-PIs at the highest 
concentrations, which could be prepared in Ringer buffer; Saq (25 µM) or Dar (100 µM).  If 
monitoring mucosal-to-serosal (M-S) permeability, donor solution also contained 10 mM 
mannitol, whereas if monitoring serosal-to-mucosal (S-M) permeability, 10 mM glucose was 
present in the donor solution. 250 µL of samples were withdrawn from the acceptor (M or S) 
side every 20 min up to 80 min and replaced by the fresh Ringer buffer containing all 
necessary ingredients at appropriate concentrations. The donor solutions were also replaced 
before each sampling time to avoid the loss of investigated compound (Saq, Dar) due to its 
intestinal metabolism. Immediately after sampling, the withdrawn samples were 
precipitated by methanol (1:3), which contained haloperidol (100 µg/L) as internal standard, 
vortexed and kept on ice for at least 15 min. Afterwards the proteins were removed by 
centrifugation for 10 minutes at 15 000 g and 4C. The supernatant was analyzed by 
LC/MS/MS for the parent drugs (Saq or Dar) and their metabolites. 
During the permeability experiments, the diffusion chambers were equipped with two pairs 
of Ag/AgCl electrodes for measuring transepithelial potential difference and short circuit 
current with a multi channel voltage-current clamp (model VCC MC6, Physiologic 
Instruments) enabling the evaluation of tissue integrity and viability during the 
experiments. Only tissues that retained their integrity and viability (described in details in 
Berginc et al (Berginc et al, 2010b)) were used for the analysis. 
During in vitro permeability experiments short-term and long-term effects were monitored. 
The expression short-term used throughout the text refers to the instant influence the 
addition of AGE supplement in 1 v/v % to the mucosal side of intestine from AGE or sham-
A group exerted (i.e. allosteric modifications). On the other hand, the expression long-term 
effects refer to the transcriptional/translation changes resulting in different protein 
expression due to 2 week supplementation of rats. 
2.2.3 Saq and Dar metabolism and transport in the rat liver slices 
Rat liver slices (250 µm thick) for the experiments were prepared and pre-incubated for 30 
min in the incubation medium (Williams medium E supplemented with L-glutamine (0.29 
mg/mL), insulin (0.13 I.U/mL), gentamicin (50 µg/mL) and ampicilin (100 µg/mL)) at 37C. 
Afterwards, each liver slice was incubated in 1.5 mL of the same medium, which also 
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contained 20 µM Saq or Dar. The samples of incubation medium were withdrawn after 30 
and 60 min for Saq and after 45 and 90 min for Dar to avoid steady state. After the 
incubation, liver slices were weighted and homogenized. All the samples were immediately 
precipitated with methanol (1:3) containing haloperidol as internal standard (100 µg/L). The 
samples were afterwards prepared for the analysis in the same manner as described for 
permeability experiments. The LC/MS/MS analysis of the liver extract samples and of the 
withdrawn samples from the incubation medium at different time points was performed. 
The transport rate (the rate of metabolite concentration increase in the incubation medium) 
of two Saq and two Dar metabolites (Saq-M1, Saq-M3, Dar-M1, Dar-M4) was determined. In 
the liver extracts concentrations of Saq/Dar and their metabolites were measured. By 
comparing concentrations of the parent drugs and their metabolites in the intracellular cell 
compartment obtained by extraction and the metabolite transport rates with the 
corresponding reference values (i.e. concentrations of Saq/Dar and their metabolites or 
metabolite transport rates determined without garlic phytochemicals) we were able to 
determine the impact of garlic supplements on the activity of efflux/uptake transporters 
into bile or back into plasma) and CYP3A4.  
2.2.4 Plasma preparation 
Prior to the LC/MS/MS analysis, each 200L plasma sample was precipitated with 3 
volumes of ice-cold methanol, briefly vortexed, left to stand on -20°C for two days and then 
centrifuged at 10 000 g for 10 min at 4°C. The supernatant was transferred to autosampler 
vials for subsequent LC/MS/MS analysis. 
2.2.5 LC/MS/MS sample analysis from studies with rat jejunum and liver slices 
LC/MS/MS analysis of the samples obtained in the in vitro transport/metabolism 
experiments was performed on a Varian 1200L triple-quadrupole LC–MS Varian (Palo Alto, 
CA, USA). The mass spectrometer was coupled to ProStar 210 binary pumps, a Varian 420 
autosampler and Varian 510 column oven. For chromatographic separation, a Phenomenex 
Kinetex 50x2.0 mm C-18 column with 2.6 m particles was used for Dar, and a Phenomenex 
Gemini 150x2.0 mm C-18 column with 3 m particles for Saq. The injection volume was 10 
L and the column temperature was 50 C. Mobile phase consisted of water and acetonitrile 
containing 0.1% of formic acid. The elution for Dar and its metabolites was performed using 
a linear gradient from 20% to 65% of organic phase in 4 minutes with a flow rate of 0.4 
mL/min, whereas that of Saq was performed using a linear gradient from 20% to 36% 
organic phase over 12 minutes with a flow rate of 0.5 mL/min. For the purpose of this 
study, two Dar (Dar-M1 – Dar carbamate hydrolysis (tr 3.3 min), Dar-M4 – Dar 
hydroxylation (tr 5.2 min)) 12 and two Saq (Saq-M1 – Saq oxidation at (1,1-
dimethylethyl)amino group (tr 8.1 min), Saq-M3 – Saq oxidation at benzyl group (tr 5.9 min)) 
(Fitzsimmons&Collins, 1996) metabolites were monitored. 
2.2.6 LC/MS/MS analyis of plasma samples 
Rat plasma samples were analyzed by a triple-quadrupole LC/MS/MS Agilent 6460 (Agilent 
Technologies, Waldbronn, Germany) equipped with a Jet-Stream ESI interface coupled to an 
Agilent 1290 Infinity UPLC. 1L of acetonitrile-precipitated rat plasma sample was injected on 
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The expression short-term used throughout the text refers to the instant influence the 
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contained 20 µM Saq or Dar. The samples of incubation medium were withdrawn after 30 
and 60 min for Saq and after 45 and 90 min for Dar to avoid steady state. After the 
incubation, liver slices were weighted and homogenized. All the samples were immediately 
precipitated with methanol (1:3) containing haloperidol as internal standard (100 µg/L). The 
samples were afterwards prepared for the analysis in the same manner as described for 
permeability experiments. The LC/MS/MS analysis of the liver extract samples and of the 
withdrawn samples from the incubation medium at different time points was performed. 
The transport rate (the rate of metabolite concentration increase in the incubation medium) 
of two Saq and two Dar metabolites (Saq-M1, Saq-M3, Dar-M1, Dar-M4) was determined. In 
the liver extracts concentrations of Saq/Dar and their metabolites were measured. By 
comparing concentrations of the parent drugs and their metabolites in the intracellular cell 
compartment obtained by extraction and the metabolite transport rates with the 
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experiments was performed on a Varian 1200L triple-quadrupole LC–MS Varian (Palo Alto, 
CA, USA). The mass spectrometer was coupled to ProStar 210 binary pumps, a Varian 420 
autosampler and Varian 510 column oven. For chromatographic separation, a Phenomenex 
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Gemini 150x2.0 mm C-18 column with 3 m particles for Saq. The injection volume was 10 
L and the column temperature was 50 C. Mobile phase consisted of water and acetonitrile 
containing 0.1% of formic acid. The elution for Dar and its metabolites was performed using 
a linear gradient from 20% to 65% of organic phase in 4 minutes with a flow rate of 0.4 
mL/min, whereas that of Saq was performed using a linear gradient from 20% to 36% 
organic phase over 12 minutes with a flow rate of 0.5 mL/min. For the purpose of this 
study, two Dar (Dar-M1 – Dar carbamate hydrolysis (tr 3.3 min), Dar-M4 – Dar 
hydroxylation (tr 5.2 min)) 12 and two Saq (Saq-M1 – Saq oxidation at (1,1-
dimethylethyl)amino group (tr 8.1 min), Saq-M3 – Saq oxidation at benzyl group (tr 5.9 min)) 
(Fitzsimmons&Collins, 1996) metabolites were monitored. 
2.2.6 LC/MS/MS analyis of plasma samples 
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Technologies, Waldbronn, Germany) equipped with a Jet-Stream ESI interface coupled to an 
Agilent 1290 Infinity UPLC. 1L of acetonitrile-precipitated rat plasma sample was injected on 
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a Phenomenex Synergi Polar-RP 100x3mm 2.5m column. The mobile phase A consisted of 
water with 0.1% formic acid and mobile phase B consisted of 98% acetonitrile with 2% water. 
The gradient elution was linear from 1% B to 90% B over 10 minutes and the flow rate was 0.4 
mL/min. After the column, the eluent was mixed with 0.2mL/min 100% acetonitrile via a 
zero-dead volume mixing tee in order to facilitate the evaporation and ionization process in 
the ESI Jet-Stream interface. The multiple reaction monitoring mode was used for the 
identification and relative quantification of AGE and GOM constituents in rat plasma (Table 4).  
2.2.7 Data analysis 







where dc/dt represents changes in HIV-PI concentration in the acceptor compartment per 
unit time under steady state conditions, V is the volume of the acceptor compartment, A is 
the exposed surface area (1 cm2) and c0  is the initial, donor concentration of HIV-PIs. 
Afterwards the ratios (Rex) were determined according to the Eq. (2) by dividing S-M Papp 
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Results in Tables and Figures are presented as means ± SD of at least 3 measurements. Data 
were evaluated statistically using SPSS 16.0 for Windows. Where appropriate, F-test for 
testing the equality of variances and, afterwards, 2-tailed Student t-test ( = 0.05), were 
used. Otherwise, one way ANOVA, followed by Bonferroni post-hoc test were applied. 
3. Results and discussion 
3.1 The impact of long-term garlic supplementation on HIV-PIs intestinal permeability 
The intestinal transporter-enzyme interplay (i.e. PGP and CYP3A4 or MRP-2 and UGT) can 
be responsible for lowering the fraction of the absorbed drugs that are subjected to the 
metabolism or transport with these proteins (Zhang et al, 2008). The PGP/MRP-2 mediated 
drug efflux from absorptive cells into the GIT lumen prolongs the overall residence time of 
drugs in the enterocytes through the more intense entero-enteric circulation, subjecting 
drugs to a more extensive intracellular phase I or phase II metabolism (Wu&Benet, 1999). 
The impact of long-term garlic supplementation on the activity of intestinal transporters and 
thus on the fraction of HIV-PIs (Saq, Dar) absorbed were assessed by evaluation of in vitro 
parent drug intestinal permeability through the rat jejunum (Table 2A, 2B). 100 µM Dar 
donor concentrations were chosen to simulate intraluminal Dar concentrations after peroral 
administration of clinical dose 12. Since low water-solubility limits achieving high Saq 
concentrations (Aungst, 1999), the highest possible Saq donor concentrations (25 µM), which 
could be prepared in Ringer buffer pH 7.4, were applied.  
Both HIV-PIs exerted low intestinal permeability regardless of whether rats were fed garlic 
supplements or not. Their M-S permeabilities were below 10×10-6 cm/s (Table 2A, 2B), the 
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limit above which drugs could be classified as highly permeable compounds according to 
our intra-laboratory experiments and FDA suggested highly permeable standards (Yu et al, 
2002). Tested HIV-PIs were also profoundly effluxed from enterocytes into the lumen (high 
Rex values, Table 2A and 2B – 1st phase designated “No Garlic”), indicating that at clinical 
Dar doses or the highest Saq doses, efflux transporters (Pgp, Mrp-2) were not saturated. This 
is in accordance with the results obtained by Holmstock (Holmstock et al, 2010). Namely, 
their Caco-2 permeability experiments and in situ intestinal perfusions of Pgp knock-down 
mice indicated a profound participation of Pgp in Dars secretion from absorptive cells even 
at the highest tested - clinical 100 µM dose. Transporter saturation was also not achieved 
with 25 μM Saq, as evident from significantly higher Rex values (higher than 3, Table 2B) 
compared to the value 1, which usually indicates complete transporter inhibition. Since 
Pgp/Mrp-2 were not inhibited in vitro, the in vivo impact of efflux transporters on limiting 
drug absorption could also be significant, owing to the higher expression of transporters in 
human small intestine than in the rats (Cao et al, 2006). Therefore, gut represents an 
important biological barrier in achieving therapeutic plasma HIV-PI levels.  
 
Table 2A  
Darunavir - 
Papp GIT (100 
µM) [cm/s] 
No garlic AGE addition 
M-S (*10-7) S-M (*10-6) Rex M-S (*10-7) S-M (*10-6) Rex 
Sham-A group 7.7 ± 0.7 20.4 ± 1.0* 26 10.4 ± 4.4 20.6 ± 1.6* 20 
AGE group 8.6 ± 0.5 13.4 ± 1.0*a 16 9.2 ± 1.1 11.8 ± 3.1* 13 
Sham-B group 9.5 ± 2.1 17.9 ± 1.8* 19    
GOM group 8.1 ± 2.1 5.8 ± 1.7*a 7.2    
 
Table 2B  
Saquinavir - 
Papp GIT (25 
µM) [cm/s] 
No garlic AGE addition 
M-S (*10-7) S-M (*10-6) Rex M-S (*10-7) S-M (*10-6) Rex 
Sham-A group 6.7 ± 0.3 2.6 ± 0.7* 3.9 5.9 ± 0.4 3.7 ± 0.3*b 6.3 
AGE group 7.0 ± 2.0 5.6 ± 1.0*a 4 5.9 ± 0.5 7.4 ± 0.4*b 13 
Sham-B group 6.9 ± 0.8 2.3 ± 0.2* 2.9      
GOM group 6.5 ± 2.7 4.9 ± 0.6*a 7.5       
HIV-PIs permeability was determined in two phases; first the permeability was measured in Ringer 
buffer pH 7.4 (20 min sampling intervals for 80 min – No garlic) and afterwards AGE was added to the 
mucosal side of rat ileum to give 1 % final AGE concentration and the experiment continued for 
additional 80 min (AGE addition). 
* - S-M Papp HIV-PI values are significantly higher than the corresponding M-S Papp values  
a – S-M Papp values of treated rats (AGE or GOM group) significantly higher/lower than reference S-M 
Papp values (sham-A and sham-B group) 
b – S-M Papp values determined after the addition of AGE significantly changed compared to S-M Papp 
values in the first phase 
Table 2. Saq and Dar intestinal permeability through rat jejunum determined in rats fed 
different garlic supplements (AGE or GOM – AGE and GOM group), saline (sham-A group) 
or sunflower seed oil (sham-B group). The permeability values of Saq and Dar after the 
addition of AGE are also given (AGE addition) in the table. 
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limit above which drugs could be classified as highly permeable compounds according to 
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2002). Tested HIV-PIs were also profoundly effluxed from enterocytes into the lumen (high 
Rex values, Table 2A and 2B – 1st phase designated “No Garlic”), indicating that at clinical 
Dar doses or the highest Saq doses, efflux transporters (Pgp, Mrp-2) were not saturated. This 
is in accordance with the results obtained by Holmstock (Holmstock et al, 2010). Namely, 
their Caco-2 permeability experiments and in situ intestinal perfusions of Pgp knock-down 
mice indicated a profound participation of Pgp in Dars secretion from absorptive cells even 
at the highest tested - clinical 100 µM dose. Transporter saturation was also not achieved 
with 25 μM Saq, as evident from significantly higher Rex values (higher than 3, Table 2B) 
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human small intestine than in the rats (Cao et al, 2006). Therefore, gut represents an 
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The short-term impact (i.e. instant/allosteric changes of transporter/enzyme activities) 
induced by AGE phytochemicals on intestinal rats ABC transporters (Pgp, Mrp-2), involved 
in HIV-PI (Saq, Dar) absorption, have been investigated in our previous studies, where no 
feeding protocols were applied (Berginc et al, 2009; Berginc et al, 2010c). In the presented 
study these effects were re-investigated with the intestine of AGE fed rats to elucidate the 
(ir)reversibility of garlic phytochemicals or phytochemical metabolites binding to the efflux 
transporters. We reported previously that activities of Pgp and Mrp-2 significantly changed 
owing to allosteric modulations exerted in the presence of AGE components (Berginc et al, 
2009; Berginc et al, 2010c). The impact of Pgp on the absorption of HIV-PIs was found to 
exceed that of Mrp-2, which has also been corroborated by Usansky (Usansky et al, 2008) in 
their in vivo study with Sprague-Dawley rats and Saq. In the case of Dar, mixed reports can 
be found regarding MRP-2/Mrp-2 importance in Dar absorption (Berginc et al, 2010c; 
Kakuda&Kiser, 2006). Based on this and the Mrp-2 expression pattern along GIT tract in rats 
(Mrp-2 expression decreases in more distal parts of rats small intestine) (Berginc et al, 2010c; 
Usansky et al, 2008), the participation of Mrp-2 in HIV-PIs intestinal absorption is minor and 
the observed short-term effects in our studies were predominately caused by modified Pgps 
activity. The noted short-term activity changes of the studied ABC transporters in our 
previous studies were explained by multiple binding sites in these transporters (four in Pgp 
and two in MRP-2) (Martin et al, 2000), which allow simultaneous binding of more 
substrates leading to allosteric modifications. Allosteric modifications induced by AGE 
phytochemicals in these studies were observed either as competitive inhibition between 
compounds (phytochemicals and drug) for an identical binding site (i.e. Dar – unchanged 
efflux) or as positive-cooperative effect and increased efflux (i.e. Saq), when the preferences 
of all involved substances for binding sites are distinct (Berginc et al, 2009; Berginc et al, 
2010c). Similar allosteric modification of intestinal transporters involved in Saq and Dar 
efflux were also observed using small intestine of AGE fed rats in this study; Saq efflux 
significantly increased, whereas Dar efflux remained unchanged (slight but statistically 
insignificant decrease - Table 2A and 2B – phase “AGE addition”).  The content of soft-
gelatin capsules containing GOM could not be tested for their short-term influence on efflux 
transporters due to its poor miscibility with the incubation buffer, which would prevent 
adequate diffusion of oily phytochemicals from emulsion to the mucosal surface. The short-
term modifications of efflux transporter activities were equally pronounced in rats, fed AGE, 
and in the control rats (sham-A group). Namely the average ratios between S-M Papp values 
after and before AGE addition were ca 1.0 for Dar and 1.5 for Saq, regardless which rats 
were used (treated or untreated – Table 2; sham-A and AGE group). This means that in the 
time-frame from the last intragastric gavage of garlic supplement and animal euthanization 
(18 h), garlic phytochemicals must have completely dissociated from intestinal efflux 
transporters to determine identical magnitude of permeability changes. Intestinal 
transporters in fed rats therefore could remain occupied with garlic phytochemicals after 
intragastric gavage but for at most 18 h per day. This could be sufficient to change 
transporter expression in the long run. However, transcriptional/translational effects and 
consequently elevated/decreased transporter expression could also be induced by binding 
of the absorbed xenobiotics on the transporters gene promoters or to the corresponding 
transcriptional factors. Both scenarios could thus contribute to potential long-term 
expression changes. In the presented study mRNA or protein levels to quantify Pgp/Mrp-2 
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expression levels in (un)treated rats were not performed, because increased mRNA levels 
for Pgp have been found to correlate well with increased protein levels and its functionality 
(MacLean et al, 2008; Englund et al, 2006). Although such correlation between mRNA and 
protein levels for Mrp-2 has not yet been established (MacLean et al, 2008), diallyl disulfide, 
garlic sulfide present in oily (i.e. GOM) preparations and in smaller amounts also in 
aqueous/hydrophilic garlic supplements (i.e. AGE) (Berginc et al, 2009), induced 
transcription of Mrp-2, leading to increased Mrp-2 protein levels in rat renal brush-border 
membrane vesicles. Owing to the established positive correlation between increased 
Pgp/Mrp-2 levels (elevated protein and mRNA levels) and their functionality, the long-term 
impact of garlic constituents on the Saq and Dar intestinal permeability was assessed 
directly by measuring their permeabilities.  
A 14-day AGE or GOM supplementation to rats significantly affected intestinal permeability 
of both antiretrovirals (Table 2A and 2B – AGE, GOM group); the efflux of Saq significantly 
increased and that of Dar significantly decreased compared to reference values (S-M Papp 
values of sham-A group – Table 2; see column “No garlic”). M-S permeabilities in both cases 
did not change (M-S Papp values sham-A or sham-B group). Sunflower seed oil, used to 
dilute GOM doses, had no impact on the permeability of tested HIV-PIs.  
The increase of Saqs S-M Papp values observed in rats fed with both garlic supplements as 
mentioned, implies that the expression of efflux transporters in the mucosal enterocytic 
membrane must have increased during long-term garlic supplementation due to the 
repeated exposure of enterocytes to garlic phytochemicals or perhaps their metabolites. In 
fact, our results partially confirm a hypothesis which has been proposed by Piscitelli 
(Piscitelli et al, 2002) to explain lower amounts of absorbed Saq in a clinical study. Our 
results are in accordance with the part of hypothesis, which claims that the transporter 
expression changes could be induced by garlic phytochemicals or their metabolites. Since 
rats were not fed HIV-PIs and garlic supplements simultaneously as performed in clinical 
study by Piscitelli, the second part of his hypothesis that the parent drug (Saq) or its 
metabolites could also be responsible for the observed effects, could not been corroborated. 
However, in the case of Dar, in spite of the suggested increased transporter expression, the 
efflux of this HIV-PI was significantly lower than that determined for the untreated rats 
(sham-A group). As we mentioned previously, Dar and Saq Pgp binding sites are not 
identical, which was confirmed in previous in vitro study on rat intestine using ritonavir 
(Rito) as potent Pgp and Mrp-2 inhibitor (Berginc et al, 2010c). While Rito significantly 
inhibited Dar efflux from enterocytes regardless of the applied Rito concentration, that was 
not true for Saq. Instead of inhibiting Pgp-mediated Saq efflux, low Rito concentrations 
stimulated active Saq excretion and the inhibition was achieved only at saturable Rito 
concentrations. This undoubtedly indicated that Dar and Rito share identical binding site on 
Pgp, whereas Saq and Rito do not; only after Rito-Pgp binding site(s) are completely 
occupied by Rito, Rito can displace Saq from its binding site on Pgp. Therefore, significant 
decrease of Dar efflux after 2-week rat supplementation with garlic products observed in 
this study was most probably due to the occupation of Dar-binding site on Pgp by garlic 
phytochemicals or their metabolites with longer half-life(s). This indicates that the 
compounds from garlic supplements remained bound to intestinal transporters for at least 
18h, additionally confirming Piscitelli′ assumptions (Piscitelli et al, 2002).  
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3.2 The impact of long-term garlic supplementation on HIV-PIs hepatic 
pharmacokinetics 
Various high-throughput screening studies using human hepatic microsomes (Foster et al, 
2001) and recombinant CYP3A4 enzymes (Pal&Mitra, 2006) indicated that lipophilic garlic 
supplements, AGE and individual garlic phytochemicals could significantly inhibit CYP3A4 
activity (short-term effect) and consequently impair HIV-PI (Saq, Dar) metabolism. The 
short-term effects of AGE on the hepatic HIV-PI distribution and metabolism in rat liver 
slices have also been investigated in our previous studies, where we have shown that AGE 
allosterically activated Pgp transport (i.e. it decreased intracellular concentrations of Pgp 
substrate - Dar) in the same manner as in the intestine but inhibited hepatic Mrp-2 transport. 
We determined that Mrp-2 inhibition observed in those studies was caused by metabolism 
of garlic flavonoids to the corresponding glucuronide metabolites, which are good MRP-
2/Mrp-2 substrates. These glucuronide metabolites bind to Mrp-2 and competitively 
displace other Mrp-2 substrates (i.e. Saq) from these transporters, causing an increase of 
intrahepatic Saq concentrations. The inhibition of CYP3A4 HIV-PI metabolism by AGE was 
also confirmed in that study (Berginc et al, 2010d). 
However after 14 days of AGE supplementation, the concentrations of both tested HIV-PIs 
in rat liver slices significantly increased (Table 3). Similar results were obtained also with 
rats fed with GOM, but the impact of GOM supplementation on the hepatic 
pharmacokinetics was obscured by the high influence of reference treatment - sunflower oil 
alone (sham-B group). Namely, if one compares intracellular concentrations of parent drugs 
and of the corresponding metabolites in the extracts from the liver slices of rats fed only 
sunflower oil (Table 3, sham-B group) with the corresponding values obtained from liver 
slices of rats fed saline (Table 3: sham-A group), it is obvious that sunflower oil itself 
exhibited pronounced effects on HIV-PI hepatic distribution and metabolism. The effect of 
GOM was thus more difficult to evaluate than that of AGE (Table 3; sham-A and AGE 
group). The daily quantities of the sunflower seed oil used to dilute GOM for sufficiently 
exact dosing and in the appropriate reference group was ca. 1 mL. According to the 
guidelines, this amount added to the rat's dietary fat intake does not influence the animal's 
condition regarding the clinical examination, hematological, biochemical and histological 
parameters (OECD, 2008). However, the increased daily fat intake was obviously sufficient 
to induce transcriptional/translational changes, which finally led to changes in HIV-PIs 
hepatic distribution and metabolism (significantly higher intracellular HIV-PI 
concentrations in rat liver slices and significantly higher formation and excretion rate of 
metabolites) compared to the reference values (Sham A group). Sunflower seed oil 
represents a good source of monounsaturated fatty acids (i.e. oleic acid), which have been 
known to reversibly increase the transcription of enzymes (among them also CYP) in liver 
and gut (Niot et al, 1997; Chen et al, 2001). The intake of higher fat quantities also interferes 
with endogenous lipid synthesis in metabolism, leading to changes in the plasma lipids and 
bile acid composition. To avoid cytotoxicity of the increased amounts of bile acids formed; 
these acids need to be excreted into the bile. Therefore, the increased production of bile acids 
had to be accompanied with the increased transporter expression to ensure cell survival. 
The excretion of bile acids into gallbladder involves the uptake of these endogenous 
compounds from plasma into hepatocytes with the aid of uptake transporters (i.e. NTCP, 
OATPs) and their excretion into the gallbladder by sinusoidal efflux proteins (Pgp, Mrp-2, S-
Pgp, MDR3) (Meier et al, 1997a). Therefore the expression of these transporters in organisms 
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fed high fat diet would also increase, explaining the effects observed in this study on the 
hepatic HIV-PI pharmacokinetics in sunflower seed oil fed animals (sham-B group).  
 
Table 3A EXTRACT (mol/mg) TRANSPORT RATE 
(µmol/min*mg) 
 Saq (*10-11) Saq-M1 (*10-13) Saq-M3 (*10-12) Saq-M1 (*10-9) Saq-M3 (*10-8) 
Sham-A group 2.9 ± 0.3 4.6 ± 1.0 2.3 ± 0.1 3.8 ± 0.4 3.7 ± 0.3 
AGE group 8.2 ± 0.2* 3.9 ± 0.7 2.4 ± 0.4 3.4 ± 0.3 3.2 ± 0.2 
Sham-B group 8.1 ± 0.4* 4.9 ± 0.2 4.7 ± 0.7* 5.6 ± 0.6* 6.4 ± 0.6* 
GOM group 10.3 ± 0.4*a 7.8 ± 0.7* 4.3 ± 0.9* 4.8 ± 0.1* 6.0 ± 0.3* 
 
Table 3B EXTRACT (mol/mg) TRANSPORT RATE 
(µmol/min*mg) 
 Dar (*10-11) Dar-M1 (*10-11) Dar-M4 (*10-12) Dar-M1 (*10-8) Dar-M4 (*10-8) 
Sham-A group 7.8 ± 0.6 2.5 ± 0.2 3.4 ± 0.2 3.6 ± 0.8 2.1 ± 0.2 
AGE group 10.3 ± 1.0* 1.7 ± 0.0* 1.7 ± 0.6* 2.7 ± 0.5 1.8 ± 0.3 
Sham-B group 8.5 ± 0.5* 2.8 ± 0.3 6.0 ± 0.4* 6.1 ± 1.4* 5.9 ± 0.1* 
GOM group 10.2 ± 1.1*a 3.2 ± 0.2* 5.0 ± 0.7* 4.7 ± 0.5 4.5 ± 0.3* 
* - the amounts of HIV-PIs and of the corresponding metabolites in the rat liver extracts or metabolite 
transport rates are significantly higher/lower than the corresponding reference values (sham-A and B 
group). 
a – significantly higher HIV-PI amounts in the extract compared to the amounts of HIV-PIs, determined 
in the extracts of rat liver extracts from control sham-A group. 
Table 3. Saq (Table 3A) and Dar (Table 3B) hepatic in vitro pharmacokinetics evaluated in rat 
liver slices obtained from rats fed with different garlic supplements (AGE or GOM groups), 
saline (sham-A group) or sunflower seed oil (sham-B group). The amounts of HIV-PIs and 
of the corresponding metabolites in the rat liver extracts and the metabolite transport rates 
from the rat liver slices into the incubation medium were determined. 
Higher intrahepatic retention of HIV-PIs after prolonged garlic consumption could thus be 
explained by two factors. First, hepatocytes were obviously exposed to lower concentration 
of xenobiotics or their metabolites, responsible for the induction of Pgp compared to 
enterocytes. Namely after peroral absorption of garlic phytochemicals, lower amounts of 
garlic phytochemicals and their corresponding metabolites could reach hepatocytes due to 
incomplete/low xenobiotic absorption through the intestinal mucosa, binding to 
enterocytes mucosal membranes, instability in GIT lumen and intraluminal metabolism, 
which altogether contributed to less profound effect on the expression of efflux transporters 
in hepatocytes than in the jejunum (Ioannides, 2003; Lawson&Wang, 2005b). Besides efflux 
transporters, Saq and Dar also utilize OATP1A2 (OATP-A), 1B1 (OATP-C) and 1B3 (OATP-
8) solute uptake transporters to distribute into the human liver (Hartkoorn et al, 2010). The 
sinusoidal rat hepatocyte membrane embodies numerous Oatp isoforms with Oatp1, Oatp2 
and Oatp4 being the most important ones (Treiber et al, 2004; Meier et al, 1997b). Because 
AGE has been shown to affect Oatp activity (Berginc et al, 2010b), increased intrahepatic 
HIV-PI concentrations observed in this study could also correspond to the increased Oatp 
expression in the liver, which by its influence on the HIV-PIs pharmacokinetics could have 
exceeded the effects of efflux transporters.  
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exceeded the effects of efflux transporters.  
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These results suggest that the observed hepatic physiological adaptations to 
supplementation of garlic products or sunflower seed oil were exerted by garlic 
phytochemicals, components of sunflower seed oil and/or the corresponding metabolites. 
Because AGE lacks oily compounds that constitute GOM and/or sunflower seed oil, the 
substances responsible for the changes in membrane transporter expression, were most 
probably different. The differences in garlic supplement composition and/or plasma levels 
of garlic phytochemicals notwithstanding, the same final effect regarding HIV-PIs and HIV-
PI-metabolite hepatic distribution were observed. The composition dissimilarities of garlic 
supplements and consequently of the produced metabolites also affected HIV-PIs Cyp3A 
metabolism in the liver slices differently. According to our results (Table 3), less Saq and 
especially Dar metabolites were formed in AGE group compared to the control sham-A 
group. However, in the presence of GOM and sunflower seed oil, Cyp metabolism of both 
investigated drugs significantly increased (note the significant increase of Saq-M1 and Dar-
M4 in Table 3). Our results are in accordance with experimental data obtained in studies 
with various oily garlic supplements and AGE (Fischer et al, 2007). Garlic oil constituents, 
diallyl sulfide, diallyl disulfide and diallyl trisulfide have been found to increase the 
transcription of several hepatic enzymes (Cyp1A1, 2B1 and 3A1, NAD(P)H quinine 
oxidoreductase 1, glutathione-S-transferase) in wild type Wistar-Kyoto rats (Fischer et al, 
2007), similarly to our findings in GOM group (increased production of HIV-PI metabolites 
and consequently their faster transport from hepatocytes into the incubation media). 
However, another clinical study on volunteers taking garlic extract (GarliPure) twice daily 
for 3 weeks indicated no impact of garlic phytochemicals on CYP3A4 expression in intestine 
or liver, while at the same time PGP expression significantly increased (Hajdaa et al, 2010). 
GarliPure extract is labeled to contain -glutamylcysteines (12 mg), alliin (4.8 mg), sulfur 
(3.9 mg), thiosulfinates (3.8 mg) and to have an allicin releasing potential, meaning that after 
consumption, this product enables in vivo allicin synthesis from alliin in ca 3.6 mg quantities. 
AGE, which we used to feed rats in this study, also predominately containes -
glutamylcysteines with S-allyl-L-cysteine being the main representative. However, AGE 
does not contain allicin because during the aging process, the content of lipophilic allicin 
degradation products declines and the compounds responsible for distinct garlic odor and 
unwanted side effects in AGE are thus minimized. However, based on our analysis, small 
amounts of these lipophilic phytochemicals are still present in AGE (Berginc et al, 2009). A 
recent analysis by Lawson and Wang (Lawson&Wang, 2001a) indicated that only one of 24 
marketed allicin-releasing brands enabled the release of the designated amount of allicin, 
whereas the release from other supplements reached only 10 to 15% of the declared values. 
Therefore, one can assume that the compositions of GarliPure and of AGE used in this 
study are very similar. Similar to observations in the study with GarliPure impact on Saq 
pharmacokinetics in humans (Hajdaa et al, 2010) we also determined no impact of long term 
AGE supplementation on Cyp3A Saq metabolism in rats, indicating that the expression of 
this enzyme remained constant in spite of AGE administration. However in the case of Dar, 
AGE significantly decreased its metabolism. Similarly to multiple binding sites in efflux 
transporters, the CYP3A4 kinetic studies by Shou (Shou et al, 1994) performed on CYP3A4 
transfected HepG2 cells indicated the existence of two binding sites in this enzyme. It is thus 
possible, that Saq and Dar, although metabolized by the same enzyme (i.e. CYP3A4), do not 
share identical binding sites on CYP3A4, which would be similar to their interaction with 
Pgp transporters. Phytochemicals or metabolites present in or derived from AGE (but not 
GOM) could have occupied the Dar but not Saq binding site on CYP3A enzyme, similarly as 
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in the case of Pgp transporter. This resulted in altered Dar but not Saq metabolism. However 
this hypothesis will be difficult to confirm until more structural and functional information 
is available about the binding sites of CYP3A enzymes.  
3.3 Plasma levels of AGE and GOM constituents and their metabolites 
The plasma levels of AGE and GOM constituents in plasma samples taken 24 hours after the 
last dosing were very low, resulting in signals near the limit of detection on a top-of-the line 
LC/MS/MS system. This fact primarily confirms that we were really observing the long-
term influences of AGE and GOM exerted through altered enzyme and transporter 
expression in our experiments with the tissue samples rather than short-term allosteric or 
competitive effects of garlic constituents remaining in the isolated animal tissues. 
Nevertheless, significantly higher levels of garlic constituents were obtained in the plasma 
from AGE group compared to the plasma of GOM group (Table 4). The levels of S-allyl-L-
cysteine, tangeretin and quercetin were 2, 5.4 and 8 times higher, respectively, in the plasma 
of AGE group compared to the GOM group. The relatively long period between the last 
dose and the plasma sampling allowed the majority of garlic-related metabolites to be 
excreted, so the only metabolite that was confidently quantified, was bergamottine 
glucuronide and it was present in the AGE group. The much higher concentration of garlic 
constituents and metabolites in the plasma of AGE group is in accordance with the results 
from the rat liver slices experiment, where it was shown that the influence of AGE 
supplementation on the Saq and Dar liver disposition was beyond that of GOM's (Table 3). 
It could be argued that the majority of GOM constituents and their metabolites were already 
eliminated especially through the lungs (they are volatile) before we performed experiments 
with the liver slice and before the plasma samples were taken, since the rats were fasting for 
18 hours before the sacrifice. On the other hand, the long term changes of hepatic protein 
expression caused by GOM supplementation should have remained relatively unchanged 
after 2 weeks in spite of short period of food and GOM deprivation. Therefore, the 
conclusion of AGE’s greater influence on HIV-PI’s hepatic disposition remains unchanged. 
 













Rutin 611->303 (+) 4,81 34 N/D N/D 
Bergammotine 339->203 (+) 10,35 N/D N/D N/D 
S-allyl-L-cysteine 162->145 (+) 2,32 1174 593 152 
Adenosine 268->136 (+) 2,62 3041 2079 515 
Tangeretine 373->343 (+) 8,55 1227 229 306 
Quercetine 301->151 (-) 6,37 412 51 116 
Bergammotin-glucuronide 515->339 (+) 6,96 1088 N/D N/D 
N/D - the response was below the limit of detection 
Table 4. The multiple reaction monitoring mode (MRM) transitions used for the LC/MS/MS 
identification and quantification of garlic constituents in rat plasma (first two columns) and the 
peak areas obtained from the plasma samples of rats fed with AGE, GOM and the reference 
group (the last three columns: Plasma-AGE, Plasma-GOM and Plasma-REF, respectively).  
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Furthermore, based on the plasma profiles from rats exposed to different garlic 
supplements, it can be concluded that constituents and their metabolites, although 
structurally and chemically different, induced similar hepatic effects regarding the 
transporter expression but exerted significantly different effect on CYP3A metabolism of 
both compounds. The affinities of these metabolites or their parent phytochemicals from 
both supplements for CYP3A are evidently different, because AGE constituents/metabolites 
inhibited/did not affect Cyp3A HIV-PI metabolism, whereas HIV-PI Cyp3A metabolism 
increased after long-term GOM supplementation. 
4. Conclusion 
Although applied at the highest possible donor concentrations, both drugs (Saq, Dar) 
displayed very low permeability in the absorptive direction and were subjected to a 
profound efflux from enterocytes back into intestinal lumen, indicating that the intestinal 
wall represents an important biological barrier for attaining therapeutic HIV-PIs plasma 
levels. 
A concomitant consumption of garlic supplements together with HIV-PIs places the infected 
patients at higher risk for therapy failure, because the components of garlic supplements 
and/or their metabolites readily bind to efflux transporters. This binding changes the 
activities of efflux transporters by allosteric modifications in short-term and leads to an 
increased expression in the long run. Although two garlic supplements with different 
compositions were used, ABC transporter activity in the intestine increased similarly in both 
cases. Long-term garlic supplementation also affected hepatic metabolism and distribution 
of both HIV-PIs. Contrary to the effects in the intestine, the up-regulation of efflux 
transporters in the liver was less important than the increased expression of uptake Oatps 
transporters, which resulted in the overall increased intrahepatic HIV-PI amounts that could 
be further subjected to Cyp3A metabolism. Although the effects of AGE and GOM were 
similar regarding the transporter expression, their effects on Cyp3A metabolism were 
significantly different. AGE inhibited Dar but not Saq Cyp3A metabolism, while in GOM 
treated rats the Cyp3A metabolism of both drugs significantly increased, highlighting 
important dissimilarities in plasma profiles of garlic phytochemicals and the corresponding 
metabolites, as shown in this study. Given the fact that garlic supplements are so widely 
used in the HIV infected population because of their protective cardiovascular and anti-
infective effects, further research should be directed at the identification of high- and low-
risk supplement – drug combinations.  
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1. Introduction 
Human African trypanosomiasis, also known as sleeping sickness, is a vector-borne 
parasitic disease. The parasites concerned are protozoa belonging to the Trypanosoma genus. 
They are transmitted to humans by tsetse fly (Glossina genus) which have acquired their 
infection from human beings or from animals harbouring the human pathogenic parasites. 
Rural populations living in regions where transmission occurs and which depend on 
agriculture, fishing, animal husbandry or hunting are the most exposed to the disease. 
Sleeping sickness threatens millions of people in 36 countries in sub-Saharan Africa. Many 
of the affected populations live in remote areas with limited access to adequate health 
services. Treatment depends on drugs that can cross the blood-brain barrier to reach the 
parasite. Such drugs are toxic and complicated to administer. Suramin, discovered in 1921, 
is one of the drugs used for the treatment. However, it provokes certain undesirable effects, 
in the urinary tract and allergic reactions. Other drugs in use are equally toxic and difficult 
to administer. Thus the need to develop new drugs is imperative. Natural products and 
medicinal plants (Antia et al, 2009; Sara et al, 2004; Bizimana et al., 2006; Okpekon et al., 
2004) have continued to contribute to the search for new and potent anti-trypanosomal 
drugs with minimal side effects. Their continued relevance in drug discovery and 
development is due to their bioactivity, biodiversity and reported safety in their use. An 
analysis of new and approved drugs for the treatment of human diseases indicated that 
natural products have continued to play a highly significant role in the drug discovery and 
development process. Thus biologically active natural products from plants, their 
derivatives or analogues contributed up to 57% of top selling prescription drugs in the 
United States in 1997 (Newman et al., 1997). This dominant role is due to the leads for the 
development of drugs that natural products give. Thus expanding, not decreasing, the 
exploration of nature as a source of novel active agents that may serve as leads and scaffolds 
for elaboration into desperately needed efficacious drugs for a multitude of disease 
indications is advocated (Newman & Cragg, 2007).  Ethnobotanical surveys have revealed 
the use of Alcornea cordifolia, Euphorbia poisonii, Monodora myristica, Prosopis africana, Spondias 
mombim, Nauclea pobeguinii, Terminalia avicennioides, Cochlospermum planchonii, Nauclea 
latifolia and Withania somnifera in the traditional medicine in parts of Nigeria (Igoli et. al., 
2005). These plants are used as spices and medicinally for the treatment of diarrhoea, 
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dysentery, diabetes, bacterial infections, fevers, pain and snake bites amongst other ailments 
by the Igede people of Benue State in Nigeria. Maytenus laevis is used in traditional medicine 
in Colombia (Nagakawa et.al., 2004; Gonzalez et al., 1982) against pain and arthritis. Before 
the introduction of synthetically prepared medicines, herbal remedies were commonly 
prescribed and were often effective. Thus herbs and spices played very important, 
sometimes magical, roles in medicine. Hence these plants were collected and their extracts/ 
compounds isolated were evaluated for anti-trypanosomal and cytotoxic activities. A high 
throughput (HTS) method was used to screen the extracts and compounds. This has become 
very useful in modern drug discovery from natural products. It is a form of standardised 
and replicate screening method which employs 96 well plates which can be used to screen 
80 extracts, compounds or fractions at the same time. It can also be adapted to obtain data to 
plot dose response curves and determine IC50 and MIC values. Using a multilabel counter, 
suitable indicators, wells with extracts, cells, organisms and controls can be read quickly by 
examining fluorescence, luminescence and optical density or by radiometry giving exact 
and replicable values free from errors of visual determinations or measurements. The 
volumes used in these wells are between 200-250µL and for half well plates 20-40µL such 
that solutions of extracts or compounds as low as 1mg dissolved in 100µL gives a stock 
solution of 10mg/ml which can be diluted for all range of concentrations typically from 20-
30µg/ml to ng or µM to nM values using serial dilution methods. This greatly enhances 
speed and efficacy of screening for hit molecules (Gray et al., 2011). Efforts were made to 
identify the active compounds contained in the extracts as much as possible. This is because 
it is the practice today to screen more and more pure compounds rather than crude extracts 
or fractions. Screening of crude extracts or mixtures/fractions does not allow understanding 
of the mode of activity of the test compounds against the target cells or tissues. Isolation of 
the active compounds is required before active concentrations can be determined. We 
hereby report on these plant extracts, the compounds obtained from them, their in vitro 
activity against the bloodstream form of Trypanosoma brucei brucei (T.b.brucei) and the 
cytotoxic activity of the active compounds/extracts against PNT2A cells. 
2. Materials and methods 
Standard methods of extraction and isolation or purification of compounds/extracts from 
plant materials were used while a standardised 96 well based assay was used to screen the 
extracts for anti-trypanosomal activity and cytotoxicity. The crude extracts as well as pure 
compounds obtained were screened in vitro for trypanosomal activity against Trypanosoma 
brucei brucei (S427) blood stream forms. Active compounds from the preliminary screens 
were further tested to confirm activity and determine their minimum inhibitory 
concentration (MIC) values.  Cytotoxicity of the active compounds and extracts was then 
tested against PNT2A cells (“normal” prostatic cells). 
2.1 General bioassay 
The anti-trypanosomal and cytotoxicity assays were performed using the REDOX indicator 
Alamar blue™. The active component of which is resazurin (blue in colour) which in the 
presence of live parasites or cells is reduced to the bright pink fluorescent resorufin. The 
fluorescence values for the test plates are measured using a microplate reader in 
fluorescence mode with excitation and emission wavelengths of 560 and 590nm respectively.  
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Wells containing active compounds are easily identified as they remain blue in colour and 
have background levels of fluorescence. The test samples are initially screened at a single 
concentration and then MIC or IC 50 values are determined for the active compounds at n=2 
or n=3. Positive and negative controls and a sterility checks are included in all assays. The 
incubation and treatment times, incubation conditions and seeding densities are optimised 
for each test species and cell line. 
2.1.1 Anti-trypanosomal activity 
Samples were tested against the bloodstream form of Trypanosoma brucei brucei (T.b.brucei) 
S427. The activity of the plant extracts and isolated compounds was determined using 
the well-established Alamar blue™ 96 well microplate assay. Samples were initially 
screened at a single concentration usually 20µg/ml for extracts or 20µM for pure 
compounds. The concentration of dimethylsulphoxide (DMSO) should not exceed 0.5% in 
the initial screen. 
Samples for testing were prepared as 10mg/ml or 10mM stock solutions in 100% DMSO. 
These were diluted with HMI-9 medium to a concentration of 1mg/ml /1mM. 4µl of the test 
sample was added to the assay well then 96µl HMI-9 medium to give a final assay 
concentration after a 1:1 dilution of 20µg/ml / 20µM.  
 1 2 3 4 5 6 7 8 9 10 11 12 
A Sterility control 1 2 3 4 5 6 7 8 9 10 1.0µM 
suramin 
B control 11 12 13 14 15 16 17 18 19 20 0.5µM 
suramin 
C control 21 22 23 24 25 26 27 28 29 30 0.25µM 
suramin  
D control 31 32 33 34 35 36 37 38 39 40 0.125µM 
suramin 
E DMSO control 41 42 43 44 45 46 47 48 49 50 0.062µM 
suramin  
F DMSO control 51 52 53 54 55 56 57 58 59 60 0.031µM 
suramin 
G DMSO control 61 62 63 64 65 66 67 68 69 70 0.015µM 
suramin  
H DMSO control 71 72 73 74 75 76 77 78 79 80 0.008µM 
suramin 
Table 1. Anti-trypanosomiasis assay plate layout. 
The screening plate was arranged as illustrated in Table 1. Controls including a sterility 
control and DMSO controls in column 1; test samples in columns 2 to 11 and a concentration 
range of suramin as a positive control in column12. Trypanosomes were counted using a 
haemocytometer and diluted to a concentration of 3x104 trypanosomes /ml, 100µl of this 
suspension was added to each well of the assay plate with the exception of well A1 the 
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2. Materials and methods 
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concentration (MIC) values.  Cytotoxicity of the active compounds and extracts was then 
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2.1 General bioassay 
The anti-trypanosomal and cytotoxicity assays were performed using the REDOX indicator 
Alamar blue™. The active component of which is resazurin (blue in colour) which in the 
presence of live parasites or cells is reduced to the bright pink fluorescent resorufin. The 
fluorescence values for the test plates are measured using a microplate reader in 
fluorescence mode with excitation and emission wavelengths of 560 and 590nm respectively.  
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Wells containing active compounds are easily identified as they remain blue in colour and 
have background levels of fluorescence. The test samples are initially screened at a single 
concentration and then MIC or IC 50 values are determined for the active compounds at n=2 
or n=3. Positive and negative controls and a sterility checks are included in all assays. The 
incubation and treatment times, incubation conditions and seeding densities are optimised 
for each test species and cell line. 
2.1.1 Anti-trypanosomal activity 
Samples were tested against the bloodstream form of Trypanosoma brucei brucei (T.b.brucei) 
S427. The activity of the plant extracts and isolated compounds was determined using 
the well-established Alamar blue™ 96 well microplate assay. Samples were initially 
screened at a single concentration usually 20µg/ml for extracts or 20µM for pure 
compounds. The concentration of dimethylsulphoxide (DMSO) should not exceed 0.5% in 
the initial screen. 
Samples for testing were prepared as 10mg/ml or 10mM stock solutions in 100% DMSO. 
These were diluted with HMI-9 medium to a concentration of 1mg/ml /1mM. 4µl of the test 
sample was added to the assay well then 96µl HMI-9 medium to give a final assay 
concentration after a 1:1 dilution of 20µg/ml / 20µM.  
 1 2 3 4 5 6 7 8 9 10 11 12 
A Sterility control 1 2 3 4 5 6 7 8 9 10 1.0µM 
suramin 
B control 11 12 13 14 15 16 17 18 19 20 0.5µM 
suramin 
C control 21 22 23 24 25 26 27 28 29 30 0.25µM 
suramin  
D control 31 32 33 34 35 36 37 38 39 40 0.125µM 
suramin 
E DMSO control 41 42 43 44 45 46 47 48 49 50 0.062µM 
suramin  
F DMSO control 51 52 53 54 55 56 57 58 59 60 0.031µM 
suramin 
G DMSO control 61 62 63 64 65 66 67 68 69 70 0.015µM 
suramin  
H DMSO control 71 72 73 74 75 76 77 78 79 80 0.008µM 
suramin 
Table 1. Anti-trypanosomiasis assay plate layout. 
The screening plate was arranged as illustrated in Table 1. Controls including a sterility 
control and DMSO controls in column 1; test samples in columns 2 to 11 and a concentration 
range of suramin as a positive control in column12. Trypanosomes were counted using a 
haemocytometer and diluted to a concentration of 3x104 trypanosomes /ml, 100µl of this 
suspension was added to each well of the assay plate with the exception of well A1 the 
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sterility check. The assay plate was incubated at 37ºC, 5% CO2 with a humidified 
atmosphere for 48 hours. After which 20µl of Alamar blue was added and the incubation 
continued for a further 24 hours. Fluorescence was then determined using the Wallac Victor 
microplate reader (Excitation 530nm Emission 590nm). The results were calculated as % of 
the DMSO control values. Minimum inhibitory concentration values (MICs) were 
determined for samples with less than 10% of control values. MIC determinations were 
carried out in duplicate. 200µg/ml test solutions were prepared in column 2 by pipetting 4µl 
of (10mg/ml) test stock solution and 196µl HMI-9 medium into each well. 100µl HMI-9 
medium was pipetted into columns 1 and 3-12 and 1:1 serial dilutions were carried out from 
columns 2 to 11. 80µl of HMI-9 medium was added to column 12 and 20µl of x10 
concentrations of suramin to give a final concentration range of 0.008 to 1.0µM. An 
inoculum of 100µl of trypanosomes at a concentration of 3x104/ml was added to each well 
except A1, and the procedure continued as previously described. 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A control 100 50 25 12.5 6.25 3.1 1.55 0.78 0.34 0.17 1.0µM 
suramin 
B control 100 50 25 12.5 6.25 3.1 1.55 0.78 0.34 0.17 0.5µM 
suramin 
C control 100 50 25 12.5 6.25 3.1 1.55 0.78 0.34 0.17 0.25µM 
suramin  
D control 100 50 25 12.5 6.25 3.1 1.55 0.78 0.34 0.17 0.125µM 
suramin 
E control 100 50 25 12.5 6.25 3.1 1.55 0.78 0.34 0.17 0.062µM 
suramin  
F control 100 50 25 12.5 6.25 3.1 1.55 0.78 0.34 0.17 0.031µM 
suramin 












































Table 2. Final assay concentrations µg/ml 
MIC values were determined as the concentration calculated to have < 5% of control values. 
2.1.2 Cytotoxicity determinations 
Cytotoxicity determinations were carried out using a modification the Alamar blue™ redox-
based microplate assay (O’Brien et al., 2000). The cytotoxic activity of the fractions and 
compounds was initially determined against PNT2A cells a “human” normal prostatic 
epithelial cell line. Initial screening was carried out at a concentration of 100µg/ml. 
Concentration response studies (300 to 0.3µg/ml) were then carried out in duplicate for 
samples with less than 60% of control values in the initial screen.  
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Cells were seeded into 96 well microplates at a density of 0.5 x 104 cells/well in 100µl 
Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen) and incubated at 37ºC, 5% CO2 
with a humidified atmosphere for 24 hours. After which DMEM solutions of test 
compounds at the desired concentrations and DMSO as a negative control and 0.1% Triton 
X as a positive control were added to give a total well volume of 200µl. The microplates 
were incubated for 24 hours before the addition of 10µl of alamar blue. After a further 20 
hours incubation fluorescence was determined using a Wallac Victor microplate reader in 
fluorescence mode (Excitation 530nm; Emission 590nm). The results were calculated as % of 
the DMSO control values. IC50 values were calculated for the concentration response data 
using Graphpad prism software.  
2.2 Isolation and structure elucidation of compounds 
Melting points (uncorr.) were determined on a Buchi B-540 melting point apparatus. The 
1H NMR and 13C NMR spectra were run on a Bruker AV 300 (400MHz) and DRX 500 
spectrometers using CDCl3 or DMSO-d6 as solvents and TMS as internal standard. 
HRESI-MS were run using Thermo LTQ Orbitrap or Thermo Exactive orbitrap mass 
spectrometer. A capillary voltage of 46.00V for the positive mode and -48.00V for the 
negative mode was used for HRESI-MS. Column chromatography were performed using 
silica gel MN-60 (Macherey-Nagel GmbH & Co. KG) and Gel filtration chromatography 
using Sephadex LH-20 (GE Health Lifescience UK) were performed in glass columns. 
Spots on TLC were visualised using Anisaldehyde-H2SO4 reagent or Dragendorff’s 
reagent for the alkaloids. Developed TLC plates were also observed under UV lamp using 
short (λ= 254 nm) and long (λ= 366 nm) wavelengths. The structures of the pure 
compounds were determined using spectroscopic methods (1D/2D NMR and mass 
spectrometry). Column chromatography (CC) were carried out on wet packed silica gel in 
glass columns eluting gradient wise with hexane, hexane-ethyl acetate, ethyl acetate and 
ethyl acetate-methanol mixtures or with Sephadex LH-20 pre-soaked and wet packed in 
methanol. After the introduction of the extracts or fractions in methanol, the Sephadex 
columns were also eluted with methanol. TLC analysis was performed on pre-coated 
silica gel aluminum plates cut to desired size. NMR experiments were run in CDCl3 or 
DMSO-d6 with TMS as internal standard on Bruker AV 300 (400MHz) or DRX-500 
spectrophotometer.  
2.2.1 Plant materials 
All plant materials were collected from Oju LGA Benue State, Nigeria between July and 
September 2008. The plants were authenticated by the Department of Forestry and Wildlife 
of the University where voucher specimens were deposited in the University of Agriculture 
Forest Herbarium. Alcornea cordifolia (bark), Euphorbia poisonii (stem), Monodora myristica 
(seeds), Prosopis Africana (bark), Spondias mombim (root), Nauclea pobeguinii (bark), Nauclea 
latifolia (bark), Cochlospermum planchonii(root) and Withania somnifera (whole plant), 
Terminalia avicennioides (bark). Maytenus laevis (root) was from samples already housed at the 
Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS). They were all sun dried 
in open air and ground using a mill. 
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based microplate assay (O’Brien et al., 2000). The cytotoxic activity of the fractions and 
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2.2.2 Extraction and identification of the components 
The plant materials (500g – 1.0kg) were air dried and extracted using hexane, ethyl acetate 
and methanol in a Soxhlet apparatus. The crude extracts were allowed to stand and 
sometimes cooled to allow for the precipitation of compounds. Where all precipitates have 
been produced or no (further) precipitation, the crude extracts or precipitates (where not a 
pure compound) were subjected to column chromatography (CC) eluting gradient- wise 
using hexane-ethyl acetate and subsequently ethyl acetate-methanol solvent mixtures. Using 
TLC as a guide, similar fractions were combined and allowed to evaporate under the fume 
hood to allow for the crystallisation of pure compounds. Where no pure compounds were 
separated and the fractions were active, such fractions were further purified via preparative 
thin layer chromatography or Gel filtration (GF) using Sephadex LH-20 to obtain the pure 
compounds. Methanol extracts which were usually viscous and complex were subjected to 
an initial vacuum liquid chromatography (VLC) to fractionate the extracts. Similar fractions 
(TLC) were also combined and further purified via column chromatography or Gel 
filtration. Flash chromatography using an iES Reveleris Automated Flash Chromatography 
system was used for the isolation of certain compounds. The column was dry packed after 
taking up the extracts with silica gel and then loaded onto the pre-packed flash column. The 
compounds were eluted starting with hexane with incremental additions of ethyl acetate, 
then with ethyl acetate with additions of methanol and finally with methanol. Using two 
variable length UV detectors and one ELSD detector, similar eluates were combined and 
confirmed by TLC and 1H NMR. Pure compounds were then allowed to settle out from the 
combined fractions. All columns were exhaustively eluted and washed with methanol. 
Washings were allowed to stand to allow for the precipitation of compounds. The 
identification of pure compounds was carried out using one dimensional 1H and 13C NMR 
spectroscopy (including J-mod, DEPT-q and DEPT 135 or 90). Spectral data of known 
compounds were compared with published spectral data and were thereby identified. 
Further 2D experiments (including correlation spectroscopy (COSY), heteronuclear multiple 
quantum coherence (HMQC), heteronuclear multiple bond correlation (HMBC) and nuclear 
overhauser enhancement spectroscopy (NOESY)) were carried out for more complex 
molecules for accurate assignments of proton and carbon chemical shifts. Assigned 
structures were confirmed using ESI-MS and HRESI-MS to confirm their mass and 
molecular formula. The various extracts produced are listed in table 3 below. Extract code 
descriptions or extensions are: precipitate (P), latex (L), Sephadex (S), methanol wash (w), 
VLC fraction (V), flash chromatography fraction (F), root (R), bark (B).  
3. Results 
3.1 Anti-trypanosomal screening 
The photographs below show the results from the concentration response studies to determine 
the MIC of the triterpenoids (compounds 11 and 12) from M.laevis. Well A1 is the sterility 
check, wells B1 to H1 negative controls and wells G2 to G11 and H2 to H11 are the DMSO 1:1 
dilution controls. Column 12 contains a concentration range of 1 to 0.008µM of the positive 
control suramin. In plate 1 compounds 11 (rows C and D) and 12 (rows E and F) are tested n=2 
over a concentration range of 100 to 0.17µM. In plate 2 compounds 11 (rows A, B and C) and 
12 (rows D,E and F) are tested  n=3 over a concentration range of 10 to 0.02µM. 
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hexane + ethyl 
acetate (HE) 
Methanol (M) 
1 Alcornea cordifolia Bark (B) ACBH ACBE ACBHE ACBM 
2 Cochlospermum 
planchonii 
Root (R) CPH CPE CPHE CPM 
3 Euphorbia poisonii Stem EPH EPE EPHE EPM 
4 Maytenus laevis Root (R) MLH MLE MLHE MLM 
5 Monodora 
myristica 
Seed MMH MME MMHE MMM 
6 Nauclea latifolia Bark (B) NLH NLE NLHE NLM 
7 Nauclea pobeguinii Bark (B) NPH NPE NPHE NPM 
8 Prosopis Africana Bark (B) PAH PAE PAHE PAM 
9 Spondias mombim Root (R) SMH SME SMHE SMM 
10 Terminalia 
avicennioides 





WSH WSE WSHE WSM 
Table 3. Extracts produced from the plant materials 
 
 
Plate 1. Photo showing MIC of compounds 11 and 12. 
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Plate 2. Photo showing MIC of compounds 11 and 12. 
The anti-trypanosomal activity and cytotoxicity against PNT2A cell lines observed for the 





Anti-trypanosomal activity Cytotoxicity 








1 ACBE-1 8 13.3  42.8  
2 ACBM-12 3 3.8 <0.2 29.9 1.5 
3 ACBM-14 7 18.0  28.5 24.2 
4 PAM-5 Column fraction 12.5    
5 PAM-6 Column fraction 19.4    
6 WSE-1a Column fraction 12.5 12.5   
7 WSE-1b Column fraction 12.5 12.5   
8 WSE-1c Column fraction 3.12 3.12   
9 MMH-1 Crude extract 8.0 12.5   
10 MME-5 Column fraction -1.2 3.125   
11 MME-10 Column fraction -1.4 3.125   
12 MMS-28  9 & 10 -1.4 6.25   
13 MME-29 Column fraction -1.3 3.125   
14 MME-41 10 6.5 12.5   
15 MME-42 9 6.5 25   
16 EPLE-1 Column fraction 0.8  64.5  
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17 EPLE-5 Column fraction -0.1 6.25 29.6  
18 EPP-1 6 1.3 1.56   
19 EPH-1 Crude extract -0.2    
20 EPHE-w  5 -0.7    
21 TASW-2 14 33.6    
22 TAHE-1 Crude extract 8.7    
23 TAHE-4 Column fraction 5.2 2.5   
24 NPE-5 Column fraction 0.8    
25 NPE-7 Column fraction 4.9 6.25 9.7 >100 
26 NPE-13 Column fraction 4.4 12.5 44.2 >100 
27 NPE-48 1 6.4 12.5 42.8 >100 
28 NPM-10 Column fraction 28.1  43.9 7.7 
29 SMHE-44 2 -0.2 25 87.5  
30 SMM-9 4 31.6  50  
31 MLHEF-14 11 3.8 0.625   
32 MLHEF-18 12 6.1 0.625   
33 WSM-w 13 78.7    
34 WSH-1 Crude extract 50.0 50.0   
35 WSH-2 Column fraction 25.0 25.0   
36 WSH-3 Column fraction 50.0 50.0  
37 MMH-3 Column fraction 6.25 6.25  
38 MMH-0 Crude extract 25.0 25.0  
39 MMH-4 Column fraction 50.0 50.0  
40 ACRHE-20 Column fraction 20 85.0  
41 NPE-57 15 100 87.8  
42 NPE-81 16 100  
43 EPH-1.4 Column fraction 100 81.2  
44 EPH-1.1 Column fraction -0.2 12.5 76.4  
45 EPH-1.6 Column fraction 107.8 79  
46 ACBME-2 Column fraction 91.0 83.2  
47 ACBHE-6 Column fraction 80.3 89.3  
48 SMHE-7 Column fraction 92.3 92.7  
49 SMHE-13 Column fraction 96.3 87.5  
50 ACRM-1 Crude extract 95.8 87.5  
51 MMM-1 Crude extract 108.2  
52 MMEV-12 VLC fraction -0.4  
53 MMEV-17 VLC fraction 0.9  
Table 4. Activity of crude extracts, fractions and compounds 
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12 MMS-28  9 & 10 -1.4 6.25   
13 MME-29 Column fraction -1.3 3.125   
14 MME-41 10 6.5 12.5   
15 MME-42 9 6.5 25   
16 EPLE-1 Column fraction 0.8  64.5  
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17 EPLE-5 Column fraction -0.1 6.25 29.6  
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35 WSH-2 Column fraction 25.0 25.0   
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38 MMH-0 Crude extract 25.0 25.0  
39 MMH-4 Column fraction 50.0 50.0  
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42 NPE-81 16 100  
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44 EPH-1.1 Column fraction -0.2 12.5 76.4  
45 EPH-1.6 Column fraction 107.8 79  
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47 ACBHE-6 Column fraction 80.3 89.3  
48 SMHE-7 Column fraction 92.3 92.7  
49 SMHE-13 Column fraction 96.3 87.5  
50 ACRM-1 Crude extract 95.8 87.5  
51 MMM-1 Crude extract 108.2  
52 MMEV-12 VLC fraction -0.4  
53 MMEV-17 VLC fraction 0.9  
Table 4. Activity of crude extracts, fractions and compounds 
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3.2 Isolated compounds 
The following compounds were isolated from the plants: 
Compound Reference Plant 
1 Hotellier et al. (1980) Nauclea pobeguinii, Nauclea latifolia 
2 Nonaka et al. (1982) Spondia mombin 
3 Lee et al. (1992) Alcornea cordifolia 
4 Nagle et al. (2006) Cocholospermum planchonii, Spondias mombin 
5 Gewali et al. (1990) Euphorbia poisonii
6 Dubery et al. (1999) Euphorbia poisonii 
7 Bankova (1990); Saha et al. (1991) Alcornea cordifolia 
8 Koetter et al. (1989) Alcornea cordifolia 
9 Nkunya et al. (2004) Monodora myristica 
10 Ishii et al (1975) Monodora myristica 
11 Gonzalez et al. (1982) Maytenus laevis 
12 Jeller et al. (2004) Maytenus laevis 
13 Nandy et al. (1989) Withania somnifera 
14 Kim et al. (2001) Terminalia avecinnoides 
15 Cerri et al.(1988) Nauclea pobeguinii, Nauclea latifolia 
16 Cerri et al. (1988) Nauclea pobeguinii, Nauclea latifolia 
Table 5. Isolated compounds and plant sources 
Some of the active compounds were identified (Mass spec and NMR: 1D, 2D including 
COSY, HSQC, HMBC, NOESY) their spectral data were compared with literature reports. 
The structures of the compounds are given in the figure below. 
3.3 NMR data for some isolated compounds 
 
Position 
Compound 9 Compound 10 
1H 13C 1H 13C 
1 8.57 br.s (NH) - 8.36 br.s (NH) - 
2 7.34 dd (J=2.8, 3.2 Hz) 126.0 (CH) 7.27 m 125.4 (CH) 
3 6.74 ddd (J= 0.8, 2.0, 3.2 Hz) 104.5 (CH) 6.62 m 103.5 (CH) 
4 8.20 d (J= 1.2 Hz) 126.2 (CH) 7.85 d (J = 0.8 Hz) 122.7 (CH) 
5 - 129.8 (C) - 126.5 (C) 
6 7.80 dd (J= 1.2, 8.4 Hz) 122.4 (CH) 7.48 dd (J = 8.4, 1.6 Hz) 121.8 (CH) 
7 7.50 d (J= 8.4 Hz) 111.7 (CH) 7.43 d (J = 8.4 Hz) 111.6 (CH) 
8 - 138.8 (C) - 137.9 (C) 
9 - 127.8 (C) - 128.2 (C) 
1` 10.06 s 192.5 (CHO) 2.41 s 27.4 (CH3) 
2` - - - 198.6 (CO) 
3` - - 6.73 d (J = 16.4 Hz) 124.7 (CH) 
4` - - 7.69 d (J = 16 Hz) 145.6 (CH) 
Table 6. The NMR spectra assignments for compounds 9 and 10.  
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The beta carboline alkaloids were isolated from the two Nauclea spp. The cathechins and 
their gallates were obtained from A. cordifolia, S. mombim and C. planchonii. Catechins 
including catechin, epicatechin, gallocatechin and five others have been reported to be active 
against nonproliferative bloodstream trypomastigote and intracellular replicative 
amastigote parasite forms of Trypanosoma cruzi (Paveto et al., 2004). The stem of E. poisonii 
afforded the steroidal triterpene and scoporone. The caffeic acid esters were isolated from 
A.cordifolia and there could be a mixture of more esters. The quinonemethide friedelene 
triterpenes were obtained from hexane and ethyl acetate extracts of M. laevis. They showed 
very good activity with MICs of 0.625µg/ml. Other pure compounds obtained are as listed 
on table 2. Some of the pure compounds were however not active when tested. Compound 
13 is one of such as well as compound 14 which did not show very good activity. The results 
of these screening supports a further investigation of the active compounds identified. These 
could be confirmed as hit molecules especially when the compound’s cytotoxicity is low 
showing selectivity which is vital for drug molecules. Compounds that are inimical to the 
growth and survival of microorganisms but do not affect the cells adversely are potential 
candidates for drug development. Some of the extracts and fractions show significant 
activity but the active compounds have not been identified in this study. Such extracts could 
be subject of further investigation to isolate or identify the active components. These results 
also lend credence to some of the ethnobotanical or traditional use of the plants as they are 
mainly used against fevers caused by malarial parasites. Interestingly, the same or similar 
compounds were isolated from the different plant samples. Some belong to the same 
families but others do not. This thus confirms their activity not being due to the crude 
extracts or fractions but the fact that these extracts or fractions contain the same or similar 
compounds. These results may easily pave way for a structure activity study as variations in 
structure and side chains or substituents on similar moieties vis-à-vis activity can easily be 
observed. For instance it can be observed that glycosidation knocks off activity from the test 
compounds.  
5. Acknowledgements 
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for the use of their iES Reveleris Automated Flash Chromatography system equipment for 
the isolation of compounds 11 and 12. 
6. References 
Antia, RE. Olayemi, JO. Aina, OO. & Ajaiyeoba, EO. (2009). In vitro and in vivo animal model 
antitrypanosomal evaluation of ten medicinal plant extracts from south west 
Nigeria. African Journal of Biotechnology, Vol.8, No.7, pp. 1437-1440 
Bankova, VS. (1990). Synthesis of Natural Esters of Substituted Cinnamic Acids. J. Nat. Prod, 
Vol.53, No.4, pp.821–824  
Bizimana, N. Uwe, Tietjen, U. Zessin, K. Drissa, Diallo, D. Djibril, C. Melzig, MF. & Clausen, 
P. (2006). Evaluation of medicinal plants from Mali for their in vitro and in vivo 
trypanocidal activity. Journal of Ethnopharmacology, Vol103, pp. 350–356 
Anti-Trypanosomal Activity and Cytotoxicity 
of Some Compounds and Extracts from Nigerian Medicinal Plants 
 
387 
Burkill, HM. (2000). Useful Plants of West Tropical Africa. (2nd edn). Vol. 5. Families S – Z. 
Crown Agents for Overseas Governments, London, pp 320-321.  
Cerri R, Aquino R, de Simone F, Pizza C (1988) New Quinovic Acid Glycosides from 
Uncaria tomentosa J. Nat. Prod. 51 (2), pp 257–261 
Collins, LA. Franzblau SG (1997). Microplate Alamar Blue Assay versus BACTEC 460 
System for High Throughput Screening of compounds against Mycobacterium 
tuberculosis and Mycobacterium aurium. Antimicrob. Agents and Chemother. Vol 41: 
pp. 1004-1009. 
Dubery I.A.; Louw A.E.; van Heerden F.R. (1999) Source: Synthesis and evaluation of 4-(3-
methyl-2-butenoxy) isonitrosoacetophenone, a radiation-induced stress metabolite 
in Citrus . Phytochemistry 50(6): 983-989 
Gonzalez JG, Monache GD, Monache FD, Marini-Bettolò GB (1982) Chuchuhuasha — A drug 
used in folk medicine in the Amazonian and Andean areas. A chemical study of 
Maytenus laevis. J. Ethnopharm. 5: 73–77 
Gray AI, Igoli JO, Edrada-Ebel R (2011). Natural Products isolation in Modern Drug 
Discovery Programmes. Humana Press New York. In press 
Hotellier F, Delaveau P, Pousset JL. (1980) Naucleidinal et epinaucleidinal, alcaloides du 
Nauclea latifolia. Phytochemistry 19. (8): 1884 - 1885. 
Igoli JO, Ogaji OG, Tor-Anyiin TA, Igoli NP (2005). Traditional Medicine Practices Amongst 
the Igede people of Nigeria. Part II. Afr. J. Trad. CAM. 2: 134-152. 
Ishii H and Murakami Y (1975) Fischer indolization and its related compounds—X 
Application of the advanced Fischer indolization of a 2-methoxyphenylhydrazone 
derivative to syntheses of some naturally occurring 6-substituted indoles. 
Tetrahedron  31(8): 933-938 
Jeller AH, Silva DHS, Luciano Morais Lião LM, Bolzani VS, Furlan M. (2004) Antioxidant 
phenolic and quinonemethide triterpenes from Cheiloclinium cognatum. 
Phytochemistry Vol 65, Issue 13: pp 1977-1982 
Kim JP, Lee IK, Yun BS, Chung SH, Shim GS, Koshino H ,Yoo ID ( 2001) Ellagic acid 
rhamnosides from the stem bark of Eucalyptus globulus. Phytochemistry 57 (4) 587-
591 
Koetter U, Kaloga M, Schilcher H.(1993) Isolierung und Struktur-aufklärung von p-
Hydroxyzimtsäurealkylester-Verbindungen aus dem Rhizom von Agropyron repens; 
1. Mitteilung. Planta Med; 59:279-280. 
Lee, MW, Morimoto S, Nonaka G, Nishioka, I (1992) Dimeric ellagitannins from Alnus 
japonica Phytochemistry, 31: 2117 
Nagle, D.G; Ferreira, D.; Zhou, Y.-D. (2006). Molecules of Interest: Epigallocatechin-3-gallate 
(EGCG): Chemical and Biomedical Perspectives.  Phytochemistry  67:1849-1855 
Nakagawa H, Takaishi Y, Fujimoto Y, Duque C, Garzon C, Sato M, Okamoto M, Oshikawa 
T, Ahmed SU (2004). Chemical constituents from the Colombian medicinal plant 
Maytenus laevis. J Nat Prod. 67(11):1919-24. 
Nandy AK, Podder, GS, Sahu , NP, Mahato SB (1989). Triterpenoids and their glucosides 
from terminalia Bellerica. Phytochemistry 28 (10): 2769-2112 
Newman D, Fairfield AS, Bhattacharya B, Grifo F, Grupenhoff JT (1997).  The  Origins of 
Prescription drugs. In: Grifo F, Rosenthal F (eds) Biodiversity and Human Health, 
Island Press, Washington, D.C: 131-163. 
 




The beta carboline alkaloids were isolated from the two Nauclea spp. The cathechins and 
their gallates were obtained from A. cordifolia, S. mombim and C. planchonii. Catechins 
including catechin, epicatechin, gallocatechin and five others have been reported to be active 
against nonproliferative bloodstream trypomastigote and intracellular replicative 
amastigote parasite forms of Trypanosoma cruzi (Paveto et al., 2004). The stem of E. poisonii 
afforded the steroidal triterpene and scoporone. The caffeic acid esters were isolated from 
A.cordifolia and there could be a mixture of more esters. The quinonemethide friedelene 
triterpenes were obtained from hexane and ethyl acetate extracts of M. laevis. They showed 
very good activity with MICs of 0.625µg/ml. Other pure compounds obtained are as listed 
on table 2. Some of the pure compounds were however not active when tested. Compound 
13 is one of such as well as compound 14 which did not show very good activity. The results 
of these screening supports a further investigation of the active compounds identified. These 
could be confirmed as hit molecules especially when the compound’s cytotoxicity is low 
showing selectivity which is vital for drug molecules. Compounds that are inimical to the 
growth and survival of microorganisms but do not affect the cells adversely are potential 
candidates for drug development. Some of the extracts and fractions show significant 
activity but the active compounds have not been identified in this study. Such extracts could 
be subject of further investigation to isolate or identify the active components. These results 
also lend credence to some of the ethnobotanical or traditional use of the plants as they are 
mainly used against fevers caused by malarial parasites. Interestingly, the same or similar 
compounds were isolated from the different plant samples. Some belong to the same 
families but others do not. This thus confirms their activity not being due to the crude 
extracts or fractions but the fact that these extracts or fractions contain the same or similar 
compounds. These results may easily pave way for a structure activity study as variations in 
structure and side chains or substituents on similar moieties vis-à-vis activity can easily be 
observed. For instance it can be observed that glycosidation knocks off activity from the test 
compounds.  
5. Acknowledgements 
The authors are grateful to Grace Davison Discovery Sciences www.discoverysciences.com 
for the use of their iES Reveleris Automated Flash Chromatography system equipment for 
the isolation of compounds 11 and 12. 
6. References 
Antia, RE. Olayemi, JO. Aina, OO. & Ajaiyeoba, EO. (2009). In vitro and in vivo animal model 
antitrypanosomal evaluation of ten medicinal plant extracts from south west 
Nigeria. African Journal of Biotechnology, Vol.8, No.7, pp. 1437-1440 
Bankova, VS. (1990). Synthesis of Natural Esters of Substituted Cinnamic Acids. J. Nat. Prod, 
Vol.53, No.4, pp.821–824  
Bizimana, N. Uwe, Tietjen, U. Zessin, K. Drissa, Diallo, D. Djibril, C. Melzig, MF. & Clausen, 
P. (2006). Evaluation of medicinal plants from Mali for their in vitro and in vivo 
trypanocidal activity. Journal of Ethnopharmacology, Vol103, pp. 350–356 
Anti-Trypanosomal Activity and Cytotoxicity 
of Some Compounds and Extracts from Nigerian Medicinal Plants 
 
387 
Burkill, HM. (2000). Useful Plants of West Tropical Africa. (2nd edn). Vol. 5. Families S – Z. 
Crown Agents for Overseas Governments, London, pp 320-321.  
Cerri R, Aquino R, de Simone F, Pizza C (1988) New Quinovic Acid Glycosides from 
Uncaria tomentosa J. Nat. Prod. 51 (2), pp 257–261 
Collins, LA. Franzblau SG (1997). Microplate Alamar Blue Assay versus BACTEC 460 
System for High Throughput Screening of compounds against Mycobacterium 
tuberculosis and Mycobacterium aurium. Antimicrob. Agents and Chemother. Vol 41: 
pp. 1004-1009. 
Dubery I.A.; Louw A.E.; van Heerden F.R. (1999) Source: Synthesis and evaluation of 4-(3-
methyl-2-butenoxy) isonitrosoacetophenone, a radiation-induced stress metabolite 
in Citrus . Phytochemistry 50(6): 983-989 
Gonzalez JG, Monache GD, Monache FD, Marini-Bettolò GB (1982) Chuchuhuasha — A drug 
used in folk medicine in the Amazonian and Andean areas. A chemical study of 
Maytenus laevis. J. Ethnopharm. 5: 73–77 
Gray AI, Igoli JO, Edrada-Ebel R (2011). Natural Products isolation in Modern Drug 
Discovery Programmes. Humana Press New York. In press 
Hotellier F, Delaveau P, Pousset JL. (1980) Naucleidinal et epinaucleidinal, alcaloides du 
Nauclea latifolia. Phytochemistry 19. (8): 1884 - 1885. 
Igoli JO, Ogaji OG, Tor-Anyiin TA, Igoli NP (2005). Traditional Medicine Practices Amongst 
the Igede people of Nigeria. Part II. Afr. J. Trad. CAM. 2: 134-152. 
Ishii H and Murakami Y (1975) Fischer indolization and its related compounds—X 
Application of the advanced Fischer indolization of a 2-methoxyphenylhydrazone 
derivative to syntheses of some naturally occurring 6-substituted indoles. 
Tetrahedron  31(8): 933-938 
Jeller AH, Silva DHS, Luciano Morais Lião LM, Bolzani VS, Furlan M. (2004) Antioxidant 
phenolic and quinonemethide triterpenes from Cheiloclinium cognatum. 
Phytochemistry Vol 65, Issue 13: pp 1977-1982 
Kim JP, Lee IK, Yun BS, Chung SH, Shim GS, Koshino H ,Yoo ID ( 2001) Ellagic acid 
rhamnosides from the stem bark of Eucalyptus globulus. Phytochemistry 57 (4) 587-
591 
Koetter U, Kaloga M, Schilcher H.(1993) Isolierung und Struktur-aufklärung von p-
Hydroxyzimtsäurealkylester-Verbindungen aus dem Rhizom von Agropyron repens; 
1. Mitteilung. Planta Med; 59:279-280. 
Lee, MW, Morimoto S, Nonaka G, Nishioka, I (1992) Dimeric ellagitannins from Alnus 
japonica Phytochemistry, 31: 2117 
Nagle, D.G; Ferreira, D.; Zhou, Y.-D. (2006). Molecules of Interest: Epigallocatechin-3-gallate 
(EGCG): Chemical and Biomedical Perspectives.  Phytochemistry  67:1849-1855 
Nakagawa H, Takaishi Y, Fujimoto Y, Duque C, Garzon C, Sato M, Okamoto M, Oshikawa 
T, Ahmed SU (2004). Chemical constituents from the Colombian medicinal plant 
Maytenus laevis. J Nat Prod. 67(11):1919-24. 
Nandy AK, Podder, GS, Sahu , NP, Mahato SB (1989). Triterpenoids and their glucosides 
from terminalia Bellerica. Phytochemistry 28 (10): 2769-2112 
Newman D, Fairfield AS, Bhattacharya B, Grifo F, Grupenhoff JT (1997).  The  Origins of 
Prescription drugs. In: Grifo F, Rosenthal F (eds) Biodiversity and Human Health, 
Island Press, Washington, D.C: 131-163. 
 
Phytochemicals – Bioactivities and Impact on Health 
 
388 
Newman DJ, Cragg GM (2007). Natural Products as Sources of new Drugs over the Last 25 
years. J. Nat. Prod. 70: 461-477. 
Nkunya, MHH, Makangara, JJ, Jonker, SA. (2004) Prenylindoles from Tanzanian Monodora 
and Isolona Species.  Natural Product Research, 18(3):  253-258 
Nonaka, GI, Miwa N and Nishioka I (1982). Stilbene glycoside gallates and 
proanthocyanidins from polygonum multiflorum. Phytochemistry 21: 429. 
O’Brien J, Wilson I, Orton T, Pognan F (2000). Investigation of the Alamar Blue (resazurin) 
fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 
267: 5421-5426. 
Okpekon, T, Yolon, S, Gleye, C, Roblot, F, Loiseau, P, Bories, C, Grellier, P, Frappier, F, 
Laurens A, Hocquemiller R ( 2004). Antiparasitic activities of medicinal plants used 
in Ivory Coast. J.Ethnopharm. 90: 91-97. 
Paveto C, Güida MC, Esteva MI, Martino V, Coussio J, Flawiá MM, Torres HN (2004). Anti-
Trypanosoma cruzi activity of green tea (Camellia sinensis) catechins. Antimicrob 
Agents Chemother. 48(1):69-74.  
Raz B, Iten M, Grether-Buhler Y, Kaminsky R, Brun R (1997). The Alamar Blue assay to 
determine drug sensitivity of African trypanosomes (T.B. rhodesiense and T.B. 
gambiense) in vitro. Acta. Trop. 68: 139-147.     
Saha,M,M,  Mallik UK, Mallik AK. (1991)  A chromenoflavanone and two caffeic esters from 
pongamia glabra Phytochemistry 30(ll): 3834-3836  
Sara Hoet, S, Opperdoes F, Brun R, Victor Adjakidjé V, Quetin-Leclercq J (2004). In vitro 
antitrypanosomal activity of ethnopharmacologically selected Beninese plants. 
Journal of Ethnopharmacology 91: 37–42 
Yuan-Wah Leong, Leslie Harrison J (1999) (20R, 23E)-Eupha-8,23-diene-3b,25-diol from 
Tripetalum cymosum. Phytochemistry 50. 849-857 
 
Phytochemicals – Bioactivities and Impact on Health 
 
388 
Newman DJ, Cragg GM (2007). Natural Products as Sources of new Drugs over the Last 25 
years. J. Nat. Prod. 70: 461-477. 
Nkunya, MHH, Makangara, JJ, Jonker, SA. (2004) Prenylindoles from Tanzanian Monodora 
and Isolona Species.  Natural Product Research, 18(3):  253-258 
Nonaka, GI, Miwa N and Nishioka I (1982). Stilbene glycoside gallates and 
proanthocyanidins from polygonum multiflorum. Phytochemistry 21: 429. 
O’Brien J, Wilson I, Orton T, Pognan F (2000). Investigation of the Alamar Blue (resazurin) 
fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 
267: 5421-5426. 
Okpekon, T, Yolon, S, Gleye, C, Roblot, F, Loiseau, P, Bories, C, Grellier, P, Frappier, F, 
Laurens A, Hocquemiller R ( 2004). Antiparasitic activities of medicinal plants used 
in Ivory Coast. J.Ethnopharm. 90: 91-97. 
Paveto C, Güida MC, Esteva MI, Martino V, Coussio J, Flawiá MM, Torres HN (2004). Anti-
Trypanosoma cruzi activity of green tea (Camellia sinensis) catechins. Antimicrob 
Agents Chemother. 48(1):69-74.  
Raz B, Iten M, Grether-Buhler Y, Kaminsky R, Brun R (1997). The Alamar Blue assay to 
determine drug sensitivity of African trypanosomes (T.B. rhodesiense and T.B. 
gambiense) in vitro. Acta. Trop. 68: 139-147.     
Saha,M,M,  Mallik UK, Mallik AK. (1991)  A chromenoflavanone and two caffeic esters from 
pongamia glabra Phytochemistry 30(ll): 3834-3836  
Sara Hoet, S, Opperdoes F, Brun R, Victor Adjakidjé V, Quetin-Leclercq J (2004). In vitro 
antitrypanosomal activity of ethnopharmacologically selected Beninese plants. 
Journal of Ethnopharmacology 91: 37–42 
Yuan-Wah Leong, Leslie Harrison J (1999) (20R, 23E)-Eupha-8,23-diene-3b,25-diol from 
Tripetalum cymosum. Phytochemistry 50. 849-857 
Phytochemicals 
Bioactivities and Impact on Health
Edited by Iraj Rasooli
Edited by Iraj Rasooli
Among the thousands of naturally occurring constituents so far identified in plants 
and exhibiting a long history of safe use, there are none that pose - or reasonably 
might be expected to pose - a significant risk to human health at current low levels of 
intake when used as flavoring substances. Due to their natural origin, environmental 
and genetic factors will influence the chemical composition of the plant essential oils. 
Factors such as species and subspecies, geographical location, harvest time, plant part 
used and method of isolation all affect chemical composition of the crude material 
separated from the plant. The screening of plant extracts and natural products for 
antioxidative and antimicrobial activity has revealed the potential of higher plants as a 
source of new agents, to serve the processing of natural products.
Photo by tamjkelly / iStock
ISBN 978-953-307-424-5
Phytochem
icals - Bioactivities and Im
pact on H
ealth
51-519 4
